Citrus Sinensis ID: 002943
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | 2.2.26 [Sep-21-2011] | |||||||
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.975 | 0.910 | 0.563 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.977 | 0.913 | 0.556 | 0.0 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.918 | 0.891 | 0.313 | 1e-92 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.891 | 0.877 | 0.306 | 2e-90 | |
| Q9SNA3 | 889 | Putative receptor-like pr | no | no | 0.900 | 0.874 | 0.316 | 6e-89 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.867 | 0.858 | 0.310 | 4e-88 | |
| C0LGP2 | 878 | Probable LRR receptor-lik | no | no | 0.878 | 0.863 | 0.307 | 5e-88 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.866 | 0.849 | 0.304 | 2e-87 | |
| C0LGD9 | 871 | Probable LRR receptor-lik | no | no | 0.869 | 0.861 | 0.312 | 3e-87 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.857 | 0.843 | 0.302 | 2e-86 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 971 bits (2510), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/946 (56%), Positives = 640/946 (67%), Gaps = 104/946 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRS-TCAQKDFVSIACCADSDFIGKYPPVNWKPDDA 59
MME I R V FV+ C + IRS + A K F SIACCADS++ + + D
Sbjct: 1 MMELQVIRIFRLVVAFVL-CLCIFIRSASSATKGFESIACCADSNYTDPKTTLTYTTDHI 59
Query: 60 WFPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVET 119
WF DK+ CR I +++ V F I GKRCYNL T+K Q YLIRG F
Sbjct: 60 WFSDKRSCRQIPEILFSHRSNKNVRKFEIYEGKRCYNLPTVKDQVYLIRGIFPFDS---- 115
Query: 120 PLISSFNVLVGVTPLSLVNST--EDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPL 177
L SSF V +GVT L + S+ ED +EG+F+A DYIDFCL K+D +P+IS +E+RPL
Sbjct: 116 -LNSSFYVSIGVTELGELRSSRLEDLEIEGVFRATKDYIDFCLLKEDVNPFISQIELRPL 174
Query: 178 NDTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTT-FSTSFTT 236
+ EYL G +VLKL+ R +LG +++++ R+PDD DRIW K + PT+ SF
Sbjct: 175 PE-EYLHGFGTSVLKLISRNNLGDTNDDI--RFPDDQNDRIWKRKETSTPTSALPLSFNV 231
Query: 237 NISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRV 296
+ D VT PLQVLQTALT P RL F+H L++ DY Y++ L+FLELN +V++ GQRV
Sbjct: 232 SNVDLKDSVTPPLQVLQTALTHPERLEFVHDGLETDDYEYSVFLHFLELNGTVRA-GQRV 290
Query: 297 FDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQ 356
FDI +NNE KKEKFD+LA GS + ALN++ANGSLN+TLV +GS FGP+ NAYEILQ
Sbjct: 291 FDIYLNNEIKKEKFDVLAGGSKNSYTALNISANGSLNITLVKA-SGSEFGPLLNAYEILQ 349
Query: 357 VRQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITI 416
R W++ET+Q D+ VI+K+R+EL +N+EN+ LESWSGDPC W+G+ C+ GS I
Sbjct: 350 ARSWIEETNQKDLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTGSSII 409
Query: 417 TGLDLSSGQIQ-----------------------------------------------GI 429
T LDLSS ++ G
Sbjct: 410 TKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYNDLSGW 469
Query: 430 LPLSVTGLTHLEKFR------------------------GFCGSEKSTHKGI-LIGIAVC 464
LP S+ L HL+ G C ++K + +IG
Sbjct: 470 LPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLINTDYGRCKAKKPKFGQVFVIGAITS 529
Query: 465 GTFLFTVAVGIFVVCFYKRKSIAGGKLEG--KGYPMTKNLVFSIDSMDDP-VKPMPVQIF 521
G+ L T+AVGI C Y+ KSI LEG K YPM N++FS+ S DD +K + V+ F
Sbjct: 530 GSLLITLAVGILFFCRYRHKSIT---LEGFGKTYPMATNIIFSLPSKDDFFIKSVSVKPF 586
Query: 522 SLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSA 581
+L+Y+E AT+QYKTLIGEGGFGSVYRGTL DGQEVAVKVRSSTSTQGTREF+NELN LSA
Sbjct: 587 TLEYIEQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLSA 646
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
I+HENLVPLLGYC E DQQILVYPFMSNGSL DRLYGEAS RK LDWPTRLSIALGAARG
Sbjct: 647 IQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPTRLSIALGAARG 706
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLHTF GRSVIHRDVKSSNILLD SMCAKVADFGFSKYAPQEGDS SLEVRGTAGYL
Sbjct: 707 LAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYL 766
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761
DPEYY TQ LS KSDVFSFGVVLLEI+SGREPLN +RPR EWSLVEWAKP+IR S++DEI
Sbjct: 767 DPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVDEI 826
Query: 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSID 821
VDP IKGGYHAEA+WR+VEVAL C+EP+S YRP MVDIVRELEDA IIENNASEYMKSID
Sbjct: 827 VDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSID 886
Query: 822 SIGGYSIGGSARYS----RRIVIPPTPTATESSLVNSQTIVPPEPR 863
S+GGS RYS +R + P+ T+T S + +QT+ P+PR
Sbjct: 887 -----SLGGSNRYSIVMDKRAL--PSTTSTAESTITTQTLSHPQPR 925
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 956 bits (2470), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/943 (55%), Positives = 632/943 (67%), Gaps = 99/943 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRS-TCAQKDFVSIACCADSDFIGKYPPVNWKPDDA 59
MME I+R V ++C + IRS + A + F SIACCADS++ +N+ D
Sbjct: 1 MMELRVICIIRLV-VACVLCLCIFIRSASSATEGFESIACCADSNYTDPKTNLNYTTDYR 59
Query: 60 WFPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVET 119
W+ DK +CR I ++++ F ID GKRCYNL TIK Q YLIRGTF D+V T
Sbjct: 60 WYSDKSNCRQIPEILLSHRSNINFRLFDIDEGKRCYNLPTIKDQVYLIRGTF-PFDSVNT 118
Query: 120 PLISSFNVLVGVTPLSLVNST--EDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPL 177
SF V +G T L V S+ ED +EG+F+A D IDFCL K+D +P+IS LE+RPL
Sbjct: 119 ----SFYVSIGATELGEVTSSRLEDLEIEGVFRAPKDNIDFCLLKEDVNPFISQLELRPL 174
Query: 178 NDTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTN 237
+ EYL S NVLKL+ R +L ++++ R+P D DRIW +P SF +
Sbjct: 175 PE-EYLHDFSTNVLKLISRNNLCGIEDDI--RFPVDQNDRIWKATSTPS-YALPLSFNVS 230
Query: 238 ISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVF 297
+ N KVT PLQVLQTALT P RL F+H L++ DY Y+++LYFLELND++K+ GQRVF
Sbjct: 231 NVELNGKVTPPLQVLQTALTHPERLEFVHVGLETDDYEYSVLLYFLELNDTLKA-GQRVF 289
Query: 298 DILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQV 357
DI +N+E KKE FD+L GS Y+ LN++ANGSLN+TLV +GS FGP+ NAYEILQ
Sbjct: 290 DIYLNSEIKKEGFDVLEGGSKYSYTVLNISANGSLNITLVKA-SGSKFGPLLNAYEILQA 348
Query: 358 RQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITIT 417
R W+ ETDQ D+ VI+K+R EL N++N+ LESWSGDPC W+GV C+ NGS IT
Sbjct: 349 RPWIDETDQTDLEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVIT 408
Query: 418 GLDLSSGQIQ-----------------------------------------------GIL 430
LDLSS ++ G L
Sbjct: 409 KLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQL 468
Query: 431 PLSVTGLTHLEKFR------------------------GFCGSEKSTHKGI-LIGIAVCG 465
P S+ L HL G C ++K + +IG G
Sbjct: 469 PESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLINTDYGRCNAKKPKFGQVFMIGAITSG 528
Query: 466 TFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDP-VKPMPVQIFSLQ 524
+ L T+AV I C Y+ KSI GK YPM N++FS+ S DD +K + V+ F+L+
Sbjct: 529 SILITLAVVILFFCRYRHKSITLEGFGGKTYPMATNIIFSLPSKDDFFIKSVSVKPFTLE 588
Query: 525 YLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
Y+E AT++YKTLIGEGGFGSVYRGTL DGQEVAVKVRS+TSTQGTREF+NELN LSAI+H
Sbjct: 589 YIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFDNELNLLSAIQH 648
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
ENLVPLLGYC E DQQILVYPFMSNGSL DRLYGE + RK LDWPTRLSIALGAARGL Y
Sbjct: 649 ENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLSIALGAARGLAY 708
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LHTF GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS SLEVRGTAGYLDPE
Sbjct: 709 LHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPE 768
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
YY TQ LS KSDVFSFGVVLLEI+SGREPLN +RPR EWSLVEWAKP+IR S++DEIVDP
Sbjct: 769 YYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYIRASKVDEIVDP 828
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIG 824
IKGGYHAEA+WR+VEVAL C+EP+S YRP MVDIVRELEDA IIENNASEYMKSID
Sbjct: 829 GIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSID--- 885
Query: 825 GYSIGGSARYS----RRIVIPPTPTATESSLVNSQTIVPPEPR 863
S+GGS RYS +R + P+ T+T S + +Q + P+PR
Sbjct: 886 --SLGGSNRYSIVMDKRAL--PSTTSTAESTITTQNVSHPQPR 924
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 283/904 (31%), Positives = 433/904 (47%), Gaps = 111/904 (12%)
Query: 16 FVIICFIVLIRSTCAQKD--FVSIACC---ADSDFIGKYPPVNWKPDDAWFPDKKDCRAI 70
+II F VL RS AQ F+S+ C ++ + K + +K D D D +
Sbjct: 10 LLIIAFTVL-RSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSD----VDYIDSGLV 64
Query: 71 TR--PAVNNKFYDRVLDF-GIDSGKR-CYNLSTIKGQDYLIRGTFLNGDNVETPLISSFN 126
+ A +F +V G+R CYN++ YLIRGTF+ G+ SF+
Sbjct: 65 GKINDAYKTQFQQQVWAVRSFPVGQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFD 124
Query: 127 VLVGVTPLS---LVNSTEDSVVEGIFKAANDYIDFCLDKKD-GDPYISGLEVRPLNDTEY 182
+ +G S ++ T S+ E I D ++ CL K P+IS LEVRPLN+ Y
Sbjct: 125 LHIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESY 184
Query: 183 LPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNN 242
L QS +++ L R S + RY +D DR+W E ST + S++
Sbjct: 185 LT-QSGSLM-LFARVYFPSSSSSF-IRYDEDIHDRVWNSFTDDETVWISTDLPIDTSNS- 240
Query: 243 AKVTVPLQVLQTALTDPN--RLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDIL 300
+P V++TA N L LD + ++F E+ + + ++ R F+I
Sbjct: 241 --YDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQN-LTANETREFNIT 297
Query: 301 INNERKKEKF---DILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQV 357
N + + L++ + + A++ ++NG N T N S P+ NA EI V
Sbjct: 298 YNGGLRWFSYLRPPNLSISTIFNPRAVS-SSNGIFNFTFAMTGN-STLPPLLNALEIYTV 355
Query: 358 RQWVQ-ETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPST--WRGVYCNTRN--- 411
+Q ET++ +V+ + +++ Y K+ SW GDPC P W G+ C+ +
Sbjct: 356 VDILQLETNKDEVSAMMNIKE---TYGLSKKI--SWQGDPCAPQLYRWEGLNCSYPDSEG 410
Query: 412 --------------GSIT--------ITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGS 449
GSIT +T LDLS+ + G +P + L K G+
Sbjct: 411 SRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSL-KLINLSGN 469
Query: 450 ---------------------------------EKSTHKGILIGIA--VCGTFLFTVAVG 474
+K + K ++ IA V G F V +
Sbjct: 470 PNLNLTAIPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILA 529
Query: 475 IFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYK 534
IF V KRK++ K G +T +V S +P + + + T ++
Sbjct: 530 IFFVI--KRKNVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERKITYPEVLKMTNNFE 587
Query: 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
++G+GGFG+VY G L DG EVAVK+ S +S QG +EF+ E+ L + H +LV L+GYC
Sbjct: 588 RVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYC 646
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ D L+Y +M+NG L++ + G+ L W R+ IA+ AA+GL YLH ++
Sbjct: 647 DDGDNLALIYEYMANGDLRENMSGKRGG-NVLTWENRMQIAVEAAQGLEYLHNGCRPPMV 705
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
HRDVK++NILL+ AK+ADFG S+ P +G+ S V GT GYLDPEYY T LS K
Sbjct: 706 HRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEK 765
Query: 715 SDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEA 774
SDV+SFGVVLLEI++ + ++ R R + +W + + I IVDP + G Y
Sbjct: 766 SDVYSFGVVLLEIVTNQPVIDKTRERPH--INDWVGFMLTKGDIKSIVDPKLMGDYDTNG 823
Query: 775 MWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN---NASEYMKSIDSIGGYSIGGS 831
W++VE+ALAC+ P S RP+M +V EL D +EN SE M S+ S+ YS+ +
Sbjct: 824 AWKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGSEEMYSMGSV-DYSLSST 882
Query: 832 ARYS 835
+ ++
Sbjct: 883 SDFA 886
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 268/874 (30%), Positives = 411/874 (47%), Gaps = 105/874 (12%)
Query: 12 RVDCFVIICFIVL-IRSTCAQKDFVSIACC---ADSDFIGKYPPVNWKPD----DAWFPD 63
R F+I F VL + Q F+S+ C + ++ K + ++ D D+ P
Sbjct: 2 RFLSFLIFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYIDSGVPG 61
Query: 64 KKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETPLIS 123
K + R + + L + + CYN S + YLIRGTF+ G+ +
Sbjct: 62 K--INEVYRTQFQQQIW--ALRSFPEGQRNCYNFSLTAKRKYLIRGTFIYGNYDGLNQLP 117
Query: 124 SFNVLVGV---TPLSLVNSTEDSVVEGIFKAANDYIDFCLDKK-DGDPYISGLEVRPLND 179
SF++ +G T +S+ SV E I D++ CL K + P+IS LE+RPLN+
Sbjct: 118 SFDLYIGPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNN 177
Query: 180 TEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNIS 239
Y+ + L +V R L S RY +D DRIWIP L + + ST + + S
Sbjct: 178 NTYVTKSGS--LIVVAR--LYFSPTPPFLRYDEDVHDRIWIPFLDNKNSLLSTELSVDTS 233
Query: 240 DNNAKVTVPLQVLQTAL-----TDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQ 294
+ VP V +TA T P ++ + D+ S Y Y ++F E+ ++++++
Sbjct: 234 N---FYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIY---MHFAEI-ENLEANET 286
Query: 295 RVFDILINNER------KKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPI 348
R F+I N + KF I + + A +L+ G+ N T ++ S P+
Sbjct: 287 REFNITYNGGENWFSYFRPPKFRITTVYNPAAVSSLD----GNFNFTF-SMTGNSTHPPL 341
Query: 349 CNAYEILQVRQWVQ-ETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPST--WRGV 405
N EI QV + Q +T Q +V+ + ++ Y + SW GDPC P W G+
Sbjct: 342 INGLEIYQVLELPQLDTYQDEVSAMMNIK---TIYGLSKR--SSWQGDPCAPELYRWEGL 396
Query: 406 YCNTRN-----------------GSIT--------ITGLDLSSGQIQGILPLSVTGLTHL 440
C+ N G+IT + LDLS+ + G +P + + +L
Sbjct: 397 NCSYPNFAPPQIISLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNL 456
Query: 441 ------------------------EKFRGFCGSEKSTHKGILIGIAVCGTFLFTVAVGIF 476
K E + ++ IA +F V V +
Sbjct: 457 TLINLSGNKNLNRSVPETLQKRIDNKSLTLIRDETGKNSTNVVAIAASVASVFAVLVILA 516
Query: 477 VVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL 536
+V RK + G T V S + F+ + T+ ++ +
Sbjct: 517 IVFVVIRKKQRTNEASGP-RSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERV 575
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+GGFG+VY G L D Q VAVK+ S +S QG +EF+ E+ L + H +LV L+GYC +
Sbjct: 576 LGKGGFGTVYHGNLDDTQ-VAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDD 634
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
D L+Y +M G L++ + G+ S L W TR+ IA+ AA+GL YLH ++HR
Sbjct: 635 GDNLALIYEYMEKGDLRENMSGKHSV-NVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHR 693
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSD 716
DVK +NILL+ AK+ADFG S+ P +G+S V GT GYLDPEYY T LS KSD
Sbjct: 694 DVKPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSD 753
Query: 717 VFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMW 776
V+SFGVVLLEI++ + +N R R + EW + I IVDP + Y +W
Sbjct: 754 VYSFGVVLLEIVTNQPVMNKNRERPH--INEWVMFMLTNGDIKSIVDPKLNEDYDTNGVW 811
Query: 777 RMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810
++VE+ALAC+ P S+ RP+M +V EL + +E
Sbjct: 812 KVVELALACVNPSSSRRPTMPHVVMELNECLALE 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SNA3|Y3463_ARATH Putative receptor-like protein kinase At3g46340 OS=Arabidopsis thaliana GN=At3g46340 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 276/871 (31%), Positives = 417/871 (47%), Gaps = 94/871 (10%)
Query: 16 FVIICFIV--LIRSTCAQKDFVSIACCAD----SDFIGKYPPVNWKPDDAWFPDKKDCRA 69
+I F + L+++ Q+ F+S+ C S +I + + + D ++ K +
Sbjct: 12 LIIATFAISNLVQAEEDQEGFISLDCGLPPNEVSPYIEPFTGLRFSSDSSFIQSGKIGKV 71
Query: 70 -ITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETPLISSFNVL 128
+ A K Y L + D + CYNL +G+ Y+IR T L G+ + F++
Sbjct: 72 DKSFEATTLKSY-MTLRYFPDGKRNCYNLIVKQGKTYMIRATALYGNYDGLNISPKFDLY 130
Query: 129 VGVTPLSLVNSTE--DSVVEGI-FKAANDYIDFCLDKKD-GDPYISGLEVRPLNDTEYLP 184
+G + +++ E VVE + + ++ +D CL K D P++S LE+RPL++ YL
Sbjct: 131 IGANFWTTLDAGEYLSGVVEEVNYIPRSNSLDVCLVKTDTSTPFLSLLELRPLDNDSYLT 190
Query: 185 GQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAK 244
G + LK RY L S++ ++ YP+D DRIW P E + +TT +N+
Sbjct: 191 GSGS--LKTFRRYYLSNSESVIA--YPEDVKDRIWEPTFDSE---WKQIWTTLKPNNSNG 243
Query: 245 VTVPLQVLQTALTDPN-RLMFLHTD-LDSGDYNYTLILYFLELNDSVKSSGQRVFDILIN 302
VP VL TA N F T+ LDS + L+F E+ S++++ R FDIL +
Sbjct: 244 YLVPKNVLMTAAIPANDSAPFRFTEELDSPTDELYVYLHFSEVQ-SLQANESREFDILWS 302
Query: 303 NERKKEKFDILALGSNYAKLALNVTA-NGSLNLTLVNVLNGSVFGPICNAYEILQVRQWV 361
E E F L + VT G NL L N S P+ NA E V +
Sbjct: 303 GEVAYEAFIPEYLNITTIQTNTPVTCPGGKCNLELKRTKN-STHPPLINAIEFYTVVNFP 361
Query: 362 Q-ETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPST--WRGVYCNTRNG------ 412
Q ET++ DV I+ ++K + N++ +W GDPC P W G+ CN+++
Sbjct: 362 QLETNETDVVAIK----DIKATYELNRI--TWQGDPCVPQKFIWEGLDCNSKDALTLPRI 415
Query: 413 ------SITITG--------------LDLSSGQIQGILPLSVTGLTHL------------ 440
S +TG LDLS+ + G +P + + L
Sbjct: 416 TSLNLSSTGLTGNIAAGIQNLTHLDKLDLSNNNLTGGVPEFLASMKSLSFINLSKNNLNG 475
Query: 441 -------------------EKFRGFCGSEKSTHKGILIGIAVCGTFLFTVAVGIFVVCFY 481
E+ R F GS T K + I + V + + V+ F
Sbjct: 476 SIPQALLKREKDGLKLSVDEQIRCFPGSCVITKKKFPVMIVALVSSAVVVILVVLVLIFV 535
Query: 482 KRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGG 541
+K + T + S+ D + FS + T+ + +GEGG
Sbjct: 536 FKKKKPSNLEDLPPSSNTPRENITSTSISDTSIETKRKRFSYSEVMEMTKNLQRPLGEGG 595
Query: 542 FGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600
FG VY G + Q+VAVK+ S +STQG +EF+ E+ L + H NLV L+GYC E D
Sbjct: 596 FGVVYHGDINGSSQQVAVKLLSQSSTQGYKEFKAEVELLLRVHHINLVSLVGYCDERDHL 655
Query: 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKS 660
L+Y +MSN L+ L G+ L W TRL IA+ AA GL YLH S++HRDVKS
Sbjct: 656 ALIYEYMSNKDLKHHLSGKHGG-SVLKWNTRLQIAVDAALGLEYLHIGCRPSMVHRDVKS 714
Query: 661 SNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSF 720
+NILLD AK+ADFG S+ +S S V GT GYLDPEYY T L+ SDV+SF
Sbjct: 715 TNILLDDQFTAKMADFGLSRSFQLGDESQVSTVVAGTPGYLDPEYYRTGRLAEMSDVYSF 774
Query: 721 GVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVE 780
G+VLLEII+ + ++ R ++ + EW + I I+DP+++G Y++ ++WR +E
Sbjct: 775 GIVLLEIITNQRVIDPAREKSH--ITEWTAFMLNRGDITRIMDPNLQGDYNSRSVWRALE 832
Query: 781 VALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
+A+ C P S RPSM +V EL++ EN
Sbjct: 833 LAMMCANPSSEKRPSMSQVVIELKECIRSEN 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 273/880 (31%), Positives = 412/880 (46%), Gaps = 131/880 (14%)
Query: 16 FVIICFIVLIRSTCAQKD--FVSIACC---ADSDFIGKYPPVNWKPDDAWFPDKKDCRAI 70
F+I +++L S AQ F+S+ C ++ + K + +K D + D +
Sbjct: 10 FLITAYVIL-ESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYI----DSGLV 64
Query: 71 TRPAVNNKFYDRVLDFGIDS---GKR-CYNLSTIKGQDYLIRGTFLNGDNVETPLISSFN 126
R + K + + + S G+R CYN + YLIR TF G+ + F+
Sbjct: 65 GRISAEYKAQLQQQTWTVRSFPEGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFD 124
Query: 127 VLVGV---TPLSLVNSTEDSVVEGIFKAANDYIDFCLDKK-DGDPYISGLEVRPLNDTEY 182
+ +G T + L +V+E I D + CL K G P+IS LE+RPLN+ Y
Sbjct: 125 IHIGPSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTY 184
Query: 183 LPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNN 242
L QS + L+G + S RY +D DR+W+ + + ST + D +
Sbjct: 185 LT-QSGS---LIGFARVFFSATPTFIRYDEDIHDRVWVRQFGNGLKSISTDL---LVDTS 237
Query: 243 AKVTVPLQVLQTALTDPNRLMFLHTD--LDSGDYNYTLILYFLELNDSVKSSGQRVFDIL 300
VP V +TA N L D LD+ + ++F E+ ++K + R F+I
Sbjct: 238 NPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQ-TLKDNDIREFNIT 296
Query: 301 INNER------KKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEI 354
N + + EKF+I L + L+ + +GS +L+ N S P+ N EI
Sbjct: 297 YNGGQNVYSYLRPEKFEISTL---FDSKPLS-SPDGSFSLSFTKTGN-STLPPLINGLEI 351
Query: 355 LQVRQWVQ-ETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPST--WRGVYC---- 407
+V ++ ETDQ +V+ + ++ Y+ KV SW GDPC P + W G+ C
Sbjct: 352 YKVLDLLELETDQDEVSAMINIK---ATYDLSKKV--SWQGDPCAPKSYQWEGLNCSYPN 406
Query: 408 -------------NTRNGSIT--------ITGLDLSSGQIQGILP--LSVTGLTHLEKFR 444
N G+IT + LDLS + G +P + L L
Sbjct: 407 SDQPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLS 466
Query: 445 GFCG--------------------------SEKSTHKG-------ILIGIAVCGTFLFTV 471
G G ++ T KG I I +V G F V
Sbjct: 467 GNLGLNSTIPDSIQQRLDSKSLILILSKTVTKTVTLKGKSKKVPMIPIVASVAGVFALLV 526
Query: 472 AVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQ 531
+ IF V +RK+ K +P + + + T
Sbjct: 527 ILAIFFVV--RRKNGESNK------------------GTNPSIITKERRITYPEVLKMTN 566
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
++ ++G+GGFG+VY G L D Q VAVK+ S +S QG +EF+ E+ L + H NLV L+
Sbjct: 567 NFERVLGKGGFGTVYHGNLEDTQ-VAVKMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLV 625
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
GYC + D L+Y +M+NG L++ + G+ L W R+ IA+ AA+GL YLH
Sbjct: 626 GYCDDGDNLALIYEYMANGDLKENMSGKRGG-NVLTWENRMQIAVEAAQGLEYLHNGCTP 684
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
++HRDVK++NILL+ AK+ADFG S+ P +G+S S V GT GYLDPEYY T L
Sbjct: 685 PMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYRTNWL 744
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771
S KSDV+SFGVVLLEI++ +P+ T + R + EW + + I I+DP + G Y
Sbjct: 745 SEKSDVYSFGVVLLEIVT-NQPV-TDKTRERTHINEWVGSMLTKGDIKSILDPKLMGDYD 802
Query: 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
W++VE+ALAC+ P S RP+M +V EL + +EN
Sbjct: 803 TNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP2|MEE39_ARATH Probable LRR receptor-like serine/threonine-protein kinase MEE39 OS=Arabidopsis thaliana GN=MEE39 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 258/840 (30%), Positives = 391/840 (46%), Gaps = 82/840 (9%)
Query: 31 QKDFVSIAC---CADSDFIGKYPPVNWKPDDAWFPDKKDCRAITRPAVNNKFYDRVLDFG 87
Q+ F+S+ C + +I + + D+ + K R N L +
Sbjct: 28 QEGFISLDCGLPLNEPPYIESETGIQFSSDENFIQSGKTGRIPKNLESENLKQYATLRYF 87
Query: 88 IDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETPLISSFNVLVGV---TPLSLVNSTEDSV 144
D + CY+L +G++YLIR TF G+ + F++ +G T + L + +V
Sbjct: 88 PDGIRNCYDLRVEEGRNYLIRATFFYGNFDGLNVSPEFDMHIGPNKWTTIDLQIVPDGTV 147
Query: 145 VEGIFKAANDYIDFCLDKKDGD-PYISGLEVRPLNDTEYLPGQSANVLKLVGRYDLGRSD 203
E I ++ + CL K P IS LE+RPL + Y+ + LK R L S+
Sbjct: 148 KEIIHIPRSNSLQICLVKTGATIPMISALELRPLANDTYIAKSGS--LKYYFRMYL--SN 203
Query: 204 NELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTALTDPN--R 261
+ RYP D +DR W+P + PE ST T+N+S+ N P L+ A T N
Sbjct: 204 ATVLLRYPKDVYDRSWVPYIQPEWNQIST--TSNVSNKN-HYDPPQVALKMAATPTNLDA 260
Query: 262 LMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGSNYAK 321
+ + L++ D L ++F E+ +K++ R FDI++N E + + Y +
Sbjct: 261 ALTMVWRLENPDDQIYLYMHFSEI-QVLKANDTREFDIILNGE----TINTRGVTPKYLE 315
Query: 322 LALNVTAN-----GSLNLTLVNVLNGSVFGPICNAYEILQVRQWVQ-ETDQADVNVIRKV 375
+ +T N G + + S P+ NA+E+ V Q Q +T++ +V I+ +
Sbjct: 316 IMTWLTTNPRQCNGGICRMQLTKTQKSTLPPLLNAFEVYSVLQLPQSQTNEIEVVAIKNI 375
Query: 376 RDE--LKKYNKENKVLESWSGDPCRPST--WRGVYCNTRNGSI----------------- 414
R L + SW GDPC P W G+ CN + S
Sbjct: 376 RTTYGLSRI--------SWQGDPCVPKQFLWDGLNCNITDISAPPRIISLNLSSSGLSGT 427
Query: 415 ---------TITGLDLSSGQIQGILPLSVTGLTHL-------EKFRGFCGSEKSTHKGIL 458
+ LDLS+ + GI+P + + L K G +
Sbjct: 428 IVSNFQNLAHLESLDLSNNSLSGIVPEFLATMKSLLVINLSGNKLSGAIPQALRDREREG 487
Query: 459 IGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDS-MDDPVKPMP 517
+ + V G ++ K + + L+F M KP P
Sbjct: 488 LKLNVLGNKELCLSSTCIDKPKKKVAVKVVAPVASIAAIVVVILLFVFKKKMSSRNKPEP 547
Query: 518 -----VQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF 572
+ F+ + T+ + +GEGGFG VY G L ++VAVK+ S TS QG +EF
Sbjct: 548 WIKTKKKRFTYSEVMEMTKNLQRPLGEGGFGVVYHGDLNGSEQVAVKLLSQTSAQGYKEF 607
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
+ E+ L + H NLV L+GYC E D L+Y +MSNG L L G+ L+W TRL
Sbjct: 608 KAEVELLLRVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGG-SVLNWGTRL 666
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-SGFS 691
IA+ AA GL YLHT +++HRDVKS+NILLD AK+ADFG S+ GD S S
Sbjct: 667 QIAIEAALGLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGGDQSQVS 726
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP 751
V GT GYLDPEYY T LS KSDV+SFG++LLEII+ + ++ + R ++ EW
Sbjct: 727 TVVAGTLGYLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVID--QTRENPNIAEWVTF 784
Query: 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
I++ +IVDP + G Y ++WR +EVA++C P S RP+M ++ L++ EN
Sbjct: 785 VIKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECLASEN 844
|
Receptor-like serine/threonine-kinase required during the endosperm development in seeds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 268/880 (30%), Positives = 413/880 (46%), Gaps = 132/880 (15%)
Query: 15 CFVIICFIVLIRSTCAQKDFVSIACC--ADSDFIGKYPPVNWKPDDAWFPDKKDCRAIT- 71
CF + F++L+R+ Q FVSI C DS + + + + DA F + +I
Sbjct: 14 CFFAV-FVLLVRAQ-DQSGFVSIDCGIPEDSSYNDETTDIKYV-SDAAFVESGTIHSIDP 70
Query: 72 --RPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQ--DYLIRGTFLNGDNVETPLISSFNV 127
+ + K + V F + + CY++ +G+ YLIR F+ G+ F++
Sbjct: 71 EFQTSSLEKQFQNVRSFP-EGNRNCYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDL 129
Query: 128 LVGVT---PLSLVNSTEDSVVEGIFKAANDYIDFCL-DKKDGDPYISGLEVRPLNDTEY- 182
+G +++ N+T E I +D++ CL DK G P++S LE+R L Y
Sbjct: 130 YLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKSNTYE 189
Query: 183 LPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNN 242
P S L L R+DLG L RY DD FDRIWIP P+ T F+ S T I NN
Sbjct: 190 TPYDS---LILFKRWDLG-GLGALPVRYKDDVFDRIWIPLRFPKYTIFNASLT--IDSNN 243
Query: 243 AKVTVPLQVLQTALTDPNRL---MFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDI 299
+ P + + T P L + + + Y + ++F E+ + + S+ R F +
Sbjct: 244 NEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVE-LPSNETREFKV 302
Query: 300 LINNERKKEKFDILALGSNY----AKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEIL 355
L+N +++ ++ + Y N + L L S PI NA E
Sbjct: 303 LLN----EKEINMSSFSPRYLYTDTLFVQNPVSGPKLEFRLQQTPR-STLPPIINAIETY 357
Query: 356 QVRQWVQE-TDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPST--WRGVYCN-TRN 411
+V +++Q TDQ DV+ I +++ KY V +SW GDPC P W+ + C+ N
Sbjct: 358 RVNEFLQSPTDQQDVDAIMRIK---SKYG----VKKSWLGDPCAPVKYPWKDINCSYVDN 410
Query: 412 GSITITGLDLSSGQIQGILPLSVTGLTHLE-----------KFRGFCGS----------- 449
S I ++LSS + G + + + LT L K F G+
Sbjct: 411 ESPRIISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEG 470
Query: 450 ------------EKSTHKGILIGI------------------------------AVCGTF 467
E+S K IL+ I +V G
Sbjct: 471 NKLSGAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVL 530
Query: 468 LFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLE 527
+A+ +F++ YK++ GG + P+ D K + + +
Sbjct: 531 GLVLAIALFLL--YKKRHRRGGSGGVRAGPL------------DTTK----RYYKYSEVV 572
Query: 528 AATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
T ++ ++G+GGFG VY G L D Q VAVK+ S +S QG +EF E+ L + H+NL
Sbjct: 573 KVTNNFERVLGQGGFGKVYHGVLNDDQ-VAVKILSESSAQGYKEFRAEVELLLRVHHKNL 631
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
L+GYC E + L+Y FM+NG+L D L GE S L W RL I+L AA+GL YLH
Sbjct: 632 TALIGYCHEGKKMALIYEFMANGTLGDYLSGEKSY--VLSWEERLQISLDAAQGLEYLHN 689
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
++ RDVK +NIL++ + AK+ADFG S+ +G++ + V GT GYLDPEY+
Sbjct: 690 GCKPPIVQRDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHL 749
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSI 766
TQ LS KSD++SFGVVLLE++SG+ + R E + + + I IVDP +
Sbjct: 750 TQKLSEKSDIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKL 809
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806
+ A + W++ EVA+AC S RP+M +V EL+++
Sbjct: 810 GERFDAGSAWKITEVAMACASSSSKNRPTMSHVVAELKES 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 266/851 (31%), Positives = 401/851 (47%), Gaps = 101/851 (11%)
Query: 31 QKDFVSIACCADSD---FIGKYPPVNWKPDDAWFPDKKDCRAITRPAVNNKFYDRVLDFG 87
Q+ F+S+ C +D + + + D + K + P + VL +
Sbjct: 27 QQGFISLDCGLQADESPYTEPLTKLTFTSDADFIKSGKSGKIQNVPGMEYIKPYTVLRYF 86
Query: 88 IDSGKRCYNLSTIKGQDYLIRGTFLNG--DNVETPLISSFNVLVGV---TPLSLVNSTED 142
D + CY L I+G +YLI F G DN+ T F++ +G T + L +
Sbjct: 87 PDGVRNCYTLIVIQGTNYLIVAMFTYGNYDNLNTH--PKFDLYLGPNIWTTVDLQRNVNG 144
Query: 143 SVVEGIFKAANDYIDFCLDKK-DGDPYISGLEVRPLNDTEYLPGQSANVLKLVGRYDLGR 201
+ E I + + CL K P IS LE+RPL + Y+P + LK + R L
Sbjct: 145 TRAEIIHIPRSTSLQICLVKTGTTTPLISALELRPLRNNTYIPQSGS--LKTLFRVHL-- 200
Query: 202 SDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTALTDPN- 260
+D++ + RYP+D DR+W P PE TS T N SD+N +P V+ TA T N
Sbjct: 201 TDSKETVRYPEDVHDRLWSPFFMPEWRLLRTSLTVNTSDDNG-YDIPEDVVVTAATPANV 259
Query: 261 -RLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKF--DILALGS 317
+ + +L++ D L+ E+ S++ + R F+I + D +G+
Sbjct: 260 SSPLTISWNLETPDDLVYAYLHVAEIQ-SLRENDTREFNISAGQDVNYGPVSPDEFLVGT 318
Query: 318 NYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQWVQ-ETDQADVNVIRKVR 376
+ + G+ +L L+ S P+ NA E ++ Q ET+ DV I+ +
Sbjct: 319 LFNTSPVKCEG-GTCHLQLIKTPK-STLPPLLNAIEAFITVEFPQSETNANDVLAIKSIE 376
Query: 377 DE--LKKYNKENKVLESWSGDPCRPST--WRGVYCNTRNGSI--TITGLDLSSGQIQGIL 430
L + SW GDPC P W G+ C N S I LDLSS ++ GI+
Sbjct: 377 TSYGLSRI--------SWQGDPCVPQQLLWDGLTCEYTNMSTPPRIHSLDLSSSELTGII 428
Query: 431 PLSVTGLTHLEKFRGFCGSEKSTHKGILIGIAVCGTFLFTVAVG------IFVVCFYKRK 484
V + +L + + S + G+ +A + L G + K K
Sbjct: 429 ---VPEIQNLTELKKLDFSNNNLTGGVPEFLAKMKSLLVINLSGNNLSGSVPQALLNKVK 485
Query: 485 SIAGGKLEGKGYPMTKNLVFSI------DSMDDPV------------------------- 513
+ G KL +G P NL FS +S+ PV
Sbjct: 486 N--GLKLNIQGNP---NLCFSSSCNKKKNSIMLPVVASLASLAAIIAMIALLFVCIKRRS 540
Query: 514 ----KPMPVQI--------FSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVR 561
P P Q ++ + A T++++ ++G+GGFG VY G + +EVAVK+
Sbjct: 541 SSRKGPSPSQQSIETIKKRYTYAEVLAMTKKFERVLGKGGFGMVYHGYINGTEEVAVKLL 600
Query: 562 SSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEAS 621
S +S QG +EF+ E+ L + H NLV L+GYC E D L+Y +M NG L+ G +
Sbjct: 601 SPSSAQGYKEFKTEVELLLRVYHTNLVSLVGYCDEKDHLALIYQYMVNGDLKKHFSGSS- 659
Query: 622 TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681
+ W RL+IA+ AA GL YLH ++HRDVKSSNILLD + AK+ADFG S+
Sbjct: 660 ---IISWVDRLNIAVDAASGLEYLHIGCKPLIVHRDVKSSNILLDDQLQAKLADFGLSRS 716
Query: 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741
P +S S V GT GYLD EYY T LS KSDV+SFGVVLLEII+ + ++ R+
Sbjct: 717 FPIGDESHVSTLVAGTFGYLDHEYYQTNRLSEKSDVYSFGVVLLEIITNKPVIDHN--RD 774
Query: 742 EWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801
+ EW K + I I+DP ++G Y + + W+ +E+A+ C+ P S RP+M +V
Sbjct: 775 MPHIAEWVKLMLTRGDISNIMDPKLQGVYDSGSAWKALELAMTCVNPSSLKRPNMSHVVH 834
Query: 802 ELEDAFIIENN 812
EL++ + ENN
Sbjct: 835 ELKECLVSENN 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 265/875 (30%), Positives = 416/875 (47%), Gaps = 135/875 (15%)
Query: 21 FIVLIRSTCAQKD--FVSIACCADSDFIGKYPPVNWKPDDAWFPDKKDCRAITRPAVNNK 78
F+V++ CAQ FVSI C D Y + K D + D + T ++++K
Sbjct: 15 FVVVLVLVCAQDQSGFVSIDCGIPED--SSY--YDEKTDIKYISDAAFVESGTIHSIDSK 70
Query: 79 FYDRVLDFGI-------DSGKRCYNLSTIKGQ--DYLIRGTFLNGDNVETPLISSFNVLV 129
F + L+ + K CY++ +G+ YLIR F+ G+ F++ +
Sbjct: 71 FQKKNLEKQFQKVRSFPEGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKAPDFDLYL 130
Query: 130 GVT---PLSLVNSTEDSVVEGIFKAANDYIDFCL-DKKDGDPYISGLEVRPLNDTEYLPG 185
GV ++L NST E I+ +D + CL DK+ G P++S LE+R L + Y
Sbjct: 131 GVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLKNNIY--E 188
Query: 186 QSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKV 245
+++ L L R+DLG + +L RY DD FDR W+P + P +TS + + +N +
Sbjct: 189 TASDSLMLYRRWDLGAT-GDLPARYKDDIFDRFWMPLMFPNFLILNTSLMIDPTSSNGFL 247
Query: 246 TVPLQVLQTALTDPN---RLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILIN 302
P V+ TA+ N + ++ + ++ + + ++F E+ + + S+ R F + +N
Sbjct: 248 P-PSVVMSTAVAPMNSSIEQIMVYWEPRDPNWKFYIYIHFAEV-EKLPSNETREFSVFLN 305
Query: 303 NERKKEKFDILAL-GSNYAKLALNVTANGSLNLTLVNVLNGSVFG---PICNAYEILQVR 358
KE+ D ++ +Y N L VL V PI NA E +
Sbjct: 306 ----KEQIDTTSVFRPSYLYTDTLYVQNPVSGPFLEFVLRQGVKSTRPPIMNAIETYRTN 361
Query: 359 QWVQ-ETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRP--STWRGVYCN-TRNGS- 413
+++ TDQ DV D + K + KV ++W GDPC P W+G+ C+ T N
Sbjct: 362 EFLDLPTDQNDV-------DAIMKIKTKYKVKKNWLGDPCAPFGYPWQGINCSYTANNPP 414
Query: 414 --------------------ITIT---GLDLSSGQIQGILPLSVTGLTHL-------EKF 443
IT+T LDLS+ ++ G +P + L L K
Sbjct: 415 RIISVNLSFSGLTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKL 474
Query: 444 RGF-----------------------------CGSEKSTHKGILIG--IAVCGTFLFTVA 472
G C ++K+ K +I +V G F +A
Sbjct: 475 TGILPEKLLERSKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLA 534
Query: 473 VGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQ 532
+ F +++S+ G L+ K Y +V T
Sbjct: 535 LISFWQFKKRQQSVKTGPLDTKRYYKYSEIV------------------------EITNN 570
Query: 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
++ ++G+GGFG VY G L G++VA+K+ S +S QG +EF E+ L + H+NL+ L+G
Sbjct: 571 FERVLGQGGFGKVYYGVL-RGEQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIG 629
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
YC E DQ L+Y ++ NG+L D L G+ S+ L W RL I+L AA+GL YLH
Sbjct: 630 YCHEGDQMALIYEYIGNGTLGDYLSGKNSS--ILSWEERLQISLDAAQGLEYLHNGCKPP 687
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
++HRDVK +NIL++ + AK+ADFG S+ EGDS S EV GT GYLDPE+YS Q S
Sbjct: 688 IVHRDVKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFS 747
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
KSDV+SFGVVLLE+I+G+ ++ R + + + + I IVDP + ++A
Sbjct: 748 EKSDVYSFGVVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNA 807
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
W++ EVALAC + R +M +V EL+++
Sbjct: 808 GLAWKITEVALACASESTKTRLTMSQVVAELKESL 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | ||||||
| 62946489 | 945 | symbiosis receptor-like kinase [Tropaeol | 0.989 | 0.903 | 0.582 | 0.0 | |
| 147818071 | 844 | hypothetical protein VITISV_026839 [Viti | 0.939 | 0.960 | 0.637 | 0.0 | |
| 255572575 | 993 | serine-threonine protein kinase, plant-t | 0.972 | 0.844 | 0.594 | 0.0 | |
| 183579823 | 934 | putative symbiosis receptor-like kinase | 0.988 | 0.913 | 0.570 | 0.0 | |
| 183579825 | 933 | symbiosis receptor-like kinase [Populus | 0.981 | 0.907 | 0.589 | 0.0 | |
| 56412259 | 923 | nodulation receptor kinase [Sesbania ros | 0.975 | 0.912 | 0.569 | 0.0 | |
| 357485325 | 901 | Nodulation receptor kinase [Medicago tru | 0.966 | 0.925 | 0.579 | 0.0 | |
| 356531383 | 895 | PREDICTED: nodulation receptor kinase-li | 0.969 | 0.935 | 0.575 | 0.0 | |
| 62946487 | 941 | symbiosis receptor-like kinase [Alnus gl | 0.987 | 0.905 | 0.557 | 0.0 | |
| 62946485 | 941 | symbiosis receptor-like kinase [Alnus gl | 0.987 | 0.905 | 0.556 | 0.0 |
| >gi|62946489|gb|AAY22388.1| symbiosis receptor-like kinase [Tropaeolum majus] | Back alignment and taxonomy information |
|---|
Score = 1048 bits (2709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/953 (58%), Positives = 659/953 (69%), Gaps = 99/953 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFI--VLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDD 58
MMERL++ RRV+CF+ I ++ S AQ FVS+ACCADS F +NW D+
Sbjct: 2 MMERLDNRSSRRVECFIFCLLILPIIFHSVSAQPGFVSVACCADSGFTDN-TLINWITDE 60
Query: 59 AWFPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVE 118
+WFPDK+ CR P N Y + F IDSGKRCYNL TIK QDYLIRG+FL GD++
Sbjct: 61 SWFPDKQGCRNFAPPVANYTGYKKARIFAIDSGKRCYNLPTIKDQDYLIRGSFLFGDSLS 120
Query: 119 TPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPLN 178
+P +SFNVLVGVTP++ V++++ VEGIF+A DYIDFCL + G+PYIS LE+R L
Sbjct: 121 SPFGTSFNVLVGVTPIARVSTSDKLEVEGIFRANRDYIDFCLAYEKGEPYISNLELRALE 180
Query: 179 DTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNI 238
++ +L +S VLKLV R DLG S E R+ DD +DRIW P T + + N+
Sbjct: 181 NSNFLKLESPVVLKLVDRVDLGGSTGE-GIRFKDDKYDRIWKPDSYLNRTIITNA---NV 236
Query: 239 SDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFD 298
S NN VTVP++ LQ+A+T+ NRL FL DLD GDY Y++ LYFLEL ++V+ GQR+FD
Sbjct: 237 SINNLNVTVPIKALQSAVTNENRLEFLKNDLDIGDYKYSVTLYFLELVENVQP-GQRLFD 295
Query: 299 ILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVR 358
I INN K E FDI A GS+Y +++ TANG LN++LV V NG FGPICNAYEILQVR
Sbjct: 296 IYINNALKWENFDISANGSDYKEVSFYATANGFLNVSLVKVPNGLGFGPICNAYEILQVR 355
Query: 359 QWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITITG 418
QW+Q+++ DVNVI V++EL K+NK N + ESWSGDPC P W G+ C + NGS IT
Sbjct: 356 QWIQQSNLNDVNVIVNVKEELLKHNKRNVLWESWSGDPCLPYPWDGLVCYSVNGSSVITE 415
Query: 419 LDLS-----------------------------------------------SGQIQGILP 431
L+LS + ++G L
Sbjct: 416 LNLSSRKLQGPIPSSIIQLTYLKDLNLSYNGFTGTIPSFTASSMLTSVDLRNNDLKGSLH 475
Query: 432 LSVTGLTHLEKF------------------------RGFCGSEKSTH--KGILIGIAVCG 465
S+ L HL+ +G CGS+ H + I+I I CG
Sbjct: 476 ESIGALQHLKTLDFGCNPQLDKELPSNFKKLGLTTDKGECGSQGPKHSTRAIIISIVTCG 535
Query: 466 TFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDP-VKPMPVQIFSLQ 524
+ LF AVGI +V FY+R+S A GK +G + ++ N++FSI S D+P +K + ++ FSL+
Sbjct: 536 SVLFIGAVGIVIVFFYRRRS-AQGKFKGSRHQISNNVIFSIPSTDEPFLKSISIEEFSLE 594
Query: 525 YLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
Y+ TQ+YK LIGEGGFGSVYRGTLPDGQEV VKVRSSTSTQGTREF+NEL LS IRH
Sbjct: 595 YITTVTQKYKVLIGEGGFGSVYRGTLPDGQEVGVKVRSSTSTQGTREFDNELTLLSTIRH 654
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
ENLVPLLGYCCEN QQILVYPFMSNGSLQDRLYGEA+ RK LDWPTRLSIALGAARGL Y
Sbjct: 655 ENLVPLLGYCCENGQQILVYPFMSNGSLQDRLYGEAAKRKVLDWPTRLSIALGAARGLTY 714
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH+ AGRS+IHRDVKSSNILLD SM AKVADFGFSKYAPQEGDS SLEVRGTAGYLDPE
Sbjct: 715 LHSLAGRSLIHRDVKSSNILLDQSMTAKVADFGFSKYAPQEGDSCASLEVRGTAGYLDPE 774
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
YYSTQ LSAKSDVFSFGVVLLEIISGREPLN RPRNEWSLVEWAKP+IRESRIDEIVDP
Sbjct: 775 YYSTQQLSAKSDVFSFGVVLLEIISGREPLNIHRPRNEWSLVEWAKPYIRESRIDEIVDP 834
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIG 824
+IKGGYHAEAMWR+VEVALACIEPFSA+RP M DIVRELED IIENNASEYMKSIDSIG
Sbjct: 835 TIKGGYHAEAMWRVVEVALACIEPFSAHRPCMADIVRELEDGLIIENNASEYMKSIDSIG 894
Query: 825 GYSI-GGSARYSRRIVIPPTPTAT-------------ESSLVNSQTIVPPEPR 863
GYS GGS R+S I++ T E S VN+Q + PPEPR
Sbjct: 895 GYSFGGGSNRFS--IIVTDKEKKTIPPPPSPPTPNPSEPSPVNTQALTPPEPR 945
|
Source: Tropaeolum majus Species: Tropaeolum majus Genus: Tropaeolum Family: Tropaeolaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147818071|emb|CAN62796.1| hypothetical protein VITISV_026839 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1036 bits (2678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/854 (63%), Positives = 626/854 (73%), Gaps = 43/854 (5%)
Query: 31 QKDFVSIACCADSDFIGKYPPVNWKPDDAWFPDKKDCRAITRPAVNNKFYDRVLDFGIDS 90
Q+ FVSI CCA+S F ++W PDD W+ + C+ I +P V N D++ F D
Sbjct: 13 QEAFVSIRCCAESTFTEPSTNISWIPDDGWYSNTLGCQNINKP-VENYQGDKIRIFKGDL 71
Query: 91 GKR-CYNLSTIKGQDYLIRGTFLNGDNVETPLISSFNVLVGVTPLSLVNSTEDSV-VEGI 148
K+ CYNLST KG +YLIRGTFL GD+V T L FNV +GVTP+ LVN ++DSV VEG+
Sbjct: 72 AKKWCYNLSTTKGHEYLIRGTFLFGDSVRTSLAILFNVSIGVTPIGLVNGSDDSVEVEGV 131
Query: 149 FKAANDYIDFCLDKKDGDPYISGLEVRPLNDTEYLPGQSANVLKLVGRYDLGRSDNELSF 208
F A N +IDFCL K GDPYI LE+RPLN +YL G +++VLKLV R D+G + ++
Sbjct: 132 FTARNHHIDFCLLKGTGDPYIYKLELRPLNVLKYLQGGTSSVLKLVKRVDVGNTGEDI-- 189
Query: 209 RYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVT----VPLQVLQTALTDPNRLMF 264
RYP DP DRIW + S P + N ++A V+ VPLQVLQTAL RL F
Sbjct: 190 RYPVDPNDRIWKAESSSIPXSLLEKTPPNPISSSANVSITTAVPLQVLQTALNHSERLEF 249
Query: 265 LHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGSNYAKLAL 324
LH DLD G YNY L LYFLE +SV +GQRVFDI INN RK FDI+A GS Y + A
Sbjct: 250 LHNDLDIGXYNYNLSLYFLEFIESV-DTGQRVFDIYINNVRKXPDFDIMADGSKYREAAF 308
Query: 325 NVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQWVQETDQADVNVIRKVRDELKKYNK 384
TANGS NLTLV V + S+FGPICNAYEI QV+ DEL K N+
Sbjct: 309 RFTANGSFNLTLVKVSDKSLFGPICNAYEIXQVK------------------DELLKKNQ 350
Query: 385 ENKVLESWSGDPCRPSTWRGVYCNTR-NGSITITGLDLSSGQIQGILPLSVTGLTHLEKF 443
NKVL SWSGDPC P W G+ CN N S IT LDL + G + S+ L L F
Sbjct: 351 GNKVLGSWSGDPCLPLVWHGLICNNSINNSPVITELDLRHNDLMGKIQESLISLPQLAMF 410
Query: 444 RGFCGSEKSTH--KGILIGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKN 501
G C + S+H +GILIG G+FLFT+AVGI VCFY++K +A GK GYP+TKN
Sbjct: 411 YGNCADQGSSHSAQGILIGTVAGGSFLFTIAVGIAFVCFYRQKLMARGKFHEGGYPLTKN 470
Query: 502 LVFSIDSMDDPV-KPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKV 560
VFS+ S+DD V K + +Q F+L+Y+E AT +YKTLIGEGGFGSVYRGTLPDGQEVAVKV
Sbjct: 471 AVFSLPSIDDIVFKSIDIQNFTLEYIEIATNKYKTLIGEGGFGSVYRGTLPDGQEVAVKV 530
Query: 561 RSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEA 620
RS+TSTQGTREFENELN LSAI+HENLVPLLGYCCE DQQILVYPFMSNGSLQDRLYGEA
Sbjct: 531 RSATSTQGTREFENELNLLSAIQHENLVPLLGYCCEYDQQILVYPFMSNGSLQDRLYGEA 590
Query: 621 STRKTLDWPTRLSIALGAARG-----------LMYLHTFAGRSVIHRDVKSSNILLDHSM 669
+ RKTLDWPTRLSIALGAARG L YLHTFAGRSVIHRDVKSSNIL+DH+M
Sbjct: 591 AKRKTLDWPTRLSIALGAARGKMFEEYFYCSGLTYLHTFAGRSVIHRDVKSSNILMDHNM 650
Query: 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
AKVADFGFSKYAPQEGDSG SLEVRGTAGYLDPEYYSTQHLSAKSDVFS+GVVLLEIIS
Sbjct: 651 SAKVADFGFSKYAPQEGDSGVSLEVRGTAGYLDPEYYSTQHLSAKSDVFSYGVVLLEIIS 710
Query: 730 GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPF 789
GREPLN RPRNEWSLVEWAKP+IR+S+I+EIVDPSIKGGYHAEAMWR+VEVALACIEP+
Sbjct: 711 GREPLNIHRPRNEWSLVEWAKPYIRDSKIEEIVDPSIKGGYHAEAMWRVVEVALACIEPY 770
Query: 790 SAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIGGYSIGGSARYSRRIVIPPTPTATES 849
SAYRP MVDIVRELEDA IIENNASEYMKSIDS GG + + R++V+PPTPT T+
Sbjct: 771 SAYRPCMVDIVRELEDALIIENNASEYMKSIDSFGGSNRFSIEKIERKVVLPPTPTLTDP 830
Query: 850 SLVNSQTIVPPEPR 863
S Q + PP+PR
Sbjct: 831 SPDILQALTPPQPR 844
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572575|ref|XP_002527221.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533397|gb|EEF35147.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1028 bits (2658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 560/942 (59%), Positives = 662/942 (70%), Gaps = 103/942 (10%)
Query: 12 RVDCFV-----IICFIVL-IRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAWFPDKK 65
R DC + I F L I STC+ F SI CCA+S F ++W DD PD
Sbjct: 65 RTDCKIPTINPIKTFTDLTICSTCS-TGFKSIKCCAES-FSIDNNNISWTSDDKLLPDNG 122
Query: 66 DCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETPLISSF 125
C+ ITR A N YD+V F I SGKRCYNL T K QDYLIRGTFL GD + + L SSF
Sbjct: 123 HCQRITRAAANYTGYDKVRLFNIKSGKRCYNLQTTKDQDYLIRGTFLYGDLLGS-LGSSF 181
Query: 126 NVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPLNDTEYLPG 185
+VL+GVT +S V S ED VEG+F+A N+YIDFCL G P+IS LE+RPL D++YL G
Sbjct: 182 DVLIGVTKISKVTSFEDLEVEGVFRATNEYIDFCLAHNKGHPHISKLELRPLADSKYLQG 241
Query: 186 QSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIW------IPKLSPEPTTFSTSFTTNIS 239
+++V +L+ R D+G + + + RYP D FDRIW I +SP+P + N
Sbjct: 242 SASSVFRLISRNDVGNAGDAI--RYPHDKFDRIWEILDPSIVSISPDPVPARS----NTG 295
Query: 240 DNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDI 299
NA TVP +VLQTALT +RL FLH +LDS +YNYTL LYFLELN +VK++ QR+F I
Sbjct: 296 IYNASTTVPTEVLQTALTHRDRLEFLHKNLDSENYNYTLFLYFLELNSTVKTT-QRLFSI 354
Query: 300 LINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQ 359
INNE K+E DIL+ GSNY ++ L VTA GSLNLTLV V N FGPI NAYEILQV+
Sbjct: 355 FINNEIKQEGIDILSSGSNYKEVVLTVTAKGSLNLTLVKVTNKYDFGPILNAYEILQVQP 414
Query: 360 WVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYC------------ 407
WVQ T+Q DV+VI+++RD+L ++NK+N +L+ WSGDPC P W+G+ C
Sbjct: 415 WVQGTNQKDVDVIKQMRDKLLQHNKDNDMLKDWSGDPCLPLPWKGLTCQPMSGSQVITIL 474
Query: 408 ---------------------------NTRNGSI-------TITGLDLSSGQIQGILP-- 431
N GSI +T +DLS + G LP
Sbjct: 475 DISSSQFHGPLPDIAGLTNLRQLNVSYNQFTGSIPPFQSSSMLTSVDLSHNDLNGSLPNW 534
Query: 432 ----------------------LSVTGLTHLEKFRGFCGSEKSTHK--GILIGIAVCGTF 467
S + + G C +++T K GI+IG G+F
Sbjct: 535 LTLLPNLTTLIFGCNPQFSNELPSSFNSSRIATDYGEC-KQRTTRKIQGIVIGTITGGSF 593
Query: 468 LFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDD-PVKPMPVQIFSLQYL 526
+ +A+G+ +VC Y+ K +A GK GK PMTKN +FS+ S DD +K + +Q+F+L+Y+
Sbjct: 594 V--LAIGLGLVCIYRHKFVALGKFNGKRQPMTKNAIFSMPSSDDVALKSINIQMFTLEYI 651
Query: 527 EAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
E ATQ+YKTLIGEGGFGSVYRGTL DGQEVAVKVRS+TS+QGTREFENELN LSAIRHEN
Sbjct: 652 ENATQKYKTLIGEGGFGSVYRGTLLDGQEVAVKVRSTTSSQGTREFENELNLLSAIRHEN 711
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
LVPLLG+CCENDQQILVYPFMSNGSLQDRLYGEA+ RKTLDWPTRLSIALGAARGL +LH
Sbjct: 712 LVPLLGFCCENDQQILVYPFMSNGSLQDRLYGEAAKRKTLDWPTRLSIALGAARGLTHLH 771
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
TFAGRSVIHRDVKSSNILLD SM AKVADFGFSKYAPQEGDSG SLEVRGTAGYLDPEYY
Sbjct: 772 TFAGRSVIHRDVKSSNILLDQSMNAKVADFGFSKYAPQEGDSGASLEVRGTAGYLDPEYY 831
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766
STQHLSAKSDVFSFGVVLLEI+SGREPLN +RPRNEWSLVEWAKP+IRES+IDEIVDPSI
Sbjct: 832 STQHLSAKSDVFSFGVVLLEIVSGREPLNIKRPRNEWSLVEWAKPYIRESKIDEIVDPSI 891
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIGGY 826
KG YHAEAMWR+VE ALACIEPFSAYRP M DIVRELEDA IIENNASEYM+SIDSIGGY
Sbjct: 892 KGAYHAEAMWRVVEAALACIEPFSAYRPCMADIVRELEDALIIENNASEYMRSIDSIGGY 951
Query: 827 SIGGSARYS-----RRIVIPPTPTATESSLVNSQTIVPPEPR 863
S GGS R+S + ++ PPTPT T S +N+QT+ PPEPR
Sbjct: 952 SFGGSNRFSIVTDKKNVLPPPTPTPTTPSPINTQTLAPPEPR 993
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|183579823|emb|CAK32638.1| putative symbiosis receptor-like kinase [Datisca glomerata] gi|183579833|emb|CAP62376.1| symbiosis receptor-like kinase [Datisca glomerata] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/943 (57%), Positives = 649/943 (68%), Gaps = 90/943 (9%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAW 60
MME L +W++R +C VI+CF L S AQ+ FVS+ACC DS+F ++W PD W
Sbjct: 2 MMEGLHNWVLRLFECLVILCFFTLFGSASAQEGFVSLACCTDSNFTNTNTNISWTPDYNW 61
Query: 61 FPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETP 120
F D+ +C IT+ VNN +R F IDSGKRCYNL+T+K Q+YLIRGTFL G +
Sbjct: 62 FSDRTNCTNITKLTVNNADDERSRIFEIDSGKRCYNLTTLKDQEYLIRGTFL-GSYSNSS 120
Query: 121 LISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPLNDT 180
++SF V VGVTPL LV+ + + VEG+F A +YIDFCL+K++G PYIS LE+RPL+
Sbjct: 121 EVTSFTVYVGVTPLDLVHLSLE--VEGVFVAKKNYIDFCLEKRNGAPYISYLELRPLHAL 178
Query: 181 EYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFS-TSFTTNIS 239
+Y G S++VLKL+ R +LG + L+ RYPDDP DRIW P +P+PT S +S N+
Sbjct: 179 DYFQGFSSDVLKLISRVNLG--NTSLAIRYPDDPSDRIWKPLSNPDPTISSISSPNINVL 236
Query: 240 DNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDI 299
+ NA V +PL VLQTALT +L+FLH+D+++ Y Y + YFLEL+++VK GQRVFDI
Sbjct: 237 NYNATVDIPLPVLQTALTHSTQLVFLHSDIETEAYEYRVFFYFLELDETVKP-GQRVFDI 295
Query: 300 LINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQ 359
IN+E++ FDILA GSNY + V ANGSLNLT V +GS GP CNAYEILQVR
Sbjct: 296 YINDEKQASGFDILANGSNYKQSVFTVLANGSLNLTFVKSSDGSPLGPTCNAYEILQVRP 355
Query: 360 WVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITITGL 419
W+QET++ DV V RDEL YNK N+VL+SWSGDPC P W G+ C + NGS IT L
Sbjct: 356 WIQETNEKDVEVSLNSRDELLAYNKVNEVLKSWSGDPCLPLPWDGLACESINGSSVITKL 415
Query: 420 DLSSGQIQG-----------------------------------------------ILPL 432
DLS + +G +LP
Sbjct: 416 DLSDHKFEGLFPFSITELPYLKTLNLSYNDFAGKVPSFPASSMLQSVDLSHNKFIGVLPE 475
Query: 433 SVTGLTHLEKFRGFC-----GSE---------------KSTHKG-------ILIGIAVCG 465
S+ L +L+ C G+E K H+G I+IG CG
Sbjct: 476 SLASLPYLKTLNFGCNQFGDGNELPPNFNSSRIKTDFGKCDHRGSPRSIQAIIIGTVTCG 535
Query: 466 TFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPV-KPMPVQIFSLQ 524
+FLFTV VGI VCF ++K + KN + S+ S+DD V +P+ + F L+
Sbjct: 536 SFLFTVMVGIIYVCFCRQKFKPRAVFDSSRPVFMKNFIISLSSIDDHVSEPINPKDFPLE 595
Query: 525 YLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
++E TQ+Y TLIGEGGFGSVYRGTLPDGQEVAVKVRS+TSTQGTREFENE LS R+
Sbjct: 596 FIEDITQKYSTLIGEGGFGSVYRGTLPDGQEVAVKVRSATSTQGTREFENERKLLSLFRN 655
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
ENLVPLLGYC ENDQQILVYPFMSNGSLQDRLYGE S RK LDWPTR+SIALGAARGL Y
Sbjct: 656 ENLVPLLGYCSENDQQILVYPFMSNGSLQDRLYGELSKRKPLDWPTRISIALGAARGLTY 715
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LHT+ G VIHRDVKSSNILLD SMCAKVADFGFSK APQEGD SLEVRGTAGYLDPE
Sbjct: 716 LHTYVGGCVIHRDVKSSNILLDQSMCAKVADFGFSKGAPQEGDVA-SLEVRGTAGYLDPE 774
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
YY++ LSAKSDVFSFGVVLLEII GREP+N R PR+EWSLVEWAKP+IR+SRIDEIVDP
Sbjct: 775 YYTSHSLSAKSDVFSFGVVLLEIICGREPINVRMPRSEWSLVEWAKPYIRQSRIDEIVDP 834
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIG 824
SIKGGYHAEAMWR+VEVA+ACIEPFSAYRP M DIVRELEDA IIENNASEYM+SIDS+
Sbjct: 835 SIKGGYHAEAMWRVVEVAVACIEPFSAYRPCMADIVRELEDALIIENNASEYMRSIDSM- 893
Query: 825 GYSIGGSARYS----RRIVIPPTPTATESSLVNSQTIVPPEPR 863
YS+GGS R+S +++ +PPTP TE S + + + PPEPR
Sbjct: 894 -YSLGGSNRFSVGNDKKMGLPPTPCPTEPSPI-THDLAPPEPR 934
|
Source: Datisca glomerata Species: Datisca glomerata Genus: Datisca Family: Datiscaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|183579825|emb|CAO99188.1| symbiosis receptor-like kinase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2632), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/949 (58%), Positives = 642/949 (67%), Gaps = 102/949 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAW 60
MM R+ W++ I+ I +I TCA+K FVSIACCA+S ++W D+ W
Sbjct: 1 MMGRMHVWMLTASVGSFIVSLIHVIHLTCAEKGFVSIACCAESSTFTDNTTISWISDEGW 60
Query: 61 FP-DKKDCRAITRPAVNNKFYDRVLDFGIDSGKR-CYNLSTIKGQDYLIRGTFLNGDNVE 118
FP + C ITR A N+ YDRV F I+ G+R CYN ST K Q+YLIR TFL D+
Sbjct: 61 FPIENTGCENITRQAENDANYDRVRIFYIEPGRRICYNFSTTKNQNYLIRATFLFDDS-- 118
Query: 119 TPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPLN 178
L +SF+V +G TP S V ++D VE +F A + +DFCL G PYIS LE+RPL
Sbjct: 119 --LGASFDVSIGFTPTSNVKLSKDLEVERVFTATHHDVDFCLMNHYGYPYISKLELRPLG 176
Query: 179 DTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTTNI 238
D +YL G+++ VLKLV R D G + N S RYPDD FDRIW P+P T S S TN
Sbjct: 177 DLKYLQGKASGVLKLVSRVDAGNTGN--SIRYPDDSFDRIW---RRPDPKTVSLSEPTNS 231
Query: 239 SD--NNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRV 296
+ ++ K TVP +VLQTALT +RL FLH +LD+ D NYT+ LYF ELN S+K+ GQRV
Sbjct: 232 TTYIHDVKKTVPAKVLQTALTHTDRLEFLHNELDTQDSNYTVFLYFFELNQSIKT-GQRV 290
Query: 297 FDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQ 356
FDI INNE K KFDI A GS Y + ALNVTA+ SLNLTLV V N S GPI NAYEILQ
Sbjct: 291 FDIYINNEIKLGKFDIWAYGSAYREAALNVTASRSLNLTLVKVENASDLGPILNAYEILQ 350
Query: 357 VRQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSI-T 415
W+Q T+Q DV VI KVR+EL NKEN++L+SWSGDPC P W+G+ C +GS+
Sbjct: 351 ---WIQGTNQQDVEVIMKVRNELMLNNKENELLQSWSGDPCFPP-WKGLKCQNISGSLPV 406
Query: 416 ITGL-----------------------------------------------DLSSGQIQG 428
ITGL DLS + G
Sbjct: 407 ITGLNISSSQFQGPIPASITELSYLKELNLSYNGFTGKIPEFPKSSVLTSVDLSFNDLSG 466
Query: 429 ILPLSVTGLTHLEKF----------------------RGFCGSEKSTHK--GILIGIAVC 464
+P S+ LT+L+ G C + ST K GI+IG
Sbjct: 467 SVPDSLASLTNLKTLYFGCNPLSSTELPSNSSRLITDSGKCSRQGSTKKTLGIVIGAITG 526
Query: 465 GTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQ 524
G+FLFT+AVG+F CF + KS + K PMTKN VFS+ S K + +Q F L
Sbjct: 527 GSFLFTLAVGMFCSCFCRNKSRTRRNFDRKSNPMTKNAVFSVASTVS--KSINIQSFPLD 584
Query: 525 YLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
YLE T +YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF+NEL LSA+RH
Sbjct: 585 YLENVTHKYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFDNELTLLSALRH 644
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEA+ RKTLDWPTRLSIALGAARGL Y
Sbjct: 645 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEAAKRKTLDWPTRLSIALGAARGLTY 704
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LHTF+GR +IHRDVKSSNILLDHSM AKV DFGFSKYAPQEGDSG SLEVRGTAGYLDPE
Sbjct: 705 LHTFSGRCIIHRDVKSSNILLDHSMNAKVTDFGFSKYAPQEGDSGASLEVRGTAGYLDPE 764
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
YYSTQHLSAKSDVFSFGVVLLEI+SGREPLN RPRNEWSLVEWAKP+IRESRIDEIVDP
Sbjct: 765 YYSTQHLSAKSDVFSFGVVLLEIVSGREPLNIHRPRNEWSLVEWAKPYIRESRIDEIVDP 824
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIG 824
IKGGYHAEAMWR+VEVAL CIEPFSAYRP M DIVRELEDA IIENNASEYMKSIDS+G
Sbjct: 825 GIKGGYHAEAMWRVVEVALVCIEPFSAYRPCMTDIVRELEDALIIENNASEYMKSIDSLG 884
Query: 825 GYSIGGSARY-SRRIVIPPTPTATES---------SLVNSQTIVPPEPR 863
GYS+GGS R+ S R I S S +N+Q + P EPR
Sbjct: 885 GYSLGGSNRFGSNRFSISTDKKIALSPPVPTPPDPSPINTQALAPLEPR 933
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|56412259|gb|AAV88623.1| nodulation receptor kinase [Sesbania rostrata] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2598), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/944 (56%), Positives = 645/944 (68%), Gaps = 102/944 (10%)
Query: 1 MMERLEDWIVR-RVDCFVIICFIVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDA 59
MME + WI+R V C +C + +RS A ++F SIACCADS++ +N+ D +
Sbjct: 1 MMELPDIWILRLAVAC--ALCLYIFLRSASASEEFESIACCADSNYTDPLTTLNYTTDYS 58
Query: 60 WFPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTF-LNGDNVE 118
WF DK+ CR I +NN+ + V F ID GKRCYNL TIK + YLIRGTF + N
Sbjct: 59 WFSDKRSCRQIPEAGLNNRSNENVRLFDIDEGKRCYNLPTIKNKVYLIRGTFPFDSTN-- 116
Query: 119 TPLISSFNVLVGVTPLSLVNST--EDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRP 176
SSF V +G+T L V S+ + VEG+F+A DYIDFCL K + +P+IS LE+RP
Sbjct: 117 ----SSFYVSIGITQLGAVRSSRLQGLEVEGVFRATKDYIDFCLVKGEVNPFISQLELRP 172
Query: 177 LNDTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTT 236
L + EYL +VLKL+ R +LG S +++ R+P D DRIW SP + F SF
Sbjct: 173 LPE-EYLHDLPTSVLKLISRNNLGGSKDDI--RFPADRSDRIWKATSSPS-SAFPLSFNV 228
Query: 237 NISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRV 296
+ D A VT PLQVLQTA+T P RL F+H L++ DY Y + LYFLE+N ++K+ GQRV
Sbjct: 229 SNVDLQANVTPPLQVLQTAITHPERLEFIHNGLETEDYGYRVFLYFLEINRTLKA-GQRV 287
Query: 297 FDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQ 356
FDI +NNE KKEKFD+L GSNY LNV+ANGSLN+TLV + S FGP+ NAYEILQ
Sbjct: 288 FDIYVNNEIKKEKFDVLDGGSNYGYTVLNVSANGSLNVTLVKA-SESEFGPLLNAYEILQ 346
Query: 357 VRQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITI 416
VR WV+ET+Q DV VI+K+R+EL N+ENK LESW+GDPC W+G+ C+ NGS I
Sbjct: 347 VRSWVEETNQTDVEVIQKMREELLLQNQENKALESWTGDPCILFPWKGIACDGSNGSTVI 406
Query: 417 TGLDLSSGQIQ-----------------------------------------------GI 429
T LDLS ++ G
Sbjct: 407 TKLDLSLSNLKGPIPSSVTEMTNLKILNLSHNSFDGYIPSFPLSSLLISIDLSYNGLRGT 466
Query: 430 LPLSVTGLTHLEKFRGFCGSEKST----------------------HK---GILIGIAVC 464
LP S+T HL+ C S HK GI+IG C
Sbjct: 467 LPESITSPLHLKSLYFGCNQHMSEEDPANLNSSLINTDYGRCKSKEHKFGQGIVIGAITC 526
Query: 465 GTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDP-VKPMPVQIFSL 523
G+ L T+AVGI VC Y++K + GK YPM N++FS+ S DD +K + +Q F+L
Sbjct: 527 GSLLVTLAVGILFVCRYRQKLLPWEGFGGKNYPMATNVIFSLPSKDDFFIKSVSIQTFTL 586
Query: 524 QYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR 583
+Y+E AT++YKTLIGEGGFGSVYRGTL DGQEVAVKVRS+TSTQGTREF+NELN LSAI+
Sbjct: 587 EYIEVATERYKTLIGEGGFGSVYRGTLNDGQEVAVKVRSATSTQGTREFDNELNLLSAIQ 646
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
HENLVPLLGYC ENDQQILVYPFMSNGSLQDRLYGE + RK LDWPTRLSIALGAARGL
Sbjct: 647 HENLVPLLGYCNENDQQILVYPFMSNGSLQDRLYGEPAKRKVLDWPTRLSIALGAARGLA 706
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
YLHTF GR VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS SLEVRGTAGYLDP
Sbjct: 707 YLHTFPGRPVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSNVSLEVRGTAGYLDP 766
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
EYY TQ LS KSDVFSFGVVLLEI+SGREPLN +RPRNEWSLVEWAKP+IR S+++EIVD
Sbjct: 767 EYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIQRPRNEWSLVEWAKPYIRASKVEEIVD 826
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSI 823
P IKGGYHAEAMWR+VEVAL C+EPFSAYRP MVDIVRELEDA IIENNASEYMKSID
Sbjct: 827 PGIKGGYHAEAMWRVVEVALQCLEPFSAYRPCMVDIVRELEDALIIENNASEYMKSID-- 884
Query: 824 GGYSIGGSARYS----RRIVIPPTPTATESSLVNSQTIVPPEPR 863
S+GGS RYS +R++ P+ T+T S + +Q++ P+PR
Sbjct: 885 ---SLGGSNRYSIVIEKRVL--PSTTSTAESTITAQSLSHPQPR 923
|
Source: Sesbania rostrata Species: Sesbania rostrata Genus: Sesbania Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357485325|ref|XP_003612950.1| Nodulation receptor kinase [Medicago truncatula] gi|21698787|emb|CAD10810.1| nodulation receptor kinase [Medicago truncatula] gi|355514285|gb|AES95908.1| Nodulation receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2534), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/915 (57%), Positives = 638/915 (69%), Gaps = 81/915 (8%)
Query: 9 IVRRVDCFVIICFIVLIRS-TCAQKDFVSIACCADSDFIGKYPPVNWKPDDAWFPDKKDC 67
I R V FV+ C + IRS + A K F SIACCADS++ + + D WF DK+ C
Sbjct: 8 IFRLVVAFVL-CLCIFIRSASSATKGFESIACCADSNYTDPKTTLTYTTDHIWFSDKRSC 66
Query: 68 RAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDNVETPLISSFNV 127
R I +++ V F I GKRCYNL T+K Q YLIRG F L SSF V
Sbjct: 67 RQIPEILFSHRSNKNVRKFEIYEGKRCYNLPTVKDQVYLIRGIFPFDS-----LNSSFYV 121
Query: 128 LVGVTPLSLVNST--EDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRPLNDTEYLPG 185
+GVT L + S+ ED +EG+F+A DYIDFCL K+D +P+IS +E+RPL + EYL G
Sbjct: 122 SIGVTELGELRSSRLEDLEIEGVFRATKDYIDFCLLKEDVNPFISQIELRPLPE-EYLHG 180
Query: 186 QSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTT-FSTSFTTNISDNNAK 244
+VLKL+ R +LG +++++ R+PDD DRIW K + PT+ SF + D
Sbjct: 181 FGTSVLKLISRNNLGDTNDDI--RFPDDQNDRIWKRKETSTPTSALPLSFNVSNVDLKDS 238
Query: 245 VTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNE 304
VT PLQVLQTALT P RL F+H L++ DY Y++ L+FLELN +V++ GQRVFDI +NNE
Sbjct: 239 VTPPLQVLQTALTHPERLEFVHDGLETDDYEYSVFLHFLELNGTVRA-GQRVFDIYLNNE 297
Query: 305 RKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQWVQET 364
KKEKFD+LA GS + ALN++ANGSLN+TLV +GS FGP+ NAYEILQ R W++ET
Sbjct: 298 IKKEKFDVLAGGSKNSYTALNISANGSLNITLVKA-SGSEFGPLLNAYEILQARSWIEET 356
Query: 365 DQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITITGLDLSSG 424
+Q D+ VI+K+R+EL +N+EN+ LESWSGDPC W+G+ C+ GS IT LDLSS
Sbjct: 357 NQKDLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTGSSIITKLDLSSN 416
Query: 425 QIQGILPLSVTGLTHLEKF----------------------------------------- 443
++G +P VT +T+L+
Sbjct: 417 NLKGAIPSIVTKMTNLQILDLSYNDLSGWLPESIISLPHLKSLYFGCNPSMSDEDTTKLN 476
Query: 444 -------RGFCGSEKSTHKGI-LIGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEG-- 493
G C ++K + +IG G+ L T+AVGI C Y+ KSI LEG
Sbjct: 477 SSLINTDYGRCKAKKPKFGQVFVIGAITSGSLLITLAVGILFFCRYRHKSIT---LEGFG 533
Query: 494 KGYPMTKNLVFSIDSMDDP-VKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPD 552
K YPM N++FS+ S DD +K + V+ F+L+Y+E AT+QYKTLIGEGGFGSVYRGTL D
Sbjct: 534 KTYPMATNIIFSLPSKDDFFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLDD 593
Query: 553 GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612
GQEVAVKVRSSTSTQGTREF+NELN LSAI+HENLVPLLGYC E DQQILVYPFMSNGSL
Sbjct: 594 GQEVAVKVRSSTSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSL 653
Query: 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672
DRLYGEAS RK LDWPTRLSIALGAARGL YLHTF GRSVIHRDVKSSNILLD SMCAK
Sbjct: 654 LDRLYGEASKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAK 713
Query: 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGRE 732
VADFGFSKYAPQEGDS SLEVRGTAGYLDPEYY TQ LS KSDVFSFGVVLLEI+SGRE
Sbjct: 714 VADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGRE 773
Query: 733 PLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAY 792
PLN +RPR EWSLVEWAKP+IR S++DEIVDP IKGGYHAEA+WR+VEVAL C+EP+S Y
Sbjct: 774 PLNIKRPRIEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTY 833
Query: 793 RPSMVDIVRELEDAFIIENNASEYMKSIDSIGGYSIGGSARYSRRIVIP----PTPTATE 848
RP MVDIVRELEDA IIENNASEYMKSID S+GGS RYS IV+ P+ T+T
Sbjct: 834 RPCMVDIVRELEDALIIENNASEYMKSID-----SLGGSNRYS--IVMDKRALPSTTSTA 886
Query: 849 SSLVNSQTIVPPEPR 863
S + +QT+ P+PR
Sbjct: 887 ESTITTQTLSHPQPR 901
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531383|ref|XP_003534257.1| PREDICTED: nodulation receptor kinase-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 977 bits (2526), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/920 (57%), Positives = 636/920 (69%), Gaps = 83/920 (9%)
Query: 2 MERLEDWIVRRVDCFVIICFIVLIRSTC--AQKDFVSIACCADSDFIGKYPPVNWKPDDA 59
ME + WI+R V + C + IRS A + F +IACCADS++ +N+ D
Sbjct: 1 MELPDIWILRLV-VACVFCLHIFIRSASGYATEGFENIACCADSNYTDPQTTLNYTTDYR 59
Query: 60 WFPDKKDCRAITRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTF-LNGDNVE 118
WFPDK CR T+ +N K V F +D GKRCYNLSTIK + YLIRGTF NG N
Sbjct: 60 WFPDKGSCRR-TKDVLNEK----VRLFFVDEGKRCYNLSTIKNKVYLIRGTFPFNGVN-- 112
Query: 119 TPLISSFNVLVGVTPLSLVNST--EDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRP 176
SSFNV +GVT L V S+ +D +EG+F+AA DYID CL K + DP IS +E+RP
Sbjct: 113 ----SSFNVSIGVTQLGAVRSSGLQDLEIEGVFRAAKDYIDICLVKGEVDPLISHIELRP 168
Query: 177 LNDTEYLPGQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFTT 236
L + EYL A+VLKL+ R L S +E+ R+P DP DRIW SP +S +
Sbjct: 169 LPE-EYLHDLPASVLKLISRNSLWGSKDEI--RFPTDPSDRIWKATSSPSSALLVSSNVS 225
Query: 237 NISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRV 296
N D + VT PLQVLQTALT P RL F+H+ +D+ D Y + LYFLELN +VK+ G+RV
Sbjct: 226 NF-DLKSNVTPPLQVLQTALTHPERLQFMHSGIDTEDNEYRVFLYFLELNSTVKA-GKRV 283
Query: 297 FDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQ 356
FDI +N E KKE+FDILA GSNY LNV+ANG LNLTLV +G+ FGP+ NAYEILQ
Sbjct: 284 FDIYVNGEIKKERFDILAEGSNYTYTVLNVSANGLLNLTLVKA-SGAEFGPLLNAYEILQ 342
Query: 357 VRQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITI 416
+R W++ET+ DV VI+K+++E+ N+ NK LESW+GDPC W+G+ C++ NGS I
Sbjct: 343 MRSWIEETNHKDVEVIQKIKEEVLLQNQGNKALESWTGDPCF-FPWQGITCDSSNGSSVI 401
Query: 417 TGLDLSSGQIQGILPLSVT------------------------GLTHLEKFRGFC----- 447
T LDLS+ +G +P S+T L HL+ C
Sbjct: 402 TKLDLSAHNFKGPIPPSITEMINLKLLDLSYNNLMGSLPESIVSLPHLKSLYFGCNKRMS 461
Query: 448 --------------------GSEKSTHKGILIGIAVCGTFLFTVAVGIFVVCFYKRKSIA 487
G E + +IG CG+ L +AVGI VC Y++K I
Sbjct: 462 EGGPANLNSSLINTDYGRCKGKEPRFGQVFVIGAITCGSLLIALAVGIIFVCRYRQKLIP 521
Query: 488 GGKLEGKGYPMTKNLVFSIDSMDD-PVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVY 546
GK Y M N++FS+ S DD +K + +Q F+L+ +E AT++YKTLIGEGGFGSVY
Sbjct: 522 WEGFGGKNYIMETNVIFSLPSKDDFLIKSVSIQTFTLEDIEVATERYKTLIGEGGFGSVY 581
Query: 547 RGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606
RGTL + QEVAVKVRS+TSTQGTREF+NELN LSAI+HENLVPLLGYC ENDQQILVYPF
Sbjct: 582 RGTLNNSQEVAVKVRSATSTQGTREFDNELNLLSAIQHENLVPLLGYCNENDQQILVYPF 641
Query: 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666
MSNGSLQDRLYGE + RK LDWPTRLSIALGAARGL YLHTF GRSVIHRDVKSSNILLD
Sbjct: 642 MSNGSLQDRLYGEPAKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLD 701
Query: 667 HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLE 726
HSMCAKVADFGFSKYAPQEGDS SLEVRGTAGYLDPEYY TQ LS KSDVFSFGVVLLE
Sbjct: 702 HSMCAKVADFGFSKYAPQEGDSNVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLE 761
Query: 727 IISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACI 786
I+SGREPL+ +RPRNEWSLVEWAKP++R S++DEIVDP IKGGYHAEAMWR+VEVAL C+
Sbjct: 762 IVSGREPLDIKRPRNEWSLVEWAKPYVRASKMDEIVDPGIKGGYHAEAMWRVVEVALHCL 821
Query: 787 EPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIGGYSIGGSARYS---RRIVIPPT 843
EPFSAYRP+MVDIVRELEDA IIENNASEYMKSID S+GGS RYS + V+P T
Sbjct: 822 EPFSAYRPNMVDIVRELEDALIIENNASEYMKSID-----SLGGSNRYSIVIEKRVLPST 876
Query: 844 PTATESSLVNSQTIVPPEPR 863
+ ES+ + +Q + P+PR
Sbjct: 877 SSTAEST-ITTQALSHPQPR 895
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62946487|gb|AAY22387.1| symbiosis receptor-like kinase [Alnus glutinosa] | Back alignment and taxonomy information |
|---|
Score = 977 bits (2525), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/952 (55%), Positives = 645/952 (67%), Gaps = 100/952 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAW 60
MME + +I+R ++ F I+CF +L+RSTC Q+ FVS+ CC+DS+F + +NW PDD+W
Sbjct: 1 MMEGSDYFILRLLEWF-ILCFFILVRSTCGQEGFVSLRCCSDSNFTDQITSINWTPDDSW 59
Query: 61 FPDKKDCRAITRPAV----NNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDN 116
FP+K CR P + +K Y + F IDSGKRCY L+TIK QDYL+RGTFL GD
Sbjct: 60 FPNKTGCR--DEPNIEAWKKHKDYGKARIFNIDSGKRCYRLTTIKEQDYLVRGTFLFGDL 117
Query: 117 VETPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRP 176
+ T L +SF+VLVGVT +S VNS+EDS VEGIF+A D+IDFCL+K GDPYIS LE+RP
Sbjct: 118 LRTTLDTSFDVLVGVTGISRVNSSEDSEVEGIFRATKDHIDFCLEKVQGDPYISKLELRP 177
Query: 177 LNDTEYLPG-QSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFT 235
L D YL S VLK V R D+G + + RYP D DRIW P + T + +
Sbjct: 178 LKDLNYLQNFSSTTVLKSVRRIDVGNTG--VDIRYPSDKSDRIWKPDTNS--TARGSRLS 233
Query: 236 TNISDNNAK-VTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQ 294
N+S+ +A T PL+VLQTAL RL F + LD DY Y + LYF ELN + K G
Sbjct: 234 VNVSNYSANNATPPLEVLQTALYHSERLEFQES-LDKRDYEYRVFLYFFELNKTSKH-GD 291
Query: 295 RVFDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEI 354
RVFDI INNE+ KE F+ILA G NY ++ +V ANGSLNLTL+ +GS+FGPICNAYEI
Sbjct: 292 RVFDIYINNEKVKENFEILANGYNYREVVWDVRANGSLNLTLIKA-SGSLFGPICNAYEI 350
Query: 355 LQVRQ----------WVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRG 404
LQVR+ VQ+TD+ DV V +VR+EL N+ N VLESWSGDPC P W+G
Sbjct: 351 LQVREINQSYGEFDLQVQQTDEKDVEVAWRVRNELLVSNQANAVLESWSGDPCLPKPWQG 410
Query: 405 VYCNTRNGSITITGLDLSSGQIQGI----------------------------------- 429
+ C NGS IT L+LSS +QG
Sbjct: 411 LACAPHNGSAIITSLNLSSTNLQGSIPHSITELANIETLNMSYNQFNGSIPEFPDSSMLK 470
Query: 430 ------------LPLSVTGLTHLEKF-----------------------RGFCGSEKSTH 454
LP S+ L HL+ G C S +S
Sbjct: 471 SVDISHNYLAGSLPESLISLPHLQSLYFGCNPYLDKEPQSSFNSTIHTDNGRCDSNESPR 530
Query: 455 KGI-LIGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDD-P 512
+ +I CG+FLFTV VG+ VC Y++KS+ G+ +GKG+ +T+N++ + S DD
Sbjct: 531 VRVSVIATVACGSFLFTVTVGVIFVCIYRKKSMPRGRFDGKGHQLTENVLIYLPSKDDIS 590
Query: 513 VKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF 572
+K + ++ F+L+ ++ AT+ YKTLIGEGGFGSVYRGTL DGQEVAVKVRS+TSTQGTREF
Sbjct: 591 IKSITIERFTLEDIDTATENYKTLIGEGGFGSVYRGTLSDGQEVAVKVRSATSTQGTREF 650
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
ENELN LS IRHENLVPLLG+C ENDQQILVYPFMSNGSLQDRLYGE + RKTLDWPTRL
Sbjct: 651 ENELNLLSEIRHENLVPLLGHCSENDQQILVYPFMSNGSLQDRLYGEPAKRKTLDWPTRL 710
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692
SIALGAARGL YLHT A R +IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD SL
Sbjct: 711 SIALGAARGLTYLHTNANRCIIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDC-VSL 769
Query: 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
EVRGTAGYLDPEYYSTQ LS KSDV+SFGVVLLEI++GREPLN RPRNEWSLVEWAK +
Sbjct: 770 EVRGTAGYLDPEYYSTQQLSDKSDVYSFGVVLLEIVTGREPLNIHRPRNEWSLVEWAKAY 829
Query: 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
IR+S+IDE+VDPSI+GGYHAEAMWR+VEVA CIE +A RP M+DI+REL++A IIE N
Sbjct: 830 IRDSQIDEMVDPSIRGGYHAEAMWRVVEVASTCIESDAASRPFMIDILRELDEALIIETN 889
Query: 813 ASEYMKSIDSIGGYSIGGSARYSRRIV-IPPTPTATESSLVNSQTIVPPEPR 863
ASEYM+SIDS+G S S +RIV P + + +E S + Q PP+PR
Sbjct: 890 ASEYMRSIDSLGTSSNRFSIVMEKRIVLPPISSSPSEPSPILPQGPSPPQPR 941
|
Source: Alnus glutinosa Species: Alnus glutinosa Genus: Alnus Family: Betulaceae Order: Fagales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62946485|gb|AAY22386.1| symbiosis receptor-like kinase [Alnus glutinosa] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/952 (55%), Positives = 645/952 (67%), Gaps = 100/952 (10%)
Query: 1 MMERLEDWIVRRVDCFVIICFIVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAW 60
MME + +I+R ++ F I+CF +L+RSTC Q+ FVS+ CC+DS+F + +NW PDD+W
Sbjct: 1 MMEGSDYFILRLLEWF-ILCFFILVRSTCGQEGFVSLRCCSDSNFTDQITSINWTPDDSW 59
Query: 61 FPDKKDCRAITRPAV----NNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLNGDN 116
FP+K CR P + +K Y + F IDSGKRCY L++IK QDYL+RGTFL GD
Sbjct: 60 FPNKTGCR--DEPNIEAWKKHKDYGKARIFNIDSGKRCYRLTSIKEQDYLVRGTFLFGDL 117
Query: 117 VETPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDKKDGDPYISGLEVRP 176
+ T L +SF+VLVGVT +S VNS+EDS VEGIF+A D+IDFCL+K GDPYIS LE+RP
Sbjct: 118 LRTTLDTSFDVLVGVTGISRVNSSEDSEVEGIFRATKDHIDFCLEKVQGDPYISKLELRP 177
Query: 177 LNDTEYLPG-QSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFSTSFT 235
L D YL S VLK V R D+G + + RYP D DRIW P + T + +
Sbjct: 178 LKDLNYLQNFSSTTVLKSVHRIDVGNTG--VDIRYPSDKSDRIWKPDTNS--TARGSRLS 233
Query: 236 TNISDNNAK-VTVPLQVLQTALTDPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQ 294
N+S+ +A T PL+VLQTAL RL F + LD DY Y + LYF ELN + K G
Sbjct: 234 VNVSNYSANNATPPLEVLQTALYHSERLEFQES-LDKRDYEYRVFLYFFELNKTSKH-GD 291
Query: 295 RVFDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFGPICNAYEI 354
RVFDI INNE+ KE F+ILA G NY ++ +V ANGSLNLTL+ +GS+FGPICNAYEI
Sbjct: 292 RVFDIYINNEKVKENFEILANGYNYKEVVWDVRANGSLNLTLIKA-SGSLFGPICNAYEI 350
Query: 355 LQVRQ----------WVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPSTWRG 404
LQVR+ VQ+TD+ DV V +VR+EL N+ N VLESWSGDPC P W+G
Sbjct: 351 LQVREINQSYGEFDLQVQQTDEKDVEVAWRVRNELLVSNQANAVLESWSGDPCLPKPWQG 410
Query: 405 VYCNTRNGSITITGLDLSSGQIQGI----------------------------------- 429
+ C NGS IT L+LSS +QG
Sbjct: 411 LACALHNGSAIITSLNLSSMNLQGSIPHSITELANIETLNMSYNQFNGSIPEFPDSSMLK 470
Query: 430 ------------LPLSVTGLTHLEKF-----------------------RGFCGSEKSTH 454
LP S+ L HL+ G C S +S
Sbjct: 471 SVDISHNYLAGSLPESLISLPHLQSLYFGCNPYLDKEPQSSFNSTIHTDNGRCDSNESPR 530
Query: 455 KGI-LIGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDD-P 512
+ +I CG+FLFTV VG+ VC Y++KS+ G+ +GKG+ +T+N++ + S DD
Sbjct: 531 VRVSVIATVACGSFLFTVTVGVIFVCIYRKKSMPRGRFDGKGHQLTENVLIYLPSKDDIS 590
Query: 513 VKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF 572
+K + ++ F+L+ ++ AT+ YKTLIGEGGFGSVYRGTL DGQEVAVKVRS+TSTQGTREF
Sbjct: 591 IKSITIERFTLEDIDTATENYKTLIGEGGFGSVYRGTLSDGQEVAVKVRSATSTQGTREF 650
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
ENELN LS IRHENLVPLLG+C ENDQQILVYPFMSNGSLQDRLYGE + RKTLDWPTRL
Sbjct: 651 ENELNLLSEIRHENLVPLLGHCSENDQQILVYPFMSNGSLQDRLYGEPAKRKTLDWPTRL 710
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692
SIALGAARGL YLHT A R +IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD SL
Sbjct: 711 SIALGAARGLTYLHTNAKRCIIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDC-VSL 769
Query: 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
EVRGTAGYLDPEYYSTQ LS KSDV+SFGVVLLEI++GREPLN RPRNEWSLVEWAK +
Sbjct: 770 EVRGTAGYLDPEYYSTQQLSDKSDVYSFGVVLLEIVTGREPLNIHRPRNEWSLVEWAKAY 829
Query: 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
IR+S+IDE+VDPSI+GGYHAEAMWR+VEVA CIE +A RP M+DI+REL++A IIE N
Sbjct: 830 IRDSQIDEMVDPSIRGGYHAEAMWRVVEVASTCIESDAASRPLMIDILRELDEALIIETN 889
Query: 813 ASEYMKSIDSIGGYSIGGSARYSRRIV-IPPTPTATESSLVNSQTIVPPEPR 863
ASEYM+SIDS+G S S +RIV P + + +E S + Q PP+PR
Sbjct: 890 ASEYMRSIDSLGTSSNRFSIVMEKRIVLPPISSSPSEPSPILPQGPSPPQPR 941
|
Source: Alnus glutinosa Species: Alnus glutinosa Genus: Alnus Family: Betulaceae Order: Fagales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | ||||||
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.454 | 0.419 | 0.416 | 3.1e-108 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.449 | 0.417 | 0.401 | 1.3e-105 | |
| TAIR|locus:2078186 | 889 | AT3G46340 [Arabidopsis thalian | 0.453 | 0.439 | 0.379 | 1.5e-98 | |
| TAIR|locus:2156549 | 895 | AT5G48740 [Arabidopsis thalian | 0.337 | 0.325 | 0.482 | 1.8e-97 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.410 | 0.397 | 0.404 | 2.1e-97 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.426 | 0.414 | 0.376 | 4.7e-97 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.443 | 0.439 | 0.375 | 6e-97 | |
| TAIR|locus:2078176 | 878 | MEE39 "maternal effect embryo | 0.333 | 0.328 | 0.452 | 1.3e-95 | |
| TAIR|locus:2078196 | 871 | AT3G46350 [Arabidopsis thalian | 0.417 | 0.413 | 0.392 | 4.8e-94 | |
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.455 | 0.439 | 0.354 | 6.4e-94 |
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 3.1e-108, Sum P(2) = 3.1e-108
Identities = 167/401 (41%), Positives = 234/401 (58%)
Query: 419 LDLSSGQIQGILPLSVTGLTHLEKFRGFCGSEKSTHKGILIGIAVCGTF-LFTVAVGIFV 477
L L + + G +P S + F G EKS KG +G+ + + F + + +
Sbjct: 490 LYLQNNVLTGTIP-SDLAKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATII 548
Query: 478 VCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPM---PVQIFSLQYLEAATQQYK 534
C KS KL GK N I + + F+L +E AT++++
Sbjct: 549 SCIVMCKSKKNNKL-GKTSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFE 607
Query: 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
IG GGFG VY G +G+E+AVKV ++ S QG REF NE+ LS I H NLV LGYC
Sbjct: 608 KRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYC 667
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
E + +LVY FM NG+L++ LYG + + W RL IA AARG+ YLHT ++I
Sbjct: 668 QEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAII 727
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
HRD+K+SNILLD M AKV+DFG SK+A +G S S VRGT GYLDPEYY +Q L+ K
Sbjct: 728 HRDLKTSNILLDKHMRAKVSDFGLSKFAV-DGTSHVSSIVRGTVGYLDPEYYISQQLTEK 786
Query: 715 SDVFSFGVVLLEIISGREPL-NTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI-KGGYHA 772
SDV+SFGV+LLE++SG+E + N N ++V+WAK I I I+DP++ + Y
Sbjct: 787 SDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSL 846
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNA 813
++MW++ E AL C++P RPSM ++ ++++DA IE A
Sbjct: 847 QSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIEKEA 887
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 1.3e-105, Sum P(2) = 1.3e-105
Identities = 160/399 (40%), Positives = 228/399 (57%)
Query: 458 LIGIAVCGTFLFTVAVG--IFVVCFYKRKSIA--GGKLEGKGYPMTK-NLVFSIDSMDDP 512
++GI++ + + VG + ++C ++ A G E K + + V +D+
Sbjct: 532 ILGISIAAVAILLLLVGGSLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEG 591
Query: 513 VKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF 572
V SL LE AT + +G G FGSVY G + DG+EVAVK+ + S+ R+F
Sbjct: 592 V----AYFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQF 647
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
E+ LS I H NLVPL+GYC E D++ILVY +M NGSL D L+G +S K LDW TRL
Sbjct: 648 VTEVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHG-SSDYKPLDWLTRL 706
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692
IA AA+GL YLHT S+IHRDVKSSNILLD +M AKV+DFG S+ +E + S
Sbjct: 707 QIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQT-EEDLTHVSS 765
Query: 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
+GT GYLDPEYY++Q L+ KSDV+SFGVVL E++SG++P++ E ++V WA+
Sbjct: 766 VAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSL 825
Query: 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
IR+ + I+DP I E++WR+ EVA C+E RP M +++ ++DA IE
Sbjct: 826 IRKGDVCGIIDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERG 885
Query: 813 ASEYMKXXXXXXXXXXXXXXXXXXXXVIPPTPTATESSL 851
+K + +P + +SL
Sbjct: 886 NENGLKSSSSSSSKAQSSRKTLLTSFLELESPDISRNSL 924
|
|
| TAIR|locus:2078186 AT3G46340 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 1.5e-98, Sum P(2) = 1.5e-98
Identities = 155/408 (37%), Positives = 226/408 (55%)
Query: 415 TITGLDLSSGQIQGILPLSVT-----GLTHL--EKFRGFCGSEKSTHKG--ILIGIAVCG 465
+++ ++LS + G +P ++ GL E+ R F GS T K ++I V
Sbjct: 462 SLSFINLSKNNLNGSIPQALLKREKDGLKLSVDEQIRCFPGSCVITKKKFPVMIVALVSS 521
Query: 466 TFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQY 525
+ + V + + F K+K L +N+ + S+ D + FS
Sbjct: 522 AVVVILVVLVLIFVFKKKKPSNLEDLPPSSNTPRENITST--SISDTSIETKRKRFSYSE 579
Query: 526 LEAATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
+ T+ + +GEGGFG VY G + Q+VAVK+ S +STQG +EF+ E+ L + H
Sbjct: 580 VMEMTKNLQRPLGEGGFGVVYHGDINGSSQQVAVKLLSQSSTQGYKEFKAEVELLLRVHH 639
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
NLV L+GYC E D L+Y +MSN L+ L G+ L W TRL IA+ AA GL Y
Sbjct: 640 INLVSLVGYCDERDHLALIYEYMSNKDLKHHLSGKHGG-SVLKWNTRLQIAVDAALGLEY 698
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-SGFSLEVRGTAGYLDP 703
LH S++HRDVKS+NILLD AK+ADFG S+ + Q GD S S V GT GYLDP
Sbjct: 699 LHIGCRPSMVHRDVKSTNILLDDQFTAKMADFGLSR-SFQLGDESQVSTVVAGTPGYLDP 757
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
EYY T L+ SDV+SFG+VLLEII+ + ++ R ++ + EW + I I+D
Sbjct: 758 EYYRTGRLAEMSDVYSFGIVLLEIITNQRVIDPAREKSH--ITEWTAFMLNRGDITRIMD 815
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
P+++G Y++ ++WR +E+A+ C P S RPSM +V EL++ EN
Sbjct: 816 PNLQGDYNSRSVWRALELAMMCANPSSEKRPSMSQVVIELKECIRSEN 863
|
|
| TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 1.8e-97, Sum P(2) = 1.8e-97
Identities = 141/292 (48%), Positives = 201/292 (68%)
Query: 519 QIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNF 578
+IFS + +++AT+ +K +IG G FG+VYRG LPDG++VAVKVR + G F NE++
Sbjct: 594 RIFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHL 653
Query: 579 LSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
LS IRH+NLV G+C E +QILVY ++S GSL D LYG S R +L+W +RL +A+ A
Sbjct: 654 LSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAVDA 713
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
A+GL YLH + +IHRDVKSSNILLD M AKV+DFG SK + S + V+GTA
Sbjct: 714 AKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTA 773
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758
GYLDPEYYST L+ KSDV+SFGVVLLE+I GREPL+ + ++LV WA+P ++
Sbjct: 774 GYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQAGAF 833
Query: 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810
EIVD +K + +M + +A+ C+ ++ RPS+ +++ +L++A+ ++
Sbjct: 834 -EIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQ 884
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 2.1e-97, Sum P(3) = 2.1e-97
Identities = 148/366 (40%), Positives = 213/366 (58%)
Query: 450 EKSTHKGILIGIA--VCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSID 507
+K + K ++ IA V G F V + IF V KRK++ K G +T +V S
Sbjct: 503 KKESKKVPMVAIAASVAGVFALLVILAIFFVI--KRKNVKAHKSPGPPPLVTPGIVKSET 560
Query: 508 SMDDPVKPMPVQIFSLQYLEAA--TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS 565
+P + + + Y E T ++ ++G+GGFG+VY G L DG EVAVK+ S +S
Sbjct: 561 RSSNP--SIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSS 617
Query: 566 TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT 625
QG +EF+ E+ L + H +LV L+GYC + D L+Y +M+NG L++ + G+
Sbjct: 618 AQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGN-V 676
Query: 626 LDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685
L W R+ IA+ AA+GL YLH ++HRDVK++NILL+ AK+ADFG S+ P +
Sbjct: 677 LTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPID 736
Query: 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745
G+ S V GT GYLDPEYY T LS KSDV+SFGVVLLEI++ + ++ R R +
Sbjct: 737 GECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTRERPH--I 794
Query: 746 VEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+W + + I IVDP + G Y W++VE+ALAC+ P S RP+M +V EL D
Sbjct: 795 NDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELND 854
Query: 806 AFIIEN 811
+EN
Sbjct: 855 CVALEN 860
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 646 (232.5 bits), Expect = 4.7e-97, Sum P(2) = 4.7e-97
Identities = 146/388 (37%), Positives = 223/388 (57%)
Query: 430 LPLSVTGLTHLEKFRGFCGSE--KSTH--KGILIGIAVCGTFLFTVAVGIFVVCFY-KRK 484
L L+V G L +G CG++ + H K I++ + V L + + V+ ++K
Sbjct: 487 LKLNVEGNPKLLCTKGPCGNKPGEGGHPKKSIIVPV-VSSVALIAILIAALVLFLVLRKK 545
Query: 485 SIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGS 544
+ + K G+ +P + + F+ + T +++++G+GGFG
Sbjct: 546 NPSRSKENGR-----------TSRSSEPPRITKKKKFTYVEVTEMTNNFRSVLGKGGFGM 594
Query: 545 VYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604
VY G + ++VAVKV S S G ++F+ E+ L + H+NLV L+GYC + + LVY
Sbjct: 595 VYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHHKNLVSLVGYCEKGKELALVY 654
Query: 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNIL 664
+M+NG L++ G+ L W TRL IA+ AA+GL YLH ++HRDVK++NIL
Sbjct: 655 EYMANGDLKEFFSGKRGD-DVLRWETRLQIAVEAAQGLEYLHKGCRPPIVHRDVKTANIL 713
Query: 665 LDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVL 724
LD AK+ADFG S+ EG+S S V GT GYLDPEYY T L+ KSDV+SFGVVL
Sbjct: 714 LDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVL 773
Query: 725 LEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALA 784
LEII+ + + R R + + EW I + I +IVDP++KG YH++++W+ VE+A+
Sbjct: 774 LEIITNQRVIE--RTREKPHIAEWVNLMITKGDIRKIVDPNLKGDYHSDSVWKFVELAMT 831
Query: 785 CIEPFSAYRPSMVDIVRELEDAFIIENN 812
C+ SA RP+M +V EL + +EN+
Sbjct: 832 CVNDSSATRPTMTQVVTELTECVTLENS 859
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 6.0e-97, Sum P(2) = 6.0e-97
Identities = 154/410 (37%), Positives = 241/410 (58%)
Query: 415 TITGLDLSSGQIQGILPLSV-----TGLT-HLEKFRGFC-GSE--KSTHKGILIGIAVCG 465
+++ ++LS ++G++P ++ GL + + + C G E +S K + +
Sbjct: 455 SLSNINLSWNNLKGLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSIS 514
Query: 466 TFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQY 525
L TV V + +V YK+K + K+ + P+TK+ + + + F+
Sbjct: 515 AILLTVVV-LLIVFIYKKKKTS--KVRHR-LPITKSEILT-----------KKRRFTYSE 559
Query: 526 LEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE 585
+EA T +++ +IGEGGFG VY G L D ++VAVK+ S +STQG ++F+ E+ L + H
Sbjct: 560 VEAVTNKFERVIGEGGFGIVYHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHT 619
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
NLV L+GYC E D LVY + +NG L+ L GE+S+ L+W +RL IA A+GL YL
Sbjct: 620 NLVNLVGYCNEEDHLALVYEYAANGDLKQHLSGESSSA-ALNWASRLGIATETAQGLEYL 678
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H +IHRDVK++NILLD AK+ADFG S+ P +S S V GT GYLDPEY
Sbjct: 679 HIGCEPPMIHRDVKTTNILLDEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEY 738
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765
Y T L+ KSDV+S G+VLLEII+ +P+ ++ R + + EW + + I I+DP
Sbjct: 739 YRTNWLTEKSDVYSMGIVLLEIITN-QPV-IQQVREKPHIAEWVGLMLTKGDIKSIMDPK 796
Query: 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASE 815
+ G Y + ++W+ +E+A++C+ P S RP+M ++ EL++ I EN+ E
Sbjct: 797 LNGEYDSSSVWKALELAMSCVNPSSGGRPTMSQVISELKECLIYENSRKE 846
|
|
| TAIR|locus:2078176 MEE39 "maternal effect embryo arrest 39" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-95, Sum P(3) = 1.3e-95
Identities = 132/292 (45%), Positives = 179/292 (61%)
Query: 521 FSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLS 580
F+ + T+ + +GEGGFG VY G L ++VAVK+ S TS QG +EF+ E+ L
Sbjct: 556 FTYSEVMEMTKNLQRPLGEGGFGVVYHGDLNGSEQVAVKLLSQTSAQGYKEFKAEVELLL 615
Query: 581 AIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR 640
+ H NLV L+GYC E D L+Y +MSNG L L G+ L+W TRL IA+ AA
Sbjct: 616 RVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGG-SVLNWGTRLQIAIEAAL 674
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-SGFSLEVRGTAG 699
GL YLHT +++HRDVKS+NILLD AK+ADFG S+ GD S S V GT G
Sbjct: 675 GLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGGDQSQVSTVVAGTLG 734
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759
YLDPEYY T LS KSDV+SFG++LLEII+ + ++ R N ++ EW I++
Sbjct: 735 YLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVIDQTR-ENP-NIAEWVTFVIKKGDTS 792
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
+IVDP + G Y ++WR +EVA++C P S RP+M ++ L++ EN
Sbjct: 793 QIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECLASEN 844
|
|
| TAIR|locus:2078196 AT3G46350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 4.8e-94, Sum P(3) = 4.8e-94
Identities = 144/367 (39%), Positives = 210/367 (57%)
Query: 447 CGSEKSTHKGILIGIAVCGTFLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTK-NLVFS 505
C +K ++I V T +F + V + + ++K + P T V S
Sbjct: 482 CNPKKKF--SVMIVAIVASTVVFVLVVSLALFFGLRKKKTSSHVKAIPPSPTTPLENVMS 539
Query: 506 IDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS 565
+ ++ M + FS + T ++ +GEGGFG+VY G L Q+VAVK+ S +S
Sbjct: 540 TSISETSIE-MKRKKFSYSEVMKMTNNFQRALGEGGFGTVYHGDLDSSQQVAVKLLSQSS 598
Query: 566 TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT 625
TQG +EF+ E++ L + H NL+ L+GYC E D L+Y +MSNG L+ L GE
Sbjct: 599 TQGYKEFKAEVDLLLRVHHINLLNLVGYCDERDHLALIYEYMSNGDLKHHLSGEHGG-SV 657
Query: 626 LDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685
L W RL IA+ AA GL YLH S++HRDVKS+NILLD + AK+ADFG S+
Sbjct: 658 LSWNIRLRIAVDAALGLEYLHIGCRPSMVHRDVKSTNILLDENFMAKIADFGLSRSFILG 717
Query: 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745
G+S S V G+ GYLDPEYY T L+ SDV+SFG+VLLEII+ + ++ R + +
Sbjct: 718 GESHVSTVVAGSLGYLDPEYYRTSRLAEMSDVYSFGIVLLEIITNQRVIDKTREKPH--I 775
Query: 746 VEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
EW + I I+DP++ G Y++ ++WR +E+A++C P S RPSM +V EL++
Sbjct: 776 TEWTAFMLNRGDITRIMDPNLNGDYNSHSVWRALELAMSCANPSSENRPSMSQVVAELKE 835
Query: 806 AFIIENN 812
I EN+
Sbjct: 836 CLISENS 842
|
|
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 6.4e-94, Sum P(2) = 6.4e-94
Identities = 144/406 (35%), Positives = 221/406 (54%)
Query: 408 NTRNGSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSEKSTHKGILIG-IAVCGT 466
N NGSI T LD +G + LS+ G T L C + K K +I +A
Sbjct: 466 NELNGSIPATLLDKER---RGSITLSIEGNTGLCSSTS-CATTKKKKKNTVIAPVAASLV 521
Query: 467 FLFTVAVGIFVVCFYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYL 526
+F + GI KRK L T L +P P+ + L Y+
Sbjct: 522 SVFLIGAGIVTFLILKRKKRTKLGLNPNSGTGTTPLHSRSHHGFEP--PVIAKNRKLTYI 579
Query: 527 EAA--TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
+ T ++ ++G GGFG VY G L + + VAVK+ + ++ G ++F+ E+ L + H
Sbjct: 580 DVVKITNNFERVLGRGGFGVVYYGVL-NNEPVAVKMLTESTALGYKQFKAEVELLLRVHH 638
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
++L L+GYC E D+ L+Y FM+NG L++ L G+ L W RL IA +A+GL Y
Sbjct: 639 KDLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGP-SILTWEGRLRIAAESAQGLEY 697
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH ++HRD+K++NILL+ AK+ADFG S+ P ++ S V GT GYLDPE
Sbjct: 698 LHNGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPE 757
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
YY T L+ KSDVFSFGVVLLE+++ + ++ +R ++ + EW + I+ IVDP
Sbjct: 758 YYRTNWLTEKSDVFSFGVVLLELVTNQPVIDMKREKSH--IAEWVGLMLSRGDINSIVDP 815
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810
++G + +W++VE A+ C+ P S+ RP+M +V +L++ +E
Sbjct: 816 KLQGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNME 861
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8L4H4 | NORK_MEDTR | 2, ., 7, ., 1, 1, ., 1 | 0.5634 | 0.9756 | 0.9102 | N/A | no |
| Q8LKZ1 | NORK_PEA | 2, ., 7, ., 1, 1, ., 1 | 0.5567 | 0.9779 | 0.9134 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 863 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 1e-69 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-23 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-09 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 1e-69
Identities = 119/348 (34%), Positives = 162/348 (46%), Gaps = 40/348 (11%)
Query: 37 IACCADSDFIGKYPPVN--WKPDDAWFPDKKDCRAIT---RPAVNNKFYDRVLDFGIDSG 91
I C S+ P W D F D I+ + +K Y + F G
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDA-GFIDTGKSGNISKENSSSFLSKPYKTLRSF--PDG 57
Query: 92 KR-CYNLSTIKGQD--YLIRGTFL-----NGDNVETPLISSFNVLVGVTPLSLVNSTEDS 143
KR CY L G+ YLIR TFL ++V +P SF++ +GV + VN + DS
Sbjct: 58 KRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSP--PSFDLYLGVNLWTTVNLSNDS 115
Query: 144 ----VVEGIFKAAN-DYIDFCL-DKKDGDPYISGLEVRPLNDTEYLPGQSANVLKLVGRY 197
V E I D + CL + G P+IS LE+RPL D+ Y + LKLV R
Sbjct: 116 GDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGSQALKLVARL 175
Query: 198 DLGRSDNELSFRYPDDPFDRIWIP-KLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTAL 256
+ G S+ + RYPDD +DRIW P SP + STS + +IS NNA P VLQTA+
Sbjct: 176 NFGGSEGTI--RYPDDVYDRIWEPFFSSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAV 233
Query: 257 T---DPNRLMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDIL 313
T L F DL ++ Y + L+F E+ R FDI IN +
Sbjct: 234 TPTNASAPLNFTW-DLVDPNFEYYVYLHFAEIQSLE----TREFDIYINGKTVYGDVSPK 288
Query: 314 ALGSNYAKL----ALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQV 357
LG++ L +NV+ G LN++LV +GS P+ NA EI +V
Sbjct: 289 YLGTDTGALYLDFPVNVSGGGLLNISLVPT-SGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 82/286 (28%), Positives = 126/286 (44%), Gaps = 44/286 (15%)
Query: 537 IGEGGFGSVYRGTLPDGQ----EVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+GEG FG VY+G L EVAVK + S + ++F E + + H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 592 GYCCENDQQILVYPFMSNGSLQD-----RLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
G C E + LV +M G L D R + + TL LS A+ A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG----DSGFSLEVRGTAGYLD 702
+ +HRD+ + N L+ + K++DFG S+ + +G L +R A
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA---- 175
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE-SRID- 759
PE ++KSDV+SFGV+L EI + G P ++R+ R+
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRLPK 228
Query: 760 -EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
E + Y E+ L+C + RP+ ++V LE
Sbjct: 229 PEYCPDEL---Y---------ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 83/284 (29%), Positives = 124/284 (43%), Gaps = 50/284 (17%)
Query: 537 IGEGGFGSVYRGTL-----PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG VY+G L EVAVK + S Q EF E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C E + +V +M G L L R L LS AL ARG+ YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGDSGFSLEVRGTAGYLDP 703
++ IHRD+ + N L+ ++ K++DFG S+ Y + G L +R A P
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK----LPIRWMA----P 172
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIIS-GREP---LNTRRPRNEWSLVEWAKPFIRESRID 759
E ++KSDV+SFGV+L EI + G +P ++ ++E+ K R +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE------VLEYLKNGYRLPQPP 226
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+ ++ L C RP+ ++V L
Sbjct: 227 NCPP-------------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-47
Identities = 86/284 (30%), Positives = 128/284 (45%), Gaps = 49/284 (17%)
Query: 537 IGEGGFGSVYRGTL-----PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG VY+GTL EVAVK + S Q EF E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C E + ++V +M G L D L + K L LS AL ARG+ YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGDSGFSLEVRGTAGYLDP 703
++ IHRD+ + N L+ ++ K++DFG S+ Y + G L +R A P
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK----LPIRWMA----P 173
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIIS-GREP---LNTRRPRNEWSLVEWAKPFIRESRID 759
E ++KSDV+SFGV+L EI + G EP ++ ++E+ K R +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE------VLEYLKKGYRLPKPP 227
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+ ++ L C RP+ ++V L
Sbjct: 228 NCPP-------------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 69/195 (35%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+GEGGFG+VY G++VA+K+ + S+ E E+ L + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ + LV + GSL+D L L L I L GL YLH+ +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHS---NGII 114
Query: 655 HRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH-LS 712
HRD+K NILLD + K+ADFG SK D + GT Y+ PE + S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 713 AKSDVFSFGVVLLEI 727
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 45/282 (15%)
Query: 537 IGEGGFGSVYRGTL-----PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG VY+GTL +VAVK + S + EF E + + + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C + + +V +M G L D L + L L +AL A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE----VRGTAGYLDPEYY 706
++ +HRD+ + N L+ ++ K++DFG S+ ++ ++ A PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA----PESL 176
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765
++KSDV+SFGV+L EI + G +P + + E+++
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP---------YPGMSNE----------EVLE-L 216
Query: 766 IKGGYHAEAM----WRMVEVALACIEPFSAYRPSMVDIVREL 803
++ GY + E+ L C RP+ ++V +L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+G G FG+VY+ G+ VAVK+ + S ++ + E+ L + H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ D LV + G L D L S L IAL RGL YLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE------YYS 707
IHRD+K NILLD + K+ADFG +K S GT Y+ PE Y
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
K DV+S GV+L E+++G+ P + ++
Sbjct: 178 P-----KVDVWSLGVILYELLTGKPPFSGENILDQ 207
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 12/200 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+GEG FG VY G+ VA+K ++ + E+ L ++H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ D+ LV + G L D L R L L YLH + +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
+HRD+K NILLD K+ADFG ++ Q GT Y+ PE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 714 KSDVFSFGVVLLEIISGREP 733
D++S GV+L E+++G+ P
Sbjct: 176 AVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQGT-REFENELNFLSAIRHENLVPLLG 592
L+G G FGSVY D G+ +AVK V S ++ E E+ LS+++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 593 YCCENDQ-QILVY-PFMSNGSLQDRLYGEAS---------TRKTLDWPTRLSIALGAARG 641
+ ++ + ++ ++S GSL L TR+ L G
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------EG 113
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLH ++HRD+K +NIL+D K+ADFG +K + VRGT ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE + +D++S G ++E+ +G+ P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 77/203 (37%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+ IG+G FG V G GQ+VAVK ST F E + ++ +RH NLV LL
Sbjct: 9 KLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLL 66
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G + + +V +M+ GSL D Y + R + +L AL G+ YL +
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVD--YLRSRGRAVITLAQQLGFALDVCEGMEYLE---EK 121
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
+ +HRD+ + N+L+ + AKV+DFG +K A Q DSG L V+ TA PE +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG-KLPVKWTA----PEALREKKF 176
Query: 712 SAKSDVFSFGVVLLEIIS-GREP 733
S KSDV+SFG++L EI S GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG+GGFG VY+ G+EVA+KV S + + NE+ L +H N+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ D+ +V F S GSL+D L ST +TL + +GL YLH+ +IH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+K++NILL K+ DFG S Q D+ + GT ++ PE + + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 716 DVFSFGVVLLEIISGREPL 734
D++S G+ +E+ G+ P
Sbjct: 179 DIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 537 IGEGGFGSVYRGT---LPDGQ--EVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG V L D +VAVK S Q +FE E+ L + HEN+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 591 LGYCCENDQQI--LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
G C + + L+ ++ +GSL+D L R ++ L + +G+ YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT-AGYLDPEYYS 707
+ IHRD+ + NIL++ K++DFG +K P++ D + E + + PE
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREP 733
T S+ SDV+SFGV L E+ + +P
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVPLLGYC 594
+G+G G VY+ P G+ A+K + R + EL L + +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL--SIALGAARGLMYLHTFAGRS 652
+ + +V +M GSL D L +K P + IA +GL YLHT R
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHT--KRH 120
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
+IHRD+K SN+L++ K+ADFG SK D + GT Y+ PE + S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYS 178
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
+D++S G+ LLE G+ P + + L++
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 537 IGEGGFGSVYRGTL----PDGQE--VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
+GEG FG V+ G P+ + VAVK + + S ++FE E L+ +HEN+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 590 LLGYCCENDQQILVYPFMSNGSLQD----------RLYGEASTRKTLDWPTRLSIALGAA 639
G C E D I+V+ +M +G L L S L L IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLE 693
G++YL A + +HRD+ + N L+ + + K+ DFG S+ Y G + L
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT--MLP 187
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+R ++ PE + + +SDV+SFGVVL EI + G++P
Sbjct: 188 IR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ GT +VAVK T F E + +RH+ LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ +V +MS GSL D L K L P + +A A G+ YL + R+ IHR
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 657 DVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
D+ + NIL+ ++ K+ADFG ++ Y +EG + F ++ TA PE +
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREG-AKFP--IKWTA----PEAANYGR 180
Query: 711 LSAKSDVFSFGVVLLEIIS-GREP 733
+ KSDV+SFG++L EI++ GR P
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 72/199 (36%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG FG+V +G GQ+VAVK ++ + Q F E ++ + H+NLV LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
N I V MS G+L + L R + L +L A G+ YL + + ++H
Sbjct: 70 HNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+ + NIL+ AKV+DFG ++ D+ L V+ TA PE + S+KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS-KLPVKWTA----PEALKHKKFSSKS 178
Query: 716 DVFSFGVVLLEIIS-GREP 733
DV+S+GV+L E+ S GR P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ G + VA+K+ S ++F+ E+ L +RH++L+ L C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ ++ M GSL L + + L + + +A A G+ YL ++ IHR
Sbjct: 74 GEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHR 128
Query: 657 DVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
D+ + NIL+ + KVADFG ++ Y S + + TA PE S
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLS----SDKKIPYKWTA----PEAASHGT 180
Query: 711 LSAKSDVFSFGVVLLEIIS 729
S KSDV+SFG++L E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV----RSSTSTQGTREFENELNFLSAIRHE-N 586
+ +GEG FG VY D + VA+KV S S + R F E+ L+++ H N
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVER-FLREIQILASLNHPPN 59
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+V L + + LV ++ GSL+D L + + L L I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 647 TFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGDSG----FSLEVRGTAGYL 701
+ + +IHRD+K NILLD K+ DFG +K P G + GT GY+
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 702 DPEYY---STQHLSAKSDVFSFGVVLLEIISGREP 733
PE S + S+ SD++S G+ L E+++G P
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 33/226 (14%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGT-REFENELNFLSAIRHENLVPLLGY 593
IG G FG VY L G+ +AVK +R + T +E +E+ L ++H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 594 CCENDQQILVYPFM---SNGSLQD-----RLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
++ VY FM S G+L++ R+ E R ++ L GL YL
Sbjct: 68 EVHREK---VYIFMEYCSGGTLEELLEHGRILDEHVIR-------VYTLQL--LEGLAYL 115
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS--LEVRGTAGYLDP 703
H+ ++HRD+K +NI LDH+ K+ DFG + + + GT Y+ P
Sbjct: 116 HS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 704 EYYSTQHLSAK---SDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
E + +D++S G V+LE+ +G+ P + NE+ ++
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS--ELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 532 QYKTLIGEGGFGSVYRG-TLPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRHENLV 588
Q LIG G FG VY+G L G VA+K + + E++ L ++H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAA--RGLMYLH 646
+G +D ++ + NGSL+ + +K +P L +GL YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ VIHRD+K++NIL K+ADFG + S V GT ++ PE
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVI 171
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
S SD++S G ++E+++G P P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 536 LIGEGGFGSVYRG-TLPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
L+G G FGSVY G L DG AVK T + ++ E E+ LS ++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL--YG-------EASTRKTLDWPTRLSIALGAAR 640
LG E D + + GSL L YG TR+ L
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
GL YLH R+ +HRD+K +NIL+D + K+ADFG +K Q + F+ +G+ +
Sbjct: 114 GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYW 167
Query: 701 LDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREP 733
+ PE + Q +D++S G +LE+ +G+ P
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-26
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG G FG V+ G + ++VA+K +R ++ +F E + + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
E LV+ FM +G L D L + R T L + L G+ YL + +VIH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD+ + N L+ + KV+DFG +++ + +G V+ ++ PE +S S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSS----PEVFSFSKYS 179
Query: 713 AKSDVFSFGVVLLEIIS-GREPLNTR 737
+KSDV+SFGV++ E+ S G+ P R
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENR 205
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGYC 594
IG+G FG VY+G L EVAVK ST + F E L H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ +V + GSL L + + L ++L AA G+ YL + ++ I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK---KLLQMSLDAAAGMEYLES---KNCI 115
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-------VRGTAGYLDPEYYS 707
HRD+ + N L+ + K++DFG S+ +E +++ ++ TA PE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTA----PEALN 168
Query: 708 TQHLSAKSDVFSFGVVLLEIISG 730
+++SDV+S+G++L E S
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
Q +G G FG V+ G + VAVK T ++F E + +RH L+ L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
C + +V M GSL + L G A + L P + +A A G+ YL +
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLEA---Q 122
Query: 652 SVIHRDVKSSNILL-DHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPE 704
+ IHRD+ + N+L+ ++++C KVADFG ++ Y +EG ++ TA PE
Sbjct: 123 NYIHRDLAARNVLVGENNIC-KVADFGLARVIKEDIYEAREGA---KFPIKWTA----PE 174
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
S KSDV+SFG++L EI++ GR P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 45/288 (15%)
Query: 536 LIGEGGFGSVYRGTL--PDGQEVAVKVRS---STSTQGTREFENELNFLSAIRHENLVPL 590
+IG+G FG VY GTL DGQ++ V+S T + +F E + H N++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 591 LGYCCEND-QQILVYPFMSNGSLQDRLYGEAS--TRKTLDWPTRLSIALGAARGLMYLHT 647
LG C ++ ++V P+M +G L++ + E T K L + L A+G+ YL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGDSGFSLEVRGTAGY 700
A + +HRD+ + N +LD S KVADFG ++ Y+ +G L V+ A
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN-HTGAKLPVKWMA-- 170
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRID 759
E TQ + KSDV+SFGV+L E+++ G P + + + ++ + R
Sbjct: 171 --LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVDSFDITV----YLLQGR-- 219
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
++ P Y + ++ EV L+C P RP+ ++V +E F
Sbjct: 220 RLLQPE----YCPDPLY---EVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
IG+G FG V G G +VAVK + +T + F E + ++ +RH NLV LLG E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 597 NDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ +V +M+ GSL D Y + R L L +L + YL + +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+ + N+L+ AKV+DFG +K A D+G L V+ TA PE + S KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWTA----PEALREKKFSTKS 180
Query: 716 DVFSFGVVLLEIIS-GREP 733
DV+SFG++L EI S GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 517 PVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENE 575
P ++F + +GEG +GSVY+ GQ VA+KV +E E
Sbjct: 1 PEEVFDILEK----------LGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKE 48
Query: 576 LNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
++ L +V G +N +V + GS+ D + T KTL +I
Sbjct: 49 ISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAIL 105
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
+GL YLH+ IHRD+K+ NILL+ AK+ADFG S V
Sbjct: 106 YQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVI 160
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
GT ++ PE + K+D++S G+ +E+ G+ P + P
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTRE---FENELNFLSAIRHENLVPLLGY 593
+G G FG V+ G +VA+K + QG+ F E N + ++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSMSPEAFLAEANLMKQLQHPRLVRL--Y 67
Query: 594 CCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
+ I ++ +M NGSL D L + T+ + +A A G+ ++ ++
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIER---KN 122
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYY 706
IHRD++++NIL+ ++C K+ADFG ++ Y +EG ++ TA PE
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA---KFPIKWTA----PEAI 175
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + KSDV+SFG++L EI++ GR P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGT-REFENELNFLSAIRHENLVPLLGYC 594
+GEG GSV + L + + A+K ++ ++ EL + + +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 595 CEN-DQQI-LVYPFMSNGSLQDRLYGEASTR--KTLDWPTRLSIALGAARGLMYLHTFAG 650
+ I + + GSL D +Y + R + + IA +GL YLH+
Sbjct: 69 LDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-GKIAESVLKGLSYLHS--- 123
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
R +IHRD+K SNILL K+ DFG S F+ GT+ Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQGKP 179
Query: 711 LSAKSDVFSFGVVLLEIISGREP 733
S SDV+S G+ LLE+ R P
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV----RSSTSTQG-TREFENELNFLSAIRHENLVP 589
L+G+G FG VY D G+E+AVK S T+ E E+ L ++HE +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 590 LLGYCCENDQQILVY-PFMSNGSLQD--RLYG---EASTRKTLDWPTRLSIALGAARGLM 643
G C +D+ + ++ +M GS++D + YG E TRK TR + G+
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY----TRQIL-----EGVE 118
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG-FSLEVRGTAGYLD 702
YLH+ ++HRD+K +NIL D + K+ DFG SK SG V GT ++
Sbjct: 119 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
PE S + K+DV+S G ++E+++ + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVPLL 591
IG G FG V RG L P +E VA+K + S+ R +F E + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G ++ +++ +M NGSL L + + G A G+ YL +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYYS 707
+ +HRD+ + NIL++ ++ KV+DFG S+ G + +R TA PE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA----PEAIA 181
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
+ ++ SDV+SFG+V+ E++S E RP + S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGE-----RPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 533 YKTLIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREF-ENELNFLSAIRHENLVP 589
IG+G FG VY DG+ +K + S ++ RE NE+ L + H N++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT------LDWPTRLSIALGAARGLM 643
E + +V + G L ++ + K LDW +L +AL
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL------K 117
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGTAGYLD 702
YLH+ R ++HRD+K NI L + K+ DFG SK + V GT YL
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLS 171
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE + + KSD++S G VL E+ + + P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 532 QYKTL--IGEGGFGSVYRG-TLPDGQEVAVKV----RSSTSTQGTREFENELNFLSAIRH 584
Y+ + IG G VY LP+ ++VA+K + TS R+ E+ +S H
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK---EVQAMSQCNH 58
Query: 585 ENLVPLLGYCC---ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
N+V Y D+ LV P++S GSL D + + R LD ++ +G
Sbjct: 59 PNVV---KYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GT 697
L YLH+ IHRD+K+ NILL K+ADFG S GD + +VR GT
Sbjct: 115 LEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR--TRKVRKTFVGT 169
Query: 698 AGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRP 739
++ PE H K+D++SFG+ +E+ +G P + P
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 537 IGEGGFGSVY----RGTLPDGQE--VAVKVRSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG V+ LP+ + VAVK S ++F+ E L+ ++H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLD-----------WPTRLSIALGAA 639
G C E ++V+ +M +G L L K L L+IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSG--FSLEVR 695
G++YL A +HRD+ + N L+ + K+ DFG S+ Y+ G L +R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
++ PE + + +SD++SFGVVL EI + G++P
Sbjct: 190 ----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 35/223 (15%)
Query: 537 IGEGGFGSVYRGTL--PDGQE----VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+GEG FG VY+G L P+ + VA+K ++ + + +EF E +S ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTRLSIALG 637
LLG C + +++ ++++G L + L G+ + + +LD L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFS 691
A G+ YL + +HRD+ + N L+ + K++DFG S+ Y + S
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS--L 187
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L VR ++ PE + +SD++SFGVVL EI S G +P
Sbjct: 188 LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-23
Identities = 104/396 (26%), Positives = 167/396 (42%), Gaps = 65/396 (16%)
Query: 86 FGIDSG-KRCYNLSTIKGQDYLIRGTFL-----NGDN-------VETPLISSFNVLVGVT 132
F + G + CYN++ + Y +R F N D+ VE ISS
Sbjct: 75 FPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISS-------- 126
Query: 133 PLSLVNSTEDSVV--EGIFKAANDYIDFCLDKK-DGDPYISGLEVRPLNDTEYLPGQSAN 189
L S+ D V E + + C GDP I +E+ ++D Y G S
Sbjct: 127 -LKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWG 185
Query: 190 ---VLKLVGRYDLGRSDNELSFRYPDDPF--DRIWIPKLSPEPTTFSTSFTTNISD---- 240
+L+ R G ++ Y D + DR W TF + IS
Sbjct: 186 QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM-----QTFGSGSDQAISTENVI 240
Query: 241 ---NNAKVTVPLQVLQTALTDPNRLMFLHTDLD-SGDYNYTLILYFLELNDSVKSSGQRV 296
+NA P + Q+AL + L +D + NY++ L+F E+++S+ + G+RV
Sbjct: 241 KKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRV 300
Query: 297 FDILINNERKKEKFDILAL-GSNYAKLALN--VTANGSLNLTLVNV-LNGSVFGPICNAY 352
FD+LIN + + DI+ + G Y L LN V +G LT+V G+ I NA
Sbjct: 301 FDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGR-TLTIVLQPKKGTH--AIINAI 357
Query: 353 EILQVRQWVQETDQADVNVIRKVRDELKKYNKENKVLES---WSGDPCRPST--WRGVYC 407
E+ ++ +T +V+ ++ ++ L L W+GDPC P W G C
Sbjct: 358 EVFEIITAESKTLLEEVSALQTLKSSLG--------LPLRFGWNGDPCVPQQHPWSGADC 409
Query: 408 --NTRNGSITITGLDLSSGQIQGILPLSVTGLTHLE 441
++ G I GL L + ++G +P ++ L HL+
Sbjct: 410 QFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQ 445
|
Length = 623 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G G V + P G+ +AVK +R + ++ EL+ L +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL--SIALGAARGLMYLHTFAGRS 652
N + +M GSL D++ E R P R+ IA+ +GL YLH
Sbjct: 69 YNNGDISICMEYMDGGSL-DKILKEVQGR----IPERILGKIAVAVLKGLTYLHE--KHK 121
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
+IHRDVK SNIL++ K+ DFG S F GT+ Y+ PE S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGNDYS 177
Query: 713 AKSDVFSFGVVLLEIISGREPL 734
KSD++S G+ L+E+ +GR P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG G VY+ T G+EVA+K Q NE+ + +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V +M GSL D + ++ P + +GL YLH+ +VIH
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIH 139
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+KS NILL K+ADFGF+ +E S V GT ++ PE + K
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKV 197
Query: 716 DVFSFGVVLLEIISGREP 733
D++S G++ +E+ G EP
Sbjct: 198 DIWSLGIMCIEMAEG-EP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 63/233 (27%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 527 EAATQQYKTLIGEGGFGSVYRGT-LPDGQ----EVAVKV-RSSTSTQGTREFENELNFLS 580
E ++ K L G G FG+VY+G +P+G+ VA+KV R TS + +E +E ++
Sbjct: 6 ETELEKIKVL-GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA 64
Query: 581 AIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR 640
++ H ++V LLG C + Q L+ M G L D + + + + L+ + A+
Sbjct: 65 SVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAK 120
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG- 699
G+ YL + ++HRD+ + N+L+ K+ DFG +K + E G
Sbjct: 121 GMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-----EYHAEGGK 172
Query: 700 ----YLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747
++ E + + KSDV+S+GV + E+++ G +P L+E
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 37/232 (15%)
Query: 532 QYKTLIGEGGFGSVYR----GTLPDGQE--VAVKV-RSSTSTQGTREFENELNFLSAIRH 584
+Y IG+G FG V++ G LP VAVK+ + S +F+ E ++ H
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKT------L 626
N+V LLG C L++ +M+ G L + L + +S RK L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 627 DWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQ 684
+L IA A G+ YL + R +HRD+ + N L+ +M K+ADFG S+ Y+
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 685 --EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ ++ +R ++ PE + +SDV+++GVVL EI S G +P
Sbjct: 185 YYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 537 IGEGGFGSVYRGT--LPDGQEVAVKVRS---STSTQGTREFENELNFLSAIRHENLVPLL 591
+G G FGSV +G + G+EV V V++ G +EF E + ++ + H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 592 GYCCENDQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
G C+ + +LV G L L E + A A G+ YL
Sbjct: 63 G-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE--- 112
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG-----YLDPE 704
+ +HRD+ + N+LL + AK++DFG S+ A G + TAG + PE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRAT---TAGRWPLKWYAPE 168
Query: 705 --YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
Y S+KSDV+S+GV L E S G +P
Sbjct: 169 CINYGK--FSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 533 YKTLIGEGGFGSV----YRGTLPD--GQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
+ +G+G FGSV Y L D G+ VAVK ++ + R+FE E+ L +++H+N
Sbjct: 8 FIQQLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 587 LVPLLGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+V G C ++ LV ++ GSL+D L R+ LD L A +G+ Y
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEY 123
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG--YLD 702
L + +HRD+ + NIL++ K+ DFG +K PQ+ + + + G + +
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY-YKVREPGESPIFWYA 179
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIIS 729
PE + S SDV+SFGVVL E+ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 536 LIGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR----------H 584
LIG+G +G VY + G+ +AVK +T R + + + A+R H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQD--RLYGEASTRKTLDWPTRLSIALGAARGL 642
N+V LG+ + + ++ GS+ R YG + GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR------FEEQLVRFFTEQVLEGL 121
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
YLH+ + ++HRD+K+ N+L+D K++DFG SK + D+ ++ ++G+ ++
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 703 PEYYSTQH--LSAKSDVFSFGVVLLEIISGREP 733
PE + SAK D++S G V+LE+ +GR P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 64/198 (32%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 534 KTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
K +G G +G VY G VAVK T EF E + I+H NLV LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
C ++ FM+ G+L D Y R+ ++ L +A + + YL ++
Sbjct: 70 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEK---KN 124
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQ 709
IHRD+ + N L+ + KVADFG S+ + +G ++ TA PE +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYN 180
Query: 710 HLSAKSDVFSFGVVLLEI 727
S KSDV++FGV+L EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 536 LIGEGGFGSVYR-GTLPDGQEVAVK-VRSSTSTQGTREFE-NELNFLSAIRHENLVPLLG 592
+G+G +GSVY+ L D Q A+K V + +Q RE NE+ L+++ H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---- 62
Query: 593 YCCENDQQIL------VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ + V + G L + RK + I + RGL LH
Sbjct: 63 --SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ ++HRD+KS+NILL + K+ D G SK + + GT Y+ PE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVW 173
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
+ S KSD++S G +L E+ + P R
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 67/207 (32%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 536 LIGEGGFGSVYRGTL--PDGQ--EVAVKVRSSTSTQGT-REFENELNFLSAIRHENLVPL 590
+G+G FG V RG G+ VAVK S +F E + ++ HENL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
G ++V GSL DRL +A + T A+ A G+ YL +
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLES--- 115
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD---SGFSLEVRGTAGYLDPEYYS 707
+ IHRD+ + NILL K+ DFG + PQ D L+V + PE
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 708 TQHLSAKSDVFSFGVVLLEIIS-GREP 733
T+ S SDV+ FGV L E+ + G EP
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 66/202 (32%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+G FG V+ GT VA+K T F E + +RHE LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 597 NDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+++ I +V +MS GSL D L GE L P + +A A G+ Y+ + +H
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD++++NIL+ ++ KVADFG ++ G ++ TA PE +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
KSDV+SFG++L E+ + GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 76/301 (25%), Positives = 127/301 (42%), Gaps = 47/301 (15%)
Query: 532 QYKTLIGEGGFGSVYRGT------LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRH 584
+GEG FG V + T VAVK ++ + S+ R+ +E N L + H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTR- 631
+++ L G C ++ +L+ + GSL+ L LD P
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 632 -------LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684
+S A +RG+ YL A ++HRD+ + N+L+ K++DFG S+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEW 743
E + R ++ E + +SDV+SFGV+L EI++ G P P +
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239
Query: 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+L+ K R R + +E M+ ++ L C + RP+ DI +EL
Sbjct: 240 NLL---KTGYRMERPENC----------SEEMYNLM---LTCWKQEPDKRPTFADISKEL 283
Query: 804 E 804
E
Sbjct: 284 E 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 7e-21
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 44/222 (19%)
Query: 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAIRH 584
+ +GEG +G VY+ G+ VA+K +R +G RE ++ L ++H
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKH 57
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
N+V LL + LV+ + L+ L L SI RGL Y
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TA 698
H+ ++HRD+K NIL++ K+ADFG ++ F + +R T
Sbjct: 114 CHS---HRILHRDLKPQNILINRDGVLKLADFGLARA--------FGIPLRTYTHEVVTL 162
Query: 699 GYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE +YST D++S G + E+I+G+ PL
Sbjct: 163 WYRAPEILLGSKHYSTA-----VDIWSVGCIFAEMITGK-PL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ T +VAVK + F E N + ++H+ LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
I+ FM+ GSL D L + +++ L P + + A G+ ++ R+ IHR
Sbjct: 73 EPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYIHR 126
Query: 657 DVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
D++++NIL+ S+ K+ADFG ++ Y +EG ++ TA PE +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA---KFPIKWTA----PEAINFGS 179
Query: 711 LSAKSDVFSFGVVLLEIIS-GREP 733
+ KSDV+SFG++L+EI++ GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ G + +VAVK T + F E N + ++H+ LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ ++ +M+ GSL D L + + L P + + A G+ Y+ ++ IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 657 DVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
D++++N+L+ S+ K+ADFG ++ Y +EG ++ TA PE +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA---KFPIKWTA----PEAINFGS 180
Query: 711 LSAKSDVFSFGVVLLEIIS-GREP 733
+ KSDV+SFG++L EI++ G+ P
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 534 KTLIGEGGFGSVYRGTL----PDGQE--VAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
K +GEG FG V+ P+ + VAVK S ++F E L+ ++HE++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQD--RLYG-------EASTRKTLDWPTRLSIALGA 638
V G C E D I+V+ +M +G L R +G E + L L IA
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSG--FSLEV 694
A G++YL A + +HRD+ + N L+ ++ K+ DFG S+ Y+ G L +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
R ++ PE + + +SDV+S GVVL EI + G++P
Sbjct: 187 R----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 84/285 (29%), Positives = 143/285 (50%), Gaps = 43/285 (15%)
Query: 534 KTLIGEGGFGSVYRGTL--PDGQEVAVKVRSSTS--TQGTR-EFENELNFLSAIRHENLV 588
+ +IG G FG V+RG L P +EVAV +++ T+ R +F +E + + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLSIALGAARGLMYL 645
L G + +++ +M NG+L L GE S+ + + + G A G+ YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV------GMLRGIAAGMKYL 123
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGY 700
+ + +HRD+ + NIL++ ++ KV+DFG S+ + + SG + +R TA
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA-- 178
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760
PE + + ++ SDV+SFG+V+ E++S E RP + S E K R+
Sbjct: 179 --PEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----RPYWDMSNHEVMKAINDGFRLPA 231
Query: 761 IVD-PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+D PS A+++++ L C + A RP VDIV L+
Sbjct: 232 PMDCPS--------AVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 536 LIGEGGFGSVYRGTLPD-------GQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENL 587
+G G FG VY GT D VAVK +R + Q +EF E + +S H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT---LDWPTRLSIALGAARGLMY 644
V LLG C N+ Q ++ M G L L R L L I L A+G +Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 645 LHTFAGRSVIHRDVKSSNILL-----DHSMCAKVADFGFSK------YAPQEGDSGFSLE 693
L IHRD+ + N L+ D K+ DFG ++ Y +EG+ L
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG--LLP 176
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
VR ++ PE + +SDV+SFGV++ EI++ G++P
Sbjct: 177 VR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 20/201 (9%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVPLLGYC 594
L+G+G FG V++GTL D VAVK Q + +F +E L H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ +V + G L + KT + AL AA G+ YL + ++ I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKT---KQLVKFALDAAAGMAYLES---KNCI 115
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS------LEVRGTAGYLDPEYYST 708
HRD+ + N L+ + K++DFG S+ QE D +S + ++ TA PE +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTA----PEALNY 168
Query: 709 QHLSAKSDVFSFGVVLLEIIS 729
S++SDV+S+G++L E S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 537 IGEGGFGSVYRG---TLPDGQ---EVAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVP 589
+G+G FG VY G + G+ VA+K + ++ R EF NE + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYG---EASTRKTLDWPTRLSI---ALGAARGLM 643
LLG ++V M+ G L+ L EA L PT A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGDSGFSLEVRG 696
YL + +HRD+ + N ++ + K+ DFG ++ Y L VR
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK---GGKGLLPVR- 186
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
++ PE + KSDV+SFGVVL E+ +
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 51/292 (17%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRS---STSTQGTREFENELNFLSAIRHENLVP 589
+G G FG VY RG D E+ V V++ S S Q +F E +S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS------IALGAARGLM 643
L+G E + ++ M+ G L+ L R + P+ L+ A A+G
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 644 YLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSK------YAPQEGDSGFSLEV 694
YL IHRD+ + N LL AK+ADFG ++ Y + G + L +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA--MLPI 185
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753
+ ++ PE + ++K+DV+SFGV+L EI S G P R + V
Sbjct: 186 K----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------T 235
Query: 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
R+D + + C + RP+ I+ ++
Sbjct: 236 GGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 33/282 (11%)
Query: 532 QYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRS-STSTQGTRE-FENELNFLSAIRHEN 586
Y+ L IG+G FG+V + DG+ + K T+ ++ +E+N L ++H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 587 LVPLLGYCCE--NDQQILVYPFM---SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
+V Y + +Y M G L + RK ++ I
Sbjct: 61 IV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 642 LMYLH--TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
L H + G +V+HRD+K +NI LD + K+ DFG +K DS F+ GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPY 175
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759
Y+ PE + KSD++S G ++ E+ + P RN+ L I+E +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA---RNQLQLAS----KIKEGKFR 228
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801
I P + + EV + + RPS ++++
Sbjct: 229 RI--PYRY----SSELN---EVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 9e-20
Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 537 IGEGGFGSV--YR------GTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENL 587
+GEG FG V Y GT G+ VAVK ++ Q T ++ E+N L + HEN+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 588 VPLLGYCCENDQQI--LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
V G C E + L+ ++ GSL+D L + L+ L A G+ YL
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG--YLDP 703
H+ + IHRD+ + N+LLD+ K+ DFG +K P EG + + G + +
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVFWYAV 179
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E S SDV+SFGV L E+++ + + + E ++ + + R+ E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+G FG V+ GT +VA+K T F E + +RH+ LVPL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 597 NDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+++ I +V FM GSL D L + K L P + +A A G+ Y+ + IH
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIH 125
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD++++NIL+ ++ K+ADFG ++ G ++ TA PE +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
KSDV+SFG++L E+++ GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 534 KTLIGEGGFGSVYRGT------LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
K +GEG FG V+ D VAVK + ++F+ E L+ ++HE++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQD--RLYGEAS----------TRKTLDWPTRLSIA 635
V G C + D I+V+ +M +G L R +G + + L L IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSG--FS 691
A G++YL A + +HRD+ + N L+ ++ K+ DFG S+ Y+ G
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L +R ++ PE + + +SDV+SFGV+L EI + G++P
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 26/217 (11%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSST---STQGTREFENELNFLSAIRHENLVPLLG 592
IG+G FG V D +++ A+K + R NE L + H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 593 YCCENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+ + LV + G L Q + E + + I L L YLH+
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWI-----CEIVLA----LEYLHS 118
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
+ +IHRD+K NILLD + DF + + GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPEVLC 172
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPL--NTRRPRNE 742
Q S D +S GV E + G+ P ++R R++
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ GT +VAVK T F E + +RH+ LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 597 NDQQI-LVYPFMSNGSLQDRLY-GEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+++ I +V +MS GSL D L GE + L P + +A A G+ Y+ + I
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHL 711
HRD++S+NIL+ + K+ADFG ++ G ++ TA PE
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 180
Query: 712 SAKSDVFSFGVVLLEIIS-GREP---LNTR 737
+ KSDV+SFG++L E+++ GR P +N R
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNR 210
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 72/278 (25%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVK----VRSSTSTQGT--REFENELNFLSAIRHENLV 588
+G G F S Y+ + G +AVK VR+++S Q E+ ++ + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+LG CE+ L +M+ GS+ L YG +++ +L RGL YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLH 120
Query: 647 TFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFS-KYAPQEGDSG-FSLEVRGTAGYLDP 703
+IHRDVK +N+L+D + ++ADFG + + A + +G F ++ GT ++ P
Sbjct: 121 E---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E + DV+S G V++E+ + + P N + N +L+ I E +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801
P ++ +V L C+E RP ++++
Sbjct: 238 PGLR------------DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V+ G +VA+K +R ++ +F E + + H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ +V +M+NG L + L + L L + + YL + IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIH 123
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD+ + N L+ KV+DFG ++Y + G V+ PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 713 AKSDVFSFGVVLLEIIS-GREPLNTR 737
+KSDV+SFGV++ E+ S G+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V G +VA+K+ S EF E + + HE LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+V +MSNG L + L K L + G+ YL + + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
D+ + N L+D C KV+DFG S+Y + G VR + PE S+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLLYSKFSS 180
Query: 714 KSDVFSFGVVLLEIIS-GREP 733
KSDV++FGV++ E+ S G+ P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGYC 594
IGEG G V T G++VAVK + Q RE NE+ + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK-KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
D+ +V F+ G+L D + T ++ ++ L + L +LH + VI
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA---QGVI 137
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
HRD+KS +ILL K++DFGF +E SL GT ++ PE S +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPEVISRLPYGTE 195
Query: 715 SDVFSFGVVLLEIISGREPLNTRRP 739
D++S G++++E++ G P P
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFE-----NELNFLSAIRHENLVP 589
++G+G +G+VY G GQ +AVK V TS E E E++ L +++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL--YGE-------ASTRKTLDWPTRLSIALGAAR 640
LG C +++ + F+ GS+ L +G T++ LD
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------- 113
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE----VRG 696
G+ YLH V+HRD+K +N++L + K+ DFG ++ G G + G
Sbjct: 114 GVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
T ++ PE + KSD++S G + E+ +G+ PL +
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 33/220 (15%)
Query: 532 QYKTLIGEGGFGSVYRGTLP-DGQEV--AVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+++ +IGEG FG V R + DG ++ A+K ++ S R+F EL L + H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYG------------EASTRKTLDWPTRLSI 634
++ LLG C + + G+L D L E T TL L
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A A G+ YL + + IHRD+ + N+L+ ++ +K+ADFG S+ G + V
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYV 173
Query: 695 RGTAGYLDPEYYSTQHL-----SAKSDVFSFGVVLLEIIS 729
+ T G L + + + L + KSDV+SFGV+L EI+S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 27/213 (12%)
Query: 536 LIGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPL 590
+IG G FG V RG L P +E VA+K ++S + + R+F +E + + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL-GAARGLMYLHTFA 649
G ++ +++ FM NG+L D + + T +L L G A G+ YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFT---VIQLVGMLRGIAAGMKYL---S 123
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS--------GFSLEVRGTAGYL 701
+ +HRD+ + NIL++ ++ KV+DFG S++ ++ S G + +R TA
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGKIPIRWTA--- 179
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + + ++ SDV+S+G+V+ E++S G P
Sbjct: 180 -PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 532 QYKTLIGEGGFGSVYRGTL-PDG--QEVAVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+++ +IGEG FG V + + DG + A+K ++ S R+F EL L + H N
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEA------------STRKTLDWPTRLSI 634
++ LLG C L + +G+L D L ST TL L
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A ARG+ YL + + IHRD+ + NIL+ + AK+ADFG S+ G + V
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYV 178
Query: 695 RGTAGYLDPEYYSTQHL-----SAKSDVFSFGVVLLEIIS 729
+ T G L + + + L + SDV+S+GV+L EI+S
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 40/228 (17%)
Query: 536 LIGEGGFGSVYRGTL-PDGQEVAVKV-------RSSTSTQGTREFENELNFLSAIRHENL 587
+IGEG F +V +E A+K+ + E + L L+ H +
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLN--GHPGI 64
Query: 588 VPLLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
+ L Y D++ L V + NG L + +LD A L YL
Sbjct: 65 IKL--YYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-----YAPQEGDSGFSLEVR----- 695
H + +IHRD+K NILLD M K+ DFG +K +P+ +
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 696 --------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
GTA Y+ PE + + SD+++ G ++ ++++G+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEV--AVK-VRSSTSTQGTREFENELNFLSAI-RHENLVPL 590
+IGEG FG V + + DG + A+K ++ S R+F EL L + H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYG------------EASTRKTLDWPTRLSIALGA 638
LG C L + +G+L D L ST TL L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
ARG+ YL + + IHRD+ + NIL+ + AK+ADFG S+ G + V+ T
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTM 170
Query: 699 GYLDPEYYSTQHL-----SAKSDVFSFGVVLLEIIS 729
G L + + + L + SDV+S+GV+L EI+S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 10/202 (4%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLVPLLGY 593
IG+G FG V++ + V + S RE E +E L+ + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ + +V + NG L L + D R I GL +LH+ + +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILLGLAHLHS---KKI 122
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
+HRD+KS N+ LD K+ D G +K ++ F+ + GT YL PE + +
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 714 KSDVFSFGVVLLEIISGREPLN 735
KSDV++ GVVL E +G+ P +
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
L+G+G FG VY D G+E+A K S +++ E E+ L ++HE +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 590 LLGYCCENDQQILV--YPFMSNGSLQDRL--YG---EASTRKTLDWPTRLSIALGAARGL 642
G + ++ L +M GS++D+L YG E+ TRK TR + G+
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY----TRQIL-----EGM 119
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYL 701
YLH ++HRD+K +NIL D + K+ DFG SK SG + V GT ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE S + K+DV+S G ++E+++ + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-18
Identities = 69/292 (23%), Positives = 134/292 (45%), Gaps = 34/292 (11%)
Query: 536 LIGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+I G G+ Y+G ++ +G + VK + S +E+ + ++H N+V L+G
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGL 751
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
C L++ ++ +L + L L W R IA+G A+ L +LH +V
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQ-----EGDSGFSLEVRGTAGYLDPEYYST 708
+ ++ I++D K P G + ++ Y+ PE T
Sbjct: 805 VVGNLSPEKIIID------------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRET 852
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768
+ ++ KSD++ FG++L+E+++G+ P + + S+VEWA+ + +D +DPSI+G
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRG 911
Query: 769 --GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMK 818
+ + ++ +AL C RP D+++ LE A ++ +K
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTGLK 963
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 536 LIGEGGFGSVYRGTL--PDGQEVAVKVRSSTSTQGTR----EFENELNFLSAIRHENLVP 589
++GEG FGSV G L DG ++ V V++ T EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 590 LLGYCCENDQQ------ILVYPFMSNGSLQDRLY----GEASTRKTLDWPTRLSIALGAA 639
L+G C E +++ PFM +G L L G + L T L + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVDIA 123
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLE 693
G+ YL R+ IHRD+ + N +L M VADFG SK Y Q + +
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA--KMP 178
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
V+ ++ E + + ++KSDV++FGV + EI + G+ P
Sbjct: 179 VK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 58/219 (26%), Positives = 113/219 (51%), Gaps = 21/219 (9%)
Query: 526 LEAATQQYKTLIGEGGFGSVYRGTL--PDGQEVAVKVRS---STSTQGTREFENELNFLS 580
++A+ + + +IG G FG V G L P +E+ V +++ + + R+F +E + +
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 581 AIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR 640
H N++ L G ++ ++V +M NGSL L + + + G A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIAS 117
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS-----LEVR 695
G+ YL + +HRD+ + NIL++ ++ KV+DFG S+ + ++ ++ + +R
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
TA PE + + ++ SDV+S+G+V+ E++S G P
Sbjct: 175 WTA----PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
L+G G FG VY D G+E+AVK S +++ E E+ L +RH+ +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 590 LLGYCCENDQQIL--VYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYL 645
G + +++ L +M GS++D+L YG + T + ++ +G+ YL
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYL 122
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYLDPE 704
H ++HRD+K +NIL D + K+ DFG SK SG ++ V GT ++ PE
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
S + K+DV+S ++E+++ + P
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 64/207 (30%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLVP 589
+G+G FG V + T G+ A+KV +E E E N LS I H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 590 LLGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA-LGAARGLMYLH 646
L + ++ LV + G L L E R + + R A + A L YLH
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEER-ARFYAAEIVLA--LEYLH 110
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ +I+RD+K NILLD K+ DFG +K EG + GT YL PE
Sbjct: 111 S---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC--GTPEYLAPEVL 165
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREP 733
+ D +S GV+L E+++G+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG G +G VY+ + G+ VA+KV + E++ L RH N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL---GAARGLMYLHTFAGRS 652
D+ +V + GSLQD +Y TR L + L IA +GL YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQV--TRGPL---SELQIAYVCRETLKGLAYLHE---TG 121
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAGYLDPEYYST 708
IHRD+K +NILL K+ADFG S ++ R GT ++ PE +
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 709 QHLS---AKSDVFSFGVVLLEIISGREPL 734
+ K D+++ G+ +E+ + P+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 73/243 (30%), Positives = 98/243 (40%), Gaps = 49/243 (20%)
Query: 515 PMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE 573
P P IF L +IGEG +G VY+ GQ VA+K+ + E +
Sbjct: 2 PDPTGIFEL----------VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIK 50
Query: 574 NELNFLSAI-RHENLVPLLG------YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTL 626
E N L H N+ G +DQ LV GS+ D + +
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLR 104
Query: 627 DWPTRLS------IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680
RL I RGL YLH VIHRD+K NILL + K+ DFG S
Sbjct: 105 KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
Query: 681 YAPQEGDSGFSLEVR----GTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIISGR 731
+ DS +L R GT ++ PE A+SDV+S G+ +E+ G+
Sbjct: 162 ----QLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
Query: 732 EPL 734
PL
Sbjct: 216 PPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
L+G+G FG VY D G+E+AVK S +++ E E+ L + HE +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 590 LLGYCCENDQQILVYPFMS---NGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMY 644
G C + + + FM GS++D+L YG + T + ++ G+ Y
Sbjct: 69 YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSY 121
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYLDP 703
LH+ ++HRD+K +NIL D K+ DFG SK SG ++ V GT ++ P
Sbjct: 122 LHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
E S + K+D++S G ++E+++ + P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 37/224 (16%)
Query: 537 IGEGGFGSVYRGTL-----PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GE FG +Y+G L Q VA+K ++ + Q EF+ E + ++ + H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLY-------------GEASTRKTLDWPTRLSIALG 637
LG + +++ +++ G L + L + + + +LD L IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGDSGF 690
A G+ YL + +H+D+ + NIL+ + K++D G S+ Y Q
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ---PKS 186
Query: 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L +R ++ PE S+ SD++SFGVVL EI S G +P
Sbjct: 187 LLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 536 LIGEGGFGSVYRG-TLPDGQEVAVK--VRSSTSTQGTRE-------FENELNFLSAIRHE 585
LIG G FGSVY G G+ +AVK S S E+ L ++HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLM 643
N+V LG + D + ++ GS+ L YG + + +GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLN 120
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAG 699
YLH R +IHRD+K +NIL+D+ K++DFG SK S + R G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
++ PE + K+D++S G +++E+++G+ P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQG-----TREFENELNFLSAIRHENLVP 589
IGEG +G VY+ G+ VA+K +R +G RE + L +RH N+V
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNIVR 62
Query: 590 LLGYCCENDQQ--ILVYPFMS---NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
L + +V+ +M G L S GL Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLL-------DSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH ++HRD+K SNIL+++ K+ADFG ++ + + ++ V T Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 705 YY--STQHLSAKSDVFSFGVVLLEIISGREPL 734
+T++ + D++S G +L E+ G+
Sbjct: 172 LLLGATRY-GPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 536 LIGEGGFGSVYRGTL------PDGQEVAVK-VRSSTSTQGTREFENELNFLSAI-RHENL 587
+GEG FG V + + VAVK ++ + + + +E+ + I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTRLSIA 635
+ LLG C + +V + ++G+L+D L +TL +S A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILL--DHSMCAKVADFGFSK------YAPQEGD 687
ARG+ +L A + IHRD+ + N+L+ DH M K+ADFG ++ Y + +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTN 193
Query: 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
L V+ A PE + + +SDV+SFGV+L EI +
Sbjct: 194 G--RLPVKWMA----PEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 6e-17
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGYC 594
IG+G G+V+ + GQEVA+K + + Q +E NE+ + +++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK-QINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
D+ +V +++ GSL D + T +D ++ + L +LH VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLH---ANQVI 137
Query: 655 HRDVKSSNILLDHSMCAKVADFGF-SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
HRD+KS N+LL K+ DFGF ++ P++ + GT ++ PE + +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGP 194
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRP 739
K D++S G++ +E++ G P P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 534 KTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLV 588
IGEG FG VY+G + VAVK + ++ RE F E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 589 PLLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKT-LDWPTRLSIALGAARGLMYL 645
L+G EN I+ + P G L+ L K LD + + + + L YL
Sbjct: 71 KLIGVITENPVWIVMELAPL---GELRSYL----QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG---DSGFSLEVRGTAGYLD 702
+ +HRD+ + N+L+ C K+ DFG S+Y E S L ++ ++
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMA 176
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + + ++ SDV+ FGV + EI+ G +P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 9e-17
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG+G G+VY + GQEVA++ + NE+ + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V +++ GSL D + T +D ++ + L +LH+ VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 656 RDVKSSNILLDHSMCAKVADFGF-SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
RD+KS NILL K+ DFGF ++ P++ + GT ++ PE + + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPK 196
Query: 715 SDVFSFGVVLLEIISGREPLNTRRP 739
D++S G++ +E+I G P P
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG G V T G++VAVK Q NE+ + HEN+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V F+ G+L D + T ++ ++ L R L YLH + VIH
Sbjct: 90 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+KS +ILL K++DFGF +E SL GT ++ PE S +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV--GTPYWMAPEVISRLPYGTEV 199
Query: 716 DVFSFGVVLLEIISGREPLNTRRP 739
D++S G++++E+I G P P
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 532 QYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-REFENELNFLSAIRHEN 586
+YK L IGEG G V++ G+ VA+K V G + E+ L A +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 587 LVPLL-----GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR- 640
+V LL G +LV +M L + L + + P + R
Sbjct: 61 VVKLLDVFPHGSGF-----VLVMEYMP-SDLSEVL-------RDEERPLPEAQVKSYMRM 107
Query: 641 ---GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
G+ Y+H ++HRD+K +N+L+ K+ADFG ++ +E +S +V T
Sbjct: 108 LLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163
Query: 698 AGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE Y + D+++ G + E+++G PL
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS-PL 200
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGYC 594
IG+G G+VY + GQEVA+K + + Q +E NE+ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIK-QMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
D+ +V +++ GSL D + T +D ++ + L +LH+ VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQVI 137
Query: 655 HRDVKSSNILLDHSMCAKVADFGF-SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
HRD+KS NILL K+ DFGF ++ P++ S S V GT ++ PE + +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRP 739
K D++S G++ +E++ G P P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 17/235 (7%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG G V T+ G+ VAVK Q NE+ + +HEN+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V F+ G+L D + T ++ ++ L + L LH + VIH
Sbjct: 88 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+KS +ILL H K++DFGF +E SL GT ++ PE S +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPEV 197
Query: 716 DVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI--VDPSIKG 768
D++S G++++E++ G P P ++ P ++ + V PS+KG
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----PKLKNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 43/277 (15%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V+ G +VA+K + ++ +F E + + H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 596 ENDQQILVYPFMSNGSLQDRL---YGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
+ +V FM NG L + L G+ S + L LS+ G+ YL S
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLS-KDML-----LSMCQDVCEGMEYLER---NS 120
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQ 709
IHRD+ + N L+ + KV+DFG ++Y + SG V+ + PE ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP----PEVFNFS 176
Query: 710 HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769
S+KSDV+SFGV++ E+ + E PF ++S E+V+ +G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFT-----------------EGKMPFEKKSNY-EVVEMISRGF 218
Query: 770 --YHAE-AMWRMVEVALACIEPFSAYRPSMVDIVREL 803
Y + A + EV +C RP+ +++R +
Sbjct: 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 531 QQYKTL--IGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQGTREFE-NELNFLSAIRHE 585
+Y+ L +GEG +G V + G+ VA+K + S + ++ E+ L +RHE
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N+V L + LV+ ++ L+ EAS L S + + Y
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLE---LLEAS-PGGLPPDAVRSYIWQLLQAIAYC 116
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H ++IHRD+K NIL+ S K+ DFGF++ S + V T Y PE
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172
Query: 706 Y--STQHLSAKSDVFSFGVVLLEIISGREPL 734
T + DV++ G ++ E++ G PL
Sbjct: 173 LVGDTNY-GKPVDVWAIGCIMAELLDGE-PL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
IG G FG V+ G L D VAVK R + +F E L H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ +V + G L E K + + AA G+ YL + + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKV---KELIQMVENAAAGMEYLES---KHCI 116
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS-------LEVRGTAGYLDPEYYS 707
HRD+ + N L+ K++DFG S+ +E D ++ + V+ TA PE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTA----PEALN 169
Query: 708 TQHLSAKSDVFSFGVVLLEIIS 729
S++SDV+SFG++L E S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLVPLLGY 593
IGEG FG +Y E V + +E E E+ L+ ++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEA----STRKTLDWPTRLSIALGAARGLMYLHTFA 649
EN + +V + G L R+ + S + L W ++S+ GL ++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD-- 119
Query: 650 GRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDS-GFSLEVRGTAGYLDPEYYS 707
R ++HRD+KS NI L + M AK+ DFG ++ Q DS + GT YL PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPL 734
+ + K+D++S G VL E+ + + P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 56/295 (18%)
Query: 536 LIGEGGFGSVYRGTLP----DGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVP 589
++G+G FGSV L Q+VAVK+ + S+ EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 590 LLGYCCENDQQ------ILVYPFMSNGSLQDRLY----GEASTRKTLDWPTRLSIALGAA 639
L+G + + +++ PFM +G L L GE TL T + + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF--TLPLQTLVRFMIDIA 123
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSGFSLEVRGT 697
G+ YL + ++ IHRD+ + N +L+ +M VADFG SK Y+ GD +G
Sbjct: 124 SGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS---GD----YYRQGC 173
Query: 698 AGYLDPEYYSTQHL-----SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
A L ++ + + L + SDV++FGV + EI++ R + ++ VE +
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENS--- 222
Query: 753 IRESRIDEIVDPSIKGG---YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
EI + IKG + + + E+ C P RPS + +LE
Sbjct: 223 -------EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 61/196 (31%), Positives = 92/196 (46%), Gaps = 30/196 (15%)
Query: 556 VAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614
VAVKV ++ R +F E+ LS + N+ LLG C + ++ +M NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 615 RLY-------GEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667
L G A K+L + T L +A A G+ YL + +HRD+ + N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 668 SMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAG---YLDPEYYSTQHLSAKSDVF 718
+ K+ADFG S+ Y +G + L +R A L ++T KSDV+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRA--PLPIRWMAWESVLLGK--FTT-----KSDVW 216
Query: 719 SFGVVLLEIIS-GREP 733
+FGV L EI++ RE
Sbjct: 217 AFGVTLWEILTLCREQ 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 62/228 (27%), Positives = 115/228 (50%), Gaps = 30/228 (13%)
Query: 523 LQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENEL 576
L+ L+ + ++G G FG+VY+G +P+G+ V + V +T + EF +E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60
Query: 577 NFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLS 633
++++ H +LV LLG C Q LV M +G L D ++ ++ L+W ++
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI- 118
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
A+G+MYL R ++HRD+ + N+L+ K+ DFG ++ EGD E
Sbjct: 119 -----AKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEK---E 165
Query: 694 VRGTAGYLDPEYYSTQ-----HLSAKSDVFSFGVVLLEIIS-GREPLN 735
G + ++ + + + +SDV+S+GV + E+++ G +P +
Sbjct: 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 78/288 (27%), Positives = 126/288 (43%), Gaps = 36/288 (12%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQ---EVAVK-VRSSTSTQGTRE-FENELNFLSAIRHENLV 588
KTL GEG FGSV G L +VAVK ++ + T+ E F +E + H N++
Sbjct: 5 KTL-GEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 589 PLLGYCCENDQQ------ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA--AR 640
L+G C + + +++ PFM +G L L PT++ + A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV-RGTAG 699
G+ YL + +S IHRD+ + N +L+ +M VADFG SK GD + +
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKMPVK 179
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758
++ E + + + KSDV+SFGV + EI + G+ P P + S I
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY----------------PGVENSEI 223
Query: 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806
+ + + + + + + +C RPS + ELE A
Sbjct: 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 78/313 (24%), Positives = 128/313 (40%), Gaps = 61/313 (19%)
Query: 533 YKTLIGEGGFGSVYRGTLPDGQE-----------------VAVKVRSSTSTQGTR-EFEN 574
+K +GEG FG V+ + + Q+ VAVK+ + + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 575 ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL---------------YGE 619
E+ LS ++ N++ LLG C + D ++ +M NG L L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 620 ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679
A + + + L +AL A G+ YL + + +HRD+ + N L+ ++ K+ADFG S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 680 K--YAPQEGDSGFSLEVRGTA----GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ YA G ++G A ++ E + SDV++FGV L EI+
Sbjct: 186 RNLYA------GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM---- 235
Query: 734 LNTRRPRNEWS---LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFS 790
L +P E + ++E A F R+ + + E+ L C
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDC 289
Query: 791 AYRPSMVDIVREL 803
RPS DI L
Sbjct: 290 RERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 536 LIGEGGFGSVY--RGTLPDGQEVAVK-VRSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
++G G FG V+ R D + V +K + T+ R +NE L + H N++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
E+ ++V + G+L + Y + LD T L + L ++HT +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAE--YIQKRCNSLLDEDTILHFFVQILLALHHVHT---K 120
Query: 652 SVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
++HRD+K+ NILLD H M K+ DFG SK + V GT Y+ PE +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKP 177
Query: 711 LSAKSDVFSFGVVLLEIIS 729
+ KSD+++ G VL E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 7e-16
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG+G G+VY + GQEVA+K + NE+ + ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V +++ GSL D + T +D ++ + L +LH+ VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHS---NQVIH 138
Query: 656 RDVKSSNILLDHSMCAKVADFGF-SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
RD+KS NILL K+ DFGF ++ P++ + GT ++ PE + + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPK 195
Query: 715 SDVFSFGVVLLEIISGREPLNTRRP 739
D++S G++ +E++ G P P
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQE----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
L+G G FG+V++G +P+G VA+K + + Q +E + + + ++ H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLSIALGAARGLMYLH 646
LLG C Q LV GSL D + ++ L+W ++ A+G+ YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
++HR++ + NILL ++ADFG + + F E + ++ E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747
+ +SDV+S+GV + E++S G EP RP L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG-----QEVAVK--VRSSTSTQGTREFENELNFLSAIRH 584
L+ EG FG ++ G L D +EV VK ++ Q T E L + H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSH 67
Query: 585 ENLVPLLGYCCEN-DQQILVYPFMSNGSL----QDRLYGEASTRKTLDWPTRLSIALGAA 639
+N++P+L C E+ + ++YP+M+ G+L Q GEA+ + L + +A+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQE----GDSGFSLEV 694
G+ YLH R VIH+D+ + N ++D + K+ D S+ P + GD+ E
Sbjct: 128 CGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN----EN 180
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
R ++ E + S+ SDV+SFGV+L E+++
Sbjct: 181 RPVK-WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 534 KTLIGEGGFGSVYRGT---LPDGQ---EVAVKVRSSTSTQGTRE-FENELNFLSAI-RHE 585
KTL G G FG V T L +VAVK+ T+ RE +EL +S + HE
Sbjct: 41 KTL-GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N+V LLG C +++ + G L + L + L LS + A+G+ +L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFL 157
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA----GYL 701
A ++ IHRD+ + N+LL H K+ DFG ++ DS + V+G A ++
Sbjct: 158 ---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYV--VKGNARLPVKWM 210
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
PE + +SDV+S+G++L EI S
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVA---VKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG+G F VY+ L DG+ VA V++ + ++ E++ L + H N++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
EN++ +V G L + ++ + T + L ++H+ +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KR 126
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
++HRD+K +N+ + + K+ D G ++ + + SL GT Y+ PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYN 184
Query: 713 AKSDVFSFGVVLLEIISGREP 733
KSD++S G +L E+ + + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 535 TLIGEGGFGSVYRGTLPDGQE------VAVKVRSSTSTQGTR-EFENELNFLSAIRHENL 587
T +G G FG V+ +E V VK T + + EF EL+ + H+N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWP-----TRLSIALGAARGL 642
V LLG C E + ++ + G L+ L S + L P ++++ A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRG 696
+L R +HRD+ + N L+ KV+ SK Y + +R
Sbjct: 131 DHLSN--AR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR---NALIPLR- 183
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGRE 732
+L PE S KSDV+SFGV++ E+ + E
Sbjct: 184 ---WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYC 594
IG+G +G VY+ T DG AVK+ S E E E N L ++ H N+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 595 CENDQQI-----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+ D+ + LV + GS+ + + G + LD I GA GL +LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-- 146
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-----GTAGYLDPE 704
+IHRDVK +NILL K+ DFG S S +R GT ++ PE
Sbjct: 147 -NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-------STRLRRNTSVGTPFWMAPE 198
Query: 705 YYSTQH-----LSAKSDVFSFGVVLLEIISGREPLNTRRP 739
+ + A+ DV+S G+ +E+ G PL P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 61/264 (23%), Positives = 118/264 (44%), Gaps = 22/264 (8%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK---VRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G F VYR T L D + VA+K + + ++ E++ L + H N++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
E+++ +V G L + ++ + T + + ++H+ R
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RR 126
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
V+HRD+K +N+ + + K+ D G ++ + + SL GT Y+ PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYN 184
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
KSD++S G +L E+ + + P + N +SL + +I++ P + +++
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLCQ---------KIEQCDYPPLPTEHYS 234
Query: 773 EAMWRMVEVALACIEPFSAYRPSM 796
E + +V + CI P RP +
Sbjct: 235 EKLRELVSM---CIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRS-STSTQGTREFENELNFLSAIRHEN 586
+ + L IG+G FG VY+ Q VA+KV + + + E+ FLS R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRL-YGEASTRKTLDWPTRLSIALGAARGLMYL 645
+ G + + ++ + GS D L G LD I GL YL
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYL 114
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAGYL 701
H IHRD+K++NILL K+ADFG S G ++ R GT ++
Sbjct: 115 H---EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMSKRNTFVGTPFWM 165
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE K+D++S G+ +E+ G PL
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPL 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL- 591
+G+G FG VY + T G A K+ S + +F E++ LS +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKET---GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
Y EN IL+ F G+L D + E + L P + L +LH+
Sbjct: 70 AYFYENKLWILI-EFCDGGAL-DSIMLE--LERGLTEPQIRYVCRQMLEALNFLHS---H 122
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFS---KYAPQEGDSGFSLEVRGTAGYLDPEY--- 705
VIHRD+K+ NILL K+ADFG S K Q+ D+ GT ++ PE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVAC 177
Query: 706 --YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
+ K+D++S G+ L+E+ P + P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 533 YKTL--IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFEN----ELNFLSAIRH 584
Y+ L IGEG +G VY+ G+ VA+K ++ ++G E+ L + H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNH 57
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT-LDWPTRLSIALGAARGLM 643
N++ LL LV+ FM D LY R+ L S +GL
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFM----DTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
+ H+ ++HRD+K N+L++ K+ADFG ++ T Y P
Sbjct: 113 FCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAP 167
Query: 704 E--YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
E + S D++S G + E++S R PL
Sbjct: 168 ELLLGDKGY-STPVDIWSVGCIFAELLSRR-PL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 526 LEAATQQYKTLIGEGGFGSVYRG--TLPDGQEVAVKV---RSSTSTQGTREFENELNFLS 580
L+ + + + ++G G FG + RG LP +E+ V + R+ S + R F E L
Sbjct: 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61
Query: 581 AIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLSIALG 637
H N+V L G + ++V +MSNG+L L G+ + + G
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP------G 115
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS-LEVRG 696
A G+ YL + +H+ + + +L++ + K++ GF + + ++ ++ + +
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKS 170
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ PE H S+ SDV+SFG+V+ E++S G P
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 68/241 (28%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGY 593
L+G G +G VY+G + GQ A+KV T + E + E+N L H N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 594 CCE------NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+ +DQ LV F GS+ D + +W + + RGL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLSHLHQ 129
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
VIHRD+K N+LL + K+ DFG S A + G GT ++ PE +
Sbjct: 130 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIA 184
Query: 708 TQH-----LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV-----------EWAKP 751
KSD++S G+ +E+ G PL P L+ +W+K
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244
Query: 752 F 752
F
Sbjct: 245 F 245
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 42/273 (15%)
Query: 505 SIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSS 563
S+D +D P IF L ++G G +G VY+G + GQ A+KV
Sbjct: 2 SLDDIDLSALRDPAGIFELV----------EVVGNGTYGQVYKGRHVKTGQLAAIKVMDV 51
Query: 564 TSTQGTREFENELNFLSAI-RHENLVPLLGYCCE------NDQQILVYPFMSNGSLQDRL 616
T + E + E+N L H N+ G + +DQ LV F GS+ D +
Sbjct: 52 TEDE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV 110
Query: 617 YGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676
DW + + RGL +LH VIHRD+K N+LL + K+ DF
Sbjct: 111 KNTKGNALKEDWIAYICREI--LRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDF 165
Query: 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH-----LSAKSDVFSFGVVLLEIISGR 731
G S A + G GT ++ PE + +SD++S G+ +E+ G
Sbjct: 166 GVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223
Query: 732 EPLNTRRPRNEWSLV-----------EWAKPFI 753
PL P L+ +W+K FI
Sbjct: 224 PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFI 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 36/267 (13%)
Query: 537 IGEGGFGS--VYRGTLPDGQEVAVKVR-SSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+G+G FG +YR T D V +V + S + R+ NE+ LS ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL--GAARGLMYLHTFAGR 651
+++ ++ + + G+L D++ +K + + + + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVSYIHK---A 120
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
++HRD+K+ NI L + K+ DFG SK E + V GT Y+ PE
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLV--EWAKPFIRESRIDEIVDPSIKG 768
+ KSD+++ G VL E+++ + + P N +V + +
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT---------------PVVS 223
Query: 769 GYHAEAMWRMVEVALACIEPFSAYRPS 795
Y +E ++ + + ++ RP+
Sbjct: 224 VYSSE----LISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVPL 590
IG G G+VY+ P G+ A+KV + Q RE E L + H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE----ILRDVNHPNVVKC 137
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
N + ++ FM GSL+ D +A G+ YLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIA--------DEQFLADVARQILSGIAYLHR--- 186
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
R ++HRD+K SN+L++ + K+ADFG S+ Q D S GT Y+ PE +T
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS--SVGTIAYMSPERINTDL 244
Query: 711 LSAK-----SDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
D++S GV +LE GR P R + +W+
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWA 282
|
Length = 353 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 39/228 (17%)
Query: 532 QYKTLIGEGGFGSV----------YRGTLP---DGQEVAVKV---RSSTSTQGTREFENE 575
+ K +GEG FG V + G DGQ V V V R+ + +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 576 LNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL--------YGEASTRKTLD 627
+ +S +++ N++ LLG C +D ++ +M NG L L + A+ ++
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 628 WPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQE 685
L +A+ A G+ YL A + +HRD+ + N L+ + K+ADFG S+ Y
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY---- 180
Query: 686 GDSGFSLEVRGTA----GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
SG ++G A ++ E + SDV++FGV L E+ +
Sbjct: 181 --SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 537 IGEGGFGSVYR----GTLPDGQE----VAVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+GEG FG V R G + VAVK ++ + + + + +E+ + I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLY------------GEASTRKTLDWPTRLSI 634
++ LLG C + ++ + + G+L++ L + L + +S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A ARG+ YL R IHRD+ + N+L+ K+ADFG ++ +
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
R ++ PE + + +SDV+SFG+++ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQ-EVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
+ ++G+G +G VY Q +A+K ++ + E+ S ++H N+V LG
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGE----ASTRKTLDWPTRLSIALGAARGLMYLHTF 648
EN + + GSL L + +T+ + T+ + GL YLH
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHD- 126
Query: 649 AGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY-- 705
++HRD+K N+L++ +S K++DFG SK G + + GT Y+ PE
Sbjct: 127 --NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVID 182
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI-VDP 764
+ A +D++S G ++E+ +G+ P +E +P ++ + P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPP-----------FIELGEPQAAMFKVGMFKIHP 231
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
I AEA L C EP R S D+ L+D F+
Sbjct: 232 EIPESLSAEAK----NFILRCFEPDPDKRASAHDL---LQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 71/229 (31%), Positives = 101/229 (44%), Gaps = 53/229 (23%)
Query: 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRS----STSTQGTREFENELNFLSAIRHEN 586
Q + IGEG +G V T P G +VA+K S T Q T E+ L +HEN
Sbjct: 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR---EIKILRRFKHEN 64
Query: 587 LVPLL------GYCCENDQQILVYPFM-------------SNGSLQDRLYGEASTRKTLD 627
++ +L + ND I V M SN +Q LY + L
Sbjct: 65 IIGILDIIRPPSFESFNDVYI-VQELMETDLYKLIKTQHLSNDHIQYFLY------QIL- 116
Query: 628 WPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA-PQEG 686
RGL Y+H +V+HRD+K SN+LL+ + K+ DFG ++ A P+
Sbjct: 117 ------------RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKS-DVFSFGVVLLEIISGREPL 734
+GF E T Y PE K+ D++S G +L E++S R PL
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 62/264 (23%), Positives = 117/264 (44%), Gaps = 22/264 (8%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK---VRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G F VYR T L DG VA+K + + + E++ L + H N++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
E+++ +V G L + ++ + T + L ++H+ R
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RR 126
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
V+HRD+K +N+ + + K+ D G ++ + + SL GT Y+ PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHENGYN 184
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
KSD++S G +L E+ + + P + N +SL + +I++ P + +++
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCK---------KIEQCDYPPLPSDHYS 234
Query: 773 EAMWRMVEVALACIEPFSAYRPSM 796
E + ++V + CI P RP +
Sbjct: 235 EELRQLVNM---CINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 537 IGEGGFGSV----YRGTLPDGQEVAVK---VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G +G V +R DG++ +K +R+++ + + E E LS ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRE-RKAAEQEAQLLSQLKHPNIVA 63
Query: 590 LL-GYCCENDQQILVYPFMSNGSLQDRLYGEAST----RKTLDWPTRLSIALGAARGLMY 644
+ E+ +V F G L +L + + ++W ++++AL Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QY 117
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH + ++HRD+K+ N+ L + KV D G ++ + D +L GT Y+ PE
Sbjct: 118 LHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL--IGTPYYMSPE 172
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
+S + + KSDV++ G + E+ + + N +
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 52/237 (21%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G +G V + +P G +AVK +R++ ++Q + +L+ + +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD----------ISMRSVD 58
Query: 595 C------------ENDQQILVYPFMS--NGSLQDRLYGEASTR-KTLDWPTRLSIALGAA 639
C E D V+ M + SL D+ Y + + T+ IA+
Sbjct: 59 CPYTVTFYGALFREGD----VWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
+ L YLH+ SVIHRDVK SN+L++ + K+ DFG S Y DS G
Sbjct: 114 KALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKP 168
Query: 700 YLDPEYY----STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
Y+ PE + + KSDV+S G+ ++E+ +GR P ++ W PF
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPF 214
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 537 IGEGGFGSVYRGTLPD---GQ---EVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G FG VY G D G+ VAVK V S S + EF NE + + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYG---EASTRKTLDWPT---RLSIALGAARGLM 643
LLG + ++V M++G L+ L EA PT + +A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAP---QEGDSGFSLEVRGTA 698
YL+ + +HRD+ + N ++ H K+ DFG ++ Y ++G G L VR A
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL-LPVRWMA 189
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
PE + SD++SFGVVL EI S
Sbjct: 190 ----PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 57/213 (26%), Positives = 108/213 (50%), Gaps = 30/213 (14%)
Query: 536 LIGEGGFGSVYRGT-LPDGQE----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
++G G FG+VY+G +P+G++ VA+K R +TS + +E +E ++++ + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEAS---TRKTLDWPTRLSIALGAARGLMYLH 646
LLG C + Q L+ M G L D + ++ L+W ++ A+G+ YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE 126
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
R ++HRD+ + N+L+ K+ DFG +K + E G + ++
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD-----EKEYHAEGGKVPIKWM 178
Query: 707 ---STQH--LSAKSDVFSFGVVLLEIIS-GREP 733
S H + +SDV+S+GV + E+++ G +P
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 33/278 (11%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGYC 594
IG+G FG V++G Q+V A+K+ + E + E+ LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ + ++ ++ GS D L LD +I +GL YLH+ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV-RGTAGYLDPEYYSTQHLSA 713
HRD+K++N+LL K+ADFG A Q D+ GT ++ PE +
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGV---AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773
K+D++S G+ +E+ G P + P L+ P P+++G Y ++
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNY-SK 227
Query: 774 AMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
+ VE AC+ ++RP+ ++ L+ FI+
Sbjct: 228 PLKEFVE---ACLNKEPSFRPTAKEL---LKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQE-VAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLLG 592
IG G FG+VY T E VAVK S + Q ++++ E+ FL ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
+ LV + GS D L +K L +I GA +GL YLH+
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 653 VIHRDVKSSNILLDHSMCAKVADFG-FSKYAPQEGDSGFSLEVRGTAGYLDPEY---YST 708
+IHRD+K+ NILL K+ADFG SK +P GT ++ PE
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWMAPEVILAMDE 194
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPL 734
K DV+S G+ +E+ + PL
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 537 IGEGGFGSVYRGT--LPDGQ-EVAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVPLLG 592
+G G FG V +G + Q +VA+KV + + + R E E + + + +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
CE + +LV S G L L G+ + + + + + G+ YL G++
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLE---GKN 115
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT--AGYLDPEYYSTQH 710
+HRD+ + N+LL + AK++DFG SK A DS + G + PE + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 711 LSAKSDVFSFGVVLLEIIS-GREP 733
S++SDV+S+G+ + E S G++P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRS-STSTQGTREFENELNFLSAIRHENLVP 589
QY+ ++G G G+VY+ L + +AVKV + + ++ +EL L ++
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 590 LLG-YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
G + EN I FM GSL +Y + + IA+ +GL YL +
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
++HRDVK SN+L++ K+ DFG S Q +S V GT Y+ PE S
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV-GTNAYMAPERISG 167
Query: 709 QHLSAKSDVFSFGVVLLEIISGREP 733
+ SDV+S G+ +E+ GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 533 YKTLIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFE---NELNFLSAIRHENLV 588
KTL G G FG V + A+K+ S ++ E NE L +IRH LV
Sbjct: 6 IKTL-GTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR-------- 640
L G ++ LV ++ G L L RK+ R AR
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL------RKS----GRFP--EPVARFYAAQVVL 112
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
L YLH+ +++RD+K N+LLD K+ DFGF+K ++L GT Y
Sbjct: 113 ALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYTL--CGTPEY 164
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741
L PE ++ D ++ G+++ E+++G P P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 537 IGEGGFGSVYR-GTLPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+G G GSV + +P G +A KV +SS Q RE L + R +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68
Query: 591 LG-YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS----IALGAARGLMYL 645
G + EN+ + FM GSL DR+Y + P + IA+ GL YL
Sbjct: 69 YGAFLNENNI-CMCMEFMDCGSL-DRIYKKGG-------PIPVEILGKIAVAVVEGLTYL 119
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
+ ++HRD+K SNIL++ K+ DFG S E + + GT+ Y+ PE
Sbjct: 120 YNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELINSIADTFVGTSTYMSPER 173
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ KSDV+S G+ ++E+ G+ P
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQE----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
++G G FG+VY+G +PDG+ VA+KV R +TS + +E +E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLSIALGAARGLMYLH 646
LLG C + Q LV M G L D + ++ L+W ++ A+G+ YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
++HRD+ + N+L+ K+ DFG ++ + + + ++ E
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747
+ + +SDV+S+GV + E+++ G +P + R L+E
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 534 KTLIGEGGFGSV-YRGTLPDGQEVAVKV------RSSTSTQGTREFENELN--FLSAIR- 583
++G G G+V + DG+ AVKV + + E LN F S ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 584 HENLVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGL 642
HE+ EN I LV + + G L+ + A T +T L + L
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVL 153
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY--APQEGDSGFSLEVRGTAGY 700
+ +H + +IHRD+KS+NILL + K+ DFGFSK A D G + GT Y
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF--CGTPYY 211
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
+ PE + + S K+D+FS GV+L E+++ + P +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 35/231 (15%)
Query: 529 ATQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTSTQGTRE-FENELNFLSA 581
+T ++ +GE FG VY+G L Q VA+K + RE F++E S
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLY------------GEASTRKTLDWP 629
++H N+V LLG + +++ + S+ L + L + + + TL+
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF------SKYAP 683
+ I A G+ +L + V+H+D+ + N+L+ + K++D G + Y
Sbjct: 125 DFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
G+S L +R ++ PE S SD++S+GVVL E+ S G +P
Sbjct: 182 LMGNS--LLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLLG 592
IG G FG+VY EV A+K S + Q ++++ E+ FL I+H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
LV + GS D L +K L +I GA +GL YLH+ +
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS---HN 145
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY---YSTQ 709
+IHRD+K+ NILL K+ADFG + A GT ++ PE
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEVILAMDEG 199
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
K DV+S G+ +E+ + PL
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/235 (27%), Positives = 104/235 (44%), Gaps = 41/235 (17%)
Query: 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE--------------NEL 576
+QY+ L G+GGFG V A +VR++ ++ E NE
Sbjct: 3 RQYRVL-GKGGFGEV----------CACQVRATGKMYACKKLEKKRIKKRKGESMALNEK 51
Query: 577 NFLSAIRHENLVPLLGYCCEN-DQQILVYPFMSNGSLQDRLY--GEASTRKTLDWPTRLS 633
L + + V L Y E D LV M+ G L+ +Y GEA + +
Sbjct: 52 QILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVF 106
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
A GL LH +++RD+K NILLD +++D G + + P+ G +++
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE----GQTIK 159
Query: 694 VR-GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
R GT GY+ PE + + D ++ G +L E+I+G+ P R+ + + VE
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 536 LIGEGGFGSV----YRGTLPDGQEVAVKVRSSTSTQGTREFE---NELNFLS-AIRHENL 587
++G+G FG V +GT + AVKV + E E L+ A +H L
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 588 VPLLGYCC--ENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAAR 640
L + C D+ V +++ G L + + E R A
Sbjct: 59 TQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR---------FYAAEIVL 107
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTA 698
GL +LH R +I+RD+K N+LLD K+ADFG K G S F GT
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC----GTP 160
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE S Q D ++ GV+L E+++G+ P
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLLG 592
IG G FG+VY + + VA+K S + Q ++++ E+ FL +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
LV + GS D L +K L +I GA +GL YLH+
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSH---E 135
Query: 653 VIHRDVKSSNILLDHSMCAKVADFG-FSKYAPQEGDSGFSLEVRGTAGYLDPEY---YST 708
IHRD+K+ NILL K+ADFG S +P GT ++ PE
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMAPEVILAMDE 188
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPL 734
K DV+S G+ +E+ + PL
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 62/231 (26%)
Query: 533 YKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN--------ELNFLSA 581
YK + +G+G FGSVY G+ VA+K + ++F + E+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK-------KMKKKFYSWEECMNLREVKSLRK 53
Query: 582 I-RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTR--KTLDWPTRLSIALGA 638
+ H N+V L END+ V+ +M LY R K SI
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 639 ARGLMYLHT---FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
+GL ++H F HRD+K N+L+ K+ADFG ++ E+R
Sbjct: 109 LQGLAHIHKHGFF------HRDLKPENLLVSGPEVVKIADFGLAR------------EIR 150
Query: 696 GTAGYLDPEYYST------------QHLSAKSDVFSFGVVLLEIISGREPL 734
Y D Y ST S+ D+++ G ++ E+ + R PL
Sbjct: 151 SRPPYTD--YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 536 LIGEGGFGSVY---RGTLPD-GQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVP 589
++G+G FG V+ + T PD GQ A+KV +++ + + E + L+ + H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 590 LLGYCCENDQQI-LVYPFMSNGSLQDRLYGEAS-TRKTLD-WPTRLSIALGAARGLMYLH 646
L Y + + ++ L+ F+ G L RL E T + + + L++AL +LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------HLH 115
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ +I+RD+K NILLD K+ DFG SK + +S GT Y+ PE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVV 170
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
+ + + +D +SFGV++ E+++G P + R E
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-RKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLLG 592
IG G FG+VY + + + VA+K S + Q ++++ E+ FL +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
LV + GS D L +K L ++ GA +GL YLH+ +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 653 VIHRDVKSSNILLDHSMCAKVADFG-FSKYAPQEGDSGFSLEVRGTAGYLDPEY---YST 708
+IHRDVK+ NILL K+ DFG S AP GT ++ PE
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWMAPEVILAMDE 188
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPL 734
K DV+S G+ +E+ + PL
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 533 YKTLIGEGGFGSVYRGTLPDGQE-----------------VAVK-VRSSTSTQGTREFEN 574
+K +GEG FG V+ ++ VAVK +R + +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 575 ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLY-------GEASTRKTLD 627
E+ +S ++ N++ LL C +D ++ +M NG L L E + T+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 628 WPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQE 685
+ T + +A A G+ YL + + +HRD+ + N L+ + K+ADFG S+ Y
Sbjct: 129 YSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY---- 181
Query: 686 GDSGFSLEVRGTA----GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
SG ++G A ++ E + SDV++FGV L EI++
Sbjct: 182 --SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-13
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 553 GQEVAVKVRSSTSTQGTRE---FENELNFLSAIRHENLVPLLGY-CCENDQQILVYPFMS 608
G EVA+K+ + + + + F E + + H N+V LL V+ ++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 609 NGSLQDRLY--GEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL- 665
+L++ L G +T ++ AL A H + ++HRD+K NI++
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACA------HN---QGIVHRDLKPQNIMVS 113
Query: 666 --DHSMCAKVADFGFSKYAPQEGDSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVF 718
AKV DFG P D+ + EV GT Y PE + ++ SD++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 719 SFGVVLLEIISGR 731
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTRE---FENELNFLSAIRHENLVP 589
+G+G FG VY +G + D E V +++ RE F NE + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYG---EASTRKTLDWPT---RLSIALGAARGLM 643
LLG + +++ M+ G L+ L E P+ + +A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ-----EGDSGFSLEVRGTA 698
YL+ +HRD+ + N ++ K+ DFG ++ + +G G L VR
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL-LPVR--- 186
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEI 727
++ PE + SDV+SFGVVL EI
Sbjct: 187 -WMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 537 IGEGGFG-SVYRGTLPDGQEVAVKVR--SSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
IGEG FG ++ + DG++ +K S S + E E+ LS ++H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEA----STRKTLDWPTRLSIALGAARGLMYLHTFA 649
EN +V + G L ++ + + LDW ++ +AL ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHD-- 119
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR--GTAGYLDPEYYS 707
R ++HRD+KS NI L K+ DFG ++ +S L GT YL PE
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEICE 174
Query: 708 TQHLSAKSDVFSFGVVLLEIIS 729
+ + KSD+++ G VL E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 46/243 (18%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRS-STSTQGTREFENELNFLSAIRH-- 584
Y+ L IG G +G+VYRG +P G+ VA+K+ + T + + E+ LS +R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 585 -ENLVPLLGYCCENDQQI-LVYPFMSNGSLQ--------DRLYGEASTRKTLDWPTRLSI 634
N+ G ++ ++ + GS++ Y R+ L
Sbjct: 61 PPNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------- 111
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
L Y+H VIHRD+K++NIL+ ++ K+ DFG + A +S
Sbjct: 112 -----VALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTF 161
Query: 695 RGTAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW 748
GT ++ PE YY T K+D++S G+ + E+ +G P + L+
Sbjct: 162 VGTPYWMAPEVITEGKYYDT-----KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
Query: 749 AKP 751
+KP
Sbjct: 217 SKP 219
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVK--VRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
L+GEG +G V + + GQ VA+K + S + E+ L +RHENLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 593 YCCENDQQILVYPFMSNGSLQD-RLY----GEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+ LV+ F+ + L D Y E+ RK L RG+ + H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL---------FQILRGIEFCHS 118
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY--APQEGDSGFSLEVRGTAGYLDPEY 705
++IHRD+K NIL+ S K+ DFGF++ AP E + + T Y PE
Sbjct: 119 ---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV----ATRWYRAPEL 171
Query: 706 YSTQHLSAKS-DVFSFGVVLLEIISGREPL 734
++ D+++ G ++ E+++G EPL
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG-EPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 35/218 (16%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVP 589
I +G +G V+ + T G A+KV + + E + LS + +V
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 590 LLGYCCENDQQI-LVYPFMSNGSLQDRL--YG---EASTRKTLDWPTRLSIALGAARGLM 643
L Y + + + LV ++ G L L G E R + I L L
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI-----AEIVL----ALE 107
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY------APQEGDSGFSLEVRGT 697
YLH+ +IHRD+K NIL+D + K+ DFG SK D + GT
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
Y+ PE Q S D +S G +L E + G P +
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGY 593
IGEG +G VY+ G+ VA+K +R T T+G E++ L + H N+V LL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 594 CCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
++ LV+ F+ QD + + +AS + P S +GL + H+
Sbjct: 68 IHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HR 120
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TAGYLDPE-- 704
V+HRD+K N+L++ K+ADFG ++ F + VR T Y PE
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 705 ----YYSTQHLSAKSDVFSFGVVLLEIISGR 731
YYST D++S G + E+++ R
Sbjct: 173 LGCKYYST-----AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLVPLLG 592
+G GGFG V + + A+K T + E +E L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 593 YCCENDQQILVY---PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
Y D++ +Y + G L L + + R IA YLH
Sbjct: 59 YRTFKDKK-YIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHN-- 111
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
R +I+RD+K N+LLD + K+ DFGF+K + G ++ GT Y+ PE +
Sbjct: 112 -RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTF--CGTPEYVAPEIILNK 167
Query: 710 HLSAKSDVFSFGVVLLEIISGREP 733
D +S G++L E+++GR P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 537 IGEGGFGSVYRGTL-------PDG-QEVAVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+GEG FG V P+ +VAVK ++S + + + +E+ + I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYG------------EASTRKTLDWPTRLSI 634
++ LLG C ++ ++ + S G+L++ L + L + +S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A ARG+ YL A + IHRD+ + N+L+ K+ADFG ++ +
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
R ++ PE + + +SDV+SFGV+L EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG G V G++VAVK+ Q NE+ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
++ ++ F+ G+L D + + TR L+ ++ + L YLH+ + VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIV---SQTR--LNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 656 RDVKSSNILLDHSMCAKVADFGF----SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
RD+KS +ILL K++DFGF SK P+ + GT ++ PE S
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK------SLVGTPYWMAPEVISRTPY 194
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRP 739
+ D++S G++++E++ G P + P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLLGY 593
IG+G FG V++G Q+V V ++ + E E+ E+ LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQV-VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ + ++ ++ GS D L A T L L +GL YLH+
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYLHS---EKK 122
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV-RGTAGYLDPEYYSTQHLS 712
IHRD+K++N+LL K+ADFG A Q D+ GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGV---AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
+K+D++S G+ +E+ G P + P L+ P P++ G +
Sbjct: 180 SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------------PTLTGEFSK 227
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
E AC+ ++RP+ ++ L+ FI++N
Sbjct: 228 P----FKEFIDACLNKDPSFRPTAKEL---LKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 537 IGEGGFGSVY------RGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+GEG FG V G G++VAVK ++ + + + E+ L + HEN+V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 590 LLGYCCEN-DQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
G C E+ I L+ F+ +GSL++ L + ++ +L A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL--EVRGTAGYLDPEY 705
R +HRD+ + N+L++ K+ DFG +K A + +++ ++ + PE
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 706 YSTQHLSAKSDVFSFGVVLLEIIS 729
SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 14/198 (7%)
Query: 537 IGEGGFGSVY--RGTLPDGQEVAVKVRSSTST-----QGTREFENELNFLSAIRHENLVP 589
+G+G FG+VY + +E +KV T + E LS + H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
E D ++ + L +L T KTL + G+ Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
R ++HRD+K+ NI L +++ K+ DFG S+ G + GT Y+ PE Q
Sbjct: 125 -RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 710 HLSAKSDVFSFGVVLLEI 727
+KSD++S G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 23/220 (10%)
Query: 532 QYKTL--IGEGGFGS--VYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
QY L +GEG FG + + D + ++R S+ + E L+ ++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRL---YGEASTRKT-LDWPTRLSIALGAARGLM 643
V + +V + G L ++ G+ T L W ++ + G+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQ 114
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
++H + V+HRD+KS NI L + K+ DFG ++ G ++ GT Y+ P
Sbjct: 115 HIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPP 169
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743
E + + KSD++S G +L E+ + + P N W
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQA----NSW 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-12
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 534 KTLIGEGGFGSVY---RGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPL 590
TL+G + + RG+ P + VA V + Q +EL+ L+A H +V
Sbjct: 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKH 130
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
+D+ +L+ + S G L ++ + L + ++ L
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYEVGLLFYQIVLALDEVHS 187
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAGYLDPEYY 706
R ++HRD+KS+NI L + K+ DFGFSK Q DS SL+V GT YL PE +
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDS-VSLDVASSFCGTPYYLAPELW 243
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPL 734
+ S K+D++S GV+L E+++ P
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 64/228 (28%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAIRHENLVP 589
IGEG +G VYR G+ VA+K VR G RE + L +RH N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70
Query: 590 LL---------------GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSI 634
L YC E D L+ + + E+ + +
Sbjct: 71 LKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTP-------FSESQVK---------CL 113
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
L RGL YLH +IHRD+K SN+LL C K+ADFG ++ + L
Sbjct: 114 MLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART--------YGLPA 162
Query: 695 RG------TAGYLDPE--YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ T Y PE T + +A D+++ G +L E+++ +PL
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
I++ RGL YL ++HRDVK SNIL++ K+ DFG S Q DS +
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSF 158
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753
V GT Y+ PE H + +SD++S G+ L+E+ GR P+ P + E F
Sbjct: 159 V-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDA---KELEAMFG 211
Query: 754 RESRIDEIVDPSIKGGYHA 772
R E + H
Sbjct: 212 RPVSEGEAKESHRPVSGHP 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 537 IGEGGFGSVY--------RGTLPDGQEVAVKVRSSTSTQ-GTREFENELNFLSAI-RHEN 586
+GEG FG V + + VAVK+ +T+ + +E+ + I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRL---------YGEASTR---KTLDWPTRLSI 634
++ LLG C ++ ++ + S G+L++ L Y R + + + +S
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
ARG+ YL A + IHRD+ + N+L+ + K+ADFG ++ +
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
R ++ PE + + +SDV+SFGV++ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGY 593
IGEG +G VY+G GQ VA+K +R + +G E++ L ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEA-STRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
+ + L++ F+S + + Y ++ + +D S +G+++ H+ R
Sbjct: 68 LMQESRLYLIFEFLS---MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TAGYLDPE-Y 705
V+HRD+K N+L+D+ K+ADFG ++ F + VR T Y PE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR--------AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ S D++S G + E+ + ++PL
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/268 (24%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGYC 594
IG+G FG VY+G +EV A+K+ + E + E+ LS + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ + ++ ++ GS D L L+ +I +GL YLH+ I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV-RGTAGYLDPEYYSTQHLSA 713
HRD+K++N+LL K+ADFG A Q D+ GT ++ PE
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGV---AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773
K+D++S G+ +E+ G P + P L+ P P+++ G +++
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLE-GQYSK 227
Query: 774 AMWRMVEVALACIEPFSAYRPSMVDIVR 801
VE AC+ +RP+ ++++
Sbjct: 228 PFKEFVE---ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 17/207 (8%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQGTREFENELNFLSAIRH-ENLVPLLG 592
IG G FG+V + G +AVK +RS+ + + +L+ + +V G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 593 YC-CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL--SIALGAARGLMYLHTFA 649
E D I + M SL D+ Y P + IA+ + L YL
Sbjct: 71 ALFREGDCWICM-ELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-- 125
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
+IHRDVK SNILLD + K+ DFG S DS G Y+ PE
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPS 182
Query: 710 HLSA---KSDVFSFGVVLLEIISGREP 733
+SDV+S G+ L E+ +G+ P
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 87/279 (31%)
Query: 534 KTLIGEGGFGSVYRGT-LPDGQE-----VAVKVRSSTSTQGTRE-FENELNFLSAI-RHE 585
KTL G G FG V T G+E VAVK+ +++ RE +EL LS + +H+
Sbjct: 44 KTL-GAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHK 102
Query: 586 NLVPLLG-------------YCCEND--------QQILVYPFMSNGSLQD---------- 614
N+V LLG YCC D + + M+ + +
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITL 162
Query: 615 --------------------------RLYGEASTRKTLD-----WPTR----LSIALGAA 639
++S K + WP L + A
Sbjct: 163 EKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVA 222
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA- 698
+G+ +L A ++ IHRDV + N+LL AK+ DFG ++ DS + V+G A
Sbjct: 223 QGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR--DIMNDSNYV--VKGNAR 275
Query: 699 ---GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
++ PE + +SDV+S+G++L EI S G+ P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 73/262 (27%), Positives = 109/262 (41%), Gaps = 46/262 (17%)
Query: 496 YPMT-KNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYR-GTLPDG 553
+P++ K ++F DS DP + T + IG+G +G V++ +G
Sbjct: 1 FPLSGKTIIF--DSFPDP---------------SDTWEIIETIGKGTYGKVFKVLNKKNG 43
Query: 554 QEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCEND-----QQILVYPFM 607
+ AVK+ E E E N L A+ H N+V G + D Q LV
Sbjct: 44 SKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102
Query: 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667
+ GS+ D + G + ++ P I A GL +LH IHRDVK +NILL
Sbjct: 103 NGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTT 159
Query: 668 SMCAKVADFGFSKYAPQEGDSGFSLEVR-----GTAGYLDPEYYSTQH-----LSAKSDV 717
K+ DFG S S +R GT ++ PE + + A+ DV
Sbjct: 160 EGGVKLVDFGVSAQLT-------STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDV 212
Query: 718 FSFGVVLLEIISGREPLNTRRP 739
+S G+ +E+ G PL P
Sbjct: 213 WSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 69/221 (31%), Positives = 92/221 (41%), Gaps = 25/221 (11%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFE---NELNFLS-AIRHENLVPL 590
++G+G FG V L G+ AVKV + E E LS A H L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 591 LGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
YCC D+ V F++ G L + + S R D A LM+LH
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLM--FHIQKSRR--FDEARARFYAAEITSALMFLHD- 114
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--DSGFSLEVRGTAGYLDPEYY 706
+ +I+RD+K N+LLDH K+ADFG K G S F GT Y+ PE
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC----GTPDYIAPEIL 168
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
D ++ GV+L E++ G P NE L E
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 69/244 (28%), Positives = 104/244 (42%), Gaps = 60/244 (24%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAIRHENLVP 589
IGEG +G VY+ G+ VA+K +R T +G RE ++ L + H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNIVR 62
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
LL ++ LV+ F+ L + Y ++S LD P S +G+ Y H
Sbjct: 63 LLDVVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--- 116
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TAGYLDP 703
V+HRD+K N+L+D K+ADFG ++ F + VR T Y P
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR--------AFGVPVRTYTHEVVTLWYRAP 168
Query: 704 E------YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR 757
E YST D++S G + E++ RRP F +S
Sbjct: 169 EILLGSRQYST-----PVDIWSIGCIFAEMV-------NRRPL-----------FPGDSE 205
Query: 758 IDEI 761
ID++
Sbjct: 206 IDQL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE--------------NEL 576
+QY+ L G+GGFG V A +VR++ + E NE
Sbjct: 3 RQYRVL-GKGGFGEV----------CACQVRATGKMYACKRLEKKRIKKRKGESMALNEK 51
Query: 577 NFLSAIRHENLVPLLGYCCEN-DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
L + + +V L Y E D LV M+ G L+ +Y + + L A
Sbjct: 52 QILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYA 108
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
GL LH + ++RD+K NILLD +++D G + P EG+S +R
Sbjct: 109 AEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EGES-----IR 159
Query: 696 G---TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPR 740
G T GY+ PE + Q + D + G ++ E+I G+ P R+ +
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 57/234 (24%), Positives = 92/234 (39%), Gaps = 20/234 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVA---VK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G FG V G G A VK +R+S + F E+ + H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGE-ASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
C E+ +LV F G L++ L + +A A GL++LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFG--FSKYAPQ--EGDSGFSLEVRGTAGYLDPEYYS 707
IH D+ N L + K+ D+G +Y ++ +R A L
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 708 ---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758
+ + KS+++S GV + E+ + +P + S + K +RE I
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVREQDI 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVP 589
+G+GGFG V R T G+ A K + + + +E E L+ + H +
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIV 56
Query: 590 LLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
L Y + + LV M+ G L+ +Y P GL +LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ- 115
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSGFSLEVRGTAGYLDPEYY 706
R +I+RD+K N+LLD+ +++D G + Q G++ GT G++ PE
Sbjct: 116 --RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA----GTPGFMAPELL 169
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
+ D F+ GV L E+I+ R P R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 537 IGEGGFGSVY--------RGTLPDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHEN 586
+GEG FG V + VAVK+ +T + + +E+ + I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRL---------YGEASTR---KTLDWPTRLSI 634
++ LLG C ++ ++ + S G+L++ L Y + + + L + +S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A ARG+ YL A + IHRD+ + N+L+ K+ADFG ++ +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
R ++ PE + + +SDV+SFGV+L EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN-----ELNFLSAIRHENLVP 589
+GEG + VY+ G+ VA+K + ++ N E+ L ++H N++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 590 LLGYCCENDQQILVYPFMSNGSLQ----DR--LYGEASTRKTLDWPTRLSIALGAARGLM 643
LL LV+ FM L+ D+ + A + S L RGL
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK---------SYMLMTLRGLE 116
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG--FSLEVRGTAGYL 701
YLH+ ++HRD+K +N+L+ K+ADFG ++ G + +V T Y
Sbjct: 117 YLHS---NWILHRDLKPNNLLIASDGVLKLADFGLAR---SFGSPNRKMTHQVV-TRWYR 169
Query: 702 DPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE + +H D++S G + E++ R P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 537 IGEGGFGSVYRGTLPDG----QEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G FG V G + G Q V ++R S S Q +F E +++H NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYG-EASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
C E +LV F G L+ L + T D T +A A GL++LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---N 119
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH- 710
+ IH D+ N LL + K+ D+G S +E ++ ++ PE H
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 711 ------LSAKSDVFSFGVVLLEIIS-GREP 733
+ +S+V+S GV + E+ G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 537 IGEGGFGSVYRGT---LPDGQ-----EVAVKVRSSTSTQGTREFENELNFLSAIRHENLV 588
+G+G F +++G + D EV +KV + + F + +S + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
G C D+ I+V ++ GSL L + W ++ L A LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-WKLEVAKQLAWA-----LHFL 116
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD------ 702
+ + H +V + N+LL K + F K + D G S+ V L+
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS----DPGISITVLPKEILLERIPWVP 172
Query: 703 PEYYS-TQHLSAKSDVFSFGVVLLEIISGRE-PLNTRRP 739
PE Q+LS +D +SFG L EI SG + PL+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
+G+GGFG V + G+ A K + +G + NE L + + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 593 YCCEN-DQQILVYPFMSNGSLQDRLY--GEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
Y E D LV M+ G L+ +Y GE + A GL +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----FPEARAIFYAAQIICGLEHLHQ-- 113
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFS-KYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
R +++RD+K N+LLD +++D G + + + G + GT GY+ PE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA----GTPGYMAPEVLQG 168
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
+ D F+ G L E+I+GR P R+ + E
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 39/233 (16%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRH 584
T +Y L +G G FG V GQ VA+K ++ ++ + EL L +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTR----KTLDWPTRLSIALGAAR 640
EN++ L I + P + L G R + L+ R
Sbjct: 69 ENIISL--------SDIFISPL-EDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
GL Y+H+ AG V+HRD+K SNIL++ + K+ DFG ++ Q+ GY
Sbjct: 120 GLKYVHS-AG--VVHRDLKPSNILINENCDLKICDFGLAR--IQDPQ---------MTGY 165
Query: 701 LDPEYYST-------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
+ YY Q + D++S G + E++ G+ + N++S++
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 6e-11
Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 52/224 (23%)
Query: 537 IGEGGFGSVYRGTLPD---GQEVAVK-----VRSSTSTQGTREFENELNFLSAIR-HENL 587
+G+G +G V++ D + VA+K R++T Q R F E+ FL + H N+
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQELGDHPNI 69
Query: 588 VPLLG-YCCENDQQI-LVYPFMSN--------GSLQD--RLYGEASTRKTLDWPTRLSIA 635
V LL END+ I LV+ +M L+D + Y I
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY----------------IM 113
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC-AKVADFGFSK-YAPQEGDSGFSL- 692
+ L Y+H+ +VIHRD+K SNILL+ S C K+ADFG ++ + E + +
Sbjct: 114 YQLLKALKYIHS---GNVIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVL 169
Query: 693 -EVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ T Y PE + + D++S G +L E++ G+ PL
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 47/128 (36%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666
M GSL D++ EA R + ++SIA+ RGL YL ++HRDVK SNIL++
Sbjct: 85 MDGGSL-DQVLKEAK-RIPEEILGKVSIAV--LRGLAYLRE--KHQIMHRDVKPSNILVN 138
Query: 667 HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLE 726
K+ DFG S + F GT Y+ PE H S +SD++S G+ L+E
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
Query: 727 IISGREPL 734
+ GR P+
Sbjct: 195 LAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 39/104 (37%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
+ + + L YL G VIHRDVK SNILLD S K+ DFG S DS
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173
Query: 694 VRGTAGYLDPEYYSTQHLSAK----SDVFSFGVVLLEIISGREP 733
G A Y+ PE + K +DV+S G+ L+E+ +G+ P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKV-RSSTSTQGTREFEN---ELNFLSAIRHENLV 588
+G G +G V+ G G+ A+KV + +T Q + E+ E L A+R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 589 PLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
L Y + D ++ L+ +++ G L LY ++ R+ IA L +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIA-EIVLALDHLHQ 123
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGTAGYLDPEYY 706
+I+RD+K NILLD + DFG SK + +E + +S GT Y+ PE
Sbjct: 124 ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF--CGTIEYMAPEVI 178
Query: 707 STQ---HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
H A D +S GV+ E+++G P +N S
Sbjct: 179 RGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/228 (21%), Positives = 96/228 (42%), Gaps = 23/228 (10%)
Query: 519 QIFSLQYLEAAT-QQYK-TLIGEGGFGSVYRGTLPDGQEVAVKV---RSSTSTQGTREFE 573
I ++ +E+ +Y LI E S+Y+G + +EV ++ E
Sbjct: 8 YINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITE 66
Query: 574 NELNFLSAIRHENLVPLLGY----CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWP 629
NE+ L I N++ + G+ + + L+ + + G L++ L E K L +
Sbjct: 67 NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFK 122
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689
T+L +A+ +GL L+ + + ++++ S + L+ + K+ G K S
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL-----SS 175
Query: 690 FSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLN 735
+ Y + + + K D++S GVVL EI +G+ P
Sbjct: 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 537 IGEGGFGSVYRG---TLPDGQEVAVKVRSSTSTQGT--REFENELNFLSAIRHENLVPLL 591
+G G FG+V +G + VAVK+ + + E E N + + + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL--HTFA 649
G CE + +LV G L L K + + + G+ YL F
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEETNF- 116
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT--AGYLDPEYYS 707
+HRD+ + N+LL AK++DFG SK A ++ + + G + PE +
Sbjct: 117 ----VHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 708 TQHLSAKSDVFSFGVVLLEIIS-GREP 733
S+KSDV+SFGV++ E S G++P
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE--------------NEL 576
+ Y+ L G+GGFG V A +VR++ ++ E NE
Sbjct: 3 RHYRVL-GKGGFGEV----------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 51
Query: 577 NFLSAIRHENLVPLLGYCCEN-DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
L + +V L Y E D LV M+ G L+ +Y + D + A
Sbjct: 52 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFDEERAVFYA 108
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
GL LH +++RD+K NILLD +++D G + P EG++ +R
Sbjct: 109 AEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGET-----IR 159
Query: 696 G---TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
G T GY+ PE + + D + G ++ E+I G+ P R+ + + VE
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
A GL +LH+ + +I+RD+K N++LD K+ADFG K G + + GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
Y+ PE + Q D ++FGV+L E+++G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 24/218 (11%)
Query: 531 QQYKTL--IGEGGFGSVY--RGTLPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIR 583
+ + +G G FG V+ R + A+KV + + NE L +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 584 HENLVPLLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
H ++ L + E+DQ+ L + ++ G L L T L A
Sbjct: 60 HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCA 113
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLH + +++RD+K NILLD K+ DFGF+K + D ++L GT YL
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK---KLRDRTWTL--CGTPEYL 165
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
PE ++ + D ++ G+++ E++ G P P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG G +G VY+ + G+ A+KV + + E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 596 ENDQQILVYPFMSNGSLQD--RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
D+ + F GSLQD + G S + + + +R ++ +GL YLH+ +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQ-IAYVSRETL-----QGLYYLHS---KGK 127
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
+HRD+K +NILL + K+ADFG S A GT ++ PE + +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 714 KS---DVFSFGVVLLEIISGREPLNTRRP 739
+ D+++ G+ +E+ + P+ P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL-GYC 594
+G+G FG VY+ + G A KV + S + ++ E++ L++ H N+V LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
EN+ IL+ F + G++ + + L P + L YLH +I
Sbjct: 73 YENNLWILI-EFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAP---QEGDSGFSLEVRGTAGYLDPEYYSTQH- 710
HRD+K+ NIL K+ADFG S Q DS GT ++ PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETS 180
Query: 711 ----LSAKSDVFSFGVVLLEIISGREPLNTRRP 739
K+DV+S G+ L+E+ P + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 23/228 (10%)
Query: 535 TLIGEGGFGSVYRGTLPDGQE-VAVKVRSSTSTQG---TREFENELNFLSAIRHENLVPL 590
T +G+GG+G V+ D E VA+K + R E + L+ + E LV L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 591 LGYCCENDQQI-LVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
L Y ++D+ + L ++ G + L G S + + A+ A L Y
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY--- 122
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
IHRD+K N L+D S K+ DFG SK +S V G+ Y+ PE
Sbjct: 123 ------IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLR 171
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAKPFIR 754
+ D +S G +L E + G P + P W L W + R
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG-YC 594
+G+G FG VY+ + G A KV + S + ++ E+ L+ H +V LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ I++ F G++ D + E + L P I L YLH+ +I
Sbjct: 80 WDGKLWIMI-EFCPGGAV-DAIMLELD--RGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSK---YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
HRD+K+ N+LL K+ADFG S Q DS GT ++ PE + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETM 187
Query: 712 SA-----KSDVFSFGVVLLEIISGREPLNTRRP 739
K+D++S G+ L+E+ P + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE--------------NEL 576
+ Y+ L G+GGFG V A +VR++ ++ E NE
Sbjct: 3 RHYRVL-GKGGFGEV----------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 51
Query: 577 NFLSAIRHENLVPLLGYCCEN-DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
L + +V L Y E D LV M+ G L+ +Y + D + A
Sbjct: 52 RILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYA 108
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
GL L +++RD+K NILLD +++D G + P EG++ VR
Sbjct: 109 AELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGET-----VR 159
Query: 696 G---TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
G T GY+ PE + + + D + G ++ E+I G+ P R+ R + V+
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 575 ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSI 634
E + L AI H +++ L G N L+ P + LY + ++ + L+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILAI 187
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
R + YLH +IHRD+K+ NI ++H + DFG + + P + ++
Sbjct: 188 ERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGW 243
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
GT PE + D++S G+VL E+ + + L +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 14/207 (6%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFEN---ELN-FLSAIRHENLVPL 590
+IG+G FG V DG+ AVKV +E ++ E N L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
++ V F++ G L L E ++ P A A L YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI-- 115
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
++++RD+K NILLD + DFG K + D+ + GT YL PE Q
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTR 737
D + G VL E++ G P R
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV---RSSTSTQGTREFENELNFLSAIRHEN--LVP 589
+IG GGFG VY D G+ A+K + QG NE LS + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 590 LLGYCCEN-DQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ Y D+ + M+ G L L +G S ++ + T + + GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFG----FSKYAPQEGDSGFSLEVRGTAGYLD 702
R V++RD+K +NILLD +++D G FSK P GT GY+
Sbjct: 115 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMA 163
Query: 703 PEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
PE + +D FS G +L +++ G P + +++
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 535 TLIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAIRHENL 587
IGEG +G+VY+ L G+ VA+K VR S +G RE L L + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFEHPNI 63
Query: 588 VPLLGYC--CENDQQI---LVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAARG 641
V LL C D+++ LV+ + QD Y + L T + RG
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680
+ +LH+ ++HRD+K NIL+ K+ADFG ++
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 533 YKTL--IGEGGFGSVYRGT-LPDGQEVAVK------VRSSTSTQGTREFENELNFLSAIR 583
Y+ L I EG +G VYR G+ VA+K + RE N L ++
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQ 62
Query: 584 HENLVPL----LGYCCENDQQI-LVYPFMSNG--SLQDRLYGE--ASTRKTLDWPTRLSI 634
H N+V + +G N +I +V ++ + SL + + S K L
Sbjct: 63 HPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-------- 111
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
L G+ +LH ++HRD+K+SN+LL++ K+ DFG ++ L V
Sbjct: 112 MLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 695 RGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE + S D++S G + E+++ ++PL
Sbjct: 169 --TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 37/216 (17%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLG-- 592
+G+G +GSVY+ P G +A+K +R + EL+ L +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 593 -------YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
C E +M GSL D+LY + + I +GL +L
Sbjct: 69 FIEGAVYMCME---------YMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR--GTAGYLDP 703
++IHRDVK +N+L++ + K+ DFG S G+ SL G Y+ P
Sbjct: 119 KE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAP 170
Query: 704 EYYSTQHLSA------KSDVFSFGVVLLEIISGREP 733
E + + +SDV+S G+ +LE+ GR P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 6/101 (5%)
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
+++ +GL YL ++HRDVK SNIL++ K+ DFG S + F
Sbjct: 108 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-- 163
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
GT Y+ PE H S +SD++S G+ L+E+ GR P+
Sbjct: 164 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 532 QYKTL--IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFE-NELNFLSAIRHENL 587
+K L +GEG + +VY+G G+ VA+K + +GT E++ + ++HEN+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYL 645
V L ++ +LV+ +M L+ + +G R LD T S +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFC 116
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H V+HRD+K N+L++ K+ADFG ++ A + FS EV T Y P+
Sbjct: 117 HE---NRVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPDV 171
Query: 706 ------YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
YST D++S G ++ E+I+GR PL +
Sbjct: 172 LLGSRTYSTS-----IDIWSVGCIMAEMITGR-PLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQG-----TREFENELNFLSAIRHENLVP 589
IG G +G+VY+ P G VA+K VR T+ G RE L L A H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA-LLKRLEAFDHPNIVR 66
Query: 590 LLGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
L+ C D++ V + R Y + L T + RGL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGTAGYLDPEYY 706
++HRD+K NIL+ K+ADFG ++ Y+ Q + V T Y PE
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT----PVVVTLWYRAPEVL 179
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPL 734
+ D++S G + E+ R+PL
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFEN---ELNFLS-AIRHENLVPL 590
++G+G FG V+ L Q A+K + E E LS A H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 591 LGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
YC ++ L V +++ G L ++ S K D P A GL +LH+
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS- 114
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
+ +++RD+K NILLD K+ADFG K GD+ GT Y+ PE
Sbjct: 115 --KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLN 735
Q + D +SFGV+L E++ G+ P +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 537 IGEGGFGSVY---RGTLPDGQEVAVKVRSSTSTQGT-------REFENELNFLSAIRHEN 586
IG G +G VY R DG+E A+K Q T RE + L ++HEN
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHEN 63
Query: 587 LVPLLGYCCEN-DQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+V L+ E+ D+ + L++ + + Q + + R ++ S+ G+ Y
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123
Query: 645 LHTFAGRSVIHRDVKSSNILL--DHSMCA--KVADFGFSK--YAP 683
LH+ V+HRD+K +NIL+ + K+ D G ++ AP
Sbjct: 124 LHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFEN---ELN-FLSAIRHENLVPL 590
+IG+G FG V DG AVKV + +E + E N L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 591 LGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
Y + +++ V +++ G L L E + P A A + YLH+
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLHSL- 115
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA--PQEGDSGFSLEVRGTAGYLDPEYYS 707
++I+RD+K NILLD + DFG K P+E S F GT YL PE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC----GTPEYLAPEVLR 169
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
+ D + G VL E++ G P +R
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFEN---ELN-FLSAIRHENLVP 589
+IG+G FG V DG+ AVKV + +E ++ E N L ++H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 590 LLGYCCENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
L D+ V +++ G L ++R + E R + ++ ALG Y
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF---YAAEIASALG------Y 111
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSGFSLEVRGTAGYLD 702
LH ++I+RD+K NILLD + DFG K + S F GT YL
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC----GTPEYLA 164
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
PE Q D + G VL E++ G P +R
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 537 IGEGGFGSV----YRGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVP 589
+G G FG V ++GT G+ A+K ++ ++ E + L + H +V
Sbjct: 26 LGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM--YLHT 647
++ + ++ + F+ G L L RK +P ++ A L YLH+
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL------RKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
+ +I+RD+K N+LLD+ KV DFGF+K P D F+L GT YL PE
Sbjct: 137 ---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTL--CGTPEYLAPEVIQ 188
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREP 733
++ D ++ GV+L E I+G P
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFE---NELNFLS-AIRHENLVPL 590
++G+G FG V L EV A+KV + + E L+ A +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 591 LGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
+CC D+ V +++ G L ++ +RK D P A LM+LH
Sbjct: 62 --HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRK-FDEPRSRFYAAEVTLALMFLHR- 114
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
VI+RD+K NILLD K+ADFG K G + + GT Y+ PE
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170
Query: 709 QHLSAKSDVFSFGVVLLEIISGREP 733
D ++ GV++ E+++G+ P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 67/245 (27%), Positives = 97/245 (39%), Gaps = 40/245 (16%)
Query: 537 IGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVP 589
I +G FGSVY R T G A+KV + + N E + V
Sbjct: 4 ISKGAFGSVYLAKKRST---GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 590 LLGYCCEN-DQQILVYPFMSNGSLQDRLYGEASTRKTL-----DWPTRLSIALGAARGLM 643
L Y ++ D LV +++ G AS KTL DW + + G+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-------ASLIKTLGGLPEDWAKQYIAEV--VLGVE 111
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
LH R +IHRD+K N+L+D + K+ DFG S+ + F GT YL P
Sbjct: 112 DLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--FV----GTPDYLAP 162
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE-----WAKPFIRESRI 758
E SD +S G V+ E + G P + P + + W + ++E
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE-EVKEFCS 221
Query: 759 DEIVD 763
E VD
Sbjct: 222 PEAVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 56/244 (22%)
Query: 530 TQQYKTL---IGEGGFGSVYRG--TLPDGQEVAVK----VRSSTSTQGTREFEN------ 574
+++Y +GEG +G V + TL G+ VA+K + S R+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 575 ----ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPT 630
EL ++ I+HEN++ L+ E D LV M + +K +D
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-----------ASDLKKVVDRKI 114
Query: 631 RLS------IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS-KYA- 682
RL+ I L GL LH +HRD+ +NI ++ K+ADFG + +Y
Sbjct: 115 RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 683 PQEGDSGFSLEVRG----------TAGYLDPEYY--STQHLSAKSDVFSFGVVLLEIISG 730
P D+ E T Y PE + ++ A D++S G + E+++G
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA-VDMWSVGCIFAELLTG 230
Query: 731 REPL 734
+ PL
Sbjct: 231 K-PL 233
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 537 IGEGGFGSVYRGTLP-DGQEVAVK-----VRSSTSTQGTREFENELNFLSAIRHENLVPL 590
IG G FG V+ T P DG+ VA+K ++ S + R F EL L +H+N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK--RVFR-ELKMLCFFKHDNVLSA 64
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS------IALGAARGLMY 644
L + Q + PF + + + ++ K + P LS RGL Y
Sbjct: 65 L----DILQPPHIDPFEEIYVVTELM--QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH+ AG ++HRD+K N+L++ + K+ DFG ++ + + EV T Y PE
Sbjct: 119 LHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174
Query: 705 -YYSTQHLSAKSDVFSFGVVLLEIISGR 731
++H ++ D++S G + E++ R
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFE--NELNFLSAIRHENLVPLLGY 593
+GEG + +VY+G + +GQ VA+KV S + +G F E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ V+ +M Q Y + RL RGL Y+H G+ +
Sbjct: 72 IHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHI 124
Query: 654 IHRDVKSSNILLDHSMCAKVADFGF--SKYAPQEGDSGFSLEVRGTAGYLDPEYY--STQ 709
+HRD+K N+L+ + K+ADFG +K P + +S EV T Y P+ +T
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---TYSSEVV-TLWYRPPDVLLGATD 180
Query: 710 HLSAKSDVFSFGVVLLEIISGR 731
+ S+ D++ G + +E++ G+
Sbjct: 181 Y-SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 44/217 (20%)
Query: 535 TLIGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFEN---------ELNFLSA 581
+ +G G +G V T G++VA+K S R F++ EL L
Sbjct: 21 SPVGSGAYGQVCSAFDTKT---GRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKH 70
Query: 582 IRHENLVPLLGYCC-----ENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
+ HEN++ LL E+ Q + LV M D L +K D + +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----AD-LNNIVKCQKLSDDHIQF-LV 124
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
RGL Y+H+ AG +IHRD+K SNI ++ K+ DFG +++ E +G+
Sbjct: 125 YQILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-TGYV---- 176
Query: 696 GTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGR 731
T Y PE + H + D++S G ++ E+++G+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 38/145 (26%), Positives = 61/145 (42%), Gaps = 16/145 (11%)
Query: 208 FRYPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTALTDPNRLMFLHT 267
Y D + + + S T N S + A T P + QT P+ +
Sbjct: 18 ITYEADTYF-------TGGSADYYVSDT-NGSSSIAGTTDPE-LYQTERYSPSSFSYYIP 68
Query: 268 DLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDI--LALGSNYA--KLA 323
L++G NYT+IL+F E+ G+RVFD+ + + + FDI A G K
Sbjct: 69 CLENG--NYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDFDIVAEAGGKGKTAHKEY 126
Query: 324 LNVTA-NGSLNLTLVNVLNGSVFGP 347
+ VT +G+L + G++ P
Sbjct: 127 IPVTVTDGTLEIHFYWAGKGTLLIP 151
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 536 LIGEGGFGSVY---RGTLPD-GQEVAVKV-RSSTSTQGTREFEN---ELNFLSAIRHENL 587
++G G +G V+ + T D G+ A+KV + + Q + E+ E N L +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSLQDRLY-----GEASTRKTLDWPTRLSIALGAARG 641
+ L Y + + ++ L+ ++S G + LY E R + + +AL
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF---YSGEIILAL----- 118
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGTAGY 700
+LH +++RD+K NILLD + DFG SK + +E + +S GT Y
Sbjct: 119 -EHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF--CGTIEY 172
Query: 701 LDPEYYSTQHLSAKS-DVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
+ PE + K+ D +S G+++ E+++G P RN S V
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
+S + ARG+ +L A R IHRD+ + NILL + K+ DFG ++ ++ D
Sbjct: 176 ISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
+ R ++ PE + + +SDV+SFGV+L EI S
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 536 LIGEGGFGSVYRGTLPDGQE----VAVKV-------RSSTSTQGTREFENELNFLSAIRH 584
++G+GG+G V++ G + A+KV R+ T T+ E N L A++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNILEAVKH 59
Query: 585 ENLVPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGA 638
+V L+ Y + ++ L+ ++S G L ++ ++ E + L + +S+AL
Sbjct: 60 PFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL---SEISLALE- 114
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
+LH + +I+RD+K NILLD K+ DFG K + EG + GT
Sbjct: 115 -----HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF--CGTI 164
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE D +S G ++ ++++G P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 537 IGEGGFGSVYRGTLPDGQE-VAVK-VRSSTSTQGTREFE-NELNFLSAIRHENLVPLLGY 593
IGEG +G+V++ + E VA+K VR +G E+ L ++H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ + LV+ + QD S +D S +GL + H+ +V
Sbjct: 68 LHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNV 120
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TAGYLDPEYYS 707
+HRD+K N+L++ + K+ADFG ++ F + VR T Y P+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR--------AFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 708 TQHLSAKS-DVFSFGVVLLEIISGREPL 734
L + S D++S G + E+ + PL
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-09
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 30/225 (13%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQG--TREFENELNFLSAIRHENLVPLL 591
LIG+GG G VY P + VA+K +R S + F E + + H +VP+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 592 GYCCENDQQILVYPFMSNGSLQDRL---YGEASTRKTL----DWPTRLSIALGAARGLMY 644
C + D P++ +L+ L + + S K L LSI + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR--------- 695
+H+ + V+HRD+K NILL + D+G + + E + ++V
Sbjct: 129 VHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 696 -------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
GT Y+ PE S +D+++ GV+L ++++ P
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 628 WPTRLSI------ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681
W + L++ + ARG+ +L A R IHRD+ + NILL + K+ DFG ++
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223
Query: 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
++ D R ++ PE + + +SDV+SFGV+L EI S G P
Sbjct: 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 28/216 (12%)
Query: 536 LIGEGGFGSVY--RGTLPDGQEVAVK---VRSSTSTQGTREFE-------NELNFL-SAI 582
+G G FG VY R +A+K V + + RE + +E+ + +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 583 RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLY-----GEASTRKTLDWPTRLSIALG 637
RH N+V END+ +V + L + + T + + W + + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMVLA 125
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
L YLH + ++HRD+ +NI+L + DFG +K Q+ V GT
Sbjct: 126 ----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGT 176
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y PE + K+DV++FG +L ++ + + P
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK---YAPQEGDSGFSLEVRGT 697
GL +LH + +I+RD+K N+LLD K+ADFG K + + F GT
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FC----GT 159
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE Q + D +SFGV+L E++ G+ P
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 45/277 (16%)
Query: 531 QQYKTL--IGEGGFGSVYRGTLPDGQEVAV--KVRSSTSTQGTREFE-NELNFLSAIRHE 585
QY+ + IGEG +G VY+ E K+R +G E++ L ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N+V L + LV+ ++ L + + ++S + + RG+ Y
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSKYAPQEGDSGFSLEVRG------TA 698
H+ V+HRD+K N+L+D A K+ADFG ++ F + VR T
Sbjct: 119 HS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------AFGIPVRTFTHEVVTL 167
Query: 699 GYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR 757
Y PE ++H S D++S G + E+++ + PL F +S
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PL-----------------FPGDSE 209
Query: 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP 794
IDE+ G E W V F + P
Sbjct: 210 IDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPP 246
|
Length = 294 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 629 PTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688
P + A + GL +LH R +I+RD+K N++LD K+ADFG K +G +
Sbjct: 101 PQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157
Query: 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
+ GT Y+ PE + Q D +++GV+L E+++G+ P +
Sbjct: 158 --TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 39/225 (17%)
Query: 533 YKTL--IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFE-NELNFLSAIRHEN- 586
Y+ L IGEG +G VY+ G+ VA+K R +G E++ L +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 587 LVPLLGYCCENDQQ-------ILVYPFMSNG--SLQDRLYGEASTRKTLDWPTRLSIALG 637
+V LL E+ ++ LV+ ++ + D L T S
Sbjct: 63 IVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQ 118
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+G+ + H V+HRD+K N+L+D K+AD G + FS+ V+
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR--------AFSIPVKS 167
Query: 697 ------TAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE + H S D++S G + E+ ++PL
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 63/237 (26%), Positives = 87/237 (36%), Gaps = 50/237 (21%)
Query: 535 TLIGEGGFGSVYRGTLPDGQEV-AVKV-RSST---STQGTREFENELNFLSAIRHENLVP 589
+IG G FG V+ D +V A+KV R S Q E + L+ +V
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVK 65
Query: 590 LLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLD--WPTRLSIA-LGAARGLMY 644
L Y D++ L V +M G L + L + R IA L A L
Sbjct: 66 L--YYSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEET-ARFYIAELVLA--LDS 116
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR--------- 695
+H IHRD+K NIL+D K+ADFG K + D + L
Sbjct: 117 VHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 696 ------------------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
GT Y+ PE + D +S GV+L E++ G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 531 QQYKTL--IGEGGFGSVY--RGTLPDGQEVAVK-VRSSTSTQGT-----REFENELNFLS 580
QQY+ + IGEG +G V+ R G+ VA+K VR T +G RE L L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 59
Query: 581 AIRHENLVPLLGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
H N+V L C D++ + + Y + + T +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGT 697
RGL +LH+ V+HRD+K NIL+ S K+ADFG ++ Y+ Q + V T
Sbjct: 120 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT----SVVVT 172
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE + D++S G + E+ R+PL
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689
++I L YLH GR +IHRDVK+ NI LD A + DFG A +
Sbjct: 186 QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG---AACKLDAHP 239
Query: 690 FSLEVRGTAGYLD---PEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ + G +G L+ PE + AK+D++S G+VL E+ L
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV---RSSTSTQGTREFENELNFLSAIRHEN--LVP 589
+IG GGFG VY D G+ A+K + QG NE LS + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 590 LLGYCCEN-DQQILVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ Y D+ + M+ G L L +G S + + + + GL ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLEHMH 114
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFG----FSKYAPQEGDSGFSLEVRGTAGYLD 702
R V++RD+K +NILLD +++D G FSK P GT GY+
Sbjct: 115 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMA 163
Query: 703 PEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
PE + +D FS G +L +++ G P + +++
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 531 QQYKTL--IGEGGFGSV---YRGTLPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIR 583
++Y+ L +G G +GSV Y L Q+VAVK R S R EL L ++
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMK 72
Query: 584 HENLVPLL-----GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
HEN++ LL EN ++ + + L + + + + + + + +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQL 127
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
RGL Y+H+ AG +IHRD+K SN+ ++ ++ DFG ++ A E +G+ T
Sbjct: 128 LRGLKYIHS-AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-TGYV----ATR 179
Query: 699 GYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGR 731
Y PE + H + D++S G ++ E++ G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 37/223 (16%)
Query: 532 QYKTL--IGEGGFGSV--YRGTLPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRHE 585
+YK + IG G +G V T G++VA+K + + EL L +H+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLY-----GEASTRKTLDWPTRLSIALGAA- 639
N++ + I G+ +Y E+ + L+
Sbjct: 65 NIIAIR--------DI----LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF 112
Query: 640 -----RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSL 692
RGL Y+H+ A VIHRD+K SN+L++ ++ DFG ++ F
Sbjct: 113 LYQLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 693 EVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
E T Y PE S + D++S G + E++ GR L
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
A GL +LH+ + +I+RD+K N++LD K+ADFG K +G + + GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTP 165
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
Y+ PE + Q D ++FGV+L E+++G+ P
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 534 KTLIGEGGFGSVY----RGTLPDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHEN 586
K+L+G G FG V + T G A+KV + + FE E + LS I +
Sbjct: 6 KSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSP 61
Query: 587 LVPLLGYCCE-NDQQILVYPFMSNG---SLQDRLYG---EASTRKTLDWPTRLSIALGAA 639
+P L Y + D LV + G SL +R E + L A
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL------------A 109
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
++ +H+ +HRD+K N+L+D + K+ADFG + L V GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPD 168
Query: 700 YLDPEYYSTQHLSAKS------DVFSFGVVLLEIISGREP 733
Y+ PE +T + K D +S GV+ E+I GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 52/228 (22%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQG-----TREFENELNFLSAIRHENLVP 589
+GEG FG VY+ + G+ VA+K + G RE + L ++H N+VP
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKHPNVVP 71
Query: 590 LLGYCCENDQQI--------LVYPFMS---NGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
L+ E + +V P+M +G L++ L L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQL 124
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF------SKYAPQEGDSGFSL 692
G+ YLH ++HRD+K++NIL+D+ K+ADFG P+ G G +
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 693 EVRG---TAGYLDPEY------YSTQHLSAKSDVFSFGVVLLEIISGR 731
+ T Y PE Y+T D++ G V E+ + R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTA-----VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 22/202 (10%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFE--NELNFLSAIRHENLVPLLGY 593
+GEG + +VY+G + +G+ VA+KV +GT F E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 594 CCENDQQILVYPFMSNGSLQ--DRLYGEASTRKTLDWPTRLSIAL-GAARGLMYLHTFAG 650
+ LV+ ++ Q D+ G P + + L RGL Y+H
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLH-------PENVKLFLFQLLRGLSYIHQ--- 121
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY--ST 708
R ++HRD+K N+L+ + K+ADFG ++ A +S EV T Y P+ ST
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGST 179
Query: 709 QHLSAKSDVFSFGVVLLEIISG 730
++ S D++ G + +E+I G
Sbjct: 180 EY-STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 17/191 (8%)
Query: 540 GGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQ 599
G G V+ T GQ V ++ +GT E L L + H +++ +
Sbjct: 77 GSEGRVFVAT-KPGQPDPVVLK--IGQKGTTLIEAML--LQNVNHPSVIRMKDTLVSGAI 131
Query: 600 QILVYPFMSNGSLQDRLYGEASTRKT-LDWPTRLSIALGAARGLMYLHTFAGRSVIHRDV 658
+V P S+ LY + R L L I GL YLH + +IHRDV
Sbjct: 132 TCMVLPHYSSD-----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDV 183
Query: 659 KSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVF 718
K+ NI ++ + D G +++ L + GT PE + ++K+D++
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIW 240
Query: 719 SFGVVLLEIIS 729
S G+VL E+++
Sbjct: 241 SAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
A+G+ +L A R IHRD+ + NILL + K+ DFG ++ ++ D + R
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
++ PE + + +SDV+SFGV+L EI S G P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 64/235 (27%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELNFLSA 581
+ IG G +G V G++VA+K + + F++ E+ L
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIK-------KISNVFDDLIDAKRILREIKLLRH 55
Query: 582 IRHENLVPLL------GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
+RHEN++ LL ND +V M E K + P L+
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDV-YIVTELM-----------ETDLHKVIKSPQPLTDD 103
Query: 636 ---------LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA-PQE 685
L RGL YLH+ A VIHRD+K SNIL++ + K+ DFG ++ P E
Sbjct: 104 HIQYFLYQIL---RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 686 GDSGFSLEVRGTAGY------LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ GF E T Y L Y+ D++S G + E++ R+PL
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKA-----IDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 535 TLIGEGGFGSVYRGT-LPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G +GSV G++VA+K R S + EL L ++HEN++ LL
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 592 GYCCE----NDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
++ Q LV P+M LQ + S K + GL Y+
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQ------YLVYQMLCGLKYI 133
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H+ AG +IHRD+K N+ ++ K+ DFG +++A E +G+ + T Y PE
Sbjct: 134 HS-AG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-TGYVV----TRWYRAPEV 185
Query: 706 -YSTQHLSAKSDVFSFGVVLLEIISGR 731
+ H + D++S G ++ E+++G+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
L YLH R +I+RD+K N+LLD K+ D+G K + GD+ + GT Y
Sbjct: 108 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
+ PE + D ++ GV++ E+++GR P +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 531 QQYKTL--IGEGGFGSVYRG-TLPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRHE 585
++Y+ L +G G +GSV G VAVK R S + EL L ++HE
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 586 NLVPLL-----GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR 640
N++ LL E + + + L + + + T + + + R
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILR 131
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
GL Y+H+ +IHRD+K SN+ ++ K+ DFG +++ E +G+ T Y
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-TGYV----ATRWY 183
Query: 701 LDPE-YYSTQHLSAKSDVFSFGVVLLEIISGR 731
PE + H + D++S G ++ E+++GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G +G VY+ L G+ AVK+ + E+ + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 596 ENDQQILVYPFMSNGSLQD--RLYGEAST-------RKTLDWPTRLSIALGAARGLMYLH 646
++ + + GSLQD + G S R+TL +GL YLH
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-------------QGLAYLH 123
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ + +HRD+K +NILL + K+ADFG + A GT ++ PE
Sbjct: 124 S---KGKMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVA 178
Query: 707 STQHLSAKS---DVFSFGVVLLEIISGREPLNTRRP 739
+ + + D+++ G+ +E+ + P+ P
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 536 LIGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFENELN---FLSAIRHENLV 588
L+G+G FG V + T G+ A+K+ E + L L RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 589 PLLGYCCENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGA--ARG 641
L +D+ V + + G L ++R++ E R GA
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-----------FYGAEIVSA 107
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLH + ++V++RD+K N++LD K+ DFG K ++G + + GT YL
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYL 163
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE D + GVV+ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELN----FLSAIRHENLVPL 590
+IG+G FG V + + AVKV + +E ++ ++ L ++H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
D+ V +++ G L Y R L+ P A A L YLH+
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLE-PRARFYAAEIASALGYLHSL-- 115
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSGFSLEVRGTAGYLDPEYYST 708
++++RD+K NILLD + DFG K S F GT YL PE
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC----GTPEYLAPEVLHK 170
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTR 737
Q D + G VL E++ G P +R
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAG 699
L +LH R +I+RD+K N+LLD K+ D+G K + GD S F GT
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC----GTPN 161
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
Y+ PE + D ++ GV++ E+++GR P +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 53/288 (18%)
Query: 537 IGEGGFGSVYRGTL---PD------GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHEN 586
+G+G F ++Y+G L D GQEV+V ++ S + F + +S + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
LV L G C D+ I+V ++ G L D +L W +L +A A L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPL-DVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 647 TFAGRSVIHRDVKSSNILL-------DHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GTA 698
+ ++H +V NIL+ + K++D G + S E R
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-------TVLSREERVERI 168
Query: 699 GYLDPEYY--STQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE 755
++ PE L+ +D +SFG LLEI S G EPL+T S E + + +
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL------SSSEKERFYQDQ 222
Query: 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
R+ P + + C RPS I+R+L
Sbjct: 223 HRLPM---PDCA---------ELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 12/114 (10%)
Query: 625 TLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684
LD LS + A+G+ +L A ++ IHRD+ + NILL H K+ DFG ++
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR--DI 264
Query: 685 EGDSGFSLEVRGTA----GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
DS + V+G A ++ PE + +SDV+S+G++L EI S G P
Sbjct: 265 RNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
GL +LH+ + +I+RD+K N++LD K+ADFG K GD+ S GT Y
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRAS-TFCGTPDY 162
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
+ PE + D +SFGV+L E++ G+ P +
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 591 LGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L Y E+ + LV M+ G L+ +Y + L+ + + G+++LH+
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM- 114
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
+++RD+K N+LLD +++D G + +G + + GT GY+ PE +
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKEE 169
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
S D F+ G + E+++GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 23/170 (13%)
Query: 575 ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWP 629
E L RH L L +D+ V + + G L ++R++ E R +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YG 101
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-- 687
+ ALG YLH+ V++RD+K N++LD K+ DFG K +G
Sbjct: 102 AEIVSALG------YLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
F GT YL PE D + GVV+ E++ GR P +
Sbjct: 153 KTFC----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFEN----ELNFLSAIRHENLVPLL 591
++GEG +G V + + +E+ V ++ ++ E + EL L ++ EN+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEI-VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 592 GYCCENDQQILVYPFMSNGSLQ--DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+ LV+ ++ L+ + + K + +L A+ H
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI---------HWCH 117
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
++HRD+K N+L+ H+ K+ DFGF++ + ++ ++ E T Y PE
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT-EYVATRWYRSPELLLGA 176
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
D++S G +L E+ G +PL
Sbjct: 177 PYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVK--VRSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
IGEG +G V++ + GQ VA+K V S + E+ L ++H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ LV+ + + ++ + L E + R + I + + + H +
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNEL--EKNPRG-VPEHLIKKIIWQTLQAVNFCHK---HNC 121
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKY-APQEGDSGFSLEVRGTAGYLDPEYY--STQH 710
IHRDVK NIL+ K+ DFGF++ D + T Y PE TQ+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGDTQY 178
Query: 711 LSAKSDVFSFGVVLLEIISGREPL 734
DV++ G V E+++G +PL
Sbjct: 179 GPP-VDVWAIGCVFAELLTG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 57/203 (28%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFENEL---NFLSAIRHENLVPLLG 592
IG+G FG V + D Q + A+K E + L L+ + +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAG 650
++ LV F++ G L L E + + L AL LH F
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALE------NLHKF-- 112
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
+VI+RD+K NILLD+ + DFG K ++ D + GT YL PE
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPELLLGHG 169
Query: 711 LSAKSDVFSFGVVLLEIISGREP 733
+ D ++ GV+L E+++G P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-07
Identities = 62/247 (25%), Positives = 99/247 (40%), Gaps = 49/247 (19%)
Query: 527 EAATQQYKTL--IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFEN-----ELNFL 579
E+ +Y+ + IG G FG V+ QE + S +G +E E E+N +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVM 66
Query: 580 SAIRHENLVPLLGYCCENDQQIL--VYPFMSNGSLQD------RLYGEASTRKTLDWPTR 631
++H+N+V + Q L + F G L +++G+ +D +
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 632 LSIALGAARGLMYLHTFA----GRSVIHRDVKSSNILLDHSM-----------------C 670
L AL Y H G V+HRD+K NI L +
Sbjct: 127 LLHALA------YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY--YSTQHLSAKSDVFSFGVVLLEII 728
AK+ DFG SK G + GT Y PE + T+ KSD+++ G ++ E+
Sbjct: 181 AKIGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 729 SGREPLN 735
SG+ P +
Sbjct: 238 SGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 531 QQYKTL--IGEGGFGSV-YRGTLPDGQEVAVK--VRSSTSTQGTREFENELNFLSAIRHE 585
+Y+ L +G G +G+V G +VA+K R S + EL L ++HE
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 586 NLVPLLGYCCENDQQ------ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAA 639
N++ LL + LV PFM G+ + L +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD------LGKLMKHEKLSEDRIQFLVYQML 128
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
+GL Y+H AG +IHRD+K N+ ++ K+ DFG ++ E +G+ + T
Sbjct: 129 KGLKYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-TGYVV----TRW 180
Query: 700 YLDPEY-YSTQHLSAKSDVFSFGVVLLEIISGR 731
Y PE + H + D++S G ++ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 62/228 (27%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFEN---------ELNFLSAIRHEN 586
IG G +G V + ++VA+K + F+N E+ L + HEN
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK-------KIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 587 LVPLLGYCCENDQQI-----LVYPFM---------SNGSLQDR-----LYGEASTRKTLD 627
++ + ++ +VY M S+ +L D LY + L
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY------QLL- 118
Query: 628 WPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687
RGL Y+H+ +V+HRD+K SN+LL+ + K+ DFG ++ ++GD
Sbjct: 119 ------------RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
Query: 688 SGFSLEVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
F E T Y PE + + DV+S G + E++ GR+PL
Sbjct: 164 --FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPL---LG 592
+G G G V+ D + VAVK T Q + E+ + + H+N+V + LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS-----IALGAARGLMYLHT 647
+ + + N + Y E L+ RGL Y+H+
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 648 FAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYA-PQEGDSGFSLEVRGTAGYLDPE- 704
+V+HRD+K +N+ ++ + K+ DFG ++ P G+ E T Y P
Sbjct: 133 ---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI--V 762
S + + D+++ G + E+++G+ + L+ + P +RE +E+ V
Sbjct: 190 LLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNV 249
Query: 763 DPSIKGGYHAE 773
PS E
Sbjct: 250 IPSFVRNDGGE 260
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 5/95 (5%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
L +LH R +I+RD+K N+LLD K+ D+G K GD+ + GT Y
Sbjct: 108 ALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF--CGTPNY 162
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735
+ PE + D ++ GV++ E+++GR P +
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 537 IGEGGFGSV----YRGTLPDGQEVAVKVRSSTSTQGTREFENELN----FLSA--IRHEN 586
+G G FG V Y+ T G+ A+K E E+ + F +A RH
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 587 LVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
LV L C + + + V + + G L ++ P + A GL YL
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYL 117
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGYLDP 703
H +++RD+K N+LLD K+ADFG K GD S F GT +L P
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC----GTPEFLAP 170
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
E + + D + GV++ E++ G P
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAP-QEGDSGFSLEVRGT 697
GL Y+H+ +V+HRD+K N+L++ K+ DFG ++ ++ ++GF E T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 698 AGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE S Q + DV+S G +L E++ GR+P+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 535 TLIGE----GGFGSVYRGTLPDGQEVAVKVRS--STSTQGTREFENELNFLSAIRHENLV 588
TLIG+ + + P VAVK + S S + + + E+ ++H N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL---GAARGLMYL 645
P + + + +V P M+ GS +D L T P L+IA L Y+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLP-ELAIAFILKDVLNALDYI 117
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-----GFSLEVRGTAGY 700
H+ + IHR VK+S+ILL ++ +S + G F +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 701 LDPE--YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
L PE + Q + KSD++S G+ E+ +G P
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 50/177 (28%)
Query: 532 QYKTL--IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFE----NELNFLSAIR 583
+Y+ L IG+G FG V++ Q VA+K V +G F E+ L ++
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLK 69
Query: 584 HENLVPLLGYC--------------------CENDQQILVYPFMSNGSLQDRLYGEASTR 623
HEN+V L+ C CE+D + +SN +++ L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD----LAGLLSNKNVKFTLSEIKKVM 125
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680
K L L+ GL Y+H ++HRD+K++NIL+ K+ADFG ++
Sbjct: 126 KML-----LN-------GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 27/237 (11%)
Query: 537 IGEGGFGSVYRGTL---PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G FG V + V VK ++++ S++ EF + + ++H N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
C E +LV+ + G L+ L E R+ +A A G+ ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HN 119
Query: 653 VIHRDVKSSNILLDHSMCAKVADF--GFSKYAPQ--EGDSGFSLEVRGTAGYLDPEYYST 708
+H D+ N L + KV D+ G S+Y E + + +R A PE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA----PELVGE 175
Query: 709 QH---LSAK----SDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758
H ++A+ S+V++ GV L E+ N +P + S E I++ ++
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVLNHVIKDQQV 227
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 51/228 (22%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVK-VRSSTSTQGTREFE----NELNFLSAIRHENLVPL 590
IGEG +G VY+ D G+ VA+K VR +G F E+ L + H N+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 591 LGYCCENDQQI----------LVYPFMSN---GSLQDRL--YGE---ASTRKTLDWPTRL 632
+ + LV+ +M + G L+ L + E S K L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------ 125
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692
GL Y H ++ +HRD+K SNILL++ K+ADFG ++ E ++
Sbjct: 126 ------LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176
Query: 693 EVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
+V T Y PE + DV+S G +L E L T++P
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGE-------LFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 58/212 (27%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 536 LIGEGGFGSVYR-GTLPDGQEVAVKVRSSTSTQGTREFENELN---FLSAIRHENLVPLL 591
L+G+G FG V G+ A+K+ E + L L RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 592 GYCCENDQQILVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGA--ARGLMY 644
D+ V +++ G L ++R++ E TR GA L Y
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR-----------FYGAEIVSALDY 110
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--DSGFSLEVRGTAGYLD 702
LH+ +++RD+K N++LD K+ DFG K EG D+ GT YL
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYLA 163
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE D + GVV+ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 34/95 (35%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--DSGFSLEVRGTAG 699
L YLH+ R V++RD+K N++LD K+ DFG K EG D GT
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 160
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
YL PE D + GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 48/208 (23%), Positives = 84/208 (40%), Gaps = 17/208 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFE-----NELNFLSAIRHENLVPLL 591
+G G FG V T + V ++ ++ ++ + +E L+ I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G + LV F+ G L R+ +P + AA+ ++
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFL------RRNKRFPNDVG-CFYAAQIVLIFEYLQSL 150
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
++++RD+K N+LLD K+ DFGF+K + + GT Y+ PE
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGH 205
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRP 739
+D ++ G+ + EI+ G P P
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 533 YKTL--IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGT-----REFENELNFLSAIRH 584
YK L +GEG + +VY+G + GQ VA+K +G RE + L ++H
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKH 62
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDW------PTRLSIAL-G 637
N+V L LV+ ++ + ++ +D + + L
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYL-----------DTDLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF--SKYAPQEGDSGFSLEVR 695
RGL Y H R V+HRD+K N+L+ K+ADFG +K P + +S EV
Sbjct: 112 LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYSNEVV 165
Query: 696 GTAGYLDPEY------YSTQHLSAKSDVFSFGVVLLEIISGR 731
T Y P+ YST D++ G + E+ +GR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTS-----LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 69/264 (26%), Positives = 109/264 (41%), Gaps = 43/264 (16%)
Query: 552 DGQE--VAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609
+G+E V +KV + F + +S + H +L + G C + I+V F+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669
G L D + R + W ++++A A L YL ++++H +V + NILL
Sbjct: 101 GPL-DVCLRKEKGRVPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 670 CA-------KVADFGFSKYAPQEGDSGFSLEVR-GTAGYLDPE-YYSTQHLSAKSDVFSF 720
A K++D G S A S E R ++ PE LS +D +SF
Sbjct: 155 LAEGTSPFIKLSDPGVSFTA-------LSREERVERIPWIAPECVPGGNSLSTAADKWSF 207
Query: 721 GVVLLEI-ISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMV 779
G LLEI G PL R P + E ++ R+ E PS K +
Sbjct: 208 GTTLLEICFDGEVPLKERTPSEKERFYE------KKHRLPE---PSCK---------ELA 249
Query: 780 EVALACIEPFSAYRPSMVDIVREL 803
+ C+ RPS I+R+L
Sbjct: 250 TLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV----AVKV-RSSTSTQGTREFEN---ELNFLSAIRHENL 587
++G G +G V+ G + A+KV + +T Q + E+ E L IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA-ARGLMYL 645
+ L Y + D ++ L+ +++ G L+ S R+ + I G L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGG----ELFTHLSQRERFK-EQEVQIYSGEIVLALEHL 121
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRGTAGYLDPE 704
H +I+RD+K NILLD + + DFG SK + E + +S GT Y+ P+
Sbjct: 122 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF--CGTIEYMAPD 176
Query: 705 YYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
H A D +S GV++ E+++G P +N +
Sbjct: 177 IVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 68/237 (28%), Positives = 97/237 (40%), Gaps = 61/237 (25%)
Query: 532 QYKTLIGEG--GFGSVY--RGTLPDGQEVAVKVRS--STSTQGTREFENELNFLSAIRHE 585
+ + IG G SVY R T P G V V++ + + + + +NE+ RH
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL------GAA 639
N++ ++ PFM+ YG A++ +P +S AL GA
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMA--------YGSANSLLKTYFPEGMSEALIGNILFGAL 111
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNIL-----------LDHSMC-------AKVA-DFGFSK 680
RGL YLH IHR++K+S+IL L H AKV DF
Sbjct: 112 RGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF---- 164
Query: 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA---KSDVFSFGVVLLEIISGREPL 734
PQ FS V +L PE Q L KSD++S G+ E+ +GR P
Sbjct: 165 --PQ-----FSTSVLP---WLSPELLR-QDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 537 IGEGGFGSVYRG--TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+GEG + +V++G L + ++R E++ L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ LV+ ++ + L+ + + + L L RGL Y H R V+
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKVL 126
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE-YYSTQHLSA 713
HRD+K N+L++ K+ADFG ++ A +S EV T Y P+ + S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 714 KSDVFSFGVVLLEIISGREPL 734
+ D++ G + E+ SGR PL
Sbjct: 185 QIDMWGVGCIFFEMASGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSS---TSTQGTREFENELNFLSAIRHENLVPLL 591
+IG G FG V Q+V A+K+ S + F E + ++ +V L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 592 GYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+C D + L V +M G L + + D P + + A ++ L
Sbjct: 109 -FCAFQDDKYLYMVMEYMPGGDLVNLM-------SNYDVPEKWA-KFYTAEVVLALDAIH 159
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
+IHRDVK N+LLD K+ADFG + G V GT Y+ PE +Q
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 710 ----HLSAKSDVFSFGVVLLEIISGREPL 734
+ + D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 21/224 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFEN---ELNFL--SAIRHENLVPL 590
IG+G FG VY+ D + + A+KV S +E + E N L + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 591 LGYCCENDQQI-LVYPFMSNGSLQDRLY--GEASTRKTLDWPTRLSIALGAARGLMYLHT 647
L + + D + LV +MS G L L G S + + L +AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL------EHLHK 114
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
+ +++RD+K NILLD + + DFG SK D+ + GT YL PE
Sbjct: 115 Y---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 708 TQHLSAKS-DVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAK 750
+ K D +S GV++ E+ G P + + + + K
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 3/98 (3%)
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
LS ARG+ +L A ++ +HRD+ + N+LL K+ DFG ++ + +
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729
++ PE + SDV+S+G++L EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 9e-06
Identities = 32/84 (38%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
IHRDVK N+LLD S K+ADFG G V GT Y+ PE +Q
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 714 ----KSDVFSFGVVLLEIISGREP 733
+ D +S GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 33/85 (38%), Positives = 43/85 (50%), Gaps = 5/85 (5%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ---- 709
IHRDVK N+LLD S K+ADFG +EG V GT Y+ PE +Q
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
+ + D +S GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 33/150 (22%), Positives = 54/150 (36%), Gaps = 16/150 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENE-LNFLSAIRHENLVP-LLGY 593
L+ G VY D + +K+ S RE E L L+ R VP +L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAILQLLA--RKGLPVPKVLAS 61
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ L+ + ++ E S + D +L+ L LH +
Sbjct: 62 GESDGWSYLLMEW-----IEGETLDEVSEEEKEDIAEQLAELLAK------LHQLPLLVL 110
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAP 683
H D+ NIL+D + D+ ++ Y P
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 58/229 (25%), Positives = 85/229 (37%), Gaps = 67/229 (29%)
Query: 533 YKTL--IGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR----HE 585
YK L IGEG F V + + G+ A+K + E N L + A+R H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHP 58
Query: 586 NLVPL-----------LGYCCE-NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS 633
N++ L L E D + Y + + R E + + +L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNL--YELIKG---RKRPLPEKRVKS---YMYQL- 109
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG-----FSK--YAPQEG 686
+ L ++H + HRD+K NIL+ K+ADFG +SK Y
Sbjct: 110 -----LKSLDHMH---RNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYT---- 156
Query: 687 DSGFSLEVRGTAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIIS 729
E T Y PE YY K D+++ G V EI+S
Sbjct: 157 ------EYISTRWYRAPECLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 537 IGEGGFGSVYRG--TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+GEG + +VY+G L D ++R E++ L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
LV+ ++ + L+ L ++ + L L RGL Y H R V+
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHR---RKVL 126
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY--STQHLS 712
HRD+K N+L++ K+ADFG ++ A +S EV T Y P+ ST + S
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183
Query: 713 AKSDVFSFGVVLLEIISGREPL 734
+ D++ G + E+ +GR PL
Sbjct: 184 TQIDMWGVGCIFYEMSTGR-PL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 55/251 (21%)
Query: 515 PMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVY--------------RGTLPDGQEVA- 557
P+P+ L++ + ++ + + G FG ++ RG Q
Sbjct: 132 PVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPK 191
Query: 558 ----VKVRSSTSTQGTREFENELNFLSAIRHENLV--------PLLGYCCENDQQILVYP 605
+ R ++ + ENE+ L + HEN++ Y +Y
Sbjct: 192 CERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYS 251
Query: 606 FMSNGSLQ--DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNI 663
FM + + DR L TR +I + Y+H + +IHRD+K NI
Sbjct: 252 FMYDEAFDWKDR---------PLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENI 298
Query: 664 LLDHSMCAKVADFG----FSKYAPQEG-DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVF 718
L+ + DFG F K +E D G+ GT PE + +D++
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEK--EREAFDYGWV----GTVATNSPEILAGDGYCEITDIW 352
Query: 719 SFGVVLLEIIS 729
S G++LL+++S
Sbjct: 353 SCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
A ++ +H+ +HRD+K N+LLD + ++ADFG Q+G S+ V GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167
Query: 699 GYLDPEYYSTQH-----LSAKSDVFSFGVVLLEIISGREPL 734
Y+ PE + D +S GV + E++ G P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+GEG + +V++G + VA+K +R E++ L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 595 CENDQQILVYPFMSNGSLQ--DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
LV+ ++ + Q D S + +L RGL Y H R
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------LRGLSYCHK---RK 123
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY--STQH 710
++HRD+K N+L++ K+ADFG ++ A +S EV T Y P+ ST++
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 711 LSAKSDVFSFGVVLLEIISGR 731
S D++ G +L E+ +GR
Sbjct: 182 -STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 34/217 (15%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTRE---FENELNFLSAIRHEN-LVPL 590
+IG G FG V L + +V A+K+ + E F E + L + +N +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWITT 65
Query: 591 LGYCCENDQQI-LVYPFMSNGSL-------QDRLYGEASTRKTLDWPTRLSIALGAARGL 642
L Y +++ + LV + G L +DRL E R L + IA+ + L
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMARFYL---AEMVIAIDSVHQL 121
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
Y +HRD+K NIL+D + ++ADFG ++G S+ V GT Y+
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 703 PEYYSTQH-----LSAKSDVFSFGVVLLEIISGREPL 734
PE + D +S GV + E++ G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 46/209 (22%)
Query: 551 PDGQEVAVK-VRSSTSTQGTREF-ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608
P G+ V V+ + T F + EL+ H N+VP +++ +V FM+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 609 NGSLQDRLYGEASTRKTLDWPTRLSIA---LGAARGLMYLHTFAGRSVIHRDVKSSNILL 665
GS +D + D + L+IA G + L Y+H +HR VK+S+IL+
Sbjct: 83 YGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI 134
Query: 666 ------------------DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY- 706
+H +V F KY S++V +L PE
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVH-DFPKY---------SVKV---LPWLSPEVLQ 181
Query: 707 -STQHLSAKSDVFSFGVVLLEIISGREPL 734
+ Q AKSD++S G+ E+ +G P
Sbjct: 182 QNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 33/257 (12%)
Query: 537 IGEGGFGSVYRGTLPDGQ---EVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLL 591
+G G +G VY+ DG+ E A+K T S RE + L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 592 G-YCCENDQQI-LVYPFMSNGSLQDRLYGEAS--TRKTLDWPTRL--SIALGAARGLMYL 645
+ +D+++ L++ + + + AS +K + P + S+ G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 646 HTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGY 700
H V+HRD+K +NIL+ K+AD GF++ L+ V T Y
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 701 LDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759
PE +H + D+++ G + E+++ EP+ R + ++ + PF ++D
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED----IKTSNPF-HHDQLD 235
Query: 760 EIVDPSIKGGYHAEAMW 776
I G+ A+ W
Sbjct: 236 RIFSVM---GFPADKDW 249
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG-FSLEVRGTA 698
R L Y+HT +V HRD+K NIL + K+ DFG ++ A + + F + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 699 GYLDPEY---YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE + +++ A D++S G + E+++G+ PL
Sbjct: 171 WYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGK-PL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 47/189 (24%), Positives = 77/189 (40%), Gaps = 16/189 (8%)
Query: 540 GGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND 598
G G V+ + PD Q V VK S+ +E L + H ++ LL
Sbjct: 180 GSEGCVFESSHPDYPQRVVVKAGWYASSV------HEARLLRRLSHPAVLALLDVRVVGG 233
Query: 599 QQILVYPFMSNGSLQDRLYGEASTR-KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRD 657
LV P + LY R + L ++A + Y+H G +IHRD
Sbjct: 234 LTCLVLP-----KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRD 285
Query: 658 VKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDV 717
+K+ N+L++ + DFG + +A + F + GT PE + + D+
Sbjct: 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 718 FSFGVVLLE 726
+S G+V+ E
Sbjct: 346 WSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE---VRGT 697
G+ +LH+ AG +IHRD+K SNI++ K+ DFG ++ A + F + V T
Sbjct: 130 GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVV--T 180
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR 731
Y PE D++S G ++ E+I G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 16/105 (15%)
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------------YAPQEGDS 688
L YLH + ++HRD+K N+L+ K+ DFG SK + ++
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+V GT Y+ PE Q D ++ G++L E + G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 37/140 (26%), Positives = 51/140 (36%), Gaps = 44/140 (31%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFGF---------SKYAPQEGD----------------- 687
IHRD+K NIL+D K+ DFG SKY Q+GD
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY-QKGDHHRQDSMEPSEEWSEID 181
Query: 688 --SGFSLEVR--------------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR 731
LE R GT Y+ PE + D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 732 EPLNTRRP-RNEWSLVEWAK 750
P P + ++ W
Sbjct: 242 PPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 531 QQYKTL--IGEGGFGSV---YRGTLPDGQEVAVKVRS---STSTQGTREFENELNFLSAI 582
++Y+ L IG G G V Y L + VA+K S T R + EL + +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 583 RHENLVPLLGY-----CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALG 637
H+N++ LL E Q + + + + +L + E LD +
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQ 134
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
G+ +LH+ AG +IHRD+K SNI++ K+ DFG ++ A G S T
Sbjct: 135 MLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
Y PE D++S G ++ E+I G ++W+ V
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 537 IGEGGFGSVYRGTLPDGQE---VAVKVRSST--STQGTREFENELNFLSAIRHENLVPLL 591
+G G +G VY+ DG++ A+K T S RE + L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 592 G-YCCENDQQI-LVYPFMSNGSLQDRLYGEAS--TRKTLDWPTRL--SIALGAARGLMYL 645
+ D+++ L++ + + + AS +K + P + S+ G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 646 HTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGY 700
H V+HRD+K +NIL+ K+AD GF++ L+ V T Y
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 701 LDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE +H + D+++ G + E+++ EP+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 531 QQYKTL--IGEGGFGSV---YRGTLPDGQEVAVKVRS---STSTQGTREFENELNFLSAI 582
++Y+ L IG G G V Y L + VA+K S T R + EL + +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 73
Query: 583 RHENLVPLLGY-----CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALG 637
H+N++ LL E Q + + + + +L + E LD +
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQ 127
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
G+ +LH+ AG +IHRD+K SNI++ K+ DFG ++ A G S T
Sbjct: 128 MLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 181
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
Y PE D++S G ++ E++ + R ++W+ V
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 8e-04
Identities = 55/240 (22%), Positives = 83/240 (34%), Gaps = 58/240 (24%)
Query: 536 LIGEGGFGSVY----RGTLPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLV 588
L+G+G G V+ +GT G+ A+KV + + E L+ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR-------- 640
L LV + G L L + LS AR
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL----QRQPG----KCLSEE--VARFYAAEVLL 114
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG------------DS 688
L YLH +++RD+K NILL S ++DF SK + E S
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 689 GFSLEVR---------------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ GT Y+ PE S + D ++ G++L E++ G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 6/85 (7%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY-----ST 708
+HRD+K N+LLD + ++ADFG +G ++ V GT Y+ PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMEDGK 182
Query: 709 QHLSAKSDVFSFGVVLLEIISGREP 733
+ D +S GV + E++ G P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 17/151 (11%)
Query: 537 IGEGGFGSVYRG-TLPDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLG 592
I G FG VY G + + AVKV + + + E + L+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 593 YCCENDQQI-LVYPFMSNGSLQDRL--YGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
Y ++ + LV ++ G ++ L YG D + A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHR-- 122
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680
+IHRD+K N+L+ + K+ DFG SK
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 55/225 (24%), Positives = 88/225 (39%), Gaps = 38/225 (16%)
Query: 537 IGEGGFGSVYRGTLPD---------GQEVAVKVRSSTSTQGTRE----FENELNFLSAIR 583
+G G +Y G L E +KV R+ F + + +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
H+++V L G C + + I+V F+ G L D S T W + +A A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPW--KFKVAKQLASALS 119
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF-SKYAP--QEGDSGFSLEVRGTAGY 700
YL + ++H +V + NILL A G + P + D G + V
Sbjct: 120 YLED---KDLVHGNVCTKNILL--------AREGIDGECGPFIKLSDPGIPITVLSRQEC 168
Query: 701 LD------PE-YYSTQHLSAKSDVFSFGVVLLEI-ISGREPLNTR 737
++ PE +++LS +D +SFG L EI +G PL +
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 528 AATQQYK--TLIGEGGFGSVYRGTLPDGQE-VAVKVRSSTSTQGTREFENELNFLSAIRH 584
+ + YK +IG G FG VY D E VA+K Q + EL + + H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK----KVLQDPQYKNRELLIMKNLNH 118
Query: 585 ENLVPLLGY----CC-ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLS--IALG 637
N++ L Y C +N++ I + M Y + R P L +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQEGDSGFSLEV 694
R L Y+H+ + + HRD+K N+L+D H++ K+ DFG +K L
Sbjct: 179 LCRALAYIHS---KFICHRDLKPQNLLIDPNTHTL--KLCDFGSAKNL---------LAG 224
Query: 695 RGTAGYLDPEYYSTQHLSAKS-------DVFSFGVVLLEIISG 730
+ + Y+ +Y L + D++S G ++ E+I G
Sbjct: 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 34/134 (25%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFGF---------------------SKYAPQEGDSG--- 689
IHRD+K N+LLD K++DFG S + Q +S
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 690 ---------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPR 740
+ GT Y+ PE + + D +S GV++ E++ G P + P+
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 741 NEW-SLVEWAKPFI 753
+ ++ W + I
Sbjct: 243 ETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 31/126 (24%), Positives = 48/126 (38%), Gaps = 33/126 (26%)
Query: 654 IHRDVKSSNILLDHSMCAKVADFG------------FSKYAPQEGDSGFSLE-------- 693
IHRD+K N+LLD K++DFG F + S FS +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 694 -------------VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPR 740
GT Y+ PE + + D +S GV++ E++ G P + P+
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 741 NEWSLV 746
+ V
Sbjct: 243 ETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 516 MPVQIFSLQYLEAA---TQQYKTL--IGEGGFG---SVYRGTLPDGQEVAVKVRS---ST 564
Q +S+Q ++ ++Y+ L IG G G + + L G VAVK S
Sbjct: 3 EDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQN 60
Query: 565 STQGTREFENELNFLSAIRHENLVPLLGY-----CCENDQQILVYPFMSNGSLQDRLYGE 619
T R + EL L + H+N++ LL E Q + + + + +L ++ E
Sbjct: 61 QTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME 119
Query: 620 ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679
LD + G+ +LH+ AG +IHRD+K SNI++ K+ DFG +
Sbjct: 120 ------LDHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 680 KYAPQEGDSGFSLE-VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISG 730
+ A + F + T Y PE D++S G ++ E++ G
Sbjct: 171 RTA----CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.004
Identities = 39/135 (28%), Positives = 55/135 (40%), Gaps = 45/135 (33%)
Query: 653 VIHRDVKSSNILLDH-SMCAKVADFGFS-------KYAPQEGDSGFSLEVRGTAGYLDPE 704
++HRDVK NI+ S K+ D G + Y P+E F L+ R Y PE
Sbjct: 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKE----FLLDPR----YAAPE 327
Query: 705 YY--STQHLSAKS--------------------DVFSFGVVLLEII-------SGREPLN 735
Y STQ SA S D++S G++ L++ S N
Sbjct: 328 QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFN 387
Query: 736 TRRPRNEWSLVEWAK 750
+ RN++ LV W K
Sbjct: 388 RQLKRNDYDLVAWRK 402
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.62 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.36 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.3 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.26 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.18 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.95 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 97.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.77 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.52 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.38 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 97.36 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.02 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.03 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.71 | |
| PLN02236 | 344 | choline kinase | 95.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.72 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.98 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.72 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-74 Score=685.16 Aligned_cols=375 Identities=23% Similarity=0.360 Sum_probs=299.1
Q ss_pred HHhhhhcccCCCeEEEecCCCCCcccCCCCcEEecCCCeecCCCCcccccCCCCCcccccccccccC-CCCcceeeeccc
Q 002943 22 IVLIRSTCAQKDFVSIACCADSDFIGKYPPVNWKPDDAWFPDKKDCRAITRPAVNNKFYDRVLDFGI-DSGKRCYNLSTI 100 (863)
Q Consensus 22 ~~~~~~~~~~~gf~sidCG~~~~~~~~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~r~f~~-~~~~~cY~~~~~ 100 (863)
+++.+++++++++++||||++++++.+.+|++|++|..|. .|... ....+......|.|+|+||. ++++|||+||++
T Consensus 13 ~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~-~~~~~-~~~~~~~~~~~~~t~R~F~~~~g~~~cY~~~~~ 90 (623)
T PLN03150 13 AVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYT-GGIPA-NATRPSFIAPPLKTLRYFPLSDGPENCYNINRV 90 (623)
T ss_pred HhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCcccc-cCccc-cccCcccccchhhccccCCcccccccceEeeec
Confidence 3344456789999999999988874334899999997774 33332 22233344567999999996 566889999999
Q ss_pred CCCeeeEeEEeeccCCCCCCCCcceeEEEcceeeEEEeCCC-----CceeeEEEEecCCceEEeecC-CCCCceeeeEee
Q 002943 101 KGQDYLIRGTFLNGDNVETPLISSFNVLVGVTPLSLVNSTE-----DSVVEGIFKAANDYIDFCLDK-KDGDPYISGLEV 174 (863)
Q Consensus 101 ~~~~ylvR~~F~yg~~~~~~~~~~Fd~~~~~~~w~~vn~~~-----~~~~e~i~~~~~~~~~vcl~~-~~~~pfIs~lEl 174 (863)
++|||+||++|+|||||+.++.|.|||++|+|+|.+|+.+. ..++|+|+.+.+++++|||.+ ++|+||||+|||
T Consensus 91 ~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv 170 (623)
T PLN03150 91 PKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEI 170 (623)
T ss_pred CCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEE
Confidence 99999999999999999998888999999999999998642 245899999999999999954 579999999999
Q ss_pred eecCCCCccccc---ccceeEEEEeeccCCCCCCCcccCCCCCC--CceeeCCCC---CCCccccccceeeecCCCCCCC
Q 002943 175 RPLNDTEYLPGQ---SANVLKLVGRYDLGRSDNELSFRYPDDPF--DRIWIPKLS---PEPTTFSTSFTTNISDNNAKVT 246 (863)
Q Consensus 175 ~~l~~~~Y~~~~---~~~~l~~~~R~n~G~~~~~~~irypdD~~--dR~W~p~~~---~~~~~~~~~~~~~~~~~~~~~~ 246 (863)
||+++++|+.+. .+.+|++++|+|+|+.+..+.+|||||+| ||+|.||.. ..+..+++...+... .+.++.
T Consensus 171 ~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~-~~~~~~ 249 (623)
T PLN03150 171 LQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKA-SNAPNF 249 (623)
T ss_pred EEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccc-cCCCcc
Confidence 999999997542 35679999999999987666799999999 999999865 345555555443322 346688
Q ss_pred CcHHHhhhcccCCCC-ceeecccCCCCCcceEEEEEEeecccccCCCCeEEEEEEECCccccccchhhhcCc-----cee
Q 002943 247 VPLQVLQTALTDPNR-LMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGS-----NYA 320 (863)
Q Consensus 247 ~P~~V~~TA~~~~~~-~~~~~~~~~~~~~~y~v~lhFaEi~~~~~~~~~R~F~I~ing~~~~~~~di~~~~~-----~~~ 320 (863)
+|+.|||||++..++ .++.|....+++..|+|+|||||++......++|+|||||||+.+.+++|+....+ .+.
T Consensus 250 ~P~~VyqTA~~~~~~~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~ 329 (623)
T PLN03150 250 YPESLYQSALVSTDTQPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVL 329 (623)
T ss_pred ChHHHhhhhccccCCCCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEE
Confidence 999999999986542 23444444567789999999999986566678999999999999999999976432 233
Q ss_pred EEEEEeecCCceEEEEeeecCCCccccccceeeeEEeecccccccchhhHHHHHhHHHHhhcccccccccCccCCCCCCC
Q 002943 321 KLALNVTANGSLNLTLVNVLNGSVFGPICNAYEILQVRQWVQETDQADVNVIRKVRDELKKYNKENKVLESWSGDPCRPS 400 (863)
Q Consensus 321 ~~~~~~~~~g~~~~~l~~t~~~S~lppilNa~Ei~~v~~~~~~t~~~d~~al~~~k~~~~~~~~~~~~~~~W~gdpc~p~ 400 (863)
++.+.++ +|.++|++.++ +++ ||||||+|||++.+....|.+.|+.||+++|+++..+. ..+|+||||.|+
T Consensus 330 ~~~v~~~-~g~l~isl~p~-~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~-----~~~W~g~~C~p~ 400 (623)
T PLN03150 330 NKTVAVS-GRTLTIVLQPK-KGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPL-----RFGWNGDPCVPQ 400 (623)
T ss_pred EeEEeec-CCeEEEEEeeC-CCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcc-----cCCCCCCCCCCc
Confidence 4444444 37899999987 433 79999999999999888899999999999999985321 248999999875
Q ss_pred --cccceeec
Q 002943 401 --TWRGVYCN 408 (863)
Q Consensus 401 --~w~gv~C~ 408 (863)
+|.|+.|+
T Consensus 401 ~~~w~Gv~C~ 410 (623)
T PLN03150 401 QHPWSGADCQ 410 (623)
T ss_pred ccccccceee
Confidence 79999995
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-65 Score=563.87 Aligned_cols=316 Identities=32% Similarity=0.484 Sum_probs=258.6
Q ss_pred EecCCCCC---cccCCCCcEEecCCCeecCCCCcccccC----CCCCcccccccccccCCCCcceeeeccc--CCCeeeE
Q 002943 37 IACCADSD---FIGKYPPVNWKPDDAWFPDKKDCRAITR----PAVNNKFYDRVLDFGIDSGKRCYNLSTI--KGQDYLI 107 (863)
Q Consensus 37 idCG~~~~---~~~~~~~~~~~~D~~~~~~~~~~~~~~~----~~~~~~~~~~~r~f~~~~~~~cY~~~~~--~~~~ylv 107 (863)
||||++.+ |+|+.|||+|++|++|+++|.+..+... .....+.|.|+|+|| ++.|+||+||+. +|+||+|
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~-~g~r~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFP-EGSRNCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcC-CCCccEEEeeccCCCCceEEE
Confidence 89997644 7888899999999999987765544111 234467899999999 666899999997 5779999
Q ss_pred eEEeeccCCCCCC-----CCcceeEEEcceeeEEEeCCCC----ceee-EEEEecCCceEEeecC-CCCC-ceeeeEeee
Q 002943 108 RGTFLNGDNVETP-----LISSFNVLVGVTPLSLVNSTED----SVVE-GIFKAANDYIDFCLDK-KDGD-PYISGLEVR 175 (863)
Q Consensus 108 R~~F~yg~~~~~~-----~~~~Fd~~~~~~~w~~vn~~~~----~~~e-~i~~~~~~~~~vcl~~-~~~~-pfIs~lEl~ 175 (863)
|++|+|||||+++ ..|.|||++|+|.|++|+.+.+ .++| +|++..+++++|||.+ ++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 2467999999999999998753 4689 5555558999999955 5688 999999999
Q ss_pred ecCCCCccc--ccccceeEEEEeeccCCCCCCCcccCCCCCCCceeeCCC-CCCCccccccceeeecCCCCCCCCcHHHh
Q 002943 176 PLNDTEYLP--GQSANVLKLVGRYDLGRSDNELSFRYPDDPFDRIWIPKL-SPEPTTFSTSFTTNISDNNAKVTVPLQVL 252 (863)
Q Consensus 176 ~l~~~~Y~~--~~~~~~l~~~~R~n~G~~~~~~~irypdD~~dR~W~p~~-~~~~~~~~~~~~~~~~~~~~~~~~P~~V~ 252 (863)
||++++|+. ...+.+|++++|+|+|++... ||||||+|||+|+|+. .+.|+.++++..+.....+.++.+|..||
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~~--iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~~~~P~~V~ 237 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSSSF--IRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNPYDAPSAVY 237 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCcccc--cCCCCCcceeeccccccCccccccccceeeecccCCccCcChHHHH
Confidence 999999963 346778999999999987643 9999999999999984 56788888866654345566799999999
Q ss_pred hhcccCCCC---ceeecccCCCCCcceEEEEEEeecccccCCCCeEEEEEEECCccccccchhhhcCc----ceeEEEEE
Q 002943 253 QTALTDPNR---LMFLHTDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGS----NYAKLALN 325 (863)
Q Consensus 253 ~TA~~~~~~---~~~~~~~~~~~~~~y~v~lhFaEi~~~~~~~~~R~F~I~ing~~~~~~~di~~~~~----~~~~~~~~ 325 (863)
|||+++.+. +++.|.. ++++..|+|+||||||+...++.++|+|||||||+.+.+++++...+. .|.++.+.
T Consensus 238 ~TA~~~~~~s~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~ 316 (347)
T PF12819_consen 238 QTARTPSNSSDPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVN 316 (347)
T ss_pred HhhhcccccccceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEE
Confidence 999997554 5777766 888889999999999998666667899999999999987666643322 24556677
Q ss_pred eecCCceEEEEeeecCCCccccccceeeeEEe
Q 002943 326 VTANGSLNLTLVNVLNGSVFGPICNAYEILQV 357 (863)
Q Consensus 326 ~~~~g~~~~~l~~t~~~S~lppilNa~Ei~~v 357 (863)
+..++.++|+|+++ .+|++||||||+|||+|
T Consensus 317 ~~~~~~~~isL~~t-~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 317 VPDSGFLNISLGPT-PDSTLPPILNALEIYKV 347 (347)
T ss_pred ecCCCEEEEEEEeC-CCCCcCceeEeeeeEeC
Confidence 77777899999999 88899999999999986
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-59 Score=517.38 Aligned_cols=289 Identities=54% Similarity=0.912 Sum_probs=259.6
Q ss_pred CccccCHHHHHHHHHhhc--ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeE
Q 002943 517 PVQIFSLQYLEAATQQYK--TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 517 ~~~~~~~~~l~~~t~~f~--~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
+.+.|++.+|+.||++|+ ++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 457899999999999997 799999999999999999999999987766543256799999999999999999999999
Q ss_pred eeCC-eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEE
Q 002943 595 CEND-QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV 673 (863)
Q Consensus 595 ~~~~-~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 673 (863)
.+.+ +++||||||+||+|.++|+..... .|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9999 599999999999999999875433 8999999999999999999999999889999999999999999999999
Q ss_pred eeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc
Q 002943 674 ADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 674 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
+|||||+..+.. .....+...||.+|+||||+..+..+.|+|||||||+|+||+||+++.+...+.+...+++|+++.+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999876542 2222211179999999999999999999999999999999999999998776666777999999999
Q ss_pred cccccccccCCccC-CCCcH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 754 RESRIDEIVDPSIK-GGYHA-EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 754 ~~~~~~~i~d~~l~-~~~~~-~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.++.+.+++||.+. +.+.. +++.++.++|++|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999997 66664 789999999999999999999999999999976653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=412.17 Aligned_cols=254 Identities=33% Similarity=0.515 Sum_probs=210.8
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcc--hHHHHHHHHHHhcCCcccccceeeeEeeCC-eeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG--TREFENELNFLSAIRHENLVPLLGYCCEND-QQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~LV~ey~~~ 609 (863)
+.+.||+|+||+||+|.+.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 445699999999999999655559999987654333 469999999999999999999999999988 79999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC-ccccCCCCCCeEecCCC-eEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS-VIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~ 687 (863)
|+|.++|+.. .+..+++..++++|.|||+||+|||+ .+ ||||||||+||||+.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999764 45689999999999999999999999 55 99999999999999997 99999999998764321
Q ss_pred CCceeeeecCCCCCCccccc--cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 688 SGFSLEVRGTAGYLDPEYYS--TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
...+...||..|||||.+. ...++.|+|||||||+||||+||+.||..... ..+...+. ...
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~------------~~~ 262 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVV------------VGG 262 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH------------hcC
Confidence 2233467999999999999 66999999999999999999999999987643 11122111 111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.....+.++...+..++.+||+.+|+.||++.|++..|+.+..
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1112222355678899999999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=408.82 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=219.2
Q ss_pred HHHHHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 525 YLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 525 ~l~~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
++.+....+.+.||+|.||+||.|.++....||||.++.. ....+.|.+|+++|++|+|+|||+++|+|..++..+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 4455566778999999999999999988889999988765 334578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
|||++|+|.++|.. ..+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||||....
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999964 345678999999999999999999999 9999999999999999999999999999995433
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
..........-...|.|||.+..++++.|||||||||+||||+| |+.|+..+... ..++.+.+
T Consensus 356 -~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~le~------------ 419 (468)
T KOG0197|consen 356 -DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLELLER------------ 419 (468)
T ss_pred -CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHHHhc------------
Confidence 23333344456789999999999999999999999999999999 99998876422 22222222
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..+-..+..|+..+.+|+..||+.+|++|||+..+...|+++..
T Consensus 420 -GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 420 -GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 11112334566779999999999999999999999999988763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=414.73 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=221.0
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCC
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCEND 598 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 598 (863)
+......|.+.||+|.||+||+|+.. +.+.||||.++..... ..++|++|+++|+.++|||||+|+|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33444456789999999999999853 3567999998877665 7889999999999999999999999999999
Q ss_pred eeEEEeecCCCCChhhhhhccCC------C----CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 599 QQILVYPFMSNGSLQDRLYGEAS------T----RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 599 ~~~LV~ey~~~gsL~~~L~~~~~------~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
..++|+|||..|+|.++|..... . +.+|+..+.+.||.|||.||+||-+ +.+|||||..+|+||+++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccc
Confidence 99999999999999999964321 1 3348899999999999999999998 889999999999999999
Q ss_pred CeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHH
Q 002943 669 MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 669 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 747 (863)
+.+||+||||+|.....+.........-..+|||||.+..+++|++||||||||||||+++ |+.|+.+....+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 9999999999997765554443333345789999999999999999999999999999999 999998764322
Q ss_pred hhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 748 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
|.+.++.+++. ..+..++.++.+|++.||+.+|++||+++||-..|+...+
T Consensus 714 -VIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 -VIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 22333344332 2345677789999999999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=435.22 Aligned_cols=268 Identities=24% Similarity=0.476 Sum_probs=222.2
Q ss_pred cCHHHHHHHHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe
Q 002943 521 FSLQYLEAATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQ 599 (863)
Q Consensus 521 ~~~~~l~~~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 599 (863)
++++++... ....++||+|+||.||+|+. .+|..||||++...... ..+|++.+++++|||||+++|+|.+.+.
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 445554432 23457899999999999996 57899999987644322 2456889999999999999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++|||||++|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 999999999999999993 38999999999999999999998767899999999999999999998886 7766
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
...... ....+|..|+|||++.+..++.|+|||||||++|||+||+.||+... .....+.+|++.........
T Consensus 830 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 830 GLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLD 902 (968)
T ss_pred cccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchh
Confidence 543211 12357899999999999999999999999999999999999996533 23456888888777666677
Q ss_pred cccCCccCCC--CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 760 EIVDPSIKGG--YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 760 ~i~d~~l~~~--~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..+|+.+... ...+++.++.+++.+||+.+|++||+|+||+++|+++..
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 7788877543 345677889999999999999999999999999998864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.35 Aligned_cols=251 Identities=31% Similarity=0.453 Sum_probs=208.5
Q ss_pred cCHHHHHHHHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCC
Q 002943 521 FSLQYLEAATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCEND 598 (863)
Q Consensus 521 ~~~~~l~~~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 598 (863)
+++.+|+. .+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 45555543 468999999999999975 6888999987443 3445688999999999999999999999999998
Q ss_pred -eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 599 -QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 599 -~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
+..++||||++|||++.+.. .+.+++...-+|+.+|.+||.|||+. ++||||||||+|||++..+++||+|||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 59999999999999999943 25699999999999999999999963 789999999999999999999999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC--CCcchhHHhhhhcccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP--RNEWSLVEWAKPFIRE 755 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~--~~~~~l~~~~~~~~~~ 755 (863)
.++.+... ......||..|||||.+.+..|+.++||||||+.++|+++|+.|+....+ .+...+..
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-------- 292 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-------- 292 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH--------
Confidence 99877543 44567899999999999999999999999999999999999999976411 11122222
Q ss_pred cccccccC---CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 SRIDEIVD---PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ~~~~~i~d---~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+++ |.+..+ ....++..++-.|++.||.+||+..|+++
T Consensus 293 ----~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 293 ----AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222 344333 23445899999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=394.32 Aligned_cols=261 Identities=23% Similarity=0.430 Sum_probs=218.6
Q ss_pred HHHHHHhhcceecccCcEEEEEEecCC----CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCee
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 600 (863)
|......++++||.|.||+||+|.++- ...||||.++.... ...++|+.|+.||.++.||||++|.|+.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 333334456899999999999999752 35699999987754 4567999999999999999999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++|.|||+||+|+.+|+.+ ...+.+.+...+..+||.||.||.+ .+.|||||.++|||++.+..+|++||||+|
T Consensus 706 MIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999654 3569999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCCCCcee-eeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 681 YAPQEGDSGFSL-EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 681 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
.+..+.+...++ .-+-..+|.|||.+...+++.+||||||||||||+++ |.+||-++...+. .
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV---I------------ 844 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---I------------ 844 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH---H------------
Confidence 886655332222 1223579999999999999999999999999999998 9999977653221 1
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..++...+-..+++|+..|.+|++.||+.+..+||.+.+|+..|+++..
T Consensus 845 -kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 845 -KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1122222223466788899999999999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.34 Aligned_cols=271 Identities=27% Similarity=0.399 Sum_probs=223.5
Q ss_pred CHHHHHHHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCee
Q 002943 522 SLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 522 ~~~~l~~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 600 (863)
.++|.-+....|.++||+|.||+|.++...++..||||+++..... ..++|.+|+++|.+++|||||+|+|+|..++..
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3455556666778999999999999999988899999998877554 458999999999999999999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++|+|||++|+|.++|..... ..+.-...++||.|||.||+||.+ .++|||||.++|+|+|.++++||+|||++|
T Consensus 611 cmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 999999999999999954422 224566778899999999999999 899999999999999999999999999999
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh--CCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS--GREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
-+.............-..+|||||.+..++++.++|||+||++|||+++ ...||..... ...++-...+++.+..
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCc
Confidence 8776666665556667889999999999999999999999999999876 7788876532 2334433344433222
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
...+ ..+.-+..++.++++.||..+.++||+++++...|++.
T Consensus 763 ~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2111 12334566789999999999999999999999998764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=373.54 Aligned_cols=244 Identities=25% Similarity=0.467 Sum_probs=205.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
...++||+|||..||+++. ..|+.||+|++.+.. ....+...+|+++.++|+|||||+++++|++.+..|||.|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3357999999999999996 889999999987642 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++. .++++++.+...+..||+.||.|||+ .+|||||||..|++|++++++||+|||||..+....+
T Consensus 101 ~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 101 HRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999983 45789999999999999999999999 8999999999999999999999999999988864433
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
...+.+||+.|+|||++.....+..+||||+|||||-|+.|++||+...-.+...-+ +..+-.-
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I----------k~~~Y~~---- 237 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI----------KLNEYSM---- 237 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH----------HhcCccc----
Confidence 345678999999999999989999999999999999999999999864321111100 0111111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.....+..+|+.++++.+|.+|||+.+|+.
T Consensus 238 ---P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 ---PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122334678999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=359.45 Aligned_cols=195 Identities=31% Similarity=0.538 Sum_probs=174.7
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|+||+||+|+++ ++.+||||.+.+. .....+-+..|+++|+.++|||||++++++..++..+||||||.+|
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 456999999999999964 6899999987765 3444566789999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC------CeEEEeeccCcccCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS------MCAKVADFGFSKYAPQ 684 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~------~~~kl~DFGla~~~~~ 684 (863)
+|.+|++. .+.+++.....++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+||.+..
T Consensus 95 DLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 95 DLSDYIRR----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999954 3479999999999999999999999 999999999999999764 5689999999999874
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
.. .....+|++.|||||++..++|+.|+|+||.|+||||+++|+.||+...
T Consensus 168 ~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 168 GS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 32 3446789999999999999999999999999999999999999998654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=354.13 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=200.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcc-------hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQG-------TREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
+-..+.||+|+||.|-+|.- ++|+.||||++++..... ....++|+++|++|+|||||++.+++...+..|+
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 33468999999999999984 579999999987653222 2235699999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccCc
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGFS 679 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla 679 (863)
|||||++|.|.+.+-. ++.+....-..++.|++.|+.|||+ ++|+||||||+|||+..+ ..+||+|||||
T Consensus 254 VlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999943 4567777778999999999999999 999999999999999755 88999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCC---CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH---LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+.... ...+.+.+||+.|.|||++.+.. +..|.|+||+|||||-+++|.+||..... ...+.+.+. .|
T Consensus 327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~----~G 397 (475)
T KOG0615|consen 327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQIL----KG 397 (475)
T ss_pred hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHh----cC
Confidence 98753 34556788999999999997654 33488999999999999999999976432 222222111 11
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. .......+..++.++++.+++..||++|||+.|+++
T Consensus 398 ~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 398 RYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 110 011223455667899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=342.44 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=209.2
Q ss_pred HHhhcceecccCcEEEEEEe-cCCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceee-eEeeCCe-eEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLG-YCCENDQ-QILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~LV~ 604 (863)
.+.+.++||+|.||+|||+. +.+|..||.|.+.-. +.+..++...|+.+|++|+|||||++++ -+.+..+ ..|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 44566899999999999998 678999999976532 3445677899999999999999999999 4455555 88999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
||+..|+|.+.+......++.+++...+++..|+++||..+|+...+ .|+||||||.||+|+.++.+||+||||+|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999977667778899999999999999999999985422 39999999999999999999999999999986
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. ........||+.||+||.+....|+.||||||+||+++||+.-+.||.+. ++.+...+ +..+...
T Consensus 180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd~~---- 246 (375)
T KOG0591|consen 180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGDYP---- 246 (375)
T ss_pred ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCCCC----
Confidence 54 33445678999999999999999999999999999999999999999864 23332221 2222211
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.+. +.--...+.+|+..|+..||+.||+.-.+++.+..
T Consensus 247 -~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 -PLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 121 12234568899999999999999996555555543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=397.50 Aligned_cols=264 Identities=28% Similarity=0.436 Sum_probs=214.8
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC--CCC----EEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCC
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP--DGQ----EVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCEND 598 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~--~g~----~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 598 (863)
+....-.+.+.||+|+||.||+|... +|. .||||.+.+. +.+...+|.+|..+|++++|||||+++|.|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 33444456789999999999999864 343 4899987765 4556689999999999999999999999999999
Q ss_pred eeEEEeecCCCCChhhhhhccCC---CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEee
Q 002943 599 QQILVYPFMSNGSLQDRLYGEAS---TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVAD 675 (863)
Q Consensus 599 ~~~LV~ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 675 (863)
..++++|||++|+|..+|+..+. ....|+....+.+|.|||+|+.||++ +++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999965421 24578999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccc
Q 002943 676 FGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 676 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
|||||.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||......+ +... ..+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~---~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLD---VLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHH---HHh
Confidence 999995544333222222234578999999999999999999999999999999 999998754322 1111 112
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.++ | +.+..|..++.+++.+||+.+|++||++..+++.++.+..
T Consensus 920 ggR--------L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GGR--------L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCc--------c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 222 1 2234466688899999999999999999999999988764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=362.94 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=202.8
Q ss_pred HHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCC-ee
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEND-QQ 600 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~ 600 (863)
.+.+.++||+|+||.||+|.. .++..||||++..... ...+.+.+|++++.++ +||||++++++|...+ ..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 345568999999999999973 2356899998865432 3346789999999999 8999999999987654 57
Q ss_pred EEEeecCCCCChhhhhhccCC----------------------------------------------------------C
Q 002943 601 ILVYPFMSNGSLQDRLYGEAS----------------------------------------------------------T 622 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~----------------------------------------------------------~ 622 (863)
++||||+++|+|.+++..... .
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 899999999999999964211 0
Q ss_pred CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCC
Q 002943 623 RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702 (863)
Q Consensus 623 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 702 (863)
...+++...+.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2358888999999999999999999 8999999999999999999999999999986543322212223346788999
Q ss_pred ccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHH
Q 002943 703 PEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEV 781 (863)
Q Consensus 703 PE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 781 (863)
||++.+..++.++|||||||+||||++ |+.||....... .+.. ....+.. .... ......+.++
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~-----~~~~----~~~~~~l~~l 309 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGTR-----MRAP----ENATPEIYRI 309 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCCC-----CCCC----CCCCHHHHHH
Confidence 999999999999999999999999997 999997643211 1111 1111110 1111 1223458899
Q ss_pred HHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 782 ALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 782 ~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+.+|++.+|++||++.|++++|++++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.54 Aligned_cols=254 Identities=31% Similarity=0.447 Sum_probs=205.8
Q ss_pred hhcceecccCcEEEEEEecCC--C--CE-EEEEEccc---CCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD--G--QE-VAVKVRSS---TSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~--g--~~-vAVK~~~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
.+.++||+|+||+||+|++.- + .. ||||..+. ......++|.+|+++|++++|||||+++|++..+...++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345899999999999999643 3 23 89998764 2345568999999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
||+|.||+|.++|... ...++..++++++.++|+||+|||+ +++|||||.++|+|++.+..+||+||||++...
T Consensus 240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999543 2369999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhh-hhcccccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWA-KPFIRESRIDEI 761 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~i 761 (863)
... .......-...|+|||.+..+.++.++|||||||++||+++ |..||.+... ..+..++ ...++.
T Consensus 314 ~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~~~~r~------ 382 (474)
T KOG0194|consen 314 QYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVKNGYRM------ 382 (474)
T ss_pred cee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHhcCccC------
Confidence 111 11112245679999999999999999999999999999999 8889987542 2233333 111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..+......+..+..+||..+|++||+|.++.+.|+.+...
T Consensus 383 -------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 383 -------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11113344577778899999999999999999999988754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=360.23 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=223.4
Q ss_pred CHHHHHHHHHhhcceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCee
Q 002943 522 SLQYLEAATQQYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 522 ~~~~l~~~t~~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 600 (863)
.-.|+++......++||-|.||.||.|+++. ...||||.++.+ .-..++|++|+.+|+.++|||+|+|+|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3345666666678999999999999999865 567999988754 34568999999999999999999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
|+|+|||.+|+|.+||+.. .+..++-...+.+|.||+.||+||.. +++|||||.++|+|+.++..+||+||||+|
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999643 34568888899999999999999998 899999999999999999999999999999
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
++..+.... ....+-.+.|.|||.+....++.|+|||+|||+||||.| |..||.+.. +. .+.
T Consensus 414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lS----------qVY 476 (1157)
T KOG4278|consen 414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LS----------QVY 476 (1157)
T ss_pred hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HH----------HHH
Confidence 986554322 223345778999999999999999999999999999999 999987642 11 122
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
++++...+-+.+..|..++.+|+++||+++|.+||+++|+-+.+|..++...
T Consensus 477 ~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 3333333334455677889999999999999999999999999998875443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.43 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=206.3
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..+...||+|.||+||+|.+.+ .||||++...... ..+.|++|+..+++-+|.||+-+.|||.+... ++|+.+|+
T Consensus 394 v~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 394 VLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred hhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 3445889999999999999853 6999998876544 45789999999999999999999999998887 99999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+-+|+.+||..+ ..++..+.+.||.|||+||.|||. ++|||||||+.||+|.+++.+||+||||+..-......
T Consensus 471 GsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 471 GSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred Cchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 999999998653 568899999999999999999999 99999999999999999999999999998644332222
Q ss_pred CceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 GFSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.......|...|||||++.. .+|++++||||||+|+|||+||..||.... .+. ++- ++..|-+ ..|..
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~dq--Iif----mVGrG~l--~pd~s 615 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-RDQ--IIF----MVGRGYL--MPDLS 615 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-hhh--eEE----Eeccccc--Cccch
Confidence 22233458889999999964 378999999999999999999999997322 111 110 1111100 01111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.....+..+|.+|+..||..++++||.+.+|+..|++++.
T Consensus 616 ---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 ---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1123456678899999999999999999999999988874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=345.75 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=199.0
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcc---hHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEeecC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG---TREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYPFM 607 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ey~ 607 (863)
..||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+++|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999887654333 4678899999999999999999999977 34678999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...++|...++++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999953 34689999999999999999999972 368899999999999999999999999998654321
Q ss_pred CCceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 688 SGFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..+...+. ..+. .+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~---~~~~-----~~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLII---NKNN-----SLK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---hcCC-----CCC
Confidence 12357899999999976 6889999999999999999999999976432 11211111 1110 011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+ +..+...+.+++.+||+.+|++|||+.|+++.|+...
T Consensus 243 ~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 L----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred C----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 1123446889999999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=324.63 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=201.0
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.++|+|+||.|||++.+ .|+.||||++..... .-.+-.++|+++|++++|+|+|.|+.+|..+..++||+||++.--
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv 87 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV 87 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence 47999999999999976 599999998765543 334567899999999999999999999999999999999997755
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+.- .....++.....+++.|+++|+.|+|+ +++|||||||+|||+..++.+||+|||+||.+... ...-
T Consensus 88 L~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~Y 158 (396)
T KOG0593|consen 88 LHELE----RYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNY 158 (396)
T ss_pred HHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchh
Confidence 55433 334568888999999999999999999 89999999999999999999999999999987632 2233
Q ss_pred eeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh-hhccc--------cc-----
Q 002943 692 LEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA-KPFIR--------ES----- 756 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~-~~~~~--------~~----- 756 (863)
+....|..|.|||.+.+ .+|....|||+.||++.||++|.+-|.+....+...++... ..++. ..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 45668999999999988 68999999999999999999999999876544433322211 11111 11
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.+.-++.-.+..-.....-+++++..|++.||.+|++-+|++.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 122222221111111223446889999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.46 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=203.4
Q ss_pred HHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 601 (863)
...+.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 345678999999999999963 246689999886543 23345788999999999 8999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC------------------------------------------------------------
Q 002943 602 LVYPFMSNGSLQDRLYGEAS------------------------------------------------------------ 621 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~------------------------------------------------------------ 621 (863)
+||||+++|+|.+++.....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 99999999999999954221
Q ss_pred -----------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 622 -----------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 622 -----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
....++|..+++++.|+++||+|||+ ++|+||||||+|||++++..+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 11257899999999999999999999 8999999999999999999999999999986643322222
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..+.++...... . ..+.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~~----~--~~~~---- 340 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKEGYR----M--LSPE---- 340 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHhCcc----C--CCCC----
Confidence 222335678999999999999999999999999999998 88898754321 122222221110 0 0011
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
....++.+++.+|++.+|++||+|.||+++|++.
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1123588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.67 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=197.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC--eeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND--QQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ey~~~ 609 (863)
..+.||+|+||.||++... +|...|||..........+.+.+|+++|.+++|||||+.+|.....+ ...+.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 3478999999999999965 49999999766553333567899999999999999999999855554 68899999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCC-CCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQ-EGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~-~~~ 687 (863)
|||.+++.... . .|+.....++..||++||+|||+ ++||||||||+||||+. ++.+||+|||+++.... ...
T Consensus 101 GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 101 GSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred CcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999995432 2 69999999999999999999998 99999999999999999 79999999999987653 111
Q ss_pred CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
........||+.|||||++..+ ....++|||||||++.||+||+.||... ....++.-....... -|.+
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~-----~P~i 244 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDS-----LPEI 244 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCC-----CCCC
Confidence 2223457799999999999854 3345999999999999999999999753 111222211111111 1222
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
. ........+++..|++.+|++|||+.++++--
T Consensus 245 p----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 P----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred C----cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 2 22334577889999999999999999997654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=345.28 Aligned_cols=237 Identities=27% Similarity=0.460 Sum_probs=199.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~ 614 (863)
+-||+|+.|.||+|++ .++.||||+++.. -+.+|+.|++|+|+||+.+.|+|......++|||||+.|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 4699999999999999 4688999976432 2468999999999999999999999999999999999999999
Q ss_pred hhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeee
Q 002943 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694 (863)
Q Consensus 615 ~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~ 694 (863)
.|. ....+.......+..+||.||.|||. +.|||||||+-||||..+-.+||+|||-++..... .....+
T Consensus 202 VLk----a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 202 VLK----AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHh----ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 994 34567888889999999999999999 88999999999999999999999999999865432 334567
Q ss_pred ecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHH
Q 002943 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEA 774 (863)
Q Consensus 695 ~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 774 (863)
.||..|||||++.....++|.||||||||||||+||..||.+...... =| .+=...|.-..+..+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw-----------GVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW-----------GVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----------eccCCcccccCcccC
Confidence 899999999999999999999999999999999999999976432110 00 000112222344566
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 775 MWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 775 ~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+..+.-|+.+||+..|.+||++++++.-|+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 777888999999999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=342.84 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=201.9
Q ss_pred HhhcceecccCcEEEEEEecCC-----------------CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD-----------------GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLG 592 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~-----------------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g 592 (863)
+.+.++||+|+||.||++.+.+ +..||+|.+..... ...++|.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4456899999999999997532 34699998765432 33467999999999999999999999
Q ss_pred eEeeCCeeEEEeecCCCCChhhhhhccC---------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccC
Q 002943 593 YCCENDQQILVYPFMSNGSLQDRLYGEA---------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRD 657 (863)
Q Consensus 593 ~~~~~~~~~LV~ey~~~gsL~~~L~~~~---------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrD 657 (863)
++.+.+..++||||+++|+|.+++.... .....++|...++++.|++.||+|||+ .+|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccC
Confidence 9999999999999999999999985421 112357889999999999999999999 8899999
Q ss_pred CCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh--CCCCCC
Q 002943 658 VKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS--GREPLN 735 (863)
Q Consensus 658 ik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt--G~~p~~ 735 (863)
|||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999999986543322222223345788999999998899999999999999999997 556776
Q ss_pred CCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 736 TRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 736 ~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.... ....+.+.......... .. . .....+...+.+++.+||+.+|++||+|.||.+.|++
T Consensus 244 ~~~~---~~~~~~~~~~~~~~~~~-~~-~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTD---EQVIENAGEFFRDQGRQ-VY-L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCH---HHHHHHHHHHhhhcccc-cc-c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4321 22233332222211100 00 0 0111233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.45 Aligned_cols=269 Identities=27% Similarity=0.404 Sum_probs=203.1
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhc--CCcccccceeeeEeeCC----eeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSA--IRHENLVPLLGYCCEND----QQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~LV~ey 606 (863)
+.++||+|+||.||||.+. ++.||||++.... .+.|++|-++.+. ++|+||++++++-.... +.+||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4578999999999999995 5999999987543 4567777777664 58999999999887666 88999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc------CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA------GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
.++|||.+||. ...++|....+|+..+++||+|||++. +++|+|||||++||||.+|+++.|+|||||.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999994 347999999999999999999999743 4689999999999999999999999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccC-CC-----CcccceechhhHHHHHHhCCCCCCCCC-CCCcchhHHhhhhcc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HL-----SAKSDVFSFGVVLLEIISGREPLNTRR-PRNEWSLVEWAKPFI 753 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~-----s~ksDV~SfGvvl~ElltG~~p~~~~~-~~~~~~l~~~~~~~~ 753 (863)
.+.............||.+|||||++.+. .+ -.+.||||+|.|||||++...-++... +.-..-...-+....
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 88766555555567899999999999764 22 247999999999999999876554211 110111111111111
Q ss_pred cccccccc-----cCCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 754 RESRIDEI-----VDPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 754 ~~~~~~~i-----~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.-+.+.+. ..|.+...+ ....+..+.+.+..||..|++.|-|+.=|-+++.++....
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 10111111 112222111 1134667889999999999999999999999998876544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=355.12 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=203.8
Q ss_pred HHHHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCCc-chHHHHHHHHHHhcC-CcccccceeeeEeeCCe
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTSTQ-GTREFENELNFLSAI-RHENLVPLLGYCCENDQ 599 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 599 (863)
...+.+.+.||+|+||.||+|.. .++..||||++...... ....+.+|+++++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 33455678999999999999873 23468999988754332 345688999999999 89999999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCC----------------------------------------------------------
Q 002943 600 QILVYPFMSNGSLQDRLYGEAS---------------------------------------------------------- 621 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 621 (863)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999853210
Q ss_pred --------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 622 --------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 622 --------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
....+++.+.++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12357888999999999999999999 8999999999999999999999999999986643322222222
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
..++..|+|||++....++.++|||||||++|||++ |+.||....... .+.... ..+ ..+.....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~----~~~-----~~~~~~~~--- 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMV----KRG-----YQMSRPDF--- 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHH----Hcc-----cCccCCCC---
Confidence 335678999999998899999999999999999997 999997543211 111111 111 00001111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....+.+++.+|++.+|++||++.||+++|++++
T Consensus 340 -~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 -APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1245889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.56 Aligned_cols=250 Identities=34% Similarity=0.538 Sum_probs=194.1
Q ss_pred hcceecccCcEEEEEEecC-----CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLP-----DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.||+|.||.||+|.+. .+..|+||+++.... ...++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 356899999865433 3468899999999999999999999999988889999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.++|... ....+++.+++.|+.||++||+|||+ .+++|+||+++|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 24568999999999999999999999 889999999999999999999999999998763222
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.............|+|||.+....++.++||||||+++|||++ |+.|+.... ...+.+.+. ++....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~----~~~~~~----- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLK----QGQRLP----- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHH----TTEETT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----ccccce-----
Confidence 2212223446789999999999999999999999999999999 788886542 122222221 111111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
....+...+.+++.+||+.+|++||+|.++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234588999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.10 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=195.8
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.++||+|+||+||.++- +.++.+|+|++++... ...+...+|..+|.+++||.||+++-.|.+.+.++||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 3458999999999999985 4689999998876542 34567789999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.||.|..+|. +...+++....-++..|+.||.|||+ ++||||||||+|||||++|+++|+||||++..-..+
T Consensus 108 ~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 108 NGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred CCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999994 34568888888999999999999999 999999999999999999999999999999654332
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
..+...+||+.|||||++.+..++..+|-||+||++|||++|.+||.... ..++.....+.. + ...
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k-~------~~~ 245 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK-L------PLP 245 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-C------CCC
Confidence 23445789999999999999999999999999999999999999997643 223333222221 0 011
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
..+ ......+++...++.+|++|-.
T Consensus 246 p~~---ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 PGY---LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred Ccc---CCHHHHHHHHHHhccCHHHhcC
Confidence 111 1224677888999999999963
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=335.19 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=203.1
Q ss_pred HHHHhhcceecccCcEEEEEEecC----CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.....+.+.||+|+||.||+|.+. .+..||+|+++.... ...+.|.+|++.+++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344566789999999999999753 367899998876532 334678999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999542 3468999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
..... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ..+.+... ++..
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~----~~~~--- 226 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVE----DGFR--- 226 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----CCCC---
Confidence 22111 11112235678999999999999999999999999999875 9999975432 11222211 1100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
. .....+...+.+++.+||+.+|++||++.|+.+.|+..
T Consensus 227 --~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 01112344688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.00 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=199.1
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey~~~ 609 (863)
++||+|.||.|||++ +.+|+.||+|++.... ........+||.+|++|.||||++|.+...+. ...|||+|||++
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 689999999999998 5789999999876554 34446678999999999999999999998877 689999999965
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
+|.-++. ...-.++..+...++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||||+++.......
T Consensus 203 -DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 203 -DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred -hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 7777763 234568999999999999999999999 999999999999999999999999999999886554433
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHH----------hhhhccccccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE----------WAKPFIRESRI 758 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~----------~~~~~~~~~~~ 758 (863)
.+..+-|..|.|||.+.+. .|+...|+||.||||.||++|++.|.+....+..+.+- |....+..
T Consensus 276 -~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~--- 351 (560)
T KOG0600|consen 276 -YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH--- 351 (560)
T ss_pred -cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc---
Confidence 3445579999999999875 79999999999999999999999998876433322221 22111110
Q ss_pred ccccCC------ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDP------SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+ .+.+. ...-....++|+-.++..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011111 11110 0011234678888999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.40 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=204.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.|.+.||+|+|++|++|+. ..+.++|||++.+.- +...+....|-++|.+| .||.|++|+-.|.+...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 45779999999999999984 568999999877642 23345567888999999 89999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|++||+|.++|+.. +.++......+|.+|+.||+|||+ .+||||||||+|||||+||++||+|||-|+.+...
T Consensus 155 ~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999543 578999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCC---------Cce--eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 686 GDS---------GFS--LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 686 ~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
... ... ...+||..|.+||++..+..+..+|+|+|||+||+|+.|.+||.... +..+.+.+..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~--- 301 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQA--- 301 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHH---
Confidence 221 111 44789999999999999999999999999999999999999998754 2222222211
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+|-.+...++ ..+.+|+.+.+..+|.+|++.++|-+
T Consensus 302 -------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 302 -------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 1222333333 34778888999999999999988766
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.80 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=204.0
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
.+||+|+.|.||.+. ..+++.||||++........+-..+|+.+|+..+|+|||+++..+..+++++.|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 589999999999998 5678999999988877777777889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+.+. ...+++.+...|+.++++||+|||. ++|+|||||.+||||+.++.+||+|||++..+..... ....
T Consensus 359 DvVt-----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~T 428 (550)
T KOG0578|consen 359 DVVT-----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRST 428 (550)
T ss_pred hhhh-----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccc
Confidence 9883 3358999999999999999999999 9999999999999999999999999999987765432 3445
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..||+.|||||+.....|.+|.||||||++++||+-|.+||-...+. ..-|.. ...| .|.++ ....
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----rAlyLI--a~ng------~P~lk--~~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYLI--ATNG------TPKLK--NPEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----HHHHHH--hhcC------CCCcC--Cccc
Confidence 67999999999999999999999999999999999999999643221 111110 0111 12221 1223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+.++..+|++.|+++||++.|+|+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3446889999999999999999999986
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.56 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=206.8
Q ss_pred HHHHhhcceecccCcEEEEEEecCC------CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCee
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 600 (863)
..++.+.+.||+|+||.||+|...+ +..||||.++..... ..+.|.+|++++++++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456677899999999999998643 478999988765444 457899999999999999999999999999999
Q ss_pred EEEeecCCCCChhhhhhccC----------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe
Q 002943 601 ILVYPFMSNGSLQDRLYGEA----------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC 670 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~----------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~ 670 (863)
++||||+++|+|.+++.... .....+++.+...++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999996432 223458899999999999999999999 89999999999999999999
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWA 749 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 749 (863)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH
Confidence 99999999986533222222223345788999999999999999999999999999999 9999865432 1222222
Q ss_pred hhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
. .+.... ........+.+++.+||+.+|++||++.||++.|+
T Consensus 238 ~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 111111 01122345889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.51 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=205.5
Q ss_pred HHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
..+.++.+.||+|+||.||+|...+++.||||.+.... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34456679999999999999998788899999876543 34577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999995432 3468999999999999999999999 8999999999999999999999999999987653211
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
........+..|+|||++.+..++.++||||||++++||++ |+.||..... ..+...+.... ..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~---~~-------- 223 (261)
T cd05068 159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGY---RM-------- 223 (261)
T ss_pred -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC---CC--------
Confidence 11111223458999999999899999999999999999999 9999875321 11111111100 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.........+.+++.+|++.+|++||+|.++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=341.07 Aligned_cols=257 Identities=20% Similarity=0.373 Sum_probs=201.2
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCC----EEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQ----EVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
..+...+.||+|+||.||+|++. +|+ .||||++.... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34455689999999999999853 343 48999886543 33456889999999999999999999999765 5679
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|+||+++|+|.+++... ...+++...++++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999543 3458899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.............++..|+|||++....++.++|||||||++|||++ |+.||+.... ..+.+... .+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~--~- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE----KGE--R- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----CCC--C-
Confidence 54322211122234678999999999999999999999999999998 9999975421 11111111 110 0
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+ .....+...+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 230 ----~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 ----L--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----C--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 0011123457899999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=348.90 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=203.2
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~L 602 (863)
..+.++||+|+||.||+|+.. .+..||||++..... ...+.|.+|+++++++. ||||++++++|.+.+..+|
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 345689999999999999842 234799998865433 23457899999999996 9999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC-------------------------------------------------------------
Q 002943 603 VYPFMSNGSLQDRLYGEAS------------------------------------------------------------- 621 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~------------------------------------------------------------- 621 (863)
||||+++|+|.++|+....
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 9999999999999864210
Q ss_pred -------------------------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe
Q 002943 622 -------------------------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC 670 (863)
Q Consensus 622 -------------------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~ 670 (863)
....+++..+++++.|+++||+|||+ .+|+||||||+|||+++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCE
Confidence 01347888999999999999999999 89999999999999999999
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWA 749 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 749 (863)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||....... .+...+
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~~~~ 353 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFYNKI 353 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHHHHH
Confidence 99999999986643322222223346788999999998899999999999999999997 999987543211 111111
Q ss_pred hhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
. .+. .+. ........+.+++.+||+.+|++||++.+|+++|+.++
T Consensus 354 ~----~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 354 K----SGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred h----cCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 110 000 11123346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=333.67 Aligned_cols=256 Identities=27% Similarity=0.491 Sum_probs=204.1
Q ss_pred HhhcceecccCcEEEEEEecCC------CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
..+.+.||+|+||.||+|.... ...||+|.+..... ....+|.+|++++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 3456899999999999998543 25799998765432 3346789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeE
Q 002943 604 YPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA 671 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~ 671 (863)
|||+++|+|.+++..... ....+++...+.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcE
Confidence 999999999999964321 11468899999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 002943 672 KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAK 750 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 750 (863)
||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||..... ..+.+.+.
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~i~ 240 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEMIR 240 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 9999999986543322222233446788999999988899999999999999999998 9999976432 12222211
Q ss_pred hcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 751 PFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 751 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.+... .........+.+++.+||+.+|.+||++.||++.|+.
T Consensus 241 ----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.87 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=207.6
Q ss_pred HHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
....+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||++++++|...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 34455689999999999999742 345689998876655566789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccC---------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEE
Q 002943 603 VYPFMSNGSLQDRLYGEA---------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV 673 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 673 (863)
||||+++++|.+++.... .....+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999996432 123458999999999999999999999 89999999999999999999999
Q ss_pred eeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhc
Q 002943 674 ADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPF 752 (863)
Q Consensus 674 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~ 752 (863)
+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.||..... ..+.+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~-- 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT-- 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--
Confidence 99999986643322111222335778999999998899999999999999999999 8999865432 11111111
Q ss_pred ccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 753 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+... ..... ....+.+++.+|++.+|.+||++.||++.|+++..
T Consensus 237 --~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 --QGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --cCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111 01111 22358999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=325.46 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=204.1
Q ss_pred HHhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcc-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 530 TQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQG-TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+...||.|..++||+|. .+.++.||||++....... .+.+.+|+..|+.++||||++++..|..+.++++||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 34456899999999999998 4678999999987654443 488999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
..||+.+.+...- ...+++.....|..++.+||.|||. ++.||||||+.|||||.+|.+||+|||.+-.+...+.
T Consensus 107 a~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 107 AGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred cCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999995432 3458999999999999999999999 9999999999999999999999999999866544332
Q ss_pred CC-ce-eeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 688 SG-FS-LEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 688 ~~-~~-~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. .. ....||+.|||||++.. ..|+.|+|||||||..+||.+|..||....+.. .|..- +. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~t----Lq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLT----LQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHH----hc-CCCCCccc
Confidence 11 11 44679999999999643 469999999999999999999999998765421 11111 11 11110000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+..+....-...+.+++..|++.||.+|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 01111111122336889999999999999999999976
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.21 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=207.8
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
..+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 344689999999999999742 35679999887666555678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEE
Q 002943 605 PFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~k 672 (863)
||+++++|.+++..... ....++|..+++++.|++.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999964321 23458999999999999999999999 8999999999999999999999
Q ss_pred EeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 002943 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKP 751 (863)
Q Consensus 673 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 751 (863)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.||..... ....+..
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-- 238 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI-- 238 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH--
Confidence 999999986543322222223446788999999999999999999999999999999 9999865432 1122211
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..+...+ ........+.+++.+|++.+|++||++.+|+++|+++..
T Consensus 239 --~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 --TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1111111 011123468899999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.74 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=196.5
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..+.||+|+||.||++.. .+|+.||||.+.... ......+.+|++++++++|+||+++.+++.+.+..++|+||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 357899999999999985 578999999876432 2233567899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 84 GGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred CCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 99999888532 23468999999999999999999999 8999999999999999999999999999987543211
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......... +-......... .
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~ 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------E 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc----------c
Confidence 22346899999999999999999999999999999999999999864321111 10111011000 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 801 (863)
.+.......+.+++.+|++.+|++||+ +.|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122345789999999999999997 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=339.46 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=203.0
Q ss_pred HHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeC-Cee
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEN-DQQ 600 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~~ 600 (863)
.+.+.+.||+|+||.||+|... .++.||+|++..... ...+.+..|++++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 3456789999999999999642 357899998865432 2345678899999999 799999999988754 567
Q ss_pred EEEeecCCCCChhhhhhccCCC---------------------------------------------------------C
Q 002943 601 ILVYPFMSNGSLQDRLYGEAST---------------------------------------------------------R 623 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~---------------------------------------------------------~ 623 (863)
++++||+++|+|.+++...... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999998532110 1
Q ss_pred ccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCc
Q 002943 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703 (863)
Q Consensus 624 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 703 (863)
..++|..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 368999999999999999999998 89999999999999999999999999999876433222222234467789999
Q ss_pred cccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHH
Q 002943 704 EYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVA 782 (863)
Q Consensus 704 E~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~ 782 (863)
|++.+..++.++|||||||+++||++ |+.||......+ .+... ...+... .. +......+.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~----~~~~~~~-----~~----~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR----LKEGTRM-----RA----PEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH----HhccCCC-----CC----CccCCHHHHHHH
Confidence 99999999999999999999999998 999997533211 11111 1111100 00 112234688999
Q ss_pred HHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 783 LACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 783 ~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+|++.+|++||++.||++.|+++++
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=326.66 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=203.4
Q ss_pred HhhcceecccCcEEEEEEecCC----CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|.+.. ...||||++..... ....+|.+|+.++++++|+||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4456899999999999998642 45799998765433 334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++++|.+++... ...+++.++++++.|++.||+|||+ .+|+|+||||+|||+++++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 86 YMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred cCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999542 2368999999999999999999999 89999999999999999999999999999877522
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+....... . +
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---~-----~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYR---L-----P 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCC---C-----C
Confidence 22211222335678999999998899999999999999999998 9999865321 112222211100 0 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
........+.+++.+|++.+|++||++.||++.|+++
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=327.20 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=203.7
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
...+.+.||+|+||.||+|... .++.||+|++... ....+++.+|++++++++|+||++++++|...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3456789999999999999864 5889999987654 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999998543 23468999999999999999999998 89999999999999999999999999999876432211
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.+.... + ..+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~----~-----~~~~~- 226 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEK----G-----YRMER- 226 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----C-----CCCCC-
Confidence 1112234668999999999999999999999999999998 9999865321 111111111 0 00111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.91 Aligned_cols=249 Identities=28% Similarity=0.485 Sum_probs=201.3
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.+.||+|+||.||++.+.++..+|+|.+... ....++|.+|++++++++||||++++++|...+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 3456889999999999999988889999987643 233567899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++++.. ...++|..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........ .
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05114 85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S 157 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence 999998543 2358999999999999999999999 89999999999999999999999999999865432211 1
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.... . ...+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~---~---~~~~~~--- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGF---R---LYRPKL--- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCC---C---CCCCCC---
Confidence 122235668999999998889999999999999999999 899997543 222222222110 0 111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
....+.+++.+|++.+|++||+|.|+++.|
T Consensus 226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123588999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=334.00 Aligned_cols=263 Identities=27% Similarity=0.445 Sum_probs=216.2
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC---CCC--EEEEEEccc-CCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP---DGQ--EVAVKVRSS-TSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQ 599 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~---~g~--~vAVK~~~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 599 (863)
|.++.....++||+|-||.||+|++. .|. .||||.-+. ......+.|+.|..+|+++.||||++|+|.|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34444455689999999999999853 333 588887665 344557889999999999999999999999975 46
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++|||.++-|.|..||..+ +..|+......++.||+.+|+|||+ ..+|||||.++|||+...-.+||+||||+
T Consensus 465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 78999999999999999543 4568899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
|.+........+ ..+-...|||||.+.-.+++.++|||.|||.+||++. |..||.+....+. ...++.|
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEnG-- 608 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIENG-- 608 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecCC--
Confidence 998766544433 4456789999999999999999999999999999998 9999987543221 1111111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccccc
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~~ 812 (863)
-+-..++.|+..+..|+.+||+.+|.+||.+.|+...|+++++.+..
T Consensus 609 -------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 609 -------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred -------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 11123456777899999999999999999999999999999976553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.63 Aligned_cols=244 Identities=26% Similarity=0.418 Sum_probs=199.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC----CC-cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST----ST-QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|.||+|++|.. .+|..||||++... .. ...+.+.+|+.++++++ ||||++++.++......++||
T Consensus 20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivm 99 (370)
T KOG0583|consen 20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVM 99 (370)
T ss_pred eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEE
Confidence 4468999999999999974 57899999976654 12 23456678999999999 999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAP 683 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~ 683 (863)
||+.+|+|.+++.. ...+.+....+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++....
T Consensus 100 Ey~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 100 EYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999943 4578889999999999999999999 899999999999999999 999999999999874
Q ss_pred CCCCCCceeeeecCCCCCCccccccCC-CC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQH-LS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...+... +..+. .
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~k----i~~~~---~ 240 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRK----IRKGE---F 240 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHH----HhcCC---c
Confidence 2223445678999999999999977 76 78999999999999999999998732 1112211 11110 0
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
. +..... ..++..++.+|+..+|.+|+++.|++
T Consensus 241 ~---~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 K---IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c---CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 111110 34588999999999999999999998
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=330.94 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=203.0
Q ss_pred HHHhhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
....+.+.||+|+||.||+|.. .++..+|+|.+..... +...+|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3445678999999999999974 3567899998865432 334678999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC-------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 603 VYPFMSNGSLQDRLYGEAS-------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
||||+++|+|.+++..... ....+++.+.+.++.|++.||+|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853211 12458899999999999999999999 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986643322222223345778999999988889999999999999999998 9989865321 122222
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
+.. .... .. .......+.+++.+|++.+|++||++.+|.+.|..
T Consensus 239 ~~~----~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 211 1100 01 11123458889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.29 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=208.3
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.++||+|+||.||+|...++..+|+|.+.........++.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 34556899999999999999888999999998877665667899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ....+++.++++++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 87 GSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 9999999643 23568999999999999999999998 88999999999999999999999999999866432211
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....++..|+|||.+....++.++||||||++++||++ |+.||..... ....+......+ +
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---------~---- 223 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYR---------M---- 223 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCc---------C----
Confidence 123345778999999988899999999999999999998 8999965431 112222211100 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.....+...+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111233468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.56 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=204.5
Q ss_pred HHHhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchH-HHHHHHHHHhcCC-cccccceeeeEeeCC-eeEEEe
Q 002943 529 ATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTR-EFENELNFLSAIR-HENLVPLLGYCCEND-QQILVY 604 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~-~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~LV~ 604 (863)
..+...++||.|.||+||+|+ ...|..||||++++......+ .-++|++.|++|+ |||||+|...+.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 345556899999999999998 567899999988776554332 3468999999998 999999999999888 999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||| ..+|.+.+..+ +..++......|+.||.+||+|+|. +++.|||+||+|||+.....+||+||||||....
T Consensus 90 E~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 999 67999999543 6789999999999999999999999 9999999999999999999999999999997754
Q ss_pred CCCCCceeeeecCCCCCCccccc-cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc--------c
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYS-TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR--------E 755 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~--------~ 755 (863)
.. --+....|..|.|||++. .+.|+.+.|+|++|||++||.+-++-|.+..+.++. -.+...+. +
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPE 236 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchh
Confidence 32 234567899999999875 568999999999999999999999999876543221 11111110 0
Q ss_pred -cccccccC---CccCC----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 756 -SRIDEIVD---PSIKG----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 756 -~~~~~i~d---~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
..+...+. |...+ ..-..+..+.++++.+|+++||.+|||+.|.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111 11111 0111255678899999999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=325.71 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=203.8
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++|
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 34568999999999999998888999999876533 23568899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........ .
T Consensus 87 ~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05072 87 SLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-A 160 (261)
T ss_pred cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-c
Confidence 999999643 23468899999999999999999999 89999999999999999999999999999876432211 1
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... .....+...... ......
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~---------~~~~~~ 228 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYR---------MPRMEN 228 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCC---------CCCCCC
Confidence 122345678999999998899999999999999999998 9999965321 122222221110 001111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
....+.+++.+|++.+|++||++.++.+.|++
T Consensus 229 ----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 ----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22458899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.32 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=203.6
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 603 (863)
.+.+.||+|+||.||++... +...+|+|++.... .+...++.+|++++.++ +|+||++++++|..++..+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 44579999999999999853 23679999876542 23345788999999999 799999999999999999999
Q ss_pred eecCCCCChhhhhhccC------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeE
Q 002943 604 YPFMSNGSLQDRLYGEA------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA 671 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~ 671 (863)
|||+++|+|.+++.... .....+++..+++++.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeE
Confidence 99999999999996421 234568999999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhh
Q 002943 672 KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAK 750 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~ 750 (863)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+..
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~- 247 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---ELFKLL- 247 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---HHHHHH-
Confidence 9999999987654322222222345678999999988899999999999999999998 99998653211 111111
Q ss_pred hcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 751 PFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 751 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+.. ..........+.+++.+|++.+|++||||.|+++.|++++
T Consensus 248 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 248 ---KEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11100 0111122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=336.56 Aligned_cols=241 Identities=23% Similarity=0.287 Sum_probs=194.8
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||++.. .+|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 478999999886542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ...+++.+...++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99999843 3468999999999999999999999 899999999999999999999999999998543221 12
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.... + +..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~----~------~~~~p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM----E------EIRFPRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHc----C------CCCCCCCC
Confidence 2345699999999999999999999999999999999999999965321 111111110 0 11111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+.+++.+|++.+|++|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 33578899999999999999 6777754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=354.44 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=202.7
Q ss_pred HhhcceecccCcEEEEEEecC-C-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-D-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||.||++... + ++.||+|.+..........+.+|+++++.++||||++++++|...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 345689999999999999743 3 67899997665555555678889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.++|+........+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999986543445578899999999999999999999 89999999999999999999999999999876543322
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......||++|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... . +.. ++ ..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~---~-~~~----~~-~~- 292 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVL---Y-GKY----DP-FP- 292 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h-CCC----CC-CC-
Confidence 233445699999999999999999999999999999999999999965321 11111111 0 110 00 11
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++||++.++++
T Consensus 293 ---~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 ---CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112245889999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.79 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=204.6
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcc-hHHHHHHHHHHhcCC-cccccceeeeEeeC
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQG-TREFENELNFLSAIR-HENLVPLLGYCCEN 597 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 597 (863)
+......+.++||+|+||.||+|++. .+..||||++....... .+.+.+|+++|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444455689999999999999853 34689999987653332 357889999999997 99999999999999
Q ss_pred CeeEEEeecCCCCChhhhhhccCC--------------------------------------------------------
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEAS-------------------------------------------------------- 621 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~-------------------------------------------------------- 621 (863)
+..++|+||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964321
Q ss_pred --------------------------------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCe
Q 002943 622 --------------------------------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNI 663 (863)
Q Consensus 622 --------------------------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NI 663 (863)
....++|...++++.|++.||+|||+ ++++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence 11347788899999999999999998 8999999999999
Q ss_pred EecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCc
Q 002943 664 LLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNE 742 (863)
Q Consensus 664 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 742 (863)
|+++++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999986543222111222346788999999998889999999999999999998 889986532111
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.+... ...+. .+.. .......+.+++.+||+.+|.+||+++||++.|++++
T Consensus 350 -~~~~~----~~~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -QFYNA----IKRGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHH----HHcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01111 11110 0001 1112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=330.14 Aligned_cols=245 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||.||++... +++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 5889999987643 233446788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999943 3468999999999999999999999 899999999999999999999999999998643222 2223
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...||..|+|||.+.+..++.++|||||||+++||++|+.||.... ..+......... ..+...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-------~~~~~~--- 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-------LRFPDG--- 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-------CCCCCc---
Confidence 4569999999999999999999999999999999999999997532 111111111110 011111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....+.+++.+|++.+|++||+...+.+.|+..+
T Consensus 216 -~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 216 -FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 2235778999999999999998766666665443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.77 Aligned_cols=241 Identities=27% Similarity=0.440 Sum_probs=205.0
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|.||.||||+-+ +.+.||+|.+.+... ...+.+.+|++++++++|||||.++.+|+...++++|.||+.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 468999999999999865 578999998876543 3356788999999999999999999999999999999999966
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|..+| ...+.+++.....|+.+++.||.|||+ .+|+|||+||.||||+.++.+|++|||+||.+.. ...+
T Consensus 86 ~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 86 DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999999 345679999999999999999999999 8999999999999999999999999999998754 4556
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.+.++||+-|||||...++.|+..+|.||+||||||+++|++||-.. .+.+.++....+ |- .+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v---~~ 219 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PV---KP 219 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CC---CC
Confidence 67889999999999999999999999999999999999999999642 233333332222 11 12
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+......+..++...++.||..|.+-.+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2244556888899999999999999998865
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.72 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=202.9
Q ss_pred hcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+++++.++||||+++++.|...+..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999852 235789998765433 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccC--------------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 606 FMSNGSLQDRLYGEA--------------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 606 y~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
|+.+|+|.+++.... .....+++...+.++.|++.||+|||+ .+++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence 999999999985321 112458899999999999999999998 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 744 (863)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+ ..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~ 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---ER 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---HH
Confidence 9999999999999986543322211223345778999999988889999999999999999999 9999965432 12
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+.++...... ... .......+.+++.+|++.+|++||++.|+++.|++++
T Consensus 238 ~~~~~~~~~~---------~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFNLLKTGYR---------MER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHHHhCCCC---------CCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 2222221110 001 1122346889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.58 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=199.2
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++..++||||+++++++...+..++||||++
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP 84 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence 4579999999999999965 58999999886542 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 85 GGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 9999999943 3468899999999999999999999 8999999999999999999999999999986543
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .+..|... .. .+...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~--------~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQ--------RPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-cc--------CCCCC
Confidence 123456899999999999999999999999999999999999999764321111 11111110 00 01100
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 224 -~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 -DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.19 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=198.3
Q ss_pred hhcceecccCcEEEEEEecC-CCC----EEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQ----EVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.+.||+|+||.||+|.+. +|+ .+++|....... ...+++..|+..+++++||||+++++++. ....++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 34578999999999999853 454 477787654332 23467888899999999999999999885 455778999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...++|...+.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++.....
T Consensus 89 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 89 LSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred eCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999542 3468999999999999999999999 88999999999999999999999999999876443
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........++..|+|||.+.++.++.++|||||||++||+++ |+.||..... ..+.+... .+.. ...+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~----~~~~--~~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLE----KGER--LAQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCc--CCCC
Confidence 32222334557789999999998899999999999999999998 9999976432 11222211 1110 0111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.. +...+.+++.+|+..+|++||++.|+++.|+.+.
T Consensus 234 ~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 QI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 1234678899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.10 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=196.6
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
+.||+|+||.||+|... +++.+|+|...... ......|.+|++++++++|+||++++++|...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 78999999865433 23346789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999532 3458899999999999999999998 899999999999999999999999999998654221111111
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....+..|+|||.+.++.++.++||||||+++|||++ |..||...... ........ .......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~-------------~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQ-------------GVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHc-------------CCCCCCc
Confidence 1123457999999999899999999999999999998 88888653321 11111110 0000111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
......+.+++.+|++.+|++||++.||.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.48 Aligned_cols=256 Identities=22% Similarity=0.373 Sum_probs=199.9
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|+||.||+|... .+..||||++..... ....+|.+|+.+++.++|+||+++++++.+....++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 445689999999999998743 356799998754332 2345789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCC------CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 604 YPFMSNGSLQDRLYGEAST------RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
|||+++|+|.+++...... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCC
Confidence 9999999999999543211 2346888999999999999999999 899999999999999999999999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+++...............++..|+|||++.+..++.++|||||||+++||++ |..||..... ....+.+. .+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~----~~ 237 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM----EG 237 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----cC
Confidence 9986543222111112235778999999998899999999999999999999 7888865422 11222111 11
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.... . .......+.+++.+|++.+|++||++.|+++.|++
T Consensus 238 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1100 1 11223468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.17 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=203.1
Q ss_pred HHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcc-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQG-TREFENELNFLSAIRHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 601 (863)
.++.+.+.||+|+||.||+|... +++.||||+++...... .+.|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34556789999999999999853 35789999987554332 356889999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccC------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 602 LVYPFMSNGSLQDRLYGEA------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
+++||+++++|.+++.... .....+++..+++++.|++.||+|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 113458889999999999999999998 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||..... ..+.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986643322222223346789999999988889999999999999999998 8888865321 122222
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
+.. +... .........+.+++..|++.+|++||++.+|++.|+.
T Consensus 239 i~~----~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRN----RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHc----CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1110 1112234458899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=346.65 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=210.1
Q ss_pred hhcceecccCcEEEEEEec-CCC----CEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDG----QEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g----~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.-.++||+|+||+||||.+ ++| .+||||++... ..+...++++|+-+|.++.||||++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999985 444 47899976544 4556789999999999999999999999998777 789999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
||+.|+|.+|++.. +..+--...+.++.|||+||.|||+ +.++||||.++|||+.+-..+||.|||+++.+..+
T Consensus 778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999653 4567888999999999999999998 89999999999999999999999999999998776
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.........+-.+.|||-|.+....++.++|||||||.+||++| |..|+++....+..++.+ .+.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~ge------- 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGE------- 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccc-------
Confidence 65544444455778999999999999999999999999999999 999998876444333322 111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
+| ..++-+...+..++.+||..|++.||+++++..++.+.
T Consensus 918 RL--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 RL--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cC--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 11 22334556688899999999999999999999988654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.87 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=200.6
Q ss_pred cceecccCcEEEEEEe-cCCCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.++||+|.||.||+|+ ...|+.||||+++..... -.....+|++.|+.++|+||+.|++++...+...||+|||+ -
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-T 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-c
Confidence 4689999999999998 567999999987765432 24567899999999999999999999999999999999995 5
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|+..++. ....++......++.++.+|++|||. +.|+||||||.|+|+++++.+||+|||||+........
T Consensus 86 dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 86 DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 89988843 34678889999999999999999999 88999999999999999999999999999988654322
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc---ccccc----
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR---IDEIV---- 762 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~i~---- 762 (863)
.+...-|..|.|||.+.+. +|+...||||.|||+.||+-|.+-|.+...-+.....-.+.....+.. +..+-
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2233578899999988764 799999999999999999999887776543222221111111001110 11111
Q ss_pred -----CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 763 -----DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 763 -----d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+.+.. .-..+....++++..++..||.+|++++|++++
T Consensus 238 ~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 222344556899999999999999999988654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.36 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=193.4
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999985 468999999876542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988843 3468999999999999999999999 899999999999999999999999999987542221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+... . . +..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~---~-~------~~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL---M-E------EIRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHh---c-C------CCCCCCCC
Confidence 22356899999999999999999999999999999999999999753211 1111100 0 0 01111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+.+++.+|++.+|++|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23577899999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.91 Aligned_cols=266 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred hhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 603 (863)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....|.+|++++++++||||++++++|... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 3457899999999988652 3678999998765432 3456788999999999999999999998764 357899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999943 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGDSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
...... ......++..|+|||.+....++.++||||||++++||++|+.|+...... ...+..+.........+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 332211 111223566799999998888999999999999999999999998653211 011111111111111112222
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
+..............+.+++.+|++.+|++||+|.+|+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 22211111222345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.72 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=198.4
Q ss_pred hcceecccCcEEEEEEecCC-CC--EEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeE
Q 002943 533 YKTLIGEGGFGSVYRGTLPD-GQ--EVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQI 601 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~-g~--~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 601 (863)
+.++||+|+||.||+|...+ ++ .+|+|.++... ....+.+.+|++++++++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999754 33 58999876542 33456788999999999999999999988542 2468
Q ss_pred EEeecCCCCChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 602 LVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
+++||+++|+|.+++.... .....+++...+.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999884322 223458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
+...............++..|+|||++....++.++||||||+++|||++ |+.||..... ..+.+... .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLR----QGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----cCCC
Confidence 87643322111122345778999999999999999999999999999999 8889865321 12222111 1111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.. . .......+.+++.+|++.+|++||++.|+++.|++++
T Consensus 233 ~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 233 LK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00 0 1122345889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.65 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=201.0
Q ss_pred hcceecccCcEEEEEEecCC----CCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCe------e
Q 002943 533 YKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQ------Q 600 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 600 (863)
+.+.||+|+||.||+|.+.. +..||||+++.... ....++.+|++.++.++|+||+++++++...+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998642 36799998765432 334678999999999999999999999876554 6
Q ss_pred EEEeecCCCCChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 601 ILVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
++|+||+++|+|..++.... .....+++...+.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999985432 223468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.++... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~----~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH----GN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CC
Confidence 987644322222222335678999999988899999999999999999999 8898865321 122222221 11
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
. ... .......+.+++.+|++.+|++||++.||++.|+++
T Consensus 233 ~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 R-----LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-----CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011 112334688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=301.89 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=210.6
Q ss_pred HhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~ 604 (863)
+.+.+.||+|||+-||.++ +.++..+|+|++.....++.+..++|++..++++|||++++++++..+. +.+|++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 4556899999999999998 6789999999988887778888999999999999999999999986543 489999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
+|...|||.+.+......+..+++.+.+.|+.++++||++||+.. ++++||||||.|||+.+.+.++|.|||.+...+-
T Consensus 103 Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i 181 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPI 181 (302)
T ss_pred ehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccce
Confidence 999999999999766556668999999999999999999999954 5799999999999999999999999999876542
Q ss_pred CCCCC-------ceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 685 EGDSG-------FSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 685 ~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
.-... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+.....++ ++
T Consensus 182 ~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl--------- 251 (302)
T KOG2345|consen 182 QIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL--------- 251 (302)
T ss_pred EeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE---------
Confidence 21111 012234789999999985 34678999999999999999999999986443221 11
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
...+..+.+.-.......+.+.+++.+|++.||.+||++.|++..++.+.
T Consensus 252 ---aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ---ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111222211111113456899999999999999999999999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.66 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||++.. .+|+.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 468999999886542 234467889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ...+++.+...++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99998843 3468999999999999999999999 899999999999999999999999999998543221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+. .... +..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~---~~~~-------~~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL---ILME-------DIKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHH---hccC-------CccCCCCC
Confidence 2335699999999999988999999999999999999999999975321 111111 1100 11111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+.+++.+|++.+|++|| ++.|+++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 23577899999999999997 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.31 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=206.2
Q ss_pred HHHhhcceecccCcEEEEEEecCC-----CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEee-CCeeE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLPD-----GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQI 601 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 601 (863)
..+.+.++||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 344556899999999999999765 7889999876543 2334678899999999999999999999876 46789
Q ss_pred EEeecCCCCChhhhhhccCCC----CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 602 LVYPFMSNGSLQDRLYGEAST----RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
+++||+++|+|.+++...... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999999543222 2568999999999999999999998 899999999999999999999999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....+ ..+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~--- 236 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGY--- 236 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCC---
Confidence 9986643322111222346778999999988889999999999999999999 9999975432 22333322211
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.. . ....+...+.+++.+|++.+|++||++.||++.|+++.
T Consensus 237 ~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 237 RL------A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 0 01112345889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.13 Aligned_cols=265 Identities=26% Similarity=0.396 Sum_probs=199.4
Q ss_pred hhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 604 (863)
.+.+.||+|+||.||++.. .++..||||.+........+.|.+|++++++++||||+++++++... ...++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 4457899999999999974 35789999998776666667899999999999999999999987543 4678999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 87 EYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999532 3458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCc-eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc----ccccc
Q 002943 685 EGDSGF-SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR----ESRID 759 (863)
Q Consensus 685 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~~~ 759 (863)
...... .....++..|+|||++.+..++.++|||||||+++||++|..++..... ...+....... ...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA----EFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch----hhhhhcccccccccchHHHH
Confidence 322111 1112234569999999988999999999999999999998876543211 00000000000 00000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
+.+...............+.+++.+||+.+|++||||.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111000011112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.03 Aligned_cols=196 Identities=27% Similarity=0.369 Sum_probs=170.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
...+.||+|+||.||++... +|..+|+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 34578999999999999965 688999998765432 3346799999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 88 GSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999943 34588999999999999999999982 359999999999999999999999999998654321
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22346899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.11 Aligned_cols=265 Identities=23% Similarity=0.410 Sum_probs=207.8
Q ss_pred HHHHhhcceecccCcEEEEEEec--------CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeC
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTL--------PDGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCEN 597 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~--------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 597 (863)
...+.+.+.||+|+||.||++.. .++..||+|...... ....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 44455678999999999999963 134579999876543 33456789999999999 899999999999999
Q ss_pred CeeEEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
...++||||+++|+|.+++..... ....++|.+++.++.|+++||+|||+ .+++||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999964321 12468899999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 744 (863)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987654332222223346678999999988889999999999999999998 7888865321
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
.++.... ..+... .....+...+.+++.+|++.+|++||+|.||++.|++++....
T Consensus 246 -~~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 -EELFKLL-KEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -HHHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1111111 111100 0111233468889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=344.38 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=207.9
Q ss_pred hhcceecccCcEEEEEEecCCC-CEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeE-ee------CCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDG-QEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYC-CE------NDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g-~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~-~~------~~~~~L 602 (863)
.+++.|.+|||+.||.+....+ .++|+|++-..+....+...+|+++|++|+ |+|||.+++.. .. .-+.+|
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 3468999999999999997665 999999887778888899999999999997 99999999932 21 136789
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
.||||.+|+|-++|..+.. ..|+..+.++|+.++++|+++||. +.++|||||||-+||||+.++..||||||-|...
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred ehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 9999999999999964432 349999999999999999999998 5588999999999999999999999999998643
Q ss_pred CCCCCCCce-------eeeecCCCCCCcccc---ccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc
Q 002943 683 PQEGDSGFS-------LEVRGTAGYLDPEYY---STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752 (863)
Q Consensus 683 ~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~ 752 (863)
......... ....-|+-|+|||++ .+..+++|+|||+|||+||-|+....||+...
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------- 262 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------- 262 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence 222211100 112368999999987 46689999999999999999999999998642
Q ss_pred ccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 753 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
...|++....-.........|.+||..||+.+|.+||++.+|++.+-++...+
T Consensus 263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12333333321222456678999999999999999999999999998876443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.86 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=204.7
Q ss_pred HHHhhcceecccCcEEEEEEecC--------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCC
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP--------DGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCEND 598 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 598 (863)
..+.+.+.||+|+||.||++... ++..+|+|++.... .....++..|+++++++ +|+||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 44556789999999999999742 23579999887542 33446788999999999 7999999999999999
Q ss_pred eeEEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec
Q 002943 599 QQILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666 (863)
Q Consensus 599 ~~~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld 666 (863)
..++||||+++|+|.+++..... ....++|.++++++.|++.||+|||+ .+++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999965321 12358999999999999999999998 8999999999999999
Q ss_pred CCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchh
Q 002943 667 HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSL 745 (863)
Q Consensus 667 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l 745 (863)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence 999999999999986643221111122234568999999998889999999999999999998 8888864321 111
Q ss_pred HHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 746 VEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 746 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.+. ...+... .........+.+++.+|++.+|++||+|.||++.|++++..
T Consensus 252 ~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHH----HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111 1111100 11112234678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.50 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=200.8
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.+.||+|+||.||+|...++..+|||.+.... ....+|.+|++++++++||||++++++|.+.+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 45668899999999999998777789999876443 33467999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++.++++++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 999998542 2368999999999999999999999 8999999999999999999999999999986543221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.+....... . ....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~-----~~~~- 224 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLR----L-----YRPH- 224 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCC----C-----CCCC-
Confidence 112235678999999998889999999999999999999 9999865432 112221111100 0 0001
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.....+.+++.+||+.+|.+||++.++++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.89 Aligned_cols=241 Identities=23% Similarity=0.334 Sum_probs=201.9
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.||.|+-|.|-.|+. .+|+.+|||++.+.. ......+++|+-+|+.+.|||+++++++++++.++|||.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 46899999999999985 679999999887653 22345678999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|-|.++|. .+++++..+..+++.||..|+.|+|. .+|+|||+||+|+|||..+++||+|||+|.+-..+.
T Consensus 97 GELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--- 166 (786)
T KOG0588|consen 97 GELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--- 166 (786)
T ss_pred chhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence 99999994 45679999999999999999999999 899999999999999999999999999998654432
Q ss_pred ceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
...+.+|++.|.+||.+.+.+|. .++||||+||||+.|+||+.||++. +...|...|.. |..
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~----G~f---------- 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQR----GVF---------- 229 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHc----Ccc----------
Confidence 23456799999999999999885 6899999999999999999999853 23334433332 211
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+.....+..+|+.+|+..||+.|.|++||++
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 011223345778999999999999999999976
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.97 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=199.5
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.+.||+|+||.||+|..+++..+|+|++.... ....+|.+|++++++++|+||+++++++...+..++|+||++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45668999999999999998777889999876433 23457889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++...+.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 999999543 2368999999999999999999999 8899999999999999999999999999986543211 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~---------~~~~~--- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAG---------YRLYR--- 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcC---------CcCCC---
Confidence 111224457999999999999999999999999999999 8999875322 1111111111 01111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
.......+.+++.+|++.+|++||+|.|+++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111344688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.07 Aligned_cols=242 Identities=26% Similarity=0.432 Sum_probs=203.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
++||+|.||.||||.. ..++.||+|++..... ....+.++|+.+|..++|+||.+++|.+..+..++++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 6899999999999995 4688999999876544 3457889999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+.|. ....+++....-|..++..||.|||. .+.+|||||+.|||+..++.+|++|||.+-.+...... ..
T Consensus 99 ~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~ 169 (467)
T KOG0201|consen 99 LDLLK----SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RK 169 (467)
T ss_pred hhhhc----cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc--cc
Confidence 99993 23445778888899999999999999 89999999999999999999999999999876543322 25
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...||+.|||||++....|+.|+||||||++.+||++|.+|+....+..- .- .+..-.-|.+.+.+.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lf-----lIpk~~PP~L~~~~S- 236 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LF-----LIPKSAPPRLDGDFS- 236 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EE-----eccCCCCCccccccC-
Confidence 67899999999999988999999999999999999999999987654211 00 112222344544433
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.+++..|++.+|+.||++.++++
T Consensus 237 ---~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 237 ---PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 34889999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=327.91 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=202.6
Q ss_pred HHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 601 (863)
...+.+.||+|+||.||++.. ..+..||||+++.... ...+.+.+|+++++++ +|+||++++++|...+..+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 445578999999999999974 1355799998775432 3345789999999999 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+++|+|.++++... ...+++.+++.++.|++.||+|||+ ++|+|+||||+|||++.++.+||+|||+++.
T Consensus 116 lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999995432 2348999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
..............++..|+|||.+....++.++|||||||++|||++ |+.||....... .+...... +.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~~~~----~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKLIKE----GY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHHHHc----CC---
Confidence 644322111122345778999999999899999999999999999998 999987543211 11111111 10
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.+... ......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 262 --~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --RMAQP----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --cCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000 11124688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=319.52 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=195.8
Q ss_pred eecccCcEEEEEEec---CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 536 LIGEGGFGSVYRGTL---PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~---~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 3578899998765432 23467899999999999999999999885 45678999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ...+++...++++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999943 2468899999999999999999998 8999999999999999999999999999987643322111
Q ss_pred -eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 691 -SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 691 -~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+... .+.. +....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~----~~~~-----~~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE----SGER-----MECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----CCCC-----CCCCC
Confidence 112234578999999988889999999999999999998 9999975432 12222211 1111 11111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.....+.+++.+|++.+|++||+|.+|.+.|++.
T Consensus 222 ----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=333.51 Aligned_cols=236 Identities=23% Similarity=0.370 Sum_probs=192.5
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 455689999999999999965 68999999876532 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 999999999943 3467888899999999999999999 89999999999999999999999999999866432
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+. +..+.. .+
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~----i~~~~~------~~ 234 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEK----ILAGRL------KF 234 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHH----HhcCCc------CC
Confidence 1234689999999999999999999999999999999999999965321 111111 111110 01
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
.... ...+.+++.+|++.||.+||+
T Consensus 235 p~~~----~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 235 PNWF----DGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHcCC
Confidence 1111 234778999999999999997
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.41 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=201.6
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
...+.++||+|+||.||+|..+++..+|+|.+..... ..+.|.+|++++++++|+|++++++++. .+..+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 4456789999999999999988888999998875433 3467999999999999999999999875 4567899999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.++++.. ....+++.+++.++.+++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 85 GSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 9999999643 23458999999999999999999999 88999999999999999999999999999865432211
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||++.+..++.++||||||++++||++ |+.||..... ....+...... . +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~---~------~---- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGY---R------M---- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC---C------C----
Confidence 1112235678999999988899999999999999999999 8999865321 12222211100 0 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=321.42 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=201.4
Q ss_pred HhhcceecccCcEEEEEEecC-CC---CEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DG---QEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+...+.||+|+||.||+|... ++ ..+|+|.+.... ....+++.+|++++++++|+|++++.+++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 344689999999999999864 23 379999876543 3335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 87 YMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999532 3468999999999999999999999 89999999999999999999999999999866433
Q ss_pred CCCCce-eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDSGFS-LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
...... .....+..|+|||++....++.++|||||||++|||++ |+.||..... ..+...... ....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~---~~~~----- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIND---GFRL----- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhc---CCCC-----
Confidence 221111 11223457999999998889999999999999999998 9999965321 111111111 0000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....+....+.+++.+|++.+|++||+|.+|++.|++++
T Consensus 230 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 -----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011123346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=349.75 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=201.0
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC--------e
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND--------Q 599 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~ 599 (863)
+.+.++||+|+||+||+++. .+|+.||||++.... ......+.+|+..+..++|+|++++...+...+ .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 34568999999999999984 579999999876543 334467889999999999999999988765432 3
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++||||+++|+|.+++.........+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 679999999999999996554445678999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... +..
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~-~~~- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA-GRY- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc-CCC-
Confidence 87643322223344569999999999999999999999999999999999999997532 1111111111 111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
++ +. ......+.+++.+|++.+|++||++.++++.
T Consensus 263 ---~~-~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 ---DP-LP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---CC-CC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 11 1223458899999999999999999999763
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.08 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=198.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
++||+|+||.||+|...+++.+|+|++...... ....|.+|++++++++||||++++++|...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 479999999999999888999999987755432 2346889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++... ...+++..++.++.+++.+|.|||+ ++++||||||+||++++++.+||+|||+++....... .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 998432 2458899999999999999999998 8999999999999999999999999999975432211 11112
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
..++..|+|||++.+..++.++||||||+++||+++ |..||...... ........ +. ... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~----~~-----~~~----~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEK----GY-----RMS----CPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----CC-----CCC----CCC
Confidence 234678999999998899999999999999999998 99999754311 11111111 10 001 111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.....+.+++.+|++.+|++||++.|++++|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.16 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=203.1
Q ss_pred HHhhcceecccCcEEEEEEecCC------CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
...+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+++++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 44456899999999999998642 46899998765432 334578899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 603 VYPFMSNGSLQDRLYGEAS------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
||||+++|+|.+++..... ....++|..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence 9999999999999964322 12357899999999999999999998 89999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
|+++...............++..|+|||.+....++.++|||||||++||+++ |+.||..... ..+.++.. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~----~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI----D 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh----c
Confidence 99986543322222223346789999999988889999999999999999998 9999865332 12222221 1
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+... .... .....+.+++.+|++.+|++|||+.|+++.|+
T Consensus 237 ~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHL-----DLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCC-----CCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 1111 12446889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.43 Aligned_cols=235 Identities=22% Similarity=0.305 Sum_probs=191.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 34588999999999999965 68999999876432 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 84 PGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999943 3468899999999999999999999 89999999999999999999999999999865432
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+. .+. ..+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~----~~~------~~~~ 218 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKIL----AGK------LEFP 218 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCC------cCCC
Confidence 1234689999999999998899999999999999999999999975431 11111111 110 0111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
... ...+.+++.+|++.||.+||+
T Consensus 219 ~~~----~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 219 RHL----DLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred ccC----CHHHHHHHHHHcCCCHHHccC
Confidence 111 235789999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.49 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=192.8
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||+||++... +|+.+|||.+..... ...+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 689999998765422 2335678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.++++........+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 99886544445679999999999999999999999 8999999999999999999999999999986543322 123
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...||..|+|||.+.+..++.++|||||||++|||++|+.||........ ..+...... .... ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~---------~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL---------NDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc---------ccCC--CCcc
Confidence 34689999999999999999999999999999999999999975432111 111111100 0000 1111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
.....+.+++.+|++.+|++||+.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~ 247 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFR 247 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 2334578899999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.05 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=206.4
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||++.. .+|..+|||.+.... .....++.+|+++++.++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 34568899999999999995 578999999765432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.........+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 99999999986443445678999999999999999999999 899999999999999999999999999988664322
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
. ......++..|+|||++.+..++.++||||||+++|||++|..||..... ...+.... +.....+.+
T Consensus 161 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~------~~~~~~~~~ 228 (267)
T cd08229 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK------IEQCDYPPL 228 (267)
T ss_pred c--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhh------hhcCCCCCC
Confidence 1 12234588999999999988899999999999999999999999864321 11111111 111111111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.. ......+.+++.+|++.+|++||||.+|+++++++
T Consensus 229 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred Cc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 12334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.37 Aligned_cols=262 Identities=18% Similarity=0.254 Sum_probs=197.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 34578999999999999975 68899999876542 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
++.|..+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 84 KNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 887765542 23468899999999999999999999 89999999999999999999999999999876432221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh---------hhcccccccc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA---------KPFIRESRID 759 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~ 759 (863)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+........ ..........
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 -NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred -cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 122346899999999999889999999999999999999999999764321111111100 0000011111
Q ss_pred cccCCccCCCC------cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGY------HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~------~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+...... .......+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111000 0112345889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=333.08 Aligned_cols=243 Identities=29% Similarity=0.381 Sum_probs=188.9
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999854 689999998765432 23467899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+.. .+.+.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 158 ~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 158 SLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred cccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 986543 34567788999999999999999 8999999999999999999999999999987643211 1
Q ss_pred eeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 691 SLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+..... ... .+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-----~~~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQ-----PPE 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccC-----CCC
Confidence 223468999999998743 234568999999999999999999997432111111111000 000 011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. .......+.+++.+||+.+|++||++.|+++
T Consensus 296 ~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 296 A----PATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred C----CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1122345889999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=324.15 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=201.7
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++...+..++|+|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 44689999999999999632 356899998877666666789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCC-----------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 606 FMSNGSLQDRLYGEAS-----------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence 9999999999964321 12358999999999999999999998 899999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+...
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~--- 238 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECIT--- 238 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHH---
Confidence 9999976543221111222335678999999999999999999999999999998 9999865332 11111111
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.+.. ... .......+.+++.+||+.+|++||++.||.+.|+
T Consensus 239 -~~~~-----~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 -QGRE-----LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -cCcc-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1100 000 0112345789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=333.05 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=201.3
Q ss_pred HHHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeC-Ce
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEN-DQ 599 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 599 (863)
..+.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 3456678999999999999963 3578999998875432 2345788999999999 689999999988654 45
Q ss_pred eEEEeecCCCCChhhhhhccCC----------------------------------------------------------
Q 002943 600 QILVYPFMSNGSLQDRLYGEAS---------------------------------------------------------- 621 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~---------------------------------------------------------- 621 (863)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864211
Q ss_pred -----CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeec
Q 002943 622 -----TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696 (863)
Q Consensus 622 -----~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 696 (863)
....++|..+++++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01347888999999999999999999 8999999999999999999999999999986543222111222345
Q ss_pred CCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHH
Q 002943 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAM 775 (863)
Q Consensus 697 t~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~ 775 (863)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... .+.. ....+... ..... ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~~-----~~~~~----~~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRM-----RAPDY----TT 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCCC-----CCCCC----CC
Confidence 678999999998899999999999999999997 999986532111 1111 11111100 00111 12
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 776 WRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 776 ~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..+.+++..||+.+|++||++.||++.|+.+++
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 357899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.71 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=191.3
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||++... +++.+|+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999964 68899999887542 23345677899888877 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|..++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988843 3468999999999999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCC--cchhHHhhhhcccccccccccCCccC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN--EWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p 225 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCC
Confidence 2234568999999999999999999999999999999999999996432111 11122222222211111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
. .....+.+++.+|++.+|++||+.
T Consensus 226 ~----~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 R----SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 223457799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.60 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred HHHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 527 EAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 527 ~~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
...++++.++||+|+||.||+|..++++.||+|.+..... ...+|.+|++++++++|+|++++++++. .+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3456677899999999999999998999999998775433 3568899999999999999999999864 5678999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998543 23468999999999999999999998 899999999999999999999999999997664221
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......++..|+|||++....++.++||||||++++|+++ |+.||..... ..+.+....... ..
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~---------~~ 223 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYR---------MP 223 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCC---------CC
Confidence 1 11122345778999999998889999999999999999999 9999975432 112221111100 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
... .....+.+++.+|++.+|++||++.++++.|+.
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 123458899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.16 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=202.4
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.++||+|+||.||+|...++..||+|++.... ...++|.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 345678999999999999998777789999887533 34467899999999999999999999874 4567899999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 85 GSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 9999999543 23467999999999999999999999 89999999999999999999999999999866433211
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||+..+..++.++||||||++++||++ |+.||...... .+.+- ...+. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~----~~~~~---------~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VERGY---------RM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHH----HhcCC---------CC
Confidence 1122346778999999998899999999999999999999 88888654321 11110 00000 00
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....+....+.+++.+|++.+|++||++.++++.|++.+
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 111233456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.95 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=199.4
Q ss_pred HhhcceecccCcEEEEEEecCC---------------CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD---------------GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~---------------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
+.+.+.||+|+||.||++...+ ...||+|...... ......|.+|++++++++|+|++++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 4456889999999999987532 2358999876543 23345789999999999999999999999
Q ss_pred eeCCeeEEEeecCCCCChhhhhhccCC--------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec
Q 002943 595 CENDQQILVYPFMSNGSLQDRLYGEAS--------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666 (863)
Q Consensus 595 ~~~~~~~LV~ey~~~gsL~~~L~~~~~--------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld 666 (863)
...+..++||||+++++|.+++..... ....+++..+++++.|+++||+|||+ .+++||||||+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEc
Confidence 999999999999999999999854321 11347899999999999999999999 8999999999999999
Q ss_pred CCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh--CCCCCCCCCCCCcch
Q 002943 667 HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS--GREPLNTRRPRNEWS 744 (863)
Q Consensus 667 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt--G~~p~~~~~~~~~~~ 744 (863)
+++.+||+|||+++...............++..|+|||.+..+.++.++|||||||+++||++ |..||..... ..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~~ 240 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---EQ 240 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---HH
Confidence 999999999999986543322212222345778999999988899999999999999999998 5667764321 12
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
..+............... .........+.+++.+|++.+|++||+|.+|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 222211111111000000 0011123468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=317.85 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=195.7
Q ss_pred eecccCcEEEEEEecC---CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 536 LIGEGGFGSVYRGTLP---DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.||+|+||.||+|.+. ++..||+|++..... ...++|.+|++++++++|+||++++++|. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 355799998866533 23467899999999999999999999885 457899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc-
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF- 690 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~- 690 (863)
|.+++... ...+++..+++++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998532 3468999999999999999999999 8999999999999999999999999999986543322111
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+....++.++|||||||++||+++ |+.||..... ..+...+.. +.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~---------~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIEQ----GKR---------LD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHC----CCC---------CC
Confidence 111224578999999988889999999999999999996 9999976432 112222111 110 01
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.+..+..++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122345688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=329.95 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=192.1
Q ss_pred ceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357899999876532 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+.+.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999843 3457888889999999999999999 899999999999999999999999999987543221
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... +...... .+. ..+
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~------~~~ 219 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGK------LNL 219 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCC------CCC
Confidence 1223356899999999999888999999999999999999999999754311 1111111 111 011
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
... ....+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111 123578999999999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.36 Aligned_cols=255 Identities=26% Similarity=0.344 Sum_probs=193.6
Q ss_pred ceecccCcEEEEEEecCC---CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD---GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~---g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998765443 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC-CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 611 SLQDRLYGEAS-TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 611 sL~~~L~~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
+|.++++.... ....+++..++.++.|+++||+|||+ .+++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965322 23356788888999999999999999 899999999999999999999999999997543322211
Q ss_pred ceeeeecCCCCCCccccccC-------CCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-------HLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
......++..|+|||++... .++.++||||||+++|||++ |+.||....... ...+.. .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh----hcccCCC
Confidence 12234567889999998642 35789999999999999997 999997543211 111111 0111122
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.++.+.... ...+.+++..|+ .+|++||++.||++.|+
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 223322221 224677888998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.00 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=203.8
Q ss_pred HhhcceecccCcEEEEEEecCC-----------------CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD-----------------GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLG 592 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~-----------------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g 592 (863)
+.+.+.||+|+||.||++...+ +..||+|++..... ...+++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3456899999999999987542 24689998775533 34567899999999999999999999
Q ss_pred eEeeCCeeEEEeecCCCCChhhhhhccCC-------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 593 YCCENDQQILVYPFMSNGSLQDRLYGEAS-------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 593 ~~~~~~~~~LV~ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
+|..++..++|+||+++++|.+++..... ....+++...+.++.|++.||+|||+ .+++||||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence 99999999999999999999999964321 12368999999999999999999998 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh--CCCCCCCCCCCCcc
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS--GREPLNTRRPRNEW 743 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt--G~~p~~~~~~~~~~ 743 (863)
+.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||.... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~~ 240 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---DQ 240 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---hH
Confidence 9999999999999986543322222333456788999999988899999999999999999998 667775432 12
Q ss_pred hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 744 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
...+...............+ ........+.+++.+|++.+|++||++.||++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 22333332222211111111 11112346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.53 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=192.5
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||++... +++.||||+++... ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999864 68899999887542 23345688999999998 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999998843 3468999999999999999999999 899999999999999999999999999997532211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCC--cchhHHhhhhcccccccccccCCccC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN--EWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 2234568999999999999999999999999999999999999997432211 11122222222211111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
... ...+.+++.+|++.+|.+||++
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCC
Confidence 122 2357889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.13 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=202.3
Q ss_pred HHhhcceecccCcEEEEEEecCC-C---CEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD-G---QEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~-g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
...+.+.||+|+||.||+|.... + ..||||++.... ....++|..|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34567899999999999998643 3 369999887542 334568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998532 3468999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCCceee-ee--cCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 685 EGDSGFSLE-VR--GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 685 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
......... .. .+..|+|||++.+..++.++|||||||++||+++ |+.||..... ....+++..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~~---~-- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDYR---L-- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCc---C--
Confidence 322111111 11 2457999999999999999999999999999887 9999975432 223333321110 0
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
....+....+.+++.+|++.+|++||+|.+|+..|+.+
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.10 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=196.5
Q ss_pred ceecccCcEEEEEEecCC-CC--EEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD-GQ--EVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-g~--~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|.+.+ +. .+++|.+.... ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 46888776433 33446788999999999 799999999999999999999999999
Q ss_pred CChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 610 GSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 610 gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
|+|.+++..... ....+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999964321 12358899999999999999999998 899999999999999999999999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+++...... .......+..|+|||++....++.++||||||++++||++ |+.||...... ...+... ...
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~---~~~ 228 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP---QGY 228 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHHh---CCC
Confidence 986432111 1111224567999999988889999999999999999997 99999653211 1111111 000
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.. .. .......+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 229 ~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL------EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC------CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 01 1112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.91 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=198.1
Q ss_pred hhcceecccCcEEEEEEecCC------CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||.||+|...+ +..||+|....... .....|.+|+.++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 345899999999999998753 56789998764432 33457999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCC---CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---eEEEeeccC
Q 002943 605 PFMSNGSLQDRLYGEAS---TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVADFGF 678 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGl 678 (863)
||+++|+|.+++..... ....++|..+++++.||+.||+|||+ .+++||||||+|||++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcc
Confidence 99999999999965421 12368999999999999999999999 8899999999999998654 699999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++................+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+.+.. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~---~~~ 239 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTG---GGR 239 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc---CCc
Confidence 987632221111112223568999999999999999999999999999997 99999754321 11111111 000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
..........+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=323.31 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=194.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD- 86 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-
Confidence 44578999999999999864 688999998765432 334567899999999999999999999999999999999997
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ...+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 87 SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 5999988432 3457889999999999999999999 8999999999999999999999999999976532221
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc-----c----cccccc
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF-----I----RESRID 759 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~-----~----~~~~~~ 759 (863)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+........... + ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457899999998865 56899999999999999999999999764322211111000000 0 000011
Q ss_pred cccCCccCCCC----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGY----HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+...... .......+.+++.+|++.+|.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111110000 0011235779999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.98 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=199.9
Q ss_pred hhcceecccCcEEEEEEecCC-CC--EEEEEEcccC-CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD-GQ--EVAVKVRSST-STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~-g~--~vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456899999999999998753 33 4788877643 233456789999999999 799999999999999999999999
Q ss_pred CCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 607 MSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
+++|+|.+++..... ....+++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEEC
Confidence 999999999964321 12358899999999999999999998 899999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||++........ ......+..|+|||++.+..++.++|||||||+++||++ |+.||...... .+.+.. .
T Consensus 162 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~~~---~ 232 (297)
T cd05089 162 DFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYEKL---P 232 (297)
T ss_pred CcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---h
Confidence 9999874322111 111223567999999998889999999999999999998 99999754321 111111 0
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.+ ..+... ......+.+++.+|++.+|.+||++.++++.|+.++..
T Consensus 233 -~~-----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 233 -QG-----YRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -cC-----CCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 001111 11234578999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.79 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=204.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++...+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 4468899999999999985 478999999765422 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.........++....+.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999885433334568889999999999999999998 8999999999999999999999999999987643221
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...++.... .. ...+..
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~-----~~~~~~- 228 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQ-----CDYPPL- 228 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hc-----CCCCCC-
Confidence 11234588899999999988899999999999999999999999864321 111211111 00 001111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
........+.+++.+||+.+|++||++.||++.|+++
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112335688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=332.12 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred hcceecccCcEEEEEEecC--CCC--EEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTLP--DGQ--EVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~--~g~--~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.-++||+|.||.|++|.|. +|. .||||++...... ...+|++|+.+|.+|+|+|+++|+|...+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3478999999999999975 344 5899998877654 56899999999999999999999999887 7788999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+.|||.+.|+. ..+..|-......+|.|||.||.||.. +++|||||.++|+||-..-.+||+||||.|.+....+
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999976 234567788889999999999999999 9999999999999999999999999999998876544
Q ss_pred CCcee-eeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 688 SGFSL-EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 688 ~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
..... ..+-.+.|+|||.+...+++.++|||+|||++|||+| |..||-+.... . +.+.+|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---q-------------IL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---Q-------------ILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---H-------------HHHhcccc
Confidence 43222 2345678999999999999999999999999999999 88998765431 1 22223322
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
-.-.....|.+.+.++++.||..+|++||++..+.+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11123445777899999999999999999999998554
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.57 Aligned_cols=255 Identities=22% Similarity=0.388 Sum_probs=200.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCC----EEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQ----EVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
..+.++||+|+||+||+|.. .+|+ .||+|++..... ...+++.+|+.+++.++|+||++++++|.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 34558999999999999984 3454 489998765433 345678899999999999999999999975 4567999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.++++.. ...+++...+.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 88 ~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 88 QLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999542 3468999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
...........++..|+|||...+..++.++|||||||++|||++ |..||+.... ..+..+...... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~----~~--- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEKGER----LP--- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCc----CC---
Confidence 322111112235678999999998899999999999999999998 9999875432 222222221100 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
........+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 232 ------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 ------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011123457899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.02 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=190.8
Q ss_pred hhcceecccCcEEEEEEec--CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcC---CcccccceeeeEee-----CCe
Q 002943 532 QYKTLIGEGGFGSVYRGTL--PDGQEVAVKVRSSTST--QGTREFENELNFLSAI---RHENLVPLLGYCCE-----NDQ 599 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~--~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~~ 599 (863)
.+.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++++++ +||||++++++|.. ...
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 3457899999999999985 3468899998764432 2234566777777666 69999999999853 346
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++|+||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred EEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 889999995 6999998543 23458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRI 758 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~ 758 (863)
+..... .......||..|+|||.+....++.++|||||||++|||++|+.||......+.. .+.+...........
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 865432 1223456899999999998889999999999999999999999999864321110 111110000000000
Q ss_pred ------ccccCCccCC---CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 ------DEIVDPSIKG---GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ------~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+.-.. .........+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0001000000 000112235679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.88 Aligned_cols=264 Identities=29% Similarity=0.430 Sum_probs=199.9
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHh--cCCcccccceeeeEeeCC----eeEEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLS--AIRHENLVPLLGYCCEND----QQILV 603 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~LV 603 (863)
+..+.+.||+|.||+||+|.+ .|+.||||++...++ +.+.+|.++.+ .|+|+||+.+++.-..++ +++||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 344568999999999999999 588999999876544 45566666665 459999999998765443 68999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHh-----ccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT-----FAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-----~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
.+|.++|||.|||. ...++-...++++..+|.||++||. +..+.|.|||||+.|||+..++.+.|+|+||
T Consensus 288 TdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999993 3578999999999999999999996 3457899999999999999999999999999
Q ss_pred cccCCCCCCC-C-ceeeeecCCCCCCccccccC----C--CCcccceechhhHHHHHHhC----------CCCCCCCCCC
Q 002943 679 SKYAPQEGDS-G-FSLEVRGTAGYLDPEYYSTQ----H--LSAKSDVFSFGVVLLEIISG----------REPLNTRRPR 740 (863)
Q Consensus 679 a~~~~~~~~~-~-~~~~~~gt~~y~aPE~~~~~----~--~s~ksDV~SfGvvl~ElltG----------~~p~~~~~~~ 740 (863)
|-......+. . ......||.+|||||++... . .-..+||||||.|+||++.. +.||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9766544321 1 12345699999999998643 1 12469999999999999863 4566554432
Q ss_pred CcchhHHhhhhcccccccccccCCccCCC-CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 741 NEWSLVEWAKPFIRESRIDEIVDPSIKGG-YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 741 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+. +..+ .++.+-. +-+.|.+... .+.+++..+.+++..||..+|..|-|+-.+-+.|.++..
T Consensus 443 DP-s~ee-MrkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DP-SFEE-MRKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CC-CHHH-Hhcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 21 1111 1111111 1122333222 245788899999999999999999999999999988763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=332.21 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=192.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV 603 (863)
.+.++||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++...+ ..++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 3457899999999999985 468999999876432 233457889999999999999999999886432 47999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+. ++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 83 FELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99995 789988842 3468999999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCC-CceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc-------
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI------- 753 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~------- 753 (863)
..... .......||..|+|||++.+ ..++.++|||||||+++||++|+.||....... ..+.+....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 32211 11233468999999999866 678999999999999999999999997543211 111110000
Q ss_pred ----ccccccccc---CCccCCCCc---HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 ----RESRIDEIV---DPSIKGGYH---AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ----~~~~~~~i~---d~~l~~~~~---~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+ .+....... ......+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 000000000 011235789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.27 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=200.1
Q ss_pred ceecccCcEEEEEEecCC--C--CEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD--G--QEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~--g--~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++|+||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999877665 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS- 688 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~- 688 (863)
|+|.+++..... ..++|...+.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965322 468999999999999999999999 89999999999999999999999999999876543221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......++..|+|||++.+..++.++|||||||+++||++ |+.||..... ..+...... ... .+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~-------~~- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGE-------RL- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCC-------cC-
Confidence 11123457889999999999999999999999999999999 9999965322 111111111 000 00
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.........+.+++.+|++.+|++||++.||++.|.
T Consensus 221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.03 Aligned_cols=199 Identities=26% Similarity=0.362 Sum_probs=171.4
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
..+.+.++||+|+||.||++... +|..+|+|++..... .....+.+|++++++++|+||++++++|.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 34455689999999999999965 688899998765432 3346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.....++.+++.||+|||+. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 85 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999943 34588899999999999999999972 369999999999999999999999999997653221
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12346899999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=329.13 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=194.4
Q ss_pred ceecccCcEEEEEEec----CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.||+|+||.||++.. .+|+.+|+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3688999998865432 233567789999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999843 3468999999999999999999999 899999999999999999999999999998654321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ........ . ... .+..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~---~-~~~------~~p~ 219 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMIL---K-AKL------GMPQ 219 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHH---c-CCC------CCCC
Confidence 122345689999999999988899999999999999999999999975421 11111111 0 000 0111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHH--HHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVD--IVRELE 804 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e--Vl~~L~ 804 (863)
. ....+.+++.+|++.+|++||++.+ +.+.++
T Consensus 220 ~----~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~ 253 (318)
T cd05582 220 F----LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR 253 (318)
T ss_pred C----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC
Confidence 1 2235778999999999999999766 444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.08 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=201.0
Q ss_pred HHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++|+||+++++++...+..++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3445689999999999999743 245899998764432 233568899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 603 VYPFMSNGSLQDRLYGEAS------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
||||+++|+|.+++..... ....+++...++++.|++.||.|||+ ++|+||||||+|||+++++.+||+||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcC
Confidence 9999999999999964221 12345677889999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
|+++...............++..|+|||.+.++.++.++|||||||+++||++ |..||..... ..+.+... .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~----~ 236 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFVM----D 236 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----c
Confidence 99986543222111122235678999999998899999999999999999999 7888865321 11111111 1
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+... .. .......+.+++.+|++.+|++||+|.|+++.|++.+
T Consensus 237 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 GGYL-----DQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCC-----CC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1000 01 1122346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=332.29 Aligned_cols=243 Identities=22% Similarity=0.274 Sum_probs=195.3
Q ss_pred HHhhcceecccCcEEEEEEecCC--CCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD--GQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~--g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45567899999999999998543 3689999876432 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999943 3468899999999999999999999 8999999999999999999999999999986542
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+-. ..+..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i----~~~~~------ 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKI----LEGII------ 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHH----hcCCC------
Confidence 2 2245699999999999988899999999999999999999999975432 1111111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
.+....+ ..+.+++.+|++.+|++|+ +++|+++
T Consensus 246 ~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0111122 3467899999999999995 6777654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.58 Aligned_cols=257 Identities=20% Similarity=0.366 Sum_probs=206.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 45689999999999999976 7999999977532 2233567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.........+++.+++.++.+++.||+|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999986543445568999999999999999999999 8999999999999999999999999999986543221
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+..... ..+... ..
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~-~~~~~~-----~~- 228 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKI-EKCDYP-----PL- 228 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhh-hcCCCC-----CC-
Confidence 1223458889999999998889999999999999999999999986432 1222221111 111100 01
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
........+.+++.+|++.+|++||++.+|+++|+++
T Consensus 229 --~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 --PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=330.09 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=193.5
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 578999999886542 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ...+++.....++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99998843 3468999999999999999999996 1589999999999999999999999999987543221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||..|+|||.+.+..++.++|||||||++|||++|+.||...... .+.+.... . ...+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~----~------~~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM----E------EIRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhc----C------CCCCCCCC
Confidence 22346999999999999999999999999999999999999999754311 11111100 0 01111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+.+++.+|++.+|++|+ ++.++++
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23477899999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.26 Aligned_cols=259 Identities=28% Similarity=0.411 Sum_probs=201.0
Q ss_pred HHhhcceecccCcEEEEEEecC-CCC--EEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQ--EVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~--~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.+.||+|+||.||+|... ++. .+|+|.+.... ....+++.+|++++.++ +|+||+++++++..++..++|+
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4456789999999999999864 454 45777665432 23446788999999999 8999999999999999999999
Q ss_pred ecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEE
Q 002943 605 PFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~k 672 (863)
||+++|+|.++++.... ....+++.+++.++.|++.||+|||+ .+++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence 99999999999964321 12368899999999999999999998 8999999999999999999999
Q ss_pred EeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 002943 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKP 751 (863)
Q Consensus 673 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 751 (863)
|+|||+++....... .....++..|+|||++.+..++.++|||||||+++||+| |..||...... ...+...
T Consensus 165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~- 237 (303)
T cd05088 165 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP- 237 (303)
T ss_pred eCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh-
Confidence 999999874321111 111224668999999988889999999999999999998 99999654321 1111111
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.+ ..... .......+.+++.+|++.+|++||++.++++.|+.++..+
T Consensus 238 ---~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 238 ---QG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ---cC-----CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 00000 1112335789999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.70 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=200.4
Q ss_pred HhhcceecccCcEEEEEEecC-----------------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-----------------DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLG 592 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-----------------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g 592 (863)
+.+.+.||+|+||.||++... ++..+|+|++.... .....+|.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345689999999999998532 24469999887543 334568999999999999999999999
Q ss_pred eEeeCCeeEEEeecCCCCChhhhhhccCC-------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 593 YCCENDQQILVYPFMSNGSLQDRLYGEAS-------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 593 ~~~~~~~~~LV~ey~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
++...+..++||||+++|+|.+++..... ....+++.+.++++.|++.||+|||+ .+++||||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEE
Confidence 99999999999999999999999965321 12357888999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh--CCCCCCCCCCCCcc
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS--GREPLNTRRPRNEW 743 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt--G~~p~~~~~~~~~~ 743 (863)
++++.+||+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..||......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~--- 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE--- 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH---
Confidence 9999999999999986543322111222334678999999888899999999999999999998 67787653321
Q ss_pred hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 744 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
................ ...+. ...+...+.+++.+|++.+|++||+|.||++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQ-VYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhcccc-ccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111000 00011 11123568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.05 Aligned_cols=251 Identities=29% Similarity=0.487 Sum_probs=204.3
Q ss_pred ceecccCcEEEEEEecCC----CCEEEEEEcccCCCcc-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQG-TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||++.... +..+++|++....... .+.+.+|++.+++++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999654 7899999887654433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCC-----CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 610 GSLQDRLYGEAST-----RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 610 gsL~~~L~~~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
++|.+++...... ...+++..+..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999653211 3679999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
...........++..|+|||.+....++.++||||||++++||++ |+.||..... ..+.+.... +. .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~~-----~ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK----GY-----R 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----CC-----C
Confidence 432222334457889999999988889999999999999999999 6999976521 122222111 10 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
. .........+.+++.+|++.+|++||++.|+++.|+
T Consensus 226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 L----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 111122346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.55 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=206.2
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC--------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEe
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP--------DGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCC 595 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 595 (863)
+....+.+.+.||+|+||.||++... .+..||+|++.... ....+++.+|+++++++ +|+||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 33445567789999999999999732 12469999876543 23456889999999999 7999999999999
Q ss_pred eCCeeEEEeecCCCCChhhhhhccC------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCe
Q 002943 596 ENDQQILVYPFMSNGSLQDRLYGEA------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNI 663 (863)
Q Consensus 596 ~~~~~~LV~ey~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NI 663 (863)
..+..++++||+++|+|.+++.... .....++|.+++.++.|++.||+|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence 9999999999999999999996432 123458899999999999999999999 8999999999999
Q ss_pred EecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCc
Q 002943 664 LLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNE 742 (863)
Q Consensus 664 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 742 (863)
|+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 999999999999999986643222111222334568999999999999999999999999999999 8888865321
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.++.... ..+... .........+.+++.+|++.+|++||+|.|+++.|+++...
T Consensus 243 ---~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 243 ---EELFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ---HHHHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111 111100 01112234688999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.88 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=193.3
Q ss_pred hhcceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.||+|+||.||+++. .+|+.||+|++.... ....+.+..|++++.+++ |+||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3457899999999999874 368899999876432 223456788999999994 9999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999953 3468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
..... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~------- 225 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK------- 225 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------
Confidence 43222 122345699999999999765 47889999999999999999999997543221111 11111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
.++.+.... ...+.+++.+|++.+|++|| ++.++++
T Consensus 226 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 112222222 23477899999999999999 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.32 Aligned_cols=261 Identities=23% Similarity=0.386 Sum_probs=200.4
Q ss_pred HHhhcceecccCcEEEEEEec-----CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQI 601 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 601 (863)
++...+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++|+|++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 444567899999999999974 357889999876543 33346799999999999999999999999875 5678
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+++++|.+++... ...++|..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998432 2368999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC---------CCcchhHHhhhh
Q 002943 682 APQEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP---------RNEWSLVEWAKP 751 (863)
Q Consensus 682 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~---------~~~~~l~~~~~~ 751 (863)
....... .......++..|+|||++.+..++.++||||||++++||++++.|...... ........++ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-R 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-H
Confidence 6433221 111234467789999999888899999999999999999998776432110 0000111111 1
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
....+... .........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111000 01112345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.35 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=198.6
Q ss_pred ceecccCcEEEEEEecCC-------CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPD-------GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-------g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 3579999775543 23456889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCC---CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-----eEEEeeccC
Q 002943 607 MSNGSLQDRLYGEAS---TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-----CAKVADFGF 678 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-----~~kl~DFGl 678 (863)
+++|+|.+++..... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 23458899999999999999999998 8899999999999999877 899999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~---~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTA---GGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhc---CCc
Confidence 986543322222222345778999999999999999999999999999998 9999864321 122222111 000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
. .........+.+++.+|++.+|++||++.+|++.|++
T Consensus 232 --------~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 --------L--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------c--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 1111233567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.99 Aligned_cols=248 Identities=32% Similarity=0.480 Sum_probs=202.5
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
...+.+.||+|+||.||+|... |+.||||.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3456689999999999999874 78999998876544 567899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999995432 2368999999999999999999999 8999999999999999999999999999987633221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
....+..|+|||++....++.++||||||++++|+++ |+.||..... ..+......... .
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~---------~---- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR---------M---- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC---------C----
Confidence 2235678999999998899999999999999999998 9999865321 112221111100 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.........+.+++.+|++.+|++||++.|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.98 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=203.2
Q ss_pred HhhcceecccCcEEEEEEecC-----CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEee--CCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-----DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCE--NDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~L 602 (863)
..+.+.||+|+||.||++.+. ++..+|||++...... ..++|.+|++++++++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999853 3678999988765443 46789999999999999999999999987 557899
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 86 IMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999543 2358999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc---ccccc
Q 002943 683 PQEGDSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI---RESRI 758 (863)
Q Consensus 683 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~---~~~~~ 758 (863)
....... ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ..+..... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF----LRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh----ccccccccccccHHHH
Confidence 5332211 1112235567999999988899999999999999999999999986532211 00000000 00000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.+.+...........+..++.+++.+|++.+|++||+|.||+++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111122335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.17 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=198.1
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP 84 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence 4579999999999999964 68999999876542 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC--
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG-- 686 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~-- 686 (863)
+|+|.+++... ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 85 GGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999532 468999999999999999999999 899999999999999999999999999998664332
Q ss_pred -------------------------CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCC
Q 002943 687 -------------------------DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741 (863)
Q Consensus 687 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 741 (863)
.........||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 0011223468999999999999999999999999999999999999997643211
Q ss_pred c-chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 002943 742 E-WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPS-MVDIVRE 802 (863)
Q Consensus 742 ~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-m~eVl~~ 802 (863)
. ..+..|.. ...-+.. .. ....+.+++.+|++ +|.+||+ +.|+++.
T Consensus 238 ~~~~i~~~~~---------~~~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 TYNKIINWKE---------SLRFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHhccCC---------cccCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 00111100 0000000 01 23457788899997 9999999 9999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.50 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=200.8
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|+||.||++... ++..||+|++.... ....++|.+|++++++++||||++++++|..++..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 344589999999999999853 46789999876543 23356799999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccC------------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 604 YPFMSNGSLQDRLYGEA------------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
+||+++|+|.+++.... .....+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEe
Confidence 99999999999996321 112357889999999999999999998 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 744 (863)
++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---~~ 240 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---EE 240 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999876543222111222234678999999998899999999999999999998 8888864321 11
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
+... +..+.... . ......++.+++.+|++.+|++||++.|+++.|++
T Consensus 241 ~~~~----~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYY----VRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH----HhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 11111110 0 11223468899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.28 Aligned_cols=238 Identities=24% Similarity=0.314 Sum_probs=188.1
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|... +++.||||+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 57899999876532 22334556677777654 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998843 3468899999999999999999999 899999999999999999999999999998643222 2
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+..-+. . . .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~---~-~------~~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSIL---N-D------RPHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---c-C------CCCCCCC
Confidence 22345689999999999998999999999999999999999999975431 11111110 0 0 0111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVD 798 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 798 (863)
....+.+++.+|++.+|++||++.+
T Consensus 219 ----~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ----ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCChH
Confidence 2234678899999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.23 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=192.3
Q ss_pred ceecccCcEEEEEEecCCC---CEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDG---QEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677655443 234578999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++++........+++.....++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999996543334456777888999999999999998 8899999999999999999999999999865322211112
Q ss_pred eeeeecCCCCCCcccccc-------CCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 691 SLEVRGTAGYLDPEYYST-------QHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .... ..... +....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~---~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVL---NHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHH---HHHHh-hcccccC
Confidence 223457889999998743 245789999999999999997 5667754321 1111 11111 1223334
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
++.+...+. ..+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 454443333 24667888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.42 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=202.4
Q ss_pred HHhhcceecccCcEEEEEEecC--------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP--------DGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQ 599 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 599 (863)
...+.+.||+|+||.||++... .+..+|+|++.... .....++.+|+++++++ +||||++++++|...+.
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3345689999999999999742 24579999877543 23346788999999999 69999999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 600 QILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
.++|+||+++|+|.+++..... ....++|.+.++++.|++.||.|||+ .+++||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcC
Confidence 9999999999999999964321 22468999999999999999999998 89999999999999999
Q ss_pred CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhH
Q 002943 668 SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLV 746 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 746 (863)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~ 246 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EELF 246 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 99999999999986643222111122234567999999998899999999999999999999 8888865321 1122
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+... .+...+ .......++.+++.+|++.+|++||++.|+++.|+++.
T Consensus 247 ~~~~----~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 KLLR----EGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHH----cCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2111 111000 11122345779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.81 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=200.1
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+++|
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 44568899999999999998877789999876543 33467899999999999999999999875 45688999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++++.. ....++|..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus 86 ~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 86 SLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999643 23458999999999999999999998 8899999999999999999999999999986543221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||...+..++.++||||||+++|||++ |+.||..... ....++...... +.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~---------~~---- 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGYR---------MP---- 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC---------CC----
Confidence 122346778999999998899999999999999999999 8999875432 112222111100 00
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
........+.+++.+|++.+|++||++.+|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.13 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=199.2
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
++||+|+||.||++...+++.||+|........ ..+.+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987765443 4568999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++... ...+++..++.++.+++.||+|||+ .+++||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999542 2367899999999999999999998 8999999999999999999999999999986542221111111
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
..++..|+|||.+.++.++.++||||||++++||+| |..||...... ...+...... .. ....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~~~~~------~~-------~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGY------RM-------PAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHHhcCC------CC-------CCCc
Confidence 234567999999988899999999999999999999 88888654321 1111111100 00 0111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.....+.+++.+|++.+|++||++.||++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 22346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=323.96 Aligned_cols=239 Identities=21% Similarity=0.324 Sum_probs=188.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHH---hcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFL---SAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.||+|+||.||+|... +|+.||||+++... ....+.+..|++++ ++++||||+++++++...+..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999854 68999999886542 22334566666554 56789999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|..+++. ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 83 YAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999988842 368999999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+ .... +. +.
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~---~i~~-~~------~~ 219 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFD---SIVN-DE------VR 219 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHh-CC------CC
Confidence 1 122345689999999999999999999999999999999999999975431 11111 1110 00 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVD 798 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 798 (863)
..... ...+.+++.+|++.+|.+||++.+
T Consensus 220 ~p~~~----~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 220 YPRFL----SREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred CCCCC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112 235778999999999999996443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=332.91 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=190.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 347899999999999985 568899999886542 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC-
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD- 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~- 687 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999943 3458888999999999999999999 8999999999999999999999999999864321000
Q ss_pred --------------------------------------------CCceeeeecCCCCCCccccccCCCCcccceechhhH
Q 002943 688 --------------------------------------------SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVV 723 (863)
Q Consensus 688 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvv 723 (863)
........||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHH--ccCcCCCCCCCHHHHH
Q 002943 724 LLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALA--CIEPFSAYRPSMVDIV 800 (863)
Q Consensus 724 l~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~--C~~~~P~~RPsm~eVl 800 (863)
+|||++|+.||........ ..+..|... . . -+. ....+. .+.+++.+ |+..++..||++.|++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~------~-~--~~~-~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENT------L-H--IPP-QVKLSP----EAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccc------c-C--CCC-CCCCCH----HHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999976432111 011111000 0 0 000 001222 34555554 6777888899999997
Q ss_pred H
Q 002943 801 R 801 (863)
Q Consensus 801 ~ 801 (863)
+
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=313.60 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=189.6
Q ss_pred ceecccCcEEEEEEecCC-------------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeE
Q 002943 535 TLIGEGGFGSVYRGTLPD-------------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-------------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 601 (863)
+.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.+++.++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999877665555668899999999999999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe-------EEEe
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC-------AKVA 674 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~-------~kl~ 674 (863)
+||||+++|+|..+++.. ...+++..+++++.|+++||+|||+ ++|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988532 3458999999999999999999999 89999999999999987654 8999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccc-cCCCCcccceechhhHHHHHH-hCCCCCCCCCCCCcchhHHhhhhc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS-TQHLSAKSDVFSFGVVLLEII-SGREPLNTRRPRNEWSLVEWAKPF 752 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~Ell-tG~~p~~~~~~~~~~~l~~~~~~~ 752 (863)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+. .. .
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~----~ 221 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---ER----F 221 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---HH----H
Confidence 99998755322 1234788999999886 467899999999999999998 58888764321110 00 0
Q ss_pred ccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 753 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.. +. .... . .....+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~-~~-~~~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YE-GQ-CMLV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Hh-cC-ccCC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 0000 0 11245789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=325.93 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=191.6
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57899999876542 23345677899998876 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999998843 3468899999999999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .. +...| ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~---~~----~~~~p---~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESIL---HD----DVLYP---VW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHH---cC----CCCCC---CC
Confidence 22345689999999999998999999999999999999999999975431 11211111 10 00011 11
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRP-------SMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RP-------sm~eVl~ 801 (863)
....+.+++.+|++.+|++|| ++.++++
T Consensus 219 ----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 ----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 123578899999999999999 5666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=323.89 Aligned_cols=239 Identities=26% Similarity=0.341 Sum_probs=188.6
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHH-HHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELN-FLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||+||+|... +|+.||||++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999964 68999999876532 222344555554 56789999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999999843 3468899999999999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~-~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNK-P------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-C------CCCCCC
Confidence 22345689999999999999999999999999999999999999975321 1111111110 0 011112
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
. ...+.+++.+|++.+|++||++.+.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 2 3357889999999999999998633
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=312.86 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=197.6
Q ss_pred ceecccCcEEEEEEecC--C--CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP--D--GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~--~--g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|... + +..+|+|.+...... ..+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999743 2 368999987755442 4567899999999999999999999876 4567999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999532 368999999999999999999998 889999999999999999999999999998764332211
Q ss_pred c-eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 690 F-SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 690 ~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+..+...... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~~~----~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESGER----L-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCc----C--------
Confidence 1 112224568999999998999999999999999999998 999997543 2223333222110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.........+.+++.+|++.+|++||++.++++.|++.
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.73 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=188.0
Q ss_pred eecccCcEEEEEEecCC-------------------------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccce
Q 002943 536 LIGEGGFGSVYRGTLPD-------------------------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPL 590 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~-------------------------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l 590 (863)
.||+|+||.||+|.+.. ...||+|++.........+|.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998876555455678899999999999999999
Q ss_pred eeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-
Q 002943 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM- 669 (863)
Q Consensus 591 ~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~- 669 (863)
+++|.+....++||||+++|+|..++... ...+++..+++++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998532 3468899999999999999999998 8999999999999997643
Q ss_pred ------eEEEeeccCcccCCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHH-hCCCCCCCCCCCC
Q 002943 670 ------CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEII-SGREPLNTRRPRN 741 (863)
Q Consensus 670 ------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~Ell-tG~~p~~~~~~~~ 741 (863)
.+|++|||+++..... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999998654321 12246788999998865 56899999999999999995 6999987543211
Q ss_pred cchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 742 EWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 742 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
...+... . ..+.... ...+.+++.+||+.+|++||+|.+|++.|
T Consensus 230 ---~~~~~~~----~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 ---KERFYEK----K-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---HHHHHHh----c-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111110 0 0011111 13578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.06 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=201.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||++... +++.|++|.+... .....+++.+|++++++++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 34578999999999999864 6899999987643 23445788999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ....+++...++++.+++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999643 23568999999999999999999998 8999999999999999999999999999986643321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......|+..|+|||+..+..++.++||||||++++||++|+.||.... ......... .+... .+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~----~~~~~-----~~-- 221 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKII----RGVFP-----PV-- 221 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH----cCCCC-----CC--
Confidence 1223458899999999999999999999999999999999999997543 111111111 11111 11
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.......+.+++.+|++.+|++||+|.++++.
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11223468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.88 Aligned_cols=251 Identities=28% Similarity=0.475 Sum_probs=193.7
Q ss_pred ceecccCcEEEEEEecC----CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ey~~ 608 (863)
+.||+|+||.||+|... ++..+|||.+.... ....+.+.+|+.+++.++|||+++++++|.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47899999999999853 24579999875432 3345678899999999999999999998764 556789999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ...+.+..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999532 2346788889999999999999998 89999999999999999999999999999865432111
Q ss_pred --CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhC-CCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 --GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISG-REPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.......++..|+|||++.+..++.++|||||||++|||++| ..||.... ...+...+.. +. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~~~----~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYLLQ----GR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhc----CC-----CCC
Confidence 111233467789999999888999999999999999999995 55665322 1222222211 10 000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
... .....+.+++.+|++.+|++||++.||++.|++++
T Consensus 223 ~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011 11245889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.99 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=195.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..++||+|+||+||++.. .+++.||||++..... .....+.+|++++++++|+||+++++++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence 357899999999999985 4689999998765322 223567889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++.....++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 84 GGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred CCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 99999988542 23468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .+.+...+... ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~----------~~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED----------QE 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc----------cc
Confidence 1234689999999999988999999999999999999999999976432111 11111111110 00
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIV 800 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl 800 (863)
.+.......+.+++.+|++.||++|| ++.+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 11122334578999999999999999 555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.03 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=201.3
Q ss_pred HhhcceecccCcEEEEEEecC-C---CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-D---GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~---g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|... + +..+|+|.++.... ...+.|.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 345689999999999999853 2 34799998765432 234678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++.+.+.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 86 YMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999543 2468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCce-eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDSGFS-LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
...... ....++..|+|||++.+..++.++||||||++++|+++ |+.||..... ..+........+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~--------- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYR--------- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCc---------
Confidence 221111 11223568999999998899999999999999999887 9999875432 112222211110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
. .........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.57 Aligned_cols=239 Identities=25% Similarity=0.351 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 57899999876542 23345567788888764 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.+...++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999843 3468899999999999999999999 899999999999999999999999999987542211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+.. . .+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~----~------~~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRM----D------NPCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----C------CCCCCcc
Confidence 22345689999999999998999999999999999999999999975431 112221110 0 1111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHH-HH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMV-DI 799 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eV 799 (863)
....+.+++.+|++.+|++||++. ++
T Consensus 219 ----~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 219 ----LTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred ----CCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 123477899999999999999997 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=294.52 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=203.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+..+++.+|+++-+.|+||||+++++|+.+....||++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 46799999999999999964 67899999876553 334578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|...|... ....++......+..|+|.||.|+|. +++|||||||+|+|++..+..||+|||.+...+
T Consensus 105 ~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 105 PRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred CCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 999999999643 34568888889999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......+||.-|++||...+...+.+.|+|++|++.+|++.|.+||...... ...+.. .-.++.+|.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI-------~k~~~~~p~-- 243 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRI-------RKVDLKFPS-- 243 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHH-------HHccccCCc--
Confidence 23345678999999999999999999999999999999999999999864411 111111 112222331
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+++.+|+..+|.+|.+..||++
T Consensus 244 -----~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 244 -----TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12234778999999999999999999875
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=323.71 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=193.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||++.. .+++.+|||++.... ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999986 467899999887542 23345688999999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988843 3468999999999999999999999 899999999999999999999999999997532211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||............++......... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~ 225 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRF 225 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCC
Confidence 22345699999999999999999999999999999999999999975432222222222222221111 011111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
. ...+.+++.+|++.+|++|+++.
T Consensus 226 ~----~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 L----SVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C----CHHHHHHHHHHhccCHHHcCCCC
Confidence 2 23477899999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.93 Aligned_cols=253 Identities=29% Similarity=0.455 Sum_probs=203.6
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.++||+|+||.||++..++++.+|||.+.... ...+++.+|++++++++|+||+++++++......++||||+++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 345568999999999999998888999999887543 3457899999999999999999999999998999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ....+++..+..++.+++.||+|||+ .+++|+||||+||++++++.+||+|||+++....... .
T Consensus 86 ~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 86 GSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999543 23468999999999999999999999 8999999999999999999999999999986643211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||.+.+..++.++||||||++++|+++ |+.||..... ....+....... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~---------~---- 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR---------M---- 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC---------C----
Confidence 1112234678999999998889999999999999999999 9999965321 112221111100 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.94 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=194.5
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~ey~~ 608 (863)
+++|+|+||.||+|.+. +++.||||+.-.... .-.+|+++|+++.|||||+|+-++.... ...||||||+
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 78999999999999964 578999997654432 2247999999999999999999886543 2358999996
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~~~ 687 (863)
. +|.+.++.....+..++.....-+..|+.+||+|||+ .+|+||||||.|+|+|.+ +.+||+|||.|+.+..+..
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 5 8998886544456678888888899999999999999 899999999999999976 9999999999998865432
Q ss_pred CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh--ccccc-------c
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP--FIRES-------R 757 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~--~~~~~-------~ 757 (863)
. .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....+. +++-++- ...+. .
T Consensus 182 n---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 182 N---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred c---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcc
Confidence 2 344578899999999875 799999999999999999999999987543322 2222111 01111 1
Q ss_pred cccccCCccCCC-----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEIVDPSIKGG-----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.-.|.+... +......+.++++.++++.+|.+|.+..|++.
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 112222333222 12233456889999999999999999999875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.32 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=190.4
Q ss_pred ceecccCcEEEEEEecCC---CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD---GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~---g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+++++.++|+||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3578888765443 233467889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC-CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 611 SLQDRLYGEAS-TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 611 sL~~~L~~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
+|.+++..... .....++...+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999965432 12345678889999999999999999 899999999999999999999999999987543322111
Q ss_pred ceeeeecCCCCCCcccccc-------CCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 690 FSLEVRGTAGYLDPEYYST-------QHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||...... ...... ...+ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQV---VREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHH---hhcc-CccC
Confidence 1122345678999998743 356889999999999999999 78888654211 111111 1111 1112
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.++.+... ....+.+++..|+ .+|++||++.||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222222 2234667778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=324.85 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=190.6
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+++.. +++.||||++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 68899999876532 23445677888888877 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999998843 3468899999999999999999999 899999999999999999999999999987543221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+... . +. . .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~---~-~~---~---~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAIL---N-DE---V---VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHh---c-CC---C---CCCCC
Confidence 22345689999999999998999999999999999999999999975431 11111111 1 10 0 01111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVD 798 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 798 (863)
....+.+++.+|++.+|++||++.+
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 219 ----LSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1235788999999999999999844
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.66 Aligned_cols=238 Identities=27% Similarity=0.411 Sum_probs=189.9
Q ss_pred ceecccCcEEEEEEecCCCC-----------EEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 535 TLIGEGGFGSVYRGTLPDGQ-----------EVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~-----------~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975432 5788876654433 6789999999999999999999999988 788999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-------eEEEeec
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-------CAKVADF 676 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-------~~kl~DF 676 (863)
+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999995432 268999999999999999999998 8999999999999999888 8999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|+++.... .....++..|+|||++... .++.++||||||+++|||++ |..|+....... ...+..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ--- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---
Confidence 99986543 1123467789999999876 78999999999999999999 577776543211 111110
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
... . .... ....+.+++.+|++.+|.+||++.||++.|+
T Consensus 221 ~~~---~-----~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH---R-----LPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC---C-----CCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 0000 0156889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.01 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=192.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++...+..++||||+.
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 86 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH- 86 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-
Confidence 44689999999999999965 689999998765433 233467899999999999999999999999999999999995
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ....+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...... .
T Consensus 87 ~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 87 TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 788888743 23458889999999999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccc-----c
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRID-----E 760 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~-----~ 760 (863)
......+|..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ....+....... ..... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcc
Confidence 1223457899999998865 45788999999999999999999999764321 111111100000 00000 0
Q ss_pred ccCCc-cC--CCCcH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 IVDPS-IK--GGYHA-------EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i~d~~-l~--~~~~~-------~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..++. .. ..... .....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01234678999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.58 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=202.2
Q ss_pred HHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+..+.++||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+|++++.+++.+ ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3455678999999999999998788889999876542 234678999999999999999999999887 77899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 84 KGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 99999999543 23468899999999999999999998 8999999999999999999999999999976543211
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......++..|+|||++....++.++|+|||||+++|+++ |+.||..... ..+.++... +...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~----~~~~-------- 222 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER----GYRM-------- 222 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhC----CCCC--------
Confidence 11122345678999999998889999999999999999999 9999975321 122222211 1000
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011223458899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=311.94 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=198.6
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+||+++++++..++..++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 345568999999999999995 5788999998876555555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 90 GGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999843 3468899999999999999999999 8999999999999999999999999999986542211
Q ss_pred CceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 GFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......|+..|+|||.+. ...++.++|||||||+++||++|+.||....+... ...+.. . ....+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~~~~-----~---~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMSK-----S---NFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--heeeec-----C---CCCCCC
Confidence 112345888999999884 34578899999999999999999999865432111 000000 0 000111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
... .......+.+++.+|++.+|++||++.++++.
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 111 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.18 Aligned_cols=248 Identities=30% Similarity=0.433 Sum_probs=197.8
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEe-eCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC-ENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~LV~ey~~ 608 (863)
.+.+.+.||+|+||.||++... |..+|+|...... ..+.|.+|+.++++++|+|++++++++. .++..++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4455689999999999999864 7889999876432 3467899999999999999999999765 4567899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++..+++++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999998543 23458899999999999999999998 899999999999999999999999999988653321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...+..+... +.. +..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~----~~~-----~~~- 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEK----GYK-----MDA- 220 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhc----CCC-----CCC-
Confidence 12234668999999998899999999999999999998 999986432 1122222211 100 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.......+.+++.+|++.+|++||++.++++.|+++
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 112234688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.29 Aligned_cols=243 Identities=26% Similarity=0.343 Sum_probs=190.8
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHH-HHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELN-FLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||++.. .+|+.+|||++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4799999999999985 478999999876532 223345556654 57789999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|..++.. ...+++.....++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 999988843 3468999999999999999999999 899999999999999999999999999997542221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+ .... +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~---~~~~-~~------~~~~~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMYD---NILH-KP------LVLRPG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHHH---HHHc-CC------ccCCCC
Confidence 22345699999999999999999999999999999999999999975421 11111 1111 00 011111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
....+.+++.+|++.+|.+||++++.++.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 223477899999999999999997554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.12 Aligned_cols=255 Identities=22% Similarity=0.407 Sum_probs=201.8
Q ss_pred HhhcceecccCcEEEEEEecC-CCC----EEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQ----EVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
..+.+.||+|+||.||+|... +|. .+|+|....... ....++.+|++++++++|+||++++++|.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 355689999999999999864 333 589998765543 344678999999999999999999999987 7889999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++...+.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++....
T Consensus 88 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 88 QLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999543 3358999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
...........++..|+|||.+....++.++||||||++++|+++ |+.||+.... ..+.+.+.. +.. .-.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~--~~~ 232 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEK----GER--LPQ 232 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhC----CCC--CCC
Confidence 322211112234568999999988889999999999999999999 9999976432 122222211 100 000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+..+...+.+++.+|+..+|++||++.++++.|+++..
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 233 -------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11122357889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=329.01 Aligned_cols=199 Identities=22% Similarity=0.347 Sum_probs=171.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||+||++... +++.||||++.... ......+.+|++++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999854 68999999886532 2233567889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 85 GGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999943 3468999999999999999999999 89999999999999999999999999999765321100
Q ss_pred ---------------------------------CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCC
Q 002943 689 ---------------------------------GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735 (863)
Q Consensus 689 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~ 735 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 01123469999999999999999999999999999999999999997
Q ss_pred CCC
Q 002943 736 TRR 738 (863)
Q Consensus 736 ~~~ 738 (863)
...
T Consensus 238 ~~~ 240 (363)
T cd05628 238 SET 240 (363)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.02 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=191.9
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||++.. ..++.||+|... .+.+.+|++++++++||||+++++++......++|+|++ .
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence 34458999999999999985 468999999643 235689999999999999999999999999999999999 4
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++...+.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 167 ~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 167 TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 789888843 3468899999999999999999999 899999999999999999999999999997543221 11
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-----chhHHhhhhc------cc---c
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-----WSLVEWAKPF------IR---E 755 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-----~~l~~~~~~~------~~---~ 755 (863)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+-....... ..+..-.... +. .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 22345699999999999999999999999999999999999988643321110 0010000000 00 0
Q ss_pred ccccccc---------CCccCCCC--cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 SRIDEIV---------DPSIKGGY--HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ~~~~~i~---------d~~l~~~~--~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.+.. .+...... ..+....+.+++.+|++.+|++|||+.|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 0122446889999999999999999999874
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=322.32 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=189.7
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHH-HHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENEL-NFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||+++.. +++.||+|++.... ....+.+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999864 67889999876532 12233444444 457889999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+.......++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 999999843 3457788888899999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+... .. . ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~---~~-~------~~~~~~ 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNIL---NK-P------LQLKPN 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHH---hC-C------cCCCCC
Confidence 23345699999999999999999999999999999999999999975321 11111111 10 0 001111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
....+.+++.+|++.+|.+||++.+.+..+.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 219 ----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 2235778999999999999999886554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=330.09 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=192.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||+||+++.. +|+.||||++.... ....+.+.+|++++..++|+||+++++++.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 3579999999999999964 68999999886532 2334567889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 85 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 85 GGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999953 3468999999999999999999999 89999999999999999999999999998754321100
Q ss_pred C------------------------------------ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCC
Q 002943 689 G------------------------------------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGRE 732 (863)
Q Consensus 689 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~ 732 (863)
. ......||+.|+|||++....++.++|||||||+++||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0112358999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCC---HHHHHH
Q 002943 733 PLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPS---MVDIVR 801 (863)
Q Consensus 733 p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs---m~eVl~ 801 (863)
||...... .....+... . ....-+.. ... ...+.+++.+|+. +|.+|++ +.|+++
T Consensus 238 Pf~~~~~~---~~~~~i~~~---~--~~~~~~~~-~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ---ETYRKIINW---K--ETLQFPDE-VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH---HHHHHHHcC---C--CccCCCCC-CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99754321 111111100 0 00000000 011 2346677888886 8999998 776654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=329.14 Aligned_cols=251 Identities=22% Similarity=0.254 Sum_probs=194.3
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.+.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3345689999999999999864 68899999886432 2334567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++.. ..++......++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 124 YMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999843 247778888999999999999999 89999999999999999999999999999865432
Q ss_pred CCCCceeeeecCCCCCCccccccC----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQ----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..... ...... .+
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~---i~~~~~--~~ 266 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSK---IMDHKN--SL 266 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHH---HHcCCC--cC
Confidence 21 112335699999999998653 4788999999999999999999999754321 11111 111000 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAY--RPSMVDIVRE 802 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~ 802 (863)
.... .......+.+++.+|++.+|++ ||++.|+++.
T Consensus 267 ---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 ---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0010 0112345778999999999987 9999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.22 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=201.1
Q ss_pred HHhhcceecccCcEEEEEEecCC----CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
...+.++||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++|+||++++++|.. +..++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 44567899999999999998643 2468999876554 3445689999999999999999999999875 5578999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++..++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 86 ELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999532 2358999999999999999999998 8999999999999999999999999999986643
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.... ......++..|+|||.+....++.++||||||++++|+++ |+.||...... ....+.... ...
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~---~~~----- 227 (270)
T cd05056 160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENG---ERL----- 227 (270)
T ss_pred ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcC---CcC-----
Confidence 3211 1112234568999999988889999999999999999996 99999764321 122221110 000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.... .....+.+++.+|+..+|++||++.++++.|+++..
T Consensus 228 -~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -PMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111 223468889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=320.87 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=186.5
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHH-HHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELN-FLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+++.. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 68899999876432 222344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 999988843 3457888899999999999999998 899999999999999999999999999987542211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+ .. .. ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i---~~-~~------~~~~-- 216 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNI---LH-KP------LQLP-- 216 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHH---hc-CC------CCCC--
Confidence 22345689999999999988999999999999999999999999975321 1111111 11 00 0111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
......+.+++.+|++.+|.+||+..
T Consensus 217 --~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 --GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11233578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.96 Aligned_cols=247 Identities=20% Similarity=0.314 Sum_probs=194.0
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||.||++... +|+.+|+|.+.... ....+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 68999999876432 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.++++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888543 23458899999999999999999999 899999999999999999999999999998664321 123
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...+........ . +... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~-~----~~~~-~~~--- 221 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED-E----VKFE-HQN--- 221 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc-c----cccc-ccc---
Confidence 3468999999999998889999999999999999999999997532211 111111111110 0 0000 011
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
...++.+++..|++.+|++||+++|+++.+
T Consensus 222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 -FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 223578999999999999999998886444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.35 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=190.1
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||++... +++.||||++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 57899999887542 23345677899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.+...++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998843 3468999999999999999999999 899999999999999999999999999987532211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... ... .....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~----~~~------~~~~~- 217 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSIL----EDE------VRYPR- 217 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHH----cCC------CCCCC-
Confidence 22335689999999999999999999999999999999999999975321 11111111 000 01111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.....+.+++.+|++.+|++||++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcCCC
Confidence 122357899999999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.90 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=195.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||+||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 3468999999999999985 468999999877542 234467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 84 PGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999532 2468999999999999999999999 8999999999999999999999999999987643322
Q ss_pred CCceeeeecCCCCCCccccc------cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYS------TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
. ......||..|+|||++. ...++.++|||||||++|||++|+.||...... +..............
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~ 230 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF 230 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC
Confidence 1 223346899999999986 456788999999999999999999999754321 111111111100000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+. .......+.+++..|++ +|++||++.++++
T Consensus 231 --~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 --PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 01122347788889998 9999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=311.67 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=197.0
Q ss_pred HHHHhh--cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 528 AATQQY--KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 528 ~~t~~f--~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.++.++ ...||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344444 36899999999999985 467889999887766666678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccC--ChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCccc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTL--DWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKY 681 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 681 (863)
||+++++|.+++.... ..+ ++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999995421 234 788889999999999999998 89999999999999986 67999999999976
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCC--CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQH--LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
...... ......|+..|+|||++.... ++.++||||||+++|||++|+.||...... ....+......
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK----- 228 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc-----
Confidence 543211 122335789999999986643 788999999999999999999998643211 11111111000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.+ +......+.+++.+|++.+|++||++.|+++
T Consensus 229 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111 1122345788999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=322.00 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=190.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcc-cccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHE-NLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|... +++.||||++.... ....+.+..|.+++..++|+ +|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 35689999999999999865 57899999876532 23446788899999999765 688899999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999843 3458899999999999999999999 899999999999999999999999999987532211
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+.. . ...+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~----~------~~~~ 220 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIME----H------NVSY 220 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHc----C------CCCC
Confidence 122345699999999999999999999999999999999999999975431 111111111 0 0111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.... ...+.+++.+|++.+|.+|++.
T Consensus 221 ~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 1112 2357889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=327.64 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=189.9
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.++||+|+||.||++.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 457899999999999985 578999999875432 2334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 85 GGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999943 3468888999999999999999999 89999999999999999999999999999633211000
Q ss_pred -----------C----------------------------------ceeeeecCCCCCCccccccCCCCcccceechhhH
Q 002943 689 -----------G----------------------------------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVV 723 (863)
Q Consensus 689 -----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvv 723 (863)
. ......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0 0012358999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcc-hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCC---CCHHHH
Q 002943 724 LLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYR---PSMVDI 799 (863)
Q Consensus 724 l~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R---Psm~eV 799 (863)
++||++|+.||......+.. .+..|... + .+... ......+.+++.+|++ +|.+| +++.|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~---------~---~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRET---------L---YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCc---------c---CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999754321110 01111000 0 00000 0112346788888887 66665 588877
Q ss_pred HHH
Q 002943 800 VRE 802 (863)
Q Consensus 800 l~~ 802 (863)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=345.70 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=201.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.++||+|+||.||+|... +|+.||||++..... ...++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 4579999999999999864 589999998765422 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhhccC-------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 609 NGSLQDRLYGEA-------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 609 ~gsL~~~L~~~~-------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+|+|.+++.... .....+++...++++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCccee
Confidence 999999985321 112346778889999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCC----------------CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchh
Q 002943 682 APQEGDS----------------GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745 (863)
Q Consensus 682 ~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 745 (863)
....... .......||+.|+|||.+.+..++.++|||||||+++||+||+.||....... +
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k---i 239 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK---I 239 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh---h
Confidence 6211100 01112458999999999999999999999999999999999999997532111 1
Q ss_pred HHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhhc
Q 002943 746 VEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP-SMVDIVRELEDAFI 808 (863)
Q Consensus 746 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~~ 808 (863)
... . .+.++.-.. ...+....+.+++.+|++.+|++|| +++++.+.|+..++
T Consensus 240 ~~~--~--------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYR--D--------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh--h--------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 0 000110000 0012234578899999999999995 68888888887764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.69 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=198.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++|+|++++++++......++||||+++++
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~ 103 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence 347899999999999985 5789999998877666566788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 104 L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~ 173 (296)
T cd06654 104 LTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (296)
T ss_pred HHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--cc
Confidence 9999842 347899999999999999999999 8999999999999999999999999999886543221 11
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....++..|+|||.+.+..++.++|||||||+++||++|+.||....+.. .+..+. ..+. +.+ ...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~----~~~~------~~~--~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIA----TNGT------PEL--QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHh----cCCC------CCC--CCc
Confidence 23458899999999998889999999999999999999999997543211 111110 0000 000 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 122345788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.85 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999965 68899999886542 23345567788888755 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.+...++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999998843 3468899999999999999999999 899999999999999999999999999987532211 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+... .. .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~----~~------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIR----VD------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hC------CCCCCCC
Confidence 23345689999999999999999999999999999999999999975321 11111111 00 1111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMV-DIV 800 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl 800 (863)
. ..++.+++.+|++.+|++||++. ++.
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 I----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 23577899999999999999985 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.75 Aligned_cols=249 Identities=30% Similarity=0.493 Sum_probs=199.9
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.+.||+|+||.||++...++..+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 35568999999999999998778899999876443 23467999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++..++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999998532 2458899999999999999999999 8899999999999999999999999999976543211 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++.+|+|||.+.++.++.++||||||+++|||++ |+.||..... ..+.+... .+ .....+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~----~~--~~~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETIN----AG--FRLYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHh----CC--CCCCCCCC---
Confidence 112235678999999998899999999999999999998 9999875321 11121111 11 01111221
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
....+.+++.+|++.+|++||++.||++.|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.78 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=194.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|+||.||+|.. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 3457899999999999985 578899999876542 33346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|..+. .+++.....++.|++.||+|||+ .+|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9997653 36788889999999999999999 899999999999999999999999999998654321
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ...++...... . ..+.+..
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~ 222 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVLPV 222 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCCCC
Confidence 22346899999999999989999999999999999999999999754322111 01111110000 0 0111111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
......+.+++.+|++.+|++||++.|+++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122357899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.66 Aligned_cols=239 Identities=22% Similarity=0.318 Sum_probs=190.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
++.+.||+|+||.||+|... +++.||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34689999999999999865 57899999877542 22334567788888877 589999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 83 VNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998843 3458899999999999999999999 899999999999999999999999999997543221
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.... .. ..+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~----~~------~~~ 220 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME----HN------VAY 220 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------CCC
Confidence 122345689999999999999999999999999999999999999975431 122221111 00 011
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+.....++.+++.+|++.+|++|++.
T Consensus 221 ----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 ----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11123457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.56 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=196.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC-----cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-----QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
..+.||+|++|.||++.. .+++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 357999999999999985 4689999998754321 1235688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.. ...+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 86 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 86 MPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred CCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999843 2458889999999999999999999 899999999999999999999999999997654321
Q ss_pred CCCc-eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGF-SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... ... ..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~---~~~-----~~~~ 227 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIA---TQP-----TNPQ 227 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHh---ccC-----CCCC
Confidence 1111 12345788999999999989999999999999999999999999653211 1111110 000 0011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+ .......+.+++.+|++.+|++||++.|+++.
T Consensus 228 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 L----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred C----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 11223457889999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=319.25 Aligned_cols=252 Identities=24% Similarity=0.436 Sum_probs=197.2
Q ss_pred hcceecccCcEEEEEEecC-CCC----EEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQ----EVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
..+.||+|+||.||+|... +|. .+|+|++..... ....++.+|+.++++++||||++++|+|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3478999999999999853 444 578898765433 2234788999999999999999999998754 46789999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 90 MPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred cCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 9999999998532 3358899999999999999999999 899999999999999999999999999998765332
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+.++... +.. ...+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~~~--~~~~- 233 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLEK----GER--LPQP- 233 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHC----CCC--CCCC-
Confidence 2211222345778999999998899999999999999999998 8999865321 122222211 100 0000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+...+.+++..|+..+|++||+|.|+++.|+.+.
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 234 ------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.35 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=205.2
Q ss_pred HHHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+..+.|.+.||+|.||.|-++.. ..|+.||||.+++... ++.-.+.+|+++|+.|+||||+.++.+|++.+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34556668999999999999985 7899999998776543 4445678999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||..+|.|.+|+. ..+.|+..+...++.||..|+.|+|. ++++|||||.+|||||+++++||+||||+.++.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999994 45679999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.. .....++|++-|.+||.+.+..|. +..|-||+||+||-|+.|..||++... ..++..+ ..|...+
T Consensus 205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQI----s~GaYrE-- 272 (668)
T KOG0611|consen 205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQI----SRGAYRE-- 272 (668)
T ss_pred cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHh----hcccccC--
Confidence 33 345567899999999999998874 689999999999999999999987542 2222211 1121111
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
++......-|+.+++..||++|-|+.+|..-
T Consensus 273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1122235578899999999999999999764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.75 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=191.3
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~e 605 (863)
+++.+.||+|+||.||++.. .+|+.||||++.... ....+.+..|.+++..+. |++|+++.+++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 35668999999999999985 468999999876532 233456778999998886 5778889999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++.. ...+++.+.+.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999843 3468999999999999999999999 89999999999999999999999999999854322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.... .. ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~----~~------~~ 219 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIME----HN------VS 219 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------CC
Confidence 1 112234589999999999998999999999999999999999999976431 112221111 00 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
. +......+.+++.+|++.+|.+|++..
T Consensus 220 ~----p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 Y----PKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred C----CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1 111223578899999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=330.39 Aligned_cols=190 Identities=23% Similarity=0.329 Sum_probs=164.1
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||++... .++.||||... ...+.+|+++|++++|+|||++++++..++..++|||++ .+
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~ 244 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS 244 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence 34589999999999999965 57899999532 234678999999999999999999999999999999999 57
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...++|.+++.|+.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 245 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 245 DLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999888432 3469999999999999999999999 8999999999999999999999999999987643322222
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~ 734 (863)
.....||..|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 33456999999999999999999999999999999999987664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=297.31 Aligned_cols=195 Identities=28% Similarity=0.416 Sum_probs=175.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcc---hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQG---TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
++.+.||.|+||.|.+++.+ +|..+|+|++++..--. .+...+|..+|+.+.||.++++.+.|.+.+..+|||||+
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 34578999999999999965 68899999988765433 345678999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|.|..+|+. .+.++......+|.+|+.||+|||+ ..|++|||||+|||||.+|.+||.|||.|+....
T Consensus 127 ~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 127 PGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred CCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999943 3579999999999999999999999 8999999999999999999999999999997643
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
.+.+.+||+.|+|||.++...+..++|-|+|||++|||+.|.+||....
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 2567889999999999999999999999999999999999999997654
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.69 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=189.6
Q ss_pred ceecccCcEEEEEEecCC--------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPD--------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.||+|+||.||+|.... ..++|+|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 235888887665555567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe--------EEEeeccC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC--------AKVADFGF 678 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~--------~kl~DFGl 678 (863)
+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999543 2368999999999999999999999 89999999999999987765 69999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCC-CCCCCCCCCCcchhHHhhhhccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGR-EPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ..... ..
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~~----~~- 220 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFY----ED- 220 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHHH----Hc-
Confidence 8754321 224578899999999864 5789999999999999999985 5554322111 01100 00
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
...+.. ....++.+++.+|++.+|++||+++++++.|+
T Consensus 221 ------~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ------RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001111 11245889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=329.04 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=168.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.++||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 357899999999999985 468899999876542 2234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC-
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD- 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~- 687 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 85 GGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999843 2457888889999999999999999 8999999999999999999999999999853311000
Q ss_pred --------------------------------------------CCceeeeecCCCCCCccccccCCCCcccceechhhH
Q 002943 688 --------------------------------------------SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVV 723 (863)
Q Consensus 688 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvv 723 (863)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000122468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 002943 724 LLEIISGREPLNTRR 738 (863)
Q Consensus 724 l~ElltG~~p~~~~~ 738 (863)
+|||++|+.||....
T Consensus 238 l~elltG~~Pf~~~~ 252 (382)
T cd05625 238 LYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.52 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=198.5
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 334568999999999999854 57899999876443 3344678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++. ...+++.....++.|+++||.|||+ ++++|+||+|+||++++++.+||+|||+++......
T Consensus 86 ~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 86 GGSALDLLK-----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 999999883 2458899999999999999999998 899999999999999999999999999998664321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......++..|+|||++.+..++.++|||||||+++||++|+.|+....+.. ...+ ...+ ..+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~-----~~~~~~- 222 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKN-----SPPTLE- 222 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcC-----CCCCCC-
Confidence 11223457889999999999899999999999999999999999986543211 1111 0011 111121
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
......+.+++.+|++.+|++||+|.||++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1234468899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=334.95 Aligned_cols=257 Identities=20% Similarity=0.285 Sum_probs=188.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC--------CeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN--------DQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~L 602 (863)
.+.++||+|+||.||+|.. .+++.||||++.... ....+|+.+|++++|+||+++++++... ...++
T Consensus 69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 3458999999999999986 468999999875432 2345799999999999999999876432 24568
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCccc
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKY 681 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~ 681 (863)
||||++ ++|.+++.........+++.....++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 999997 57877775433345678999999999999999999999 899999999999999965 4799999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc--cccc--
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF--IRES-- 756 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--~~~~-- 756 (863)
...... .....||..|+|||++.+. .++.++|||||||++|||++|+.||......+ .+....... ....
T Consensus 221 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 221 LLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPTEDQL 295 (440)
T ss_pred ccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHH
Confidence 643221 2234689999999998664 68999999999999999999999997643211 111111000 0000
Q ss_pred -----ccccc-----cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 -----RIDEI-----VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 -----~~~~i-----~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...++ ....+...++.....++.+++.+|++.+|.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 0001111111122346889999999999999999999874
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.27 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=189.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.++||+|+||.||++... +++.+|+|++.+. .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999965 5889999987642 2223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ..++......++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 126 ~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 126 PGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999842 247888899999999999999999 8999999999999999999999999999987643221
Q ss_pred CCceeeeecCCCCCCccccccC----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .............
T Consensus 198 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~---- 266 (370)
T cd05621 198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL---- 266 (370)
T ss_pred -eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc----
Confidence 112345699999999998754 3788999999999999999999999754311 1111111100000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCC--CCCCHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSA--YRPSMVDIVRE 802 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~--~RPsm~eVl~~ 802 (863)
.+.. .......+.+++..|++.++. .||++.|+++.
T Consensus 267 -~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 -NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0100 111233466777888875544 38888887663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.92 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=198.2
Q ss_pred hcceecccCcEEEEEEecCC--CCEEEEEEcccCC----------CcchHHHHHHHHHHhc-CCcccccceeeeEeeCCe
Q 002943 533 YKTLIGEGGFGSVYRGTLPD--GQEVAVKVRSSTS----------TQGTREFENELNFLSA-IRHENLVPLLGYCCENDQ 599 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~--g~~vAVK~~~~~~----------~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~ 599 (863)
+.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++|+||+++++++.+.+.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45789999999999999764 6889999765321 1223457788888875 799999999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++||||+++++|.+++.........+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999999885433344568999999999999999999995 257999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .+...
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~ 231 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIV----EAVYE 231 (269)
T ss_pred eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHh----hccCC
Confidence 8654332 22345688999999999988899999999999999999999999864321 11111111 11111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+.... .....+.+++.+|++.+|++||+|.||.++|+
T Consensus 232 ----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 10011 12245788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=312.35 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=203.3
Q ss_pred HHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
..+.+.+.||+|+||+||++.. .+|+.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 3455668999999999999985 468899999876543 33457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.. .+.+++.....++.+++.||.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998843 34689999999999999999999962 479999999999999999999999999987543221
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCC-----cchhHHhhhhcccccccccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN-----EWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~i 761 (863)
.....|+..|+|||++.+..++.++|||||||+++|+++|+.||....... ...+.++........
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 123468999999999988899999999999999999999999998644311 112222222221110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
.+.+. ..+....+.+++.+|++.+|++||++.||++..
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 112334688999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.39 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=199.2
Q ss_pred hhcceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||++++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 445789999999999999764 88999998765433 678999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ....+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 84 ~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 84 SVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred cHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 99999843 23568999999999999999999999 8899999999999999999999999999987643321 1
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....+... ... . .. ...+.+. .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~-~----~~-----~~~~~~~--~ 221 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM-I----PN-----KPPPTLS--D 221 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh-h----cc-----CCCCCCC--c
Confidence 2234578899999999998999999999999999999999999975432111 000 0 00 0000110 1
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++||++.||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1122345889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=325.41 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=196.1
Q ss_pred HHhhcceecccCcEEEEEEecC---CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.+.||+|+||.||++... .+..||||.+... +.+.+|++++++++||||+++++++...+..++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 3455689999999999999743 3578999987543 3457899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+. ++|.+++. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 168 ~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 95 78888882 23568999999999999999999999 899999999999999999999999999998665433
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc-------
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID------- 759 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 759 (863)
.........||..|+|||++.+..++.++|||||||++|||++|+.||.............-+...+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333334569999999999999999999999999999999999999997654322111111111100000000
Q ss_pred cc------cCCccCCCCc-------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 760 EI------VDPSIKGGYH-------AEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 760 ~i------~d~~l~~~~~-------~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+ ........+. ......+.+++.+|++.+|++||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0112346788999999999999999999764
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.09 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=193.4
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.++||+|+||+||++.. .+++.+|+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 47899999999999986 4689999998765432 2234578899999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.++++.. ....+++.....++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 85 GDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred ccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 9999988543 23469999999999999999999999 8999999999999999999999999999976543211
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....|+..|+|||++.+..++.++|+|||||+++||++|+.||........ .... ........ ....
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~-~~~~~~~~------~~~~-- 225 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEV-DRRVLETE------EVYS-- 225 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHhhhccc------cccC--
Confidence 1234689999999999988999999999999999999999999975432111 1111 11111110 0111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
.+....+.+++..|++.+|++||++.|.
T Consensus 226 --~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 226 --AKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred --ccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 1122347789999999999999995433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.16 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=196.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||++... +|..+|+|.+..... ...+++.+|++++.+++||||++++++|..++..++|+||+++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 34578999999999999854 688899998765432 2345688999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++.....++.|+++||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 84 GSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 999999953 24688999999999999999999972 479999999999999999999999999987653221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc-----------
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI----------- 758 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------- 758 (863)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||...... ....+..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCC
Confidence 22346889999999998888999999999999999999999998653311 111111110000000
Q ss_pred ---------cccc-------CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 759 ---------DEIV-------DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 759 ---------~~i~-------d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+.. .+.+.. ......+.+++.+|++.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 001100 0122358899999999999999999998765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=328.23 Aligned_cols=199 Identities=23% Similarity=0.305 Sum_probs=168.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 457899999999999985 468999999876432 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC-
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD- 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~- 687 (863)
+|+|.+++.. ...++......++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|........
T Consensus 85 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 85 GGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999943 3457888889999999999999999 8999999999999999999999999999853311000
Q ss_pred ----------------------------------------CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHH
Q 002943 688 ----------------------------------------SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEI 727 (863)
Q Consensus 688 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~El 727 (863)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134699999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 002943 728 ISGREPLNTRR 738 (863)
Q Consensus 728 ltG~~p~~~~~ 738 (863)
++|+.||....
T Consensus 238 l~G~~Pf~~~~ 248 (376)
T cd05598 238 LVGQPPFLADT 248 (376)
T ss_pred hhCCCCCCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=328.67 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=193.8
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~ 604 (863)
..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 357899999999999985 578999999876432 233467889999999999999999999998776 789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+. ++|.+++. ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9996 67888773 23568999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc-----
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI----- 758 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----- 758 (863)
... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||........... +.........
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~~~ 231 (372)
T cd07853 156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAMRS 231 (372)
T ss_pred Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHHHH
Confidence 221 112234578999999998774 578999999999999999999999976543211111 1000000000
Q ss_pred ----------ccccCC-ccCC--CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 759 ----------DEIVDP-SIKG--GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 759 ----------~~i~d~-~l~~--~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.....+ .... ....+....+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0000 0011123457899999999999999999998763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=310.24 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=193.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc--------------chHHHHHHHHHHhcCCcccccceeeeEeeC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ--------------GTREFENELNFLSAIRHENLVPLLGYCCEN 597 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~--------------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 597 (863)
+.+.||+|.||.|-+|+. .+++.||||++.+.... ..+...+|+.+|++++|||||+|+.+..+.
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 357899999999999994 57999999987653211 124678999999999999999999998754
Q ss_pred --CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEee
Q 002943 598 --DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVAD 675 (863)
Q Consensus 598 --~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 675 (863)
+..|||+|||..|.+...= .....|+..+..++..++..||+|||. ++||||||||+|+||++++++||+|
T Consensus 181 ~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeec
Confidence 5789999999999876432 222339999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccCCCCCCCC---ceeeeecCCCCCCccccccCC----CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh
Q 002943 676 FGFSKYAPQEGDSG---FSLEVRGTAGYLDPEYYSTQH----LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 676 FGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 748 (863)
||.+.......... ......||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.. +..+.+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---~~~l~~- 329 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---ELELFD- 329 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---HHHHHH-
Confidence 99998664332211 112356999999999987742 3568999999999999999999996532 111211
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
.|+...|.-....+.-..+.+|++++++.||++|.+..+|....
T Consensus 330 -----------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 330 -----------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 22222221111223455688999999999999999999987644
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.83 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=195.1
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..++||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++|+|++++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3478999999999999854 688999998765432 223457889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++........
T Consensus 84 g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 84 GGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 999999985432 3458899999999999999999998 8999999999999999999999999999976543221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............. ..... . ......
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~--~----~~~~~~ 226 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE--V----QEEYSE 226 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh--h----hhhcCc
Confidence 123468999999999999999999999999999999999999997643211101010 00000 0 001111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 801 (863)
.+ ...+.+++.+|++.+|++||+ +.|+++
T Consensus 227 ~~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KF----SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cC----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 22 234789999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.84 Aligned_cols=240 Identities=20% Similarity=0.316 Sum_probs=195.3
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
-+.||+|+||.||+++- ..|..+|+|++++..- ...+..+.|-.+|....++.||+|+-.|.+.+.+||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 37899999999999985 4699999999887643 3345678899999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC----
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE---- 685 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~---- 685 (863)
|++..+|. ....|+.......+.+++.|++-||. .++|||||||+|+|||..|++||+||||+.-+...
T Consensus 226 GD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 226 GDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999994 44679999999999999999999999 99999999999999999999999999998532110
Q ss_pred -----------------CCCC-----ce-------------------eeeecCCCCCCccccccCCCCcccceechhhHH
Q 002943 686 -----------------GDSG-----FS-------------------LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVL 724 (863)
Q Consensus 686 -----------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl 724 (863)
.+.. .. ....||+-|||||++.+..|+..+|.||+|||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0000 00 124599999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 725 LEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 725 ~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
||||.|-+||....+.+. ..+..|...+..... .....+..+||.+|+. ||++|-.
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999987665443 245666433221110 0111456788899998 9999976
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.87 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=198.2
Q ss_pred hcceecccCcEEEEEEecC----CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC------ee
Q 002943 533 YKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQ 600 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 600 (863)
+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999853 36889999876543 234567889999999999999999999886543 23
Q ss_pred EEEeecCCCCChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 601 ILVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
++++||+.+|+|.+++.... .....+++...++++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence 78899999999998885332 122357889999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++...............++..|++||.+....++.++||||||+++|||++ |+.||..... ..+..+.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~---~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKG---NR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcC---Cc
Confidence 986643322112223345678999999988889999999999999999999 8888865421 2222222211 00
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
. .. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 234 ~------~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 L------KQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C------CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 012234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.60 Aligned_cols=246 Identities=29% Similarity=0.436 Sum_probs=192.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeC------CeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCEN------DQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~LV~ 604 (863)
+.+.||+|+||.||+|... +++.||+|+..... ....++..|+.++.++ +|+||+++++++... ...++||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3578999999999999864 68899999876543 3456788999999998 699999999998753 4578999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ....+++.....++.|++.||+|||+ ++|+|+||||+||++++++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 89 EFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999999542 23468899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.. .......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .... .....
T Consensus 164 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~--~~~~~-- 232 (272)
T cd06637 164 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL--IPRNP-- 232 (272)
T ss_pred cc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--HhcCC--
Confidence 21 1223456899999999986 3357889999999999999999999996533211 1100 00000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 233 ---~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ---APRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---CCCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111111 112235789999999999999999999865
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.75 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=199.9
Q ss_pred ceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
-+||+|.||+||.|+..+ ...+|||-+.....+..+-+.+|+.+.++|+|+|||+++|.|.+++..-+.||.+++|||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999655 4579999887776666777899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccC--ChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeeccCcccCCCCCCCCc
Q 002943 614 DRLYGEASTRKTL--DWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 614 ~~L~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+.|... -+++ ++.+.-.+..||.+||.|||+ ..|||||||-+|||++ -.|.+||+|||-++.+-. -...
T Consensus 661 sLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~ 732 (1226)
T KOG4279|consen 661 SLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPC 732 (1226)
T ss_pred HHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc--CCcc
Confidence 999543 2345 666777889999999999999 8999999999999997 578999999999986632 2344
Q ss_pred eeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
+....||.-|||||++..+ .|...+|||||||.+.||.|||+||...... .-. +++-|..+ +. .
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---qAA-----MFkVGmyK--vH----P 798 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---QAA-----MFKVGMYK--VH----P 798 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---hHh-----hhhhccee--cC----C
Confidence 5667899999999999765 5889999999999999999999999754321 111 11111110 11 2
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.+...+...++++|+.++|.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 334555667889999999999999999999865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=304.19 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=199.8
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEccc--CCCcchHHHHHHHHHHhcCCcccccceeeeEee-----CCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSS--TSTQGTREFENELNFLSAIRHENLVPLLGYCCE-----NDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~LV~ey 606 (863)
+.||+|+||.|+.+.. .+|+.||||++.. ......+.-.+|+++|+.++|+||+.+...+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 6799999999999985 4789999998763 334445778899999999999999999998865 3467999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
| .-+|.+.++ .++.|+......+..|+.+||.|+|+ .+|+||||||+|+|++.+...||+||||||......
T Consensus 108 M-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 108 M-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred H-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9 678888883 34458999999999999999999999 899999999999999999999999999999886543
Q ss_pred CCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC--
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD-- 763 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d-- 763 (863)
.....+...-|..|.|||.+.. ..|+...||||.|||+.||++|++-|.+....+...+...+.....+..+..+-.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 3444566778999999998754 5899999999999999999999999988764443333322221111111111110
Q ss_pred --------CccCCC-C---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 --------PSIKGG-Y---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 --------~~l~~~-~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
|..... + -.......+++..+++..||.+|+|+.|.++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000 0 0122234678999999999999999998865
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.51 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=194.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 87 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD- 87 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-
Confidence 34578999999999999864 678899998765432 233567899999999999999999999999999999999997
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 88 KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 4888887432 3457889999999999999999999 8999999999999999999999999999976432211
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc------c
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI------V 762 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i------~ 762 (863)
......++..|+|||.+.+ ..++.++|||||||+++||+||+.||......+...................+ .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1123457899999998865 46889999999999999999999999765432221111111000000000000 0
Q ss_pred C---CccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 D---PSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d---~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+ +..... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 000000 00112335779999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=311.09 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=199.4
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence 34457899999999999985 57999999988766555667789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 101 GSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999842 357899999999999999999999 8999999999999999999999999999976543221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......++..|+|||.+.+..++.++|||||||+++|+++|+.||....+... +.. ....+ . +.+ .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~~~-~-----~~~--~ 236 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATNG-T-----PEL--Q 236 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----eccCC-C-----CCC--C
Confidence 12234588899999999998899999999999999999999999965432111 000 00000 0 000 0
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122334778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=324.35 Aligned_cols=238 Identities=23% Similarity=0.362 Sum_probs=197.0
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEe
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 604 (863)
...|.++||+|+||+|+++.++ +++.+|||++++... ...+....|.+++... +||.|++|+..+..+++.+.||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456799999999999999975 578999999988753 3445667888888777 4999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+.+|++..+. ....++......+|..|+.||.|||+ ++||+||||.+|||||.+|++||+||||+|....
T Consensus 449 ey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 449 EYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999955444 23568999999999999999999999 9999999999999999999999999999996542
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
. ...+.+..||+.|||||++.+..|+...|-|||||+||||+.|..||.+..+ .+++|.
T Consensus 521 ~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee~Fds 579 (694)
T KOG0694|consen 521 Q--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EEVFDS 579 (694)
T ss_pred C--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HHHHHH
Confidence 2 2345678999999999999999999999999999999999999999986432 112222
Q ss_pred ccCC--CCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 765 SIKG--GYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 765 ~l~~--~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.+.. .++.-...+.+.|+.+.+..+|++|-.+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 1233344567888999999999999887
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=319.79 Aligned_cols=188 Identities=23% Similarity=0.356 Sum_probs=161.0
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++...+..++|+||+ .
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence 445689999999999999965 5788999974332 3457999999999999999999999999999999999 5
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ....+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 ~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 141 SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 789888843 23568999999999999999999999 89999999999999999999999999999754322 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~ 734 (863)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456899999999999999999999999999999999965554
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=304.02 Aligned_cols=247 Identities=25% Similarity=0.466 Sum_probs=196.0
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCC------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.||+|+||+||+|...+|+.+|||.+..... ...+.+.+|++++++++|+||++++++|.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 478999999999999988899999998764321 12356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC-
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG- 686 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~- 686 (863)
++++|.+++.. ...+++.....++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++......
T Consensus 85 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 85 PGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999943 2457899999999999999999998 889999999999999999999999999987653211
Q ss_pred ---CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 ---DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ---~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.........|+..|+|||++.+..++.++||||||++++||++|+.||........ ...... ..+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~---~~~-----~~ 227 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFYIGA---HRG-----LM 227 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHHhhh---ccC-----CC
Confidence 11112234588999999999988899999999999999999999999975432110 100000 000 11
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+...+ ...+.+++.+|++.+|++||++.|+++
T Consensus 228 ~~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCC----CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122222 335788999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=308.14 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=196.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||++++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34578999999999999965 57788999887665556678899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|..++... ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++...... ..
T Consensus 88 ~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 88 AVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988532 3468999999999999999999999 899999999999999999999999999987653221 11
Q ss_pred eeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 691 SLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.....++..|+|||++. +..++.++|||||||++|||++|+.||....... ...... . ........+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~----~-~~~~~~~~~- 231 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA----K-SEPPTLAQP- 231 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh----h-cCCCCCCCc-
Confidence 22345889999999984 3457789999999999999999999987532111 111110 0 000011111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|.+||++.++++
T Consensus 232 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 ------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112245789999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.35 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=199.2
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 3468999999999999864 58899999876543 334567899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ..+++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 88 ~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 88 SALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 99999842 358889999999999999999998 899999999999999999999999999997664322 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....++..|+|||++.+..++.++|||||||+++||++|+.||....+... .. .+........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~-------------~~~~~~~~~~ 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LF-------------LIPKNNPPTL 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hh-------------hhhcCCCCCC
Confidence 2234578899999999988899999999999999999999999975432111 00 0000011122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23445678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.93 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=196.1
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcc---------hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQG---------TREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~---------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.||+|+||.||+|.. .+++.+|+|.+....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 457899999999999985 468899999876543221 2468899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|+||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 84 FLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999943 3468899999999999999999998 89999999999999999999999999999876
Q ss_pred CCCCCC----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 683 PQEGDS----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 683 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
...... .......|+..|+|||.+.+..++.++||||||++++||++|+.||...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~--------- 224 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKI--------- 224 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHH---------
Confidence 532111 1112245788999999999888999999999999999999999999753211 111000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+.. .....+.+++.+|++.+|++||++.||++
T Consensus 225 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011111211 22345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.41 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=198.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||.|+||.||+|... +++.||+|++.... ......+.+|++++++++|+|++++++++.+....++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 44578999999999999964 68899999876543 33456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++...... .
T Consensus 84 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 84 GSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred CcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 999999843 268999999999999999999999 889999999999999999999999999998765432 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......++..|+|||++.+..++.++||||||+++|||+||+.||....+. .... ..... ..+.+...
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~----~~~~~-----~~~~~~~~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF----LIPKN-----NPPSLEGN 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH----Hhhhc-----CCCCCccc
Confidence 223345888999999999989999999999999999999999999754321 1111 01111 11111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+++.+|++.+|++||+++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02335788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.77 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=197.4
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 345568899999999999985 4688999998876655555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.. ...+++.+.+.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 90 GGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999843 3468999999999999999999999 899999999999999999999999999987653221
Q ss_pred CceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 GFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||....+... +...... . ...+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~-----~---~~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKS-----N---FQPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhcc-----C---CCCCc
Confidence 1123346899999999874 45688999999999999999999999865332111 1100000 0 00011
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ......+.+++.+|++.+|++||++.+|++
T Consensus 231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1100 011235788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.46 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=198.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++.+..++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 34589999999999999854 6889999987543 233456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ....++....+.++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++.......
T Consensus 83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 9999988532 23457889999999999999999999 8999999999999999999999999999976643221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......|+..|+|||.+.+..++.++||||||+++++|++|+.||..... ..... .. ..+.... +.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~---~~-~~~~~~~-----~~-- 221 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLIL---KV-CQGSYKP-----LP-- 221 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHH---HH-hcCCCCC-----CC--
Confidence 22345688999999999988899999999999999999999999975321 11111 10 1111110 11
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
......+.+++.+||+.+|++||++.|++..
T Consensus 222 --~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 --SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122357889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.86 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=198.7
Q ss_pred hcceecccCcEEEEEEecC------CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
..+.||+|+||.||+|+.+ +.+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 3478999999999999854 3467999987655443 35689999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCC-----CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 606 FMSNGSLQDRLYGEAST-----RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
|+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999999644311 1268999999999999999999998 889999999999999999999999999987
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
........ ......++..|+|||.+.+...+.++||||||++++||++ |..||..... ..+..... .+...
T Consensus 166 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~----~~~~~ 237 (275)
T cd05046 166 DVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQ----AGKLE 237 (275)
T ss_pred ccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHH----cCCcC
Confidence 54322111 1122345778999999988888999999999999999999 7888864321 11222111 11111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.. ........+.+++.+|++.+|++||++.|+++.|+
T Consensus 238 ~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 01112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.71 Aligned_cols=246 Identities=30% Similarity=0.450 Sum_probs=196.1
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.+.||+|+||.||+|.. +++.||+|...... ....+.+|+.++++++|||++++++++... ..++||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 345678999999999999975 67889999876432 346789999999999999999999998654 57999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999543 23458899999999999999999998 899999999999999999999999999987643221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....+..|+|||++.+..++.++||||||++++||++ |+.||...... .+.+... .+... +
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~---~----- 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVE----KGYRM---E----- 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh----CCCCC---C-----
Confidence 12234568999999998899999999999999999998 99998754321 1111111 11000 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
........+.+++.+|++.+|++||++.++++.|++
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223457899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.22 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=196.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcch--HHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGT--REFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~--~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||+||++... +++.+|+|++........ ....+|+.++++++|+||+++++++......++||||+++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 4579999999999999965 567899999877654332 2345699999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++. ....+++..++.++.|+++||++||+ .+|+|+||||+||++++++.++|+|||++..... ...
T Consensus 83 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 83 GSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp EBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence 99999995 34568999999999999999999999 8999999999999999999999999999975411 122
Q ss_pred ceeeeecCCCCCCccccc-cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYS-TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||.+. +...+.++||||+|++++||++|+.||......+. .......... .... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~----~~~~-~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKR----PLPS-SS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHT----HHHH-HT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhcccc----cccc-cc--
Confidence 233456899999999998 78899999999999999999999999986411111 1111110000 0000 00
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+.+++..|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001257899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=309.29 Aligned_cols=249 Identities=28% Similarity=0.399 Sum_probs=193.1
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEe-----eCCeeEEEeec
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCC-----ENDQQILVYPF 606 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~LV~ey 606 (863)
.+.||+|+||.||++.. .+++.+|+|++.... ....++.+|+.+++++ +|+||++++++|. .++..++||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 47899999999999986 468899999876432 2346788999999999 6999999999884 34568999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.........+++.....++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999999886433344568899999999999999999999 899999999999999999999999999998664321
Q ss_pred CCCceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.......|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +... ........
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~~-----~~~~~~~~ 249 (286)
T cd06638 179 --LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFKI-----PRNPPPTL 249 (286)
T ss_pred --CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhhc-----cccCCCcc
Confidence 11223468999999998853 4578899999999999999999999975432111 1110 00000111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.++.. ....+.+++.+|++.+|++||++.||++.
T Consensus 250 ~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 250 HQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111 12358899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=314.57 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=192.9
Q ss_pred hcceeccc--CcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 533 YKTLIGEG--GFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G--~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+.++||+| +||+||++.. .+|+.||||++..... ...+.+.+|+++++.++||||++++++|..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34689999 7899999986 5789999998865432 23356778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985321 2358999999999999999999999 8999999999999999999999999987543321111
Q ss_pred C-----CceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc------
Q 002943 688 S-----GFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR------ 754 (863)
Q Consensus 688 ~-----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~------ 754 (863)
. .......++..|+|||++.+ ..++.++|||||||+++||++|+.||....... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence 0 01112346778999999976 458899999999999999999999997543211 01010000000
Q ss_pred ---ccc-----cccccCCcc-----------------CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ---ESR-----IDEIVDPSI-----------------KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ---~~~-----~~~i~d~~l-----------------~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... .....+..+ ...........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000000 00011122346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.07 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=198.5
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 457899999999999984 5789999998876655566788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ..+++.+++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 103 L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~ 172 (296)
T cd06655 103 LTDVVTE-----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KR 172 (296)
T ss_pred HHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cC
Confidence 9998832 358999999999999999999999 8999999999999999999999999999886543221 12
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....++..|+|||.+.+..++.++|||||||++|||++|+.||........ +. .... ..... +. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~-~~~~----~~~~~-----~~--~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY-LIAT----NGTPE-----LQ--NP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHh----cCCcc-----cC--Cc
Confidence 234588899999999988899999999999999999999999976432111 11 0000 00000 00 01
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112235778999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.29 Aligned_cols=259 Identities=21% Similarity=0.252 Sum_probs=196.2
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCccc-ccceeeeEeeCC------eeEEEe
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHEN-LVPLLGYCCEND------QQILVY 604 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~~LV~ 604 (863)
++||+|.||+||+|+. .+|+.||+|++..... .......+|+.+|++++|+| ||+|.+++...+ ..+||+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5699999999999994 5789999998765544 23456789999999999999 999999999877 788999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+ .-+|..++.........++-.....++.|+.+||+|||+ ++|+||||||.|||+++++.+||+|||+|+....
T Consensus 97 e~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 999 569999995443222456778899999999999999999 8999999999999999999999999999996542
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc---ccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI---RESRIDE 760 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~---~~~~~~~ 760 (863)
... ..+...+|..|.|||++.+. .|+...||||+|||+.||++++.-|.+....+. ...+...+ .+.....
T Consensus 173 p~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q---l~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 173 PMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ---LFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred Ccc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH---HHHHHHHcCCCCccCCCC
Confidence 221 23445688999999999887 799999999999999999999999987653221 11111111 0000000
Q ss_pred c---cCC--ccCC-----CCcHH---HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 761 I---VDP--SIKG-----GYHAE---AMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 761 i---~d~--~l~~-----~~~~~---~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+ .|- .... ..... ......+++.+|++.+|.+|.|+..+++.
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 010 0000 00000 01357789999999999999999988775
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=312.61 Aligned_cols=198 Identities=23% Similarity=0.340 Sum_probs=160.7
Q ss_pred ceecccCcEEEEEEecC---CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey~~~ 609 (863)
++||+|+||+||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 68999999999999854 46789999876442 23567899999999999999999998854 456789999985
Q ss_pred CChhhhhhccC-----CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe----cCCCeEEEeeccCcc
Q 002943 610 GSLQDRLYGEA-----STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSK 680 (863)
Q Consensus 610 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla~ 680 (863)
++|.+++.... .....+++.....++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58888774221 122358889999999999999999999 899999999999999 466789999999998
Q ss_pred cCCCCCCC-CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 681 YAPQEGDS-GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 681 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
........ .......||+.|+|||++.+. .++.++||||+||+++||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76432211 112345689999999998764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.61 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=188.8
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC-----cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-----QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 604 (863)
..+.||+|+||.||++.. .++..||+|++..... +..+.+.+|++++++++|+||+++++++.+. ...++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 357999999999999986 4689999998754321 2235688999999999999999999988753 5678999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++++|.+++.. ...+++...+.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 86 EYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999943 2358899999999999999999998 8899999999999999999999999999986543
Q ss_pred CCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... +........ ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~-----~~~ 227 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQ-----PTN 227 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcC-----CCC
Confidence 2111 1112345889999999999888999999999999999999999999753211 111111000 011
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+.. .....+.+++ +|+..+|++||+|.||++
T Consensus 228 ~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 22211 1122344444 788899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=307.02 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=189.7
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcC---CcccccceeeeEeeC-----CeeE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAI---RHENLVPLLGYCCEN-----DQQI 601 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~~~~ 601 (863)
+.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+++++++ +||||+++++++... ...+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 4578999999999999864 6899999987654322 234566777777666 699999999988642 4578
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 84 LVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 9999997 5898888542 23458999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhccccccc--
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRI-- 758 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~-- 758 (863)
..... ......||..|+|||++.+..++.++|||||||+++||++|++||......... .+..+..........
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 158 YSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 64321 122345789999999999889999999999999999999999999654321110 111111000000000
Q ss_pred ----ccccCCccCC---CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 ----DEIVDPSIKG---GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ----~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.... ....+....+.+++.+|++.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 001122345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=303.30 Aligned_cols=244 Identities=28% Similarity=0.472 Sum_probs=196.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC-----CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-----TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++......++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 3478999999999999976 78999999876543 22446789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 84 VPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999943 2458899999999999999999999 899999999999999999999999999988654332
Q ss_pred CCCceeeeecCCCCCCccccccCC-CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......++..|+|||.+.... ++.++|+||||++++||++|+.||....... .+..+. ...... .
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~-----~ 222 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG----RSKELP-----P 222 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH----hcccCC-----C
Confidence 123345889999999987776 8999999999999999999999997543111 111110 000110 1
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+. ......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IP----DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cC----CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11 112345778999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.95 Aligned_cols=199 Identities=22% Similarity=0.353 Sum_probs=170.7
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++... +++.||||++.... ......+.+|++++.+++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 3578999999999999864 68999999886432 2334578889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 85 GGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999843 3468899999999999999999999 89999999999999999999999999998754321100
Q ss_pred ---------------------------------CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCC
Q 002943 689 ---------------------------------GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLN 735 (863)
Q Consensus 689 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~ 735 (863)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred CCC
Q 002943 736 TRR 738 (863)
Q Consensus 736 ~~~ 738 (863)
...
T Consensus 238 ~~~ 240 (360)
T cd05627 238 SET 240 (360)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=317.21 Aligned_cols=236 Identities=23% Similarity=0.240 Sum_probs=182.6
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcC---CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAI---RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
||+|+||+||+|+.. +|+.||||++..... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 689999998764322 2223455677777665 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ...+++.....++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998843 3468899999999999999999999 899999999999999999999999999997543221 1
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||..|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+.. . +..+. ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~---~-i~~~~------~~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYR---N-IAFGK------VRFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHH---H-HHcCC------CCCCC
Confidence 22345699999999998765 478999999999999999999999975321 11111 1 11111 01111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
. .....+.+++.+|++.+|++||++.
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1 1123467899999999999999644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.39 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=194.9
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC---c-------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---Q-------GTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.||+|+||.||+|.. .+|+.+|||.+..... . ..+.+.+|++++++++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 47899999999999985 4689999997653211 1 12467889999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|+||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999432 468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCC--CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQH--LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
.............|+..|+|||.+.... ++.++||||||++++|+++|+.||....... .+.+ ... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~~-~~~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK----LGN-KRSAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH----hhc-cccCC
Confidence 4322222233456889999999987654 7899999999999999999999996432110 0111 000 00111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+++.. ..+....+.+++.+|++.+|++||+|.||++
T Consensus 232 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 1123356888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=301.16 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=199.6
Q ss_pred hcceecccCcEEEEEEecCC-----CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLPD-----GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.||+|+||.||++...+ +..||+|++...... ..+.+..|++++.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998653 488999998665443 567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999995432 1228999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.... ....++..|+|||.+.+..++.++||||+|++++||++ |+.||.... ...+.+..... ... .
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~----~~~-----~ 224 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKKG----YRL-----P 224 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcC----CCC-----C
Confidence 2111 12337789999999988889999999999999999999 788886532 12222222111 100 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
.. ......+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 ~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KP----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01 11234588899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.96 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=199.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 3457999999999999884 568899999865442 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.... ...+++.++..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 83 GGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999995432 3568999999999999999999998 8899999999999999999999999999987644321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||.+.+..++.++||||||++++||++|+.||..... .+....... +....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~~~-------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ-GNYTP-------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CCCCC--------
Confidence 22334589999999999888899999999999999999999999965321 111111111 11111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
........+.+++.+|++.+|++||++.|+++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 011223458889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.56 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=196.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34578999999999999975 58999999876442 2234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|..++. ....+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 84 HTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 998888763 23458999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhccc-------cc-cc
Q 002943 689 GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIR-------ES-RI 758 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~-------~~-~~ 758 (863)
......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+.. .+......... .. ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1123357889999999876 46789999999999999999999999764322111 01111000000 00 00
Q ss_pred ccccCCccCCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+....... ......+.+++.+|++.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0001111100001 011345789999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.67 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=199.8
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey~ 607 (863)
+.+.||.|+||.||++.. .+|+.+|+|.+.... ....+.+..|++++++++|+||+++++++.. +...+++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 457899999999999985 468899999876443 2334578899999999999999999998764 34678999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc--CCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA--GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
++++|.+++.........+++...+.++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 999999999654344567999999999999999999999432 389999999999999999999999999999876543
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.. ......++..|+|||.+.+..++.++||||||+++++|++|+.||.... ...+.+... .+.. +
T Consensus 164 ~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~----~~~~-----~- 228 (265)
T cd08217 164 SS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIK----EGKF-----R- 228 (265)
T ss_pred cc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHh----cCCC-----C-
Confidence 22 1223468999999999998889999999999999999999999997643 111222111 1111 1
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+.+++.+|++.+|++||++.+|++
T Consensus 229 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 ---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111223346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=308.20 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=199.0
Q ss_pred CHHHHHHHHHhh--cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeC
Q 002943 522 SLQYLEAATQQY--KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCEN 597 (863)
Q Consensus 522 ~~~~l~~~t~~f--~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 597 (863)
+..++..++.+| .+.||+|+||.||++.. .+++.+|+|++.... ....++.+|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 334444444444 47899999999999986 468899999876532 2345678899999999 799999999998754
Q ss_pred C-----eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEE
Q 002943 598 D-----QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 598 ~-----~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~k 672 (863)
+ ..++|+||+++|+|.++++........+++..++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEE
Confidence 3 5799999999999999986443345578999999999999999999998 8999999999999999999999
Q ss_pred EeeccCcccCCCCCCCCceeeeecCCCCCCccccccCC-----CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHH
Q 002943 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH-----LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 673 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 747 (863)
|+|||+++....... ......|+..|+|||.+.... ++.++|||||||++|||++|+.||...... ..+.+
T Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLFK 244 (291)
T ss_pred Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHHH
Confidence 999999986543221 112345889999999986543 688999999999999999999999754321 11111
Q ss_pred hhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 748 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. .....+.+ ..+....+.+++.+|++.+|++||++.|+++
T Consensus 245 ~~~-----~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPR-----NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred Hhc-----CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 10111111 1122345889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=316.26 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=190.6
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 601 (863)
+...+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 34458999999999999985 46899999987643 2234567889999999999999999999986543 468
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+++ +|.+.++ ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 103 lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 103 LVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred EEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 99999964 6666662 247888899999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch------------hHH--
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS------------LVE-- 747 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~------------l~~-- 747 (863)
.... .......||..|+|||.+.+..++.++|||||||++|||++|+.||.......... +..
T Consensus 173 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 4322 11233468999999999999999999999999999999999999997643211000 000
Q ss_pred --hhhhcccc------cccccccCCccCC---CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 748 --WAKPFIRE------SRIDEIVDPSIKG---GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 748 --~~~~~~~~------~~~~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+...... ....+........ .........+.+++.+|++.+|++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0000000000000 000112345789999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.60 Aligned_cols=199 Identities=24% Similarity=0.306 Sum_probs=168.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.++||+|+||.||+++.+ +++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 34589999999999999965 57889999875421 223345888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999532 3468899999999999999999999 8999999999999999999999999999976533221
Q ss_pred CCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 1122346999999999986 346789999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.29 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=196.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC-CeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN-DQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV~ey~ 607 (863)
.+.+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+... ...++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 35689999999999999854 57899999876443 23446788999999999999999999987644 4678999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++... ....+++.+++.++.+++.|++|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 83 EGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999542 23468999999999999999999999 899999999999999999999999999998664322
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......+++.|+|||.+.+..++.++||||||++++||++|+.||..... ........ .+... .+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~-----~~- 222 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRII-EGKLP-----PM- 222 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hcCCC-----CC-
Confidence 122334588999999999999999999999999999999999999875321 11111111 11110 11
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++||++.|+++
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 ---PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=319.57 Aligned_cols=250 Identities=22% Similarity=0.253 Sum_probs=189.9
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 344589999999999999965 68899999875422 22345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ..++......++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 125 MPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred CCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999842 247888889999999999999999 899999999999999999999999999998664322
Q ss_pred CCCceeeeecCCCCCCccccccC----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQ----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
. .......||+.|+|||++... .++.++|||||||++|||++|+.||..... .... .............
T Consensus 197 ~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~~~~~~~~~ 269 (371)
T cd05622 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTY---SKIMNHKNSLTFP 269 (371)
T ss_pred c-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHH---HHHHcCCCcccCC
Confidence 1 112345699999999998754 378899999999999999999999975431 1111 1111110000111
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAY--RPSMVDIVRE 802 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~~ 802 (863)
+ .......+.+++.+|+...+.+ ||++.|+++.
T Consensus 270 ~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 270 D-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred C-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1 0112334678888999843332 6787777664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.57 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=197.2
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.++||+|+||.||+|... +++.+++|++........+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 345578999999999999965 5899999998776666677899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...... ..
T Consensus 94 ~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 94 GAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999887432 3458999999999999999999998 89999999999999999999999999998754322 11
Q ss_pred ceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 690 FSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... .+....... .. .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~-----~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SE-----PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhc-CC-----Cc
Confidence 223456889999999985 34567899999999999999999999865321 111111111 00 01
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+. ........+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110 01122335788999999999999999998865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=309.60 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=193.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 34578999999999999864 68899999876443 2334567899999999999999999999999999999999996
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...+++.....++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++.......
T Consensus 88 ~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 88 KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 6999888432 3458899999999999999999999 8999999999999999999999999999976432211
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---cccccccc---
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRIDEIV--- 762 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i~--- 762 (863)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+ .......... ......+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 11223468899999988654 57889999999999999999999997543211 1111111000 00000000
Q ss_pred ------CCccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 ------DPSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 ------d~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+..... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111000 00112335789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.70 Aligned_cols=197 Identities=23% Similarity=0.343 Sum_probs=160.0
Q ss_pred ceecccCcEEEEEEecC---CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 58999999999999864 35789999876543 23467899999999999999999998854 456789999986
Q ss_pred CChhhhhhccC-----CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe----cCCCeEEEeeccCcc
Q 002943 610 GSLQDRLYGEA-----STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSK 680 (863)
Q Consensus 610 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla~ 680 (863)
++|.+++.... .....+++.....++.|++.||.|||+ .+|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57777764211 123458899999999999999999999 899999999999999 567899999999998
Q ss_pred cCCCCCCC-CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 681 YAPQEGDS-GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 681 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
........ .......||..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76432211 112335689999999998764 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=310.42 Aligned_cols=199 Identities=24% Similarity=0.312 Sum_probs=168.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 34588999999999999964 6899999987642 2223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999432 3458889999999999999999999 8999999999999999999999999999876543221
Q ss_pred CCceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 11223468999999999863 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=308.29 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=195.6
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.++||+|+||.||+|... +++.||+|++...... ..+.+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH 84 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence 4578999999999999975 5899999987654322 346788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.++... ...++|.+++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.......
T Consensus 85 ~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07846 85 TVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 155 (286)
T ss_pred cHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence 999887632 2358999999999999999999999 8999999999999999999999999999986643321
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccc-------c-ccc
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRE-------S-RID 759 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~-------~-~~~ 759 (863)
......++..|+|||++.+ ..++.++||||||++++||++|+.||......+. ..+..+....... . ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223457889999999875 3578899999999999999999999864321110 0111111110000 0 000
Q ss_pred cccCCccCCCC-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGY-----HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+...... .......+.+++.+|++.+|++||+|.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00011110000 1122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.81 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=200.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++...+..+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 44578999999999999864 57889999987766666788999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++.+...++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++........ .
T Consensus 86 ~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~ 157 (262)
T cd06613 86 SLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K 157 (262)
T ss_pred cHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence 999988432 2468899999999999999999998 8999999999999999999999999999976543211 1
Q ss_pred eeeeecCCCCCCccccccC---CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 691 SLEVRGTAGYLDPEYYSTQ---HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ...... .+...+.+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~~--------~~~~~~~~~ 227 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLISK--------SNFPPPKLK 227 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh--------ccCCCcccc
Confidence 2234578899999999777 789999999999999999999999975432111 111000 000001111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
........+.+++.+|++.+|.+||++.+|+.
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 --DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11223456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=313.02 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=203.9
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe-eEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQ-QILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~LV~ey~~ 608 (863)
..+++|+|+||.++..+.+ ++..+++|.+... .....+..++|+.++++++|||||.+.+.+.+++. .++||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 4478999999999998864 5778999976543 33344577899999999999999999999999988 999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
||+|.+.+.... ...++.....+++.|++.|+.|||+ ..|+|||||+.||++..+..+||+|||+||.+....
T Consensus 88 Gg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 88 GGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred CCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 999999995433 4678899999999999999999998 899999999999999999999999999999886543
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....+.||+.||.||.+.+.+|..|+||||+||+++||++-+++|..... ..|+.-.. + ...+| +
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~---~-----~~~~P-l-- 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKIN---R-----GLYSP-L-- 226 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHh---h-----ccCCC-C--
Confidence 234567899999999999999999999999999999999999999986432 11222111 1 11111 1
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+.....++..++..|++.+|..||++.+++.+
T Consensus 227 --p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 --PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22233458889999999999999999999987
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.79 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=193.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+.++++++||||+++++++..++..++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4578999999999999964 68999999876432 2234678899999999999999999999999999999999997
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.... ....+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...... .
T Consensus 83 ~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (285)
T cd07861 83 MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--R 156 (285)
T ss_pred CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--c
Confidence 78988885432 23568999999999999999999999 899999999999999999999999999997653221 1
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc-------ccc----cc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF-------IRE----SR 757 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~-------~~~----~~ 757 (863)
......++..|+|||.+.+. .++.++|||||||+++||+||+.||....... .+....... +.. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223568899999988654 57889999999999999999999997543211 011000000 000 00
Q ss_pred cccccCCccCC---CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEIVDPSIKG---GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+..... ........++.+++.+|++.+|++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000012345679999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=317.43 Aligned_cols=259 Identities=20% Similarity=0.267 Sum_probs=191.4
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 601 (863)
+...+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 334588999999999999854 68899999876542 22346778999999999999999999988643 3468
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||++ ++|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 99 LVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred EEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 9999996 56777662 247888999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hH--------H-----
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LV--------E----- 747 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~--------~----- 747 (863)
.... .......||..|+|||.+.+..++.++|||||||+++||++|+.||.......... .. +
T Consensus 169 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 5322 11233468999999999999899999999999999999999999997543111100 00 0
Q ss_pred --hhhhcccc-cccccccCCc-----cC---CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 748 --WAKPFIRE-SRIDEIVDPS-----IK---GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 748 --~~~~~~~~-~~~~~i~d~~-----l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+...... .....+..+. +. ..........+.+++.+|++.+|++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000000 00 00111123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=303.41 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=196.2
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+++.+.||+|+||.||++... +|..||+|.+... .......+.+|++++++++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 345678999999999999965 7899999987643 22334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.... ....+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999885421 234689999999999999999999962 489999999999999999999999999997653221
Q ss_pred CceeeeecCCCCCCccccccCC------CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQH------LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.....++..|+|||.+.+.. ++.++|||||||++|||++|+.||........ ..-... ...+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~-~~~~~----- 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSA-IVDGD----- 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHH-HhhcC-----
Confidence 12335788999999986543 47899999999999999999999965322111 110000 00010
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.+ .......+.+++.+|++.+|++||++.+++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0111 1123445788999999999999999998876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.78 Aligned_cols=255 Identities=25% Similarity=0.321 Sum_probs=199.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey~~ 608 (863)
+.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|... +..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3478999999999999974 688999998775433 3456789999999999999999999998654 36899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.........+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 999999885433345568899999999999999999999 8999999999999999999999999999875532211
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC--CCcchhHHhhhhcccccccccccCCcc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP--RNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
....++..|+|||.+.+..++.++||||||+++|||++|+.||+.... .....+..+...... ..+.+ ..
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN----PELKD-EP 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc----hhhcc-CC
Confidence 234578899999999999999999999999999999999999976532 112223333222110 01100 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. .......+.+++.+|++.+|++||||.||++
T Consensus 233 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 0112346889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.39 Aligned_cols=244 Identities=26% Similarity=0.383 Sum_probs=196.9
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
..||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 5699999999999985 468899999887655555677899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++.. ..+++.+...++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++........ ....
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 177 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS 177 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence 98832 358899999999999999999999 8999999999999999999999999999976543221 1233
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..|+..|+|||++.+..++.++||||||++++||++|+.||...... ....-.. ....+.+.... .
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~---------~~~~~~~~~~~--~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIR---------DNLPPRVKDSH--K 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---------hcCCCcccccc--c
Confidence 46899999999998888999999999999999999999999753321 1111000 11111111111 1
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
....+.+++.+|++.+|++||++.|+++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 22357788999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.80 Aligned_cols=199 Identities=24% Similarity=0.306 Sum_probs=169.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34579999999999999964 67899999876432 223456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 84 VGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999542 2468899999999999999999999 8999999999999999999999999999986643221
Q ss_pred CCceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.......||+.|+|||++.+ +.++.++|||||||+||||++|+.||...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 11223469999999999875 46788999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.17 Aligned_cols=244 Identities=23% Similarity=0.367 Sum_probs=197.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
..||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999986 468999999987655555677889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....... ....
T Consensus 107 ~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 107 DIVS-----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred HHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 9773 2458899999999999999999998 8999999999999999999999999999976543221 1233
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..|+..|+|||++.+..++.++|||||||+++||++|+.||..... ......... .. .+... ....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~----~~-----~~~~~--~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRD----SP-----PPKLK--NAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc----cC-----CCCcc--ccCC
Confidence 5689999999999988999999999999999999999999975332 111111111 00 00000 0001
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
....+.+++.+|++.+|++||++.|+++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12347889999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.97 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=198.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||++.. .+|+.+|+|.+... .....+++.+|++++++++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 3457999999999999985 46899999987643 23344688999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ....+++.+.++++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 83 GGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999998532 23357899999999999999999998 8999999999999999999999999999986543221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......|+..|+|||++.+...+.++|||||||+++||++|+.||..... .+.+..... +.. +..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~-~~~-----~~~-- 221 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR-GSY-----PPV-- 221 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc-CCC-----CCC--
Confidence 11234578899999999988999999999999999999999999864321 111111111 110 001
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++||+|.||++
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 --SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=303.58 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=198.0
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||++... +++.+|+|+.........+.|.+|++++++++|+|++++++++..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 344578999999999999964 6889999998766555667899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 87 GALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred CcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999998432 3468999999999999999999999 8999999999999999999999999999876533211
Q ss_pred ceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 690 FSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .+..+. .+.. +
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-----~~~~-----~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKIL-----KSEP-----P 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHh-----cCCC-----C
Confidence 223456899999999875 3456789999999999999999999997543211 111110 1100 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+. ........+.+++.+|++.+|.+||++.+|++
T Consensus 227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 110 01112235778999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.45 Aligned_cols=262 Identities=21% Similarity=0.311 Sum_probs=197.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 44578999999999999965 58899999876432 3344678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
++.|..++. ....+++.+...++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.......
T Consensus 84 ~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 84 RTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 877766552 23458999999999999999999999 8999999999999999999999999999987654332
Q ss_pred CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhhhcc--------ccccc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAKPFI--------RESRI 758 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~~~~--------~~~~~ 758 (863)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||......+... +........ .....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 122334578899999999888 88999999999999999999999997543211100 000000000 00000
Q ss_pred -----ccccCCcc-CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 -----DEIVDPSI-KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 -----~~i~d~~l-~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+..++.. ...+......++.+++.+|++.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00011122466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=335.58 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=207.8
Q ss_pred HHHHhhcceecccCcEEEEEEecC----C----CCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeC
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLP----D----GQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEN 597 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~----~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 597 (863)
.....+.+.||+|.||.|++|.+. . ...||||+++.... ...+.+..|+++|..+ +|+|++.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 333345679999999999999853 1 45799998876543 4567899999999999 599999999999999
Q ss_pred CeeEEEeecCCCCChhhhhhccC---C-------CC--ccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEA---S-------TR--KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~---~-------~~--~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
+..++|.||+..|+|.++|+..+ . .. ..|+....+.++.|||.||+||++ .++|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999997654 0 01 238899999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeee--cCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCc
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVR--GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNE 742 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 742 (863)
.++..+||+||||||........... ... -...|||||.+....++.|+|||||||+||||+| |..||.+... .
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 99999999999999976543332211 111 2456999999999999999999999999999999 8999975321 1
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+.++. ++|... ..+..+..++.++++.||+.+|++||++.|+++.|+..+
T Consensus 529 ~~l~~~l----~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EELLEFL----KEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHH----hcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1223332 233211 122234556889999999999999999999999999854
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.58 Aligned_cols=254 Identities=20% Similarity=0.241 Sum_probs=199.6
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+..++..++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999864 578999998765432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC-
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD- 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~- 687 (863)
+++|.+++.. ...+++.....++.+++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 85 GGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999943 2468999999999999999999999 8999999999999999999999999999874211100
Q ss_pred ------------CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 688 ------------SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 688 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
........++..|+|||++....++.++|+||||+++|||++|+.||..... .++......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~- 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVIS- 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-
Confidence 0011123578899999999888899999999999999999999999965321 111111110
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+ ....+.... .....+.+++.+|++.+|++||++.++.+.|+..+
T Consensus 231 ~---~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 231 D---DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred c---ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0 011111111 12335789999999999999999988888888765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.85 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=198.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||.||+|.. .++..+|||+..... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 34557899999999999985 468899999876443 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++. ...+++.....++.+++.|+.|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 86 ~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999983 2358899999999999999999998 8999999999999999999999999999876543211
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||.+.+...+.++|||||||+++||++|..||..... ....... ..+. .+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLI----PKNN-----PPTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHH----hcCC-----CCCCCc
Confidence 12234578899999999888899999999999999999999999865321 1111111 1110 011111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.....+.+++.+|++.+|.+||+|.++++.
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223457889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=326.83 Aligned_cols=257 Identities=20% Similarity=0.285 Sum_probs=186.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc------cccceeeeEeeC-CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE------NLVPLLGYCCEN-DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~~-~~~~LV 603 (863)
.+.++||+|+||+||+|.. ..++.||||+++... ...+++..|++++++++|. +++++++++... ...++|
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 3458999999999999986 457899999886432 2234566778777777654 588888888754 478899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC--------------
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-------------- 669 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-------------- 669 (863)
||++ +++|.+++.. ...+++.....|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 211 MPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred Eecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 9988 7889888843 34689999999999999999999972 4899999999999998765
Q ss_pred --eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHH
Q 002943 670 --CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 670 --~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~ 747 (863)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||+.....+...+..
T Consensus 284 ~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 284 PCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999998864321 1234569999999999999999999999999999999999999997644322111111
Q ss_pred ---------hhhhc--------cc-ccccccccCCcc----CCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 748 ---------WAKPF--------IR-ESRIDEIVDPSI----KGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 748 ---------~~~~~--------~~-~~~~~~i~d~~l----~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
|.... +. .+.+....++.. .... .......+++|+.+|++.||++|||+.|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 11000 00 000000001000 0000 0011245779999999999999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.40 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=190.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHH-HhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNF-LSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||++... +|+.||+|++..... ....++..|+.. ++.++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 34578999999999999965 689999998765432 234456666665 666789999999999999999999999995
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.........+++...+.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 78988886543344678999999999999999999998 5 89999999999999999999999999998654221
Q ss_pred CCceeeeecCCCCCCcccccc----CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYST----QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ...+... .. + ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~----~~-~-----~~ 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQV----VE-E-----PS 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHH----Hh-c-----CC
Confidence 1223457889999998865 45688999999999999999999999643210 0011111 00 0 01
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+.. ......+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11110 112345889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=314.33 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=190.8
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 601 (863)
+.+.+.||+|+||.||++.. ..++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 34458999999999999985 468899999886532 23346788999999999999999999987543 3569
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||++ ++|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 106 IVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 9999996 57777762 247888999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hH--------Hhhh--
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LV--------EWAK-- 750 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~--------~~~~-- 750 (863)
..... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+... +. ++..
T Consensus 176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 53321 1233468999999999999999999999999999999999999997543211100 00 0000
Q ss_pred -----hcccc-c-----ccccccCCccC---CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 751 -----PFIRE-S-----RIDEIVDPSIK---GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 751 -----~~~~~-~-----~~~~i~d~~l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... . .........+. ..........+.+++.+|++.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0 00000000000 0001112346789999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.37 Aligned_cols=249 Identities=25% Similarity=0.456 Sum_probs=196.3
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.||+|+||.||++.. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 47899999999999985 5789999998764331 1246788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQE 685 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~ 685 (863)
+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 85 MAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred cCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 999999999843 3468899999999999999999999 8999999999999998765 6999999999766433
Q ss_pred CCC--CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDS--GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
... .......++..|+|||.+.+..++.++||||+|++++||++|+.||............ ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-----~~~ 229 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA-----TTA 229 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhcc-----CCC
Confidence 111 1122345789999999998888999999999999999999999999653321111111 100000 001
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 230 ~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 P----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred C----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1 122223356889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.29 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=197.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||++.. .+++.+|||.+.... ....+.+.+|++++++++|+|++++++.+..++..++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 3457899999999999985 468899999876542 2345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~~~ 687 (863)
+++|.+++... ....+++..+..++.++++||+|||+ ++++|+||||+||+++++ ..+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 83 GGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999543 23458999999999999999999999 899999999999999854 5689999999987643321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....++..|+|||.+.+..++.++||||||++++||++|+.||+.... ........ . +.... +.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~---~-~~~~~-----~~ 222 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIM---S-GTFAP-----IS 222 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHH---h-cCCCC-----CC
Confidence 2234588999999999988899999999999999999999999975432 11111111 1 00011 11
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. .....+.+++.+|++.+|++||++.|+++
T Consensus 223 ~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 D----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 12345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=336.30 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=193.6
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~e 605 (863)
+.+.+.||+|+||+||++... .+..+|+|.+.... ......|..|+.++++++|||||++++++... ...+||||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 345689999999999999864 57789999876442 23346788999999999999999999988543 56899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc----CCCccccCCCCCCeEecCC-------------
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA----GRSVIHRDVKSSNILLDHS------------- 668 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~----~~~iiHrDik~~NILld~~------------- 668 (863)
|+++|+|.++|.........+++...+.|+.||+.||+|||+.. .++||||||||+||||+.+
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n 174 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccc
Confidence 99999999999653333457999999999999999999999843 1469999999999999642
Q ss_pred ----CeEEEeeccCcccCCCCCCCCceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCc
Q 002943 669 ----MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742 (863)
Q Consensus 669 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~ 742 (863)
..+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||||||||+||+.||.....
T Consensus 175 ~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--- 248 (1021)
T PTZ00266 175 LNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--- 248 (1021)
T ss_pred cCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc---
Confidence 358999999998664322 1234468999999999854 4588999999999999999999999975321
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....... +..+ +.+... .....+.+|+..||+.+|.+||++.|+++
T Consensus 249 --~~qli~~-lk~~-------p~lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 --FSQLISE-LKRG-------PDLPIK---GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --HHHHHHH-HhcC-------CCCCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1111111 1111 111100 11235789999999999999999999984
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.44 Aligned_cols=258 Identities=21% Similarity=0.223 Sum_probs=193.3
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcc--hHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQG--TREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey~~~ 609 (863)
+.|++|.||.||+|+.+ +++.||+|+++...... .-.-++|+.+|.+++|||||.+..+... -+..++|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 68999999999999964 68899999887654221 2346799999999999999999887654 4578999999964
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
+|...+... .+++...+...+..|+.+|++|||+ .-|+|||||++|+|+.+.|.+||+||||||.+.... .
T Consensus 162 -DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k 232 (419)
T KOG0663|consen 162 -DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--K 232 (419)
T ss_pred -hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc--c
Confidence 888888533 3678889999999999999999999 789999999999999999999999999999876432 2
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC-----
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD----- 763 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d----- 763 (863)
..+...-|..|.|||.+.+. .|++..|+||+|||+.|++++++-|.+....+..+.+-.......+.....+.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 23456679999999999875 699999999999999999999999987654333221111100000000000000
Q ss_pred ---------CccCCCCcHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 ---------PSIKGGYHAE-AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ---------~~l~~~~~~~-~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+...+... ..+.-.++.-..+..||.+|-|+.|.++
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0111111111 1234567788889999999999988754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.99 Aligned_cols=244 Identities=24% Similarity=0.397 Sum_probs=195.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIR---HENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+.+.||+|+||.||+|.. .+++.+|+|.+.... .....++.+|++++++++ |+|+++++++|..+...++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 347899999999999995 578999999876543 334567889999999997 999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++.. ..+++...+.++.|++.||+|||+ .+|+|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 85 EGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998832 268999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......|+..|+|||.+.++ .++.++|||||||++|||++|+.||...... .+... ... ...+.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~-~~~-----~~~~~~ 222 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMML-IPK-----SKPPRL 222 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhc-ccc-----CCCCCC
Confidence 12334688999999988654 4688999999999999999999999754321 11110 000 011112
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... .....+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 12345889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=304.14 Aligned_cols=244 Identities=27% Similarity=0.398 Sum_probs=192.8
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+...+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|++++++++|||++++.++|...+..++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 344578999999999999864 689999998764432 2335788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
++ |+|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++.....
T Consensus 97 ~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 97 CL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred hC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 96 6777776422 3468999999999999999999998 89999999999999999999999999999765432
Q ss_pred CCCceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...... ....... . .. .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~~~---~-~~-----~ 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIA---Q-ND-----S 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHHHh---c-CC-----C
Confidence 1235788999999874 456888999999999999999999998654211 1100000 0 00 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+.+. .......+.+++.+||+.+|++||+|.+|+..
T Consensus 232 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 11234468899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=295.89 Aligned_cols=249 Identities=26% Similarity=0.427 Sum_probs=197.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
..+.||+|+||.||+|.. .+++.+++|.+...... ..+.+.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 347899999999999985 47899999987765443 567899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++..+..++.++++||+|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 84 ~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 84 GTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999843 2357899999999999999999999 899999999999999999999999999998764432211
Q ss_pred c--eeeeecCCCCCCccccccCC---CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 690 F--SLEVRGTAGYLDPEYYSTQH---LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 690 ~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
. .....++..|+|||++.+.. .+.++||||||++++|+++|+.||..... .......... + ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~----~-----~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGA----G-----HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhc----C-----CCC
Confidence 1 11245788999999998766 88999999999999999999999975421 1111111110 0 011
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 226 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111 112345778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=301.75 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=198.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||+++++++|...+..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 3457899999999999985 468899999887655555678899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ..+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 102 ~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 102 SLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred cHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 99999842 357899999999999999999999 8999999999999999999999999999876543322 1
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....++..|+|||.+....++.++||||||+++||+++|+.||......... . .....+. +.. ..
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~~------~~~--~~ 237 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNGT------PEL--QN 237 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCCC------CCC--CC
Confidence 22345888999999998888999999999999999999999999754321110 0 0000000 000 01
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.......+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.18 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=191.1
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEee------CCeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCE------NDQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~LV~ 604 (863)
+.+.||+|+||.||+|.. .+++.+|+|+..... ....++..|+.++.++ +|+||+++++++.. .+..+++|
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 357999999999999996 468899999876543 2345788999999999 69999999999853 45789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||+++....
T Consensus 99 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 99 EFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999985432 3457888899999999999999999 8999999999999999999999999999876532
Q ss_pred CCCCCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+..... . ..
T Consensus 174 ~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--~----------~~ 239 (282)
T cd06636 174 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--L----------IP 239 (282)
T ss_pred ccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--h----------Hh
Confidence 211 122345889999999885 3467889999999999999999999996543211100 0 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+.+.. ......+.+++.+|++.+|.+||++.|+++
T Consensus 240 ~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 001111111 112346889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.96 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=189.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC-----CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-----TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 604 (863)
..++||+|+||.||+|... +|..||||.+.... ....+.+.+|++++++++|+||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3579999999999999864 58999999765322 12235788899999999999999999988764 4678999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++++|.+++.. ...+++...++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 86 EHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 99999999999843 2357888899999999999999998 8899999999999999999999999999986532
Q ss_pred CCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.+ ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~----~~~~~-----~~ 227 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--MAAIFK----IATQP-----TN 227 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--HHHHHH----HhcCC-----CC
Confidence 2111 111234588999999999888899999999999999999999999964321 111111 00000 01
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+ .........+.+++.+|+. +|++||++.||++
T Consensus 228 ~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 228 P----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 1122233456778888885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=295.66 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=201.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||.|+||+||+|.. .++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 4467899999999999995 468899999886543 23557899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++..... ...+++.....++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 84 GSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999954321 2468999999999999999999998 899999999999999999999999999997665433221
Q ss_pred --ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 690 --FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 690 --~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......|+..|+|||++... ..+.++|||||||+++||++|+.||....... .+.+.... ..+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~----------~~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN----------DPPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC----------CCCCc
Confidence 22334588999999998877 78999999999999999999999997543211 11111111 01111
Q ss_pred CCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... .......+.+++.+|++.+|++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110 0122356789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=307.89 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=205.0
Q ss_pred HhhcceecccCcEEEEEEecCC-CCEEEEEEcccCCCc---chHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQ---GTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+++|+++. |||||.+.+.++.....++|||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmE 116 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVME 116 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEE
Confidence 3455899999999999999764 999999988766543 3458899999999998 9999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC----CeEEEeeccCccc
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS----MCAKVADFGFSKY 681 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~~ 681 (863)
++.+|.|.+.+... .++......++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||+++.
T Consensus 117 L~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 117 LCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred ecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999543 28999999999999999999999 999999999999999543 5799999999998
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
... ........||+.|+|||.+....++..+||||.||++|.|++|.+||.......... .+..+..
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~--- 255 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF--- 255 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC---
Confidence 765 234556789999999999999999999999999999999999999998754322111 1111111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.............+.+++..|+..+|.+|+++.++++
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1222233334556788999999999999999999988
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=305.49 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=195.0
Q ss_pred hhcceecccCcEEEEEEecC---CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 603 (863)
.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 34578999999999999964 47899999887633 33346778999999999999999999999988 789999
Q ss_pred eecCCCCChhhhhhccCC-CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC----CCeEEEeeccC
Q 002943 604 YPFMSNGSLQDRLYGEAS-TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH----SMCAKVADFGF 678 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DFGl 678 (863)
|||+++ +|.+++..... ....++......++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999964 67766643222 22478899999999999999999999 89999999999999999 99999999999
Q ss_pred cccCCCCCCC-CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCc-------chhHHhh
Q 002943 679 SKYAPQEGDS-GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-------WSLVEWA 749 (863)
Q Consensus 679 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-------~~l~~~~ 749 (863)
++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.||........ ..+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 9876433221 112234578899999988764 578999999999999999999999976543220 0111111
Q ss_pred hhccc-----------ccccccccCCccCCCCc---------H--HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 750 KPFIR-----------ESRIDEIVDPSIKGGYH---------A--EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 750 ~~~~~-----------~~~~~~i~d~~l~~~~~---------~--~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+-. ........+......+. . .....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000000 0 12345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=284.95 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=196.6
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCCc----c----hHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEE
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ----G----TREFENELNFLSAI-RHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~----~----~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 603 (863)
+++||.|..+.|-++..+ +|++.|+|++...... . .++-..|+.+|+++ .||+|+.+.+++......++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 478999999999988864 6889999987643221 1 13445799999999 599999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+|.|+.|.|.++| ...-.++.....+|+.|+.+|++|||. ++|+||||||+|||+|+++++||+|||.|..++
T Consensus 102 Fdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999 345679999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCCceeeeecCCCCCCcccccc------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
.+.. ....+||++|+|||.+.. ..|+...|+|++||++|-|+.|.+||-.... +-. ..++.+|+
T Consensus 175 ~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlM----LR~ImeGk 244 (411)
T KOG0599|consen 175 PGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLM----LRMIMEGK 244 (411)
T ss_pred Cchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHH----HHHHHhcc
Confidence 6533 346789999999998853 3578899999999999999999999954210 111 11111221
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. + .......+......+|+.+|++.||.+|.|.+|+++
T Consensus 245 y-q-----F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 245 Y-Q-----FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c-c-----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 0 111112234456789999999999999999999986
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=305.98 Aligned_cols=252 Identities=22% Similarity=0.255 Sum_probs=197.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|++++++++|+||+++++.+...+..++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 3578999999999999965 5899999987755332 44678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ....+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 85 GGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999998532 23568999999999999999999999 89999999999999999999999999998755322110
Q ss_pred C---------------------------ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCC
Q 002943 689 G---------------------------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741 (863)
Q Consensus 689 ~---------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~ 741 (863)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0 0112357889999999998889999999999999999999999997543211
Q ss_pred cchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 742 EWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 742 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.+.+ +.+....-.........+.+++.+|++.+|++||++...++++.
T Consensus 240 --~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 240 --TFSN-------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred --HHHH-------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 1111 11111100001113456889999999999999999555544443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=300.30 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=197.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 3457899999999999996 468999999876554 233467999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ...+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 82 PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 99999998533 2568999999999999999999999 8999999999999999999999999999987654322
Q ss_pred CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc-----------
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES----------- 756 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------- 756 (863)
.......++..|+|||.+.+. .++.++||||+|++++||++|++||..... .....+....+...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccCc
Confidence 112234588999999998654 468899999999999999999888865332 11111111111000
Q ss_pred -ccccccCCccCC----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 -RIDEIVDPSIKG----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 -~~~~i~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+..+.-.. ....+....+.+++.+|++.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 000122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=308.14 Aligned_cols=238 Identities=28% Similarity=0.432 Sum_probs=195.0
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcc---hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQG---TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||.|+||.||-++. .+.+.||||+++-...+. ..++++|+..|.+++|||++.+.|++......+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 5799999999999985 567899999987665544 467899999999999999999999999999999999999 56
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
|-.|.|. ..+++|-...+..|+.++..||+|||+ .+.||||||+.||||.+.+.+||+|||.|....+.
T Consensus 111 SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 111 SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 7777763 235678899999999999999999999 88999999999999999999999999998876543
Q ss_pred eeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCCcc
Q 002943 691 SLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
..+.||+.|||||++. .++|+-|+||||+||+..||...++|+-.+....- .++.+- -.|.|
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-------------esPtL 245 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------------ESPTL 245 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-------------CCCCC
Confidence 3567999999999885 46899999999999999999999999865542110 011110 11222
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ..+-...+..++-.|++.-|.+|||..++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2 2233446888999999999999999988765
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.67 Aligned_cols=254 Identities=24% Similarity=0.310 Sum_probs=188.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~L 602 (863)
...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++... ...++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence 3457899999999999985 568899999876532 22345678999999999999999999987543 35689
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
++|++ +++|.+++. ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 98 ~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 98 VTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 99988 789988773 2358999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc---------
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF--------- 752 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--------- 752 (863)
... .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||....... .+..+....
T Consensus 169 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 432 123468999999999876 568899999999999999999999996532111 011110000
Q ss_pred -ccccccccccC--CccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 753 -IRESRIDEIVD--PSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 753 -~~~~~~~~i~d--~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+........+. +..... ........+.+++.+|++.+|++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000000 00001124678999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.89 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=203.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++.+.||+|++|.||++... +++.|+||++..... ...+++.+|++.+.+++|+|++++++++...+..++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 34589999999999999976 589999998776544 4457899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ..+++..++.++.|+++||+|||+. .+++|+||+|+||+++.++.++|+|||+++........
T Consensus 84 ~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 84 GSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999432 5689999999999999999999972 67999999999999999999999999999876433221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..........+.++... . ..+.+...
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~-----~~~~~~~~ 226 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----G-----PPPSLPAE 226 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----C-----CCCCCCcc
Confidence 2245688999999999999999999999999999999999999976542122222222221 0 00111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.....+.+++.+|++.+|++||++.|+++.
T Consensus 227 ---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 ---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 033568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.37 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=191.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD- 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence 34578999999999999965 6899999987654322 23467789999999999999999999999999999999997
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 87 TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 5999988532 2368899999999999999999999 8999999999999999999999999999875432111
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccccc----
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRIDEI---- 761 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i---- 761 (863)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... ......+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122346889999998875 457899999999999999999999996543110 00000000000 0000000
Q ss_pred --c--------CCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 --V--------DPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 --~--------d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0011246779999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=315.60 Aligned_cols=244 Identities=23% Similarity=0.462 Sum_probs=195.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEE---EEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe--eEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVA---VKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQ--QILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vA---VK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~LV~e 605 (863)
|..+||+|+|=+||||... +|.+|| ||.-+.. +....+.|..|+.+|+.|+|+||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999864 577887 4432221 23345789999999999999999999999987665 678999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~ 684 (863)
.|..|+|..|+.. .+.++......+|.||.+||.|||++. ++|||||||-+||+|+. -|.+||+|+|||..+..
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999943 356788899999999999999999965 89999999999999974 58999999999998753
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. ...+.||+.|||||++. ..|.+..||||||+.++||+|+..||..... .-.+...|...++...+..+-||
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCH
Confidence 32 23478999999999997 7899999999999999999999999975432 22333444433333333333332
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
++.+++..|+.. .++|||+.|+++
T Consensus 272 ------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 367899999999 999999999865
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.08 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=193.9
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+...+.||+|+||.||+++. .+++.+|+|.+..... ...+.+.+|++++++++|+|+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 34457899999999999995 4688999998765432 2335788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
++ |+|.+.+... ...++|.++..++.+++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 5888777432 3468999999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
....|+..|+|||++. .+.++.++|||||||+++||++|+.||...... ..+..+... +.
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~----~~------ 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN----ES------ 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhc----cC------
Confidence 2345888999999974 456889999999999999999999998653211 111111110 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+.. ........+.+++.+|++.+|++||++.||++.+-
T Consensus 242 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 001 01122345789999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=296.26 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=199.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||++... +++.+|+|.+..... ...+++.+|++++++++||||+++++.+...+..++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34578999999999999975 689999998766532 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...++......++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 84 GSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999998532 2568889999999999999999997 25899999999999999999999999999876532211
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
....++..|+|||++.+..++.++||||||++++||++|+.||...... .....+......... -+.+...
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~ 227 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP------PPRLPSG 227 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC------CCCCChh
Confidence 1156888999999999999999999999999999999999999754311 111222221111110 0111111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+++.+|+..+|++||++.|++.
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 ---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13345889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=301.56 Aligned_cols=257 Identities=21% Similarity=0.244 Sum_probs=194.8
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-----chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-----GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.||+|+||.||+|... +|+.||||.+...... ....+..|++++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 4578999999999999964 6899999988655432 235677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+ +|+|.+++.... ..+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 84 M-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred c-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9 999999995321 368999999999999999999999 899999999999999999999999999998764432
Q ss_pred CCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---------c
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---------S 756 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---------~ 756 (863)
. ......++..|+|||.+.+ ..++.++|||||||+++||++|..||......+ ........... .
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcc
Confidence 1 1122346788999998855 467899999999999999999988876533211 11111000000 0
Q ss_pred ccccccCCccCCCC-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDEIVDPSIKGGY-----HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~i~d~~l~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.............. .......+.+++.+|++.+|++||++.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001 1123456889999999999999999999977
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.06 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=195.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCC------eeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCEND------QQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~LV 603 (863)
.+.+.||+|+||.||+|... +++.+++|++..... ..+++.+|+++++++ +|+||+++++++.... ..++|
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 34589999999999999974 678999998765543 346789999999999 6999999999997654 48999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++++|.+++.........+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999986543335678999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCCCCceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
... .......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... ..+.+.. .+.
T Consensus 165 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-----~~~- 234 (275)
T cd06608 165 STL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFKIP-----RNP- 234 (275)
T ss_pred cch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHHhh-----ccC-
Confidence 321 11223458899999998754 34678999999999999999999999653211 1111110 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.+. ...+....+.+++.+|+..+|++|||+.|+++
T Consensus 235 ----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 ----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111 11123446889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.87 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=196.9
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 6999999999999985 478899999876655555667899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 99843 358899999999999999999999 8999999999999999999999999999876543221 1223
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..|+..|+|||.+.+..++.++||||||++++||++|+.||....+ .+...... ... .+.+.. ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~-~~~-----~~~~~~--~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIR-DNL-----PPKLKN--LHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHH-hcC-----CCCCcc--ccc
Confidence 4588999999999888899999999999999999999999865322 11111111 110 011110 111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+.+++.+|++.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2346889999999999999999998875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=300.01 Aligned_cols=258 Identities=19% Similarity=0.233 Sum_probs=191.9
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|+.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 82 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD- 82 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence 4578999999999999964 68999999876432 2233567889999999999999999999999999999999996
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++... ...+++...+.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 83 QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 6888887432 3468999999999999999999999 8999999999999999999999999999986533211
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc------cccccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES------RIDEIV 762 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~i~ 762 (863)
......++..|+|||.+.+. .++.++|||||||+++||+||+.|+....... ...+......... .+.+..
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 11233578899999998765 46899999999999999999998864332111 1111100000000 000000
Q ss_pred CCc----cCC-----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPS----IKG-----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~----l~~-----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. ... .........+.+++.+|++.+|.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000 001112346789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.88 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=202.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
++..+||+|+||.|||+..+ .|+.+|||..... .+.+++.+|+.+|++.+.|++|+++|.+.....+++|||||..|
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 34578999999999999865 6999999987654 35678999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+..+.++. ++++|...+...+.....+||+|||. ..-||||||+.||||+.++.+||+|||.|-.+.. ....
T Consensus 114 SiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK 185 (502)
T KOG0574|consen 114 SISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK 185 (502)
T ss_pred cHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence 99999953 45789999999999999999999999 7789999999999999999999999999976532 2233
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
...+.||+.|||||++..-.|..++||||+|+...||..|++||.+..+..- .-++.... -|.+ ..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT~P-----PPTF--~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPTKP-----PPTF--KK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccCCC-----CCCC--CC
Confidence 4567899999999999999999999999999999999999999976543110 00000000 0111 11
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+-...+-+++.+|+-.+|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2233456889999999999999999888765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.13 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=191.0
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||.||+++.. +++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 489999998765432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999532 358899999999999999999999 899999999999999999999999999998765432 122
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...++..|++||.+....++.++|+||||+++|||++|+.||...... . .+....... ......++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~~~---------~~~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-P---MEIYNDILK---------GNGKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-H---HHHHHHHhc---------cCCCCCCCc
Confidence 345788999999998888999999999999999999999999765321 1 111111110 000011111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.....+.+++.+|++.+|++||++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCC
Confidence 124468899999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.68 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=184.9
Q ss_pred eecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHh---cCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 536 LIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLS---AIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~---~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+||+|+||.||++.. .+++.+|||.+..... .....+.+|..+++ ..+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 4689999998765422 22233445544433 4479999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998843 3469999999999999999999999 889999999999999999999999999987553221
Q ss_pred CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..........+.+... .....+.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 219 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVELP 219 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcCCc
Confidence 122458999999999864 568899999999999999999999997543222111111100 0111121
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
......+.+++.+|++.+|++|| +++|+++
T Consensus 220 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 220 ----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 12234578899999999999999 5877755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.69 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=200.5
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeecCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPFMS 608 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey~~ 608 (863)
.+.||+|++|.||+|... +++.|++|+...... ...+.+.+|++++++++|+||+++++.+... +..++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 478999999999999975 689999998766543 4467889999999999999999999999988 88999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++... ..+++..+..++.++++||+|||+ .+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 85 ~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999432 378999999999999999999999 89999999999999999999999999999877544321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......++..|+|||.+.+...+.++||||||++++||++|+.||..... ...-.......... .
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~---------~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP---------P 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC---------c
Confidence 112345688999999999888899999999999999999999999976431 11111111100000 1
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+.+++.+|++.+|++||++.|+++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=296.89 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=198.4
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||.||+++.. +|+.+++|++..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999998865543 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC----
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS---- 688 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~---- 688 (863)
.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999532 368999999999999999999998 89999999999999999999999999998765433211
Q ss_pred --CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 689 --GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 689 --~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......++..|+|||.......+.++||||||++++||++|+.||...... ...+.... +... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~----~~~~------~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILN----GKIE------W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----CCcC------C
Confidence 1223345788999999998888999999999999999999999999754321 11111110 1000 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.... .....+.+++.+|++.+|++||++.++.+.|+..+
T Consensus 221 ~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 221 PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 0000 01346789999999999999999988887776543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.13 Aligned_cols=246 Identities=28% Similarity=0.414 Sum_probs=198.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||+|+||.||+|... +++.+++|++..... ..+.+.+|++++++++|+|++++++++...+..++|+||+++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 3478999999999999976 688999998876544 56778999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.... ..+++..++.++.+++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 102 L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 173 (286)
T cd06614 102 LTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KR 173 (286)
T ss_pred HHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hh
Confidence 999995432 379999999999999999999999 8999999999999999999999999999875543221 12
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....... ....... .......+ .
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~~~-----~~~~~~~~-------~ 239 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLITT-----KGIPPLKN-------P 239 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-----cCCCCCcc-------h
Confidence 23457889999999988889999999999999999999999986532211 1111100 00011000 1
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|.+||++.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112345889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.51 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=200.8
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++...+..++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3478999999999999975 689999999877655566789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++..+..++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 84 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 84 LKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99998432 2578999999999999999999999 8999999999999999999999999999987654321 2
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....++..|+|||++.+...+.++||||||++++||++|+.||....... ....... .......++
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~----~~~~~~~~~------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKIAT----NGPPGLRNP------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHh----cCCCCcCcc-------
Confidence 34568899999999988889999999999999999999999997542111 1111000 001111110
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011345889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=298.86 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=195.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey~ 607 (863)
+.+.||+|+||.||+|+.. +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 3578999999999999865 58899999887653 33346788999999999999999999999988 8899999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+ ++|.+++... ...+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 83 D-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred c-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 7 5898888432 2468999999999999999999999 8899999999999999999999999999986654321
Q ss_pred CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccc---c
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRID---E 760 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~---~ 760 (863)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......... ..... .
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 A-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccccc
Confidence 1 1223346788999998765 457899999999999999999999997543211 1111110000 00000 0
Q ss_pred -----------ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 -----------IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 -----------i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.......+...+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000011112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.78 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=200.5
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.++||+|+||.||++.. .+++.+|+|.+.... .....++.+|++++++++|+||+++.+++......++|+||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 457899999999999974 478899999876543 23345788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.........+++...+.++.+++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99999986543344678999999999999999999998 89999999999999999999999999999876543
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......++..|+|||.+.+..++.++|+||||++++||++|+.||..... ..+...+. .+... .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~---------~ 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQ----RGKYP---------P 220 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCCCC---------C
Confidence 12224578899999999998999999999999999999999999975431 11111111 11111 1
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
........+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.08 Aligned_cols=242 Identities=24% Similarity=0.300 Sum_probs=196.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
++.+.||.|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 34589999999999999975 589999998865432 34578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+++|.+++.. ...+++.....++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 83 LGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999943 2468899999999999999999998 899999999999999999999999999988664332
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......|+..|+|||.+.+..++.++|+||||+++++|++|+.||....... .++....... .. +
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~----~--- 219 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--AD----V--- 219 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cc----c---
Confidence 1233458889999999998889999999999999999999999998654321 1111111110 00 0
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
..+......+.+++.+|++.+|.+||++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 220 -LYPATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred -cCcccCcHHHHHHHHHHccCChhHcCCcc
Confidence 11112235688999999999999999994
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.23 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=192.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||++.. .+|+.+|+|.+..... .....+.+|+.++.++. |+||+++++++...+..+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 446899999999999985 4689999998765432 34567889999999996 9999999999999999999999985
Q ss_pred CChhhhhhc-cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 610 GSLQDRLYG-EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 610 gsL~~~L~~-~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
++|.++... .......+++....+++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 162 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-- 162 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence 455544321 111235689999999999999999999972 489999999999999999999999999997653321
Q ss_pred CceeeeecCCCCCCccccccC---CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQ---HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+........ ..+.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~~~ 230 (288)
T cd06616 163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DPPI 230 (288)
T ss_pred -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CCCc
Confidence 11233588899999998776 68899999999999999999999997532 111111111111 0112
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+...........+.+++.+|++.+|++||++.||++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2111112234468899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.09 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=202.3
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEc--ccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVR--SSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~--~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+...++||+||.+.||++...+.+.+|+|++ ...+.+...-|.+|+++|.+|+ |.+||+|++|-..++.+|+||||-
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 3345789999999999999988899999864 3445566678999999999996 999999999999999999999976
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+.+|..+|.... .....| .+..+..|++.++.++|+ .+|||.||||.|+|+-. |.+||+|||+|..+..+..
T Consensus 443 -d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 443 -DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred -cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 779999995432 223335 778899999999999999 89999999999999964 5799999999999988776
Q ss_pred CCceeeeecCCCCCCccccccC-----------CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-----------HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
.-......||..||+||.+... +.+.++||||+|||||+|+.|+.||.... -.| .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~-------a 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI-------A 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH-------H
Confidence 6667778899999999988533 35689999999999999999999997421 122 1
Q ss_pred ccccccCCccCCCCcH-HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHA-EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~-~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
++..+.||.-.-+++. ..-.++++++..|++.||++||+..|+++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3556667654333321 12223899999999999999999999976
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.79 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=194.4
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|... +++.+|+|.++..... ....+.+|++++++++||||+++++++... +..++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 445588999999999999975 5889999987654322 234577899999999999999999999877 88999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+. ++|.+++... ...+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 87 YVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 996 5999988532 2368999999999999999999999 88999999999999999999999999999866443
Q ss_pred CCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHH---------hhh--hc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVE---------WAK--PF 752 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~---------~~~--~~ 752 (863)
.. ......++..|+|||.+.+. .++.++|+||||++++||++|+.||.......... +.. |.. ..
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 21 11234578899999998764 46889999999999999999999997543211100 000 000 00
Q ss_pred --ccccccccccCCccCCCCcHH-HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 753 --IRESRIDEIVDPSIKGGYHAE-AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 753 --~~~~~~~~i~d~~l~~~~~~~-~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.............+...+... ....+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111111 2445788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.21 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=190.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|++++++++|+||+++.+++..++..++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 457899999999999985 4689999998765433 233567899999999999999999999999999999999995 7
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+.+.....++.|++.||+|||+ .+|+|+||||+|||++.++++||+|||+++........
T Consensus 88 ~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-- 159 (291)
T cd07870 88 DLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-- 159 (291)
T ss_pred CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--
Confidence 887777432 2457888899999999999999999 88999999999999999999999999999764332111
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHH-hhhhccc-c----------cc
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE-WAKPFIR-E----------SR 757 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~-~~~~~~~-~----------~~ 757 (863)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||+......+ .+.+ |...... . ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhhcccc
Confidence 1223478899999998764 578899999999999999999999975432111 1111 0000000 0 00
Q ss_pred cccccC---C-ccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEIVD---P-SIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i~d---~-~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+... + .+.... .......+.+++.+|++.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0 000000 0011345778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.12 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=193.7
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccC--CCcchHHHHHHHHHHhcC-CcccccceeeeEeeC--CeeEEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST--STQGTREFENELNFLSAI-RHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~LV 603 (863)
.+.+.+.||+|+||.||+|... +|+.+|||++... .......+.+|+.+++++ +|+||++++++|... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 3445689999999999999965 6889999987542 223345677899999999 999999999998654 367999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||++ ++|.+++.. ..++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 88 FEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99996 699988832 268899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCC---CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc----
Q 002943 684 QEGDS---GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---- 755 (863)
Q Consensus 684 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 755 (863)
..... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+..............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 43221 12233468999999998765 45788999999999999999999999754321110000000000000
Q ss_pred ----cccccccC----CccC--CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 756 ----SRIDEIVD----PSIK--GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 756 ----~~~~~i~d----~~l~--~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.....+++ .... .....+....+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000111 0000 00001123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.56 Aligned_cols=234 Identities=25% Similarity=0.370 Sum_probs=190.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 34678999999999999864 68999999876532 223466889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 84 PGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999998432 468999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||..... ....+... .+. ..+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~------~~~~ 218 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKIL----EGK------VRFP 218 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCC------ccCC
Confidence 2234588999999999888889999999999999999999999975331 11111110 111 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP 794 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP 794 (863)
... ...+.+++.+|++.+|.+||
T Consensus 219 ~~~----~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 219 SFF----SPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred ccC----CHHHHHHHHHHccCCHHHcc
Confidence 111 34578899999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.85 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=196.8
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 4578999999999999965 58899999876542 23446788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~~ 688 (863)
++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 84 GDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999543 23357999999999999999999998 8999999999999999875 579999999986643221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......|+..|+|||+..+..++.++||||||++++||++|+.||.... ..++....... .... ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~-----~~- 223 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-YFAP-----IS- 223 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-cCCC-----CC-
Confidence 1223458899999999988889999999999999999999999986432 22222221111 1111 11
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 ---PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112235889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.05 Aligned_cols=257 Identities=20% Similarity=0.246 Sum_probs=192.3
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 478999999999999864 68999999876443 2233578899999999999999999999999999999999995 6
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ....+++.....++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++....... .
T Consensus 84 ~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 156 (284)
T cd07860 84 DLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--T 156 (284)
T ss_pred CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--c
Confidence 899988543 23568999999999999999999999 8999999999999999999999999999986543211 1
Q ss_pred eeeeecCCCCCCccccccCC-CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc-c------------
Q 002943 691 SLEVRGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE-S------------ 756 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-~------------ 756 (863)
.....++..|+|||.+.+.. ++.++||||||++++||+||+.||...... ..+.+.....-.. .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 12234688999999887654 588999999999999999999999653211 1111111100000 0
Q ss_pred --ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 --RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 --~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+. .........+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000011234678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=282.25 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=197.0
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+++.+.||+|.|+.||++.. +.|+.+|+|++... +..+.+++.+|+++-+.|+||||++|.....+....+||+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 34557899999999999874 57999999976433 3446788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~~~ 684 (863)
.+|+|..-+-. +...++...-..+.||.++|.|+|. ++|||||+||.|+||- ..--+||+|||+|..+..
T Consensus 93 ~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 93 TGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred cchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999876632 2456677778899999999999999 9999999999999994 445689999999998762
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
........||++|||||++...+|+..+|||+.||||+-|+.|++||.+.. ...+.+-+.. +... +++
T Consensus 166 ---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~----g~yd--~~~ 233 (355)
T KOG0033|consen 166 ---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKA----GAYD--YPS 233 (355)
T ss_pred ---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhc----cccC--CCC
Confidence 223345679999999999999999999999999999999999999997632 2223332221 1100 111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. +-....++..+|+.+|+..||.+|.|+.|.++
T Consensus 234 ~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 P----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred c----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 11122334678899999999999999988864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.45 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=193.5
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|++|.||+|.. .+|..||||++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+ +
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-D 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-C
Confidence 347899999999999985 479999999876543 223457889999999999999999999999999999999999 5
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.... ...+++..++.++.|+++||+|||+ ++++|+||+|+||+++.++.+||+|||+++.......
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 79999985432 2468999999999999999999999 8999999999999999999999999999976533211
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc--------cccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES--------RIDE 760 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~~ 760 (863)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+.+......... .+.+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence 11223468899999988664 56889999999999999999999997543211 1111111000000 0000
Q ss_pred c-------cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 I-------VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i-------~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ..+... .........+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000 001112246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=294.64 Aligned_cols=255 Identities=23% Similarity=0.256 Sum_probs=191.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCC-cccccceeeeEeeC--CeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIR-HENLVPLLGYCCEN--DQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~LV~ey~ 607 (863)
+.+.||+|+||.||+|.. .+++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 457899999999999985 468999999876542 222334567899999985 99999999999987 8899999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+ |+|.+++... ...++|.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 83 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 83 D-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred C-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 6 6888888432 2468999999999999999999999 89999999999999999 9999999999986643222
Q ss_pred CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc-----------cc
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI-----------RE 755 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~ 755 (863)
. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... .....+..... ..
T Consensus 155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhcc
Confidence 1 22357889999997654 5678899999999999999999999976432 11222211111 00
Q ss_pred cccccccCCccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 SRIDEIVDPSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ~~~~~i~d~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
........+...+. ........+.+++.+|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00011111110000 01123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=299.26 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=190.5
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCC--------e
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEND--------Q 599 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~ 599 (863)
+.+.++||+|+||.||++... +++.||||.+..... .....+.+|++++++++||||++++++|...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 344588999999999999864 689999998754322 22345678999999999999999999987654 3
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++||||+. ++|.+++.. ....+++.+.+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 499999996 588888743 23468999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCC--CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 680 KYAPQEGDS--GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 680 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||......................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 111233578899999988664 46889999999999999999999997543221111111111100000
Q ss_pred cccc-----ccCC-ccCCCC---------cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDE-----IVDP-SIKGGY---------HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~-----i~d~-~l~~~~---------~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ..+. .+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 0000 000000 0001235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=293.55 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=191.7
Q ss_pred ecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||+||++.. .+|+.+|+|.+.... ....+.+..|++++++++|||++++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468999999876432 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 99995432 2468999999999999999999999 899999999999999999999999999998654321 112
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...++..|+|||++.+..++.++||||||++++||++|+.||.......... + ....... ........
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~~~~------~~~~~~~~--- 220 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRRTLE------MAVEYPDK--- 220 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhcccc------ccccCCcc---
Confidence 3457889999999988889999999999999999999999997643211100 0 0000000 00011111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHH-HHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVD-IVREL 803 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~e-Vl~~L 803 (863)
....+.+++.+|++.+|++||+.+| ....|
T Consensus 221 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 221 -FSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred -CCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 2335789999999999999996655 44433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.33 Aligned_cols=197 Identities=25% Similarity=0.384 Sum_probs=168.7
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-c-----ccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-H-----ENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|.||.|-||.. .+++.||||+++... .-.++-..|+.+|..|+ | -|+|++++|+..+++.+||
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 34468999999999999984 569999999987653 23355678999999997 4 4999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC--CCeEEEeeccCccc
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--SMCAKVADFGFSKY 681 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DFGla~~ 681 (863)
+|.+ .-+|.++|..+ ....++......|+.||+.||.+||+ .+|||+||||+||||.+ ...+||+|||.|..
T Consensus 267 fELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9988 67999999654 34569999999999999999999998 99999999999999964 34799999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~ 739 (863)
..... .....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..+
T Consensus 341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 64322 144568899999999999999999999999999999999888877653
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.54 Aligned_cols=262 Identities=20% Similarity=0.222 Sum_probs=190.9
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCe-----eEEE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQ-----QILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~-----~~LV 603 (863)
..+.||+|+||.||+|... +|+.||||...... ....+.+.+|++++++++ |+||+++++++...+. .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 3578999999999999964 68999999865443 223467889999999995 6999999999987665 7999
Q ss_pred eecCCCCChhhhhhccCCC-CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCccc
Q 002943 604 YPFMSNGSLQDRLYGEAST-RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKY 681 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 681 (863)
|||+++ +|.+++...... ...+++...+.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999975 898888643322 4568999999999999999999999 89999999999999998 89999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRID 759 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~ 759 (863)
...... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+.+.... .......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (295)
T cd07837 161 FSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT-PTEQVWP 237 (295)
T ss_pred cCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC-CChhhCc
Confidence 532211 1122346888999998865 4578999999999999999999999975322110 000000000 0000000
Q ss_pred cc---cC----CccCC----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EI---VD----PSIKG----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i---~d----~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. .+ +.... .........+.+++.+|++.+|.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00 00000 000122345889999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.30 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=191.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~ 604 (863)
.+.++||+|+||.||+|.. .+|+.||||.++... ......+.+|+.++++++|+||+++++++.... ..++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 3458999999999999985 578999999886432 233466889999999999999999999876543 579999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||++ ++|.+++. ...+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 88 e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 88 ELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred hhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9996 58887773 2468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCC-CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---cccc
Q 002943 685 EGD-SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---SRID 759 (863)
Q Consensus 685 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~ 759 (863)
... ........|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ....+....+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHHH
Confidence 221 111223458899999998755 46889999999999999999999999653211 111111111110 0011
Q ss_pred cccCCcc-------C--CCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 760 EIVDPSI-------K--GGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 760 ~i~d~~l-------~--~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+.+... . .... ......+.+++.+|++.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111000 0 0000 1123458899999999999999999998775
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=295.19 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=196.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
.+||+|+||.||++.. .+|+.||||.+..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999876655555677999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
+++. ...+++.....++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++....... .....
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 9873 2357899999999999999999999 899999999999999999999999999987654322 11233
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..|+..|+|||.+.+..++.++||||||++++||++|+.||..... ........... .+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~---------~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL---------PPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhC---------CcccCC--ccc
Confidence 4588999999999888899999999999999999999999875321 11111111111 111110 011
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+.+++.+|++.+|.+||++.|+++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2234778899999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=296.02 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=192.2
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC--------
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND-------- 598 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 598 (863)
.+.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++|||++++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 3445689999999999999975 58899999876543 223356788999999999999999999987655
Q ss_pred --eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 599 --QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 599 --~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
..++|+||+++ +|.+.+... ...+++...+.++.|++.||+|||+ .+|+|+||||+||++++++.+||+||
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999975 777776432 3468999999999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhhhccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAKPFIR 754 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~~~~~ 754 (863)
|+++........ ......++..|+|||.+.+. .++.++|||||||+++||++|+.||.......... +.+......
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 238 (302)
T cd07864 161 GLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC- 238 (302)
T ss_pred cccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 999876543221 11223467889999988653 57889999999999999999999997533211110 001000000
Q ss_pred ccccccc--------cCC------ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEI--------VDP------SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i--------~d~------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+ .++ .+.... ......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 000 000000 012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=288.14 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=201.4
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||++... +++.+++|++..... ...+++.+|++++++++|+|++++++.+...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 3578999999999999964 689999998876543 4556789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.........+++..+..++.+++.||+|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 99999996543334679999999999999999999999 899999999999999999999999999998664432 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
......|+..|+|||......++.++||||+|+++++|++|+.||..... ..+.. .... ... +.+..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~-----~~~~~- 225 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELAL---KILK-GQY-----PPIPS- 225 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHH---HHhc-CCC-----CCCCC-
Confidence 22334688899999999888899999999999999999999999965431 11111 1111 011 11111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+++.+|++.+|++||++.|+++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 ---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=292.59 Aligned_cols=261 Identities=22% Similarity=0.312 Sum_probs=194.9
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|++|.||+|+.. +|+.||||.+...... ....+.+|++++++++|+||+++++++...+..++||||++ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-K 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-c
Confidence 4578999999999999975 6889999987655432 34667889999999999999999999999999999999997 5
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....... .
T Consensus 83 ~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 156 (284)
T cd07836 83 DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--T 156 (284)
T ss_pred cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--c
Confidence 8888885432 23468999999999999999999998 8999999999999999999999999999976533211 1
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhhhcccccccccc-----cC
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAKPFIRESRIDEI-----VD 763 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~i-----~d 763 (863)
.....++..|++||.+.+. .++.++|||||||++|||++|+.||......+... +.+..... .......+ ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP-TESTWPGISQLPEYK 235 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC-ChhhHHHHhcCchhc
Confidence 1233478899999988664 56889999999999999999999997643221100 11100000 00000000 00
Q ss_pred CccC-------CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIK-------GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ..........+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=303.76 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=193.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~e 605 (863)
+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4578999999999999854 68999999876543 2334677889999999999999999998763 346799999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+. |+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 89 ~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 89 LME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred hhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 995 689998843 3458999999999999999999999 89999999999999999999999999999765433
Q ss_pred CCC--CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh--------hhccc
Q 002943 686 GDS--GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA--------KPFIR 754 (863)
Q Consensus 686 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~--------~~~~~ 754 (863)
... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............-. .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 221 11223468899999998865 46889999999999999999999999764321111000000 00000
Q ss_pred ccccccccCC-ccCCCC-----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDP-SIKGGY-----HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~-~l~~~~-----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+..+. ...... .......+.+++.+|++.+|++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011111100 000001 1123456899999999999999999998876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=296.78 Aligned_cols=256 Identities=17% Similarity=0.190 Sum_probs=180.7
Q ss_pred HhhcceecccCcEEEEEEecCC----CCEEEEEEcccCCCcch-----------HHHHHHHHHHhcCCcccccceeeeEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQGT-----------REFENELNFLSAIRHENLVPLLGYCC 595 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g~~~ 595 (863)
+.+.++||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 3456899999999999999654 45677775433322111 11223344566778999999999776
Q ss_pred eCC----eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeE
Q 002943 596 END----QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA 671 (863)
Q Consensus 596 ~~~----~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~ 671 (863)
... ..++++|++. .++.+.+.. ....++.....++.|+++||+|||+ ++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 554 3467777763 456665522 1235678889999999999999999 899999999999999999999
Q ss_pred EEeeccCcccCCCCCCC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH
Q 002943 672 KVADFGFSKYAPQEGDS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 746 (863)
||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+++||++|+.||........ +.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LI 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HH
Confidence 99999999866432211 111234699999999999999999999999999999999999999976532211 11
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
..... +.+..+..+.+.- ..+...+.+++..|++.+|++||++.++.+.|
T Consensus 244 ~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKC----DFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHH----HHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10000 0001111111110 11234588999999999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=289.46 Aligned_cols=241 Identities=21% Similarity=0.300 Sum_probs=185.7
Q ss_pred eecccCcEEEEEEec-CCCCEEEEEEcccCCCc---chHHHHHHHH---HHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 536 LIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---GTREFENELN---FLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---~~~~f~~E~~---~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+||+|+||.||++.. .+++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46889999987654321 1223444443 4444579999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998842 3469999999999999999999999 889999999999999999999999999997553221
Q ss_pred CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....|+..|+|||.+.++ .++.++|||||||+++||++|+.||............. .. ...++.+.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~---------~~~~~~~~ 219 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MT---------LTMAVELP 219 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hh---------hccCCCCC
Confidence 1233589999999998754 68999999999999999999999997643222111100 00 00111121
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
.. ....+.+++.+|++.+|.+|| ++.|+++
T Consensus 220 ~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred Cc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 234688999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=290.19 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=190.2
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHH-HhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNF-LSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||+|.. .+|+.||||.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999986 4689999998765432 222344555544 4455899999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999843 2468899999999999999999999 8999999999999999999999999999876432
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+.+..++.++||||||++++||++|..||...... ...+-. ..+... ..+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~--~~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNI----LSRRIN--WPEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HhcccC--CCCcc---
Confidence 12335788999999998888899999999999999999999999754321 111100 000000 00011
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.......+.+++.+|++.+|++||++.++.+.|...
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence 112234588999999999999999988777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=286.07 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=208.5
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeC-CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEN-DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV 603 (863)
+.+.++-+|.||.||+|.+. +.+.|.||.++... .-....|+.|.-++..+.|||+.++.+.|.+. +..+.+
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 33568899999999999653 45667888665543 33456788999999999999999999999765 467888
Q ss_pred eecCCCCChhhhhhc----cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 604 YPFMSNGSLQDRLYG----EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~----~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
|.++.-|+|..+|.. .....+.++-.+...+|.|++.||+|||. .++||.||.++|+++|+...+||+|=.|+
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhc
Confidence 999999999999962 22345678888999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
|.+.+.+.............||+||.+....|+..+|||||||+||||+| |+.|+...++.+ ... ++++|.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~----ylkdGy- 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEH----YLKDGY- 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHH----HHhccc-
Confidence 98877766555555567889999999999999999999999999999999 999997654322 111 122221
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
++ ..+.+|+.++..++.-||...|++||+.++++.-|.+.
T Consensus 516 ------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 516 ------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11 22345677899999999999999999999999999764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=303.76 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=192.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV~ 604 (863)
..+.||+|+||.||++.. .+|+.||||.+... .......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 357899999999999985 46899999987643 233345678899999999999999999988654 3479999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+. ++|.+++. ....+++.....++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 89 ELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred eCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 9995 78988883 23468999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhh-------hcccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAK-------PFIRE 755 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~-------~~~~~ 755 (863)
.. .......++..|+|||.+.. ..++.++|||||||+++||++|+.||.......... +.+... .....
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 22 12233457889999998865 468899999999999999999999997543111100 000000 00000
Q ss_pred cccccc-------cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 756 SRIDEI-------VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 756 ~~~~~i-------~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
....+. .++.+. .........+.+++.+|++.+|++||++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 000000 0011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=297.24 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=190.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey 606 (863)
++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++|+||+++++++... +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34578999999999999964 689999998764432 2234567899999999999999999998755 468999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+. ++|.+++... ...+++.++..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 90 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 90 CE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred CC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 96 5888888432 2568999999999999999999999 889999999999999999999999999998764332
Q ss_pred CCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhh-------hcccccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAK-------PFIRESR 757 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~-------~~~~~~~ 757 (863)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.++.. +.+....
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1 1122345788999999865 457899999999999999999999997543211111 111000 0000000
Q ss_pred c-c--cccCCccCC--CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 I-D--EIVDPSIKG--GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~-~--~i~d~~l~~--~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. . .+-...... .........+.+++.+|++.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0 000000000 000012345778999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=293.13 Aligned_cols=256 Identities=20% Similarity=0.247 Sum_probs=196.2
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|++|.||++... +|+.+++|.+...... ....+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 468999999999999864 6889999987654332 456788999999999999999999999999999999999964
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 ~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 83 DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 888888432 2578999999999999999999999 899999999999999999999999999998765432 11
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---cccccccC---
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---SRIDEIVD--- 763 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d--- 763 (863)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+ ........+.. .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhh
Confidence 1234578899999998876 78999999999999999999999996543211 11110000000 00000000
Q ss_pred ---CccC-------CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 ---PSIK-------GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ---~~l~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... .....+...++.+++.+|++.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=294.72 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=190.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|++|.||+|... +|+.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34578999999999999965 689999998765432 334678899999999999999999999999999999999995
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~~ 687 (863)
++|.+++... ....+++.....++.|++.||+|||+ ++++||||||+||+++. +..+||+|||+++.......
T Consensus 85 -~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 85 -LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred -ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 6888887432 22346778888999999999999999 89999999999999985 56799999999976543211
Q ss_pred CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhccccc-----cccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRES-----RIDE 760 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~-----~~~~ 760 (863)
......++..|+|||++.+. .++.++|||||||++|||+||+.||......+.. ...++........ .+..
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11233578899999988664 5789999999999999999999999754321110 0000000000000 0000
Q ss_pred cc--CCccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 IV--DPSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i~--d~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. -+..... ........+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000000 00112345789999999999999999999976
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=298.43 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=192.1
Q ss_pred ceeccc--CcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEG--GFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G--~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
..||+| +||+||++.. .+|+.||||++..... ...+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999986 4799999998765432 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.... ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999985432 2358899999999999999999998 899999999999999999999999998654332111110
Q ss_pred -----ceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc---------c
Q 002943 690 -----FSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF---------I 753 (863)
Q Consensus 690 -----~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~---------~ 753 (863)
......++..|+|||++.+. .++.++|||||||+++||++|+.||....... .+.+..... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 00112346679999999764 47899999999999999999999997643211 111100000 0
Q ss_pred -----------------------cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 -----------------------RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 -----------------------~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+..+...........+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000111111222222345567899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=294.38 Aligned_cols=259 Identities=20% Similarity=0.271 Sum_probs=191.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4455566666666665 7899999987654 334456899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC----
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS---- 688 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~---- 688 (863)
.+++... ....+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999543 23458889999999999999999999 89999999999999999999999999998755322111
Q ss_pred -CceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc----cc------
Q 002943 689 -GFSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI----RE------ 755 (863)
Q Consensus 689 -~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~----~~------ 755 (863)
.......++..|+|||.+... .++.++|||||||++|||++|+.||...... ..+.+...... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhh
Confidence 111234477889999998763 5789999999999999999999999754321 11111111000 00
Q ss_pred -ccccc----ccCCccCC----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 -SRIDE----IVDPSIKG----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 -~~~~~----i~d~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ..++.... .........+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 01111100 111122346889999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=288.49 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=191.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC-----CCcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST-----STQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 603 (863)
.+.+.||+|+||.||+|.. .+|..||+|.+... ..+..+.+.+|++++++++|+||+++++++... +..++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 3458999999999999985 46899999976432 123346788999999999999999999998764 457899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+||+++++|.+++.. ...+++....+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 85 VEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 999999999999843 2357899999999999999999998 899999999999999999999999999998653
Q ss_pred CCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
..... .......++..|+|||++.+..++.++|||||||+++||++|+.||...... ..+.+. .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~~-----~ 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----ATQP-----T 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH----HcCC-----C
Confidence 22111 1112345889999999999888999999999999999999999999753211 011110 0000 0
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.+ +......+.+++.+|++ +|..||+..+++.
T Consensus 227 ~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 22233458889999999 5799999997764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=301.42 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=191.9
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 601 (863)
+...+.||+|+||.||++.. .+|+.||||.+... .....+++.+|++++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 33458899999999999985 47899999987643 223345678899999999999999999988644 3469
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+. ++|.+.+.. .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 98 lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 98 LVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999995 688888732 27888999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hH--------Hh----
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LV--------EW---- 748 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~--------~~---- 748 (863)
..... ......++..|+|||.+.+..++.++|||||||+++||++|+.||.......... +. ++
T Consensus 168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 168 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 54321 1223457889999999999999999999999999999999999997543211000 00 00
Q ss_pred ---hhhcccc------cccccccCCcc----CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 749 ---AKPFIRE------SRIDEIVDPSI----KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 749 ---~~~~~~~------~~~~~i~d~~l----~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....... ....++....+ ...........+.+++.+|++.+|++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 00011111111 00001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=288.38 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=192.1
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcC---CcccccceeeeEeeCCe-----eE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAI---RHENLVPLLGYCCENDQ-----QI 601 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~~ 601 (863)
+.+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|+++++++ +|+|++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999976 489999998764322 2234566788777666 59999999999988776 89
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||+++.
T Consensus 83 l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999996 58998885432 2358999999999999999999999 8899999999999999999999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc---c
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR---I 758 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~ 758 (863)
...... .....++..|+|||.+.+..++.++|||||||+++||++|+.||......+ .+..........+. .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcC
Confidence 643321 122347889999999999899999999999999999999999987543211 11111111000000 0
Q ss_pred ------ccccCCccCC---CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 ------DEIVDPSIKG---GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ------~~i~d~~l~~---~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......... ....+....+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=295.02 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=191.7
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+...+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++.+++...+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 333578999999999999964 6789999987543 222345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+. |+|.+.+... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 6888877432 3458899999999999999999998 89999999999999999999999999998765432
Q ss_pred CCCceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
....++..|+|||.+. ...++.++|||||||++|||++|+.||....... .+..+.. +..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~-----~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ-----NES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHHhh-----cCC-----
Confidence 2235788999999974 3567889999999999999999999986532111 0111111 000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
+... .......+.+++.+|++.+|++||++.+|++..
T Consensus 232 ~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111 112234578899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.89 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=193.7
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||+||+|... +++.|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4578999999999999975 578999998765432 22334567999999999 999999999999999999999999 8
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.... ...+++.+++.++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 82 GNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 99999885432 3468999999999999999999999 8999999999999999999999999999986643221
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHH---------hhhhccccccc
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVE---------WAKPFIRESRI 758 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~---------~~~~~~~~~~~ 758 (863)
.....++..|+|||.+.. ..++.++|+||||++++||++|+.||......+.. .... |..........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123457889999998754 45789999999999999999999999654321110 0000 11100000000
Q ss_pred ccccCCccC---CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIK---GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+..... ..........+.+++.+|++.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 0000011356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=284.88 Aligned_cols=244 Identities=25% Similarity=0.438 Sum_probs=198.1
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 4578999999999999864 678999998876654 3456789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 84 GSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 999999843 2568999999999999999999998 89999999999999999999999999999876543221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||...+..++.++||||+|++++||++|+.||..... . ...|... . .. .+.+..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~--~~~~~~~--~-~~-----~~~~~~- 221 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--M--AALFRIV--Q-DD-----HPPLPE- 221 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--H--HHHHHHh--c-cC-----CCCCCC-
Confidence 2334588999999999888889999999999999999999999875321 1 1111100 0 00 011111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+++.+|++.+|++||++.|++.
T Consensus 222 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 ---GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12345789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=294.37 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=190.3
Q ss_pred hhcceecccCcEEEEEEecCC-CCEEEEEEcccCCC-cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTST-QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+|...+ ++.||||++..... ....++..|++++.+.. |+||++++++|......++||||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 456899999999999999764 89999998865432 23456777888777775 9999999999999999999999984
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
++|.+++... ...+++..+..++.|++.||+|||+. ++|+||||+|+||++++++.+||+|||++........
T Consensus 98 -~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~- 170 (296)
T cd06618 98 -TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA- 170 (296)
T ss_pred -cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-
Confidence 5777766332 24789999999999999999999972 4899999999999999999999999999976543221
Q ss_pred CceeeeecCCCCCCccccccCC----CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQH----LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.....++..|+|||++.+.. ++.++||||||+++|||++|+.||..... .......+ .... ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~---~~~~-~~----- 237 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKI---LQEE-PP----- 237 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHH---hcCC-CC-----
Confidence 12234788999999987654 78899999999999999999999965321 11111111 1110 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.+.. ......++.+++.+|++.+|++||++.++++.
T Consensus 238 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00123458899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=300.49 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=188.9
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEEe
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILVY 604 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV~ 604 (863)
.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|+||+++++++.... ..++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 47899999999999985 468999999876432 223456889999999999999999999987543 468999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+. .+|.+++ ...+++.....++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 100 PYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred cccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 9996 4777665 2358899999999999999999999 8899999999999999999999999999986532
Q ss_pred CCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh--------cccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP--------FIRE 755 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~--------~~~~ 755 (863)
. .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||................. ....
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2 123357889999999876 4688999999999999999999999975432111100000000 0000
Q ss_pred cccccccC--CccC-CCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHhh
Q 002943 756 SRIDEIVD--PSIK-GGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVRE--LEDAF 807 (863)
Q Consensus 756 ~~~~~i~d--~~l~-~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~--L~~~~ 807 (863)
......++ +... ... .......+.+++.+|++.+|++||++.|+++. ++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000 0000 000 00122357899999999999999999999853 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=302.56 Aligned_cols=267 Identities=25% Similarity=0.356 Sum_probs=197.2
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEEee
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILVYP 605 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV~e 605 (863)
.+.||+|+||.||+|+. ..|+.||||.+..... ...+...+|+++|++++|+|||++++.-.+.. ..++|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 36899999999999994 5799999998776543 33456679999999999999999998765543 5789999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CC--CeEEEeeccCccc
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HS--MCAKVADFGFSKY 681 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~--~~~kl~DFGla~~ 681 (863)
||.+|||...|.... +...|+..+.+.+..+++.||.|||+ ++|+||||||.||++- ++ -.-||+|||.||-
T Consensus 98 yC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999996543 34679999999999999999999998 8999999999999993 33 3579999999998
Q ss_pred CCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
++.+. ....+.||..|++||.+.. +.|+..+|.|||||++||.+||..||.+........-..|....-+...+.-
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 86543 4567889999999999985 7899999999999999999999999976432211111222222111111111
Q ss_pred ccCCccCCC------------CcHHHHHHHHHHHHHccCcCCCCCC--CHHHHHHHHHHhh
Q 002943 761 IVDPSIKGG------------YHAEAMWRMVEVALACIEPFSAYRP--SMVDIVRELEDAF 807 (863)
Q Consensus 761 i~d~~l~~~------------~~~~~~~~l~~l~~~C~~~~P~~RP--sm~eVl~~L~~~~ 807 (863)
..++...+. ........+-......+..+|++|- ...+....+.+++
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 112222111 1122333444555566667788887 5555555555554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.36 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=200.1
Q ss_pred hhcceecccCcEEEEEEecCC-CCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
++.+.||.|.-|+||++++.+ +..+|+|++.+..- ......+.|-+||+.+.||-+..|++.+..++..+||||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 345789999999999999865 58999999877643 33456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC--
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE-- 685 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~-- 685 (863)
+||+|...++.. ..+.++......+|.++.-||+|||- .+||.|||||+||||-++|++-|+||.|+......
T Consensus 160 pGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999988653 45679999999999999999999999 99999999999999999999999999997533110
Q ss_pred ------------------------------C-C---------------------CCceeeeecCCCCCCccccccCCCCc
Q 002943 686 ------------------------------G-D---------------------SGFSLEVRGTAGYLDPEYYSTQHLSA 713 (863)
Q Consensus 686 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 713 (863)
. . ...+...+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 00112356899999999999999999
Q ss_pred ccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCC
Q 002943 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYR 793 (863)
Q Consensus 714 ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R 793 (863)
+.|-|+|||+||||+.|+.||.+...... +..++-..+.=....+....+.+||...+..||++|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999987653221 222222222111112445568899999999999999
Q ss_pred CC----HHHHH
Q 002943 794 PS----MVDIV 800 (863)
Q Consensus 794 Ps----m~eVl 800 (863)
-. +.||-
T Consensus 380 lg~~rGA~eIK 390 (459)
T KOG0610|consen 380 LGSKRGAAEIK 390 (459)
T ss_pred hccccchHHhh
Confidence 88 55553
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=289.47 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=203.5
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
++++.||+|.|..|-+++. -.|..||||++.+..- .....+.+|++-|+.++|||||+|+.+......+|||+|.-.
T Consensus 21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD 100 (864)
T KOG4717|consen 21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD 100 (864)
T ss_pred hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence 3457899999999999984 5899999999877643 334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~~~~~ 687 (863)
+|+|.+|+.. ....+++....+++.||..|+.|+|. ..+|||||||+||.+- .-|-+||.|||++..+.++..
T Consensus 101 ~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 101 GGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred CchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999999943 34568899999999999999999999 8899999999999874 567899999999987765543
Q ss_pred CCceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.+..+|+..|-|||.+.+..|+ ++.||||+|||||-|++|+.||+.....+. +..++|-..
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY 236 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY 236 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc
Confidence 3456799999999999999886 579999999999999999999987553322 333444332
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.....++.+|+..|+..+|++|.+.+||+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 123344556889999999999999999999865
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=297.09 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=197.9
Q ss_pred cceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
...||-|+||.|||++.++ +-..|-|++...+....++|+-|+++|+.+.||+||+|++.+...+.++++.|||.||-.
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 3568899999999999765 444567888888888889999999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
+..+.. -...|...++.-++.+++.||.|||+ ++|||||||+.|||+.-+|.++|+|||.+-.... ......
T Consensus 117 DaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD 188 (1187)
T KOG0579|consen 117 DAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD 188 (1187)
T ss_pred hHHHHH---hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence 988843 24579999999999999999999999 9999999999999999999999999999754321 112234
Q ss_pred eeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 693 EVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.+.||+.|||||+.. ..+|+.++|||||||.|.||..+.+|-....+.. .+.. +.......++-|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllK-----iaKSePPTLlqP--- 258 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK-----IAKSEPPTLLQP--- 258 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHH-----HhhcCCCcccCc---
Confidence 577999999999875 3578999999999999999999999976543211 0111 111111111111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..-...+.++...|+..||..||++.++++
T Consensus 259 ----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ----chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 122345889999999999999999999876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=284.80 Aligned_cols=234 Identities=20% Similarity=0.289 Sum_probs=182.0
Q ss_pred ecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCChhh
Q 002943 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614 (863)
Q Consensus 537 LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~ 614 (863)
||+|+||.||++.. .++..+|+|......... . |+.....+ +|+|++++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999985 468889999876542211 1 22222222 69999999999999999999999999999999
Q ss_pred hhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCCCCCCceee
Q 002943 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 615 ~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
++... ..+++.+...++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++..... ..
T Consensus 99 ~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~ 165 (267)
T PHA03390 99 LLKKE----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SC 165 (267)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------cc
Confidence 99432 378999999999999999999999 8899999999999999988 9999999998765422 12
Q ss_pred eecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHH
Q 002943 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 773 (863)
..++..|+|||++.+..++.++||||||++++||++|+.||..... .......+..... .. .... ..
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--~~------~~~~----~~ 232 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQ--KK------LPFI----KN 232 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhc--cc------CCcc----cc
Confidence 3588999999999998999999999999999999999999974432 2222223322210 00 0001 12
Q ss_pred HHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 002943 774 AMWRMVEVALACIEPFSAYRPS-MVDIVR 801 (863)
Q Consensus 774 ~~~~l~~l~~~C~~~~P~~RPs-m~eVl~ 801 (863)
....+.+++.+|++.+|.+||+ +.|+++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2345789999999999999995 687763
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=290.36 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=198.5
Q ss_pred hcceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEE
Q 002943 533 YKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.||+|+||.||++.. .+++.+|||++.... ....+.+.+|++++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 457899999999999874 357889999876432 22345688999999999 599999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++.. ...+++.....++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 84 LDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999843 2468899999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCccccccCC--CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQH--LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.... .......|+..|+|||.+.+.. .+.++||||||++++||++|..||....... ...+........
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------ 227 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------ 227 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc------
Confidence 3321 1122345889999999987765 7889999999999999999999986422111 111111111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
++...... ...+.+++.+|++.+|++|||+.+|.+.|+...
T Consensus 228 -~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 -KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred -CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 11111112 234778999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.42 Aligned_cols=240 Identities=28% Similarity=0.422 Sum_probs=189.3
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||+||+|+. .+|+.|++|++..... ...+.+.+|++++++++|+|++++++++.+.+..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 6799999999999985 4688999998765433 233568899999999999999999999999999999999995 6
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 106 ~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 106 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 78777743 23468999999999999999999998 89999999999999999999999999998643221
Q ss_pred eeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 691 SLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
....|+..|+|||++. ...++.++|||||||++|||++|+.||...... ....... .. .. +...
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~---~~-~~-----~~~~ 241 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIA---QN-DS-----PTLQ 241 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHH---hc-CC-----CCCC
Confidence 2345888999999984 456888999999999999999999998654321 1111111 00 00 1110
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.......+.+++.+|++.+|.+||++.++++.
T Consensus 242 ---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112357889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.46 Aligned_cols=256 Identities=20% Similarity=0.248 Sum_probs=191.2
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCCcc--------------hHHHHHHHHHHhcCCcccccceeeeEeeCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQG--------------TREFENELNFLSAIRHENLVPLLGYCCEND 598 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 598 (863)
.+.||+|+||+||+|... +++.||||.+....... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999854 68999999875442221 125779999999999999999999999999
Q ss_pred eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 599 QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 599 ~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 9999999996 799998842 3458899999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCC------------CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchh
Q 002943 679 SKYAPQEGD------------SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745 (863)
Q Consensus 679 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 745 (863)
++....... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||...... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI---DQ 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 976541110 0111123468889999998764 4688999999999999999999999754321 11
Q ss_pred HHhhhhccccc---ccccc--------c----CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 746 VEWAKPFIRES---RIDEI--------V----DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 746 ~~~~~~~~~~~---~~~~i--------~----d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+....... ..... . .+.... ........+.+++.+|++.+|++||++.|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111000 00000 0 000000 00112346789999999999999999999875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=315.22 Aligned_cols=267 Identities=18% Similarity=0.235 Sum_probs=183.7
Q ss_pred HHhhcceecccCcEEEEEEecCC--CCEEEEEE--------------cc---cCCCcchHHHHHHHHHHhcCCcccccce
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD--GQEVAVKV--------------RS---STSTQGTREFENELNFLSAIRHENLVPL 590 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~--g~~vAVK~--------------~~---~~~~~~~~~f~~E~~~l~~l~H~niv~l 590 (863)
.+.+.+.||+|+||+||++.++. +...++|. +. .........+.+|+++|++++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 34556899999999999987532 22222221 10 0112234568899999999999999999
Q ss_pred eeeEeeCCeeEEEeecCCCCChhhhhhccCCC-CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEAST-RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 591 ~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
++++...+..++|+|++ .++|.+++...... ...........|+.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 99999999999999998 56788877543211 2223455677899999999999999 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCC-CCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP-LNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p-~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.+ +..........+.+.
T Consensus 305 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999987643221 122345699999999999999999999999999999999998754 433221111112111
Q ss_pred hhhcc-ccc-------ccccccCCc-cC---CCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 749 AKPFI-RES-------RIDEIVDPS-IK---GGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 749 ~~~~~-~~~-------~~~~i~d~~-l~---~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....- ... .+.+.++.. +. .... ......+.+++.+|++.||++|||+.|+++
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000 000 000000000 00 0000 001224667889999999999999999976
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=286.85 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=192.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC-----CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-----STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||.||++... .+..+++|+++.. ......++..|++++++++||||+++++++.+.+..++|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 34578999999999999854 3455666654432 12233467789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||||+||++++ ..+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999999986543445679999999999999999999999 89999999999999986 46999999999866432
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+....... + ..+.
T Consensus 159 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-----~~~~ 224 (260)
T cd08222 159 CD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-----PTPS 224 (260)
T ss_pred cc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C-----CCCC
Confidence 21 2223457889999999988888999999999999999999999986432 1111111110 1 1111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+ .......+.+++.+|++.+|++||++.|+++
T Consensus 225 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 L----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 1223346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=298.43 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=197.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV 603 (863)
.+.+.||+|+||.||+|... +|+.+|||++.... ....+.+.+|+++++.++|+||+++++++...+ ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 34578999999999999965 58999999876543 334567899999999999999999999998775 78999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||++ ++|.+++.. ...+++..++.++.+++.||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 83 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 83 TELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred ecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99997 589888843 2379999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhhhhc-------c
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWAKPF-------I 753 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~~~~-------~ 753 (863)
..... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... +....... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 43211 112234578899999999887 78999999999999999999999997654211100 00000000 0
Q ss_pred cccccccccCC-ccCCC-----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 754 RESRIDEIVDP-SIKGG-----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 754 ~~~~~~~i~d~-~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
......+.+.. ..... ........+.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 00000 001123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=292.91 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=189.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCC--------ee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCEND--------QQ 600 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------~~ 600 (863)
.+.++||+|+||.||+|... +++.+|||++...... ....+.+|++++++++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34578999999999999954 6899999987544322 2346788999999999999999999875443 46
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++|+||+. ++|.+.+.. ....+++.+...++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||+++
T Consensus 91 ~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 91 YMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 89999996 467777643 23469999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCCC---------ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 002943 681 YAPQEGDSG---------FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAK 750 (863)
Q Consensus 681 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 750 (863)
......... ..+...++..|+|||.+.+. .++.++|||||||+++||++|+.||................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 654322111 11234578889999987654 57899999999999999999999997543221111100000
Q ss_pred hcccc------ccccccc--------CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 751 PFIRE------SRIDEIV--------DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 751 ~~~~~------~~~~~i~--------d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ..+.... .+.+... .......+.+++.+|++.+|++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 0000000 0111000 0112246889999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=285.35 Aligned_cols=256 Identities=23% Similarity=0.288 Sum_probs=194.9
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+..|++++++++|+|++++++++...+..++|+||++ +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 468999999999999965 58999999877653 3334678899999999999999999999999999999999997 6
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++..++.++.++++||+|||+ .+|+||||+|+||++++++.+||+|||+++....... .
T Consensus 83 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 83 DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 999999532 1468999999999999999999999 8999999999999999999999999999987643221 1
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccc---cccc--
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESR---IDEI-- 761 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~---~~~i-- 761 (863)
.....++..|+|||.+.+. .++.++|||||||+++||++|+.||...... ........... +.. ...+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1223457789999998776 7899999999999999999999999654311 11111110000 000 0000
Q ss_pred cCCccC---CC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIK---GG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~---~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.... .. ........+.+++.+|++.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 00 00011346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=287.35 Aligned_cols=241 Identities=22% Similarity=0.285 Sum_probs=187.5
Q ss_pred hcceecccCcEEEEEEec----CCCCEEEEEEcccCCC----cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEE
Q 002943 533 YKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTST----QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 457899999999999985 4689999998765322 2346688999999999 599999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+||+++++|.+++.. ...+++.....++.|+++||.|||+ .+++||||||+|||+++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 84 LDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999943 3457888999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.... .......|+..|+|||.+... .++.++||||||++++||++|+.||...... ....+.........
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~----- 228 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE----- 228 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC-----
Confidence 3221 112234588999999998753 4678999999999999999999999643211 11122211111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCC
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP 794 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP 794 (863)
+.. +......+.+++.+|++.+|++||
T Consensus 229 --~~~----~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 229 --PPY----PQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred --CCC----CccCCHHHHHHHHHHhcCCHHHhc
Confidence 111 111234578999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=287.49 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=195.8
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+.+.||+|+||.||++... +|+.||+|++.... ....+.+..|++++++++ |+||+++++++...+..++||||+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence 4578999999999999964 79999999876532 233467889999999998 999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++.. ...+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 85 PNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999943 2369999999999999999999998 8999999999999999999999999999986543221
Q ss_pred C------------------CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 002943 688 S------------------GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA 749 (863)
Q Consensus 688 ~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~ 749 (863)
. .......++..|+|||......++.++||||||++++|+++|+.||..... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~ 234 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQKI 234 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH
Confidence 1 112234578899999999888899999999999999999999999975431 1111111
Q ss_pred hhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCH----HHHH
Q 002943 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSM----VDIV 800 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm----~eVl 800 (863)
.. .+. .........+.+++.+|++.+|++||++ .+++
T Consensus 235 ~~----------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 235 LK----------LEY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred Hh----------cCC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 10 000 1111123458899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=297.51 Aligned_cols=261 Identities=19% Similarity=0.275 Sum_probs=189.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC-------------
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN------------- 597 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------------- 597 (863)
.+.+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 3457899999999999985 46899999988766666667889999999999999999999876544
Q ss_pred -CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEee
Q 002943 598 -DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVAD 675 (863)
Q Consensus 598 -~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~D 675 (863)
...++|+||++ ++|.+++. ...+++.....++.|++.||+|||+ .+|+||||||+||+++ ++..+||+|
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 68988873 2358899999999999999999999 8999999999999997 566899999
Q ss_pred ccCcccCCCCCC-CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc
Q 002943 676 FGFSKYAPQEGD-SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 676 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||................+..
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999976532211 111122357889999998654 567889999999999999999999997543211110000000000
Q ss_pred cccccccc--------cCCccCCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 RESRIDEI--------VDPSIKGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ~~~~~~~i--------~d~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+. .+........ .....++.+++.+|++.+|++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 0000000000 012245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=294.15 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=187.7
Q ss_pred hhcceecccCcEEEEEEecC-C--CCEEEEEEcccCC--CcchHHHHHHHHHHhcC-CcccccceeeeEeeC----CeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-D--GQEVAVKVRSSTS--TQGTREFENELNFLSAI-RHENLVPLLGYCCEN----DQQI 601 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~--g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~~~ 601 (863)
.+.+.||+|+||.||++... . +..||||++.... ....+.+.+|+++++++ +|+||+++++++... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 34578999999999999964 3 7899999876432 22345788999999999 599999999976433 3567
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+++||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 83 ~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 83 LYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 8888885 789998842 3468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCC--CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---c
Q 002943 682 APQEGDS--GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---E 755 (863)
Q Consensus 682 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~ 755 (863)
....... .......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .........+. .
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 5432211 11223468999999998765 46889999999999999999999999764321 11111000000 0
Q ss_pred cccccccCC-------------cc-CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 756 SRIDEIVDP-------------SI-KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 756 ~~~~~i~d~-------------~l-~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
..+..+.++ .. ...........+.+++.+|++.+|++||++.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 00 0000011234688999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=314.45 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=182.9
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEee----------------
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCE---------------- 596 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------------- 596 (863)
++||+||||.|||++.+ ||+.+|||++... +........+|++.|++|+|||+|+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 68999999999999965 8999999987655 33445678899999999999999999833311
Q ss_pred --------------------------------------------------------------------------------
Q 002943 597 -------------------------------------------------------------------------------- 596 (863)
Q Consensus 597 -------------------------------------------------------------------------------- 596 (863)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCc
Q 002943 597 ---------------N--------DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653 (863)
Q Consensus 597 ---------------~--------~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 653 (863)
+ ..+|+-||||+.-.|+++++.+.... .-...++++.+|++||+|+|+ .+|
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 0 12467889998888888875432111 355678999999999999999 889
Q ss_pred cccCCCCCCeEecCCCeEEEeeccCcccCC----------------CCCCCCceeeeecCCCCCCccccccC---CCCcc
Q 002943 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAP----------------QEGDSGFSLEVRGTAGYLDPEYYSTQ---HLSAK 714 (863)
Q Consensus 654 iHrDik~~NILld~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k 714 (863)
|||||||.||+||++..+||+|||+|.... ........+...||.-|+|||.+.+. +|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998621 01122234567899999999999765 49999
Q ss_pred cceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCC
Q 002943 715 SDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP 794 (863)
Q Consensus 715 sDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP 794 (863)
+|+||+|||++||+. ||..... .... ...++.+.+..- ..+..+....-.+++.++++.||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsME--Ra~i----L~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSME--RASI----LTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHH--HHHH----HHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999986 4654321 1111 111223332221 112233344456889999999999999
Q ss_pred CHHHHHH
Q 002943 795 SMVDIVR 801 (863)
Q Consensus 795 sm~eVl~ 801 (863)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=295.49 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=192.4
Q ss_pred CHHHHHHHHHhh--cceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee
Q 002943 522 SLQYLEAATQQY--KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE 596 (863)
Q Consensus 522 ~~~~l~~~t~~f--~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 596 (863)
...++...+.+| .+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 334455555555 37899999999999984 578999999876532 2234568889999999999999999998864
Q ss_pred C------CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe
Q 002943 597 N------DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC 670 (863)
Q Consensus 597 ~------~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~ 670 (863)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3 3467888876 7899888732 358999999999999999999999 89999999999999999999
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEW 748 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~ 748 (863)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... +...
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999865322 123457889999998866 468889999999999999999999996533211000 0000
Q ss_pred h-------hhccccccc-------ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 749 A-------KPFIRESRI-------DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 749 ~-------~~~~~~~~~-------~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
. ...+..... ......... .........+.+++.+|++.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000 000000000 0000123357899999999999999999888653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=293.65 Aligned_cols=239 Identities=25% Similarity=0.407 Sum_probs=194.5
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcc--hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQG--TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|.|+.|..++. ..|..||||.+.+..-.. .+.+.+|+++|..++|||||+++.+......+++||||..+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 57899999999999985 469999999988765432 345889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
.+.++|... ..+.......+..|+.++++|||+ +.|+|||||++||||+.++++||+|||++..+... ..
T Consensus 141 e~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~ 210 (596)
T KOG0586|consen 141 ELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LM 210 (596)
T ss_pred hhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc---cc
Confidence 999999543 345557788899999999999999 89999999999999999999999999999887633 23
Q ss_pred eeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....|++.|.|||++.+.++ .+++|+||+|++||-|++|..||++.. +.++-++.+.+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRPRVLRGK 271 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccchheeee
Confidence 445679999999999998876 579999999999999999999998643 111112222221
Q ss_pred Cc--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 770 YH--AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 770 ~~--~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+. .-...++-+++++.+-.+|.+|+++.++.+
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11 011123567778888889999999888754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.61 Aligned_cols=236 Identities=25% Similarity=0.285 Sum_probs=191.7
Q ss_pred ecccCcEEEEEEecC-CCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 537 IGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
||+|+||.||++... +++.+|+|++...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999987654332 345788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++.. ...+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999943 2368999999999999999999999 899999999999999999999999999998664332 1223
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...++..|++||...+...+.++|+||||++++|+++|+.||..... ..+.+.+.. . ...+..
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~----~------~~~~~~---- 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK----D------PLRFPE---- 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc----C------CCCCCC----
Confidence 44578899999999888889999999999999999999999965321 111111111 0 001111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVD 798 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~e 798 (863)
.....+.+++.+|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345789999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=288.73 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=189.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++++++||||+++.+++.. .+..++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 358999999999999985 47899999987543 22334678899999999999999999998865 56788999998
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++. ...+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 93 ~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 93 GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 578988873 2357888888999999999999999 899999999999999999999999999997543221
Q ss_pred CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hH--------Hhhhhccccccc
Q 002943 689 GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LV--------EWAKPFIRESRI 758 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~--------~~~~~~~~~~~~ 758 (863)
....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... +. +|..........
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 22356889999998866 568999999999999999999999997543211100 01 111111111000
Q ss_pred ccccCCccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 759 DEIVDPSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 759 ~~i~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.-...-........ .....+.+++.+|++.+|++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000011111 123568899999999999999999988553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=319.98 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=190.5
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEccc--CCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSS--TSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+||.|.||.||-|. +.+|...|+|-+.. ......+...+|+.++..++|||+|+.+|+-..++..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 579999999999998 56799999995433 334455778899999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC--C
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS--G 689 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~--~ 689 (863)
|.+.+.. ....++.....+..|++.|++|||+ .+||||||||.||+|+.++.+|++|||.|+.+....+. .
T Consensus 1321 La~ll~~----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1321 LASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999932 2345666667788999999999999 89999999999999999999999999999877544211 1
Q ss_pred ceeeeecCCCCCCccccccCC---CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc-ccccccccccCCc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQH---LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF-IRESRIDEIVDPS 765 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~i~d~~ 765 (863)
......||+.|||||.+.+.. -.-+.||||+|||++||+||++||..... +|+..+ +..|.. |.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~-----Pq 1461 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK-----PQ 1461 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC-----CC
Confidence 112356999999999997643 34579999999999999999999986542 233221 122222 22
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
+.+ ....+-.+++.+|++.||++|-++.|+
T Consensus 1462 ~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1462 IPE----RLSSEGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred Cch----hhhHhHHHHHHHHHhcCchhhhHHHHH
Confidence 222 223345688899999999999766644
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=267.09 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=190.3
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
...||.|..|.|+++... .|...|||.+.... ....+.++..+.++.+-+ +|.||+.+|||..+....+.||.|. -
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 457999999999999964 58999999766554 444567777888777665 8999999999999999999999983 4
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
.++.+|.. ..+++++...-++...+..||.||.+ .++|||||+||+|||+|+.|++|++|||++-.+.. +..
T Consensus 176 C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkA 247 (391)
T KOG0983|consen 176 CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKA 247 (391)
T ss_pred HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccc
Confidence 55555532 34568888888999999999999988 37899999999999999999999999999976543 223
Q ss_pred eeeeecCCCCCCccccccC---CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 691 SLEVRGTAGYLDPEYYSTQ---HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.+...|.+.|||||.+... +|+.++|||||||.|+||.||+.||..... +......+. .+ .-|.|.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvl---n~------ePP~L~ 316 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVL---NE------EPPLLP 316 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHH---hc------CCCCCC
Confidence 4456799999999999643 688999999999999999999999986431 111111111 11 113333
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
++. .-...+.++...|++.|+.+||...++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 221 12335889999999999999999998865
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.57 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=192.9
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
-++||+||||.||-+... +|.-+|.|.+.+.. .++....++|-.+|.+++.+.||.+--.+..++.++||+..|.+
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 379999999999999864 68899999765542 34556678999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.-||+... ...++....+.+|.+|+.||++||. ..||.||+||+|||||+.|+++|+|+|||..++....
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 99999997543 3579999999999999999999999 8999999999999999999999999999987765432
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....||.||||||++....|+...|-||+||+||||+.|+.||......... +-+.+...+ |+ .+
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~-------~~---~e 408 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLE-------DP---EE 408 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhc-------ch---hh
Confidence 22337999999999999999999999999999999999999999764322211 001111100 11 12
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
++..-.++...+....++.+|++|-.-+
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2222233455566677788998886544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=290.61 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=188.3
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEE
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV 603 (863)
..+.||+|+||.||++.. .+|..||||++.... ....+.+.+|++++++++|+||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 357899999999999984 578999999875432 223456889999999999999999999887553 35899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+ +++|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 ~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 99 MPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 9999 779988873 2358999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hh--------HHhhhhcc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SL--------VEWAKPFI 753 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l--------~~~~~~~~ 753 (863)
.. .....++..|+|||.+.+ ..++.++|+||||++++|+++|+.||......... .+ .++.....
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 SE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 32 123357889999999876 45889999999999999999999999754321000 00 00000000
Q ss_pred cccccccccC--CccCC----CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 RESRIDEIVD--PSIKG----GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ~~~~~~~i~d--~~l~~----~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......... +.... .........+.+++.+|++.+|++||++.++++
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 245 -SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred -chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 00000 000112335789999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=292.71 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=189.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCe------eEEE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQ------QILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~LV 603 (863)
+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+|++++.+++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 3578999999999999965 68899999876432 2234567889999999999999999998876554 8999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 99 ~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 99 THLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 9998 6799998842 468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc--------
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR-------- 754 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 754 (863)
.. .....++..|+|||.+.+ ..++.++|||||||+++|+++|+.||....... ..........
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHh
Confidence 32 122357889999999865 367889999999999999999999997543211 1111000000
Q ss_pred ---ccccccccCCcc---CCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ---ESRIDEIVDPSI---KGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ---~~~~~~i~d~~l---~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.... ...+ .......+.+++.+|++.+|++|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000 0000 0012456889999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=268.64 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=192.5
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
..||.|+||+|+|-.. +.|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..++.||.| ..|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 4699999999999986 4699999998776544 5567888998875555 6999999999999999999999999 567
Q ss_pred hhhhhhc-cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 612 LQDRLYG-EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 612 L~~~L~~-~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
|+.+... ....+..+++...-+|..-..+||.||.+. ..|||||+||+|||||..|.+||+|||++-.+.. +-.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiA 223 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIA 223 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH---HHH
Confidence 6654421 122345688888889999999999999873 7899999999999999999999999999876542 222
Q ss_pred eeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.+...|...|||||.+... .|+.+|||||+|++|+|+.||+.|+.... ++.+.+..... |.. |.+..
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~-gdp-----p~l~~ 292 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVI-GDP-----PILLF 292 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHc-CCC-----CeecC
Confidence 3445688899999998643 48899999999999999999999997532 12222222111 111 11211
Q ss_pred -CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 -GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 -~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
....+....++.++-.|+..+..+||...++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112345568899999999999999999988664
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=267.35 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=199.4
Q ss_pred CHHHHHHHHHhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCe
Q 002943 522 SLQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQ 599 (863)
Q Consensus 522 ~~~~l~~~t~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 599 (863)
+++++-+-|. ++||+|+|+.|--++ +.+|.++|||++.+..........+|++++...+ |+||+.|+.+|+++..
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 3556555444 689999999999887 7889999999999887778888999999999996 9999999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeec
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADF 676 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DF 676 (863)
.|||||-|.+|+|..+++. ++.+++.+..++..+||.||.|||. ++|.|||+||+|||-.+- .-+||+||
T Consensus 151 FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred EEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999953 4578999999999999999999999 999999999999999644 34899999
Q ss_pred cCcccCCCCCC-----CCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH
Q 002943 677 GFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746 (863)
Q Consensus 677 Gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 746 (863)
.|..-...... ........|+..|||||+.. ...|+.+.|.||+|||||-|++|.+||.+.-..+.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---- 299 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---- 299 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----
Confidence 99754322111 11123456899999999763 34688999999999999999999999987654321
Q ss_pred HhhhhcccccccccccC----CccC-C--CCcHH----HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 747 EWAKPFIRESRIDEIVD----PSIK-G--GYHAE----AMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d----~~l~-~--~~~~~----~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.|- .|...+..- .++. + +++.+ ...+..+++...+-.++.+|-++.+++.
T Consensus 300 GWd-----rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWD-----RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred Ccc-----CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 111111000 0011 1 12221 2334456666667789999999888876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=308.29 Aligned_cols=142 Identities=27% Similarity=0.351 Sum_probs=126.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.++||+|+||.||+|... +++.||||++..... .....+..|+.+++.++|+||+++++++...+..+|||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 34589999999999999965 689999998865432 22367889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++++|.+++.. ...+++...+.++.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999943 2357888999999999999999999 799999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=270.22 Aligned_cols=222 Identities=18% Similarity=0.121 Sum_probs=176.7
Q ss_pred cCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhhhhhc
Q 002943 540 GGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYG 618 (863)
Q Consensus 540 G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~ 618 (863)
|.||.||++.. .+++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999985 468999999886543 334555566666799999999999999999999999999999999843
Q ss_pred cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCC
Q 002943 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698 (863)
Q Consensus 619 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 698 (863)
. ..+++.....++.|++.||+|||+ ++|+||||||+||+++.++.++++|||++...... .....++.
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 2 358999999999999999999999 89999999999999999999999999988755432 12234577
Q ss_pred CCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHH
Q 002943 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRM 778 (863)
Q Consensus 699 ~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 778 (863)
.|+|||.+.+..++.++||||+|++++||++|+.|+....... .......+... ....+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~~~~----~~~~~ 205 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNIPEW----VSEEA 205 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCCccc----CCHHH
Confidence 8999999988889999999999999999999998875321100 00000011111 22357
Q ss_pred HHHHHHccCcCCCCCCCHHHH
Q 002943 779 VEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 779 ~~l~~~C~~~~P~~RPsm~eV 799 (863)
.+++.+|++.+|++||++.+.
T Consensus 206 ~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHccCCHHHhcCCCcc
Confidence 889999999999999997544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.91 Aligned_cols=238 Identities=25% Similarity=0.347 Sum_probs=193.1
Q ss_pred CcEEEEEEecC-CCCEEEEEEcccCCCcc-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhhhhhc
Q 002943 541 GFGSVYRGTLP-DGQEVAVKVRSSTSTQG-TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYG 618 (863)
Q Consensus 541 ~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~ 618 (863)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999987665544 68899999999999999999999999999999999999999999999843
Q ss_pred cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCC
Q 002943 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698 (863)
Q Consensus 619 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 698 (863)
. ..+++..++.++.++++++.|||+ .+++|+||+|+||++++++.++|+|||++....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 238899999999999999999999 799999999999999999999999999998765432 223445788
Q ss_pred CCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHH
Q 002943 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRM 778 (863)
Q Consensus 699 ~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 778 (863)
.|++||......++.++||||||++++||++|+.||.... ....+.++... +.... . .........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~----~~~~~----~---~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGK----PKPPF----P---PPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhc----cCCCC----c---cccccCCHHH
Confidence 9999999988889999999999999999999999986532 11122222111 00000 0 0000023468
Q ss_pred HHHHHHccCcCCCCCCCHHHHHH
Q 002943 779 VEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 779 ~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=261.63 Aligned_cols=238 Identities=22% Similarity=0.312 Sum_probs=190.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcch---HHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGT---REFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.|-++||+|.||.|-+++-+ .|+.+|+|++++.-.-.. ..-+.|-++|+..+||.+..|.-.+...+.+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 45689999999999999854 689999999887644333 33467889999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+|.|.-+|.. .+.++.......-..|+.||.|||+ ++||.||||.+|.|||.+|++||+||||++.--. .
T Consensus 251 nGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~ 321 (516)
T KOG0690|consen 251 NGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--Y 321 (516)
T ss_pred cCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--c
Confidence 99999999943 4567888888889999999999999 8999999999999999999999999999985432 2
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
...+...+||+.|+|||++....|....|-|.+|||+|||++||.||...... .+.+.+. +.++ +..
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl-------~ed~---kFP 388 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELIL-------MEDL---KFP 388 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHH-------hhhc---cCC
Confidence 33455688999999999999999999999999999999999999999764321 1211111 1111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
..... +...|....+..+|++|-.
T Consensus 389 r~ls~----eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 389 RTLSP----EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ccCCH----HHHHHHHHHhhcChHhhcC
Confidence 12222 3445666778899999953
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=274.07 Aligned_cols=243 Identities=24% Similarity=0.372 Sum_probs=193.4
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+++||+|.||+||-|+. ++|+.||||++.+.. .....++.+|+.+|++++||.||.+...|+..+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 48999999999999986 579999999987654 344578899999999999999999999999999999999999 66
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccCcccCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla~~~~~~~~ 687 (863)
+..+.+.. .....|+...-..+..||..||.|||. ++|+|+||||+||||... -.+||+|||.||.....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 66555533 235678888889999999999999999 999999999999999643 46999999999988643
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....+.||+.|+|||++..+.|...-|+||.|||+|--++|..||..... ..+-++-+.-++....
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~P---------- 787 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNP---------- 787 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCc----------
Confidence 345567899999999999999999999999999999999999999975321 1112222222222111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
..+.....++++-..++..-.+|-+...-+
T Consensus 788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 122333466777788888888888876543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=267.68 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=188.3
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEcccCC--Ccc-----hHHHHHHHHHHhcCCcccccceeeeEe-eCCeeEEEee
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTS--TQG-----TREFENELNFLSAIRHENLVPLLGYCC-ENDQQILVYP 605 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~--~~~-----~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~LV~e 605 (863)
++||+|||++|||+. +...+-||||+..... ... .+...+|.++.+.|.||.||++++|+. +.+.++-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 579999999999998 5667889999743321 111 134568999999999999999999986 5567889999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYA 682 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~ 682 (863)
||++.+|+-||. ..+.++..+...|+.||+.||.||.+. .++|||-||||.||||-. .|.+||.||||++.+
T Consensus 549 YceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 549 YCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred ecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 999999999993 456789999999999999999999984 489999999999999954 578999999999998
Q ss_pred CCCCCCC-----ceeeeecCCCCCCccccccC----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc
Q 002943 683 PQEGDSG-----FSLEVRGTAGYLDPEYYSTQ----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 683 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
..+.... .+....||..|++||++.-+ +.+.|.||||.|||+|..+.|+.||..... ...+.+.
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqe----- 696 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQE----- 696 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhh-----
Confidence 7665432 23346799999999988533 678899999999999999999999975321 1222222
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
..+...-+-.+.. .+....+...++.+|++..-++|....++
T Consensus 697 --NTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 697 --NTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred --hchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 1111111111100 01112345678999999999999665544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=282.83 Aligned_cols=236 Identities=23% Similarity=0.314 Sum_probs=189.3
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+...+|.|+|+.|-++.. .+++..+||++.+.. .+-.+|+.++.+. +|+||+++.+.+.+..+.++|||.+.
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 34556799999999999985 568999999987662 2345677666666 69999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe-cCCCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL-DHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl-d~~~~~kl~DFGla~~~~~~~~ 687 (863)
+|-|.+.+... .... .++..|+.+|+.++.|||+ +++|||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 400 GGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99888877432 2223 6777899999999999999 999999999999999 69999999999999977654
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
....+-|..|.|||++....+++++|+||||++||||++|+.||...... ..+... +. .
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~----i~------------~ 528 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR----IQ------------M 528 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----hc------------C
Confidence 22335688999999999999999999999999999999999999865432 111111 11 1
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.++........+|+.+|++.+|.+||+|.++..
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222333445778999999999999999998854
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=283.35 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=202.3
Q ss_pred hhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEee-----CCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCE-----NDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~LV~ 604 (863)
.|.+.||.|.+|.||+++ .++|+..|||++..... ..++.+.|.++|+.. .|||++.++|++.. +++++|||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 456899999999999998 56799999998776543 346778899999988 59999999999864 46899999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
|||.+||..|.+.... ...+.|....-|+..+++|+.+||. ..++|||||-.||||..++.+||.|||++..+..
T Consensus 101 EfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999996554 6789999999999999999999999 8899999999999999999999999999987643
Q ss_pred CCCCCceeeeecCCCCCCccccccC-----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
..+......||+.|||||++... .|+..+|+||+|++..||.-|.+|+.++.+.- .++. +.
T Consensus 176 --T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~---Ip 241 (953)
T KOG0587|consen 176 --TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFL---IP 241 (953)
T ss_pred --ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhcc---CC
Confidence 22334456799999999999654 46778999999999999999999998765311 1110 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
-.|..+-..+..-..++.+++..|+..|-++||++.++++
T Consensus 242 --RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 --RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1122221234455678999999999999999999998875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=235.48 Aligned_cols=195 Identities=26% Similarity=0.342 Sum_probs=163.7
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
++||+|.||+||||+. ..++.||+|+.... +..-....++|+.+++.++|+|||++++....+...-||+||| ..+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHH
Confidence 5899999999999995 45789999975543 3334467889999999999999999999999999999999999 557
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|..+.. ..++.++......++.|+.+||.|+|+ +++.|||+||.|.|++.+++.|++|||+++...-.. ..-
T Consensus 87 lkkyfd---slng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv--rcy 158 (292)
T KOG0662|consen 87 LKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCY 158 (292)
T ss_pred HHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eee
Confidence 887773 345678999999999999999999999 899999999999999999999999999999764321 111
Q ss_pred eeeecCCCCCCccccccC-CCCcccceechhhHHHHHHh-CCCCCCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIIS-GREPLNTRR 738 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~ 738 (863)
....-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 223468899999998876 47889999999999999998 666676544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=283.08 Aligned_cols=256 Identities=22% Similarity=0.263 Sum_probs=176.0
Q ss_pred hhcceecccCcEEEEEEec-----------------CCCCEEEEEEcccCCCcchHH--------------HHHHHHHHh
Q 002943 532 QYKTLIGEGGFGSVYRGTL-----------------PDGQEVAVKVRSSTSTQGTRE--------------FENELNFLS 580 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-----------------~~g~~vAVK~~~~~~~~~~~~--------------f~~E~~~l~ 580 (863)
.+.++||+|+||.||+|.+ .+++.||||++........++ +..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3458999999999999963 245689999876544332233 344777778
Q ss_pred cCCcccc-----cceeeeEee--------CCeeEEEeecCCCCChhhhhhccCC--------------------CCccCC
Q 002943 581 AIRHENL-----VPLLGYCCE--------NDQQILVYPFMSNGSLQDRLYGEAS--------------------TRKTLD 627 (863)
Q Consensus 581 ~l~H~ni-----v~l~g~~~~--------~~~~~LV~ey~~~gsL~~~L~~~~~--------------------~~~~l~ 627 (863)
+++|.++ ++++++|.. ++..+|||||+++|+|.++|+.... ....++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8876654 778888764 3568999999999999999974311 112457
Q ss_pred hhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccc
Q 002943 628 WPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707 (863)
Q Consensus 628 ~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 707 (863)
|..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||.+.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhc
Confidence 78899999999999999999 889999999999999999999999999997654322111 11223578999999875
Q ss_pred cCCC----------------------CcccceechhhHHHHHHhCCC-CCCCCCCCC------cchhHHhhhhccccccc
Q 002943 708 TQHL----------------------SAKSDVFSFGVVLLEIISGRE-PLNTRRPRN------EWSLVEWAKPFIRESRI 758 (863)
Q Consensus 708 ~~~~----------------------s~ksDV~SfGvvl~ElltG~~-p~~~~~~~~------~~~l~~~~~~~~~~~~~ 758 (863)
.... ..+.||||+||+++||++|.. |+....... ...+..|.. .....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~- 460 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK- 460 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC-
Confidence 4321 235799999999999999875 665322110 111222221 11111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCC---CCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFS---AYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P---~~RPsm~eVl~ 801 (863)
.+-... ........+++.+++..+| .+|+|+.|+++
T Consensus 461 ---~~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 ---YDFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ---CCcccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 010111 1122346677778887655 78999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=257.28 Aligned_cols=202 Identities=25% Similarity=0.324 Sum_probs=165.5
Q ss_pred hcceecccCcEEEEEEecC---C--CCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTLP---D--GQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~---~--g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ 604 (863)
....||+|.||.|||+.-. + ...+|||.++..... -.....+|+.+++.++|||++.|..++.+ +...+|++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 3578999999999999643 2 237999988765332 23567899999999999999999998877 67889999
Q ss_pred ecCCCCChhhhhhc-cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC----CeEEEeeccCc
Q 002943 605 PFMSNGSLQDRLYG-EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS----MCAKVADFGFS 679 (863)
Q Consensus 605 ey~~~gsL~~~L~~-~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DFGla 679 (863)
||.+. +|.+.++- .....+.++......|..||..|+.|||+ .=|+||||||.|||+..+ |.+||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99965 77777743 22334678999999999999999999999 669999999999999766 99999999999
Q ss_pred ccCCCCCCCC-ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 680 KYAPQEGDSG-FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 680 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
|.+...-..- ....+.-|..|.|||.+.+. .|+.+.|||+.|||..||+|-.+-|....
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9875443222 23456679999999999875 69999999999999999999988886654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=264.74 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=193.4
Q ss_pred HHHHHHHhhcceecccCcEEEEEEecCC-CCEEEEEEcccCCCcc---hHHHHHHHHHHhcC-CcccccceeeeEeeCCe
Q 002943 525 YLEAATQQYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQG---TREFENELNFLSAI-RHENLVPLLGYCCENDQ 599 (863)
Q Consensus 525 ~l~~~t~~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~---~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 599 (863)
.+.....+|..+||+|+||.|-++.-++ .+.+|||++++.-.-. .+--..|-++|+.. +-|.++++..++..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3555667899999999999999998654 5679999988764222 22234566777666 46899999999999999
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
++.||||+.+|+|--++.. -..+.++....+|..||-||-+||+ ++||.||||.+|||||.++++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999888843 3457778889999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
+....+ ...+....||+.|+|||.+..++|+...|-|||||+||||+.|++||++... ..+.+-
T Consensus 498 KEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~a----------- 561 (683)
T KOG0696|consen 498 KENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQA----------- 561 (683)
T ss_pred cccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH-----------
Confidence 854332 2334567899999999999999999999999999999999999999987542 222221
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
+.+... .++.....+.+.+...-+...|.+|-.
T Consensus 562 -I~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 -IMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 112111 233334445667777888889998853
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=288.66 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=163.8
Q ss_pred hhcceecccCcEEEEEEecC-C----CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeee------EeeCCee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-D----GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGY------CCENDQQ 600 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~----g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~~~~~~ 600 (863)
.+.+.||+|+||.||+|++. + +..||||++...... +.+..| .+.+..+.++..++.. +....+.
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34589999999999999964 4 689999986543211 111111 1222223333332221 2456688
Q ss_pred EEEeecCCCCChhhhhhccCCC----------------CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeE
Q 002943 601 ILVYPFMSNGSLQDRLYGEAST----------------RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNIL 664 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NIL 664 (863)
+|||||+++++|.+++...... ...........++.|++.||+|||+ ++|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEE
Confidence 9999999999999998543110 0011123455799999999999999 89999999999999
Q ss_pred ecC-CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC----------------------CCCcccceechh
Q 002943 665 LDH-SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ----------------------HLSAKSDVFSFG 721 (863)
Q Consensus 665 ld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV~SfG 721 (863)
+++ ++.+||+|||+|+.+..... .......+++.|+|||.+... .+..++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 68999999999986643322 223345689999999965322 234567999999
Q ss_pred hHHHHHHhCCCCCCCCCC-------CCcchhHHhhhhcccccccccccCCccCCCCc--HHHHHHHHHHHHHccCcCCCC
Q 002943 722 VVLLEIISGREPLNTRRP-------RNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH--AEAMWRMVEVALACIEPFSAY 792 (863)
Q Consensus 722 vvl~ElltG~~p~~~~~~-------~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~--~~~~~~l~~l~~~C~~~~P~~ 792 (863)
|+||||+++..+++.... .....+..|....... ..+.+...+. ........+|+.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766542100 0011122221111000 0000000000 001123458999999999999
Q ss_pred CCCHHHHHH
Q 002943 793 RPSMVDIVR 801 (863)
Q Consensus 793 RPsm~eVl~ 801 (863)
|||+.|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=262.71 Aligned_cols=265 Identities=20% Similarity=0.251 Sum_probs=198.2
Q ss_pred HHHHHHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc--c----cccceeeeEeeC
Q 002943 525 YLEAATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRH--E----NLVPLLGYCCEN 597 (863)
Q Consensus 525 ~l~~~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H--~----niv~l~g~~~~~ 597 (863)
|.....+.+..++|+|.||.|-++... .+..||||+++..... .+.-+-|+++|+++.+ | -+|.+.+|+.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 333344445578999999999999854 4789999988765433 2345679999999943 2 378888999999
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC----------
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---------- 667 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---------- 667 (863)
++.++|+|.| +-|+.++|..+ .-.+++..+...|+.|++++++|||+ ..++|-||||+|||+-+
T Consensus 164 ghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccC
Confidence 9999999998 67999999543 34568888999999999999999999 89999999999999922
Q ss_pred ----------CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 668 ----------SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 668 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
+..+||+|||-|..-... ...+..|..|.|||++.+-.++.++||||+||||.|+.||...|+.-
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 346899999999864332 24567899999999999999999999999999999999999998765
Q ss_pred CCCCcchhHHhhh--------------hccccccc-----------ccccCCcc----CCCCcHHHHHHHHHHHHHccCc
Q 002943 738 RPRNEWSLVEWAK--------------PFIRESRI-----------DEIVDPSI----KGGYHAEAMWRMVEVALACIEP 788 (863)
Q Consensus 738 ~~~~~~~l~~~~~--------------~~~~~~~~-----------~~i~d~~l----~~~~~~~~~~~l~~l~~~C~~~ 788 (863)
...+...+-+.+. +.+..+++ ..+.++-. .-.....+..++++|+..++..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 4322221222111 11111111 11111100 0012335677899999999999
Q ss_pred CCCCCCCHHHHHH
Q 002943 789 FSAYRPSMVDIVR 801 (863)
Q Consensus 789 ~P~~RPsm~eVl~ 801 (863)
||.+|+|++|+++
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=251.03 Aligned_cols=245 Identities=19% Similarity=0.276 Sum_probs=188.7
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEee----CCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCE----NDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~LV~ey~~ 608 (863)
++||-|-.|.|-.+..+ .|+.+|+|++... ....+|+++.-.. .|||||++++++.+ ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 78999999999999864 6889999987643 3346788876555 59999999998864 356789999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~~~~ 685 (863)
+|.|.+.+... ....+++.+.-.|..||+.|+.|||+ .+|.||||||+|+|.. .|...||+|||+|+.-..
T Consensus 143 GGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~- 216 (400)
T KOG0604|consen 143 GGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE- 216 (400)
T ss_pred chHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC-
Confidence 99999999543 35679999999999999999999999 8999999999999995 466799999999986442
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
........-|+.|.|||++...+|+...|+||+||++|-|++|-+||-..... .+.--.+..++.|. -+
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq-y~----- 285 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ-YE----- 285 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC-cc-----
Confidence 22234456799999999999999999999999999999999999999654321 11100111111110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+...-.....+...+++...+..+|.+|-|+.|+..
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 011111234556778999999999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=240.34 Aligned_cols=197 Identities=27% Similarity=0.347 Sum_probs=166.3
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
..||+|++|.|-+-++ .+|+..|+|++...- .+..++.+.|+.+..+. .+|.+|.++|........++.||.| .-|
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS 130 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS 130 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence 5799999999988885 589999999876553 44557788888876555 6999999999999999999999999 568
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|+.+-..--.....+++...-+||..+.+||.|||+. ..+||||+||+|||++.+|.+||+|||++-.+... -..
T Consensus 131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iAk 205 (282)
T KOG0984|consen 131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IAK 205 (282)
T ss_pred HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh---hHH
Confidence 8877655445667899999999999999999999994 68999999999999999999999999999776432 122
Q ss_pred eeeecCCCCCCcccccc----CCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 692 LEVRGTAGYLDPEYYST----QHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~----~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
+...|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+..
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 33568889999999854 36899999999999999999999999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=279.01 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=184.4
Q ss_pred cceecccCcEE-EEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 534 KTLIGEGGFGS-VYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 534 ~~~LG~G~fG~-Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
++++|.|+-|+ ||+|.. +|++||||++-.... .-.++|+..|+.- +|||||++++.-.++...|+..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 36789998865 799998 688999998765432 3457899999888 5999999998888888999999999 779
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-----CCeEEEeeccCcccCCCCC
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-----SMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DFGla~~~~~~~ 686 (863)
|++++...........-...+.+..|++.||++||+ .+||||||||.||||+. ..+++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 999996531111111114457788999999999999 89999999999999975 3689999999999886554
Q ss_pred CCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhC-CCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 687 DSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISG-REPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..- ......||.||+|||.+....-+...||||+|||+|..++| ..||......+ .++.. ....+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~~---- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLVH---- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Cccceee----
Confidence 322 13456799999999999998888899999999999999995 99997643211 11111 0000000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. ..++ ...+|+.++++.+|..||++.+|+.
T Consensus 735 -L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 -LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 1111 5778999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-29 Score=246.14 Aligned_cols=260 Identities=20% Similarity=0.319 Sum_probs=188.1
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccC-CCc-chHHHHHHHHHHhcCCcccccceeeeEeeC--------CeeEEE
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSST-STQ-GTREFENELNFLSAIRHENLVPLLGYCCEN--------DQQILV 603 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~-~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~LV 603 (863)
.+||+|.||+||+++.. .|+.||+|+.-.. ... -...-++|+++|..++|+|++.++..|... ...+||
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 58999999999999965 5778899854322 222 234568999999999999999999999643 347999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+++|+. +|.-.|. .....++..+..+++.++..||.|+|. ..|+|||+||.|+|++.++.+||+|||+++.+.
T Consensus 103 f~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999964 7777772 234578889999999999999999999 889999999999999999999999999998664
Q ss_pred CCCCC--CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh--------hhhc
Q 002943 684 QEGDS--GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW--------AKPF 752 (863)
Q Consensus 684 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~--------~~~~ 752 (863)
..... ..-+...-|..|.+||.+.+. .++++.|||.-|||+.||.||.+-+++........++.- +|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 33221 112333458999999998775 689999999999999999999988876543322232221 1111
Q ss_pred cccccccccc--CCccCCCCc--HHHH------HHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 753 IRESRIDEIV--DPSIKGGYH--AEAM------WRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 753 ~~~~~~~~i~--d~~l~~~~~--~~~~------~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...-.+-+-+ .|--++.+. .+.+ ...++++...+..||.+|+...+++.
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111111111 111111110 0111 14667888899999999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=284.96 Aligned_cols=200 Identities=26% Similarity=0.304 Sum_probs=173.0
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
..+.+.++||+|+||.|..++.+ .++.+|.|++++- ......-|..|-.+|..-+.+=|+.|.-.|.+.+++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 34445689999999999999975 5889999998762 2344567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
|||+||+|-..|... ..++......++..|+-||.-||+ .++|||||||+|||||..|++||+|||-+-.+..
T Consensus 155 dY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999432 268888888999999999999999 8999999999999999999999999999877764
Q ss_pred CCCCCceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNT 736 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~ 736 (863)
++. ..+....|||-|++||++.. +.|...+|-||+||++|||+.|..||..
T Consensus 228 dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 228 DGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 433 33445679999999999853 5789999999999999999999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=263.85 Aligned_cols=236 Identities=22% Similarity=0.324 Sum_probs=191.6
Q ss_pred ceecccCcEEEEEEecCCCC-EEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQ-EVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~-~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..||-||||.|=++..++.. .+|+|++++... ...+....|-.+|...+.+.||+|+--+.+....|++||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999999875433 488887766533 33445678999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
.|...|+ .++.++..+...++..+.+|++|||. ++||.|||||+|.+||.+|-+||.|||+|+.+..+. .
T Consensus 506 ElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---K 575 (732)
T KOG0614|consen 506 ELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---K 575 (732)
T ss_pred hhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC---c
Confidence 9999994 34578888899999999999999999 999999999999999999999999999999886543 3
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
+.+.+||+.|.|||.+.....+..+|.||+|++++||++|++||....+....+++- + | +..+ .+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---k----G-id~i-------~~ 640 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---K----G-IDKI-------EF 640 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---h----h-hhhh-------hc
Confidence 557889999999999999989999999999999999999999998765432222111 0 0 1111 11
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
+........+++++.+..+|.+|-.
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhc
Confidence 2222334667888888899999965
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.77 Aligned_cols=210 Identities=34% Similarity=0.536 Sum_probs=182.9
Q ss_pred ecccCcEEEEEEecCC-CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhh
Q 002943 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~ 614 (863)
||+|++|.||++...+ ++.+++|+....... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999988765443 34679999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCCCCCCCceee
Q 002943 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGDSGFSLE 693 (863)
Q Consensus 615 ~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~ 693 (863)
++.... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. +..++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 984321 468999999999999999999999 79999999999999999 89999999999986644321 1223
Q ss_pred eecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 694 VRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 694 ~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
..+...|++||..... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=256.75 Aligned_cols=207 Identities=22% Similarity=0.365 Sum_probs=169.6
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+-||-|+||+|.++. .+....+|.|.+.+.+- ........|-.||+....+=||+|+-.|.+++.+|+||||+++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 569999999999997 44567899998776542 23345678999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC--------
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA-------- 682 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~-------- 682 (863)
++-.+|-. .+.+.+.....++.+++.|+++.|. .++|||||||+|||||.+|++||.||||+.-+
T Consensus 715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999843 3457777778888999999999999 89999999999999999999999999998522
Q ss_pred -CCCCCCC-------------------------------ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhC
Q 002943 683 -PQEGDSG-------------------------------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISG 730 (863)
Q Consensus 683 -~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG 730 (863)
..+.... ......||..|+|||++....++..+|-||.||||+||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 1110000 00124699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCc-chhHHh
Q 002943 731 REPLNTRRPRNE-WSLVEW 748 (863)
Q Consensus 731 ~~p~~~~~~~~~-~~l~~~ 748 (863)
+.||....+.+. ..+..|
T Consensus 868 ~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINW 886 (1034)
T ss_pred CCCccCCCCCcceeeeeeh
Confidence 999987665443 334444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=240.03 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=191.9
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCC-----eeEEEee
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEND-----QQILVYP 605 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~e 605 (863)
++-||-|+||.||..+. .+|+.||.|++..... ...+.+.+|+++|...+|.|++..++.....+ +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 36799999999999986 4799999997764422 34578889999999999999999988776543 5678888
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
.| ..+|...+ -+.+.|+-....-+..||.+||+|||+ .+|.||||||.|.|++.+...||+||||+|....+
T Consensus 138 Lm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchh
Confidence 88 45676666 456678888888899999999999999 89999999999999999999999999999977654
Q ss_pred CCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh--------hhccccc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA--------KPFIRES 756 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 756 (863)
...+ .+...-|..|.|||.+.+. .|+...||||.||++.||+-.|-.|+...+.....++--. .+...+|
T Consensus 210 ~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 210 DRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 4333 3334468899999999875 7999999999999999999999888765544333222111 1111112
Q ss_pred ccccccC-----CccCCCC---c-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 002943 757 RIDEIVD-----PSIKGGY---H-AEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803 (863)
Q Consensus 757 ~~~~i~d-----~~l~~~~---~-~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L 803 (863)
.-..++. |.+..-+ + ...-.+.+.+.+.++..+|.+|.+..+.+.-+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111 1111001 0 01112345677788999999999988887654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=232.82 Aligned_cols=197 Identities=32% Similarity=0.500 Sum_probs=171.2
Q ss_pred hcceecccCcEEEEEEecCC-CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999765 899999998766554 5678999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.... ..+++.....++.++++++.+||+ .+++|+||+++||+++.++.++|+|||++........ ..
T Consensus 83 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 83 DLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 9999985432 128899999999999999999999 7999999999999999999999999999987654321 12
Q ss_pred eeeeecCCCCCCcccc-ccCCCCcccceechhhHHHHHHhCCCCCCC
Q 002943 691 SLEVRGTAGYLDPEYY-STQHLSAKSDVFSFGVVLLEIISGREPLNT 736 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~ElltG~~p~~~ 736 (863)
.....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=234.26 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=190.8
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
-++||+|+|.+|-.++++ ..+.+|+|++++.- ..+..-.+.|-.+..+. +||.+|-|..++..+..+++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 478999999999999975 57889999877643 33344566777777666 69999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|--++. +...|+......+...|.-||.|||+ .+||.||||.+|||||..+++||.|+|+++..-.. .
T Consensus 335 ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~--g 405 (593)
T KOG0695|consen 335 GGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--G 405 (593)
T ss_pred Ccceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC--C
Confidence 999987773 34568888888999999999999999 99999999999999999999999999999865333 2
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCC-CcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPR-NEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
..+....||+.|+|||.+.+..|....|-|++||+++||+.||.||+..... .+.+-.++.-+.+-+ +.++
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kqir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQIR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hccc
Confidence 3455678999999999999999999999999999999999999999853221 123333333333222 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
.+.....+...+...-++.||.+|-.
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11112234556777888999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=242.65 Aligned_cols=191 Identities=24% Similarity=0.393 Sum_probs=162.8
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--------chHHHHHHHHHHhcCC---cccccceeeeEeeCCeeE
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--------GTREFENELNFLSAIR---HENLVPLLGYCCENDQQI 601 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~ 601 (863)
-+.+|+|+||.|+.+..+ +..+|+||++.+...- ..-..-.|+++|..++ |+||++++.+|++++..+
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 368999999999999976 4668999987764321 1123457999999997 999999999999999999
Q ss_pred EEeecC-CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 602 LVYPFM-SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 602 LV~ey~-~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
|++|-. ++.+|.+++ ..+..+++.+...|..||+.|+++||+ ++|||||||-+||.+|.+|-+||+|||.|.
T Consensus 646 l~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchh
Confidence 999965 456899998 345679999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCC
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLN 735 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~ 735 (863)
+...+. -...+||.+|.|||++.+.+|- ..-|||++|++||-++....||-
T Consensus 719 ~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 665433 2356899999999999988764 55899999999999999988874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=214.75 Aligned_cols=254 Identities=19% Similarity=0.326 Sum_probs=188.6
Q ss_pred HHHhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCC--eeEEEe
Q 002943 529 ATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCEND--QQILVY 604 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~LV~ 604 (863)
..+++.+++|+|.|++||.|. ..+.+.++||+++... .+.+.+|+++|..|+ ||||++|++...+.. ...||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 344556899999999999998 5678999999987653 467889999999997 999999999987654 567999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAP 683 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~ 683 (863)
||+.|.+..... +.|+.........++..||.|+|+ .+|+|||+||.|+++|.. -..+|+|+|||.+.-
T Consensus 115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999998877655 357778888999999999999999 899999999999999964 579999999999886
Q ss_pred CCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh--------ccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP--------FIR 754 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~--------~~~ 754 (863)
++.+..+. ..+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||-.... +...++.-++- .+.
T Consensus 185 p~~eYnVR---VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYNVR---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCceeeee---eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 65443322 24556788998865 4578889999999999999999999854321 11122221110 011
Q ss_pred ccccccccCCccCC---CCc------------H-HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKG---GYH------------A-EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~---~~~------------~-~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+ .+||.+.+ ... . -...+.++++-..+..|-++|||++|...
T Consensus 261 KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111 13332211 000 0 01234677888888999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=230.79 Aligned_cols=129 Identities=25% Similarity=0.327 Sum_probs=106.7
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-----c---ccccceeeeEee----C
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-----H---ENLVPLLGYCCE----N 597 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~----~ 597 (863)
+-..++||.|.|++||++.. .+.+-||+|+.+.... -.+.-+.||++|++++ | .+||+|+++|.. +
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 33468999999999999985 5678899998765432 2355688999999994 2 479999999975 4
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
.+.++|+|++ +-+|..++... .-+.++.....+|+.||+.||.|||..| +|||-||||+||||
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 5889999999 77888888433 3456899999999999999999999975 79999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=225.66 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=184.6
Q ss_pred eecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEEeec
Q 002943 536 LIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILVYPF 606 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV~ey 606 (863)
-+|.|.- .|..+.. -.++.||+|..... .....+...+|..++..++|+|+++++.++.-.. +.++|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 5677776 5555542 35889999975443 2334466789999999999999999999986543 56899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
| .++|.+.++ -.++-.+...|..|++.|+.|||+ .+|+||||||+||++..+...||.|||+|+.....
T Consensus 103 m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 103 M-DANLCQVIL------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred h-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 9 678888885 346777888999999999999999 89999999999999999999999999999864322
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc----------
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES---------- 756 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 756 (863)
-..+....|..|.|||.+.+..+.+.+||||.||++.||++|+.-|.+.. .+.+|.+..-..|
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHHHh
Confidence 23445668889999999999889999999999999999999999887543 3444432110000
Q ss_pred -----------------cccccc-CCccCC--CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 -----------------RIDEIV-DPSIKG--GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 -----------------~~~~i~-d~~l~~--~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+ |..... +.+.-......+++.+++-.+|++|.+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 001111 111110 011123345678899999999999999998865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=211.72 Aligned_cols=254 Identities=16% Similarity=0.292 Sum_probs=185.1
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcC-Ccccccceeee-EeeCCeeEEEeec
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGY-CCENDQQILVYPF 606 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~LV~ey 606 (863)
.+++.+.||+|.||.+-+++++ ..+.+++|-+... ....++|.+|...--.| .|.||+.-+.. +...+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 3566789999999999999975 4678999976543 33457899998765566 58999988764 5666788899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CCCeEEEeeccCcccCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DFGla~~~~~ 684 (863)
++.|+|.+.+. ...+.+....+++.|++.|+.|+|+ +++||||||.+|||+- +..++||+|||+++..+.
T Consensus 104 aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998872 2457778889999999999999999 9999999999999993 456899999999875432
Q ss_pred CCCCCceeeeecCCCCCCccccccC-----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
- .....-+..|.+||..... ...+.+|||.||++++.++||+.|++... .......+|.. +..+...
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~--w~~rk~~ 247 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQ--WLKRKNP 247 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHH--HhcccCc
Confidence 1 1123356789999977542 35678999999999999999999998432 22233333322 2222111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
. -|+....+.. ++..+-.+-+..++++|=-..++-++-...
T Consensus 248 ~--~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 248 A--LPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred c--CchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 1 1222223333 355666778889999997777776665443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=271.31 Aligned_cols=196 Identities=17% Similarity=0.250 Sum_probs=140.3
Q ss_pred cCCc-ccccceeeeE-------eeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC
Q 002943 581 AIRH-ENLVPLLGYC-------CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652 (863)
Q Consensus 581 ~l~H-~niv~l~g~~-------~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 652 (863)
.++| +||++++++| .+.+..++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 4566 6888899988 2334567888987 6799999953 23569999999999999999999999 89
Q ss_pred ccccCCCCCCeEecC-------------------CCeEEEeeccCcccCCCCCC--------------CCceeeeecCCC
Q 002943 653 VIHRDVKSSNILLDH-------------------SMCAKVADFGFSKYAPQEGD--------------SGFSLEVRGTAG 699 (863)
Q Consensus 653 iiHrDik~~NILld~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 699 (863)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566667776654211000 000011347888
Q ss_pred CCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHH
Q 002943 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMV 779 (863)
Q Consensus 700 y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 779 (863)
|||||++.+..++.++|||||||+||||++|..|+.... ..+...... .+.+.. .....+..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999988764311 011111100 111111 11123456
Q ss_pred HHHHHccCcCCCCCCCHHHHHH
Q 002943 780 EVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 780 ~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.++.+|++.+|.+||+|.||++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999975
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=234.42 Aligned_cols=272 Identities=20% Similarity=0.209 Sum_probs=201.9
Q ss_pred ccCHHHHHHHHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCC------cccccceee
Q 002943 520 IFSLQYLEAATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIR------HENLVPLLG 592 (863)
Q Consensus 520 ~~~~~~l~~~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g 592 (863)
.+.+-|+....+.+....|+|-|++|..|... -|+.||||++.... ...+.=+.|+++|++|+ --|+++|+-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 34455666666666678899999999999854 58899999987653 23345578999999996 358999999
Q ss_pred eEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeE
Q 002943 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCA 671 (863)
Q Consensus 593 ~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~ 671 (863)
.|...+++|||+|-+ ..+|.+.|.... .+-.|.......++.|+.-||..|.. .+|+|.||||.|||+++. ..+
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCccee
Confidence 999999999999977 679999996543 34568888899999999999999998 789999999999999875 568
Q ss_pred EEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 002943 672 KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAK- 750 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~- 750 (863)
||||||-|.......- +...-+-.|.|||.+.+..|+...|+||.||.||||.||+..|.+.....-..+..-+.
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999999987643221 12223567999999999999999999999999999999999998765322111111111
Q ss_pred ----hccccccc---------------------------ccccCC------ccCCC--C---cHHHHHHHHHHHHHccCc
Q 002943 751 ----PFIRESRI---------------------------DEIVDP------SIKGG--Y---HAEAMWRMVEVALACIEP 788 (863)
Q Consensus 751 ----~~~~~~~~---------------------------~~i~d~------~l~~~--~---~~~~~~~l~~l~~~C~~~ 788 (863)
.+++.+.. ...+.| .|.+. + ....+..+.+|+-.|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 11111110 011111 01110 1 223466788899999999
Q ss_pred CCCCCCCHHHHHH
Q 002943 789 FSAYRPSMVDIVR 801 (863)
Q Consensus 789 ~P~~RPsm~eVl~ 801 (863)
||++|.+..++++
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999988764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-25 Score=242.65 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=195.4
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
-..+|.|.||.|||++. ..++..|||+++........-.++|+-+++..+|+||+.++|-+...+..++.|||+.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 36899999999999995 46889999998887777777888999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
++.-|.. .+|+..+...++....+||+|||+ .+-+|||||-.|||+.+.+.+|++|||.+-.+.. .-....
T Consensus 100 Qdiy~~T----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~Krk 170 (829)
T KOG0576|consen 100 QDIYHVT----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRK 170 (829)
T ss_pred cceeeec----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh--hhhhhh
Confidence 9988643 578899999999999999999999 8889999999999999999999999999865432 122334
Q ss_pred eeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC-CccCC
Q 002943 693 EVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD-PSIKG 768 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d-~~l~~ 768 (863)
...||+.|||||+.. .+.|..++|||+.|+...|+-.-++|.-...+.. +..+... ...+ |.+++
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk----S~~qpp~lkD 239 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK----SGFQPPTLKD 239 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc----cCCCCCcccC
Confidence 567999999999873 4578899999999999999988777754322110 1111111 1111 12221
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. .-...+-+++..|+-.+|++||+...+++
T Consensus 240 k~--kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 12234678999999999999999887654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=219.30 Aligned_cols=192 Identities=29% Similarity=0.417 Sum_probs=159.0
Q ss_pred cceecccCcEEEEEEecC----CCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCC
Q 002943 534 KTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.++||+|.|++||++.+. ....||+|.+...+.- ....+|+++|..+. +.||+++.+++..++..++|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 579999999999999864 3678999987665433 45889999999995 9999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCCCC-
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEG- 686 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~- 686 (863)
.-...+++. .++..........+..||+++|. ++||||||||+|+|.+. -+.-.|.|||||...+...
T Consensus 119 H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 119 HDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999988883 46788889999999999999999 99999999999999974 4678899999997211000
Q ss_pred -------------C----------------------------CCceeeeecCCCCCCccccccC-CCCcccceechhhHH
Q 002943 687 -------------D----------------------------SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVL 724 (863)
Q Consensus 687 -------------~----------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl 724 (863)
. ........||+||.|||++... ..+++.||||-|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0001123599999999998754 578899999999999
Q ss_pred HHHHhCCCCCCCC
Q 002943 725 LEIISGREPLNTR 737 (863)
Q Consensus 725 ~ElltG~~p~~~~ 737 (863)
+-+++++.||-..
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=206.71 Aligned_cols=168 Identities=23% Similarity=0.273 Sum_probs=126.0
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ...++|.+++.|+.|+++||+|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999532 3469999999999999999999998 43 999999999999999 99998764321
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
..||..|||||++.+..++.++|||||||++|||+||+.||....... ..+..+....... ++.-. .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~~~-~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPRDR-S 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Ccccc-c
Confidence 258899999999999999999999999999999999999996532211 1111111111100 00000 0
Q ss_pred CcHHHH--HHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 770 YHAEAM--WRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 770 ~~~~~~--~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
...... ..+.+++.+|++.+|++||++.|+++.+....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 111112 25899999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-24 Score=212.20 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=190.9
Q ss_pred HHhhcceecccCcEEEEEEecCCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
..++..+|.+...|+.|+|++..+ .+++|++... .....++|..|.-.|+-+.||||++++|.|....+..++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345667899999999999999654 4555665443 3344578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+.|||.+.||+. ..-.++-.+..++|.++|+||+|||+.. +-|..--|.+..+++|++.+++|+ .+-+++....
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe-- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE-- 343 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeec--
Confidence 999999999864 3456788899999999999999999943 445555789999999999999875 2222221111
Q ss_pred CCceeeeecCCCCCCccccccCCCC---cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLS---AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s---~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
....-.+.||+||.++..+.+ ..+|+|||.++||||.|...||....+.+.. .+.. .|
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkia-----le---- 404 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIA-----LE---- 404 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhh-----hc----
Confidence 111236789999999876543 4799999999999999999999876543310 0000 11
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.++...++.....+.+++.-|++.||.+||.+..|+-.||+.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 122223333445688999999999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=218.30 Aligned_cols=162 Identities=21% Similarity=0.193 Sum_probs=125.2
Q ss_pred HhhcceecccCcEEEEEEecC--CCCEEEEEEcccCC-----CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP--DGQEVAVKVRSSTS-----TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~--~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|+||+||+|... +++.||||++.... ....+.|.+|+++|++++|+|+++.+.. .+..+||
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 345689999999999999864 57888999865331 1234568999999999999999864322 2467999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCC-CCCCeEecCCCeEEEeeccCcccC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDV-KSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~DFGla~~~ 682 (863)
|||+++++|.. +. ... ...++.+++++|.|||+ ++|+|||| ||+|||++.++.+||+|||+|+..
T Consensus 97 mE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 97 RGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 99999999963 21 001 14678899999999999 89999999 999999999999999999999976
Q ss_pred CCCCCCCc------eeeeecCCCCCCccccccC
Q 002943 683 PQEGDSGF------SLEVRGTAGYLDPEYYSTQ 709 (863)
Q Consensus 683 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 709 (863)
........ -+...+++.|+|||++...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54332111 1345688999999999654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=208.41 Aligned_cols=261 Identities=22% Similarity=0.260 Sum_probs=194.0
Q ss_pred HhhcceecccCcEEEEEEecCCC--CEEEEEEcccCCCcchHHHHHHHHHHhcCCc----ccccceeeeE-eeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDG--QEVAVKVRSSTSTQGTREFENELNFLSAIRH----ENLVPLLGYC-CENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g--~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~LV 603 (863)
+.+.++||+|+||.||++...+. ..+|+|............+..|+.++..+.+ +++..++... ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34468999999999999996543 5899998766544433378889999998873 5888888888 477788999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-----CeEEEeeccC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-----MCAKVADFGF 678 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-----~~~kl~DFGl 678 (863)
|+.+ +-+|.++..... .+.++..+.++|+.|+..+|++||+ .+++||||||.|++++.. ..+.|.|||+
T Consensus 100 M~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred Eecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9987 889999774332 5679999999999999999999999 899999999999999864 4699999999
Q ss_pred cccCC--CCCCC------CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHHhh
Q 002943 679 SKYAP--QEGDS------GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVEWA 749 (863)
Q Consensus 679 a~~~~--~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~~~ 749 (863)
++... ..... .......||..|.++....+...+.+.|+||++.++.|++.|..|+.......... +.+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98322 11111 00123569999999999999999999999999999999999999996644222111 11110
Q ss_pred hhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
. ...... . ... ....+.++...+-..+..++|....+...|++....+
T Consensus 254 ~--------~~~~~~-~-~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 R--------KLLTDR-F-GDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred h--------hhcccc-c-cCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 0 011110 0 111 2234555666666689999999999999998887543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.1e-21 Score=187.78 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=195.7
Q ss_pred HhhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc-ccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH-ENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+...++||+|+||.+|.|. ..+|.+||||+.+..... .++..|.++.+.|+| ..|..+..|..+++...||||.+
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 4456899999999999998 678999999987654433 467889999999975 67777888888999999999988
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla~~~~~~ 685 (863)
+.||.+.+. -....++..+.+-+|-|+..-++|+|. +++|||||||+|+|..-+ ..+.++|||||+.+...
T Consensus 94 GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 94 GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 889999883 234568889999999999999999999 889999999999999744 46889999999866432
Q ss_pred CC-CC----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 686 GD-SG----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 686 ~~-~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
.. .+ ......||.+|.+-....+...+.+.|+-|+|.+|+.+.-|..||++..+.......+.+.+. ++.-
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~s~ 243 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KMST 243 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hcCC
Confidence 21 11 123467999999888887888899999999999999999999999987654432222222111 1110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+ ..|...++. ++.-.+.-|-..--++-|...-+-+.+.-++.
T Consensus 244 ~i-e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PI-EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CH-HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 00 112223333 36666777888888889987777666655543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-20 Score=192.23 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=196.4
Q ss_pred hhcceecccCcEEEEEEe-cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|.||..+.|+ +-+++.||||.....+. ..++..|.+..+.|. .++|...+-+-.++.+..||+|.+ +
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 446899999999999998 67899999997655443 356788888888885 688888888888888999999988 8
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-----CCeEEEeeccCcccCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-----SMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DFGla~~~~~ 684 (863)
-||+|+.. -+...++..+...+|.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+..
T Consensus 108 PSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 108 PSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred cCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 89998873 345679999999999999999999999 89999999999999963 34689999999997754
Q ss_pred CC-CCCc----eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EG-DSGF----SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~-~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.. ..+. .....||.+||+-....+.+.+.+.|+=|+|-|++..+-|..||++........-.+.+....+...+.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 32 2222 234569999999999999999999999999999999999999999876544433333332222222222
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
++. ..+ +++...-++.+. ..+-.+-|...-+...+.+++..
T Consensus 262 ~Lc-----~g~-P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 262 VLC-----EGF-PEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHH-----hcC-HHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHh
Confidence 221 122 233333444443 45667788887777777666643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=196.64 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=195.2
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcc-cccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHE-NLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++...+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 3468999999999999976 88999987765443 367899999999999988 79999999977777899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~ 687 (863)
+++|.+++...... ..+.......+..+++.++.|+|+ .+++|||+||+||+++... .++++|||+++.......
T Consensus 82 ~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 82 GGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999776432111 368888999999999999999999 7899999999999999988 799999999986544332
Q ss_pred CC----ceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCC-CcchhHHhhhhcccccccc
Q 002943 688 SG----FSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPR-NEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 688 ~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~ 759 (863)
.. ......||..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ......+........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----
Confidence 21 2345679999999999987 57888999999999999999999997654321 011111111111100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001000001223467788899999999999999887764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=182.30 Aligned_cols=138 Identities=18% Similarity=0.198 Sum_probs=107.7
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCc--c-------hHHH-----------------HHHHHHHhcCCccccc
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--G-------TREF-----------------ENELNFLSAIRHENLV 588 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~niv 588 (863)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999889999999987654211 1 1122 3499999999888764
Q ss_pred ceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHH-HhccCCCccccCCCCCCeEecC
Q 002943 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL-HTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 589 ~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iiHrDik~~NILld~ 667 (863)
....+. ....+|||||+++++|..... ....++......++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPIL--LKSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEE--ecCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 433322 223489999999887765431 124688899999999999999999 56 7899999999999998
Q ss_pred CCeEEEeeccCcccC
Q 002943 668 SMCAKVADFGFSKYA 682 (863)
Q Consensus 668 ~~~~kl~DFGla~~~ 682 (863)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=201.48 Aligned_cols=218 Identities=26% Similarity=0.388 Sum_probs=167.1
Q ss_pred HhcCCcccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCc-cccC
Q 002943 579 LSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV-IHRD 657 (863)
Q Consensus 579 l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i-iHrD 657 (863)
|+.+.|.|+.+++|.|.++...+.|.+|+..|+|.+.+.. ....++|.....+..+|+.||+|||+ .+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 4678999999999999999999999999999999999954 35679999999999999999999998 444 9999
Q ss_pred CCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC-------CCCcccceechhhHHHHHHhC
Q 002943 658 VKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-------HLSAKSDVFSFGVVLLEIISG 730 (863)
Q Consensus 658 ik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~SfGvvl~ElltG 730 (863)
++++|+++|....+||+|||+.................-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998876431111111222345679999998763 147789999999999999999
Q ss_pred CCCCCCCCCCCc-chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 731 REPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 731 ~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+.||+....... ..++.++.. .-...+-|.+.... +....+..++..||..+|.+||++.+|-..++.+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999987443222 234443332 11122223322111 3333688999999999999999999999988876643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-20 Score=216.92 Aligned_cols=253 Identities=19% Similarity=0.230 Sum_probs=183.6
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcch----HHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGT----REFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~----~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
..+++|.|++|.|+.... ......+.|..... ..... ..+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 357899999997777653 33333444422210 11111 225568888888999999998888877777766799
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|++. +|...+... ..+.-..+..+..|+.+|++|||+ .+|.|||+|++|+++..++.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999998432 357777888999999999999999 89999999999999999999999999999766544
Q ss_pred CCC--CceeeeecCCCCCCccccccCCCCc-ccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 686 GDS--GFSLEVRGTAGYLDPEYYSTQHLSA-KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 686 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.+. .......|+..|+|||.+.+..|.+ ..||||.||++..|++|+.||......+... .+ .....+.....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~----~~~~~~~~~~~ 548 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT----NNYSDQRNIFE 548 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh----hcccccccccc
Confidence 333 5566788999999999999999887 5899999999999999999997644322210 00 00000000000
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
-+ .............++.++++.+|.+|-+|.+|++
T Consensus 549 ~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred Ch---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 0011233455778999999999999999999865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=182.59 Aligned_cols=168 Identities=15% Similarity=0.155 Sum_probs=129.7
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHH---------HHHHHHHHhcCCcccccceeeeEeeC----
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTRE---------FENELNFLSAIRHENLVPLLGYCCEN---- 597 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~---------f~~E~~~l~~l~H~niv~l~g~~~~~---- 597 (863)
+...++||.|+||.||+... ++..+|||++........+. +++|++.+.+++|++|..+..++...
T Consensus 33 y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred eEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 34458999999999999766 57789999987554333322 68999999999999999998886533
Q ss_pred ----CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEE
Q 002943 598 ----DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV 673 (863)
Q Consensus 598 ----~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 673 (863)
+..+|||||+++.+|.++.. ++. ....+++.+|..||+ .+++|||+||+||+++.++ ++|
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEE
Confidence 35789999999999988741 221 345689999999999 8999999999999999988 999
Q ss_pred eeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh
Q 002943 674 ADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729 (863)
Q Consensus 674 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt 729 (863)
+|||..+........ ..+.....+..++|+||||+.+.-+..
T Consensus 176 iDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 176 IDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999988755322110 113344556679999999999876643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=173.75 Aligned_cols=140 Identities=17% Similarity=0.148 Sum_probs=110.2
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcc--------------------------hHHHHHHHHHHhcCCccccc
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG--------------------------TREFENELNFLSAIRHENLV 588 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~--------------------------~~~f~~E~~~l~~l~H~niv 588 (863)
..||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 5799999999999998789999999877543210 11235789999999999875
Q ss_pred ceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 589 ~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
....+... ..+|||||++++++..... ....++.....+++.+++.++.+||+. .+|+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-C
Confidence 55444332 3489999999886544321 123567788999999999999999972 5899999999999999 8
Q ss_pred CeEEEeeccCcccCC
Q 002943 669 MCAKVADFGFSKYAP 683 (863)
Q Consensus 669 ~~~kl~DFGla~~~~ 683 (863)
+.++|+|||+++...
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-19 Score=205.20 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=181.2
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC-CcchHHHHHHHHH--HhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS-TQGTREFENELNF--LSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||++.|=+|.+|+.++|. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-......|||-+|.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv- 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV- 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence 45688999999999999998888 8899876554 3344455444433 55568999999988776777778888888
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc--CCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY--APQEG 686 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~--~~~~~ 686 (863)
.-+|.|.| ..+.-|...+...|+.|+..||..+|. .+|+|+|||.+|||+..=.-+.|+||.--|. ++.+.
T Consensus 104 khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 45788877 455668888899999999999999999 9999999999999999999999999987653 23332
Q ss_pred CCCcee---eeecCCCCCCccccccC-----------CCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 002943 687 DSGFSL---EVRGTAGYLDPEYYSTQ-----------HLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKP 751 (863)
Q Consensus 687 ~~~~~~---~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 751 (863)
...... +.+.-..|+|||.+... ..+++.||||.||++.||++ |+++|.... |..+-..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~~ 250 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRSG 250 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhcc
Confidence 222221 11233479999987431 26789999999999999998 788886421 2222111
Q ss_pred --cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 752 --FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 752 --~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
...+..+.++-|+ .+.++++.|++.+|++|-++.+.++.-.+.
T Consensus 251 ~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred CccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0011112222222 366899999999999999999999985443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=163.60 Aligned_cols=184 Identities=17% Similarity=0.127 Sum_probs=136.2
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCCc----chHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCC
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ----GTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~----~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
...|++|+||+||.+.- ++.+++.+.+.....- ..+.|.+|+++|++|. |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 36899999999997765 6778887766544321 1125889999999995 5889999886 44699999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCC-CCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDV-KSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDi-k~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+.+|.+.+. . ....++.+++++|+++|+ .+|+|||| ||+|||++.++.++|+|||+|........
T Consensus 82 G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP-----R------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh-----h------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999876441 0 113577899999999999 89999999 79999999999999999999985543321
Q ss_pred C-------Cc----eeeeecCCCCCCccccccC-CCC-cccceechhhHHHHHHhCCCCCCC
Q 002943 688 S-------GF----SLEVRGTAGYLDPEYYSTQ-HLS-AKSDVFSFGVVLLEIISGREPLNT 736 (863)
Q Consensus 688 ~-------~~----~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~SfGvvl~ElltG~~p~~~ 736 (863)
. .. ......++.|++|+-..-- ..+ ...+-++-|.-+|.++|++.+.-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00 0112357778888754221 223 456788889999999999887643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-17 Score=166.32 Aligned_cols=133 Identities=17% Similarity=0.206 Sum_probs=104.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-----CcccccceeeeEeeCC---e-eEEEee
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-----RHENLVPLLGYCCEND---Q-QILVYP 605 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~LV~e 605 (863)
+.||+|+||.||. .-.++.. +||+.........+++.+|+++++.+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6899999999996 3234444 79987765555667899999999999 5799999999998874 3 337899
Q ss_pred c--CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHH-HHHHhccCCCccccCCCCCCeEecC----CCeEEEeeccC
Q 002943 606 F--MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGL-MYLHTFAGRSVIHRDVKSSNILLDH----SMCAKVADFGF 678 (863)
Q Consensus 606 y--~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~iiHrDik~~NILld~----~~~~kl~DFGl 678 (863)
| +++|+|.+++.. ..++.. ..++.++..++ +|||+ .+|+||||||+|||++. +..++|+||+.
T Consensus 86 ~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 86 FDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 9 558999999933 124444 35677888777 99999 89999999999999973 34899999554
Q ss_pred c
Q 002943 679 S 679 (863)
Q Consensus 679 a 679 (863)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.1e-17 Score=171.40 Aligned_cols=230 Identities=23% Similarity=0.337 Sum_probs=148.1
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCc----------ccccceeeeEe----
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRH----------ENLVPLLGYCC---- 595 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H----------~niv~l~g~~~---- 595 (863)
.+.||.|+++.||.++.. .|+++|||+..... ....+++++|.-....+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 478999999999999965 58999999754433 2334667777655555432 12222222221
Q ss_pred -----eCC--------eeEEEeecCCCCChhhhhh---ccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCC
Q 002943 596 -----END--------QQILVYPFMSNGSLQDRLY---GEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVK 659 (863)
Q Consensus 596 -----~~~--------~~~LV~ey~~~gsL~~~L~---~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik 659 (863)
... ..+++|+-+ .++|.+.+. ........+....++.+..|+++.+++||+ .+++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 111 235677777 678887753 222234456677888899999999999999 999999999
Q ss_pred CCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC--------CCCcccceechhhHHHHHHhCC
Q 002943 660 SSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ--------HLSAKSDVFSFGVVLLEIISGR 731 (863)
Q Consensus 660 ~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~SfGvvl~ElltG~ 731 (863)
|+|++++.+|.++|+||+........ ... ...+..|.+||..... .++.+.|.|++|+++|.|.||+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999876543221 111 2356789999977442 4788999999999999999999
Q ss_pred CCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCC
Q 002943 732 EPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYR 793 (863)
Q Consensus 732 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R 793 (863)
.||+...+... .+| .+. ... +..+.+..|+...++.+|.+|
T Consensus 248 lPf~~~~~~~~---~~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEAD---PEW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGST---SGG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccc---ccc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986532111 011 111 122 456678899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=190.20 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=180.3
Q ss_pred HHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEEEee
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR---HENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~e 605 (863)
.++.+.+.||+|+||+||+|...+|+.||+|+-+.... -+|---.+++.||+ -+-|..+.....-.+..+||+|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 34445689999999999999988899999998665543 23333344555555 2344445555566788899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-------CCCeEEEeeccC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-------HSMCAKVADFGF 678 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-------~~~~~kl~DFGl 678 (863)
|.+-|+|.+++. ..+.++|...+.++.|+++-++.||. .+|||+||||+|+||. +..-++|+|||.
T Consensus 775 y~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 775 YSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred ccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 999999999994 56789999999999999999999999 8899999999999993 245689999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
+-.+.--.+...-....+|-++-.+|+..++.++.+.|.|.+..+++-|+.|+.-- ...|.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g~- 908 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNGS- 908 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCCc-
Confidence 96553322333334567899999999999999999999999999999999997521 00111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...++..++.-+..+...+++.+++- .+-..=|...++...|++.+.
T Consensus 909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 909 SWMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ceeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHH
Confidence 11112222222233334455555555 444555778888888887763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=162.76 Aligned_cols=134 Identities=22% Similarity=0.362 Sum_probs=114.2
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCc--------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--------GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.||+|++|.||+|.. +|..++||+....... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999987 6788999975543321 123578899999999999998888888888889999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+++++|.+++... .+ .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998421 12 888999999999999999 8999999999999999 78899999998874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=163.95 Aligned_cols=140 Identities=17% Similarity=0.172 Sum_probs=108.3
Q ss_pred hhcceecccCcEEEEEEe--cCCCCEEEEEEcccCCCc------------------------chHHHHHHHHHHhcCCcc
Q 002943 532 QYKTLIGEGGFGSVYRGT--LPDGQEVAVKVRSSTSTQ------------------------GTREFENELNFLSAIRHE 585 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~--~~~g~~vAVK~~~~~~~~------------------------~~~~f~~E~~~l~~l~H~ 585 (863)
.+.+.||+|+||.||+|. ..+|+.||||++...... ....+..|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 456899999999999998 678999999987643210 012356899999999763
Q ss_pred c--ccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC-ccccCCCCCC
Q 002943 586 N--LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS-VIHRDVKSSN 662 (863)
Q Consensus 586 n--iv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-iiHrDik~~N 662 (863)
. +.+.+++ ...++||||+++++|...+.. ...+...+...++.|++.++.+||+ .+ |+||||||+|
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 3 3333432 235899999999888765421 2234555678999999999999999 88 9999999999
Q ss_pred eEecCCCeEEEeeccCcccCC
Q 002943 663 ILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 663 ILld~~~~~kl~DFGla~~~~ 683 (863)
|+++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=185.02 Aligned_cols=186 Identities=27% Similarity=0.329 Sum_probs=153.8
Q ss_pred eecccCcEEEEEEe----cCCCCEEEEEEcccCCCcc--hHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCC
Q 002943 536 LIGEGGFGSVYRGT----LPDGQEVAVKVRSSTSTQG--TREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~----~~~g~~vAVK~~~~~~~~~--~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+|+|.||.|+++. .+.|..+|.|++.+..... ......|..++..++ ||.+|++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 2457788988766543221 114456788888887 9999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|.|...+.. ....+..........++-+++++|+ .+|+|||+|++||+++.+|++|+.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988843 3345666667777888999999999 89999999999999999999999999999876443221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNT 736 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~ 736 (863)
+||..|||||.+. .....+|-||||++++||+||..||..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 6899999999998 456789999999999999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-16 Score=158.74 Aligned_cols=131 Identities=24% Similarity=0.386 Sum_probs=108.5
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCc--------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--------GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.||+|+||.||+|.+ +|..+++|........ ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 6788999975543211 1245778999999999988776666777777789999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
++++|.+++... .. .++.+++++|.+||+ .+++|+|++|.||+++ ++.+++.|||+++..
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987321 11 789999999999999 8999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9e-16 Score=157.15 Aligned_cols=136 Identities=19% Similarity=0.198 Sum_probs=107.6
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCc----------------------chHHHHHHHHHHhcCCccc--
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ----------------------GTREFENELNFLSAIRHEN-- 586 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~----------------------~~~~f~~E~~~l~~l~H~n-- 586 (863)
+.+.+.||+|+||.||++..++|+.||||++...... ....+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4456889999999999999888999999986543210 0123677899999998874
Q ss_pred ccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec
Q 002943 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666 (863)
Q Consensus 587 iv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld 666 (863)
+...++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+|+||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 444443 2455899999999999765410 2346788999999999999 8999999999999999
Q ss_pred CCCeEEEeeccCcccCC
Q 002943 667 HSMCAKVADFGFSKYAP 683 (863)
Q Consensus 667 ~~~~~kl~DFGla~~~~ 683 (863)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.3e-16 Score=180.69 Aligned_cols=132 Identities=20% Similarity=0.333 Sum_probs=109.3
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEE-cccCCC-------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKV-RSSTST-------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~-~~~~~~-------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.++||+|+||+||+|.+.+.. +++|+ ..+... ...+.+.+|++++++++|++++....++...+..++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 578999999999999875543 44443 221111 123468899999999999999998888888888899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|+++++|.+++. .+..++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999883 357899999999999999 899999999999999 5778999999999854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=157.88 Aligned_cols=198 Identities=23% Similarity=0.276 Sum_probs=138.5
Q ss_pred CcccccceeeeEee---------------------------CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHH
Q 002943 583 RHENLVPLLGYCCE---------------------------NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635 (863)
Q Consensus 583 ~H~niv~l~g~~~~---------------------------~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia 635 (863)
+|||||++.++|.+ ...+||||.-+ ..+|.++|.. ...+...+.-|.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987743 22468888876 4689999943 345667778889
Q ss_pred HHHHHHHHHHHhccCCCccccCCCCCCeEe--cCCC--eEEEeeccCcccCCCC----CCCCceeeeecCCCCCCccccc
Q 002943 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILL--DHSM--CAKVADFGFSKYAPQE----GDSGFSLEVRGTAGYLDPEYYS 707 (863)
Q Consensus 636 ~~ia~gL~yLH~~~~~~iiHrDik~~NILl--d~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 707 (863)
.|+.+|+.|||. ++|.|||+|++|||+ |+|. ...|+|||.+---... ..........|...-||||...
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 899999999999999 4444 4678999987432211 0111122344778899999886
Q ss_pred cCC------CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHH
Q 002943 708 TQH------LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEV 781 (863)
Q Consensus 708 ~~~------~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 781 (863)
... --.|+|.|+.|.+.||++....||-.. +++.+... .+++..+ |.+. ..+...+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r---Gem~L~~r---~Yqe~qL-----Palp----~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR---GEMLLDTR---TYQESQL-----PALP----SRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc---chheechh---hhhhhhC-----CCCc----ccCChHHHHH
Confidence 532 125899999999999999999999752 22211110 0122222 1222 2233447788
Q ss_pred HHHccCcCCCCCCCHHHHHHHHH
Q 002943 782 ALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 782 ~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+...++.+|.+|++..-....|+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 89999999999999877766665
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5e-16 Score=170.97 Aligned_cols=172 Identities=24% Similarity=0.348 Sum_probs=128.5
Q ss_pred eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 599 QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 599 ~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
.+++.|+++...+|.+||.+.. .....+|...+.++.|++.|++| ++.+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4789999999999999996543 34567889999999999999999 5799999999999999999999999999
Q ss_pred cccCCCCC----CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 679 SKYAPQEG----DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 679 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
........ .....+...||..||+||.+.+..|+.|+||||+|++|+||+. =..+++... ...-+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 87665443 1223355679999999999999999999999999999999998 222221110 00001
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+++ +++|....+++. =..+..+++...|.+||+.
T Consensus 473 r~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 473 RDG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hcC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchH
Confidence 111 122222222222 2367789999999999943
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=138.63 Aligned_cols=134 Identities=20% Similarity=0.263 Sum_probs=114.9
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc--ccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH--ENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
+.||+|.++.||++...+ ..++||....... ...+.+|+.+++.++| .++.+++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 579999999999999855 7899998765433 4678999999999987 5899999988888889999999988777
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
..+ +......++.+++++|++||.....+++|+|++|+||++++++.+++.|||+++..
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 543 55677889999999999999865567999999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-14 Score=141.20 Aligned_cols=138 Identities=20% Similarity=0.222 Sum_probs=97.5
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCCc--chHHH----------------------HHHHHHHhcCCccc--c
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--GTREF----------------------ENELNFLSAIRHEN--L 587 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--~~~~f----------------------~~E~~~l~~l~H~n--i 587 (863)
.+.||+|+||.||+|...+|+.||||+....... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3679999999999999888999999987653221 11111 34555566654432 3
Q ss_pred cceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 588 v~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|.. ++|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence 333332 34689999999965432211000 011 56788999999999999972 6799999999999999
Q ss_pred CCeEEEeeccCcccCC
Q 002943 668 SMCAKVADFGFSKYAP 683 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~ 683 (863)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-13 Score=144.83 Aligned_cols=135 Identities=16% Similarity=0.156 Sum_probs=105.2
Q ss_pred ceec-ccCcEEEEEEecCCCCEEEEEEcccCC-------------CcchHHHHHHHHHHhcCCcccc--cceeeeEeeCC
Q 002943 535 TLIG-EGGFGSVYRGTLPDGQEVAVKVRSSTS-------------TQGTREFENELNFLSAIRHENL--VPLLGYCCEND 598 (863)
Q Consensus 535 ~~LG-~G~fG~Vy~g~~~~g~~vAVK~~~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~ 598 (863)
..|| .||.|+||+.... +..++||+..... ......+.+|++++.+++|+++ .+.++++..+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5798 8999999999884 7789998764321 1223467889999999998875 66777654432
Q ss_pred e----eEEEeecCCC-CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEE
Q 002943 599 Q----QILVYPFMSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV 673 (863)
Q Consensus 599 ~----~~LV~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl 673 (863)
. .++|+|++++ .+|.+++.. ..++. ..+.+++.+|.+||+ .+|+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~----~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSE----EQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCH----HHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 3599999997 689988732 22333 236789999999999 89999999999999999899999
Q ss_pred eeccCcccC
Q 002943 674 ADFGFSKYA 682 (863)
Q Consensus 674 ~DFGla~~~ 682 (863)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.3e-14 Score=165.01 Aligned_cols=208 Identities=23% Similarity=0.282 Sum_probs=133.0
Q ss_pred cceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.++|-.|+||.||..+++. .+.+|+|+-+... +.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence 4789999999999998764 5678886432211 0100 12222222222 333
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC-----
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----- 687 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~----- 687 (863)
...+. ..+.++. +++.+++|||+ .+|+|||+||+|.|+..-+++|+.||||++.......
T Consensus 139 ~tllk----~~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 139 ATLLK----NIGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhcc----cCCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 33331 1123332 22788999999 9999999999999999999999999999874321100
Q ss_pred --------CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 688 --------SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 688 --------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.-....+.||+.|+|||++..+.|....|-|++|+|+||.+-|+.||.+..+++-. -+.+...+ ...
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--g~visd~i---~wp 278 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQVISDDI---EWP 278 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--hhhhhhhc---ccc
Confidence 00112357999999999999999999999999999999999999999876432211 11111000 001
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
|- |.. ...+..+++.+.++.+|..|---...
T Consensus 279 E~-dea--------~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 279 EE-DEA--------LPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred cc-CcC--------CCHHHHHHHHHHHHhChHhhcccchh
Confidence 10 111 12245667777888888888543333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-13 Score=162.89 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=181.8
Q ss_pred cceecccCcEEEEEEecCC--CCEEEEEEcccCC--CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCC
Q 002943 534 KTLIGEGGFGSVYRGTLPD--GQEVAVKVRSSTS--TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~--g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+-||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.+|..
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~ 104 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD 104 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence 3569999999998887543 3456666555443 222233445777777776 9999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHH-hccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCC-C
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH-TFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQ-E 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~-~ 685 (863)
+|++.+-+.. ......+....-....|+..++.|+| . .++.||||||+|.+++..+ ..|++|||+|..... .
T Consensus 105 g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 105 GGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccc--CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999887731 11114555667788899999999999 6 8899999999999999999 999999999987766 3
Q ss_pred CCCCceeeeec-CCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDSGFSLEVRG-TAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|...... ..
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~-------~~ 251 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGR-------FT 251 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccc-------cc
Confidence 33334444567 9999999999884 45678999999999999999999987654322 122222222100 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... .......++...++..+|..|.+.+++..
T Consensus 252 ~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 QLPWN----SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCccc----cCChhhhhcccccccCCchhccccccccc
Confidence 00111 11223556777788899999999887643
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-13 Score=133.96 Aligned_cols=150 Identities=28% Similarity=0.375 Sum_probs=83.5
Q ss_pred EEeeccCCCCCCCcccCCCCCCCceeeCCCCCCCccccc--cce----eeecCCCCCCCCcHHHhhhcccCCCCceeecc
Q 002943 194 VGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPEPTTFST--SFT----TNISDNNAKVTVPLQVLQTALTDPNRLMFLHT 267 (863)
Q Consensus 194 ~~R~n~G~~~~~~~irypdD~~dR~W~p~~~~~~~~~~~--~~~----~~~~~~~~~~~~P~~V~~TA~~~~~~~~~~~~ 267 (863)
+.|+|+|+.. | .|..+..|.+|.......... +.. ............+..+|||+|.+..++.|...
T Consensus 2 ~~~IN~Gg~~------~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip 74 (174)
T PF11721_consen 2 VLRINAGGPA------Y-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIP 74 (174)
T ss_dssp EEEEEETSSS------E-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE
T ss_pred EEEEECCCCc------c-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEe
Confidence 5799999975 3 789999999995432222100 000 01112223356688999999997555444332
Q ss_pred cCCCCCcceEEEEEEeeccccc----CCCCeEEEEEEECCccccccchhhhc-Ccce-eEEE-E-Eee-cCCceEEEEee
Q 002943 268 DLDSGDYNYTLILYFLELNDSV----KSSGQRVFDILINNERKKEKFDILAL-GSNY-AKLA-L-NVT-ANGSLNLTLVN 338 (863)
Q Consensus 268 ~~~~~~~~y~v~lhFaEi~~~~----~~~~~R~F~I~ing~~~~~~~di~~~-~~~~-~~~~-~-~~~-~~g~~~~~l~~ 338 (863)
..++..|.|.|||||+.... .+.++|+|||+|||+++.++|||.+. |+.. .... . .+. .+|.++|.+.+
T Consensus 75 --~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~ 152 (174)
T PF11721_consen 75 --VVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVW 152 (174)
T ss_dssp ----S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEE
T ss_pred --cCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEe
Confidence 25567799999999996422 23789999999999999999999874 3322 1111 1 222 57889998886
Q ss_pred ecCC-------Ccc-cccccee
Q 002943 339 VLNG-------SVF-GPICNAY 352 (863)
Q Consensus 339 t~~~-------S~l-ppilNa~ 352 (863)
..++ +.. -|+||||
T Consensus 153 ~~~~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 153 AGKGTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp E--SEEEEEEESSSSSSSEEEE
T ss_pred cCCCcEEeeccccCCCcEEeeC
Confidence 4333 222 3888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.5e-12 Score=148.73 Aligned_cols=140 Identities=21% Similarity=0.215 Sum_probs=100.5
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcc----------------------------------------hHHHHH
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG----------------------------------------TREFEN 574 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~----------------------------------------~~~f~~ 574 (863)
+.||+|++|.||+|++++|+.||||+........ +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999875432110 012555
Q ss_pred HHHHHhcCC----cccccceeeeE-eeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHH-HHHHHHhc
Q 002943 575 ELNFLSAIR----HENLVPLLGYC-CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR-GLMYLHTF 648 (863)
Q Consensus 575 E~~~l~~l~----H~niv~l~g~~-~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~-gL~yLH~~ 648 (863)
|++.+.+++ |.+-+.+-..+ ......+|||||+++++|.+...... ... .+.+++..+++ .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh-
Confidence 666665553 22223332222 22456799999999999998764221 111 34567777766 4677887
Q ss_pred cCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 649 ~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
.+++|+|+||.||++++++.+++.|||++..+.
T Consensus 276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=135.86 Aligned_cols=203 Identities=20% Similarity=0.266 Sum_probs=142.6
Q ss_pred HHHhcCCcccccceeeeEeeCC-----eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC
Q 002943 577 NFLSAIRHENLVPLLGYCCEND-----QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651 (863)
Q Consensus 577 ~~l~~l~H~niv~l~g~~~~~~-----~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 651 (863)
.-|-.+-|-|||++..|+.+.. ...++.|||+.|+|..+|++.......+......+++-||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455667999999999986543 4678999999999999998877777888888889999999999999999 559
Q ss_pred CccccCCCCCCeEecCCCeEEEeeccCcccCCCC--CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh
Q 002943 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE--GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS 729 (863)
Q Consensus 652 ~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt 729 (863)
+|+|+++.-+-|++..++-+||.----....... ..........+-++|.+||+-...+.+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887522111100000 00001112346789999999888888889999999999999988
Q ss_pred CCCCCCCCCCC--CcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 730 GREPLNTRRPR--NEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 730 G~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+..--...... .+.++.. +...+. + .+ =..++..|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~-~i~~le--------n-~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN-VIIGLE--------N-GL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhh-heeecc--------C-cc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 76432111110 0000000 000000 0 01 123556799999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.6e-11 Score=117.13 Aligned_cols=131 Identities=18% Similarity=0.185 Sum_probs=96.6
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~ 614 (863)
+.|+.|.++.||++... |..+++|+...... ....+..|+++++.+.+.++++-+-.+ .....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCcccc
Confidence 46789999999999874 77899998654432 234578899999999766655433222 2334689999999988754
Q ss_pred hhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc--CCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA--GRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 615 ~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 112345678999999999832 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-11 Score=136.83 Aligned_cols=253 Identities=20% Similarity=0.191 Sum_probs=180.1
Q ss_pred HHHHHHHhhcceecc--cCcEEEEEEec---CCCCEEEEEE--cccCCCcchHHHHHHHHHHhcCC-cccccceeeeEee
Q 002943 525 YLEAATQQYKTLIGE--GGFGSVYRGTL---PDGQEVAVKV--RSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCE 596 (863)
Q Consensus 525 ~l~~~t~~f~~~LG~--G~fG~Vy~g~~---~~g~~vAVK~--~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 596 (863)
+......++.+.+|+ |.+|.||++.. .++..+|+|. +.....+....=.+|+....+++ |+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 345555666788999 99999999987 3688899996 33333333344456777777775 9999999889999
Q ss_pred CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHH----HHHHHHhccCCCccccCCCCCCeEecCC-CeE
Q 002943 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR----GLMYLHTFAGRSVIHRDVKSSNILLDHS-MCA 671 (863)
Q Consensus 597 ~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~iiHrDik~~NILld~~-~~~ 671 (863)
++..++-+|++ +.+|.++.+... ..++....+.+..+... ||.++|+ .+++|-|+||.||++..+ ...
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence 99999999988 578888875432 23555566666666666 9999999 899999999999999999 899
Q ss_pred EEeeccCcccCCCCCCCC---ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh
Q 002943 672 KVADFGFSKYAPQEGDSG---FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 748 (863)
++.|||+...+....... ......|...|++||...+ -++.++|+|++|.+.+|..+|-........ ..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCc
Confidence 999999998776543222 1223357888999998754 567889999999999999998766543210 011
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ..+.+ . +..++...-..++.....++++.+|..|++.+++..
T Consensus 336 ~--~~r~~-----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 S--QLRQG-----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--ccccc-----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 11111 1 111111111223444788899999999998877654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.7e-11 Score=137.31 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=89.8
Q ss_pred ceecccCcEEEEEEecCC-CCEEEEEEcccCCCcc----------------------------------hH------HHH
Q 002943 535 TLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQG----------------------------------TR------EFE 573 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~----------------------------------~~------~f~ 573 (863)
+-||+|++|.||+|++++ |+.||||+..+.-... .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999876442100 01 234
Q ss_pred HHHHHHhcCC----cccccceeeeEee-CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHH-HHHHHh
Q 002943 574 NELNFLSAIR----HENLVPLLGYCCE-NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG-LMYLHT 647 (863)
Q Consensus 574 ~E~~~l~~l~----H~niv~l~g~~~~-~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~g-L~yLH~ 647 (863)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++++.|.+.-.-.. ...+ +..++...++. +..++.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~~~~~Qif~ 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVEVFFTQVFR 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 4544444442 3333332222222 346789999999999987431111 1111 12233222221 222333
Q ss_pred ccCCCccccCCCCCCeEecCCC----eEEEeeccCcccCCC
Q 002943 648 FAGRSVIHRDVKSSNILLDHSM----CAKVADFGFSKYAPQ 684 (863)
Q Consensus 648 ~~~~~iiHrDik~~NILld~~~----~~kl~DFGla~~~~~ 684 (863)
.+++|+|+||.||+++.++ .+++.|||+...+..
T Consensus 279 ---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 ---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 7899999999999999888 999999999986654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=112.18 Aligned_cols=143 Identities=19% Similarity=0.278 Sum_probs=111.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcc--cccceeeeEeeCC---eeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHE--NLVPLLGYCCEND---QQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~LV~ey~~ 608 (863)
+.|+.|..+.||+++..+|..+++|+...... ....++..|+++++.+++. ++.+++.++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778999998654432 2456789999999999764 4566777776543 5689999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA--------------------------------------- 649 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------------------------- 649 (863)
+.+|.+.+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776521 34677778888888888888888521
Q ss_pred --------------CCCccccCCCCCCeEecC--CCeEEEeeccCcccC
Q 002943 650 --------------GRSVIHRDVKSSNILLDH--SMCAKVADFGFSKYA 682 (863)
Q Consensus 650 --------------~~~iiHrDik~~NILld~--~~~~kl~DFGla~~~ 682 (863)
...++|+|+++.||+++. +..+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245799999999999998 677899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=105.98 Aligned_cols=137 Identities=15% Similarity=0.133 Sum_probs=96.3
Q ss_pred ceecccCcEEEEEEecCC-------CCEEEEEEcccCCC----------------------cchHHHH----HHHHHHhc
Q 002943 535 TLIGEGGFGSVYRGTLPD-------GQEVAVKVRSSTST----------------------QGTREFE----NELNFLSA 581 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-------g~~vAVK~~~~~~~----------------------~~~~~f~----~E~~~l~~ 581 (863)
..||.|.-+.||.|.-.+ +..+|||+.+.... ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 57999997543210 0112233 79999999
Q ss_pred CCc--ccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHH-HhccCCCccccCC
Q 002943 582 IRH--ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL-HTFAGRSVIHRDV 658 (863)
Q Consensus 582 l~H--~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iiHrDi 658 (863)
+.. -++...+++ ...+|||||+.+..+....- ....++..+...+..+++.+|..| |. .+|||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 864 345555543 56789999997654422110 111234445667789999999999 77 79999999
Q ss_pred CCCCeEecCCCeEEEeeccCcccCC
Q 002943 659 KSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 659 k~~NILld~~~~~kl~DFGla~~~~ 683 (863)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.3e-09 Score=120.78 Aligned_cols=166 Identities=19% Similarity=0.195 Sum_probs=122.9
Q ss_pred cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChh
Q 002943 550 LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWP 629 (863)
Q Consensus 550 ~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~ 629 (863)
..++.+|.|...+...........+-++.|+.+|||||++++......+..|||+|-+. -|..++.. +.-.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 34688888887776655444556788899999999999999999999999999999774 35555522 2234
Q ss_pred hHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC
Q 002943 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709 (863)
Q Consensus 630 ~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 709 (863)
..--.+.||+.||.|||+. .+++|++|.-+.|++++.|+.||++|-++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 4555678999999999975 4799999999999999999999999988754432211 00011122345666654332
Q ss_pred CCCcccceechhhHHHHHHhC
Q 002943 710 HLSAKSDVFSFGVVLLEIISG 730 (863)
Q Consensus 710 ~~s~ksDV~SfGvvl~ElltG 730 (863)
. -..|.|.||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 236999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-08 Score=98.61 Aligned_cols=131 Identities=23% Similarity=0.352 Sum_probs=102.3
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCc--------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--------GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+++|+-..+|.+.+. |.++.+|...+.... ....-.+|++++.+++--.|-.-+-+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999774 445777854333221 1134568999999998666666666777888889999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
++-.|.+.+... +..++..+-+-+.-||. .+|+|+||.++||++..+. +.++||||+...
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888321 35677788888889999 8999999999999998776 999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.4e-09 Score=120.95 Aligned_cols=241 Identities=22% Similarity=0.220 Sum_probs=170.0
Q ss_pred hcceecccCcEEEEEEec--CCCCEEEEEEcccCCCcchH--HHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecC
Q 002943 533 YKTLIGEGGFGSVYRGTL--PDGQEVAVKVRSSTSTQGTR--EFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~--~~g~~vAVK~~~~~~~~~~~--~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
+...||.|.|+.|++... .++..+++|.+.+....... .-..|+-+...+ .|.++++....+...+..++--||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 347899999999999863 46889999976655433222 123566666666 4888888888888888888999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~~ 686 (863)
+++++...+ .....++...++++..+++.++.++|+ +.++|+|+||+||++..+ +.-+++|||++..+....
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec
Confidence 999987766 234567888899999999999999998 899999999999999875 889999999986432111
Q ss_pred CCCceeeeecCCCCC--CccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 687 DSGFSLEVRGTAGYL--DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
....+.-+++ +++......+-.+.|++|||.-+.|.+++..--.. ..+|.. +..+. -+
T Consensus 422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~~--i~~~~-----~p 481 (524)
T KOG0601|consen 422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSLT--IRSGD-----TP 481 (524)
T ss_pred -----ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------ccccee--eeccc-----cc
Confidence 1111233344 55555666788899999999999999998643221 111211 11111 11
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.+.+. ...+..++..+...++..||...+.....+.
T Consensus 482 ~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 NLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred CCCch-----HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 22211 1345667777888999999998887665543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=8.5e-08 Score=93.17 Aligned_cols=142 Identities=21% Similarity=0.267 Sum_probs=104.9
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEc-ccCCC-------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVR-SSTST-------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~-~~~~~-------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+|-+|+-+.|+++.+ .|+...||.. .+.-. -..+...+|+++|.+++--.|.--.-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5788999999999988 5777778743 32211 1234667899999999866665555567777778899999
Q ss_pred CCC-CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---eEEEeeccCcccC
Q 002943 607 MSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVADFGFSKYA 682 (863)
Q Consensus 607 ~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGla~~~ 682 (863)
+++ .++.+++...... .........++..|-+.+.-||. ..|||+||..+||+|..++ .+.++||||+...
T Consensus 92 ~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 966 4788888543221 22223336788889999999999 8999999999999996554 4689999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=103.45 Aligned_cols=170 Identities=18% Similarity=0.265 Sum_probs=131.1
Q ss_pred cEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEeecCCC-CChhhh
Q 002943 542 FGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYPFMSN-GSLQDR 615 (863)
Q Consensus 542 fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ey~~~-gsL~~~ 615 (863)
-.+.||+.. .||..|.+|++.....+....--.-++.++++.|.|+|++..++.. ....+|||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 367899884 5899999999854444443344556889999999999999988763 3467899999987 678877
Q ss_pred hhccC-----------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 616 LYGEA-----------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 616 L~~~~-----------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
.+... ..+..+++...+.++.|++.||.++|+ .++.-+-|.+++||++.+.+++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 65332 123457778999999999999999999 7888899999999999999999999998776654
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p 733 (863)
+.. |-+.. -.+-|.=.||.+++.|.||+..
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 421 11111 2457888899999999999653
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.8e-08 Score=95.22 Aligned_cols=131 Identities=13% Similarity=0.167 Sum_probs=70.3
Q ss_pred EEEecCCCCCcccCCCCcEEecCCCeecCCCCcc------------cccCC---CCCcccccccccccCCCCcceeeecc
Q 002943 35 VSIACCADSDFIGKYPPVNWKPDDAWFPDKKDCR------------AITRP---AVNNKFYDRVLDFGIDSGKRCYNLST 99 (863)
Q Consensus 35 ~sidCG~~~~~~~~~~~~~~~~D~~~~~~~~~~~------------~~~~~---~~~~~~~~~~r~f~~~~~~~cY~~~~ 99 (863)
++|+||+.. + ++..|+.|.+|..|. ++... ..... ...+..|+|.|.=+ ..+.|.||+
T Consensus 3 ~~IN~Gg~~-~-~~~~g~~w~~D~~~~--~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~ 75 (174)
T PF11721_consen 3 LRINAGGPA-Y-TDSSGIVWEADQYYT--GGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPV 75 (174)
T ss_dssp EEEEETSSS-E-EETTTEEE-SSSSST--TSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE-
T ss_pred EEEECCCCc-c-cCCCCCEEcCCCCCC--CCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEec
Confidence 689999754 4 444899999988773 22220 00011 11134677888754 246899997
Q ss_pred cCCCeeeEeEEeeccCCCC--CCCCc---ceeEEEcce-eeEEEeCC----C---CceeeE-EEEecCCceEEeec----
Q 002943 100 IKGQDYLIRGTFLNGDNVE--TPLIS---SFNVLVGVT-PLSLVNST----E---DSVVEG-IFKAANDYIDFCLD---- 161 (863)
Q Consensus 100 ~~~~~ylvR~~F~yg~~~~--~~~~~---~Fd~~~~~~-~w~~vn~~----~---~~~~e~-i~~~~~~~~~vcl~---- 161 (863)
.+.|.|.|||+|.--.+.. ....| .|||+++|. ....++.. . ....+. -+...++.|.++|.
T Consensus 76 ~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~ 155 (174)
T PF11721_consen 76 VPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGK 155 (174)
T ss_dssp -S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--
T ss_pred CCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCC
Confidence 7999999999994442222 11111 599999996 22222221 1 122233 22347788998886
Q ss_pred --------CCCCCceeeeE
Q 002943 162 --------KKDGDPYISGL 172 (863)
Q Consensus 162 --------~~~~~pfIs~l 172 (863)
...+.|.||||
T Consensus 156 ~~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 156 GTLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp SEEEEEEESSSSSSSEEEE
T ss_pred CcEEeeccccCCCcEEeeC
Confidence 56788999987
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.8e-07 Score=94.16 Aligned_cols=125 Identities=22% Similarity=0.319 Sum_probs=81.7
Q ss_pred EEEEEecCCCCEEEEEEcccCCC-------------c--------c-----hHHHHHHHHHHhcCCcc--cccceeeeEe
Q 002943 544 SVYRGTLPDGQEVAVKVRSSTST-------------Q--------G-----TREFENELNFLSAIRHE--NLVPLLGYCC 595 (863)
Q Consensus 544 ~Vy~g~~~~g~~vAVK~~~~~~~-------------~--------~-----~~~f~~E~~~l~~l~H~--niv~l~g~~~ 595 (863)
.||.|...+|..+|||+...... . . .....+|.+.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999999999999997543210 0 0 12356899999999765 44555543
Q ss_pred eCCeeEEEeecCC--CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHH-HhccCCCccccCCCCCCeEecCCCeEE
Q 002943 596 ENDQQILVYPFMS--NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL-HTFAGRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 596 ~~~~~~LV~ey~~--~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iiHrDik~~NILld~~~~~k 672 (863)
...+|||||++ +..+...... .++......++.++...+..+ |. .+|+|+||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 24579999998 5444443311 122445567788888866664 56 799999999999999988 999
Q ss_pred EeeccCcccC
Q 002943 673 VADFGFSKYA 682 (863)
Q Consensus 673 l~DFGla~~~ 682 (863)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.8e-07 Score=96.50 Aligned_cols=140 Identities=15% Similarity=0.090 Sum_probs=99.4
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCC-----------cchHHHHHHHHHHhcCCccc--ccceeeeEee-----C
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTST-----------QGTREFENELNFLSAIRHEN--LVPLLGYCCE-----N 597 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~-----------~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~-----~ 597 (863)
.+-+-....|.+..+ +|+.+.||....... .....+.+|.+.+.++...+ ....+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343333444667766 677899996533221 11124789999998885433 3444566543 2
Q ss_pred CeeEEEeecCCCC-ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-------CC
Q 002943 598 DQQILVYPFMSNG-SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-------SM 669 (863)
Q Consensus 598 ~~~~LV~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-------~~ 669 (863)
...+||+|++++- +|.+++.... ....+...+..++.+++..+.-||. .+|+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 3578999999876 8998873211 2234556778899999999999999 99999999999999975 57
Q ss_pred eEEEeeccCccc
Q 002943 670 CAKVADFGFSKY 681 (863)
Q Consensus 670 ~~kl~DFGla~~ 681 (863)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3e-08 Score=117.56 Aligned_cols=198 Identities=23% Similarity=0.291 Sum_probs=133.4
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+-+-+|.++.++...-. .|...++|+..... ....+....+-.++-..+||-+++..--+.-.....||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 35667888888877632 34344444332221 111222222222332334555554444444567789999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC-----
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE----- 685 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~----- 685 (863)
+|...||... ..+..........+..+++|||. ..+.|||++|.|.|...++..+++|||......-.
T Consensus 890 ~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 890 DLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999986543 23333334445567788999998 66999999999999999999999999843311100
Q ss_pred -----------------C-------CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC
Q 002943 686 -----------------G-------DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739 (863)
Q Consensus 686 -----------------~-------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~ 739 (863)
. +........||..|.+||...+......+|.|++|++++|.++|..||....+
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 00112234589999999999999999999999999999999999999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.3e-06 Score=87.50 Aligned_cols=133 Identities=23% Similarity=0.235 Sum_probs=92.2
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCC----------------------cchHHHHHHHHHHhcCCcc--cc
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST----------------------QGTREFENELNFLSAIRHE--NL 587 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~----------------------~~~~~f~~E~~~l~~l~H~--ni 587 (863)
.+.+.||.|.-+.||.|..++|.++|||.-..... ......++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34689999999999999999999999995332110 0112456888999988654 55
Q ss_pred cceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 588 v~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
.+.+++ +..++||||+++--|...- ++-...-.|+..|.+-+.-+-. .++||+|+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 555543 4568999999885554321 1222223344444444433334 68999999999999999
Q ss_pred CCeEEEeeccCcc
Q 002943 668 SMCAKVADFGFSK 680 (863)
Q Consensus 668 ~~~~kl~DFGla~ 680 (863)
|+.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=101.83 Aligned_cols=144 Identities=17% Similarity=0.229 Sum_probs=88.7
Q ss_pred EEecCCCC-----CcccCCC--CcEEecCCCeecCCCCc----ccccC---C-C-CCcccccccccccCCCCcceeeecc
Q 002943 36 SIACCADS-----DFIGKYP--PVNWKPDDAWFPDKKDC----RAITR---P-A-VNNKFYDRVLDFGIDSGKRCYNLST 99 (863)
Q Consensus 36 sidCG~~~-----~~~~~~~--~~~~~~D~~~~~~~~~~----~~~~~---~-~-~~~~~~~~~r~f~~~~~~~cY~~~~ 99 (863)
+|+||+.. .|.||.- .|.|.+|+.|....... ..+.. . . ....-|+|+|.+........|.+++
T Consensus 195 R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v 274 (623)
T PLN03150 195 RLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDV 274 (623)
T ss_pred EEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEeec
Confidence 79999742 2333322 79999998865321110 01110 0 0 1112588998886433345999999
Q ss_pred cCCCeeeEeEEeeccCCCC-CCCCcceeEEEcceeeEE-EeC---CC----CceeeEEEEecCCceEEeecCCCC-Ccee
Q 002943 100 IKGQDYLIRGTFLNGDNVE-TPLISSFNVLVGVTPLSL-VNS---TE----DSVVEGIFKAANDYIDFCLDKKDG-DPYI 169 (863)
Q Consensus 100 ~~~~~ylvR~~F~yg~~~~-~~~~~~Fd~~~~~~~w~~-vn~---~~----~~~~e~i~~~~~~~~~vcl~~~~~-~pfI 169 (863)
.++++|+||+||..-.... ....-.|||++++..+.. ++. +. ..+.+..+...++.+.|.|....+ .|||
T Consensus 275 ~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~pil 354 (623)
T PLN03150 275 DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHAII 354 (623)
T ss_pred CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCccee
Confidence 8999999999997653211 111225999999974332 221 11 123455555556778899966544 5999
Q ss_pred eeEeeeecCC
Q 002943 170 SGLEVRPLND 179 (863)
Q Consensus 170 s~lEl~~l~~ 179 (863)
|||||..+-.
T Consensus 355 NaiEI~~~~~ 364 (623)
T PLN03150 355 NAIEVFEIIT 364 (623)
T ss_pred eeeeeeeccc
Confidence 9999998875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=81.84 Aligned_cols=138 Identities=14% Similarity=0.098 Sum_probs=102.1
Q ss_pred ecccCcEEEEEEecCCCCEEEEEEcccC------CCcchHHHHHHHHHHhcCCcc--cccceeeeEe-eC----CeeEEE
Q 002943 537 IGEGGFGSVYRGTLPDGQEVAVKVRSST------STQGTREFENELNFLSAIRHE--NLVPLLGYCC-EN----DQQILV 603 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~~g~~vAVK~~~~~------~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~-~~----~~~~LV 603 (863)
-|+||-+.|++-.+. |+.+-+|+-... .+.+...|.+|...|.++... .+.+.+ ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367999999998774 447889964311 134667899999999999643 344444 443 22 135799
Q ss_pred eecCCC-CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe--EEEeeccCcc
Q 002943 604 YPFMSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC--AKVADFGFSK 680 (863)
Q Consensus 604 ~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DFGla~ 680 (863)
+|-+++ -+|.+++... ...+.+...+..+..++++.++-||+ .++.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5898888332 12345777888999999999999999 89999999999999986556 9999997665
Q ss_pred c
Q 002943 681 Y 681 (863)
Q Consensus 681 ~ 681 (863)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3e-07 Score=105.51 Aligned_cols=151 Identities=23% Similarity=0.299 Sum_probs=101.4
Q ss_pred HHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-------CceeeeecCCCCCCcccccc
Q 002943 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-------GFSLEVRGTAGYLDPEYYST 708 (863)
Q Consensus 636 ~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 708 (863)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+......... ....-......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999984 68999999999999999999999999987644332111 11111224567999999999
Q ss_pred CCCCcccceechhhHHHHHHhCCCC-CCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccC
Q 002943 709 QHLSAKSDVFSFGVVLLEIISGREP-LNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIE 787 (863)
Q Consensus 709 ~~~s~ksDV~SfGvvl~ElltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~ 787 (863)
...+.++|+||+|++++-+..|..+ +....... .+.. ..-.+..-.-.+..+...++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~--------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSF--------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhh--------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 8889999999999999999954443 43221110 0000 00001000112223344567777788999
Q ss_pred cCCCCCCCHHHHHH
Q 002943 788 PFSAYRPSMVDIVR 801 (863)
Q Consensus 788 ~~P~~RPsm~eVl~ 801 (863)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.9e-06 Score=84.57 Aligned_cols=107 Identities=21% Similarity=0.234 Sum_probs=84.3
Q ss_pred hHHHHHHHHHHhcCCc--ccccceeeeEeeCC----eeEEEeecCCCC-ChhhhhhccCCCCccCChhhHHHHHHHHHHH
Q 002943 569 TREFENELNFLSAIRH--ENLVPLLGYCCEND----QQILVYPFMSNG-SLQDRLYGEASTRKTLDWPTRLSIALGAARG 641 (863)
Q Consensus 569 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~LV~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~g 641 (863)
.....+|...+.++.. -...+.+++..... ..+||+|++++. +|.+++.... .++...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 3467788888888853 34556667666533 458999999884 7999884321 25666788999999999
Q ss_pred HHHHHhccCCCccccCCCCCCeEecCCC---eEEEeeccCcccC
Q 002943 642 LMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVADFGFSKYA 682 (863)
Q Consensus 642 L~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGla~~~ 682 (863)
++-||+ .+|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 9999999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.2e-06 Score=95.23 Aligned_cols=144 Identities=21% Similarity=0.257 Sum_probs=95.0
Q ss_pred hhc-ceecccCcEEEEEEecCCCCEEEEEEcccCCCcc--------------------------h----H----------
Q 002943 532 QYK-TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG--------------------------T----R---------- 570 (863)
Q Consensus 532 ~f~-~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~--------------------------~----~---------- 570 (863)
.|+ +-|+.++-|.||+|++++|+.||||+....-... . +
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 344 5699999999999999999999999865431110 0 0
Q ss_pred HHHHHHHHHhcCC-----cccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHH-HHH
Q 002943 571 EFENELNFLSAIR-----HENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG-LMY 644 (863)
Q Consensus 571 ~f~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~g-L~y 644 (863)
++.+|...+.+++ .+++.--.=|..-....+|+|||++|-.+.+...-.. ..++ +..++..++++ +..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q 280 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQ 280 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHH
Confidence 2345555555553 2332222222333567899999999988888752211 2333 33444444443 222
Q ss_pred HHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 645 LH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
+-. .++.|.|..|.||+++.+++..+.|||+...+..
T Consensus 281 ~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 5799999999999999999999999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.4e-05 Score=79.75 Aligned_cols=139 Identities=13% Similarity=0.178 Sum_probs=85.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc--cceeeeEeeCCeeEEEeecCCCCC-
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL--VPLLGYCCENDQQILVYPFMSNGS- 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~LV~ey~~~gs- 611 (863)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888765433 33456889999999875443 566777777777889999998863
Q ss_pred hhhhh---------------------hccCCCCccCChhhHHH-HHH----------HHH-HHHHHHHh-ccCCCccccC
Q 002943 612 LQDRL---------------------YGEASTRKTLDWPTRLS-IAL----------GAA-RGLMYLHT-FAGRSVIHRD 657 (863)
Q Consensus 612 L~~~L---------------------~~~~~~~~~l~~~~~~~-ia~----------~ia-~gL~yLH~-~~~~~iiHrD 657 (863)
+...+ |...... .....+.. +.. .+. ....+|.. .....++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1110000 11111000 000 001 11222221 1124578999
Q ss_pred CCCCCeEecCCCeEEEeeccCccc
Q 002943 658 VKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 658 ik~~NILld~~~~~kl~DFGla~~ 681 (863)
+.|.||++++++ +.|.||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.4e-06 Score=94.94 Aligned_cols=181 Identities=19% Similarity=0.153 Sum_probs=131.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc-ccceeeeEeeCCeeEEEeecCCCC-Ch
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN-LVPLLGYCCENDQQILVYPFMSNG-SL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~LV~ey~~~g-sL 612 (863)
+-+++|+++++||.+-...+...+|.+... ....-++++|.+++||| .+..++-+..++..+++++++..| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 456889999999988544444446654433 34556899999999999 777777777777888999999877 22
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
..-. ......+...+...+...-++++++||+ -.=+||| |||..+ ...|..||+....+.... ...
T Consensus 323 ~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 323 ALEM---TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred cccC---ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 2111 1112234444555667777889999998 3358998 777765 678999999987765432 234
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCC
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~ 734 (863)
...+++.++|||......+..+.|+|+.|+--.++.-|-+|-
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 456899999999999999999999999999777777776654
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0001 Score=82.09 Aligned_cols=154 Identities=23% Similarity=0.229 Sum_probs=92.9
Q ss_pred eccCCCCCCCccc-CCCCCCCceeeCCCCCCCccccccceeeecCCCCCCCCcHHHhhhcccCC--CCceeecccCCCCC
Q 002943 197 YDLGRSDNELSFR-YPDDPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTALTDP--NRLMFLHTDLDSGD 273 (863)
Q Consensus 197 ~n~G~~~~~~~ir-ypdD~~dR~W~p~~~~~~~~~~~~~~~~~~~~~~~~~~P~~V~~TA~~~~--~~~~~~~~~~~~~~ 273 (863)
++||++.+ .. |.||.-+|.|.+|.....+..+.. + ....+..-..+...|+|||.=+ .+.-|........+
T Consensus 1 IdCG~~~~---~s~y~D~~tg~~~~~D~~~~~~g~~~~--i-~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~ 74 (347)
T PF12819_consen 1 IDCGSSSN---SSSYVDDSTGRTWVSDDDFIDTGKSGN--I-SSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGG 74 (347)
T ss_pred CcCCCCCC---CcccccCCCCcEEeCCCCcccCCCccc--c-ccccCCcCCccccccceEEEcCCCCccEEEeeccCCCC
Confidence 57998864 34 999999999999974322111111 1 0011111246788999999843 22222221111245
Q ss_pred cceEEEEEEeecccccCC----CCeEEEEEEECCccccccchhhh--cCcceeEEEEEeecCCceEEEEeeecCCCcccc
Q 002943 274 YNYTLILYFLELNDSVKS----SGQRVFDILINNERKKEKFDILA--LGSNYAKLALNVTANGSLNLTLVNVLNGSVFGP 347 (863)
Q Consensus 274 ~~y~v~lhFaEi~~~~~~----~~~R~F~I~ing~~~~~~~di~~--~~~~~~~~~~~~~~~g~~~~~l~~t~~~S~lpp 347 (863)
.+|+|||||-=....-.. ...-.||+++++..+.. .+... ....+..+.++++.++.+.+.|+++..++ -|
T Consensus 75 ~~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~t-V~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~--~p 151 (347)
T PF12819_consen 75 GKYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWST-VNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGT--FP 151 (347)
T ss_pred ceEEEEEEeccccccccccccccCCcceEEEECCceeEE-EEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCC--CC
Confidence 599999999855321110 11346999999987632 11111 12345566778887789999999983322 28
Q ss_pred ccceeeeEEeec
Q 002943 348 ICNAYEILQVRQ 359 (863)
Q Consensus 348 ilNa~Ei~~v~~ 359 (863)
.|||+||..+..
T Consensus 152 FIsaiEl~~lp~ 163 (347)
T PF12819_consen 152 FISAIELRPLPD 163 (347)
T ss_pred ceeEEEEEECCc
Confidence 999999987743
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.1e-05 Score=78.23 Aligned_cols=104 Identities=24% Similarity=0.201 Sum_probs=82.8
Q ss_pred HHHHHHHhcCCc-ccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC
Q 002943 573 ENELNFLSAIRH-ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651 (863)
Q Consensus 573 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 651 (863)
..|.-+++.+++ +++.+++|+| ..++|.||...+++...- .....-...+|..|.+||.++++.+++|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 458888889976 6999999999 347789999877664220 0001112468999999999999999999986656
Q ss_pred CccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 652 ~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
.+.-+|++++|+-+++++++|+.|...+-.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 688999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.2e-05 Score=82.42 Aligned_cols=260 Identities=15% Similarity=0.157 Sum_probs=149.3
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeE------eeCCe-eEEEee
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYC------CENDQ-QILVYP 605 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~------~~~~~-~~LV~e 605 (863)
.+-||+|+-+.+|-.--- +. -+-|+.......... +.++.|... .||-+-.-+.+= -++.. .-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 357999999999954311 11 233554443332221 223333343 455433311111 11222 446666
Q ss_pred cCCCCC-hhhhhhc--cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 606 FMSNGS-LQDRLYG--EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 606 y~~~gs-L~~~L~~--~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
.+++.- ...++.- .+.+-...+|...++.+..+|.+.+-||+ .+.+-+|+.++|+|++++..+.|.|=.--...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 665542 2222211 11233468899999999999999999999 78999999999999999999999875433222
Q ss_pred CCCCCCCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhC-CCCCCCCCCCCc-chhHHhhhhcccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISG-REPLNTRRPRNE-WSLVEWAKPFIRE 755 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG-~~p~~~~~~~~~-~~l~~~~~~~~~~ 755 (863)
.. ........|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+...... .+-.+- -+..
T Consensus 168 ~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~ 241 (637)
T COG4248 168 AN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAH 241 (637)
T ss_pred cC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhc
Confidence 11 11223346889999999754 33456789999999999999986 999976542110 000000 0000
Q ss_pred cccccccCCc--c---CCCCcHHH-HHHHHHHHHHccCc--CCCCCCCHHHHHHHHHHhh
Q 002943 756 SRIDEIVDPS--I---KGGYHAEA-MWRMVEVALACIEP--FSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 756 ~~~~~i~d~~--l---~~~~~~~~-~~~l~~l~~~C~~~--~P~~RPsm~eVl~~L~~~~ 807 (863)
+.....-|.+ + ....+-+. ...+..+-.+|+.. ++.-||+.+-.+..|..+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 1111111100 0 01111111 12344556677764 3678999999888876553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00017 Score=76.26 Aligned_cols=141 Identities=20% Similarity=0.172 Sum_probs=85.3
Q ss_pred ecccCc-EEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCCChhh
Q 002943 537 IGEGGF-GSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNGSLQD 614 (863)
Q Consensus 537 LG~G~f-G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~ 614 (863)
|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||++++.+|.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 334444 789999764 4788889765443 345778999988884 4345566777766667899999999887764
Q ss_pred hh-------------------hccCCCCccCC--hhhHHHHHH--------------------HHHHHHHHHHh----cc
Q 002943 615 RL-------------------YGEASTRKTLD--WPTRLSIAL--------------------GAARGLMYLHT----FA 649 (863)
Q Consensus 615 ~L-------------------~~~~~~~~~l~--~~~~~~ia~--------------------~ia~gL~yLH~----~~ 649 (863)
.. |.......... ...++.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11110000111 000110000 01111222211 11
Q ss_pred CCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 25599999999999999988889999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=6.4e-05 Score=86.64 Aligned_cols=142 Identities=18% Similarity=0.220 Sum_probs=91.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcc-------------------------------------hHHHHHHHH
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG-------------------------------------TREFENELN 577 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~-------------------------------------~~~f~~E~~ 577 (863)
+-||.-+.|.||+|++++|+.||||+-+..-... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999754321110 113556665
Q ss_pred HHhcC----Ccccccc---eeee-EeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc
Q 002943 578 FLSAI----RHENLVP---LLGY-CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649 (863)
Q Consensus 578 ~l~~l----~H~niv~---l~g~-~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 649 (863)
-..+. +|-+... +=.+ ..-...++|+||||+|..+.+...-. ...++-. .|+..+.++ |++.--
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~---~i~~~l~~~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---KRGISPH---DILNKLVEA--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---HcCCCHH---HHHHHHHHH--HHHHHH
Confidence 55544 3444111 1112 22345789999999998777665322 1223333 333333332 222222
Q ss_pred CCCccccCCCCCCeEecC----CCeEEEeeccCcccCCC
Q 002943 650 GRSVIHRDVKSSNILLDH----SMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~----~~~~kl~DFGla~~~~~ 684 (863)
..+++|+|-.|.||++.. ++++.+-|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 257999999999999983 77899999999876643
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.5e-05 Score=59.76 Aligned_cols=41 Identities=27% Similarity=0.668 Sum_probs=28.2
Q ss_pred chhhHHHHHhHHHHhhcccccccccCccCCC-CCCCcccceeec
Q 002943 366 QADVNVIRKVRDELKKYNKENKVLESWSGDP-CRPSTWRGVYCN 408 (863)
Q Consensus 366 ~~d~~al~~~k~~~~~~~~~~~~~~~W~gdp-c~p~~w~gv~C~ 408 (863)
++|+.||++||+++.. ++.+.+.+|+... =.||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~--~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNN--DPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT---SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhccc--ccCcccccCCCcCCCCCeeeccEEeC
Confidence 4789999999999953 4567899998542 334789999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00024 Score=72.48 Aligned_cols=129 Identities=16% Similarity=0.181 Sum_probs=83.1
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHH---------HHHHHHHhcCCc---ccccceeeeEee-----C
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF---------ENELNFLSAIRH---ENLVPLLGYCCE-----N 597 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f---------~~E~~~l~~l~H---~niv~l~g~~~~-----~ 597 (863)
+++-......|.+-.. +|..+.+|..........+.| .+++..+.+++. -....++.++.. .
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 4444444555555554 578899997665443333322 244444444432 333333333332 2
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
...+|+|||++|..|.+... ++. .++..++.++.-||. .++.|+|+.|.|+++.+++ +++.||+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECc
Confidence 34578999999988876541 221 355667788999999 8999999999999999665 8999998
Q ss_pred Ccc
Q 002943 678 FSK 680 (863)
Q Consensus 678 la~ 680 (863)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=75.86 Aligned_cols=143 Identities=18% Similarity=0.165 Sum_probs=85.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceeeeEeeC---CeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLGYCCEN---DQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~---~~~~LV~ey~~~ 609 (863)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++.++... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 468999999999999877 69999986544 44567889999998886443 45666654332 346899999999
Q ss_pred CChhh----------------hh---hccCCCCccCChhh---------HHHH------------HHHHHH-HHHHHHh-
Q 002943 610 GSLQD----------------RL---YGEASTRKTLDWPT---------RLSI------------ALGAAR-GLMYLHT- 647 (863)
Q Consensus 610 gsL~~----------------~L---~~~~~~~~~l~~~~---------~~~i------------a~~ia~-gL~yLH~- 647 (863)
..+.. .+ |..........+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 11 11101111111111 0000 112222 3334433
Q ss_pred ---ccCCCccccCCCCCCeEec-CCCeEEEeeccCcc
Q 002943 648 ---FAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSK 680 (863)
Q Consensus 648 ---~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~ 680 (863)
.....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1346799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00024 Score=73.29 Aligned_cols=136 Identities=18% Similarity=0.213 Sum_probs=86.3
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCcc---------hHH---------------HHHHHHHHhcCC--cccccc
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG---------TRE---------------FENELNFLSAIR--HENLVP 589 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~---------~~~---------------f~~E~~~l~~l~--H~niv~ 589 (863)
.|..|.-..||+|.-.++..+|||+........ ... ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 567888899999998889999999876432111 011 124555555553 222222
Q ss_pred eeeeEeeCCeeEEEeecCCCCC-hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 590 LLGYCCENDQQILVYPFMSNGS-LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 590 l~g~~~~~~~~~LV~ey~~~gs-L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
-+++ ....|||||+.... -.-.| ..-++.......+..++++.+.-|-.. .++||+||..=|||+. +
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceee----cCCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence 2222 24579999996531 11111 111122224556667777777766542 5799999999999999 8
Q ss_pred CeEEEeeccCcccCC
Q 002943 669 MCAKVADFGFSKYAP 683 (863)
Q Consensus 669 ~~~kl~DFGla~~~~ 683 (863)
+.+.|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00055 Score=85.17 Aligned_cols=148 Identities=12% Similarity=0.255 Sum_probs=91.9
Q ss_pred ceecccCcEEEEEEecCCC---CEEEEEEcccCC-CcchHHHHHHHHHHhcCC-cccc--cceeeeEeeC---CeeEEEe
Q 002943 535 TLIGEGGFGSVYRGTLPDG---QEVAVKVRSSTS-TQGTREFENELNFLSAIR-HENL--VPLLGYCCEN---DQQILVY 604 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~LV~ 604 (863)
+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5688999999999886554 467777654432 223457889999999995 6665 7778888764 4578999
Q ss_pred ecCCCCChhhh-----------------------hhccCCC-------CccCCh--------hhHHHH---------HHH
Q 002943 605 PFMSNGSLQDR-----------------------LYGEAST-------RKTLDW--------PTRLSI---------ALG 637 (863)
Q Consensus 605 ey~~~gsL~~~-----------------------L~~~~~~-------~~~l~~--------~~~~~i---------a~~ 637 (863)
||+++-.+.+. ||..... ..+..+ .....- .-.
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987643221 1211100 011111 111000 112
Q ss_pred HHHHHHHHHhccC--------CCccccCCCCCCeEecC-CC-eEEEeeccCcccC
Q 002943 638 AARGLMYLHTFAG--------RSVIHRDVKSSNILLDH-SM-CAKVADFGFSKYA 682 (863)
Q Consensus 638 ia~gL~yLH~~~~--------~~iiHrDik~~NILld~-~~-~~kl~DFGla~~~ 682 (863)
+.+.+.+|..... ..+||+|+++.|||++. +. ..-|.||.++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 3344566744221 35999999999999985 33 3579999988644
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0012 Score=67.05 Aligned_cols=127 Identities=22% Similarity=0.335 Sum_probs=89.5
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCC----------------CcchHHHHHHHHHHhcCC------cccccceee
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS----------------TQGTREFENELNFLSAIR------HENLVPLLG 592 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv~l~g 592 (863)
..||+|+.=.||. +++.....||+..... ....+++.+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999999985 4556667888776554 223467778877666665 889999999
Q ss_pred eEeeCCeeEEEeecCCC--C----ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec
Q 002943 593 YCCENDQQILVYPFMSN--G----SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666 (863)
Q Consensus 593 ~~~~~~~~~LV~ey~~~--g----sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld 666 (863)
+...+...-+|+|.+.+ | +|.+++.. ..++. . +...+-+-..||-+ ..|+.+|++|.||++.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHH---cCCeecCCCcccEEEE
Confidence 99999999999997754 2 57777722 23443 2 22233334456655 6799999999999995
Q ss_pred CC---C-eEEEee
Q 002943 667 HS---M-CAKVAD 675 (863)
Q Consensus 667 ~~---~-~~kl~D 675 (863)
.. . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00043 Score=69.87 Aligned_cols=125 Identities=26% Similarity=0.388 Sum_probs=89.0
Q ss_pred HHHhhcceecccCc-EEEEEEecCCCCEEEEEEccc---CCC------------------cchHHHHHHHHHHhcCC---
Q 002943 529 ATQQYKTLIGEGGF-GSVYRGTLPDGQEVAVKVRSS---TST------------------QGTREFENELNFLSAIR--- 583 (863)
Q Consensus 529 ~t~~f~~~LG~G~f-G~Vy~g~~~~g~~vAVK~~~~---~~~------------------~~~~~f~~E~~~l~~l~--- 583 (863)
+...|-+.||.|.- |.|||+++ +|+.+|+|+... ... .-..-|..|++..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45566789999999 99999998 677999998321 100 01135889999988885
Q ss_pred cccc--cceeeeEeeC------------------CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHH
Q 002943 584 HENL--VPLLGYCCEN------------------DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643 (863)
Q Consensus 584 H~ni--v~l~g~~~~~------------------~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~ 643 (863)
+.++ |+.+||..=. ....+|.||++... ....+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccchhHHHHHHHHHH
Confidence 4466 8999987322 12356777665432 112344566777888
Q ss_pred HHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 644 yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.+|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8998 89999999999987 4689999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=71.77 Aligned_cols=75 Identities=13% Similarity=0.115 Sum_probs=56.4
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc---ccccceeeeEeeC---CeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH---ENLVPLLGYCCEN---DQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~LV~ey~~ 608 (863)
+.||.|..+.||+....++ .+.+|..+. ......|..|.+.|+.|.- -.+.+++++|... +..+||||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 5799999999999987666 467776432 1123578999999998853 3677888887643 56899999999
Q ss_pred CCCh
Q 002943 609 NGSL 612 (863)
Q Consensus 609 ~gsL 612 (863)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00096 Score=70.13 Aligned_cols=140 Identities=19% Similarity=0.261 Sum_probs=76.3
Q ss_pred eecccCcE-EEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc---cccceeeeEeeCC---eeEEEeecCC
Q 002943 536 LIGEGGFG-SVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE---NLVPLLGYCCEND---QQILVYPFMS 608 (863)
Q Consensus 536 ~LG~G~fG-~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~LV~ey~~ 608 (863)
.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.+.++.+...+ ..+++|++++
T Consensus 4 ~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 4 PVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 46767765 58975 235777864432 2345788999999888532 2333344333222 3478999998
Q ss_pred CCChhhh------------------hhccCCCCccC-------------ChhhHH--HHH-------HHHHHH-HH-HHH
Q 002943 609 NGSLQDR------------------LYGEASTRKTL-------------DWPTRL--SIA-------LGAARG-LM-YLH 646 (863)
Q Consensus 609 ~gsL~~~------------------L~~~~~~~~~l-------------~~~~~~--~ia-------~~ia~g-L~-yLH 646 (863)
+.++.+. ||.-....... .|.... .+. .+.... ++ +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8766422 12111100000 011110 000 011111 11 111
Q ss_pred h--ccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 647 T--FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 647 ~--~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
. .....++|+|+.+.|||++++...-|.||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1234589999999999999877678999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0013 Score=64.42 Aligned_cols=128 Identities=22% Similarity=0.349 Sum_probs=84.5
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
..+.||+|.+|.||+|.+. |..+|+|+...++. ...++.|+++|..++--++.+=+-.+ ++-.+.|||+.+-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcch
Confidence 3578999999999999985 45899997665443 46789999999999866655433222 222344999988788
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCC-C-CCeEecCCCeEEEeeccCccc
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVK-S-SNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik-~-~NILld~~~~~kl~DFGla~~ 681 (863)
.++-... +-.+. ..+++.---|.. .+|-|..|. | .||++.+ ..+.|+||.-|+.
T Consensus 100 ~~~~~~~-------~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG-------DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc-------cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 7765211 11222 233333222333 678888886 3 4555554 4999999988763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00018 Score=91.78 Aligned_cols=78 Identities=17% Similarity=0.411 Sum_probs=57.0
Q ss_pred ccchhhHHHHHhHHHHhhcccccccccCcc-CCCCCCCcccceeecCCCCceEEEEEecCcCcccccCCCcccCCccccc
Q 002943 364 TDQADVNVIRKVRDELKKYNKENKVLESWS-GDPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQGILPLSVTGLTHLEK 442 (863)
Q Consensus 364 t~~~d~~al~~~k~~~~~~~~~~~~~~~W~-gdpc~p~~w~gv~C~~~~~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~ 442 (863)
+.+.|..||+++|+++. +|.+.+.+|+ ++.| |.|.|+.|+.. .+++.|||++|+++|.+|..+..++.|+.
T Consensus 26 ~~~~~~~~l~~~~~~~~---~~~~~~~~w~~~~~~--c~w~gv~c~~~---~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 26 LHAEELELLLSFKSSIN---DPLKYLSNWNSSADV--CLWQGITCNNS---SRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred CCHHHHHHHHHHHHhCC---CCcccCCCCCCCCCC--CcCcceecCCC---CcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 45689999999999984 4556788997 4556 79999999642 35777777777777777766666666666
Q ss_pred cccccCC
Q 002943 443 FRGFCGS 449 (863)
Q Consensus 443 l~~s~n~ 449 (863)
|+++.|.
T Consensus 98 L~Ls~n~ 104 (968)
T PLN00113 98 INLSNNQ 104 (968)
T ss_pred EECCCCc
Confidence 6665543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0028 Score=66.45 Aligned_cols=73 Identities=19% Similarity=0.258 Sum_probs=48.4
Q ss_pred ceecccCcEEEEEEecCC--CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccc-eeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPD--GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVP-LLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~--g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.|..|-...+|+....+ +..+++|+...... ......+|+.++..+...++++ +++.+ . ..+||||+++-+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCCc
Confidence 356777788999998764 67899997654322 2223457888888886544443 33332 2 247999998876
Q ss_pred h
Q 002943 612 L 612 (863)
Q Consensus 612 L 612 (863)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0036 Score=66.69 Aligned_cols=139 Identities=14% Similarity=0.118 Sum_probs=79.6
Q ss_pred ecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEeecCCCCChhhh
Q 002943 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYPFMSNGSLQDR 615 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ey~~~gsL~~~ 615 (863)
+..|-.+.+|+.. .+|..+++|+.......-.-...+|.++++.+....++ ++++.+ ...+||||+++..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 4557778899887 45678889975543322212457899999988654443 333332 23689999998665421
Q ss_pred -----------------hhccCCCCccCChhhHH-HHH---------HHHHHHHHHHHhc-----cCCCccccCCCCCCe
Q 002943 616 -----------------LYGEASTRKTLDWPTRL-SIA---------LGAARGLMYLHTF-----AGRSVIHRDVKSSNI 663 (863)
Q Consensus 616 -----------------L~~~~~~~~~l~~~~~~-~ia---------~~ia~gL~yLH~~-----~~~~iiHrDik~~NI 663 (863)
||.......+++...++ ... ..+.+-+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12211111122222111 110 0111112222111 124589999999999
Q ss_pred EecCCCeEEEeeccCccc
Q 002943 664 LLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 664 Lld~~~~~kl~DFGla~~ 681 (863)
++++++ ++|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0079 Score=67.78 Aligned_cols=75 Identities=19% Similarity=0.218 Sum_probs=52.8
Q ss_pred ceecccCcEEEEEEecCCC-CEEEEEEcccC-----C--CcchHHHHHHHHHHhcCC-c--ccccceeeeEeeCCeeEEE
Q 002943 535 TLIGEGGFGSVYRGTLPDG-QEVAVKVRSST-----S--TQGTREFENELNFLSAIR-H--ENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g-~~vAVK~~~~~-----~--~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~LV 603 (863)
+.||.|.+..||++...+| +.+.||.-... . ......+..|.+.|..+. + .++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4789999999999998877 58999974311 1 123456777888888763 2 345556655 44567899
Q ss_pred eecCCCCC
Q 002943 604 YPFMSNGS 611 (863)
Q Consensus 604 ~ey~~~gs 611 (863)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0044 Score=67.48 Aligned_cols=142 Identities=19% Similarity=0.152 Sum_probs=85.0
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceeee------EeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLGY------CCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~LV~ey 606 (863)
+.|..|....+|+....+ ..+++|+... ....+...|++++..+.+.+ +.+.+.. ....+..++|++|
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 356677778999987654 4688897654 23355677888888885433 3444332 1223456799999
Q ss_pred CCCCChhh----hh----------hccCC-------CCccCChhhHHH----------HHHHHHHHHHHHHh----ccCC
Q 002943 607 MSNGSLQD----RL----------YGEAS-------TRKTLDWPTRLS----------IALGAARGLMYLHT----FAGR 651 (863)
Q Consensus 607 ~~~gsL~~----~L----------~~~~~-------~~~~l~~~~~~~----------ia~~ia~gL~yLH~----~~~~ 651 (863)
++|..+.. .+ |.... ......|..... ....+...+.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98876532 11 11100 011123332211 11123334445443 2235
Q ss_pred CccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 652 SVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 652 ~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
.++|+|+.|.|||++++....|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 69999999999999998878999998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0044 Score=75.89 Aligned_cols=196 Identities=21% Similarity=0.225 Sum_probs=132.6
Q ss_pred HHHHHHHHhcCCcccccceeeeEeeCCeeE----EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHh
Q 002943 572 FENELNFLSAIRHENLVPLLGYCCENDQQI----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647 (863)
Q Consensus 572 f~~E~~~l~~l~H~niv~l~g~~~~~~~~~----LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~ 647 (863)
.+-|.+.+.++.|+|++.+++|-.++...- +..|++..-++...+. ....++..+.+.+..++.+||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 446777888999999999999887665433 3456777777777763 33467788888899999999999999
Q ss_pred ccCCCccccCCCCC---CeEecCCCeEEEe--eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCc--ccceech
Q 002943 648 FAGRSVIHRDVKSS---NILLDHSMCAKVA--DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA--KSDVFSF 720 (863)
Q Consensus 648 ~~~~~iiHrDik~~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDV~Sf 720 (863)
....|.-+..+ +...+.++...++ ||+.++........ .....+..+.++|......+.. ..|+|.+
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 44555555444 4455666777777 88888766433221 1223455677888776655444 4799999
Q ss_pred hhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 721 GVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 721 Gvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
|..+..+..|..+-.... ....+++. .... .+.+....|+..++++|++..+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDV-----LSTS---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhcc-----ccch---hhhhhhhhhcchhhhhccchhhhh
Confidence 999999999865432111 00111111 0111 355677889999999999999988
Q ss_pred HHH
Q 002943 801 REL 803 (863)
Q Consensus 801 ~~L 803 (863)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.024 Score=62.10 Aligned_cols=143 Identities=19% Similarity=0.175 Sum_probs=81.7
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceeeeE------eeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLGYC------CENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~------~~~~~~~LV~ey 606 (863)
+.++.|.-..+|+....+| .+++|+..... ...+...|++++..|.... +.+.+... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4566777789999876555 57788754421 2344566777777774322 33443321 123456899999
Q ss_pred CCCCChhh--------------hhhccCCC---C-----ccCChhhHH------------HHHHHHHHHHHHHHh----c
Q 002943 607 MSNGSLQD--------------RLYGEAST---R-----KTLDWPTRL------------SIALGAARGLMYLHT----F 648 (863)
Q Consensus 607 ~~~gsL~~--------------~L~~~~~~---~-----~~l~~~~~~------------~ia~~ia~gL~yLH~----~ 648 (863)
++|..+.. .+|..... . ..-.|.... .....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98854321 01211000 0 011222111 011123344555542 2
Q ss_pred cCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 649 ~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
...+++|+|+.+.||+++++....|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.026 Score=61.59 Aligned_cols=141 Identities=23% Similarity=0.280 Sum_probs=82.7
Q ss_pred eecccCcEEEEEEecCC-------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEeecC
Q 002943 536 LIGEGGFGSVYRGTLPD-------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~-------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ey~ 607 (863)
.|..|-...+|+....+ ++.+++|+..... .......+|.+++..+....+. ++++++. + .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 45556667899988765 5789999865543 2234567888888888644443 4444443 2 3589999
Q ss_pred CCCChhhh-----------------hhccCCCC-------ccCChhhHHH--------------------------HHHH
Q 002943 608 SNGSLQDR-----------------LYGEASTR-------KTLDWPTRLS--------------------------IALG 637 (863)
Q Consensus 608 ~~gsL~~~-----------------L~~~~~~~-------~~l~~~~~~~--------------------------ia~~ 637 (863)
+|..+... ||...... ...-|....+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766431 11111110 0001111100 0112
Q ss_pred HHHHHHHHHh------ccCCCccccCCCCCCeEecCC----CeEEEeeccCccc
Q 002943 638 AARGLMYLHT------FAGRSVIHRDVKSSNILLDHS----MCAKVADFGFSKY 681 (863)
Q Consensus 638 ia~gL~yLH~------~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~~ 681 (863)
+.+-+.+|.. .....++|+|+.+.|||++++ ..++++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334432 234679999999999999985 7899999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.049 Score=60.00 Aligned_cols=142 Identities=17% Similarity=0.163 Sum_probs=77.6
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceee------eEeeCCeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLG------YCCENDQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~LV~ey 606 (863)
+.|+.|....+|+....+| .+++|+... ...+....|++++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 3466777789999887655 688897652 12234445666666653222 223232 11234567899999
Q ss_pred CCCCChhh-----------h---hhccCC-------CCccCChh-hHHHH------------H-HHHHHHHHHHHhc---
Q 002943 607 MSNGSLQD-----------R---LYGEAS-------TRKTLDWP-TRLSI------------A-LGAARGLMYLHTF--- 648 (863)
Q Consensus 607 ~~~gsL~~-----------~---L~~~~~-------~~~~l~~~-~~~~i------------a-~~ia~gL~yLH~~--- 648 (863)
+++..+.. . ||.... ....+.|. ....- . ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98864321 1 111110 01112231 11111 1 1111122333211
Q ss_pred -cCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 649 -AGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 649 -~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
...++||+|+.+.|||++.+...-|.||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24589999999999999977667899998765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.058 Score=58.13 Aligned_cols=32 Identities=22% Similarity=0.405 Sum_probs=26.1
Q ss_pred CCccccCCCCCCeEecCCCe-EEEeeccCcccC
Q 002943 651 RSVIHRDVKSSNILLDHSMC-AKVADFGFSKYA 682 (863)
Q Consensus 651 ~~iiHrDik~~NILld~~~~-~kl~DFGla~~~ 682 (863)
..++|+|+++.|||+++++. .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997554 569999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.043 Score=59.37 Aligned_cols=72 Identities=26% Similarity=0.391 Sum_probs=48.1
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR---HENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.++.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 568888999999988 578899999765 233457889998888884 345778888888777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.013 Score=62.67 Aligned_cols=132 Identities=19% Similarity=0.201 Sum_probs=86.4
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccC--CC--------------cc------hHHHHHHHHHHhcCC-cc-cc
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSST--ST--------------QG------TREFENELNFLSAIR-HE-NL 587 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~--~~--------------~~------~~~f~~E~~~l~~l~-H~-ni 587 (863)
.+.+.||-|.-+.+|.+...+|++.++|..... +. +. .-...+|...|+.|. |. -+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 346899999999999999999999999953211 10 00 112346777787774 22 22
Q ss_pred cceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 588 v~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
.+.++ .+..++|||++.+-.|...-+. .+.++.. ..+..-+.-|-. .++||+|..-=||++++
T Consensus 175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly---~~lm~~Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 175 PKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLY---DDLMGLIVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCccc----ccceeeHHHhhcccceeeeeec-------CChHHHH---HHHHHHHHHHHH---cCceecccchheeEEec
Confidence 23333 3456789999988777654321 2222222 222222333444 79999999999999999
Q ss_pred CCeEEEeeccCcc
Q 002943 668 SMCAKVADFGFSK 680 (863)
Q Consensus 668 ~~~~kl~DFGla~ 680 (863)
+..++++||--..
T Consensus 238 d~~i~vIDFPQmv 250 (465)
T KOG2268|consen 238 DDKIVVIDFPQMV 250 (465)
T ss_pred CCCEEEeechHhh
Confidence 9999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.14 Score=57.03 Aligned_cols=140 Identities=16% Similarity=0.240 Sum_probs=79.8
Q ss_pred ecccCcEEEEEEecCC-----CCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEeecCCCC
Q 002943 537 IGEGGFGSVYRGTLPD-----GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~~-----g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ey~~~g 610 (863)
|-.|-.-.+|+....+ +..+.+|+........ -...+|..++..+...++. ++++.+.. . .|+||+++-
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCC
Confidence 4346677889887532 3678999876654322 2336789898888655554 34554422 2 579999776
Q ss_pred Chhhh-----------------hhccCCCC-c-cCChhhHHHHHH-----------------HHHHHHHHHHh-----cc
Q 002943 611 SLQDR-----------------LYGEASTR-K-TLDWPTRLSIAL-----------------GAARGLMYLHT-----FA 649 (863)
Q Consensus 611 sL~~~-----------------L~~~~~~~-~-~l~~~~~~~ia~-----------------~ia~gL~yLH~-----~~ 649 (863)
+|... +|...... . ...|.+..++.. .+...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65421 12211111 1 111222222211 11112222221 22
Q ss_pred CCCccccCCCCCCeEecC-CCeEEEeeccCccc
Q 002943 650 GRSVIHRDVKSSNILLDH-SMCAKVADFGFSKY 681 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 681 (863)
...++|+|+++.|||+++ +..++++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 47899999987653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.17 Score=55.43 Aligned_cols=30 Identities=33% Similarity=0.417 Sum_probs=25.5
Q ss_pred CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
..+++|+|+.+.||+++. ..+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367899999999999987 567899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.18 Score=55.00 Aligned_cols=131 Identities=17% Similarity=0.293 Sum_probs=75.5
Q ss_pred CCEEEEEEccc--CCCcchHHHHHHHHHHhcCCc--ccccceeeeEeeCC--eeEEEeecCCCCChhhhhhcc-------
Q 002943 553 GQEVAVKVRSS--TSTQGTREFENELNFLSAIRH--ENLVPLLGYCCEND--QQILVYPFMSNGSLQDRLYGE------- 619 (863)
Q Consensus 553 g~~vAVK~~~~--~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~LV~ey~~~gsL~~~L~~~------- 619 (863)
++++++. ... ..........+|.++|+.+.- --.-+.+++|.++. ..+.||+|+++..+.+.+...
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 7777777 331 122233455677888877742 33445677887766 668999999874333222110
Q ss_pred --------------CCC-------------CccCChhhHHHHH--------HHHHHHHHHHHhcc-----CCCccccCCC
Q 002943 620 --------------AST-------------RKTLDWPTRLSIA--------LGAARGLMYLHTFA-----GRSVIHRDVK 659 (863)
Q Consensus 620 --------------~~~-------------~~~l~~~~~~~ia--------~~ia~gL~yLH~~~-----~~~iiHrDik 659 (863)
... .+.-.|...++.+ -...+-..||+... ...++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 000 0011122222111 11122344554422 2469999999
Q ss_pred CCCeEecCCCeEEEeeccCcccCCC
Q 002943 660 SSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 660 ~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
+.|++++.+...=|.||+++..-.+
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCCc
Confidence 9999999988899999999886543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.19 Score=55.71 Aligned_cols=80 Identities=18% Similarity=0.191 Sum_probs=49.5
Q ss_pred eecccCcEEEEEEecCCC-CEEEEEEcc----c---CCCcchHHHHHHHHHHhcCC--cccccceeeeEeeCCeeEEEee
Q 002943 536 LIGEGGFGSVYRGTLPDG-QEVAVKVRS----S---TSTQGTREFENELNFLSAIR--HENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g-~~vAVK~~~----~---~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV~e 605 (863)
.||-|...-||++..++| +.|+||.-. . .-+-......-|.+.|+... -|..|+-+ |+.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence 579999999999998765 589999522 1 11223344456777776653 34444432 2345556679999
Q ss_pred cCCCC-Chhhhh
Q 002943 606 FMSNG-SLQDRL 616 (863)
Q Consensus 606 y~~~g-sL~~~L 616 (863)
+++.. .|.+.|
T Consensus 81 dL~~~~ilR~~L 92 (370)
T TIGR01767 81 DLSHHKIARKGL 92 (370)
T ss_pred hCccchHHHHHH
Confidence 99653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.24 Score=54.57 Aligned_cols=140 Identities=19% Similarity=0.255 Sum_probs=82.8
Q ss_pred ecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc------ccceee----eEeeCCeeEEEeec
Q 002943 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN------LVPLLG----YCCENDQQILVYPF 606 (863)
Q Consensus 537 LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g----~~~~~~~~~LV~ey 606 (863)
|.+ .-..+|+....+|.. ++|+.... ....+...|++.|..|.-.. +..+=| ........+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 456789988877777 88877665 34456677888887774222 122212 11111366789999
Q ss_pred CCCCChhh-----h----------hhc--------cCCCCccCChh-------------hHHHHHHHHHHHHHHHHhcc-
Q 002943 607 MSNGSLQD-----R----------LYG--------EASTRKTLDWP-------------TRLSIALGAARGLMYLHTFA- 649 (863)
Q Consensus 607 ~~~gsL~~-----~----------L~~--------~~~~~~~l~~~-------------~~~~ia~~ia~gL~yLH~~~- 649 (863)
++|..+.. . ||. .........|. .......++...++.+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99887773 1 111 11111234443 11123334444444444311
Q ss_pred ---CCC---ccccCCCCCCeEecCCCe-EEEeeccCcc
Q 002943 650 ---GRS---VIHRDVKSSNILLDHSMC-AKVADFGFSK 680 (863)
Q Consensus 650 ---~~~---iiHrDik~~NILld~~~~-~kl~DFGla~ 680 (863)
... +||+|+.|.|||++.+.. ..+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 122 899999999999998875 8999998765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.21 Score=54.65 Aligned_cols=139 Identities=19% Similarity=0.191 Sum_probs=89.6
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCC-------C--cc-------------hH----HHHHHHHHHhcCCcccc
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS-------T--QG-------------TR----EFENELNFLSAIRHENL 587 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~-------~--~~-------------~~----~f~~E~~~l~~l~H~ni 587 (863)
.-.|..|.-.-||.+.-.+|..+|||+.+..- . .+ .+ -.+.|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35678899999999999999999999765320 0 00 00 13457777777754332
Q ss_pred cceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 588 v~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
..---.. -...+|||+|+..-. |-. .......++......+-.++++-|.-|-+.| .+||.||.--|+|+-
T Consensus 229 P~PePIl--Lk~hVLVM~FlGrdg---w~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGRDG---WAA-PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCcee--eecceEeeeeccCCC---CcC-cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 2111111 123479999985321 110 0112334666667777788888888887755 699999999999985
Q ss_pred CCeEEEeeccCccc
Q 002943 668 SMCAKVADFGFSKY 681 (863)
Q Consensus 668 ~~~~kl~DFGla~~ 681 (863)
+|.+.|+|-+-+.-
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 56799999876643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.0034 Score=78.36 Aligned_cols=160 Identities=12% Similarity=0.018 Sum_probs=109.7
Q ss_pred HHHHHHHhcCCcccccceeeeEe--eCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhc--
Q 002943 573 ENELNFLSAIRHENLVPLLGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF-- 648 (863)
Q Consensus 573 ~~E~~~l~~l~H~niv~l~g~~~--~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-- 648 (863)
..|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+-........++..-....-.+......-.|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34444556668888766544332 33466889999999999999865444444444433333333324444444432
Q ss_pred cCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHH
Q 002943 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEII 728 (863)
Q Consensus 649 ~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ell 728 (863)
.+.--+|+++|+.|.++..+..+|++++||.+...+.. .......+++-|+.|+....-+++.++|+|..|+-++++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23457899999999999999999999999999332211 1112234677889999988888999999999999999998
Q ss_pred hCCCCC
Q 002943 729 SGREPL 734 (863)
Q Consensus 729 tG~~p~ 734 (863)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.15 Score=52.39 Aligned_cols=30 Identities=27% Similarity=0.467 Sum_probs=21.3
Q ss_pred CCccccCCCCCCeEe-cCCCeEEEeeccCcc
Q 002943 651 RSVIHRDVKSSNILL-DHSMCAKVADFGFSK 680 (863)
Q Consensus 651 ~~iiHrDik~~NILl-d~~~~~kl~DFGla~ 680 (863)
.-++|.|+.+.|||+ +.++.++++||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 458999999999999 889999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.98 E-value=0.35 Score=53.59 Aligned_cols=141 Identities=18% Similarity=0.233 Sum_probs=78.2
Q ss_pred eecccCcEEEEEEecCC----CCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEeecCCCC
Q 002943 536 LIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.|..|=...+|+....+ +..|.+|+....... .-...+|..+++.+...++- ++++++. .+ +|.+|+++-
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34446667788886543 247889987654432 23346888899888765554 4555542 22 589999766
Q ss_pred Chhhh-----------------hhccCCC-Cc-cCChhhHHHHHHH----------------------HHHHHHHHHh--
Q 002943 611 SLQDR-----------------LYGEAST-RK-TLDWPTRLSIALG----------------------AARGLMYLHT-- 647 (863)
Q Consensus 611 sL~~~-----------------L~~~~~~-~~-~l~~~~~~~ia~~----------------------ia~gL~yLH~-- 647 (863)
.|... +|..... .. .--|....++..+ +.+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 54221 1221111 11 1122222221111 1111222221
Q ss_pred ---ccCCCccccCCCCCCeEecC-CCeEEEeeccCccc
Q 002943 648 ---FAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKY 681 (863)
Q Consensus 648 ---~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 681 (863)
....-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999974 57899999987653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.57 Score=59.75 Aligned_cols=142 Identities=21% Similarity=0.291 Sum_probs=79.9
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-------ccccccee-ee--E--ee-CC--e
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-------HENLVPLL-GY--C--CE-ND--Q 599 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-------H~niv~l~-g~--~--~~-~~--~ 599 (863)
+.|+ |..-.+|+....+|..+++|+...... ......|.+.|..|. -|.+++-. |- . .. .+ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 346788998888888999998876432 234445555665442 23333322 11 1 11 12 3
Q ss_pred eEEEeecCCCCChhhhh-----------------hc------cCCCCccCChhhH-----------------HHHHHHHH
Q 002943 600 QILVYPFMSNGSLQDRL-----------------YG------EASTRKTLDWPTR-----------------LSIALGAA 639 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L-----------------~~------~~~~~~~l~~~~~-----------------~~ia~~ia 639 (863)
.+-+++|+++..|.+.. |. .......+.|..+ ..++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999987776511 10 0111123444321 12222232
Q ss_pred HHHH-----HHHhccCCCccccCCCCCCeEecCCC--eEE-EeeccCcc
Q 002943 640 RGLM-----YLHTFAGRSVIHRDVKSSNILLDHSM--CAK-VADFGFSK 680 (863)
Q Consensus 640 ~gL~-----yLH~~~~~~iiHrDik~~NILld~~~--~~k-l~DFGla~ 680 (863)
+..+ .|. .....+||.|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 2221 121 2346799999999999999875 454 99999775
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.33 Score=53.27 Aligned_cols=32 Identities=16% Similarity=0.297 Sum_probs=28.2
Q ss_pred CCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
..+++|+|+.+.|||+++++...++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 35799999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.73 Score=52.07 Aligned_cols=79 Identities=11% Similarity=0.108 Sum_probs=50.6
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccC----CC---cchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEEEe
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSST----ST---QGTREFENELNFLSAIR---HENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~ 604 (863)
+.||-|....||+.... +..++||.-... +. .....-..|.+.|+.+. ..++.+++.+|. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 57899999999998864 556999964311 11 12223334566665553 246777888876 5568899
Q ss_pred ecCCC--CChhhhh
Q 002943 605 PFMSN--GSLQDRL 616 (863)
Q Consensus 605 ey~~~--gsL~~~L 616 (863)
|++++ ..+.+.|
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 2444444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 863 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-59 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-59 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-167
Identities = 128/301 (42%), Positives = 180/301 (59%), Gaps = 5/301 (1%)
Query: 515 PMPVQIFSLQYLEAATQQY--KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF 572
P L LE AT + K LIG G FG VY+G L DG +VA+K R+ S+QG EF
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
E E+ LS RH +LV L+G+C E ++ IL+Y +M NG+L+ LYG ++ W RL
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692
I +GAARGL YLHT R++IHRDVKS NILLD + K+ DFG SK + + S
Sbjct: 143 EICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
V+GT GY+DPEY+ L+ KSDV+SFGVVL E++ R + PR +L EWA
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
++++IVDP++ E++ + + A+ C+ S RPSM D++ +LE A ++ +
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
Query: 813 A 813
Sbjct: 320 V 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-138
Identities = 124/307 (40%), Positives = 184/307 (59%), Gaps = 7/307 (2%)
Query: 504 FSIDSMDDP-VKPMPVQIFSLQYLEAATQ--QYKTLIGEGGFGSVYRGTLPDGQEVAVKV 560
F + + +DP V ++ FSL+ L+ A+ K ++G GGFG VY+G L DG VAVK
Sbjct: 2 FDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 561 RSSTSTQGT-REFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGE 619
TQG +F+ E+ +S H NL+ L G+C +++LVYP+M+NGS+ L
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 620 ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679
++ LDWP R IALG+ARGL YLH +IHRDVK++NILLD A V DFG +
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
K D+ + VRGT G++ PEY ST S K+DVF +GV+LLE+I+G+ + R
Sbjct: 182 KLMD-YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 740 RNE--WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMV 797
N+ L++W K ++E +++ +VD ++G Y E + ++++VAL C + RP M
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 798 DIVRELE 804
++VR LE
Sbjct: 301 EVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-133
Identities = 99/311 (31%), Positives = 158/311 (50%), Gaps = 22/311 (7%)
Query: 507 DSMDDPVKPMPVQIFSLQYLEAATQ--------QYKTLIGEGGFGSVYRGTLPDGQEVAV 558
++ V FS L+ T +GEGGFG VY+G + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 559 KVRSS----TSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD 614
K ++ T+ + ++F+ E+ ++ +HENLV LLG+ + D LVY +M NGSL D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674
RL L W R IA GAA G+ +LH IHRD+KS+NILLD + AK++
Sbjct: 120 RLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 175
Query: 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
DFG ++ + + + + + GT Y+ PE ++ KSD++SFGVVLLEII+G +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 735 NTRRPRNEWSLVEWAKPFIRESR-IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYR 793
+ R L++ + E + I++ +D + + ++ M VA C+ R
Sbjct: 235 DEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKR 291
Query: 794 PSMVDIVRELE 804
P + + + L+
Sbjct: 292 PDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 7e-79
Identities = 67/309 (21%), Positives = 115/309 (37%), Gaps = 31/309 (10%)
Query: 521 FSLQYLEAATQQYK--TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNF 578
+ L + + + G FG V++ + VAVK+ Q + E E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 579 LSAIRHENLVPLLGYCCE----NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSI 634
L ++HEN++ +G + L+ F GSL D L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 635 ALGAARGLMYLHTFAGRS-------VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687
A ARGL YLH + HRD+KS N+LL +++ A +ADFG +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 688 SGFSLEVRGTAGYLDPEYYSTQHL-----SAKSDVFSFGVVLLEIISGREPLNTRRPRNE 742
+G + GT Y+ PE + D+++ G+VL E+ S +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 743 WSLVEWAKPF-----IRESRIDEIVDPSIKGGYHA-EAMWRMVEVALACIEPFSAYRPSM 796
E ++E + + P ++ + M + E C + + R S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 797 VDIVRELED 805
+ +
Sbjct: 307 GCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-61
Identities = 79/290 (27%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVP 589
K IG G FG+V+R G +VAVK+ + EF E+ + +RH N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+G + +V ++S GSL L+ R+ LD RLS+A A+G+ YLH
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
++HR++KS N+L+D KV DFG S+ S S GT ++ PE +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDE 214
Query: 710 HLSAKSDVFSFGVVLLEIISGREP--------------LNTRRPRNEWSLVEWAKPFIRE 755
+ KSDV+SFGV+L E+ + ++P +R
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------------- 258
Query: 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
I ++P + A + C RPS I+ L
Sbjct: 259 -EIPRNLNPQV-----AAIIEG-------CWTNEPWKRPSFATIMDLLRP 295
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 69/309 (22%), Positives = 119/309 (38%), Gaps = 44/309 (14%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELN--FLSAIRHENLVP 589
+ LIG G +G+VY+G+L D + VAVKV S + Q F NE N + + H+N+
Sbjct: 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIAR 71
Query: 590 LLGYCCEND-----QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+ + +LV + NGSL L T DW + +A RGL Y
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAY 126
Query: 645 LHTFAGRS------VIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSL 692
LHT R + HRD+ S N+L+ + ++DFG S + ++
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 693 EVRGTAGYLDPEY-------YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE--- 742
GT Y+ PE + + D+++ G++ EI L E
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 743 -WSLVEWAKPFIRESRIDEIVD---PSIKGGY--HAEAMWRMVEVALACIEPFSAYRPSM 796
+ P + ++ + P + ++ A+ + E C + + R +
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 797 VDIVRELED 805
+ +
Sbjct: 307 QXAEERMAE 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-60
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 34/279 (12%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+ + ++G G FG V + ++VA+K S S + + F EL LS + H N+V L
Sbjct: 11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLY 67
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G C LV + GSL + L+G A +S L ++G+ YLH+ +
Sbjct: 68 GACLNP--VCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 652 SVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
++IHRD+K N+LL K+ DFG + + +G+A ++ PE + +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSN 179
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD----PSI 766
S K DVFS+G++L E+I+ R+P + + RI V P +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP--------------FDEIGGPAFRIMWAVHNGTRPPL 225
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ + C + RPSM +IV+ +
Sbjct: 226 IKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-57
Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 532 QYKTLIGEGGFGSVYRGT-LPDGQEVAVKV-------RSSTSTQGTREFENELNFLSAIR 583
+Y+ IG+GGFG V++G + D VA+K + + +EF+ E+ +S +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
H N+V L G ++ +V F+ G L RL + + W +L + L A G+
Sbjct: 82 HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIE 136
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHS-----MCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
Y+ ++HRD++S NI L +CAKVADFG S+ + G
Sbjct: 137 YMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----LGNF 190
Query: 699 GYLDPEYYSTQHL--SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756
++ PE + + K+D +SF ++L I++G P + + K
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP---------FDEYSYGKIKFINM 241
Query: 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+E + P+I + V C RP IV+EL +
Sbjct: 242 IREEGLRPTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-56
Identities = 73/286 (25%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV----RSSTSTQGTREFENELNFLSAIRHENL 587
+ +IG GGFG VYR G EVAVK +Q E + ++H N+
Sbjct: 10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+ L G C + LV F G L L + K + ++ A+ ARG+ YLH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 648 FAGRSVIHRDVKSSNILLDHSM--------CAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
A +IHRD+KSSNIL+ + K+ DFG ++ + G
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYA 179
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759
++ PE S SDV+S+GV+L E+++G P + ++ +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP---------FRGIDGLA--VAYGVAM 228
Query: 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ I ++ C P RPS +I+ +L
Sbjct: 229 NKLALPIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-56
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 61/295 (20%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVP 589
+ T + E G +++G G ++ VKV ST+ +R+F E L H N++P
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 590 LLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+LG C + +M GSL + L+ T +D + AL ARG+ +LHT
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
+ + S ++++D M A+++ G ++ PE
Sbjct: 130 L-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-------RMYAPAWVAPEALQ 181
Query: 708 TQ---HLSAKSDVFSFGVVLLEIISGREP--------------LNTRRPRNEWSLVEWAK 750
+ +D++SF V+L E+++ P L RP
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----------- 230
Query: 751 PFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
I + P + ++ M C+ A RP IV LE
Sbjct: 231 ------TIPPGISPHV-----SKLMKI-------CMNEDPAKRPKFDMIVPILEK 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-55
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 35/293 (11%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G+G FG + T G+ + +K + R F E+ + + H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
++ + + ++ G+L+ + S W R+S A A G+ YLH+ ++IH
Sbjct: 78 KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEG------------DSGFSLEVRGTAGYLDP 703
RD+ S N L+ + VADFG ++ E D V G ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E + + K DVFSFG+VL EII PR + + +D
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------VRGFLD 241
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEY 816
+ + C + RPS V + LE + + A
Sbjct: 242 RYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLET--LRMHLAGHL 288
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVP 589
IG G FG+VY+G +VAVK+ ++ + Q + F+NE+ L RH N++
Sbjct: 27 TVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+GY I V + SL L+ + + IA ARG+ YLH
Sbjct: 85 FMGYSTAPQLAI-VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE---YY 706
+S+IHRD+KS+NI L K+ DFG + + S ++ G+ ++ PE
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPS 765
+ S +SDV++FG+VL E+++G+ P + R++ +V S++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+K + C++ RPS I+ E+E+
Sbjct: 258 MK------------RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 76/335 (22%), Positives = 134/335 (40%), Gaps = 36/335 (10%)
Query: 494 KGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDG 553
G + + S S P+ VQ + + Q IG+G +G V+ G G
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQI-----QMVKQIGKGRYGEVWMGKW-RG 60
Query: 554 QEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQI----LVYPFMSN 609
++VAVKV +T + E E+ +RHEN++ + + L+ + N
Sbjct: 61 EKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119
Query: 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS-----VIHRDVKSSNIL 664
GSL D L TLD + L +A + GL +LHT + + HRD+KS NIL
Sbjct: 120 GSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 665 LDHSMCAKVADFGFSKYAPQEGDSGF--SLEVRGTAGYLDPE----YYSTQHLSA--KSD 716
+ + +AD G + + + GT Y+ PE + H + +D
Sbjct: 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 717 VFSFGVVLLEIISGREPLNTRRP-RNEWSLVEWAKPFIRESRIDEIVD----PSIKGGYH 771
++SFG++L E+ + + + + P E + + PS +
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY-EDMREIVCIKKLRPSFPNRWS 293
Query: 772 A-EAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ E + +M ++ C A R + + + + L
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 60/289 (20%), Positives = 102/289 (35%), Gaps = 40/289 (13%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVP 589
+ LIG+G FG VY G EVA+++ + + F+ E+ RHEN+V
Sbjct: 36 EIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+G C ++ +L + + LD IA +G+ YLH
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA-- 148
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSK---YAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ ++H+D+KS N+ D+ + DFG G +L PE
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 707 STQ---------HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF-IRES 756
S SDVF+ G + E+ + P T+ + W ++ +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPN 262
Query: 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ I ++ L C RP+ ++ LE
Sbjct: 263 LSQIGMGKEIS------------DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 51/307 (16%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF--ENELNFLSAIRHENLVP 589
+G+G +G V+RG+ G+ VAVK+ SS + + + E EL +RHEN++
Sbjct: 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILG 66
Query: 590 LLGYCCENDQQI----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
+ + L+ + GSL D L TLD + L I L A GL +L
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 646 HTFAGRS-----VIHRDVKSSNILLDHSMCAKVADFGFSK---YAPQEGDSGFSLEVRGT 697
H + + HRD+KS NIL+ + +AD G + + + D G + V GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GT 180
Query: 698 AGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP 751
Y+ PE + D+++FG+VL E+ + ++ P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPP 232
Query: 752 FIRESRIDEIVD------------PSIKGGYHA-EAMWRMVEVALACIEPFSAYRPSMVD 798
F D + P+I + + + + ++ C + R + +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 799 IVRELED 805
I + L
Sbjct: 293 IKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-51
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 29/296 (9%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+ IG+G FG V+RG G+EVAVK+ SS + E E+ +RHEN++ +
Sbjct: 45 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFI 102
Query: 592 GYCCENDQQI----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+++ LV + +GSL D L R T+ + +AL A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 648 FAGRS-----VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE--VRGTAGY 700
+ + HRD+KS NIL+ + +AD G + D+ GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 701 LDPE----YYSTQHLSA--KSDVFSFGVVLLEIISGREPLNTRRP-RNEWSLVEWAKPFI 753
+ PE + +H + ++D+++ G+V EI + + + + P +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 754 RESRIDEIVD---PSIKGGYHA-EAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
E R P+I + + EA+ M ++ C A R + + I + L
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 66/206 (32%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
IG G FG V+ G L D VAVK R + +F E L H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ +V + G L E L T L + AA G+ YL + + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPEYYST 708
HRD+ + N L+ K++DFG S+ YA G V+ TA PE +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP--VKWTA----PEALNY 289
Query: 709 QHLSAKSDVFSFGVVLLEIIS-GREP 733
S++SDV+SFG++L E S G P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP 315
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE----VAVK-VRSSTSTQGTREFENELNFLSAIRHEN 586
+IG+G FG VY G D + A+K + T Q F E + + H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 587 LVPLLGYCCENDQQIL-VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
++ L+G + + P+M +G L + S ++ +S L ARG+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAG 699
A + +HRD+ + N +LD S KVADFG ++ Y + L V+ TA
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA- 196
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
E T + KSDV+SFGV+L E+++ G P
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 537 IGEGGFGSVYRGTLPDG----QEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IG G FG VY GTL D AVK + T +F E + H N++ LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 592 GYCCENDQQIL-VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
G C ++ L V P+M +G L++ + + + L A+G+ YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPE 704
+ +HRD+ + N +LD KVADFG ++ Y +G L V+ A E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA----LE 202
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
TQ + KSDV+SFGV+L E+++ G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-40
Identities = 72/199 (36%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
IG+G FG V G G +VAVK + +T + F E + ++ +RH NLV LLG E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 597 NDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ +V +M+ GSL D Y + R L L +L + YL G + +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+ + N+L+ AKV+DFG +K A L V+ TA PE + S KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA----PEALREKKFSTKS 367
Query: 716 DVFSFGVVLLEIIS-GREP 733
DV+SFG++L EI S GR P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 537 IGEGGFGSVYRGTLPDG----QEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IG G FG VY GTL D AVK + T +F E + H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 592 GYCCENDQQIL-VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
G C ++ L V P+M +G L++ + + + L A+G+ +L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK------YAPQEGDSGFSLEVRGTAGYLDPE 704
+ +HRD+ + N +LD KVADFG ++ + +G L V+ A E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LE 266
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
TQ + KSDV+SFGV+L E+++ G P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 74/308 (24%), Positives = 120/308 (38%), Gaps = 47/308 (15%)
Query: 532 QYKTLIGEGGFGSVYRGTLP-----DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
+Y + +G+G FGSV G VAVK + R+F+ E+ L A+ +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 587 LVPLLGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+V G +Q LV ++ +G L+D L R LD L + +G+ Y
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEY 142
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAG 699
L + R +HRD+ + NIL++ K+ADFG +K P + D + A
Sbjct: 143 LGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA- 198
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRI 758
PE S S +SDV+SFGVVL E+ + + + E P +
Sbjct: 199 ---PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR--- 252
Query: 759 DEIVDPSIKGGYHAEAMWRMV----------EVALACIEPFSAYRPSMVDIVRELEDAFI 808
+ ++ G R+ E+ C P RPS + +L+ +
Sbjct: 253 ---LLELLEEGQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM--L 301
Query: 809 IENNASEY 816
+
Sbjct: 302 WSGSRGCE 309
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 36/289 (12%)
Query: 537 IGEGGFGSVYRGTL-----PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FG V G+ VAVK ++ Q ++ E++ L + HE+++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 591 LGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
G C + LV ++ GSL+D L R ++ L A G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHA- 152
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDP 703
+ IHRD+ + N+LLD+ K+ DFG +K P+ + V A P
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA----P 206
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762
E SDV+SFGV L E+++ + E + + + +
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR------L 260
Query: 763 DPSIKGGYHAEAM----WRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
++ G + + C E +++RP+ +++ L+
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 72/199 (36%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
IG+G FG V G G +VAVK + +T + F E + ++ +RH NLV LLG E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 597 NDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ +V +M+ GSL D Y + R L L +L + YL G + +H
Sbjct: 86 EKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+ + N+L+ AKV+DFG +K A L V+ TA PE + S KS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA----PEALREKKFSTKS 195
Query: 716 DVFSFGVVLLEIIS-GREP 733
DV+SFG++L EI S GR P
Sbjct: 196 DVWSFGILLWEIYSFGRVP 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 532 QYKTLIGEGGFGSVYRGTLP-----DGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHE 585
+ +GEG FG V G++VAVK + + + + E+ L + HE
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 586 NLVPLLGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
N+V G C E+ L+ F+ +GSL++ L + ++ +L A+ +G+
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMD 140
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTA 698
YL + R +HRD+ + N+L++ K+ DFG +K + + V A
Sbjct: 141 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757
PE SDV+SFGV L E+++ + + + +
Sbjct: 198 ----PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-- 251
Query: 758 IDEIVDPSIKGGYHAEAM----WRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ ++K G + ++ C E + R S +++ E
Sbjct: 252 ----LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 537 IGEGGFGSVYRGTL-PDGQE----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+G G FG+VY+G P+G++ VA+K R +TS + +E +E ++++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C L+ M G L D + + + L+ + A+G+ YL
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYL---ED 135
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYY 706
R ++HRD+ + N+L+ K+ DFG +K E G + ++ A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LESI 191
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + +SDV+S+GV + E+++ G +P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQE---VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G FGSV +G ++ VA+KV + T T E E + + + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L+G C+ + +LV G L L G+ R+ + + + G+ YL
Sbjct: 75 LIG-VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYL---E 127
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPE 704
++ +HRD+ + N+LL + AK++DFG SK + S ++ A PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PE 183
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + S++SDV+S+GV + E +S G++P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 30/290 (10%)
Query: 532 QYKTLIGEGGFGSVYRGTLP-----DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
++ +G+G FGSV G+ VAVK ++ + R+FE E+ L +++H+N
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 587 LVPLLGYCCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+V G C ++ L+ ++ GSL+D L ++ +D L +G+ Y
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEY 129
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAG 699
L T + IHRD+ + NIL+++ K+ DFG +K PQ+ + + A
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA- 185
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759
PE + S SDV+SFGVVL E+ + E ++ P E+ + +
Sbjct: 186 ---PESLTESKFSVASDVWSFGVVLYELFTYIEK--SKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 760 EIVDPSIKGGYHAEAM----WRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ +K + + C RPS D+ ++
Sbjct: 241 --LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 38/328 (11%)
Query: 497 PMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLP----- 551
P T+NL F +M + F ++L ++ +G+G FGSV
Sbjct: 15 PTTENLYFQ-GAMGSAFEDRDPTQFEERHL-----KFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 552 DGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQ--ILVYPFMS 608
G+ VAVK + ST R+FE E+ L +++H+N+V G C ++ L+ ++
Sbjct: 69 TGEVVAVKKLQHSTEEH-LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668
GSL+D L ++ +D L +G+ YL T + IHRD+ + NIL+++
Sbjct: 128 YGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENE 181
Query: 669 MCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVV 723
K+ DFG +K PQ+ + + A PE + S SDV+SFGVV
Sbjct: 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA----PESLTESKFSVASDVWSFGVV 237
Query: 724 LLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAM----WRMV 779
L E+ + E ++ P E+ + + + +K +
Sbjct: 238 LYELFTYIEK--SKSPPAEFMRMIGNDKQGQMIVFH--LIELLKNNGRLPRPDGCPDEIY 293
Query: 780 EVALACIEPFSAYRPSMVDIVRELEDAF 807
+ C RPS D+ ++
Sbjct: 294 MIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 39/297 (13%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G +G VY G VAVK + T EF E + I+H NLV LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ FM+ G+L D Y R+ + L +A + + YL ++ I
Sbjct: 286 TREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHL 711
HR++ + N L+ + KVADFG S+ + +G ++ TA PE +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771
S KSDV++FGV+L EI + P L + V ++ Y
Sbjct: 397 SIKSDVWAFGVLLWEIAT-----YGMSPYPGIDLSQ--------------VYELLEKDYR 437
Query: 772 AEAMW----RMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIG 824
E ++ E+ AC + + RPS +I + E F + + E K + G
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 494
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQE-----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+G G FG+V++G E V +KV + Q + + + + ++ H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C LV ++ GSL D + R L L+ + A+G+ YL
Sbjct: 81 LG-LCPGSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYL---EE 133
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYY 706
++HR++ + N+LL +VADFG + P + S ++ A E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA----LESI 189
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ +SDV+S+GV + E+++ G EP
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IG G G V G L P ++ VA+K +++ + + R+F +E + + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G ++V +M NGSL L + + + G G+ YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYY 706
+HRD+ + N+L+D ++ KV+DFG S+ + D +G + +R TA PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAI 226
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + S+ SDV+SFGVV+ E+++ G P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+G FG V+ GT VA+K + F E + +RHE LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ +V +MS GSL D L + T K L P + +A A G+ Y+ + +HR
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 304
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
D++++NIL+ ++ KVADFG ++ G ++ TA PE +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773
KSDV+SFG++L E+ + R P E V ++ GY
Sbjct: 361 KSDVWSFGILLTELTTKG-----RVPYPGMVNRE--------------VLDQVERGYRMP 401
Query: 774 AMW----RMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
+ ++ C RP+ + LED F
Sbjct: 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 537 IGEGGFGSVYRGTLPDGQE----VAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+GEG FGSV G L VAVK ++S + EF +E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 591 LGYCCENDQQI-----LVYPFMSNGSLQD--RLYGEASTRKTLDWPTRLSIALGAARGLM 643
LG C E Q ++ PFM G L + K + T L + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTA 698
YL + R+ +HRD+ + N +L M VADFG SK GD + V+ A
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIA 217
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
E + + ++KSDV++FGV + EI + G P
Sbjct: 218 ----IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-37
Identities = 73/288 (25%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V+ T +VAVK S F E N + ++H+ LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ ++ FM+ GSL D + ++ P + + A G+ ++ R+ IHR
Sbjct: 254 KEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHR 308
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
D++++NIL+ S+ K+ADFG ++ G ++ TA PE + +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 714 KSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
KSDV+SFG++L+EI++ GR P P S E V +++ GY
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPY----PG--MSNPE--------------VIRALERGYRM 404
Query: 773 EAMW----RMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEY 816
+ + + C + RP+ I L+D S+Y
Sbjct: 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD--FYTATESQY 450
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 537 IGEGGFGSVYRGTLPDG---QEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G FG+V +G + VAVK+ + E E N + + + +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G CE + +LV G L L + + + + + G+ YL
Sbjct: 85 G-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYY 706
+ +HRD+ + N+LL AK++DFG SK + + + V+ A PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECI 192
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ S+KSDV+SFGV++ E S G++P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG G FG V+ G + +VA+K R ++ +F E + + H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
E LV FM +G L D L + R T L + L G+ YL VIH
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD+ + N L+ + KV+DFG +++ + +G V+ + PE +S S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFSRYS 183
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
+KSDV+SFGV++ E+ S G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V G +VAVK ++ + ++ EF E + + H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ +V ++SNG L + L K L+ L + G+ +L IH
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD+ + N L+D +C KV+DFG ++Y + G V+ +A PE + S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYFKYS 183
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
+KSDV++FG+++ E+ S G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 9e-37
Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 37/283 (13%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+G FG V+ GT VA+K + F E + +RHE LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ +V +MS GSL D L + T K L P + +A A G+ Y+ + +HR
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHR 387
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAP---QEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
D++++NIL+ ++ KVADFG ++ G ++ TA PE +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773
KSDV+SFG++L E+ + R P E V ++ GY
Sbjct: 444 KSDVWSFGILLTELTTKG-----RVPYPGMVNRE--------------VLDQVERGYRMP 484
Query: 774 AMW----RMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENN 812
+ ++ C RP+ + LED F
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 537 IGEGGFGSVYRGTLPDGQE------VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G FG VY G + VA+K V + S + EF NE + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL------YGEASTRKTLDWPTRLSIALGAARGLM 643
LLG + +++ M+ G L+ L + +A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTA 698
YL +HRD+ + N ++ K+ DFG ++ E D L VR +
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMS 208
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + SDV+SFGVVL EI + +P
Sbjct: 209 ----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQE-----VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+G G FG+VY+G E VA+K R +TS + +E +E ++++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C L+ M G L D + + + L+ + A+G+ YL
Sbjct: 83 LG-ICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYL---ED 135
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYY 706
R ++HRD+ + N+L+ K+ DFG +K E G + ++ A E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LESI 191
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + +SDV+S+GV + E+++ G +P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 28/217 (12%)
Query: 537 IGEGGFGSVYRGTLPDG----QEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPL 590
+G+G FGSV L +VAVK+ ++ EF E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 591 LGYCCENDQQI------LVYPFMSNGSLQD--RLYGEASTRKTLDWPTRLSIALGAARGL 642
+G + + ++ PFM +G L L T + + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGT 697
YL + R+ IHRD+ + N +L M VADFG S+ GD L V+
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYYRQGCASKLPVKWL 206
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
A E + + SDV++FGV + EI++ G+ P
Sbjct: 207 A----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 537 IGEGGFGSVYRGTLPDG-QEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G +G VY G VAVK ++ T EF E + I+H NLV LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ FM+ G+L D Y R+ + L +A + + YL ++ I
Sbjct: 79 TREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYYSTQ 709
HRD+ + N L+ + KVADFG S+ GD +G ++ TA PE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTA----PESLAYN 187
Query: 710 HLSAKSDVFSFGVVLLEIIS-GREP 733
S KSDV++FGV+L EI + G P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V G +VA+K ++ + ++ EF E + + HE LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ ++ +M+NG L + L R L + + YL + +H
Sbjct: 90 KQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQE---GDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD+ + N L++ KV+DFG S+Y + G VR + PE S
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYSKFS 199
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
+KSD+++FGV++ EI S G+ P
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V+ G +VAVK ++ + + F E N + ++H+ LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ ++ +M NGSL D L + + L L +A A G+ ++ R+ IH
Sbjct: 78 TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQ---EGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
RD++++NIL+ ++ K+ADFG ++ G ++ TA PE + +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 188
Query: 713 AKSDVFSFGVVLLEIIS-GREP 733
KSDV+SFG++L EI++ GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IGEG FG V++G P+ VA+K ++ TS +F E + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G EN I + + G L+ L + +LD + + A + L YL +
Sbjct: 83 GVITENPVWI-IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYL---ESK 135
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYYS 707
+HRD+ + N+L+ + C K+ DFG S+Y ++ S L ++ A PE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMA----PESIN 190
Query: 708 TQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ ++ SDV+ FGV + EI+ G +P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVKV---RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G FG V RG P G+ VAVK + + +F E+N + ++ H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L G ++ V GSL DRL + T A+ A G+ YL
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---E 138
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPE 704
+ IHRD+ + N+LL K+ DFG + PQ D + A PE
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PE 194
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
T+ S SD + FGV L E+ + G+EP
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G FG V G L P +E VA+K ++ + + R+F E + + H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G ++ ++V +M NGSL L + + G A G+ YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYY 706
+HRD+ + NIL++ ++ KV+DFG + + + G + +R T+ PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEAI 222
Query: 707 STQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + ++ SDV+S+G+VL E++S G P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 70/226 (30%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE---VAVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+++ +IGEG FG V + + A+K ++ S R+F EL L + H N
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTRLSI 634
++ LLG C L + +G+L D L ST TL L
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ-EGDSGFSLE 693
A ARG+ YL + + IHRD+ + NIL+ + AK+ADFG S+ + L
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 694 VRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
VR A E Y+T SDV+S+GV+L EI+S G P
Sbjct: 205 VRWMA----IESLNYSVYTT-----NSDVWSYGVLLWEIVSLGGTP 241
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE---VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPL 590
IG G FG VY+G L G++ VA+K +++ + + +F E + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
G + +++ +M NG+L L + + G A G+ YL A
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEY 705
+ +HRD+ + NIL++ ++ KV+DFG S+ + + SG + +R TA PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEA 221
Query: 706 YSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
S + ++ SDV+SFG+V+ E+++ G P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+GEG FG VY G G++ VAVK + + +F +E + + H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G E + ++ G L L + +L T + +L + + YL
Sbjct: 80 G-IIEEEPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYL---ESI 132
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYYS 707
+ +HRD+ NIL+ C K+ DFG S+Y ++ D S L ++ + PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMS----PESIN 187
Query: 708 TQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + SDV+ F V + EI+S G++P
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQE---VAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G FGSV +G ++ VA+KV + T T E E + + + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L+G C+ + +LV G L L G+ R+ + + + G+ YL
Sbjct: 401 LIG-VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYL---E 453
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPE 704
++ +HR++ + N+LL + AK++DFG SK + S ++ A PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PE 509
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ + S++SDV+S+GV + E +S G++P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 34/217 (15%)
Query: 537 IGEGGFGSVYRGTL--------PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV 588
+G+G F +++G EV +KV + F + +S + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
G C D+ ILV F+ GSL L + ++ +L +A A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFL--- 129
Query: 649 AGRSVIHRDVKSSNILLD--------HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
++IH +V + NILL + K++D G S +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQERIPWVP-- 185
Query: 701 LDPE---YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE ++L+ +D +SFG L EI S G +P
Sbjct: 186 --PECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 532 QYKTLIGEGGFGSVYRGTL------PDGQEVAVK-VRSSTSTQGTREFENELNFLSAI-R 583
+ +G G FG V + VAVK ++ + R +EL L I
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 584 HENLVPLLGYCCENDQQILV-YPFMSNGSLQDRL------------YGEASTRKTLDWPT 630
H N+V LLG C + ++V F G+L L E + L
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 631 RLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG---- 686
+ + A+G+ +L A R IHRD+ + NILL K+ DFG ++ ++
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L ++ A PE + + +SDV+SFGV+L EI S G P
Sbjct: 207 KGDARLPLKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 50/237 (21%)
Query: 532 QYKTLIGEGGFGSVYRGTLPD--------GQEVAVK-VRSSTSTQGTREFENELNFLSAI 582
+GEG FG V VAVK ++ + + + +E+ + I
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 583 -RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWP 629
+H+N++ LLG C ++ ++ + S G+L++ L + + +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YA 682
+S ARG+ YL A + IHRD+ + N+L+ + K+ADFG ++ Y
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 683 PQEGDSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L V+ A PE Y+ +SDV+SFGV++ EI + G P
Sbjct: 215 KTTNG---RLPVKWMA----PEALFDRVYTH-----QSDVWSFGVLMWEIFTLGGSP 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG------QEVAVK-VRSSTSTQGTREFENELNFLSAIRH 584
++ +GE FG VY+G L Q VA+K ++ EF +E + ++H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTRL 632
N+V LLG ++ +++ + S+G L + L + + + L+ P +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQE 685
+ A G+ YL + V+H+D+ + N+L+ + K++D G + Y
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 686 GDSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L +R A PE +S SD++S+GVVL E+ S G +P
Sbjct: 189 NS---LLPIRWMA----PEAIMYGKFSI-----DSDIWSYGVVLWEVFSYGLQP 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 37/289 (12%)
Query: 531 QQYKTLIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTRE-FENELNFLSAIRHENL 587
++ IG G F +VY+G EVA ++ T+ R+ F+ E L ++H N+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 588 VPLLGYCCENDQQ----ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
V + +LV M++G+L+ L K + S +GL
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQ 143
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
+LHT +IHRD+K NI + K+ D G + F+ V GT ++
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA 198
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762
PE Y ++ DV++FG+ +LE+ + P + + + ++ + D++
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--VTSGVKPASFDKVA 255
Query: 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL-EDAFIIE 810
P +K E+ CI R S +++L AF E
Sbjct: 256 IPEVK------------EIIEGCIRQNKDERYS----IKDLLNHAFFQE 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 537 IGEGGFGSVYRGTL--PDGQE--VAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IGEG FG V++G P+ VA+K ++ TS +F E + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G + ++ + G L+ L + +LD + + A + L YL +
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYL---ESK 510
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYLDPEYYS 707
+HRD+ + N+L+ + C K+ DFG S+Y ++ S L ++ A PE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMA----PESIN 565
Query: 708 TQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ ++ SDV+ FGV + EI+ G +P
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 50/237 (21%)
Query: 532 QYKTLIGEGGFGSVYRGTL--------PDGQEVAVK-VRSSTSTQGTREFENELNFLSAI 582
+GEG FG V + VAVK ++ + + + +E+ + I
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 583 -RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWP 629
+H+N++ LLG C ++ ++ + S G+L++ L + + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YA 682
+S ARG+ YL A + IHRD+ + N+L+ + K+ADFG ++ Y
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 683 PQEGDSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L V+ A PE Y+ +SDV+SFGV++ EI + G P
Sbjct: 261 KTTNG---RLPVKWMA----PEALFDRVYTH-----QSDVWSFGVLMWEIFTLGGSP 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 55/242 (22%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG------QEVAVK-VRSSTSTQGTREFENELNFLSAIRH 584
+GEG FG V + T VAVK ++ + S R+ +E N L + H
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL--------------------YGEASTRK 624
+++ L G C ++ +L+ + GSL+ L + +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 625 TLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK---- 680
L +S A ++G+ YL A ++HRD+ + NIL+ K++DFG S+
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 681 ---YAPQEGDSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GR 731
Y + + V+ A E Y+T +SDV+SFGV+L EI++ G
Sbjct: 203 EDSYVKRSQG---RIPVKWMA----IESLFDHIYTT-----QSDVWSFGVLLWEIVTLGG 250
Query: 732 EP 733
P
Sbjct: 251 NP 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 537 IGEGGFGSVYRGTL------PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G FG VY G + P +VAVK + S Q +F E +S H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL---YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+G ++ + ++ M+ G L+ L S +L L +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 647 TFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSK------YAPQEGDSGFSLEVRGT 697
IHRD+ + N LL AK+ DFG ++ Y + G + L V+
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA--MLPVKWM 212
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + ++K+D +SFGV+L EI S G P
Sbjct: 213 P----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE------VAVKVRSSTSTQGTREFENELNFLSAIRHE 585
K +GEG FG V+ + VAVK S ++F+ E L+ ++H+
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----------YGEASTRKTLDWPTRLSI 634
++V G C E ++V+ +M +G L L GE L L++
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEGD 687
A A G++YL AG +HRD+ + N L+ + K+ DFG S+ Y
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 688 SGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L +R PE ++T +SDV+SFGVVL EI + G++P
Sbjct: 221 ---MLPIRWMP----PESILYRKFTT-----ESDVWSFGVVLWEIFTYGKQP 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 34/229 (14%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE------VAVK-VRSSTSTQGTREFENELNFLSAI-R 583
+ +G G FG V T + VAVK ++ S +EL LS +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRL--------------YGEASTRKTLDWP 629
H N+V LLG C +++ + G L + L LD
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--- 686
LS + A+G+ +L A ++ IHRD+ + NILL H K+ DFG ++ +
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 687 -DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L V+ A PE + +SDV+S+G+ L E+ S G P
Sbjct: 203 VKGNARLPVKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 46/233 (19%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG------QEVAVKVRSSTSTQGTREFENELNFLSAIRHE 585
K +GEG FG V+ + VAVK + ++F+ E L+ ++HE
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWPTRLS 633
++V G C + D I+V+ +M +G L L + L L
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-------YAPQEG 686
IA A G++YL A + +HRD+ + N L+ ++ K+ DFG S+ Y
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 687 DSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L +R PE ++T +SDV+SFGV+L EI + G++P
Sbjct: 195 T---MLPIRWMP----PESIMYRKFTT-----ESDVWSFGVILWEIFTYGKQP 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 532 QYKTLIGEGGFGSVYRGTLPD--------GQEVAVK-VRSSTSTQGTREFENELNFLSAI 582
+GEG FG V +VAVK ++S + + + +E+ + I
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 583 -RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL------------YGEASTRKTLDWP 629
+H+N++ LLG C ++ ++ + S G+L++ L + + L
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--- 686
+S A ARG+ YL A + IHRD+ + N+L+ K+ADFG ++
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 687 -DSGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ L V+ A PE Y+ +SDV+SFGV+L EI + G P
Sbjct: 249 KTTNGRLPVKWMA----PEALFDRIYTH-----QSDVWSFGVLLWEIFTLGGSP 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE------VAVK-VRSSTSTQGTREFENELNFLSAI-R 583
Q+ +G G FG V T + VAVK ++S+ +EL +S + +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRL----------YGEASTRKTLDWPTRLS 633
HEN+V LLG C +++ + G L + L A T L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SG 689
+ A+G+ +L A ++ IHRDV + N+LL + AK+ DFG ++ + +
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 690 FSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
L V+ A PE Y+ +SDV+S+G++L EI S G P
Sbjct: 226 ARLPVKWMA----PESIFDCVYTV-----QSDVWSYGILLWEIFSLGLNP 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 58/227 (25%), Positives = 85/227 (37%), Gaps = 20/227 (8%)
Query: 524 QYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLS 580
+ + Y + +GEGGF V L DG A+K Q E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 581 AIRHENLVPLLGYCCENDQQ----ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIAL 636
H N++ L+ YC L+ PF G+L + + L L + L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 637 GAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-------G 689
G RGL +H + HRD+K +NILL + D G A +
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 690 FSLEVRGTAGYLDPE---YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
R T Y PE S + ++DV+S G VL ++ G P
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQE------VAVK-VRSSTSTQGTREFENELNFLSAI-R 583
++ ++G G FG V T + VAVK ++ + +EL ++ +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 584 HENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-------------------YGEASTRK 624
HEN+V LLG C + L++ + G L + L E
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 625 TLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684
L + L A A+G+ +L +S +HRD+ + N+L+ H K+ DFG ++
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 685 EG----DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
+ L V+ A PE + KSDV+S+G++L EI S G P
Sbjct: 225 DSNYVVRGNARLPVKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 66/240 (27%), Positives = 102/240 (42%), Gaps = 51/240 (21%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG------QEVAVK-VRSSTSTQGTREFENELNFLSAIRH 584
+Y IGEG FG V++ P VAVK ++ S +F+ E ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL--------------------YGEASTRK 624
N+V LLG C L++ +M+ G L + L +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 625 TLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684
L +L IA A G+ YL + R +HRD+ + N L+ +M K+ADFG S+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI-Y 225
Query: 685 EGD-----SGFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
D ++ +R PE Y+T +SDV+++GVVL EI S G +P
Sbjct: 226 SADYYKADGNDAIPIRWMP----PESIFYNRYTT-----ESDVWAYGVVLWEIFSYGLQP 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 72/340 (21%), Positives = 131/340 (38%), Gaps = 34/340 (10%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREF-ENELNFLSAIRHE 585
++Y L IGEG FG DG++ +K + S + RE E+ L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N+V EN +V + G L R+ A L + L ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H R ++HRD+KS NI L ++ DFG ++ + GT YL PE
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEI 196
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765
+ + KSD+++ G VL E+ + + + +LV I P
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVL----KIISGSF-----PP 244
Query: 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSIGG 825
+ Y + + + + RPS+ I LE F I +++
Sbjct: 245 VSLHYSYD----LRSLVSQLFKRNPRDRPSVNSI---LEKGF-IAKRIEKFLSPQLIAEE 296
Query: 826 YSIGGSARYSRRIVIPPTPTATES--SLVNSQTIVPPEPR 863
+ + +++ + + P + ++ S++ +Q I P +
Sbjct: 297 FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAK 336
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-33
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 537 IGEGGFGSVYRGTLPDG------QEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G FG VY G + +VAVK + S Q +F E +S H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL---YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+G ++ + ++ M+ G L+ L S +L L +A A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 647 TFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSK------YAPQEGDSGFSLEVRGT 697
IHRD+ + N LL AK+ DFG ++ Y + G + L V+
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA--MLPVKWM 253
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + ++K+D +SFGV+L EI S G P
Sbjct: 254 P----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 64/304 (21%), Positives = 112/304 (36%), Gaps = 51/304 (16%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHEN 586
++ + +G GGFG V+ D A+K +R + E+ L+ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 587 LVPLLGYCCEND---------QQILVYPFM---SNGSLQDRLYGEASTRKTLDWPTRLSI 634
+V E + ++ +Y M +L+D + T + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHI 123
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
L A + +LH+ + ++HRD+K SNI KV DFG Q+ + L
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 695 R----------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
GT Y+ PE S K D+FS G++L E++ P +T+ R
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR-- 235
Query: 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+R + P + + + + P RP ++I +E
Sbjct: 236 --TLTD--VRNLKF-----PPLFTQKYPCE----YVMVQDMLSPSPMERPEAINI---IE 279
Query: 805 DAFI 808
+A
Sbjct: 280 NAVF 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 27/294 (9%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK---VRSSTSTQGTREFENELNFLSAIRH 584
++ IG G F VYR L DG VA+K + + + E++ L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
N++ E+++ +V G L + ++ + T + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
+H R V+HRD+K +N+ + + K+ D G ++ + + S + GT Y+ PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
+ KSD++S G +L E+ + + P N +SL I + + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLC----KKIEQCDYPPL--P 259
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMK 818
S Y E + ++ CI P RP + + + A + + ++
Sbjct: 260 S--DHYSEE----LRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLE 304
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/300 (23%), Positives = 122/300 (40%), Gaps = 30/300 (10%)
Query: 526 LEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLS 580
+ + + Y+ L IG G +G + DG+ + K S + + +E+N L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 581 AIRHENLVPLLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
++H N+V + L V + G L + R+ LD L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 639 ARGLMYLHT--FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
L H G +V+HRD+K +N+ LD K+ DFG ++ D+ F+ G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756
T Y+ PE + + KSD++S G +L E+ + P ++ L IRE
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELAG----KIREG 231
Query: 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEY 816
+ I Y E + E+ + +RPS+ +I LE+ I+E++ +
Sbjct: 232 KF-----RRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEI---LENPLILEHHHHHH 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 60/280 (21%), Positives = 101/280 (36%), Gaps = 41/280 (14%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAI-R 583
Q ++ L +G G +G V++ DG+ AVK RS + +G ++ E+ + +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 584 HENLVPLLGYCCENDQQILVYPFM--SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
H V L E L SLQ +L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQ---TELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L +LH+ + ++H DVK +NI L K+ DFG + G +G G Y+
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYM 223
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761
PE + +DVFS G+ +LE+ E + + +R+
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACNMELPHGGEGWQQ----------LRQG----Y 268
Query: 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801
+ P G +E V + +EP R + ++
Sbjct: 269 LPPEFTAGLSSEL----RSVLVMMLEPDPKLRATAEALLA 304
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 30/222 (13%)
Query: 531 QQYKTL--IGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH-- 584
+ Y L IG GG V++ Q A+K Q + NE+ +L+ ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 585 ENLVPLLGYCCENDQQILVYPFM--SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGL 642
+ ++ L Y DQ I Y M N L L +K++D R S +
Sbjct: 69 DKIIRLYDY-EITDQYI--YMVMECGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAV 121
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
+H ++H D+K +N L+ M K+ DFG + + S GT Y+
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 703 PE-----------YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE S +S KSDV+S G +L + G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 30/222 (13%)
Query: 531 QQYKTL--IGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHEN 586
+ Y L IG GG V++ Q A+K Q + NE+ +L+ ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 587 L--VPLLGYCCENDQQILVYPFM--SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGL 642
+ L Y DQ I Y M N L L +K++D R S +
Sbjct: 88 DKIIRLYDY-EITDQYI--YMVMECGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAV 140
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
+H ++H D+K +N L+ M K+ DFG + + S GT Y+
Sbjct: 141 HTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 703 PE-----------YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE S +S KSDV+S G +L + G+ P
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 60/300 (20%), Positives = 109/300 (36%), Gaps = 55/300 (18%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
+K + IG GGFG V++ DG+ +K + E E+ L+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNI 66
Query: 588 VPLLGYCCENDQQILVYP----------------FMSNGSLQDRLYGEASTRKTLDWPTR 631
V G D F G+L+ + E + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
L + +G+ Y+H+ + +I+RD+K SNI L + K+ DFG + G
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP 751
+GT Y+ PE S+Q + D+++ G++L E++ +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----------------A 221
Query: 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
F ++ D I + + + + RP+ +I L + +
Sbjct: 222 FETSKFFTDLRDGIISDIFDKKEK----TLLQKLLSKKPEDRPNTSEI---LRTLTVWKK 274
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 28/215 (13%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENL--VPLL 591
IG GG V++ Q A+K Q + NE+ +L+ ++ + + L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 592 GYCCENDQQILVYPFM--SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
Y DQ I Y M N L L +K++D R S + +H
Sbjct: 123 DY-EITDQYI--YMVMECGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 173
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE----- 704
++H D+K +N L+ M K+ DFG + + S G Y+ PE
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 705 ------YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
S +S KSDV+S G +L + G+ P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 526 LEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH 584
E + ++G+G +G VY G L + +A+K ++ ++ E+ ++H
Sbjct: 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 78
Query: 585 ENLVPLLGYCCENDQQILVYPFM---SNGSLQDRL---YGEAS---------TRKTLDWP 629
+N+V LG EN + FM GSL L +G T++ L
Sbjct: 79 KNIVQYLGSFSENGF---IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL--- 132
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDS 688
GL YLH ++HRD+K N+L++ +S K++DFG SK
Sbjct: 133 ----------EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 689 GFSLEVRGTAGYLDPE--YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ GT Y+ PE + +D++S G ++E+ +G+ P
Sbjct: 180 TET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 19/209 (9%)
Query: 531 QQYKTLIGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLV 588
++ +G G FG V+R G + AVK VR EL + + +V
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------EELVACAGLSSPRIV 113
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
PL G E + + GSL + L L A GL YLH
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLH-- 167
Query: 649 AGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGDSGFSLE---VRGTAGYLDPE 704
R ++H DVK+ N+LL A + DFG + +G L + GT ++ PE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ AK D++S ++L +++G P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 4e-29
Identities = 41/270 (15%), Positives = 80/270 (29%), Gaps = 60/270 (22%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHE--- 585
++G+ + T G+ V V S + + +E L L I+++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 586 ----------NLVPLLGYCCEND-----------QQILVYPFM--SNGSLQDRLYGEAST 622
+LV + +YP M + + + L +ST
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 623 RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682
K+L RL + L R L LH ++H ++ +I+LD + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 683 PQEGDSGFSLEVRGTAGYLDPEY----------YSTQHLSAKSDVFSFGVVLLEIISGRE 732
G S G+ PE + ++ D ++ G+ + I
Sbjct: 262 ------GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 733 PLNTRRPRNEWSLV--------EWAKPFIR 754
P + + + +
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQPVRALLE 345
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 67/307 (21%), Positives = 116/307 (37%), Gaps = 61/307 (19%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAI- 582
T ++ L IG G FGSV++ DG A+K RS G+ + + E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 583 RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGL 642
+H ++V E+D ++ + + GSL D + + L RGL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHS-------------------MCAKVADFGFSKYAP 683
Y+H S++H D+K SNI + + + K+ D G
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--- 182
Query: 684 QEGDSGFSLEVRGTAGYLDPE--YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741
S E G + +L E + HL K+D+F+ + ++ PRN
Sbjct: 183 -RISSPQVEE--GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL-----PRN 233
Query: 742 EWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801
+W + IR+ R+ P I E E+ I P RPS + +
Sbjct: 234 ---GDQWHE--IRQGRL-----PRIPQVLSQEFT----ELLKVMIHPDPERRPSAMAL-- 277
Query: 802 ELEDAFI 808
++ + +
Sbjct: 278 -VKHSVL 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-29
Identities = 43/212 (20%), Positives = 76/212 (35%), Gaps = 27/212 (12%)
Query: 532 QYK--TLIGEGGFGSVYRG--TLPDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHEN 586
QY+ I GG G +Y +G+ V +K S + E FL+ + H +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 587 LVPLLGYCCENDQQILVYPFM-----SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
+V + + D+ ++ SL+ + L ++ L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPA 194
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLH +++ D+K NI+L K+ D G G + GT G+
Sbjct: 195 LSYLH---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG------YLYGTPGFQ 244
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE T + +D+++ G L +
Sbjct: 245 APEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
+G+G FG+VY +A+KV ++ G E+ S +RH N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
GY + + L+ + G++ L D + A L Y H+ +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHS---K 128
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+K N+LL + K+ADFG+S +AP + GT YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMH 184
Query: 712 SAKSDVFSFGVVLLEIISGREP 733
K D++S GV+ E + G+ P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 39/248 (15%), Positives = 76/248 (30%), Gaps = 22/248 (8%)
Query: 534 KTLIGEGGFGSVYRGT------LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
L+GEG F VY T + Q+ +KV+ + + L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRL-YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ + +LV S G+L + + + + K + +S A+ + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCA-----------KVADFGFSKYAPQEGDSGFSLEVR 695
+IH D+K N +L + + D G S
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE 755
T+G+ E S + + + D F + ++ G + + E +
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGECKPEGLFRRLPHL 305
Query: 756 SRIDEIVD 763
+E
Sbjct: 306 DMWNEFFH 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 27/265 (10%), Positives = 59/265 (22%), Gaps = 42/265 (15%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+ G V+ + ++ A+KV + S + + E+
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 592 GYC----------------------CENDQQI----LVYPFM--SNGSLQDRLYGEASTR 623
++D + L+ P L L R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683
+ R L + ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 684 QEGDSGFSLEVRGTAGYLDPEYY--STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741
G Y E+ ST + + + G+ + + P P
Sbjct: 246 TRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 742 EWSLVEWAKPFIRESRIDEIVDPSI 766
+ S + + +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPL 325
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 41/271 (15%), Positives = 82/271 (30%), Gaps = 61/271 (22%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHENLV 588
++G+ + T G+ V V S + + +E L L I+++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 589 PLL--------------------GYCCENDQQI----LVYPFM--SNGSLQDRLYGEAST 622
+ E D + +YP M + + + L +ST
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 623 RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682
K+L RL + L R L LH ++H ++ +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 683 PQEGDSGFSLEVRGTAGYLDPEY-----------YSTQHLSAKSDVFSFGVVLLEIISGR 731
G + + G+ PE ++ D ++ G+V+ I
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 732 EPLNTRRPRNEWSLV--------EWAKPFIR 754
P+ + + + +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLE 341
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
+G+GGF + + + A K+ +S RE E++ ++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G+ +ND +V SL + RK L P G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHR---N 160
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+K N+ L+ + K+ DFG + E D + GT Y+ PE S +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 712 SAKSDVFSFGVVLLEIISGREP 733
S + DV+S G ++ ++ G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
+G+GGF + + + A K+ +S RE E++ ++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G+ +ND +V SL + RK L P G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHR---N 134
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+K N+ L+ + K+ DFG + E D + GT Y+ PE S +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 712 SAKSDVFSFGVVLLEIISGREP 733
S + DV+S G ++ ++ G+ P
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPP 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
L+G+G F VYR + G EVA+K+ + + G + +NE+ ++H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 592 GYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
Y E+ + LV NG + L + K G++YLH+
Sbjct: 78 NYF-EDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHS--- 130
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
++HRD+ SN+LL +M K+ADFG + + + GT Y+ PE +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 711 LSAKSDVFSFGVVLLEIISGREP 733
+SDV+S G + ++ GR P
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPP 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 26/234 (11%)
Query: 524 QYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLS 580
Q +E + + + EGGF VY + G+E A+K S + R E+ F+
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 581 AIR-HENLVPLLGYCCENDQQ-------ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL 632
+ H N+V ++ L+ + G L + L + +R L T L
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 633 SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS- 691
I R + ++H +IHRD+K N+LL + K+ DFG + D +S
Sbjct: 140 KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 692 ---------LEVRGTAGYLDPE---YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ T Y PE YS + K D+++ G +L + + P
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 19/211 (9%)
Query: 537 IGEG--GFGSVYRGT-LPDGQEVAVKVRS--STSTQGTREFENELNFLSAIRHENLVPLL 591
IG+G +V P G+ V V+ + + S + + EL+ H N+VP
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
+++ +V FM+ GS +D + ++ I G + L Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHH---M 147
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-----SGFSLEVRGTAGYLDPEYY 706
+HR VK+S+IL+ ++ + G F +L PE
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 707 STQHLS---AKSDVFSFGVVLLEIISGREPL 734
Q+L AKSD++S G+ E+ +G P
Sbjct: 208 -QQNLQGYDAKSDIYSVGITACELANGHVPF 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 14/245 (5%)
Query: 537 IGEGGFGSVYRGTL-PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLG-Y 593
+G G G V++ + P G +A K+ + EL L +V G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ + I M GSL D++ +A + +++ +GL YL +
Sbjct: 101 YSDGEISI-CMEHMDGGSL-DQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE--KHKI 153
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSA 713
+HRDVK SNIL++ K+ DFG S Q DS + V GT Y+ PE H S
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSV 209
Query: 714 KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAE 773
+SD++S G+ L+E+ GR P+ + + P
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 774 AMWRM 778
Sbjct: 270 DSRPP 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 536 LIGEGGFGSVYRGTLPD---GQEVAVKV-RSSTSTQGT--REFENELNFLSAIRHENLVP 589
+G GG +VY D +VA+K + + FE E++ S + H+N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
++ E+D LV ++ +L + + + L T ++ G+ + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD-M 130
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
++HRD+K NIL+D + K+ DFG +K A E + V GT Y PE +
Sbjct: 131 R--IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 710 HLSAKSDVFSFGVVLLEIISGREP 733
+D++S G+VL E++ G P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 59/239 (24%), Positives = 91/239 (38%), Gaps = 18/239 (7%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLL--- 591
+G GGFG V R G++VA+K + RE + E+ + + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 592 ---GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
ND +L + G L+ L + L ++ + L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 649 AGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
+IHRD+K NI+L + K+ D G++K Q E GT YL PE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPEL 194
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
+ + D +SFG + E I+G P +W K D++
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 36/237 (15%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
++ + +G+G FG V + D + A+K T + +E+ L+++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 587 LVPLLGYCCENDQQILVYP-------------FMSNGSLQDRLYGEASTRKTLDWPTRLS 633
+V E + + NG+L D + S
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
+ L Y+H+ + +IHRD+K NI +D S K+ DFG +K + D
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 694 VR------------GTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737
GTA Y+ E T H + K D++S G++ E+I R
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLG 592
K ++G G G++ + D ++VAVK + + E+ L H N++
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVIRY-- 83
Query: 593 YCCENDQQILVYPFMS--NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
+C E D+Q Y + +LQ+ + + L+ +++ GL +LH+
Sbjct: 84 FCTEKDRQ-FQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS--- 136
Query: 651 RSVIHRDVKSSNILL-----DHSMCAKVADFGFSKYAPQEGDSGFSL--EVRGTAGYLDP 703
+++HRD+K NIL+ + A ++DFG K G FS V GT G++ P
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL-AVGRHSFSRRSGVPGTEGWIAP 195
Query: 704 EYYS---TQHLSAKSDVFSFGVVLLEIISGREP 733
E S ++ + D+FS G V +IS
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 52/214 (24%), Positives = 84/214 (39%), Gaps = 23/214 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLG- 592
++G+G +V+RG G A+KV ++ S + E L + H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 593 YCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
+ L+ F GSL L E S L L + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 652 SVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
++HR++K NI+ D K+ DFG ++ D + + GT YL P+ Y
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYE 188
Query: 708 --------TQHLSAKSDVFSFGVVLLEIISGREP 733
+ A D++S GV +G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 66/234 (28%), Positives = 99/234 (42%), Gaps = 18/234 (7%)
Query: 517 PVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV-RSSTSTQGTREF 572
++I Q+ + + K L IG G +GSV + P GQ +AVK RS+ + ++
Sbjct: 8 KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL 67
Query: 573 ENELNF-LSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
+L+ + + +V G + M + S D+ Y + P
Sbjct: 68 LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSF-DKFYKYVYSVLDDVIPEE 125
Query: 632 L--SIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689
+ I L + L +L +IHRD+K SNILLD S K+ DFG S Q DS
Sbjct: 126 ILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 690 FSLEVRGTAGYLDPE----YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
G Y+ PE S Q +SDV+S G+ L E+ +GR P
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 65/224 (29%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 532 QYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV----RSSTSTQGTREFENELNFLSAIRH 584
Y+ IG G V P ++VA+K + TS E E+ +S H
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD---ELLKEIQAMSQCHH 72
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQD----RLYGEASTRKTLDWPTRLSIALGAAR 640
N+V D+ LV +S GS+ D + LD T +I
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----G 696
GL YLH IHRDVK+ NILL ++ADFG S + GD + VR G
Sbjct: 133 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK-VRKTFVG 188
Query: 697 TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T ++ PE Y K+D++SFG+ +E+ +G P
Sbjct: 189 TPCWMAPEVMEQVRGYDF-----KADIWSFGITAIELATGAAPY 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG+G G+VY + GQEVA++ + NE+ + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
D+ +V +++ GSL D + T +D ++ + L +LH+ VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+KS NILL K+ DFGF A + + GT ++ PE + + K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 716 DVFSFGVVLLEIISGREPLNTRRP 739
D++S G++ +E+I G P P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFENELNF-LSAIRHENLVPLLGY 593
+G G +G V + +P GQ +AVK +R++ ++Q + +L+ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+ M + SL +T+ IA+ + L +LH+ SV
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE----YYSTQ 709
IHRDVK SN+L++ K+ DFG S D G Y+ PE + +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 710 HLSAKSDVFSFGVVLLEIISGREPLNT 736
S KSD++S G+ ++E+ R P ++
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 20/204 (9%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQG-TREFENELNFLSAIRHENLVPLLGYC 594
IG+G FG V++G + VA+K+ + + + E+ LS + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ + ++ ++ GS D L LD +I +GL YLH+ I
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 141
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAGYLDPEYYSTQH 710
HRD+K++N+LL K+ADFG + G + R GT ++ PE
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVA------GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 711 LSAKSDVFSFGVVLLEIISGREPL 734
+K+D++S G+ +E+ G P
Sbjct: 196 YDSKADIWSLGITAIELARGEPPH 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 536 LIGEGGFGSVYRGTLPD---GQEVAVKV-RSSTST-QGTRE-FENELNFLSAIRHENLVP 589
L+G GG G VY D + VA+K+ + S+ R + E ++ ++VP
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+ + + Q + ++ L L + L P ++I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL--EVRGTAGYLDPEYYS 707
HRDVK NIL+ A + DFG + D + GT Y+ PE +S
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKLTQLGNTVGTLYYMAPERFS 208
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREP 733
H + ++D+++ VL E ++G P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IGEG G V G++VAVK+ Q NE+ + +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
++ ++ F+ G+L D + ++ L+ ++ + L YLH + VIH
Sbjct: 113 VGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD+KS +ILL K++DFGF A D + GT ++ PE S + +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222
Query: 716 DVFSFGVVLLEIISGREPLNTRRP 739
D++S G++++E++ G P + P
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSP 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 536 LIGEGGFGSVYRG-TLPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
+G+G FG+VY + +A+KV +S +G E+ S +RH N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
Y + + L+ F G L L + + + + A L Y H R
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEE-LADALHYCHE---R 133
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+K N+L+ + K+ADFG+S +AP GT YL PE +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKTH 189
Query: 712 SAKSDVFSFGVVLLEIISGREP 733
K D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 40/217 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G+G FG VY+ G A KV + S + ++ E+ L+ H +V LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ + ++ F G++ + + L P + L +LH+ + +IH
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIH 140
Query: 656 RDVKSSNILLDHSMCAKVADFGFSK----------------Y--APQEGDSGFSLEVRGT 697
RD+K+ N+L+ ++ADFG S Y AP EV
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP---------EVVMC 191
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
D Y K+D++S G+ L+E+ P
Sbjct: 192 ETMKDTPY------DYKADIWSLGITLIEMAQIEPPH 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 17/211 (8%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-RSSTSTQGTREFENELNFL-SAIRHENLVPLLGY 593
+G G G V++ G +AVK R S + + + +L+ + + +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
N + M + + + + + + + + L YL V
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE-----YYST 708
IHRDVK SNILLD K+ DFG S + D G A Y+ PE +
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739
++DV+S G+ L+E+ +G+ P +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 536 LIGEGGFGSVYRGTLPD---GQEVAVKV-RSSTSTQGT--REFENELNFLSAIRHENLVP 589
++G GG V+ D ++VAVKV R+ + + F E +A+ H +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 590 LLGYCCENDQQI-LVYPFM---SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
+ L Y M +L+D + T + + + A + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFS 132
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL----EVRGTAGYL 701
H G +IHRDVK +NI++ + KV DFG ++ DSG S+ V GTA YL
Sbjct: 133 HQ-NG--IIHRDVKPANIMISATNAVKVMDFGIARAI---ADSGNSVTQTAAVIGTAQYL 186
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE + A+SDV+S G VL E+++G P
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQEVAVKV-----------------RSSTSTQGTREFENEL 576
+TL +G F + D + A+K + +F+NEL
Sbjct: 37 RTL-NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 577 NFLSAIRHENLVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
++ I++E + G N ++ ++Y +M N S+ K + +
Sbjct: 95 QIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 636 LGAAR----GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
+ Y+H +++ HRDVK SNIL+D + K++DFG S+Y + G
Sbjct: 154 KCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210
Query: 692 LEVRGTAGYLDPEYYSTQHL--SAKSDVFSFGVVLLEIISGREP 733
RGT ++ PE++S + AK D++S G+ L + P
Sbjct: 211 ---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 4e-25
Identities = 52/214 (24%), Positives = 84/214 (39%), Gaps = 23/214 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLG- 592
++G+G +V+RG G A+KV ++ S + E L + H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 593 YCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
+ L+ F GSL L E S L L + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 652 SVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
++HR++K NI+ D K+ DFG ++ D + + GT YL P+ Y
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYE 188
Query: 708 T--------QHLSAKSDVFSFGVVLLEIISGREP 733
+ A D++S GV +G P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 517 PVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENE 575
P ++F + +GEG +GSVY+ GQ VA+K +E E
Sbjct: 27 PEEVFDVLEK----------LGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKE 74
Query: 576 LNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA 635
++ + ++V G +N +V + GS+ D + KTL +I
Sbjct: 75 ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATIL 131
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
+GL YLH IHRD+K+ NILL+ AK+ADFG + V
Sbjct: 132 QSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVI 186
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
GT ++ PE + +D++S G+ +E+ G+ P
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 69/255 (27%), Positives = 96/255 (37%), Gaps = 49/255 (19%)
Query: 508 SMDDPVKPMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSST 564
SM + L L ++ + +G G +G VY+G + GQ A+KV T
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 565 STQGTREFENELNFLSAI-RHENLVPLLG-----YCCENDQQI-LVYPFMSNGSLQDRLY 617
E + E+N L H N+ G D Q+ LV F GS+ D +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI- 118
Query: 618 GEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677
+ + TL I RGL +LH VIHRD+K N+LL + K+ DFG
Sbjct: 119 -KNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 678 FSK----------------Y--APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFS 719
S Y AP EV D Y KSD++S
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAP---------EVIACDENPDATY------DFKSDLWS 219
Query: 720 FGVVLLEIISGREPL 734
G+ +E+ G PL
Sbjct: 220 LGITAIEMAEGAPPL 234
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-23
Identities = 62/246 (25%), Positives = 97/246 (39%), Gaps = 45/246 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+G G +G V E A+K+ ++S ST + E+ L + H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 594 CCENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
E+ + LV G L D + + E I G+ YLH
Sbjct: 105 -FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---------IIKQVLSGVTYLHK 154
Query: 648 FAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
+++HRD+K N+LL + K+ DFG S + E GTA Y+ PE
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPE 208
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRNEWSLV-EW 748
++ K DV+S GV+L +++G P + EW V E
Sbjct: 209 VLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267
Query: 749 AKPFIR 754
AK I+
Sbjct: 268 AKDLIK 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLVPLLG 592
IG G FG+VY + + + VA+K S + Q +++ E+ FL +RH N + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
LV + GS D L +K L ++ GA +GL YLH+ +
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS---HN 174
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR----GTAGYLDPEYYST 708
+IHRDVK+ NILL K+ DFG + + GT ++ PE
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS----------IMAPANSFVGTPYWMAPEVILA 224
Query: 709 QHLS---AKSDVFSFGVVLLEIISGREPL 734
K DV+S G+ +E+ + PL
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 8e-23
Identities = 45/245 (18%), Positives = 78/245 (31%), Gaps = 51/245 (20%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVPL 590
IG+G +G V A+K+ + + + E+ + + H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALG------------- 637
+ LV G L D+L + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 638 ---------------AARGLM--------YLHTFAGRSVIHRDVKSSNILLDHSMCA--K 672
+M YLH + + HRD+K N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 673 VADFGFSK-YAPQEGDSGFSLEVR-GTAGYLDPE--YYSTQHLSAKSDVFSFGVVLLEII 728
+ DFG SK + + + + GT ++ PE + + K D +S GV+L ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 729 SGREP 733
G P
Sbjct: 271 MGAVP 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 65/247 (26%), Positives = 94/247 (38%), Gaps = 46/247 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
+G+G FG V GQE AVKV R E+ L + H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 593 YCCENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ E+ LV + G L D + + E + I G+ Y+H
Sbjct: 94 F-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---------IIRQVLSGITYMH 143
Query: 647 TFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
++HRD+K N+LL ++ DFG S + S + GTA Y+ P
Sbjct: 144 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAP 197
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRNEWSLV-E 747
E + K DV+S GV+L ++SG P N +W V E
Sbjct: 198 EVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 748 WAKPFIR 754
AK IR
Sbjct: 257 SAKDLIR 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-22
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 40/230 (17%)
Query: 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLG 592
+ ++G G G+V G+ VAVK E+ L+ H N++
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRY-- 74
Query: 593 YCCENDQQILVYPFMS--NGSLQDRLYGEASTRKTLDWPTRL---SIALGAARGLMYLHT 647
YC E + +Y + N +LQD + + + + L S+ A G+ +LH
Sbjct: 75 YCSETTDR-FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 648 FAGRSVIHRDVKSSNILLDHSMC-------------AKVADFGFSKYAPQEGDSGFSLEV 694
+IHRD+K NIL+ S ++DFG K G S F +
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-DSGQSSFRTNL 189
Query: 695 R---GTAGYLDPE-------YYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
GT+G+ PE + + L+ D+FS G V I+S G+ P
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 67/265 (25%), Positives = 102/265 (38%), Gaps = 55/265 (20%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--------RSSTSTQGTRE-FENELN 577
+ Y+ ++G G V R P +E AVK+ S+ Q RE E++
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 578 FLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTR 631
L + H N++ L N LV+ M G L D L E TRK +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM----- 130
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
++ + LH +++HRD+K NILLD M K+ DFGFS +
Sbjct: 131 RALL----EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLR 181
Query: 692 LEVRGTAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR------- 738
EV GT YL PE + + D++S GV++ +++G P R+
Sbjct: 182 -EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 739 --------PRNEWSLV-EWAKPFIR 754
EW + K +
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVS 265
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 60/250 (24%), Positives = 95/250 (38%), Gaps = 45/250 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVPL 590
IG+G F V R GQ+ AVK+ +S+ T + + E + ++H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM------- 643
L + +V+ FM L + A S A A M
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADA------GFVYSEA--VASHYMRQILEAL 143
Query: 644 -YLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
Y H ++IHRDVK +LL ++S K+ FG + + G GT
Sbjct: 144 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--GRVGTPH 198
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR--------------PRNEWSL 745
++ PE + DV+ GV+L ++SG P + +WS
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258
Query: 746 V-EWAKPFIR 754
+ E AK +R
Sbjct: 259 ISESAKDLVR 268
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 38/226 (16%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--------RSSTSTQGTREFENELNF 578
+Y +G G G V ++VA+++ S+ E E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 579 LSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLS 633
L + H ++ + + + + +V M G L D++ EA+ +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL--------- 243
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGF 690
+ YLH +IHRD+K N+LL + K+ DFG SK G++
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSL 297
Query: 691 SLEVRGTAGYLDPE---YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ GT YL PE T + D +S GV+L +SG P
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-21
Identities = 62/254 (24%), Positives = 98/254 (38%), Gaps = 43/254 (16%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH 584
T++Y+ +G+G F V R + GQE A + S + ++ E E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAA 639
N+V L E L++ ++ G L + + Y EA + L A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC------IQQILEA- 122
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+++ H V+HR++K N+LL K+ADFG + E + F G
Sbjct: 123 --VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAG 175
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRN 741
T GYL PE D+++ GV+L ++ G P P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP 235
Query: 742 EWSLV-EWAKPFIR 754
EW V AK I
Sbjct: 236 EWDTVTPEAKDLIN 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+G+G FG V + QE AVKV ++S + T E+ L + H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 594 CCENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
E+ +V + G L D + + E + I G+ Y+H
Sbjct: 90 -LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFSGITYMHK 139
Query: 648 FAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
+++HRD+K NILL + K+ DFG S + + GTA Y+ PE
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPE 193
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ K DV+S GV+L ++SG P
Sbjct: 194 VLRGTY-DEKCDVWSAGVILYILLSGTPP 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 29/216 (13%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
+ + ++G G F V+ G+ A+K + ENE+ L I+HEN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARG 641
+V L LV +S G L DR+ Y E + +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-----QQV----LSA 118
Query: 642 LMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
+ YLH ++HRD+K N+L ++S + DFG SK +G GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKM----EQNGIMSTACGT 170
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
GY+ PE + + S D +S GV+ ++ G P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 62/254 (24%), Positives = 93/254 (36%), Gaps = 44/254 (17%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH 584
+ Y +G+G F V R G E A K+ S + ++ E E ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAA 639
N+V L E LV+ ++ G L + + Y EA + I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-----QQI----L 115
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+ Y H+ ++HR++K N+LL K+ADFG + DS G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAG 169
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRN 741
T GYL PE S D+++ GV+L ++ G P P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 229
Query: 742 EWSLV-EWAKPFIR 754
EW V AK I
Sbjct: 230 EWDTVTPEAKSLID 243
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 45/254 (17%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH 584
++Y ++G+G FG V + QE AVKV ++S + T E+ L + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAA 639
N++ L ++ +V + G L D + + E + I
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVF 131
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
G+ Y+H +++HRD+K NILL + K+ DFG S + ++ + G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMK-DRIG 185
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRN 741
TA Y+ PE + K DV+S GV+L ++SG P +
Sbjct: 186 TAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244
Query: 742 EWSLV-EWAKPFIR 754
+W + + AK IR
Sbjct: 245 QWRTISDDAKDLIR 258
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 50/257 (19%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
T Y+ IG G + R E AVK+ + T E E L +H N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 587 LVPLLGYCCENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAAR 640
++ L ++ + + +V M G L D++ + E L +I +
Sbjct: 78 IITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTIT----K 127
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+ YLH + V+HRD+K SNIL + ++ DFGF+K ++G +
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL--RAENGLLMTPCY 182
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR------------------ 738
TA ++ PE Q A D++S GV+L +++G P
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 739 PRNEWSLV-EWAKPFIR 754
W+ V + AK +
Sbjct: 243 SGGYWNSVSDTAKDLVS 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 68/265 (25%), Positives = 104/265 (39%), Gaps = 56/265 (21%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV-------RSSTSTQGTRE-FENELNF 578
Q+Y +IG G V R G E AVK+ S + RE E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 579 LSAIR-HENLVPLLGYCCENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTR 631
L + H +++ L+ E+ + LV+ M G L D L E TR +
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM----- 206
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
S+ + +LH +++HRD+K NILLD +M +++DFGFS +
Sbjct: 207 RSLL----EAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKL 256
Query: 692 LEVRGTAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR------- 738
E+ GT GYL PE + + D+++ GV+L +++G P RR
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 739 --------PRNEWSLV-EWAKPFIR 754
EW K I
Sbjct: 317 IMEGQYQFSSPEWDDRSSTVKDLIS 341
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 55/305 (18%)
Query: 482 KRKSIAGGKLEGKGY-PMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL--IG 538
G K+ GK P + + + P PV++ + Y L +G
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ----GSVYDYYDILEELG 60
Query: 539 EGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN 597
G FG V+R G+ K ++ +NE++ ++ + H L+ L +
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 598 DQQILVYPFMSNGSLQDRL------YGEAS----TRKTLDWPTRLSIALGAARGLMYLHT 647
+ +L+ F+S G L DR+ EA R+ + GL ++H
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------------GLKHMHE 167
Query: 648 FAGRSVIHRDVKSSNILLDHSMCA--KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
S++H D+K NI+ + + K+ DFG + D + TA + PE
Sbjct: 168 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTT-ATAEFAAPEI 221
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREP----------LNTRR-----PRNEWSLV-EWA 749
+ + +D+++ GV+ ++SG P N +R + +S V A
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281
Query: 750 KPFIR 754
K FI+
Sbjct: 282 KDFIK 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 62/254 (24%), Positives = 93/254 (36%), Gaps = 44/254 (17%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH 584
+ Y +G+G F V R G E A K+ S + ++ E E ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAA 639
N+V L E LV+ ++ G L + + Y EA + I
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-----QQI----L 138
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+ Y H+ ++HR++K N+LL K+ADFG + DS G
Sbjct: 139 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAG 192
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRN 741
T GYL PE S D+++ GV+L ++ G P P
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252
Query: 742 EWSLV-EWAKPFIR 754
EW V AK I
Sbjct: 253 EWDTVTPEAKSLID 266
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREF--ENELNFLSAIRHENLVPL 590
L+GEG +G V AVK+ + E + E+ L +RH+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 591 LG-YCCENDQQI-LVYPFMSNGS--LQDRLYGEASTRKTLDWPTRLSIALGAAR------ 640
+ E Q++ +V + G + D + K R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-----PEK------RFPVC--QAHGYFCQL 118
Query: 641 --GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
GL YLH + ++H+D+K N+LL K++ G ++ +G+
Sbjct: 119 IDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 699 GYLDPEYYSTQHL--SAKSDVFSFGVVLLEIISGREP 733
+ PE + K D++S GV L I +G P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 65/305 (21%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 487 AGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL-----IGEGG 541
+ K+ S ++D P P P + + A + T+ +G G
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 542 FGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQ 600
FG V++ G ++A K+ + + E +NE++ ++ + H NL+ L +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 601 ILVYPFMSNGSLQDRL------YGEAST----RKTLDWPTRLSIALGAARGLMYLHTFAG 650
+LV ++ G L DR+ E T ++ + G+ ++H
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------------GIRHMHQ--- 205
Query: 651 RSVIHRDVKSSNILLDHSMCA--KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
++H D+K NIL + K+ DFG ++ + + GT +L PE +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNF-GTPEFLAPEVVNY 262
Query: 709 QHLSAKSDVFSFGV---VLLEIISGREP----------LNTRR-----PRNEWSLV-EWA 749
+S +D++S GV +LL SG P N E+ + E A
Sbjct: 263 DFVSFPTDMWSVGVIAYMLL---SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 750 KPFIR 754
K FI
Sbjct: 320 KEFIS 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV-------------RSSTSTQGTREFENELNFLSAI 582
+G G +G V E A+KV + + E NE++ L ++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 583 RHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALG 637
H N++ L + LV F G L +++ + E I
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---------IMKQ 154
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
G+ YLH +++HRD+K NILL + + K+ DFG S + D +
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLR-DR 208
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
GTA Y+ PE ++ + K DV+S GV++ ++ G P
Sbjct: 209 LGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPP 246
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 530 TQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV--------RSSTSTQGTREFENELNF 578
+Y +G G G V ++VA+K+ S+ E E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 579 LSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLS 633
L + H ++ + + + + +V M G L D++ EA+ +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-----YQ 122
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGF 690
+ L + YLH +IHRD+K N+LL + K+ DFG SK G++
Sbjct: 123 MLLA----VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSL 172
Query: 691 SLEVRGTAGYLDPE---YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ GT YL PE T + D +S GV+L +SG P
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGY 593
+GEG +G V + VAVK+ E + E+ + HEN+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR--------GLMYL 645
E + Q L + S G L DR+ E A+ G++YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP----------DAQRFFHQLMAGVVYL 121
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GTAGYLDPE 704
H + HRD+K N+LLD K++DFG + L GT Y+ PE
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPE 177
Query: 705 YYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
+ + DV+S G+VL +++G P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 67/257 (26%), Positives = 98/257 (38%), Gaps = 61/257 (23%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G F V + G+E A K SS E E E+N L IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL-----YGEAS----TRKTLDWPTRLSIALGAAR 640
L +L+ +S G L D L E ++ LD
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD------------- 119
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCA----KVADFGFSKYAPQEGDSGFSLEVRG 696
G+ YLH+ + + H D+K NI+L K+ DFG + E + F + G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFK-NIFG 173
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGV---VLLEIISGREP----------LNTRR----- 738
T ++ PE + + L ++D++S GV +LL SG P N
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SGASPFLGETKQETLTNISAVNYDF 230
Query: 739 PRNEWSLV-EWAKPFIR 754
+S E AK FIR
Sbjct: 231 DEEYFSNTSELAKDFIR 247
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGY 593
+GEG +G V + VAVK+ E + E+ + HEN+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR--------GLMYL 645
E + Q L + S G L DR+ E A+ G++YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP----------DAQRFFHQLMAGVVYL 121
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GTAGYLDPE 704
H G + HRD+K N+LLD K++DFG + L GT Y+ PE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPYVAPE 177
Query: 705 YYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
+ + DV+S G+VL +++G P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGYC 594
+G G FG V+ G E +K + +Q E E E+ L ++ H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 595 CENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM--------YL 645
E+ + +V G L +R+ + K LS LM Y
Sbjct: 90 -EDYHNMYIVMETCEGGELLERIVSAQARGK------ALSEG--YVAELMKQMMNALAYF 140
Query: 646 HTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
H+ + V+H+D+K NIL K+ DFG ++ + D + GTA Y+
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAA-GTALYMA 194
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE + + ++ K D++S GVV+ +++G P
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 24/240 (10%)
Query: 509 MDDPVKPMPVQIFSLQYLEAATQQYKT---------LIGEGGFGSVYRGTL-PDGQEVAV 558
MD SLQ+ + Q K ++GEG F +V +E A+
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAI 60
Query: 559 KVRSSTSTQGTREFE---NELNFLSAIRHENLVPLLGYCCENDQQI-LVYPFMSNGSLQD 614
K+ + E + +S + H V L + ++D+++ + NG L
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLK 119
Query: 615 RLYGEASTRKTLDWPTRLSIA-LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV 673
+ + TR A + +A L YLH G+ +IHRD+K NILL+ M ++
Sbjct: 120 YIRKI---GSFDETCTRFYTAEIVSA--LEYLH---GKGIIHRDLKPENILLNEDMHIQI 171
Query: 674 ADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
DFG +K E + GTA Y+ PE + + SD+++ G ++ ++++G P
Sbjct: 172 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 39/186 (20%), Positives = 67/186 (36%), Gaps = 14/186 (7%)
Query: 562 SSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEAS 621
+S ++ + +N V L + +L+D +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN-RRC 156
Query: 622 TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681
+ + + L I + A + +LH + ++HRD+K SNI KV DFG
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 682 APQEGDSGFSLEVR----------GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR 731
Q+ + L GT Y+ PE + S K D+FS G++L E++
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273
Query: 732 EPLNTR 737
R
Sbjct: 274 STQMER 279
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 64/304 (21%), Positives = 112/304 (36%), Gaps = 54/304 (17%)
Query: 482 KRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL--IGE 539
GK+ ++ N + + P PV+I + Y +G
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH----DHVLDHYDIHEELGT 167
Query: 540 GGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND 598
G FG V+R T G A K + E+ +S +RH LV L +++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 599 QQILVYPFMSNGSLQDRL------YGEAS----TRKTLDWPTRLSIALGAARGLMYLHTF 648
+ +++Y FMS G L +++ E R+ GL ++H
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------------GLCHMHE- 273
Query: 649 AGRSVIHRDVKSSNILLDHSMCA--KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ +H D+K NI+ K+ DFG + + + + GTA + PE
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPEVA 328
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREP----------LNTRR-----PRNEWSLV-EWAK 750
+ + +D++S GV+ ++SG P N + + +S + E K
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 751 PFIR 754
FIR
Sbjct: 389 DFIR 392
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 39/218 (17%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFEN----ELNFLSAIRHE--N 586
L+G GGFGSVY G + D VA+K + S G E+ L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 587 LVPLLGYCCENDQQILVYPFMSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLM-- 643
++ LL + D +L+ L D + T + L L AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERG-----ALQEEL--ARSFFWQ 157
Query: 644 ------YLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
+ H V+HRD+K NIL+D + K+ DFG D+ ++ G
Sbjct: 158 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-G 210
Query: 697 TAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
T Y PE+ + V+S G++L +++ G P
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 51/244 (20%), Positives = 87/244 (35%), Gaps = 43/244 (17%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG G +G V A K + F+ E+ + ++ H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 596 ENDQQI-LVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
E++ I LV + G L +R+ + E+ + I + Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------IMKDVLSAVAYCHK-- 124
Query: 650 GRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+V HRD+K N L K+ DFG + + +V GT Y+ P+
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKV-GTPYYVSPQVL 180
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRR---------------PRNEWSLV-EWAK 750
+ + D +S GV++ ++ G P + P +W V A+
Sbjct: 181 EGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 751 PFIR 754
IR
Sbjct: 240 SLIR 243
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 26/240 (10%)
Query: 508 SMDDPVKPMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV--RS 562
++++P K + ++ + +Q+Y T+ +G G FG V+ +EV VK +
Sbjct: 2 ALEEPPKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKE 60
Query: 563 STSTQGTREFEN------ELNFLSAIRHENLVPLLGYCCENDQQI-LVYPFMSNGS-LQD 614
E E+ LS + H N++ +L EN LV +G L
Sbjct: 61 KVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-ENQGFFQLVMEKHGSGLDLFA 119
Query: 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674
+ LD P I + YL + +IHRD+K NI++ K+
Sbjct: 120 FI----DRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172
Query: 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS-TQHLSAKSDVFSFGVVLLEIISGREP 733
DFG + A E F GT Y PE + + +++S GV L ++ P
Sbjct: 173 DFGSA--AYLERGKLFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 63/264 (23%), Positives = 97/264 (36%), Gaps = 59/264 (22%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLS 580
Y +G G F V + G E A K R+S E E E++ L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 581 AIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEAST----RKTLDWPTR 631
+ H N++ L +L+ +S G L D L E ++ LD
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---- 126
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGD 687
G+ YLHT + + H D+K NI+L K+ DFG + +
Sbjct: 127 ---------GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----E 170
Query: 688 SGFSLEVR-GTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP----------LNT 736
G + GT ++ PE + + L ++D++S GV+ ++SG P N
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 737 RR-----PRNEWSLV-EWAKPFIR 754
+S E AK FIR
Sbjct: 231 TSVSYDFDEEFFSHTSELAKDFIR 254
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-19
Identities = 62/254 (24%), Positives = 95/254 (37%), Gaps = 55/254 (21%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G F V + G E A K R+S E E E++ L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL-----YGEAST----RKTLDWPTRLSIALGAAR 640
L +L+ +S G L D L E ++ LD
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------------- 126
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAPQEGDSGFSLEVRG 696
G+ YLHT + + H D+K NI+L K+ DFG + D + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFG 180
Query: 697 TAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP----------LNTRR-----PRN 741
T ++ PE + + L ++D++S GV+ ++SG P N
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 742 EWSLV-EWAKPFIR 754
+S E AK FIR
Sbjct: 241 FFSQTSELAKDFIR 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSA 581
Q+Y+ L IGEG +G+V++ + VA+K VR +G RE + L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKE 57
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAAR 640
++H+N+V L + + LV+ F QD + Y + S LD S +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFD-SCNGDLDPEIVKSFLFQLLK 112
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG---- 696
GL + H+ R+V+HRD+K N+L++ + K+A+FG ++ F + VR
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA--------FGIPVRCYSAE 161
Query: 697 --TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y P+ YST D++S G + E+ + PL
Sbjct: 162 VVTLWYRPPDVLFGAKLYST-----SIDMWSAGCIFAELANAGRPL 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 41/220 (18%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGT--------REFENELNFLSAIRH 584
L+G+GGFG+V+ G L D +VA+KV R+ E + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGS-LQDRLYGEASTRKTLDWPTRLSIALGAARGLM 643
++ LL + + +LV L D + T K L +R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-----TEKG-----PLGEGP--SRCFF 145
Query: 644 --------YLHTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSKYAPQEGDSGFSLEV 694
+ H+ R V+HRD+K NIL+D K+ DFG D ++
Sbjct: 146 GQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD 199
Query: 695 RGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
GT Y PE+ S + + V+S G++L +++ G P
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 505 SIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGTLPDGQEVAVK-VR 561
++ +DDP K + V + E Y IG G FG V++ L + EVA+K V
Sbjct: 14 KLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL 73
Query: 562 SSTSTQGTREFEN-ELNFLSAIRHENLVPLLGYCCENDQQI------LVYPFMSNGSLQD 614
+ F+N EL + ++H N+V L + N + LV ++ ++
Sbjct: 74 QD------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR 126
Query: 615 RLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKV 673
A ++T+ R L Y+H+ + HRD+K N+LLD S K+
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKL 183
Query: 674 ADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY-------STQHLSAKSDVFSFGVVLLE 726
DFG +K + Y+ YY + + D++S G V+ E
Sbjct: 184 IDFGSAKIL---------IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234
Query: 727 IISGREPL 734
++ G+ PL
Sbjct: 235 LMQGQ-PL 241
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 53/220 (24%), Positives = 83/220 (37%), Gaps = 32/220 (14%)
Query: 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLL 591
+ ++GEG V L QE AVK+ E+ L + H N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 592 GYCCENDQQILVYPFMSNGSLQDRL-----YGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ E D+ LV+ M GS+ + + E + +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-----QDVA----SALDFLH 128
Query: 647 TFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVR-----GTA 698
+ + HRD+K NIL + K+ DF GD G+A
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 699 GYLDPEYYSTQHLSAKS-----DVFSFGVVLLEIISGREP 733
Y+ PE A D++S GV+L ++SG P
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 45/250 (18%), Positives = 87/250 (34%), Gaps = 55/250 (22%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V+R + K + E++ L+ RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 596 ENDQQILVYPFMSNGSLQDRL------YGEAS----TRKTLDWPTRLSIALGAARGLMYL 645
++ ++++ F+S + +R+ E + + L +L
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------------ALQFL 118
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCA--KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
H+ ++ H D++ NI+ + K+ +FG ++ + F L Y P
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLF-TAPEYYAP 172
Query: 704 EYYSTQHLSAKSDVFSFGV---VLLEIISGREP----------LNTRR-----PRNEWSL 745
E + +S +D++S G VLL SG P N +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLL---SGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 746 V-EWAKPFIR 754
+ A F+
Sbjct: 230 ISIEAMDFVD 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/242 (22%), Positives = 87/242 (35%), Gaps = 56/242 (23%)
Query: 532 QYKT--LIGEGGFGSVYRGT-LPDGQEVAVKV-------------------RSSTSTQGT 569
QY IG+G +G V D A+KV + + G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 570 REFEN-------ELNFLSAIRHENLVPLLGYC---CENDQQI-LVYPFMSNGSLQDRL-- 616
+ E+ L + H N+V L N+ + +V+ ++ G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 617 --YGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674
E R + I G+ YLH + +IHRD+K SN+L+ K+A
Sbjct: 132 KPLSEDQARFYF----QDLIK-----GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIA 179
Query: 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS---AKSDVFSFGVVLLEIISGR 731
DFG S +G GT ++ PE S DV++ GV L + G+
Sbjct: 180 DFGVS--NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
Query: 732 EP 733
P
Sbjct: 238 CP 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 27/205 (13%), Positives = 53/205 (25%), Gaps = 46/205 (22%)
Query: 536 LIGEGGFGSVYRGTLPD---GQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVP 589
G ++ D ++VA+ + +E + LS I +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
+L ++V ++ GSLQ+ + + A H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHR-A 148
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
G V S + + +A +
Sbjct: 149 G--VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
+ + D+ G L ++ R PL
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPL 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 525 YLEAATQQYKTL--IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGT-----REFENEL 576
Y + ++Y+ L +GEG +G VY+ G+ VA+K +R +G R E+
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EI 70
Query: 577 NFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIA 635
+ L + H N+V L+ LV+ FM +D + + + L
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLD-ENKTGLQDSQIKIYL 125
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR 695
RG+ + H ++HRD+K N+L++ K+ADFG ++ F + VR
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA--------FGIPVR 174
Query: 696 G------TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y P+ YST D++S G + E+I+G+ PL
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTS-----VDIWSIGCIFAEMITGK-PL 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 61/258 (23%), Positives = 95/258 (36%), Gaps = 63/258 (24%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G G F V + G + A K +SS + E E++ L I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRL-----YGEAS----TRKTLDWPTRLSIALGAAR 640
L IL+ ++ G L D L E ++ L+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN------------- 125
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCA----KVADFGFSKYAPQEGDSGFSLEVR- 695
G+ YLH+ + H D+K NI+L K+ DFG + D G +
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIF 178
Query: 696 GTAGYLDPEYYSTQHLSAKSDVFSFGV---VLLEIISGREP----------LNTRR---- 738
GT ++ PE + + L ++D++S GV +LL SG P N
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL---SGASPFLGDTKQETLANVSAVNYE 235
Query: 739 -PRNEWSLV-EWAKPFIR 754
+S AK FIR
Sbjct: 236 FEDEYFSNTSALAKDFIR 253
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 55/261 (21%), Positives = 96/261 (36%), Gaps = 49/261 (18%)
Query: 493 GKGYPMTKNLVFSIDSMDDPVKPMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGTL 550
G G M+ N + D +++ G+G FG+V G
Sbjct: 1 GPGSMMSLNAAAAADERSRKE----------------MDRFQVERMAGQGTFGTVQLGKE 44
Query: 551 -PDGQEVAVK-VRSSTSTQGTREFENELNFLSAIRHENLVPLL------GYCCENDQ-QI 601
G VA+K V + RE + + L+ + H N+V L G D
Sbjct: 45 KSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102
Query: 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSS 661
+V ++ + +L + R + LH + V HRD+K
Sbjct: 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPH 160
Query: 662 NILLDHSMCA-KVADFGFSK-YAPQEGDSGFSLEVRGTAGYLDPE------YYSTQHLSA 713
N+L++ + K+ DFG +K +P E ++ + Y PE +Y+T
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTA---- 212
Query: 714 KSDVFSFGVVLLEIISGREPL 734
D++S G + E++ G P+
Sbjct: 213 -VDIWSVGCIFAEMMLGE-PI 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 53/256 (20%), Positives = 90/256 (35%), Gaps = 61/256 (23%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRH-ENLVPLLG 592
+G G F V + GQE A K + E +E+ L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 593 YCCENDQQILVYPFMSNGSLQDRL-------YGEAST----RKTLDWPTRLSIALGAARG 641
+ IL+ + + G + E ++ L+ G
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------------G 143
Query: 642 LMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GT 697
+ YLH +++H D+K NILL K+ DFG S+ L GT
Sbjct: 144 VYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHACELREIMGT 196
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGV---VLLEIISGREP----------LNTRR-----P 739
YL PE + ++ +D+++ G+ +LL + P LN +
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLL---THTSPFVGEDNQETYLNISQVNVDYS 253
Query: 740 RNEWSLV-EWAKPFIR 754
+S V + A FI+
Sbjct: 254 EETFSSVSQLATDFIQ 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 35/211 (16%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYC 594
+GEG F + Q AVK+ S T+ E+ L H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEVF 75
Query: 595 CENDQQI-LVYPFMSNGSLQDRL-----YGE---ASTRKTLDWPTRLSIALGAARGLMYL 645
+ LV ++ G L +R+ + E + + L + ++
Sbjct: 76 -HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------VSAVSHM 122
Query: 646 HTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
H V+HRD+K N+L + ++ K+ DFGF++ P + T Y
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAA 177
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE + D++S GV+L ++SG+ P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 1e-17
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 47/225 (20%)
Query: 531 QQYKTL--IGEGGFGSVYRGTLPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAI 582
++Y L IGEG +G VY+ G+ A+K +R +G RE ++ L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKEL 57
Query: 583 RHENLVPLLGYCCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAARG 641
+H N+V L + +LV+ + QD + + L+ T S L G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLD-VCEGGLESVTAKSFLLQLLNG 112
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG----- 696
+ Y H R V+HRD+K N+L++ K+ADFG ++ F + VR
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARA--------FGIPVRKYTHEI 161
Query: 697 -TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y P+ YST D++S G + E+++G PL
Sbjct: 162 VTLWYRAPDVLMGSKKYST-----TIDIWSVGCIFAEMVNGT-PL 200
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 58/263 (22%), Positives = 94/263 (35%), Gaps = 58/263 (22%)
Query: 530 TQQY---KTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE 585
T Y K ++G G G V GQ+ A+K+ S + +E ++ A
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL-LYDSPKARQEVDH---HWQASGGP 82
Query: 586 NLVPLLGYCCENDQQI----LVYPFMSNGSLQDRL-------YGEASTRKTLDWPTRLSI 634
++V +L ++ M G L R+ + E + + I
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM-----RDI 137
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFS 691
+ +LH+ ++ HRDVK N+L + K+ DFGF+K Q
Sbjct: 138 G----TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NAL 186
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR------------- 738
T Y+ PE + D++S GV++ ++ G P +
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 739 ------PRNEWSLV-EWAKPFIR 754
P EWS V E AK IR
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIR 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPL 590
KT IG+G F V + G+EVA+K+ ++ + ++ E+ + + H N+V L
Sbjct: 21 KT-IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 591 LGY-CCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR-------- 640
+ E ++ + L+ + S G + D L R+ AR
Sbjct: 80 --FEVIETEKTLYLIMEYASGGEVFDYLVAH----------GRMKEKE--ARSKFRQIVS 125
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS-KYAPQEGDSGFSLEVRGTAG 699
+ Y H + ++HRD+K+ N+LLD M K+ADFGFS ++ F G
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPP 178
Query: 700 YLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
Y PE + + + DV+S GV+L ++SG P
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSA 581
++Y+ + IGEG +G V++ GQ VA+K S RE + L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQ 58
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEA-STRKTLDWPTRLSIALGAAR 640
++H NLV LL + LV+ + + E ++ + SI +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCD----HT-VLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
+ + H + IHRDVK NIL+ K+ DFGF++ D + EV T Y
Sbjct: 114 AVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEV-ATRWY 168
Query: 701 LDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE Y DV++ G V E++SG PL
Sbjct: 169 RSPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV-PL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSA 581
++Y+ L +GEG +G V + G+ VA+K S + RE + L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQ 80
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKT-LDWPTRLSIALGAAR 640
+RHENLV LL C + + LV+ F+ + + LD+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVD----HT-ILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
G+ + H+ ++IHRD+K NIL+ S K+ DFGF++ G+ + EV T Y
Sbjct: 136 GIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YDDEV-ATRWY 190
Query: 701 LDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
PE Y DV++ G ++ E+ G PL
Sbjct: 191 RAPELLVGDVKYGKA-----VDVWAIGCLVTEMFMGE-PL 224
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 37/214 (17%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVPLL 591
+G G FG V G G +VAVK+ R + + E+ L RH +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 592 GY-CCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR--------G 641
Y +V ++S G L D + R+ AR
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYI----CKHG------RVEEM--EARRLFQQILSA 123
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GTAGY 700
+ Y H V+HRD+K N+LLD M AK+ADFG S G L G+ Y
Sbjct: 124 VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD----GEFLRTSCGSPNY 176
Query: 701 LDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
PE S + + D++S GV+L ++ G P
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 61/272 (22%), Positives = 95/272 (34%), Gaps = 47/272 (17%)
Query: 512 PVKPMPVQIFSLQYLEAATQQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQG 568
+P +A + ++ +G G VYR + A+KV T +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK- 92
Query: 569 TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRL-----YGEASTR 623
+ E+ L + H N++ L + LV ++ G L DR+ Y E
Sbjct: 93 -KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFS 679
+ I + YLH ++HRD+K N+L + K+ADFG S
Sbjct: 152 DAV-----KQIL----EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPL-KIADFGLS 198
Query: 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR- 738
K E V GT GY PE + D++S G++ ++ G EP R
Sbjct: 199 KIV--EHQVLMK-TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 739 ---------------PRNEWSLV-EWAKPFIR 754
W V AK +R
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 531 QQYKTL--IGEGGFGSVYRG--TLPDGQEVAVK-VRSSTSTQGT-----REFENELNFLS 580
QQY+ + IGEG +G V++ G+ VA+K VR T +G RE L L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLE 69
Query: 581 AIRHENLVPLL----GYCCENDQQI-LVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSI 634
H N+V L + + ++ LV+ + QD Y + + T +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDM 125
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
RGL +LH+ V+HRD+K NIL+ S K+ADFG ++ +S ++
Sbjct: 126 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSFQM 174
Query: 695 RGTAG-----YLDPEY-----YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T+ Y PE Y+T D++S G + E+ + PL
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATP-----VDLWSVGCIFAEMFRRK-PL 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 56/225 (24%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VR-------SSTSTQGTREFENELNFLSAIRHENL 587
+G G + +VY+G G VA+K V+ ST+ RE ++ + ++HEN+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI---RE----ISLMKELKHENI 65
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAA------RG 641
V L ++ LV+ FM D L +R + P L + L +G
Sbjct: 66 VRLYDVIHTENKLTLVFEFMD----ND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG----- 696
L + H ++HRD+K N+L++ K+ DFG ++ F + V
Sbjct: 121 LAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA--------FGIPVNTFSSEV 169
Query: 697 -TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y P+ YST D++S G +L E+I+G+ PL
Sbjct: 170 VTLWYRAPDVLMGSRTYST-----SIDIWSCGCILAEMITGK-PL 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 48/230 (20%)
Query: 532 QYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREF------E-NELNFLS 580
+Y+ + IG G +G+VY+ G VA+K VR G E L L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 581 AIRHENLVPLL----GYCCENDQQI-LVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSI 634
A H N+V L+ + + ++ LV+ + QD R Y + + L T +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDL 125
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
RGL +LH ++HRD+K NIL+ K+ADFG ++ +S ++
Sbjct: 126 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI--------YSYQM 174
Query: 695 RGTAG-----YLDPEY-----YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE Y+T D++S G + E+ + PL
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYAT-----PVDMWSVGCIFAEMFRRK-PL 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 53/273 (19%), Positives = 87/273 (31%), Gaps = 83/273 (30%)
Query: 537 IGEGGFGSVYRGTL------PDGQEVAVK-VRSSTSTQGTREFENE-------------- 575
+G G FG V + VAVK ++ + R +E
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 576 -------------------------LNFLSAIRHE-NLVPLLGYCCENDQQILVYPFMSN 609
+L + R+E G + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 610 GSLQDRLYGEAST------------------------RKTLDWPTRLSIALGAARGLMYL 645
D + S+ + L + + A+G+ +L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD----SGFSLEVRGTAGYL 701
A R IHRD+ + NILL K+ DFG ++ ++ D L ++ A
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA--- 263
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREP 733
PE + + +SDV+SFGV+L EI S G P
Sbjct: 264 -PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 45/258 (17%), Positives = 85/258 (32%), Gaps = 58/258 (22%)
Query: 509 MDDPVKPMPVQIFSLQYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVK--VRSSTST 566
M + + + + + + I G +G+V G +G VA+K + +
Sbjct: 2 MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 567 QGTREFEN---------ELNFLSAIRHENLVPLLG----YCCENDQQI-LVYPFM----- 607
+ + E+ L+ H N++ L + ++ LV M
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 608 -----SNGSLQDR-----LYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRD 657
+ + +Y L GL LH AG V+HRD
Sbjct: 122 QVIHDQRIVISPQHIQYFMY------HIL-------------LGLHVLHE-AG--VVHRD 159
Query: 658 VKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY-YSTQHLSAKSD 716
+ NILL + + DF ++ ++ Y PE + + D
Sbjct: 160 LHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVD 216
Query: 717 VFSFGVVLLEIISGREPL 734
++S G V+ E+ + + L
Sbjct: 217 MWSAGCVMAEMFNRK-AL 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 52/230 (22%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSA 581
+Y+ + +GEG +G VY+ + VA+K +R +G RE ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKE 89
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
++H N++ L N + L++ + D L + S G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAE----ND-LKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCA-----KVADFGFSKYAPQEGDSGFSLEVRG 696
+ + H+ R +HRD+K N+LL S + K+ DFG ++ F + +R
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--------FGIPIRQ 193
Query: 697 ------TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE +YST D++S + E++ PL
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTS-----VDIWSIACIWAEMLMKT-PL 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 530 TQQYKTL--IGEGGFGSVYRGTL-PDGQEVAVK-VRSSTSTQGTREFEN-ELNFLSAIRH 584
Y IG G FG VY+ L G+ VA+K V + F+N EL + + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDH 106
Query: 585 ENLVPLLGYCCENDQQI------LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
N+V L + + ++ LV ++ ++ + ++TL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 639 ARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSK-YAPQEGDSGFSLEVRG 696
R L Y+H+ + HRD+K N+LLD K+ DFG +K E ++
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYIC 218
Query: 697 TAGYLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ Y PE Y++ DV+S G VL E++ G+ P+
Sbjct: 219 SRYYRAPELIFGATDYTSS-----IDVWSAGCVLAELLLGQ-PI 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 63/216 (29%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVP 589
TL G G FG V G G +VAVK+ R + E+ L RH +++
Sbjct: 22 DTL-GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 590 LLGY-CCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR------- 640
L Y I +V ++S G L D + + RL +R
Sbjct: 81 L--YQVISTPSDIFMVMEYVSGGELFDYI-----CKNG-----RLDEK--ESRRLFQQIL 126
Query: 641 -GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GTA 698
G+ Y H V+HRD+K N+LLD M AK+ADFG S G L G+
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD----GEFLRTSCGSP 179
Query: 699 GYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
Y PE S + + D++S GV+L ++ G P
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 7e-16
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 21/216 (9%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKV---RSSTSTQGTREFENELNFLSAIRHEN---LV 588
+IG GGFG VY D ++ A+K + QG NE LS + + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 589 PLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+ Y ++ + M+ G L L + R A GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAA-EIILGLEHMHN 310
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
R V++RD+K +NILLD +++D G + ++ GT GY+ PE
Sbjct: 311 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 363
Query: 708 TQHLSAKS-DVFSFGVVLLEIISGREPLNTRRPRNE 742
S D FS G +L +++ G P + +++
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-16
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 536 LIGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTREFE---NELNFLSAIRHENLV 588
++G GGFG V+ + T G+ A K + + + ++ E L+ + +V
Sbjct: 192 VLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 589 PLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWP-TRLSIALGAARGLMYLH 646
L Y E + LV M+ G ++ +Y P A GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH 306
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGYLDPE 704
R++I+RD+K N+LLD +++D G + G++ GT G++ PE
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA----GTPGFMAPE 359
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ D F+ GV L E+I+ R P
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 42/152 (27%), Positives = 66/152 (43%), Gaps = 23/152 (15%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFEN--------ELNFLSAIRHEN 586
+GEG F +VY+ Q VA+K ++ E ++ E+ L + H N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
++ LL LV+ FM D + + L + L +GL YL
Sbjct: 74 IIGLLDAFGHKSNISLVFDFME----TDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677
H ++HRD+K +N+LLD + K+ADFG
Sbjct: 129 HQ---HWILHRDLKPNNLLLDENGVLKLADFG 157
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTRE-FENELNFLSAIRHENLVP 589
+TL GEG FG V T Q+VA+K R E E+++L +RH +++
Sbjct: 15 ETL-GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 590 LLGY-CCENDQQILVYPFM--SNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR------ 640
L Y I + + G L D + K R++ R
Sbjct: 74 L--YDVITTPTDI--VMVIEYAGGELFDYI-----VEKK-----RMTED--EGRRFFQQI 117
Query: 641 --GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVR-GT 697
+ Y H ++HRD+K N+LLD ++ K+ADFG S G L+ G+
Sbjct: 118 ICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD----GNFLKTSCGS 170
Query: 698 AGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
Y PE + + + DV+S G+VL ++ GR P
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLL 591
IG+G FG V D +++ A+K + E N EL + + H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 592 GYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
Y ++++ + +V + G L Q+ + E + + + L +AL YL
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---FICELVMALD------YL 131
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD-SGFSLEVRGTAGYLDPE 704
+ +IHRD+K NILLD + DF + P+E + + GT Y+ PE
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA----GTKPYMAPE 184
Query: 705 YYSTQHLSAKS---DVFSFGVVLLEIISGREPLNTRRPRNEWSLVE 747
+S++ + S D +S GV E++ GR P + R + +V
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 60/231 (25%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGT-----REFENELNFLSAIRHENLVP 589
IG+G FG V++ GQ+VA+K V +G R E+ L ++HEN+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 590 LLGYCCENDQQI--------LVYPFMSN--GSLQDRLYGEASTRKTLDWPTRLSIALGAA 639
L+ C LV+ F + L + +
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLL 134
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
GL Y+H ++HRD+K++N+L+ K+ADFG ++ FSL
Sbjct: 135 NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA--------FSLAKNSQPN 183
Query: 700 ----------YLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE Y D++ G ++ E+ + P+
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGP-----PIDLWGAGCIMAEMWTRS-PI 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 54/268 (20%), Positives = 93/268 (34%), Gaps = 67/268 (25%)
Query: 530 TQQYKTL---IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELN-FLSAIRH 584
YK +G G G V + ++ A+K+ + E+ A +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQC 114
Query: 585 ENLVPLLGYCCENDQQI-----LVYPFMSNGSLQDRL-------YGE---ASTRKTLDWP 629
++V ++ EN +V + G L R+ + E + K++
Sbjct: 115 PHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--- 170
Query: 630 TRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEG 686
+ YLH+ ++ HRDVK N+L + K+ DFGF+K
Sbjct: 171 ---------GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TS 216
Query: 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR-------- 738
+ + T Y+ PE + D++S GV++ ++ G P +
Sbjct: 217 HNSLT-TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275
Query: 739 -----------PRNEWSLV-EWAKPFIR 754
P EWS V E K IR
Sbjct: 276 KTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 24/157 (15%), Positives = 47/157 (29%), Gaps = 18/157 (11%)
Query: 213 DPFDRIWIPKLSPEPTTFSTSFTTNISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLDSG 272
D + ++ + + + + QT + + + + G
Sbjct: 19 DVHGIHYRKDPLEGRVGRASDYGMKLPILRS-NPEDQVLYQTERYNEDSFGYDIPIKEEG 77
Query: 273 DYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGSNYAKLALNVTA---N 329
Y L+L F E S Q+VFD+ +N + DI + +
Sbjct: 78 --EYVLVLKFAE--VYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKK 133
Query: 330 GSLNLTL----------VNVLNGSVFGPICNAYEILQ 356
G L++ V + G P A I++
Sbjct: 134 GKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 51/220 (23%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVK-VR-------SSTSTQGTREFENELNFLSAIRHENL 587
+GEG + +VY+G VA+K +R T+ RE ++ L ++H N+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI---RE----VSLLKDLKHANI 62
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQD-RLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
V L LV+ ++ +D + Y + ++ RGL Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLD----KDLKQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRG------TAGY 700
+ V+HRD+K N+L++ K+ADFG ++ S+ + T Y
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIPTKTYDNEVVTLWY 166
Query: 701 LDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
P+ YSTQ D++ G + E+ +GR PL
Sbjct: 167 RPPDILLGSTDYSTQ-----IDMWGVGCIFYEMATGR-PL 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 56/216 (25%), Positives = 81/216 (37%), Gaps = 43/216 (19%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
IG G FG + VAVK ++ RE N ++RH N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN----HRSLRHPNIVRF- 81
Query: 592 GY-CCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR--------G 641
+ ++ + S G L +R+ R S AR G
Sbjct: 82 -KEVILTPTHLAIIMEYASGGELYERI-----CNAG-----RFSED--EARFFFQQLLSG 128
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCA--KVADFGFSKYAPQEGDSGFSLEVR-GTA 698
+ Y H+ + HRD+K N LLD S K+ DFG+SK + + GT
Sbjct: 129 VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTP 181
Query: 699 GYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREP 733
Y+ PE Q +DV+S GV L ++ G P
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 39/223 (17%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
++Y+ L IG G G V + VA+K + +R F+N EL
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-------KLSRPFQNQTHAKRAYRELV 76
Query: 578 FLSAIRHENLVPLL-----GYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
+ + H+N++ LL E Q + +V M +L + + LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI------QMELDHERM 129
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
+ G+ +LH+ AG +IHRD+K SNI++ K+ DFG A G S
Sbjct: 130 SYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMM 183
Query: 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE D++S G ++ E+I G L
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VL 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 41/224 (18%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
++Y+ L IG G G V + VA+K + +R F+N EL
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-------KLSRPFQNQTHAKRAYRELV 113
Query: 578 FLSAIRHENLVPLL-----GYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
+ + H+N++ LL E Q + LV M + +L + + LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI------QMELDHERM 166
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSKYAPQEGDSGF 690
+ G+ +LH+ +IHRD+K SNI++ S C K+ DFG A G S
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK-SDCTLKILDFGL---ARTAGTSFM 219
Query: 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
T Y PE D++S G ++ E++ + L
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-IL 262
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 54/240 (22%), Positives = 93/240 (38%), Gaps = 62/240 (25%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK----VRSSTSTQGT-REFENELNFLSA 581
+ ++ +GEG +G V T P G+ VA+K T RE + L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKH 65
Query: 582 IRHENLVPLL----GYCCENDQQI-LVYPFM--------SNGSLQDR-----LYGEASTR 623
+HEN++ + EN ++ ++ M S L D +Y
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------ 119
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683
+TL R + LH + VIHRD+K SN+L++ + KV DFG ++
Sbjct: 120 QTL-------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 684 QEGDSGFSLEVRGTA--GYLDPEYY-------STQHLSAKSDVFSFGVVLLEIISGREPL 734
+ + + ++ +Y ++ S DV+S G +L E+ R P+
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 5e-14
Identities = 48/221 (21%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 537 IGEGGFGSVYRG---TLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G +G VY+ D ++ A+K + S RE + L ++H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 592 GYCCE-NDQQI-LVYPFMSN--GSLQDRLYGEASTRKTLDWPTRL--SIALGAARGLMYL 645
D+++ L++ + + + + +K + P + S+ G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 646 HTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKY--APQEGDSGFSLEVRGTAG 699
H V+HRD+K +NIL+ K+AD GF++ +P + + V T
Sbjct: 145 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 700 YLDPE------YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
Y PE +Y+ D+++ G + E+++ P+
Sbjct: 201 YRAPELLLGARHYTKA-----IDIWAIGCIFAELLTSE-PI 235
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 18/205 (8%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
++G+GGFG V + ++ A K + +G NE L + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 592 GYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
Y E + LV M+ G L+ +Y A GL LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAA-EICCGLEDLHR--- 304
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGYLDPEYYST 708
+++RD+K NILLD +++D G + + P EG G GT GY+ PE
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV----GTVGYMAPEVVKN 359
Query: 709 QHLSAKSDVFSFGVVLLEIISGREP 733
+ + D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 50/242 (20%), Positives = 90/242 (37%), Gaps = 64/242 (26%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK---VRSSTSTQGT-REFENELNFLSAI 582
+Y L +G GG G V+ + VA+K + S + RE + + +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRL 65
Query: 583 RHENLVPLL-------------GYCCENDQQI-LVYPFM--------SNGSLQDR----- 615
H+N+V + + +V +M G L +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 616 LYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA-KVA 674
+Y + L RGL Y+H+ A V+HRD+K +N+ ++ K+
Sbjct: 126 MY------QLL-------------RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIG 163
Query: 675 DFGFSKYA-PQEGDSGFSLEVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGRE 732
DFG ++ P G E T Y P S + + D+++ G + E+++G+
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK- 222
Query: 733 PL 734
L
Sbjct: 223 TL 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 20/213 (9%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTRE---FENELNFLSAIRHENL 587
+ +IG G FG V L + +V A+K+ + E F E + L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA-LGAARGLMYL 645
L Y ++D + LV + G L L + R + R +A + A + +
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEM-ARFYLAEMVIA--IDSV 191
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H +HRD+K NIL+D + ++ADFG ++G S+ V GT Y+ PE
Sbjct: 192 HQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247
Query: 706 YSTQHLSAKS-----DVFSFGVVLLEIISGREP 733
D +S GV + E++ G P
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 45/222 (20%), Positives = 90/222 (40%), Gaps = 42/222 (18%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGT-REFENELNFLSAIR-H 584
Y+ + +G G + V+ + + ++V VK+ + RE + L +R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKILENLRGG 90
Query: 585 ENLVPLLG--YCCENDQQILVYPFMSNGSLQDRLYGEAS-------TRKTLDWPTRLSIA 635
N++ L + LV+ ++N + +LY + + L
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEIL--------- 140
Query: 636 LGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSK-YAPQEGDSGFSLE 693
+ L Y H+ ++HRDVK N+++DH ++ D+G ++ Y P +++
Sbjct: 141 ----KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVR 190
Query: 694 VRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
V + + PE Q D++S G +L +I +EP
Sbjct: 191 V-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 55/233 (23%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK----VRSSTSTQGT-REFENELNFLSA 581
+Y L IGEG +G V + VA+K T Q T RE + L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLR 81
Query: 582 IRHENLVPLLG----YCCENDQQI-LVYPFM--------SNGSLQDR-----LYGEASTR 623
RHEN++ + E + + +V M L + LY
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------ 135
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YA 682
+ L RGL Y+H+ A V+HRD+K SN+LL+ + K+ DFG ++
Sbjct: 136 QIL-------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 683 PQEGDSGFSLEVRGTAGYLDPEY-YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
P +GF E T Y PE +++ + D++S G +L E++S R P+
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 54/254 (21%), Positives = 97/254 (38%), Gaps = 59/254 (23%)
Query: 526 LEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVK-VRSSTSTQGTREFEN-ELNFLS 580
LE ++++Y +G G FG V + G+ A+K V ++N EL+ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD------PRYKNRELDIMK 55
Query: 581 AIRHENLVPLLG--YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDW---------- 628
+ H N++ L+ Y +++ P + L + G + K++
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 629 -----PTRLSIALGAA--------------------RGLMYLHTFAGRSVIHRDVKSSNI 663
P L L + R + ++H+ + HRD+K N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 664 LLDHSMCA-KVADFGFSK-YAPQEGDSGFSLEVRGTAGYLDPE-YYSTQHLSAKSDVFSF 720
L++ K+ DFG +K P E S+ + Y PE + D++S
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 721 GVVLLEIISGREPL 734
G V E+I G+ PL
Sbjct: 229 GCVFGELILGK-PL 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFEN---ELNFLSAIRHENL 587
+Y L+G+G FG V A+K+ E + E L RH L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAARG 641
L Y + ++ V + + G L ++R++ E R I
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG-----AEIVSA---- 260
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YLH+ V++RD+K N++LD K+ DFG K ++G + + GT YL
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYL 316
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE D + GVV+ E++ GR P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 22/209 (10%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFE---NELNFLSAIRHENL 587
+G G FG V + A+K+ ++ E NE L A+ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL---SIALGAARGLMY 644
V L +N +V +++ G + L + + R I L Y
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLT----FEY 156
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH +I+RD+K N+L+D +V DFGF+K + ++L GT L PE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTL--CGTPEALAPE 208
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
++ + D ++ GV++ E+ +G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 54/230 (23%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
+ Y + +G G +GSV G++VA+K + +R F++ EL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELL 75
Query: 578 FLSAIRHENLVPLL-----GYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
L ++HEN++ LL N LV PFM LQ +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM------GLKFSEEKI 128
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691
+ +GL Y+H+ AG V+HRD+K N+ ++ K+ DFG +++A E
Sbjct: 129 QYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE------ 179
Query: 692 LEVRGTAGYLDPEYY-------STQHLSAKSDVFSFGVVLLEIISGREPL 734
GY+ +Y S H + D++S G ++ E+++G+ L
Sbjct: 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 67/237 (28%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
++Y+ L +G G +GSV G VAVK + +R F++ EL
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-------KLSRPFQSIIHAKRTYRELR 80
Query: 578 FLSAIRHENLVPLL-----GYCCENDQQI-LVYPFM-------------SNGSLQDRLYG 618
L ++HEN++ LL E + LV M ++ +Q +Y
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY- 139
Query: 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678
+ L RGL Y+H+ A +IHRD+K SN+ ++ K+ DFG
Sbjct: 140 -----QIL-------------RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 679 SKYAPQEGDSGFSLEVRGTAGYLDPE-YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
++ + T Y PE + H + D++S G ++ E+++GR L
Sbjct: 179 AR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TL 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 46/266 (17%), Positives = 86/266 (32%), Gaps = 85/266 (31%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
Y IG G +G VY + VA+K + R FE+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-------KVNRMFEDLIDCKRILREIT 77
Query: 578 FLSAIRHENLVPLLG----YCCENDQQI-LVYPFM---------SNGSLQDR-----LYG 618
L+ ++ + ++ L ++ +V + L + LY
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136
Query: 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678
L G ++H +G +IHRD+K +N LL+ KV DFG
Sbjct: 137 -----NLL-------------LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 679 SKYAPQEGDSGFSLEVRGTAGYLDP---------EYYST------------QHLSAKSDV 717
++ E D+ ++ + T ++ + D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 718 FSFGVVLLEIISGREP----LNTRRP 739
+S G + E+++ + R P
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 52/244 (21%), Positives = 86/244 (35%), Gaps = 59/244 (24%)
Query: 531 QQYKT--LIGEGGFGSVYRGT---------LPDGQEVAVKVRSSTSTQGTREFENELNF- 578
+Q+K G +Y P Q+ ++K+ + NE NF
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL-----FNEQNFF 96
Query: 579 --------LSAIRHENLVPLLG----YCC---ENDQQILVYPFMSNGSLQDRLYGEASTR 623
++ + PLL ++ + LV P + SLQ L + S +
Sbjct: 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL--DVSPK 153
Query: 624 KTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV--ADFGFSK- 680
L + L +A L +LH +H +V + NI +D ++V A +GF+
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 681 YAPQEG------DSGFSLEVRGTAGYLDPEYYSTQ-HL----SAKSDVFSFGVVLLEIIS 729
Y P S G E+ S H S +SD+ S G +L+ +
Sbjct: 211 YCPSGKHVAYVEGSRSPH--EGDL-----EFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 730 GREP 733
G P
Sbjct: 264 GFLP 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 60/179 (33%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
+Y+ IG G +G V + + VA+K + R FE+ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-------KILRVFEDLIDCKRILREIA 104
Query: 578 FLSAIRHENLVPLL----GYCCENDQQI-LVYPFM---------SNGSLQDR-----LYG 618
L+ + H+++V +L E ++ +V + L + LY
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY- 163
Query: 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFG 677
L G+ Y+H+ AG ++HRD+K +N L++ KV DFG
Sbjct: 164 -----NLL-------------VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFG 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 53/215 (24%), Positives = 80/215 (37%), Gaps = 30/215 (13%)
Query: 536 LIGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTRE---FENELNFLSAIRHENLV 588
+IG G F V + T GQ A+K+ + E F E + L +
Sbjct: 68 VIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 589 PLLGYCCENDQQIL--VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA-LGAARGLMYL 645
L + D+ L V + G L L + R + R +A + A + +
Sbjct: 125 QL--HFAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFYLAEIVMA--IDSV 178
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H +HRD+K NILLD ++ADFG +G + V GT YL PE
Sbjct: 179 HRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEI 234
Query: 706 YSTQHLSAKS-------DVFSFGVVLLEIISGREP 733
+ D ++ GV E+ G+ P
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFE---NELNFLSAIRHENLVPLL 591
+G G FG V+ A+KV ++ E +E LS + H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRL---SIALGAARGLMYLHTF 648
G + Q ++ ++ G L L ++ + + + L L YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLA----LEYLH-- 123
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
+ +I+RD+K NILLD + K+ DFGF+K D ++L GT Y+ PE ST
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYTL--CGTPDYIAPEVVST 177
Query: 709 QHLSAKSDVFSFGVVLLEIISGREP 733
+ + D +SFG+++ E+++G P
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 55/239 (23%), Positives = 87/239 (36%), Gaps = 49/239 (20%)
Query: 531 QQYKT--LIGEGGFGSVYRGTLPDGQ------EVAVKVRSSTSTQGTRE--FENELNFLS 580
+K IG+GGFG +Y + + VKV S + E F
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 581 AIRHENL--------VPLLGYCCENDQQILVYPFM---SNG-SLQDRLYGEASTRKTLDW 628
I+ VP +D+ Y FM G LQ +Y + K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANA--KRFSR 151
Query: 629 PTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV--ADFGFSK-YAPQE 685
T L ++L L Y+H +H D+K+SN+LL++ +V D+G + Y P+
Sbjct: 152 KTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 686 G------DSGFSLEVRGTAGYLDPEYYSTQ-HL----SAKSDVFSFGVVLLEIISGREP 733
D GT E+ S H S + D+ G +++ ++G P
Sbjct: 209 VHKAYAADPKRCH--DGTI-----EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 8e-12
Identities = 36/202 (17%), Positives = 59/202 (29%), Gaps = 57/202 (28%)
Query: 529 ATQQYKTL--IGEGGFGSVYRGTLPDGQEVAVKV--------RSSTSTQGTREFENELNF 578
T++ + IGEG FG V++ D VA+K+ + + + E E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 579 LSAI---------RHENLVPLLGYCC------------------------------ENDQ 599
+ R E + L C ++DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVK 659
+V F G +++ K T SI L HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 660 SSNILLDHSMCAKVADFGFSKY 681
N+LL + K+ K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKS 211
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 49/215 (22%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 536 LIGEGGFGSVY---RGTLPDGQEV-AVKV-RSSTSTQGTREFEN---ELNFLSAIRHENL 587
++G+GG+G V+ + T + ++ A+KV + + + ++ + E N L ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAAR- 640
V L+ Y + ++ L+ ++S G L ++ ++ E + A
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC------------FYLAEI 130
Query: 641 --GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTA 698
L +LH + +I+RD+K NI+L+H K+ DFG K + +G + GT
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CGTI 185
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE + D +S G ++ ++++G P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 27/215 (12%)
Query: 532 QYKTLIGEGGFGSVY----RGTLPDGQEVAVKVRSSTSTQGTRE---FENELNFLSAIRH 584
+ +IG G FG V + T + A+K+ S + F E + ++
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 585 ENLVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIA-LGAARGL 642
+V L Y ++D+ + +V +M G L + + S + R A + A L
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLA--L 181
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
+H+ IHRDVK N+LLD S K+ADFG +EG V GT Y+
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 703 PEYYSTQHLSAK----SDVFSFGVVLLEIISGREP 733
PE +Q D +S GV L E++ G P
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 58/254 (22%), Positives = 105/254 (41%), Gaps = 80/254 (31%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
++Y+ + +G+G +G V++ G+ VAVK + F+N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIM 60
Query: 578 FLSAIR-HENLVPLLG-YCCENDQQI-LVYPFM--------SNGSLQDR-----LYGEAS 621
L+ + HEN+V LL +ND+ + LV+ +M L+ +Y
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY---- 116
Query: 622 TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA-KVADFGFSK 680
+ + + + YLH+ G ++HRD+K SNILL+ + C KVADFG S+
Sbjct: 117 --QLI-------------KVIKYLHS-GG--LLHRDMKPSNILLN-AECHVKVADFGLSR 157
Query: 681 YAPQEGDSGFSLEVRGTAGYLDP--------EYYST------------QHLSAKSDVFSF 720
++ + + +Y +T + D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 721 GVVLLEIISGREPL 734
G +L EI+ G+ P+
Sbjct: 218 GCILGEILCGK-PI 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 35/214 (16%)
Query: 536 LIGEGGFGSVY---RGTLPDGQEV-AVKV--------RSSTSTQGTREFENELNFLSAIR 583
++G+G FG V+ + + D +++ A+KV R T+ R + L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER------DILVEVN 84
Query: 584 HENLVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRL---SIALGAA 639
H +V L Y + + ++ L+ F+ G L RL E T + + +AL
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEED-VKFYLAELAL--- 137
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
L +LH +I+RD+K NILLD K+ DFG SK + +S GT
Sbjct: 138 -ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVE 191
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE + + + +D +SFGV++ E+++G P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 51/239 (21%), Positives = 81/239 (33%), Gaps = 52/239 (21%)
Query: 531 QQYKT--LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL 587
Q+ IG GGFG +Y ++ A V + F +EL F + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDC 95
Query: 588 --------------VPLLGYC-----CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDW 628
+PL + +V + LQ T
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKIS----GQNGTFKK 150
Query: 629 PTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKV--ADFGFSK-YAPQE 685
T L + + L Y+H +H D+K++N+LL + +V AD+G S Y P
Sbjct: 151 STVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 686 G------DSGFSLEVRGTAGYLDPEYYSTQ-HL----SAKSDVFSFGVVLLEIISGREP 733
+ GT E+ S H S +SDV G +L + G+ P
Sbjct: 208 NHKQYQENPRKGH--NGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 67/237 (28%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFEN---------ELN 577
Y+ L +G G +G+V G +VA+K + R F++ EL
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-------KLYRPFQSELFAKRAYRELR 76
Query: 578 FLSAIRHENLVPLL-----GYCCENDQQI-LVYPFM--------SNGSLQDR-----LYG 618
L +RHEN++ LL ++ LV PFM + L + +Y
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY- 135
Query: 619 EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678
+ L +GL Y+H AG +IHRD+K N+ ++ K+ DFG
Sbjct: 136 -----QML-------------KGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 679 SKYAPQEGDSGFSLEVRGTAGYLDPEY-YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
++ A DS + V T Y PE + + D++S G ++ E+I+G+ L
Sbjct: 175 ARQA----DSEMTGYV-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 48/219 (21%), Positives = 78/219 (35%), Gaps = 41/219 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENE-LNFLSAIRHENLVP-LLGY 593
IG G FG + G L + VA+K+ S E L + +P + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
+V + SL+D +T T L IA+ + Y+H+ +++
Sbjct: 74 GPCGKYNAMVLELLGP-SLEDLF---DLCDRTFSLKTVLMIAIQLISRMEYVHS---KNL 126
Query: 654 IHRDVKSSNILL---DHSMCAKV--ADFGFSKY---------APQEGDSGFSLEVRGTAG 699
I+RDVK N L+ + + DF +K P GTA
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL----TGTA- 181
Query: 700 YLDPEYYS-TQHL----SAKSDVFSFGVVLLEIISGREP 733
Y S HL S + D+ + G + + + G P
Sbjct: 182 ----RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 56/213 (26%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFEN---ELNFLSAIRHENLVPLL 591
L+G+G FG V A+K+ E + E L RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 592 GYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAAR---GL 642
Y + ++ V + + G L ++R++ E R A L
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR------------FYGAEIVSAL 118
Query: 643 MYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGY 700
YLH R V++RD+K N++LD K+ DFG K +G F GT Y
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPEY 171
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
L PE D + GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 54/276 (19%), Positives = 85/276 (30%), Gaps = 98/276 (35%)
Query: 527 EAATQQYKTL---IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAI 582
A YK +G G G V + ++ A+K+ + E+
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 583 -RHENLVPLLGYCCENDQQI-----LVYPFMSNGSLQDRL-------YGEASTRKTLDWP 629
+ ++V ++ EN +V + G L R+ + E
Sbjct: 68 SQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER--------- 117
Query: 630 TRLSIALGAARGLM--------YLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGF 678
A +M YLH+ ++ HRDVK N+L + K+ DFGF
Sbjct: 118 --------EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738
A E G Y D++S GV++ ++ G P +
Sbjct: 167 ---AK---------ETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNH 202
Query: 739 -------------------PRNEWSLV-EWAKPFIR 754
P EWS V E K IR
Sbjct: 203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 52/219 (23%), Positives = 79/219 (36%), Gaps = 41/219 (18%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENE-LNFLSAIRHENLVP-LLGY 593
IGEG FG ++ GT L + Q+VA+K S E L+ +P + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYYF 74
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
E +LV + SL+D L + T A + +H +S+
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 654 IHRDVKSSNILLDHSMCAK-----VADFGFSKY---------APQEGDSGFSLEVRGTAG 699
++RD+K N L+ V DFG K+ P GTA
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL----SGTA- 182
Query: 700 YLDPEYYS-TQHL----SAKSDVFSFGVVLLEIISGREP 733
Y S HL S + D+ + G V + + G P
Sbjct: 183 ----RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENE-LNFLSAIRHENLVP-LLGY 593
IG G FG +Y GT + G+EVA+K+ + E++ + +P +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IPTIRWC 73
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
E D ++V + SL+D + T L +A + Y+H+ ++
Sbjct: 74 GAEGDYNVMVMELLGP-SLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 654 IHRDVKSSNILLDHSMCAK---VADFGFSK-YAPQEG------DSGFSLEVRGTAGYLDP 703
IHRDVK N L+ + DFG +K Y +L GTA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL--TGTA----- 179
Query: 704 EYYSTQ-HL----SAKSDVFSFGVVLLEIISGREP 733
Y S HL S + D+ S G VL+ G P
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVP-LLGYC 594
IG G FG +Y GT + +EVA+K+ + + + E ++ +P + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
E D +LV + SL+D + L T L +A + ++H +S +
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVH---SKSFL 125
Query: 655 HRDVKSSNILLDHSMCAK---VADFGFSKY---------APQEGDSGFSLEVRGTAGYLD 702
HRD+K N L+ A + DFG +K P + GTA
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL----TGTA---- 177
Query: 703 PEYYS-TQHL----SAKSDVFSFGVVLLEIISGREP 733
Y S HL S + D+ S G VL+ + G P
Sbjct: 178 -RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 39/248 (15%)
Query: 507 DSMDDPVKPMPVQIFSLQYLEAATQQYK-------TLIGEGGFGSVYRGTLPDGQEV-AV 558
+ M+ P P + ++ K +IG+G FG V + AV
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAV 68
Query: 559 KVRSSTSTQGTREFENELN----FLSAIRHENLVPLLGYCCENDQQI-LVYPFMSNGSL- 612
KV + +E ++ ++ L ++H LV L + + ++ V +++ G L
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELF 127
Query: 613 ----QDRLYGEASTRKTLDWPTRLSIALGAAR---GLMYLHTFAGRSVIHRDVKSSNILL 665
++R + E R AA L YLH ++++RD+K NILL
Sbjct: 128 YHLQRERCFLEPRAR------------FYAAEIASALGYLH---SLNIVYRDLKPENILL 172
Query: 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLL 725
D + DFG K + + + GT YL PE Q D + G VL
Sbjct: 173 DSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 230
Query: 726 EIISGREP 733
E++ G P
Sbjct: 231 EMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 20/206 (9%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFENELN----FLSAIRHENLVPL 590
++G+G FG V E+ AVK+ + E + + L L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 591 LGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
C + ++ V +++ G L + + + A A GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAA-EIAIGLFFLQ--- 459
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGYLDPEYYS 707
+ +I+RD+K N++LD K+ADFG K +G F GT Y+ PE +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC----GTPDYIAPEIIA 515
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREP 733
Q D ++FGV+L E+++G+ P
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 57/216 (26%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKV---------RSSTSTQGTREFENELNFLSAIRHE 585
+IG G + V L + A+KV Q + F A H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-----FEQASNHP 70
Query: 586 NLVPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAA 639
LV L C + + ++ V +++ G L + R E R I+L
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-----AEISLA-- 122
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGT 697
L YLH R +I+RD+K N+LLD K+ D+G K + GD S F GT
Sbjct: 123 --LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GT 173
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE + D ++ GV++ E+++GR P
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKV---------RSSTSTQGTREFENELNFLSAIRHE 585
+IG G + V L + A++V Q + F A H
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-----FEQASNHP 113
Query: 586 NLVPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAA 639
LV L C + + ++ V +++ G L + R E R I+L
Sbjct: 114 FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-----AEISLA-- 165
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGT 697
L YLH R +I+RD+K N+LLD K+ D+G K + GD S F GT
Sbjct: 166 --LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC----GT 216
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE + D ++ GV++ E+++GR P
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 536 LIGEGGFGSVYRGTLPDGQEV-AVKVRSSTSTQGTREFENELN----FLSAIRHENLVPL 590
++G+G FG V + + ++ AVKV + E + A H L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 591 LGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAAR---G 641
C + ++ V F++ G L + R + EA R AA
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR------------FYAAEIISA 136
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
LM+LH + +I+RD+K N+LLDH K+ADFG K G + + GT Y+
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--CGTPDYI 191
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE D ++ GV+L E++ G P
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700
GL +LH + +++RD+K NILLD K+ADFG K + GT Y
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDY 184
Query: 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
+ PE Q + D +SFGV+L E++ G+ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 536 LIGEGGFGSVY---RGTLPDGQEV-AVKV-RSSTSTQGTREFE---NELNFLSAIRHEN- 586
++G G +G V+ + + D ++ A+KV + +T Q + E E L IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 587 LVPLLGYCCENDQQI-LVYPFMSNGSL-----QDRLYGEASTRKTLDWPTRLSIALGAAR 640
LV L Y + + ++ L+ +++ G L Q + E + +
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ------------IYVGE 167
Query: 641 ---GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK-YAPQEGDSGFSLEVRG 696
L +LH +I+RD+K NILLD + + DFG SK + E + + G
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF--CG 222
Query: 697 TAGYLDPE---YYSTQHLSAKSDVFSFGVVLLEIISGREP 733
T Y+ P+ + H A D +S GV++ E+++G P
Sbjct: 223 TIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASP 261
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-09
Identities = 61/380 (16%), Positives = 118/380 (31%), Gaps = 102/380 (26%)
Query: 491 LEGKGYPMTKNLVFSIDSMDDPVKPMPV----QIFSLQY--LEAATQQYKTLIGEGGFG- 543
+ + Y ++ +++ D+ V L+ LE + + G G G
Sbjct: 107 MMTRMYIEQRDRLYN-DN--QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 544 SVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND----- 598
+ VA+ V S Q + + ++ +L+ L C +
Sbjct: 164 TW----------VALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETVLEM 201
Query: 599 QQILVYPFMSNG-SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS-VIHR 656
Q L+Y N S D R+ R L+ + ++
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNI---------KLRIHSIQAELRRLLKSKPYE-NCLLVLL 251
Query: 657 DVKSSNIL--LDHSMC--------AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+V+++ + S C +V DF + SL+ + E
Sbjct: 252 NVQNAKAWNAFNLS-CKILLTTRFKQVTDFLSAATTTH-----ISLDHH-SMTLTPDE-- 302
Query: 707 STQHLSAKSDVFSFGVVLL--EIISGREPL-------NTRRPRNEWSLVEWAKPFIRESR 757
+ L K L E+++ P + R W W +
Sbjct: 303 -VKSLLLK--YLDCRPQDLPREVLTT-NPRRLSIIAESIRDGLATWD--NWKHVNC--DK 354
Query: 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMV--------------DIVREL 803
+ I++ S+ AE +R + L+ + P SA+ P+++ +V +L
Sbjct: 355 LTTIIESSLNVLEPAE--YRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 804 EDAFIIENNASEYMKSIDSI 823
++E E SI SI
Sbjct: 412 HKYSLVEKQPKESTISIPSI 431
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 101/677 (14%), Positives = 194/677 (28%), Gaps = 210/677 (31%)
Query: 61 FPDKKDCRAI---TRPAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIRGTFLN-GDN 116
F D DC+ + + ++ + D ++ + T L+ +
Sbjct: 29 FVDNFDCKDVQDMPKSILSKEEIDHII-----------MSKDAVSGTLRLFWTLLSKQEE 77
Query: 117 -----VETPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCLDK--KDGDPYI 169
VE L ++ L ++P+ TE + + YI+ D+ D +
Sbjct: 78 MVQKFVEEVLRINYKFL--MSPI----KTEQRQPSMMTRM---YIE-QRDRLYNDNQVFA 127
Query: 170 SGLEVRP------------LNDTEYLP-------GQS---ANVLKLVGRYDLGRSDNELS 207
R L + + G++ +V ++
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL----------SYKVQ 177
Query: 208 FRYPDDPFDRIWI-------PKLSPEP-TTFSTSFTTNI---SDNNAKVTVPLQVLQTAL 256
+ F W+ P+ E N SD+++ + + + +Q L
Sbjct: 178 CKMDFKIF---WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 257 TDPNRLMFLHTDLDSGDYNYTL-ILYFLELNDSVKSSGQ-RVFD----ILINNERKKEKF 310
RL+ Y L +L +V+++ F+ IL+ R K+
Sbjct: 235 ---RRLLKSK------PYENCLLVL------LNVQNAKAWNAFNLSCKILLTT-RFKQVT 278
Query: 311 DILALGSNYAKLALNVTANG-----SLNLTLVNVLNGSVFG-PICNAYEILQVRQWVQET 364
D L+ + ++L+ + +L L+ L+ P E+L
Sbjct: 279 DFLS-AATTTHISLDHHSMTLTPDEVKSL-LLKYLDCRPQDLPR----EVLTTNPRR--- 329
Query: 365 DQADVNVI-RKVRDELKKYNKENKVLESWSGDPCRPSTWRGVYCNTRNGSITITGLDLSS 423
+++I +RD W+ V C+ I + L
Sbjct: 330 ----LSIIAESIRD-----------------GLATWDNWKHVNCDKLTTIIESSLNVLEP 368
Query: 424 GQIQGIL-PLSVTGLTHLEKFRGFCGSEKSTHKGILIGIAVCGTF---LFTVAVGIFVVC 479
+ + + LSV F I + + V + V
Sbjct: 369 AEYRKMFDRLSV--------FP----------PSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 480 FYKRKSIAGGKLEGKGYPMTKNLVFSIDSMDDPVKPMPVQIFSL------QYLEAATQQY 533
+K + K SI S+ +K ++L Y T
Sbjct: 411 LHKYSLVEKQP---------KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
Query: 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFEN---ELNFLSA-IRHE---- 585
LI Y + +++ + F + FL IRH+
Sbjct: 462 DDLIPPYLDQYFY-------SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514
Query: 586 ----NLVPLL-------GYCCENDQQILVYPFMSNGSLQDRL--YGEASTR-KTLDWPTR 631
+++ L Y C+ND + Y + N ++ D L E K D
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPK---YERLVN-AILDFLPKIEENLICSKYTDL--- 567
Query: 632 LSIALGAARGLMYLHTF 648
L IAL A ++
Sbjct: 568 LRIALMAEDEAIFEEAH 584
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 7e-09
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 641 GLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTA 698
GL +L + +I+RD+K N++LD K+ADFG K +G F GT
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC----GTP 185
Query: 699 GYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
Y+ PE + Q D ++FGV+L E+++G+ P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 49/282 (17%), Positives = 81/282 (28%), Gaps = 87/282 (30%)
Query: 532 QYKTLIGEGGFGSVYRG-TLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR------- 583
+G G F +V+ + + VA+KV S T +E+ L ++R
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDP 98
Query: 584 -HENLVPLLGY-----------CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
E +V LL C +V+ + + L + S + L P
Sbjct: 99 NREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLK--WIIKSNYQGLPLPCV 148
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL-------------------------- 665
I +GL YLHT +IH D+K NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 666 -----------------------DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLD 702
+ K+AD G + + + T Y
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRS 261
Query: 703 PEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744
E + +D++S + E+ +G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 18/57 (31%), Positives = 25/57 (43%), Gaps = 3/57 (5%)
Query: 388 VLESWSGD-PCRPSTWRGVYCNTRNGSITITGLDLSSGQIQG--ILPLSVTGLTHLE 441
L SW C TW GV C+T + + LDLS + +P S+ L +L
Sbjct: 23 TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 44/231 (19%), Positives = 90/231 (38%), Gaps = 54/231 (23%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV-RSSTSTQGTREFENELNFLSAIR---------- 583
+G G F +V+ + + VA+K+ R T E+E+ L +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 584 -HENLVPLLG---YCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGA 638
+++ LL + N + +V+ + +L + +K L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALI------KKYEHRGIPLIYVKQI 136
Query: 639 AR----GLMYLHTFAGRSVIHRDVKSSNILLDHSMCA------KVADFGFSKYAPQEGDS 688
++ GL Y+H G +IH D+K N+L++ K+AD G + + +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--- 191
Query: 689 GFSLEVRGTAGYLDPE-----YYSTQHLSAKSDVFSFGVVLLEIISGREPL 734
++ ++ T Y PE + +D++S ++ E+I+G + L
Sbjct: 192 -YTNSIQ-TREYRSPEVLLGAPWGC-----GADIWSTACLIFELITG-DFL 234
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 18/59 (30%), Positives = 26/59 (44%), Gaps = 12/59 (20%)
Query: 388 VLESWSG--DPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQGI---LPLSVTGLTHLE 441
+L WS +PC + GV C +T +DLSS + + S+ LT LE
Sbjct: 29 LLPDWSSNKNPCT---FDGVTCRDDK----VTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.4 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.3 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 98.24 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.12 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.05 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.75 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 97.72 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.6 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.07 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 95.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.76 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.28 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 92.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 90.38 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 89.96 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 89.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 89.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.48 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 82.42 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 82.09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 80.2 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-54 Score=466.24 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=215.5
Q ss_pred HHHHHHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeC
Q 002943 525 YLEAATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEN 597 (863)
Q Consensus 525 ~l~~~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 597 (863)
++...+.+|.++||+|+||+||+|.+. +++.||||+++.... ...++|.+|++++++++|||||+++|+|.+.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344445577899999999999999863 467899999875543 3457899999999999999999999999999
Q ss_pred CeeEEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
+..+||||||++|+|.++|+.... ....++|.++++|+.|||+||+|||+ ++||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEE
Confidence 999999999999999999964321 13469999999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 744 (863)
++++++||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||.... ...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHH
Confidence 9999999999999997654443344455679999999999999999999999999999999999 899997643 223
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
+.+.+.. +... ..+.++...+.+|+.+||+.+|++||||.||++.|+..
T Consensus 256 ~~~~i~~----~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRN----RQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHT----TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHc----CCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3333221 1111 11223345688999999999999999999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=463.38 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=207.0
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 45689999999999999864 478899999987777777899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCC-----------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 606 FMSNGSLQDRLYGEAS-----------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
||++|+|.++|+.... ...+++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 9999999999965321 23569999999999999999999999 899999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.... ...+.+.+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~-- 275 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCITQ-- 275 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHHH--
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc--
Confidence 9999997755444444455679999999999999999999999999999999999 999997643 2222222221
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+.. +.. +..+...+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 276 --g~~-----~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 --GRE-----LER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --TCC-----CCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCC-----CCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 110 111 112334688999999999999999999999999988643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=459.68 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=212.6
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 45689999999999999863 477899999987776677899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccC---------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 606 FMSNGSLQDRLYGEA---------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 606 y~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
||++|+|.++|+... .....++|.++++|+.|||+||+|||+ ++||||||||+||||++++.+||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCc
Confidence 999999999996532 234579999999999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
|+|+...............||+.|||||++.+..++.|+|||||||+||||+| |+.||..... ..+...+. .
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i~----~ 245 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT----Q 245 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHH----H
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----c
Confidence 99987654333222334569999999999999999999999999999999999 9999976432 22222222 1
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+... ..+..+..++.+|+.+||+.+|++||||+||++.|+++..
T Consensus 246 ~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 246 GRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2111 1112233468899999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=445.22 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=200.6
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|+||+||+|++.+ .||||+++... .+..++|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 456899999999999999754 69999886543 3345789999999999999999999999865 568999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.++|+.. ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++++||+|||+|+.........
T Consensus 116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999643 3469999999999999999999999 899999999999999999999999999999775444333
Q ss_pred ceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 690 FSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|||||++.+ +.++.|+|||||||+||||+||+.||...... ..+...+.... ..|.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~--------~~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGY--------ASPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTC--------CCCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCC--------CCCCc
Confidence 4455679999999999964 46899999999999999999999999764321 11111111111 11211
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
. ....++...+.+|+.+||+.+|++||||.||++.|+.+.
T Consensus 260 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 260 S-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp T-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred c-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 112233456889999999999999999999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=435.95 Aligned_cols=269 Identities=26% Similarity=0.350 Sum_probs=201.5
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC----eeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND----QQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~ey~~ 608 (863)
+.++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+.+ ..+||||||+
T Consensus 7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 468999999999999998 589999999865422 1223445666677899999999999998764 5799999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-----CCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-----GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
+|+|.++|+. ..++|..+++++.|+|+||+|||+.+ .++||||||||+||||++++++||+|||+|+...
T Consensus 85 ~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 85 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999953 35899999999999999999999842 3589999999999999999999999999998765
Q ss_pred CCCCC--CceeeeecCCCCCCccccccC------CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh-----hh
Q 002943 684 QEGDS--GFSLEVRGTAGYLDPEYYSTQ------HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW-----AK 750 (863)
Q Consensus 684 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~-----~~ 750 (863)
..... .......||+.|||||++.+. .++.|+|||||||+||||+||+.|+........ ....+ ..
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~~~~~~~ 238 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVPSDPSV 238 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSCSSCCH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhcccccchH
Confidence 43321 122345799999999999764 367899999999999999999888754321110 00000 00
Q ss_pred hcccccccccccCCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 751 PFIRESRIDEIVDPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 751 ~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..+......+.++|.+.... ..++...+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00000011122233332221 235667889999999999999999999999999988643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=446.14 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=212.4
Q ss_pred HHHhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCc-ccccceeeeEeeC-Ce
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRH-ENLVPLLGYCCEN-DQ 599 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~-~~ 599 (863)
..+.+.+.||+|+||+||+|.+. .++.||||++...... ..++|.+|+++|.+++| ||||+++|+|.+. +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 34455689999999999999853 2468999998765433 35679999999999965 8999999999765 56
Q ss_pred eEEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 600 QILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
.+||||||++|+|.++|+.... ....++|.+++.++.|||+||+|||+ ++||||||||+||||++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCC
Confidence 8999999999999999965321 23468999999999999999999999 89999999999999999
Q ss_pred CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhH
Q 002943 668 SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLV 746 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 746 (863)
++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||....... .+.
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~~~ 298 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC 298 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 99999999999998765544434455679999999999999999999999999999999998 999997643211 122
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
. .+.++.. +..... +..++.+++.+||+.||++||||.||++.|+.+++.
T Consensus 299 ~----~i~~g~~-----~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 299 R----RLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp H----HHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHcCCC-----CCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 2 1222211 111112 234588999999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=416.01 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=194.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ 604 (863)
.|.++||+|+||+||+|.. .+++.||||++.... ....+.|.+|+++|++++|||||+++++|.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 3567899999999999985 468999999876543 2334679999999999999999999999865 34579999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeeccCcccCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAP 683 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~ 683 (863)
|||++|+|.+++.. ...+++.....++.||+.||+|||+.. ++||||||||+||||+ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999953 346899999999999999999999821 3399999999999997 48999999999998643
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
. .......||+.|||||.+.+ +++.++|||||||+||||+||+.||..... ...+...+.. +....
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~----~~~~~--- 249 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS----GVKPA--- 249 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTT----TCCCG---
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHc----CCCCC---
Confidence 2 23445679999999998865 699999999999999999999999975321 1112222111 11100
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 250 -~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 -SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122 24788999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=421.22 Aligned_cols=250 Identities=24% Similarity=0.251 Sum_probs=201.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.++||+|+||+||+|+. .+|+.||||+++... .+.+|+++|++++|||||++++++.+++..+||||||++|+
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 347899999999999995 469999999987542 23579999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCCCCCC-
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEGDSG- 689 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~~~~- 689 (863)
|.++|.. ...+++.+...++.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+.........
T Consensus 137 L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 137 LGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999953 3469999999999999999999999 8999999999999999887 69999999999775432211
Q ss_pred --ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 690 --FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 690 --~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|||||.+.+..++.++|||||||+||||+||+.||........ ...+... ..... .+.
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~--~~~~~-----~~~ 279 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASE--PPPIR-----EIP 279 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHS--CCGGG-----GSC
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcC--CCCch-----hcC
Confidence 12335799999999999999999999999999999999999999976543221 1111110 00000 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.. ....+.+++.+||+.||++|||+.|+++.|..+++
T Consensus 280 ~~----~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 280 PS----CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc----CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 12 23457889999999999999999999999988774
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=422.23 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=203.5
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.++||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 46899999999999996 47999999998777666677899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCcee
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
.+++.. ..+++.+...++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.... ....
T Consensus 159 ~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~ 228 (346)
T 4fih_A 159 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 228 (346)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccc
Confidence 999843 358999999999999999999999 899999999999999999999999999998765432 2234
Q ss_pred eeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcH
Q 002943 693 EVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 772 (863)
...||+.|||||++.+..|+.++|||||||+||||++|+.||.... ...+...+.. + ..+.+. ...
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~----~-----~~~~~~--~~~ 294 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRD----N-----LPPRLK--NLH 294 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----S-----SCCCCS--CGG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHc----C-----CCCCCC--ccc
Confidence 5679999999999999999999999999999999999999997542 1222222111 1 111111 111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 773 EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 773 ~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12345789999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=429.15 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=196.8
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++.+++..+||||||+
T Consensus 27 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3458999999999999985 5799999999875532 335679999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.++|... ....+++.+.+.++.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+..... .
T Consensus 107 gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 107 GGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp TCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred CCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 99999999543 23457888999999999999999999 89999999999999999999999999999976432 1
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......||+.|||||.+.+..|+.++|||||||+||||+||+.||.... ...+...+ .. +.. +.+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i---~~-~~~-----~~~~~ 247 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKI---IS-GSF-----PPVSL 247 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH---HH-TCC-----CCCCT
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHH---Hc-CCC-----CCCCc
Confidence 12234579999999999999999999999999999999999999997542 11222111 11 111 11112
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 35789999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=410.89 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=205.9
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 45568999999999999985 57999999998653 234457799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 114 ~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999953 3469999999999999999999999 899999999999999999999999999999876554
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.........||+.|||||.+.+..++.++||||+||+||||+||+.||.... ...+.+.+.. +. ..+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~----~~------~~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIK----LE------YDF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----TC------CCC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----CC------CCC
Confidence 4444556789999999999999999999999999999999999999997532 2222221111 11 112
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
....+ .++.+++.+|++.||++|||+.|++
T Consensus 254 p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 22233 3478899999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=423.08 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=203.9
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.++||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||++|+
T Consensus 155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 347899999999999995 4699999999887766677789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ..+++.+...++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 235 L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~ 304 (423)
T 4fie_A 235 LTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 304 (423)
T ss_dssp HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCB
T ss_pred HHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccc
Confidence 9999843 358999999999999999999999 899999999999999999999999999998765432 223
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+...+.. + ..+.+.. .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~----~-----~~~~~~~--~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRD----N-----LPPRLKN--L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH----S-----CCCCCSC--T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHc----C-----CCCCCcc--c
Confidence 45679999999999999999999999999999999999999997542 1222222111 1 1111111 0
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111235788999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=397.97 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=187.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||+||+|.. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 34568999999999999985 579999999986543 23346799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+ +|+|.+++.. ...+++.+...++.|++.||+|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 95 ~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 95 A-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp C-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred C-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9 7899999953 3469999999999999999999999 899999999999999999999999999998764322
Q ss_pred CCCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......||+.|||||.+.+..+ +.++||||+||++|||+||+.||.... ...+.+.+. .+. ..
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~----~~~------~~ 230 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNIS----NGV------YT 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HTC------CC
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----cCC------CC
Confidence 2334679999999999998876 579999999999999999999997532 111222111 111 11
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+....+ ..+.+++.+|++.||++|||+.|+++
T Consensus 231 ~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111222 34788999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=404.56 Aligned_cols=282 Identities=45% Similarity=0.783 Sum_probs=248.1
Q ss_pred HHHHHHhh--cceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 526 LEAATQQY--KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 526 l~~~t~~f--~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
++..+.+| .+.||+|+||.||+|...+|+.||||++........+.+.+|++++++++||||++++++|.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 33334444 4789999999999999888999999998877777778899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++.........++|..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999996554445579999999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
............||..|+|||.+.+..++.++||||||+++|||++|+.||....+.....+.+|.......+.+..+++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 43333334455689999999999999999999999999999999999999988776666777888777777777888888
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
+.+......+....+.+++.+|++.+|++||++.||++.|+.++..+
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 88887788889999999999999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=405.41 Aligned_cols=241 Identities=22% Similarity=0.268 Sum_probs=189.8
Q ss_pred HhhcceecccCcEEEEEEec----CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
+.+.+.||+|+||+||+|+. ..++.||||+++... ......+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 34568999999999999974 247899999886543 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
|||++|+|.+++.. ...+++.+...++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999953 3469999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. .......||+.|||||.+.+..++.++|||||||+||||+||+.||.... ...+...+.. +. .
T Consensus 179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~----~~------~ 243 (304)
T 3ubd_A 179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILK----AK------L 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CC------C
T ss_pred CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHc----CC------C
Confidence 22 22334679999999999999999999999999999999999999997643 1122221111 11 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
.+....+ ..+.+++.+||+.||++|||+.
T Consensus 244 ~~p~~~s----~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 244 GMPQFLS----PEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSTTCS
T ss_pred CCCCcCC----HHHHHHHHHHcccCHHHCCCCC
Confidence 1111222 3578899999999999999953
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=394.96 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=184.6
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCC----------
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCEND---------- 598 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---------- 598 (863)
+.+.+.||+|+||+||+|+. .+|+.||||++.....+ ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 34468999999999999985 47999999988655433 3467899999999999999999999987654
Q ss_pred --eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 599 --QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 599 --~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
..++|||||++|+|.+++.... .....++...+.++.||+.||+|||+ ++|+||||||+||||+.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996432 22345677788999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCCCC----------ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH
Q 002943 677 GFSKYAPQEGDSG----------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746 (863)
Q Consensus 677 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 746 (863)
|+|+......... ..+...||+.|||||.+.+..++.++|||||||+||||++ ||... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHH
Confidence 9999775432211 1233569999999999999999999999999999999996 76431 1111
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ...... |. ...+....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~-~~~~~~-----p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLTD-VRNLKF-----PP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH-HHTTCC-----CH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhcCCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10000 011110 00 01122334678999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=394.19 Aligned_cols=290 Identities=40% Similarity=0.743 Sum_probs=251.0
Q ss_pred ccccCHHHHHHHHHhhc--ceecccCcEEEEEEecCCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeE
Q 002943 518 VQIFSLQYLEAATQQYK--TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 518 ~~~~~~~~l~~~t~~f~--~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
...+++.+++..+.+|. +.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||++++++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 46788899988888774 89999999999999988899999999876543 2344789999999999999999999999
Q ss_pred eeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 595 ~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
...+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997765556679999999999999999999999444499999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC--CCCcchhHHhhhhc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR--PRNEWSLVEWAKPF 752 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~--~~~~~~l~~~~~~~ 752 (863)
|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||+... ......+.+|+...
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998764332 222334569999999999998899999999999999999999999996321 23345678888888
Q ss_pred ccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 753 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.....+..+.+..+......+....+.+++.+|++.+|++|||+.||++.|++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 88888888999988888889999999999999999999999999999999997543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=388.61 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=194.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~L 602 (863)
.+.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++... +..+|
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 3458999999999999985 5799999999865433 2346788999999999999999999987643 57899
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|||||+ |+|.+++. ....+++.....++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+
T Consensus 137 vmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 137 VLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 999995 78999994 34579999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCC--CCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---cc
Q 002943 683 PQEG--DSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ES 756 (863)
Q Consensus 683 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~ 756 (863)
.... .........||+.|||||++.+. .++.++||||+||+++||++|+.||.+... ......+..... ..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCChH
Confidence 4322 12233456799999999998875 569999999999999999999999976432 111111111000 00
Q ss_pred c--------cccc---cCCccCCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 R--------IDEI---VDPSIKGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~--------~~~i---~d~~l~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. .... +.+...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000 000000000 0011235789999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=376.21 Aligned_cols=194 Identities=27% Similarity=0.407 Sum_probs=164.9
Q ss_pred hhcceecccCcEEEEEEec----CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.++||+|+||+||+|+. ..++.||||++.... ...++.+|+++|+++ +|||||++++++.+.+..++||||
T Consensus 24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 3458999999999999974 246789999876543 345688999999998 699999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQE 685 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~ 685 (863)
+++|+|.+++. .+++.+...++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 102 ~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 102 LEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp CCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred CCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999982 48899999999999999999999 899999999999999877 79999999999865432
Q ss_pred CC--------------------------CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 686 GD--------------------------SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 686 ~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
.. ........||+.|||||.+.+. .++.++||||+||+++||+||+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 0112234699999999999775 5899999999999999999999999654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.61 Aligned_cols=281 Identities=35% Similarity=0.604 Sum_probs=229.1
Q ss_pred ccccCHHHHHHHHHhhc--------ceecccCcEEEEEEecCCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCCcc
Q 002943 518 VQIFSLQYLEAATQQYK--------TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS----TQGTREFENELNFLSAIRHE 585 (863)
Q Consensus 518 ~~~~~~~~l~~~t~~f~--------~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H~ 585 (863)
...|++.+++.++.+|. +.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 46799999999999985 5699999999999997 68899999876532 23356789999999999999
Q ss_pred cccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 586 niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999996432 23569999999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchh
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 745 (863)
++++.+||+|||+++...............||..|+|||.+.+ .++.++||||||+++|||++|+.||....... .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 9999999999999987654333222334568999999998865 57899999999999999999999998654322 12
Q ss_pred HHhhhhcc-cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 746 VEWAKPFI-RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 746 ~~~~~~~~-~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+..... ....+.+.+++.+. .........+.+++.+|++.+|++||++.||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22211111 11223444555543 345667788999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=398.50 Aligned_cols=249 Identities=21% Similarity=0.305 Sum_probs=204.1
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 34568999999999999985 47999999998776655667889999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC--CeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS--MCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~--~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.++|.. ....+++.+...++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 239 g~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 239 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999999943 23569999999999999999999999 899999999999999854 89999999999987533
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|||||++.+..++.++||||+||+||||++|+.||..... ..+...+... ... +++...
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~--~~~----~~~~~~ 380 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSC--DWN----MDDSAF 380 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTT--CCC----CCSGGG
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhC--CCC----CCcccc
Confidence 223456799999999999999999999999999999999999999976432 1222211110 000 111111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+ ..+.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222 34778999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=378.08 Aligned_cols=260 Identities=24% Similarity=0.415 Sum_probs=209.9
Q ss_pred hhcceecccCcEEEEEEec--------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTL--------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~--------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 601 (863)
.+.+.||+|+||.||+|.. .++..||||++..... ...+++.+|+++++++ +||||++++++|...+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 4468999999999999974 2456799999876533 3346799999999999 8999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 602 LVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
+||||+++|+|.+++..... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCC
Confidence 99999999999999965321 12458999999999999999999999 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~~~~~ 317 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFKL 317 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999987654333222333457889999999999999999999999999999999 9999976432 112221
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
+.. +.. +.. +..+...+.+++.+||+.+|++||++.|+++.|+.++...
T Consensus 318 ~~~----~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 318 LKE----GHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHT----TCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hhc----CCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111 110 111 1122345889999999999999999999999999988543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=366.62 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=207.5
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.++||+|+||+||+|.. .+++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 3468999999999999996 468999999887766666788999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC-
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG- 689 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~- 689 (863)
+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 93 TLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp BHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999542 3468999999999999999999999 899999999999999999999999999998764332211
Q ss_pred -----------ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 690 -----------FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 690 -----------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
......||+.|+|||.+.+..++.++||||||+++|||++|..|+.......... .. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-~~---------~~ 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-GL---------NV 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-SB---------CH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-hh---------hh
Confidence 0113569999999999999999999999999999999999999987543221100 00 00
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....++..... ....+.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 237 ~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 RGFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111111111 1234788999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.46 Aligned_cols=270 Identities=24% Similarity=0.330 Sum_probs=205.8
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC----eeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND----QQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~ey~ 607 (863)
.+.++||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++||||+
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence 34689999999999999875 7899999986543 23345677999999999999999999998754 369999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-------CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-------GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++|+|.+++.. ..++|..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 105 EKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999999953 34899999999999999999999820 1299999999999999999999999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccC-----CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-----HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
...............||+.|+|||.+.+. .++.++|||||||++|||+||+.||.....................
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 76544333333345799999999999763 4566889999999999999999999865432222211111110000
Q ss_pred ccc-----ccccCCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 756 SRI-----DEIVDPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 756 ~~~-----~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..+ .....+.+.... ...+...+.+++.+||+.+|++|||+.||++.|+++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 011111111111 12456679999999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=390.89 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=190.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHH---HHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFE---NELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~---~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.++||+|+||+||+|+. .+|+.||||++.+.. ......+. .++++++.++|||||++++++.+.+..+|||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 3458999999999999995 469999999886432 22222333 4467778889999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
|||++|+|.++|.. ...+++.....++.||+.||+|||+ ++||||||||+||||+.++++||+|||+|+....
T Consensus 272 Ey~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999953 3469999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. .....||+.|||||++.. ..|+.++|+||+||+||||++|+.||......+...+...... . .
T Consensus 345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~------~ 410 (689)
T 3v5w_A 345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M------A 410 (689)
T ss_dssp CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----C------C
T ss_pred CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----C------C
Confidence 32 234579999999999975 5799999999999999999999999975433222112111111 0 1
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCC
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPS 795 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs 795 (863)
..+....+ ..+.+|+.+|++.||++|++
T Consensus 411 ~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 411 VELPDSFS----PELRSLLEGLLQRDVNRRLG 438 (689)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSCGGGCTT
T ss_pred CCCCccCC----HHHHHHHHHHccCCHhHCCC
Confidence 11222233 34789999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=367.66 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=205.3
Q ss_pred HhhcceecccCcEEEEEEecC----CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|... .+..||||++.... ....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 344589999999999999964 34569999987653 3345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 131 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 131 YMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred CCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999532 3469999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCc-eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDSGF-SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
..... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+.... .
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~---------~ 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGY---------R 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTC---------C
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC---------C
Confidence 22211 222346778999999999999999999999999999999 9999975431 12222111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
. .........+.+++.+||+.+|++||++.||++.|+.++..
T Consensus 273 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 L----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0 11112234588999999999999999999999999998743
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=375.64 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=196.5
Q ss_pred HhhcceecccCcEEEEEEecC----CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|+.. ++..||||++.... ....++|.+|++++++++||||++++++|.+.+..++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 344689999999999999864 57789999987653 3345689999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 127 ~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 127 YMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999532 3468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCc-eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDSGF-SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.+.+.....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~--------- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYR--------- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEE---------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC---------
Confidence 22111 122345788999999999999999999999999999998 9999975431 122222111110
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..........+.+++.+|++.+|++||+|.||+++|+.++..
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 011112334688999999999999999999999999998743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.40 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=198.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||+||+|+. +|+.||||++..... ...++|.+|++++++++||||+++++++...+..++||||+++
T Consensus 40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 3p86_A 40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118 (309)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence 4468999999999999987 688999998866543 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 119 ~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~- 193 (309)
T 3p86_A 119 GSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF- 193 (309)
T ss_dssp CBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-
Confidence 99999995421 12349999999999999999999999 67 9999999999999999999999999998653321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... ...+.
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~--------~~~~~ 261 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCK--------RLEIP 261 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCC--------CCCCC
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC--------CCCCC
Confidence 122345699999999999999999999999999999999999999976432 111111111000 01111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
... ...+.+++.+||+.+|++||++.|+++.|+.++.
T Consensus 262 ~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 262 RNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 122 2358899999999999999999999999998874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=378.39 Aligned_cols=254 Identities=27% Similarity=0.357 Sum_probs=205.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|... +++.||||++..... ...++|.+|+++|++++||||++++++|...+..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 44689999999999999975 789999998875432 2345789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 197 g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 197 GDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999532 3468999999999999999999999 899999999999999999999999999998653321111
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....+.+.. +.. .
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~----~~~-----~---- 334 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEK----GGR-----L---- 334 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHT----TCC-----C----
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC-----C----
Confidence 1112235778999999998999999999999999999998 9999976431 122222211 110 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+..+...+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 011112345889999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.83 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=212.4
Q ss_pred cccCHHHHHHHHHh----------h--cceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc
Q 002943 519 QIFSLQYLEAATQQ----------Y--KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE 585 (863)
Q Consensus 519 ~~~~~~~l~~~t~~----------f--~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ 585 (863)
..+++++++.++.. + .+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45888999888864 2 368999999999999965 7999999998877777778899999999999999
Q ss_pred cccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 586 niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
||+++++++...+..++||||+++|+|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 99999999999999999999999999999983 2358999999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchh
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSL 745 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l 745 (863)
+.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH
Confidence 9999999999999987654321 22345699999999999999999999999999999999999999975321 111
Q ss_pred HHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 746 VEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 746 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...... . ..+.+.. .......+.+++.+|++.+|++||++.|+++
T Consensus 250 ~~~~~~----~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRLRD----S-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHH----S-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhc----C-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1 1111110 1112235788999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.36 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred HhhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 603 (863)
+.+.+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||++++++|... ...++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 34568999999999999984 36889999998876666667899999999999999999999998654 568999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999543 3458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc----ccc
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE----SRI 758 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~----~~~ 758 (863)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...+........ ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCTHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCccccchhHHHH
Confidence 43221 112233467789999999999999999999999999999999998864210 011100000000 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.+.+...............+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0001111111112223346889999999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.30 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=206.4
Q ss_pred hhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCe-eEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQ-QIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~-~~L 602 (863)
.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||++++++|.+.+. .++
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i 104 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 104 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence 3458999999999999962 3568999999876433 3346799999999999 79999999999987654 899
Q ss_pred EeecCCCCChhhhhhccCCC------------------------------------------------------------
Q 002943 603 VYPFMSNGSLQDRLYGEAST------------------------------------------------------------ 622 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~------------------------------------------------------------ 622 (863)
||||+++|+|.+++......
T Consensus 105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (359)
T 3vhe_A 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED 184 (359)
T ss_dssp EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence 99999999999999654321
Q ss_pred --CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCC
Q 002943 623 --RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGY 700 (863)
Q Consensus 623 --~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 700 (863)
...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...............||..|
T Consensus 185 ~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 185 LYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp TTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred hhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 1228999999999999999999999 89999999999999999999999999999876544333334456689999
Q ss_pred CCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHH
Q 002943 701 LDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMV 779 (863)
Q Consensus 701 ~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 779 (863)
+|||.+.+..++.++|||||||++|||++ |+.||....... .+..... .+. ........ ...+.
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~----~~~-----~~~~~~~~----~~~l~ 326 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGT-----RMRAPDYT----TPEMY 326 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHH----HTC-----CCCCCTTC----CHHHH
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHH----cCC-----CCCCCCCC----CHHHH
Confidence 99999999999999999999999999998 999997643211 1111111 111 01111112 23588
Q ss_pred HHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 780 EVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 780 ~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+++.+|++.+|++||++.||++.|++++.
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.28 Aligned_cols=254 Identities=21% Similarity=0.367 Sum_probs=197.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCE----EEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQE----VAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~----vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||+||+|... +|+. ||+|.+.... ....++|.+|++++++++||||++++++|...+ .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 44689999999999999853 4543 5888775433 345678999999999999999999999998765 778999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 97 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred ecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999643 3468999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~----------- 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGE----------- 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTC-----------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHHcCC-----------
Confidence 33333344557889999999999999999999999999999999 99999764321 1222211110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.......+...+.+++.+||+.+|++||+|.|+++.|+.+..
T Consensus 237 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001111223468899999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=369.66 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=211.2
Q ss_pred HhhcceecccCcEEEEEEec--------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCee
Q 002943 531 QQYKTLIGEGGFGSVYRGTL--------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~--------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 600 (863)
+.+.+.||+|+||.||+|+. ..+..||||++..... ...+++.+|+++++++ +||||++++++|...+..
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 150 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence 34568999999999999984 2346799998876533 3346789999999999 899999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 601 ILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 227 (382)
T ss_dssp EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTT
T ss_pred EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCC
Confidence 999999999999999965431 12469999999999999999999999 899999999999999999
Q ss_pred CeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHH
Q 002943 669 MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 669 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 747 (863)
+.+||+|||+++...............+|..|+|||.+.+..++.++|||||||+++||++ |+.||..... ..+.+
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~~~~ 304 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFK 304 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence 9999999999987654433333344567889999999999999999999999999999999 9999975431 12222
Q ss_pred hhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 748 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
.+.. +. .+..... ....+.+++.+||+.+|++||++.||++.|+.++....
T Consensus 305 ~~~~----~~-----~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 305 LLKE----GH-----RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHT----TC-----CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHc----CC-----CCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2211 11 0111111 23458899999999999999999999999999985543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=386.91 Aligned_cols=258 Identities=28% Similarity=0.390 Sum_probs=210.9
Q ss_pred HHhhcceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.++||+|+||.||+|.+.. +..||||++.... ...++|.+|+++|++++||||++++++|...+..++|||||+
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 34556899999999999999764 8899999987653 346789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 300 ~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 300 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence 99999999643 23568999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......++..|+|||.+....++.++|||||||+||||+| |+.||..... ..+.+.+.... .
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-------------~ 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDY-------------R 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTC-------------C
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-------------C
Confidence 11122346788999999999999999999999999999999 9999976432 12222221111 0
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
......+...+.+++.+||+.+|++||+|.||++.|+.++...
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 0111223346889999999999999999999999999887543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=355.87 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=201.9
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (297)
T 3fxz_A 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (297)
T ss_dssp CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCC
Confidence 347899999999999985 5799999999877666667789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 104 L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 173 (297)
T 3fxz_A 104 LTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (297)
T ss_dssp HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CB
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--cc
Confidence 9999943 258999999999999999999999 8999999999999999999999999999987654322 23
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .....+. .. + ...
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~---~~~~~~~-~~-----~--~~~ 239 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALY---LIATNGT-PE-----L--QNP 239 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHHCS-CC-----C--SCG
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC-CC-----C--CCc
Confidence 3456999999999999999999999999999999999999999754311 1111 0000000 00 0 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 122345789999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=380.47 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=206.4
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|...++..||||++.... ...++|.+|+++|++++||||+++++++. .+..++||||+++|+
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred EEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 4568999999999999999889999999987643 45678999999999999999999999986 667899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 269 L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~ 342 (454)
T 1qcf_A 269 LLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR 342 (454)
T ss_dssp HHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTT
T ss_pred HHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-ecc
Confidence 999995421 2358899999999999999999999 8999999999999999999999999999987643211 111
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....+|..|+|||.+....++.++|||||||+||||+| |+.||..... ..+.+.+....+ . ..
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~---~----------~~ 406 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYR---M----------PR 406 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCC---C----------CC
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC---C----------CC
Confidence 22346788999999999999999999999999999999 9999976431 122222211110 0 01
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+..+...+.+++.+||+.+|++||||.+|++.|+++..
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11233468899999999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=357.09 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=209.8
Q ss_pred HhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34568999999999999974 3578999999875543 3356789999999999 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC--------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 603 VYPFMSNGSLQDRLYGEAS--------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
||||+++|+|.+++..... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCC
Confidence 9999999999999965421 12358999999999999999999999 899999999999999999
Q ss_pred CeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHH
Q 002943 669 MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 669 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 747 (863)
+.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||....... .+..
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~ 259 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYK 259 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHH
Confidence 9999999999987765433323334557889999999999999999999999999999999 999997643211 1111
Q ss_pred hhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 748 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...... .+..... ....+.+++.+|++.+|.+||++.|+++.|++++.
T Consensus 260 ~~~~~~---------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 260 MIKEGF---------RMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHTC---------CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCC---------CCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111110 0111111 23458899999999999999999999999998874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=350.67 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=206.6
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 4458999999999999998889999999987543 345679999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 92 L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 164 (269)
T 4hcu_A 92 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 164 (269)
T ss_dssp HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred HHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccc
Confidence 9999953 23468999999999999999999999 8999999999999999999999999999986543211 111
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....+|..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+...... .+......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~---------~~~~~~~~ 232 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF---------RLYKPRLA 232 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTC---------CCCCCTTS
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCc---------cCCCCCcC
Confidence 22346778999999999999999999999999999999 9999976431 11222111110 01111111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 233 ----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 ----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 2358899999999999999999999999998863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=357.78 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=208.0
Q ss_pred hhcceecccCcEEEEEEec------CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3458999999999999975 345889999987543 234467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCC--------------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeE
Q 002943 605 PFMSNGSLQDRLYGEAS--------------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNIL 664 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NIL 664 (863)
||+++|+|.+++..... ....+++..++.++.|+++||+|||+ .+|+||||||+|||
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIl 182 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNIL 182 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEE
Confidence 99999999999965432 12358999999999999999999999 89999999999999
Q ss_pred ecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcc
Q 002943 665 LDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEW 743 (863)
Q Consensus 665 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~ 743 (863)
+++++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--- 259 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE--- 259 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987654332222233457888999999999899999999999999999999 99999764321
Q ss_pred hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 744 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+.+.+.. +. .+..... ....+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 260 ~~~~~~~~----~~-----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 RLFNLLKT----GH-----RMERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GHHHHHHT----TC-----CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhc----CC-----cCCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12222111 11 0111112 23458899999999999999999999999998874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=371.22 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=207.2
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|+||.||+|.+. +++.||||++.... .....++.+|+.++++++||||+++++++...+..++|
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 345689999999999999843 46789999986543 34456789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccC---CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---eEEEeecc
Q 002943 604 YPFMSNGSLQDRLYGEA---STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVADFG 677 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFG 677 (863)
|||+++|+|.+++.... .....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999996543 223568999999999999999999999 8999999999999999544 59999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+.+.+.....
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGGR-- 304 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCC--
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC--
Confidence 9975433222222334567899999999999999999999999999999998 999997643 1222222221110
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+.. .......+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 305 -------~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 -------MDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 001 112233588999999999999999999999999988643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=361.97 Aligned_cols=261 Identities=24% Similarity=0.379 Sum_probs=206.5
Q ss_pred HhhcceecccCcEEEEEEec------CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTS-TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 34568999999999999985 245689999886543 33457899999999999 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCC-------------------CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCe
Q 002943 603 VYPFMSNGSLQDRLYGEAST-------------------RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNI 663 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NI 663 (863)
||||+++|+|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhE
Confidence 99999999999999653211 1348999999999999999999999 8999999999999
Q ss_pred EecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCc
Q 002943 664 LLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNE 742 (863)
Q Consensus 664 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 742 (863)
|++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 282 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 282 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH-
Confidence 999999999999999987654433333334567889999999999999999999999999999998 999997653211
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.+........ .+.. +......+.+++.+||+.+|.+||++.|+++.|+.++..
T Consensus 283 -~~~~~~~~~~---------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 283 -NFYKLIQNGF---------KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp -HHHHHHHTTC---------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -HHHHHHhcCC---------CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1222211110 0111 111234588999999999999999999999999988743
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.21 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=194.2
Q ss_pred HhhcceecccCcEEEEEEecCCC----CEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCee----
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDG----QEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQ---- 600 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g----~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 600 (863)
+.+.+.||+|+||.||+|..... ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 34568999999999999997543 27999988765 334457899999999999999999999999877665
Q ss_pred --EEEeecCCCCChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 601 --ILVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 601 --~LV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999995432 222368999999999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...... .
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~---~ 255 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNYLIG---G 255 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT---T
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHHHhc---C
Confidence 99987654433333334557889999999999999999999999999999999 99999764321 12221111 0
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.. .. ........+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 256 ~~------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 256 NR------LK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp CC------CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------CC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 00 111223458899999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=373.12 Aligned_cols=248 Identities=30% Similarity=0.442 Sum_probs=203.0
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC-eeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND-QQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... |+.||||+++... ..+.|.+|+++|++++||||++++++|.+.+ ..++|||||++|
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred EEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 34589999999999999985 7899999987643 4578999999999999999999999987765 789999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 273 ~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 273 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp BHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 999999643 22347899999999999999999999 899999999999999999999999999998543221
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+.. +. .. .
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~----~~-----~~----~ 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----GY-----KM----D 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHT----TC-----CC----C
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CC-----CC----C
Confidence 12357889999999999999999999999999999998 999997654322 2222111 10 00 1
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+..+...+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111233468899999999999999999999999998763
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=362.70 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=206.5
Q ss_pred hcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.||+|+||.||+|... +++.||||++..... ...+.|.+|++++++++||||++++++|...+..++|||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence 4588999999999999864 357899999876533 335679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCC--------------------CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 606 FMSNGSLQDRLYGEAST--------------------RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
|+++|+|.+++...... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEE
Confidence 99999999999653211 2579999999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~ 744 (863)
+.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~ 284 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH---EE 284 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HH
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh---HH
Confidence 9999999999999986543322222334568899999999999999999999999999999999 9999975421 11
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+...+ ..+... ..... ....+.+++.+||+.+|++||++.||++.|+++..
T Consensus 285 ~~~~~----~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 285 VIYYV----RDGNIL-----ACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHH----HTTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHH----hCCCcC-----CCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 22211 111111 11112 23458899999999999999999999999998863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=376.56 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=201.8
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|...++..||||++.... ...++|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 4568999999999999999888899999987654 345789999999999999999999999876 67899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 265 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~ 338 (452)
T 1fmk_A 265 LLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTAR 338 (452)
T ss_dssp HHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecc
Confidence 99999532 12458999999999999999999999 899999999999999999999999999998764322 1122
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+.+.... + . ..
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~---~------~----~~ 402 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGY---R------M----PC 402 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTC---C------C----CC
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC---C------C----CC
Confidence 23457889999999999999999999999999999999 9999976432 11222211110 0 0 11
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+..+...+.+++.+||+.+|++|||+.+|++.|++++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11233468899999999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=351.51 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=204.1
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||++...++..||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 4468999999999999999888899999987553 345789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 106 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 178 (283)
T 3gen_A 106 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 178 (283)
T ss_dssp HHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HST
T ss_pred HHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-ccc
Confidence 99999542 3468999999999999999999999 8999999999999999999999999999986543211 111
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+.+.... ........
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~---------~~~~~~~~ 246 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGL---------RLYRPHLA 246 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTC---------CCCCCTTC
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhccc---------CCCCCCcC
Confidence 22346778999999999999999999999999999998 9999976432 11111111110 01111111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 247 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 247 ----SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 2358899999999999999999999999998874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.23 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=201.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCE----EEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQE----VAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~----vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||.||+|... +++. ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++|+|
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 34589999999999999853 4543 7888765443 344567889999999999999999999986 566889999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 95 YLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred eCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999542 3579999999999999999999999 89999999999999999999999999999987655
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........||..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+.+..... ...+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~------~~~~ 239 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEKGER------LAQP 239 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHTTCB------CCCC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHcCCC------CCCC
Confidence 44444455678899999999999999999999999999999999 99999864422 22222111100 0000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
. .....+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 240 ~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 240 Q-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp T-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred C-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 011236789999999999999999999999998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=350.70 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=206.2
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|...++..||||++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 45689999999999999998888999999875533 45679999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 90 L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~ 162 (268)
T 3sxs_A 90 LLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSS 162 (268)
T ss_dssp HHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EEC
T ss_pred HHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcc
Confidence 99999543 3468999999999999999999999 8999999999999999999999999999986643321 112
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....+|..|+|||.+.+..++.++||||||++++||++ |+.||..... ......... +. ....+ ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~~--~~~~~---~~~ 230 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQ----GH--RLYRP---HLA 230 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHT----TC--CCCCC---TTS
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHc----CC--CCCCC---CcC
Confidence 23346778999999998899999999999999999999 9999975432 111111111 00 00111 111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...+.+++.+|++.+|++|||+.|+++.|+.+..
T Consensus 231 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 ----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2358899999999999999999999999988753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.49 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=197.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhc--CCcccccceeeeEeeC----CeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSA--IRHENLVPLLGYCCEN----DQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~LV~e 605 (863)
.+.+.||+|+||+||+|+. +|+.||||++... ..+.+..|.+++.. ++||||+++++++... ...++|||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred EEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 3468999999999999998 6899999988643 34556667777666 7999999999997653 45789999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-----CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-----GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
|+++|+|.+++. ...+++..+++++.|++.||+|||+.. +++|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 87 YHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 999999999993 246999999999999999999999211 2899999999999999999999999999997
Q ss_pred cCCCCCCCC--ceeeeecCCCCCCccccccC------CCCcccceechhhHHHHHHhC----------CCCCCCCCCCCc
Q 002943 681 YAPQEGDSG--FSLEVRGTAGYLDPEYYSTQ------HLSAKSDVFSFGVVLLEIISG----------REPLNTRRPRNE 742 (863)
Q Consensus 681 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~SfGvvl~ElltG----------~~p~~~~~~~~~ 742 (863)
......... ......||+.|+|||.+.+. .++.++|||||||++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 654322211 11234699999999999876 445799999999999999999 777765433221
Q ss_pred chhHHhhhhcccccccccccCCccCC-CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKG-GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~-~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
............. ..+.+.. .........+.+++.+||+.+|++|||+.||++.|+++
T Consensus 242 -~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 -SFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -CHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -chhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1111111111111 1111111 12234667899999999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.98 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=198.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 34589999999999999864 789999998765432 3346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 90 GELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999983 33469999999999999999999999 899999999999999999999999999998664333223
Q ss_pred ceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ......|...... ..+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~---- 230 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKTY-------LNP---- 230 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTTCTT-------STT----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhccccc-------CCc----
Confidence 3344579999999999987765 77899999999999999999999764322 1122222221110 000
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 231 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0112235778999999999999999998865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.91 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=202.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++.. .+++.||||++..... ...+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 3458999999999999985 4789999998754433 23467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 94 EGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999532 468999999999999999999999 8999999999999999999999999999987643321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+......... .... .....
T Consensus 167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~~~~ 237 (294)
T 4eqm_A 167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TTDVR 237 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HHHSC
T ss_pred -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-chhcc
Confidence 122345699999999999999999999999999999999999999976431 11111111110 0000 00111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhhcc
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-SMVDIVRELEDAFII 809 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~~~ 809 (863)
.. ....+.+++.+|++.+|++|| +++++.+.|+.++..
T Consensus 238 ~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 238 KD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11 234588999999999999998 999999999988743
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.24 Aligned_cols=260 Identities=19% Similarity=0.231 Sum_probs=207.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++......++||||+ +
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 3458999999999999994 678999999876443 335688999999999 7999999999999999999999999 9
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe-----EEEeeccCcccCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC-----AKVADFGFSKYAPQ 684 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~-----~kl~DFGla~~~~~ 684 (863)
++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 90 PSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999999543 3468999999999999999999999 89999999999999987776 99999999987654
Q ss_pred CCCC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3221 11234569999999999999999999999999999999999999998754333222222211111101111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+ +.... ...+.+++.+|++.+|++||++.+|++.|++++..
T Consensus 244 ~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 244 E-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp H-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 11112 24588999999999999999999999999998743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=357.10 Aligned_cols=243 Identities=24% Similarity=0.350 Sum_probs=198.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 3458999999999999996 689999999886543 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ..+++.....++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 98 GGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp TCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 99999999542 458999999999999999999999 899999999999999999999999999998664332
Q ss_pred CceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|+|||.+.+..+. .++|||||||+++||++|+.||..... ..+.+.+.. +.. .+.
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~----~~~------~~p 234 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLR----GKY------RIP 234 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CCC------CCC
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCC------CCC
Confidence 22345699999999999888765 799999999999999999999976421 112211111 110 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 235 FYM----STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp TTS----CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112 234778999999999999999998865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.01 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=190.1
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCC----cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST----QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... |+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 44689999999999999974 88999998765432 23467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC--------CCeEEEeeccCc
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--------SMCAKVADFGFS 679 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--------~~~~kl~DFGla 679 (863)
++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||++
T Consensus 89 ~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 89 RGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 9999999983 346899999999999999999999932223999999999999986 778999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
+...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||..... ........ .. .
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~---~~-~-- 230 (271)
T 3dtc_A 164 REWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA---MN-K-- 230 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH---TS-C--
T ss_pred ccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh---cC-C--
Confidence 8654322 2234689999999999999999999999999999999999999975431 11111100 00 0
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
..... .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --LALPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --CCCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00111 112234588999999999999999999999999853
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=352.70 Aligned_cols=260 Identities=18% Similarity=0.213 Sum_probs=207.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 3458999999999999995 5789999998765432 35689999999999 9999999999999999999999999 9
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe-----EEEeeccCcccCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC-----AKVADFGFSKYAPQ 684 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~-----~kl~DFGla~~~~~ 684 (863)
++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 89 PSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999999543 3579999999999999999999999 89999999999999999887 99999999987643
Q ss_pred CCCCC-----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI- 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence 32211 123457999999999999999999999999999999999999999875433322222211110000000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
..+.... . .+.+++..|++.+|.+||++.+|++.|++++...
T Consensus 242 ----~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 ----EVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ----HHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0011111 2 6889999999999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=381.92 Aligned_cols=250 Identities=23% Similarity=0.393 Sum_probs=200.5
Q ss_pred eecccCcEEEEEEecC---CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 536 LIGEGGFGSVYRGTLP---DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999863 46689999987653 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-Cc
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-GF 690 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 690 (863)
|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999953 24569999999999999999999999 89999999999999999999999999999876533221 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+.+.. +... .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~----~~~~---------~ 559 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKRM---------E 559 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHT----TCCC---------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc----CCCC---------C
Confidence 122346789999999999999999999999999999998 9999986532 222222221 1100 1
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+..+...+.+++.+||+.+|++||++.+|++.|+.++.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111233468899999999999999999999999998864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.73 Aligned_cols=272 Identities=20% Similarity=0.276 Sum_probs=210.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCC--eeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEND--QQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ey~ 607 (863)
.+.++||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 34589999999999999965 58999999987543 334577889999999999999999999998765 779999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe----cCCCeEEEeeccCcccCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla~~~~ 683 (863)
++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 92 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 92 PCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp TTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999996432 22349999999999999999999999 899999999999999 888899999999998765
Q ss_pred CCCCCCceeeeecCCCCCCccccc--------cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYS--------TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIR 754 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~ 754 (863)
.... .....||..|+|||.+. +..++.++|||||||++|||++|+.||........ ..+...+.....
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 4322 23456999999999986 56789999999999999999999999975432211 111111111111
Q ss_pred cccccccc---------CCcc--CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 755 ESRIDEIV---------DPSI--KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 755 ~~~~~~i~---------d~~l--~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
...+..+. ++.+ ...........+.+++.+|++.||++|||+.|+++...+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 11111100 0111 12344566778899999999999999999999999998776443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.67 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=192.6
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCc--ccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--QGTREFENELNFLSAIRH--ENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++...+++.||||++..... +..+.+.+|++++.+++| +||+++++++...+..++||| +
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 34589999999999999998899999998765432 334678999999999986 999999999999999999999 5
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+|+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 91 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 91 GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 68999999954 3468999999999999999999999 8999999999999997 57899999999987754433
Q ss_pred CCceeeeecCCCCCCcccccc-----------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-----------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . ...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~---~~~-------- 229 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISK-------- 229 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHH--------
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--H---HHH--------
Confidence 333445679999999999865 6789999999999999999999999975321 1 111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+..++++.....++......+.+++.+||+.+|++|||+.|+++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111112111111111122357899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=359.56 Aligned_cols=261 Identities=23% Similarity=0.412 Sum_probs=207.4
Q ss_pred HhhcceecccCcEEEEEEec--------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCee
Q 002943 531 QQYKTLIGEGGFGSVYRGTL--------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQ 600 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~--------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 600 (863)
+.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||++++++|...+..
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 116 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 116 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCce
Confidence 34568999999999999985 3577899999875533 3456789999999999 899999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC
Q 002943 601 ILVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS 668 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~ 668 (863)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCC
Confidence 999999999999999965432 12358999999999999999999999 899999999999999999
Q ss_pred CeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHH
Q 002943 669 MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVE 747 (863)
Q Consensus 669 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~ 747 (863)
+.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+..
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~ 270 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EELFK 270 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HHHHH
Confidence 9999999999987654322222233457889999999998889999999999999999999 9999975421 11222
Q ss_pred hhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 748 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.+.. +.. +..... ....+.+++.+|++.+|.+||++.|+++.|+.++...
T Consensus 271 ~~~~----~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 271 LLKE----GHR-----MDKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHH----TCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhc----CCC-----CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111 110 111111 2345889999999999999999999999999998543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.64 Aligned_cols=258 Identities=28% Similarity=0.389 Sum_probs=210.6
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|... ++..||||++... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 93 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 93 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 345689999999999999965 4889999988654 33457899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 94 ~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 167 (288)
T 3kfa_A 94 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 167 (288)
T ss_dssp EEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-E
T ss_pred CcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-c
Confidence 9999999543 23568999999999999999999999 8899999999999999999999999999987653321 2
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......+|..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+...... ....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~~~~---------~~~~-- 233 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDY---------RMER-- 233 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTC---------CCCC--
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhccC---------CCCC--
Confidence 2233457889999999999999999999999999999999 9999976432 11222211110 0111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
.......+.+++.+|++.+|++||++.|+++.|+.++....
T Consensus 234 --~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11123458899999999999999999999999999885443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=359.80 Aligned_cols=267 Identities=18% Similarity=0.194 Sum_probs=204.3
Q ss_pred hhcceecccCcEEEEEEecCC------CCEEEEEEcccCCCcc-----------hHHHHHHHHHHhcCCcccccceeeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTSTQG-----------TREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
.+.+.||+|+||.||+|...+ ++.||||++....... ...+..|+..+..++|+||+++++++
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 117 (364)
T 3op5_A 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG 117 (364)
T ss_dssp EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence 446899999999999998754 4789999876553211 12344566677888999999999999
Q ss_pred eeC----CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CC
Q 002943 595 CEN----DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HS 668 (863)
Q Consensus 595 ~~~----~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~ 668 (863)
... ...+|||||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++ .+
T Consensus 118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 118 LHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCT
T ss_pred eeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCC
Confidence 775 4579999999 99999999542 3569999999999999999999999 8999999999999999 88
Q ss_pred CeEEEeeccCcccCCCCCCCC-----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc
Q 002943 669 MCAKVADFGFSKYAPQEGDSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743 (863)
Q Consensus 669 ~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 743 (863)
+.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||...... .
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~--~ 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD--P 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--H
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--H
Confidence 999999999998764332111 112345999999999999999999999999999999999999999853221 1
Q ss_pred hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 744 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
....+...... ..+.+++++.+.... ....+.+++..|++.+|++||++.+|++.|++++....
T Consensus 269 ~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 269 KYVRDSKIRYR-ENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHH-HCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhh-hhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 22222222111 123344443332111 12358889999999999999999999999999885433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.76 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=200.6
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ------GTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.+.||+|+||.||++... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3455689999999999999964 6899999987654322 35679999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC----eEEEeeccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM----CAKVADFGF 678 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGl 678 (863)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 92 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999942 3568999999999999999999999 8999999999999999887 899999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.. ...
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~----~~~ 234 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSA----VNY 234 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH----TCC
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHh----cCC
Confidence 987653321 2345699999999999999999999999999999999999999975321 111111110 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ..+..... ....+.+++.+|++.+|++|||+.|+++
T Consensus 235 -~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -E-FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -C-CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C-cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000011 1235789999999999999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.73 Aligned_cols=256 Identities=30% Similarity=0.502 Sum_probs=191.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|+.. ..||||++..... ...+.|.+|++++++++||||+++++++ ..+..++||||+++
T Consensus 27 ~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~ 103 (289)
T 3og7_A 27 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEG 103 (289)
T ss_dssp EEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCE
T ss_pred eeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCC
Confidence 44689999999999999864 3599998865533 3346799999999999999999999965 45668999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 104 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 104 SSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred CcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999943 24568999999999999999999999 899999999999999999999999999998665433333
Q ss_pred ceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 690 FSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||..|+|||.+. +..++.++||||||+++|||++|+.||..... ...+.+.+.. +... +.+
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~----~~~~----~~~ 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGR----GSLS----PDL 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHH----TSCC----CCT
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcc----cccC----cch
Confidence 334456999999999986 56788899999999999999999999976432 1112222211 1111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
. .........+.+++.+|++.+|++||++.|++++|+++.
T Consensus 248 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 S-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp T-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred h-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 111122346889999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=344.98 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=195.8
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.++||+|+||+||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++ |
T Consensus 25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 103 (311)
T 3niz_A 25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-K 103 (311)
T ss_dssp EEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-E
T ss_pred hhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-C
Confidence 4589999999999999988899999998765432 234678899999999999999999999999999999999997 5
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 104 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 175 (311)
T 3niz_A 104 DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--S 175 (311)
T ss_dssp EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--c
Confidence 88888843 23468999999999999999999999 8999999999999999999999999999987643221 2
Q ss_pred eeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---cccccc-----
Q 002943 691 SLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---SRIDEI----- 761 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~i----- 761 (863)
.....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||......+.. .. ....... ......
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PK-IFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HH-HHHHHCCCCTTTSGGGTTSHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHHCCCChHHhhhhhccch
Confidence 233468999999999876 56899999999999999999999999865433221 11 1110000 000000
Q ss_pred -cCCcc--CCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 -VDPSI--KGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 -~d~~l--~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+... ..... .....++.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000 011235789999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.39 Aligned_cols=249 Identities=30% Similarity=0.526 Sum_probs=198.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcc-------hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQG-------TREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
.+.+.||+|+||.||+|.. .+++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 4568999999999999986 578999999876543322 267899999999999999999999986655 699
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEecCCCe-----EEEeec
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLDHSMC-----AKVADF 676 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld~~~~-----~kl~DF 676 (863)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++. +||+||
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred EEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 9999999999988542 3579999999999999999999999 67 999999999999987776 999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccc--cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS--TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
|+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .........
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~--- 244 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINMIRE--- 244 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHHHHHH---
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHHHHhc---
Confidence 99985432 233456999999999983 4567899999999999999999999997643211 111111111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.+ ..+.+... ....+.+++.+|++.+|++||++.|+++.|+++
T Consensus 245 ~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG-----LRPTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC-----CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC-----CCCCCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 11112222 234588999999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.79 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=195.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCE----EEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQE----VAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~----vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||.||+|.. .+++. ||+|.+... .....+++.+|++++++++||||++++++|.... .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 4458999999999999985 34543 577766443 3445678999999999999999999999998765 788999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 97 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred ecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999543 3468999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.+.+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~~----------- 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGE----------- 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTC-----------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCC-----------
Confidence 33333334457889999999999999999999999999999999 99999764321 1222211110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 237 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 --RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 000111123358899999999999999999999999998864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=345.47 Aligned_cols=254 Identities=21% Similarity=0.367 Sum_probs=193.4
Q ss_pred hhcceecccCcEEEEEEecCC----CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|.... +..||||+...... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEec
Confidence 456899999999999998642 45799998765433 33467899999999999999999999984 5678899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 97 CTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp CTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999999542 3468999999999999999999999 899999999999999999999999999998764332
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+.. +.. ..
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~----~~~-----~~ 237 (281)
T 1mp8_A 171 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN----GER-----LP 237 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT----TCC-----CC
T ss_pred c-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHc----CCC-----CC
Confidence 1 11223456789999999999999999999999999999997 99999764321 22222111 100 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+.. .....+.+++.+|++.+|++||++.|+++.|++++..
T Consensus 238 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 238 MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111 2234588999999999999999999999999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.09 Aligned_cols=267 Identities=23% Similarity=0.378 Sum_probs=202.3
Q ss_pred HhhcceecccCcEEEEEEec-----CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 602 (863)
+.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... +..++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34468999999999999983 468899999887543 34457899999999999999999999999876 66899
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 103 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999543 3458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---ccc
Q 002943 683 PQEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---SRI 758 (863)
Q Consensus 683 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 758 (863)
...... .......||..|+|||.+.+..++.++||||||++++||++|+.|+..... ............ ..+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHHHH
Confidence 543221 112234578889999999999999999999999999999999988643210 000000000000 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
...+...............+.+++.+|++.+|.+|||+.|+++.|+.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000001111111222346889999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.17 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=199.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+++.. +|+.||||++.+. .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 34589999999999999864 6899999988654 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 88 NGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp TTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 99999999953 2468999999999999999999999 899999999999999999999999999998643322
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+. . +. ..+.
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~---~-~~------~~~p 225 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELIL---M-EE------IRFP 225 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---H-CC------CCCC
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHH---c-CC------CCCC
Confidence 22344679999999999999999999999999999999999999997532 111111111 1 00 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+ ..+.+++.+|++.+|++|| ++.|+++
T Consensus 226 ~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1222 3578899999999999999 7888765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.34 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=196.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|... ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||+++|+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCB
T ss_pred eeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCC
Confidence 34689999999999999974 788999988643 34578999999999999999999999887 45799999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe-EEEeeccCcccCCCCCCCCc
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC-AKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~-~kl~DFGla~~~~~~~~~~~ 690 (863)
|.+++.... ....+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||+++.....
T Consensus 86 L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----- 159 (307)
T 2eva_A 86 LYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----- 159 (307)
T ss_dssp HHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence 999996432 2235788999999999999999999865578999999999999988875 899999999765322
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||..|+|||.+.+..++.++||||||++++||++|+.||...... ... ..|... .+. .+.+....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~-~~~~~~---~~~-----~~~~~~~~ 229 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFR-IMWAVH---NGT-----RPPLIKNL 229 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHH-HHHHHH---TTC-----CCCCBTTC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHH-HHHHHh---cCC-----CCCccccc
Confidence 12345899999999999999999999999999999999999999754321 111 111110 111 11111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
...+.+++.+|++.+|++|||+.|+++.|+.+...
T Consensus 230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 23578999999999999999999999999988643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=380.30 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=206.2
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.++||+|+||.||+|.+.++..||||++.... ...++|.+|+++|++++|+||++++++|.+ +..++|||||++|
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~g 346 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 346 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTE
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCC
Confidence 34568999999999999999888899999987654 345789999999999999999999999876 6789999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++|... ....+++.+++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 347 sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~ 420 (535)
T 2h8h_A 347 SLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 420 (535)
T ss_dssp EHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HT
T ss_pred cHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ec
Confidence 999999532 12458999999999999999999999 8999999999999999999999999999987643210 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....++..|+|||.+....++.++|||||||+||||++ |+.||..... ..+.+.+.... ++ .
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~---~~----------~ 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGY---RM----------P 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTC---CC----------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC---CC----------C
Confidence 122346788999999999999999999999999999999 9999976431 12222221110 00 0
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
....+...+.+++.+||+.+|++||++.+|++.|+.++.
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111233468899999999999999999999999998874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=352.23 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=199.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ------GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||.||++... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEE
Confidence 44689999999999999964 6899999988765332 2467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC----eEEEeeccCcc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM----CAKVADFGFSK 680 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGla~ 680 (863)
||+++|+|.+++.. ...+++.....++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 95 ELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp ECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999942 3569999999999999999999999 8999999999999998776 79999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+...+.. +..
T Consensus 168 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~----~~~-- 235 (361)
T 2yab_A 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITA----VSY-- 235 (361)
T ss_dssp ECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHT----TCC--
T ss_pred EcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----cCC--
Confidence 765432 12345699999999999999999999999999999999999999975321 111111111 000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
-.++...... ...+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0011111111 235789999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=359.73 Aligned_cols=268 Identities=26% Similarity=0.386 Sum_probs=207.1
Q ss_pred HhhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEe--eCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC--ENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~LV 603 (863)
+.+.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++. +.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34568999999999999983 468899999988776666678999999999999999999999887 45568899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999542 2358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh---hhcccccccc
Q 002943 684 QEGDSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA---KPFIRESRID 759 (863)
Q Consensus 684 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~---~~~~~~~~~~ 759 (863)
...... ......||..|+|||.+.+..++.++||||||++++||++|+.||..... ...... ........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA----EFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHCC----CCHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc----hhhhhcccccccccHHHHH
Confidence 432211 12234578889999999998899999999999999999999999864211 000000 0000000011
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+.+...............+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111222334568899999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.29 Aligned_cols=260 Identities=26% Similarity=0.377 Sum_probs=207.0
Q ss_pred HhhcceecccCcEEEEEEecCC------CCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|.... +..||||++..... ...+.+.+|+++++++ +||||++++++|...+..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 3456899999999999998532 34899998876543 3456789999999999 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC----------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEE
Q 002943 603 VYPFMSNGSLQDRLYGEAS----------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~k 672 (863)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEE
Confidence 9999999999999964311 13468999999999999999999999 8999999999999999999999
Q ss_pred EeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhh
Q 002943 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKP 751 (863)
Q Consensus 673 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~ 751 (863)
|+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+| |+.||....... .+......
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~ 282 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKLVKD 282 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHHHHH
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHHHhc
Confidence 999999987654333222334557889999999999999999999999999999999 999997643211 11121111
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
... ...... ....+.+++.+|++.+|.+||++.||++.|+++..
T Consensus 283 ~~~---------~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 283 GYQ---------MAQPAF----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp TCC---------CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CCCCCC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 110 001111 12458899999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=351.16 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=207.2
Q ss_pred hhcceecccCcEEEEEEec------CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCC-eeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEND-QQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~L 602 (863)
.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||++++++|...+ ..++
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l 109 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 109 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence 3458999999999999973 3578999999876543 2346789999999999 7999999999988765 4899
Q ss_pred EeecCCCCChhhhhhccCCC------------CccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe
Q 002943 603 VYPFMSNGSLQDRLYGEAST------------RKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC 670 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~ 670 (863)
||||+++|+|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCC
Confidence 99999999999999654321 2238899999999999999999999 89999999999999999999
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWA 749 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~ 749 (863)
+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .+....
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~ 264 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRL 264 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HHHHHh
Confidence 99999999987654433333334568899999999999999999999999999999998 999997643211 111111
Q ss_pred hhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
. .+.. ....... ...+.+++.+|++.+|.+||++.||++.|+.+++.
T Consensus 265 ~----~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 265 K----EGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp H----HTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c----cCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1 1110 1111112 23588999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.18 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=199.6
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|+.. |+.||||++.... ....+.|.+|++++++++||||+++++++... +..++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 44689999999999999984 8899999887653 23346799999999999999999999999877 7789999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
++|+|.+++... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 92 PYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp TTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999643 23468999999999999999999998 66 999999999999999999999999987653221
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCc---ccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSA---KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
...||+.|+|||.+.+...+. ++||||||+++|||++|+.||..... ..... .....+ .
T Consensus 167 -------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~---~~~~~~-----~ 228 (271)
T 3kmu_A 167 -------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGM---KVALEG-----L 228 (271)
T ss_dssp -------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHH---HHHHSC-----C
T ss_pred -------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHH---HHHhcC-----C
Confidence 235899999999998765444 79999999999999999999975431 11111 111111 1
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.+.+.... ...+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 229 ~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11122222 335889999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.24 Aligned_cols=253 Identities=29% Similarity=0.432 Sum_probs=206.1
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||++...+++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34689999999999999988889999999876543 34689999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 90 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 162 (267)
T 3t9t_A 90 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 162 (267)
T ss_dssp HHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HST
T ss_pred HHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-ccc
Confidence 99999543 3468999999999999999999999 8999999999999999999999999999986543211 111
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+.+..... +.....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~---------~~~~~~- 229 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFR---------LYKPRL- 229 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCC---------CCCCTT-
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCc---------CCCCcc-
Confidence 22346788999999998999999999999999999999 8999975421 112221111100 001111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
....+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 230 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=382.56 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=198.4
Q ss_pred ceecccCcEEEEEEec---CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTL---PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~---~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.||+|+||.||+|.+ ..++.||||+++.... ...++|.+|+++|++++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 5799999999999964 3467899999876433 33578999999999999999999999996 4568899999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS- 688 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~- 688 (863)
|+|.+++.. ...+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999953 3468999999999999999999999 89999999999999999999999999999876543221
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......+|..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+.+.+.. +.. .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~----~~~-----~--- 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEK----GER-----M--- 591 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT----TCC-----C---
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC-----C---
Confidence 22233457889999999999999999999999999999998 9999976432 122222111 110 0
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.....+...+.+++..||+.+|++||++.+|++.|++++
T Consensus 592 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111123346889999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.46 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=193.1
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCC--cccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIR--HENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|+++|++++ |+||+++++++...+..++||| +
T Consensus 59 ~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~ 137 (390)
T 2zmd_A 59 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 137 (390)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-C
T ss_pred EEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-c
Confidence 3458999999999999998889999999886543 234577999999999996 5999999999999999999999 5
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 138 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 138 GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 689999999542 368899999999999999999999 8999999999999996 57899999999987754433
Q ss_pred CCceeeeecCCCCCCcccccc-----------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-----------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . ....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~---~~~~------- 277 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKL------- 277 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--H---HHHH-------
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--H---HHHH-------
Confidence 323344579999999999865 4688999999999999999999999975321 1 1111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
..++++......+......+.+++.+||+.+|++||++.|+++.
T Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111111111112357899999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=349.39 Aligned_cols=245 Identities=22% Similarity=0.271 Sum_probs=190.9
Q ss_pred HHHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEE
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 603 (863)
...+.+.++||+|+||+||+|... +|+.||||++..... ....++..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 344555689999999999999965 799999998765432 2234555666666555 899999999999999999999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+ +++|.+++... ...++|..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 78999998543 3469999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
... ......||++|+|||++.+ .++.++|||||||++|||++|+.|+.... ..... ..+.. .
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~-----~~~~~----~ 270 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQL-----RQGYL----P 270 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHH-----TTTCC----C
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHH-----hccCC----C
Confidence 322 2234569999999999876 78999999999999999999977664311 11111 11111 1
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+... ....+.+++.+|++.+|++|||+.|+++
T Consensus 271 ~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 2345889999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=347.14 Aligned_cols=247 Identities=17% Similarity=0.243 Sum_probs=200.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... +|+.+|+|++... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 34589999999999999864 6889999987644 334467889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC--CCeEEEeeccCcccCCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--SMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 87 ~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 87 DIFERINT---SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp BHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 99999943 23468999999999999999999999 89999999999999987 7899999999998765332
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+.. +... .++....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~----~~~~--~~~~~~~ 228 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMN----AEYT--FDEEAFK 228 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH----TCCC--CCHHHHT
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHc----CCCC--CChhhhc
Confidence 23456799999999999988899999999999999999999999975321 111111111 0000 0000001
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ....+.+++.+|++.+|++|||+.|+++
T Consensus 229 ~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 E----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1345789999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=347.24 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=200.1
Q ss_pred HhhcceecccCcEEEEEEecCC-C-------CEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD-G-------QEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~-g-------~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|.... + ..||+|++........+.+.+|++++++++||||+++++++...+..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 3456899999999999998643 3 5799999877766677889999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe--------EEEe
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC--------AKVA 674 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~--------~kl~ 674 (863)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++. +||+
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999543 3458999999999999999999999 89999999999999998887 9999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||+++.... .....||..|+|||.+.+ ..++.++||||||+++|||++|..|+..... ..........
T Consensus 164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~~~~~-- 233 (289)
T 4fvq_A 164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKLQFYED-- 233 (289)
T ss_dssp CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHT--
T ss_pred cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHHHHhhc--
Confidence 9999875432 123458999999999987 6789999999999999999996544432211 1111111110
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
... +.... ...+.+++.+|++.+|++|||+.|+++.|++++.
T Consensus 234 -~~~--------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 234 -RHQ--------LPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -TCC--------CCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -cCC--------CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 11111 1247789999999999999999999999998874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=352.84 Aligned_cols=268 Identities=24% Similarity=0.389 Sum_probs=204.8
Q ss_pred hhcceecccCcEEEEEEecC-----CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeC--CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-----DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEN--DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 603 (863)
.+.+.||+|+||+||++.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 34589999999999888642 688999999876532 3356789999999999999999999999874 578999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999943 248999999999999999999999 899999999999999999999999999998775
Q ss_pred CCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
..... .......+|..|+|||.+.+..++.++||||||++++||++|+.||...... ......+.........+.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHH
Confidence 43221 1123345788899999999989999999999999999999999998642110 000000100000001111111
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+..............+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111112222334568899999999999999999999999998763
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=351.08 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=202.0
Q ss_pred HHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccC-----CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST-----STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
..+.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3455678999999999999985 47899999987532 12245789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe---EEEeeccCc
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC---AKVADFGFS 679 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DFGla 679 (863)
||||+++|+|.+++.........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543344568999999999999999999999 89999999999999986554 999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.+... .+...
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~----~~~~~ 250 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGII----KGKYK 250 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHH----HTCCC
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHH----cCCCC
Confidence 8765432 12234569999999999999999999999999999999999999997531 11111111 01000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.++...... ...+.+++.+|++.+|++||++.|+++
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111 245789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=346.83 Aligned_cols=267 Identities=27% Similarity=0.381 Sum_probs=199.5
Q ss_pred HHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC--CcccccceeeeEeeC----CeeE
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI--RHENLVPLLGYCCEN----DQQI 601 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~----~~~~ 601 (863)
...+.+.+.||+|+||.||+|+.. |+.||||++... ....+..|.+++..+ +||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 344556799999999999999975 899999987543 234455666666555 899999999999887 6889
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-----CCCccccCCCCCCeEecCCCeEEEeec
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-----GRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+||
T Consensus 112 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 99999999999999943 35899999999999999999999821 129999999999999999999999999
Q ss_pred cCcccCCCCCCCCc--eeeeecCCCCCCccccccCCCCcc------cceechhhHHHHHHhC----------CCCCCCCC
Q 002943 677 GFSKYAPQEGDSGF--SLEVRGTAGYLDPEYYSTQHLSAK------SDVFSFGVVLLEIISG----------REPLNTRR 738 (863)
Q Consensus 677 Gla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k------sDV~SfGvvl~ElltG----------~~p~~~~~ 738 (863)
|+++.......... .....||+.|+|||.+.+.....+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99976643322111 123469999999999988766665 9999999999999999 55554432
Q ss_pred CCCcchhHHhhhhcccccccccccCCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 739 PRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 739 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.... ..... ...... ....+.+.... ..++...+.+++.+||+.+|++||++.||++.|+.+...
T Consensus 267 ~~~~-~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 267 PSDP-SYEDM-REIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CSSC-CHHHH-HHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCC-chhhh-HHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 2211 11111 000000 11111111111 225677899999999999999999999999999988743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.58 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=204.2
Q ss_pred ceecccCcEEEEEEecC---CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||+|... +++.||||++..... ...+++.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999853 578899999876533 3457799999999999999999999999 566789999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-C
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-G 689 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~ 689 (863)
+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 99999943 34569999999999999999999999 89999999999999999999999999999876433221 1
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+.. +.. +...
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~----~~~-----~~~~- 235 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKR-----MECP- 235 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHT----TCC-----CCCC-
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhc----CCc-----CCCC-
Confidence 1122346889999999998889999999999999999999 9999976432 122222211 110 1111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
......+.+++.+|++.+|++||++.|+++.|+.++..
T Consensus 236 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 236 ---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 12234688999999999999999999999999998743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=354.83 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=195.9
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.+.||+|+||.||+|.. .+|+.||||++........+++.+|++++++++||||++++++|...+..+|||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 36799999999999985 57999999998876656677899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe--cCCCeEEEeeccCcccCCCCCCCCc
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL--DHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl--d~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9998532 3468999999999999999999999 899999999999999 6778999999999987654322
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.......+. ..+......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~-------~~~~~~~~~ 315 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRWD-------LEDEEFQDI 315 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC-------SCSGGGTTS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCC-------CChhhhccC
Confidence 22345999999999999889999999999999999999999999764311 111111111000 001111122
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+++.+|++.+|++||++.|+++
T Consensus 316 ----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 ----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 235889999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.01 Aligned_cols=254 Identities=28% Similarity=0.503 Sum_probs=192.6
Q ss_pred hcceecccCcEEEEEEecC--CC--CEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLP--DG--QEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~--~g--~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ey 606 (863)
+.++||+|+||.||+|... ++ ..||||.+.... ....++|.+|++++++++||||++++++|.+ .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 4578999999999999863 22 468999886543 3445789999999999999999999999765 4578999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 173 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 173 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999953 23468899999999999999999999 899999999999999999999999999998664322
Q ss_pred CC--CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 DS--GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. .......+|..|+|||.+.+..++.++|||||||++|||+| |..||......+ +...... +. ....
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~----~~--~~~~ 317 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQ----GR--RLLQ 317 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHT----TC--CCCC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHc----CC--CCCC
Confidence 11 11233457889999999999999999999999999999999 677776543221 2222111 11 0001
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+ . .....+.+++.+||+.+|++||++.|+++.|+.++.
T Consensus 318 p---~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 318 P---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1 122358899999999999999999999999998873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.75 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=204.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 4568999999999999998888899999886543 34578999999999999999999999986 456899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 94 L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 167 (279)
T 1qpc_A 94 LVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR 167 (279)
T ss_dssp HHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred HHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccc
Confidence 99999432 12368999999999999999999999 8999999999999999999999999999987643221 111
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+.+...... .+.....
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~---------~~~~~~~- 234 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGY---------RMVRPDN- 234 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTC---------CCCCCTT-
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhccc---------CCCCccc-
Confidence 23346789999999998889999999999999999999 9999975431 12222111110 0111111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
....+.+++.+|++.+|++||++.++++.|++++.
T Consensus 235 ---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 22458899999999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=346.92 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=194.2
Q ss_pred hhcceecccCcEEEEEEecC----CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCe-----e
Q 002943 532 QYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQ-----Q 600 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 600 (863)
.+.+.||+|+||.||+|... .++.||||++..... ...+.+.+|++++++++||||+++++++.+.+. .
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 34588999999999999753 345899998875432 334678999999999999999999999987653 4
Q ss_pred EEEeecCCCCChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 601 ILVYPFMSNGSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 99999999999999985332 234579999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.... +.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~----~~ 266 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYLLH----GH 266 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHT----TC
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHHc----CC
Confidence 987654332222334457889999999999999999999999999999999 8899876432 122221111 10
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+.... .....+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 267 -----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 267 -----RLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp -----CCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011111 223458899999999999999999999999998863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.07 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=190.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--------------------------cchHHHHHHHHHHhcCCc
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--------------------------QGTREFENELNFLSAIRH 584 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--------------------------~~~~~f~~E~~~l~~l~H 584 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 4468999999999999985 4688999998765431 123568999999999999
Q ss_pred ccccceeeeEee--CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCC
Q 002943 585 ENLVPLLGYCCE--NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSN 662 (863)
Q Consensus 585 ~niv~l~g~~~~--~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~N 662 (863)
|||+++++++.. .+..++||||+++|+|.+++. ...+++..++.++.|+++||+|||+ .+|+||||||+|
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 999999999986 567899999999999988652 3469999999999999999999999 899999999999
Q ss_pred eEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCC---CCcccceechhhHHHHHHhCCCCCCCCCC
Q 002943 663 ILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH---LSAKSDVFSFGVVLLEIISGREPLNTRRP 739 (863)
Q Consensus 663 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~ElltG~~p~~~~~~ 739 (863)
||++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~- 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred EEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc-
Confidence 999999999999999998764322 1223456999999999997765 3778999999999999999999997532
Q ss_pred CCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 740 RNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 740 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+..... ..... . +. .... ...+.+++.+|++.+|++||++.|+++
T Consensus 245 --~~~~~~~~~----~~~~~-~--~~-~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 --IMCLHSKIK----SQALE-F--PD-QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --HHHHHHHHH----HCCCC-C--CS-SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHHHHHHHh----cccCC-C--CC-cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111111 11000 0 00 1112 235889999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=340.25 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=200.2
Q ss_pred cceecccCcEEEEEEecC-C---CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCee-EEEeecC
Q 002943 534 KTLIGEGGFGSVYRGTLP-D---GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQ-ILVYPFM 607 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~---g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~LV~ey~ 607 (863)
.++||+|+||+||+|... + +..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999853 2 23799998875433 3456789999999999999999999999877665 9999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999954 24568999999999999999999999 8999999999999999999999999999986543221
Q ss_pred --CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 688 --SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 688 --~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
........+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ....+......... ..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~---------~~ 248 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRR---------LP 248 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCC---------CC
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCC---------CC
Confidence 112223457889999999999999999999999999999999655543321 12222222221110 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.... ....+.+++.+|++.+|.+|||+.|+++.|++++.
T Consensus 249 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 249 QPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 22358899999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=337.59 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=205.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeE-eeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC-CENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... .+++.+|++++++++|++++..+.++ ...+..++||||+ +
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 3458999999999999995 6799999998765433 35689999999999998877777766 5566789999999 9
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~~~ 686 (863)
++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 89 ~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 89 PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999999532 3469999999999999999999999 899999999999999 588999999999998765432
Q ss_pred CCC-----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 687 DSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 687 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 239 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH---
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch---
Confidence 211 123456999999999999999999999999999999999999999875433322222211111000000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
+.+.... ...+.+++.+|++.+|++||++.||++.|++++....
T Consensus 240 --~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 --EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp --HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0011112 2358899999999999999999999999999875443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=349.84 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=200.4
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 4455689999999999999864 689999998865432 2346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccCcccCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGFSKYAP 683 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla~~~~ 683 (863)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 110 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 110 VTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999843 3468999999999999999999999 899999999999999864 459999999998765
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+...+.. +... ...
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~----~~~~-~~~ 251 (362)
T 2bdw_A 183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKA----GAYD-YPS 251 (362)
T ss_dssp TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----TCCC-CCT
T ss_pred CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh----CCCC-CCc
Confidence 322 1234569999999999999899999999999999999999999997532 1122221111 1100 000
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+. .......+.+++.+|++.+|++||++.|+++.
T Consensus 252 ~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 PE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 01123457899999999999999999998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=338.31 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=204.8
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeE-eeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC-CENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||.||+|.. .+++.||||++..... .+++.+|++++++++|++++..++++ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 34568999999999999995 6789999998654432 34688999999999998888877766 5667789999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999999532 3469999999999999999999999 899999999999999 78999999999999876543
Q ss_pred CCCC-----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 686 GDSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 686 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
.... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-
Confidence 2211 1234568999999999999999999999999999999999999998755433222222111110000000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
.+...+ ...+.+++.+|++.+|++||++.||++.|++++....
T Consensus 241 ----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 ----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 011112 2358899999999999999999999999999885443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.05 Aligned_cols=249 Identities=19% Similarity=0.295 Sum_probs=202.4
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 344689999999999999864 6899999998766555567899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC--CCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--SMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 133 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 999999943 23468999999999999999999999 89999999999999974 578999999999876432
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+... .. ..++...
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~----~~--~~~~~~~ 274 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRC----DW--EFDEDAF 274 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHC----CC--CCCSSTT
T ss_pred -cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhC----CC--CCCcccc
Confidence 22334579999999999999999999999999999999999999997642 11122211110 00 0111111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+.+++.+|++.+|++|||+.|+++
T Consensus 275 ~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 122 235789999999999999999999976
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.42 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=193.8
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCC----------
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEND---------- 598 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---------- 598 (863)
+.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 344689999999999999975 79999999886543 334578999999999999999999999986654
Q ss_pred -----------------------------------------------eeEEEeecCCCCChhhhhhccCCCCccCChhhH
Q 002943 599 -----------------------------------------------QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631 (863)
Q Consensus 599 -----------------------------------------------~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~ 631 (863)
..++||||+++|+|.+++.... ......+..+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~ 166 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVC 166 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHH
Confidence 2789999999999999996543 2345677789
Q ss_pred HHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC----------CceeeeecCCCCC
Q 002943 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS----------GFSLEVRGTAGYL 701 (863)
Q Consensus 632 ~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~ 701 (863)
+.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999999 89999999999999999999999999999876543211 1123346999999
Q ss_pred CccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHH
Q 002943 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEV 781 (863)
Q Consensus 702 aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l 781 (863)
|||.+.+..++.++|||||||++|||++|..|+... ..+.... ..... + .........+.++
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~----~~~~~-----~----~~~~~~~~~~~~l 305 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDV----RNLKF-----P----LLFTQKYPQEHMM 305 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHH----HTTCC-----C----HHHHHHCHHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHh----hccCC-----C----cccccCChhHHHH
Confidence 999999999999999999999999999987654210 0111100 00000 0 0112333457899
Q ss_pred HHHccCcCCCCCCCHHHHHH
Q 002943 782 ALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 782 ~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+|++.+|++||++.|+++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.27 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=198.2
Q ss_pred hcceecccCcEEEEEEecCC-----CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLPD-----GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~-----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.||+|+||.||+|.... +..||||++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 34789999999999998642 24699998875432 3345789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 128 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 128 MENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp CTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999999542 3468999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 687 DSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.+.. +. ..
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~----~~-----~~ 269 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAIND----GF-----RL 269 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT----TC-----CC
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHC----CC-----cC
Confidence 211 1122346788999999999999999999999999999999 9999965431 112221111 10 00
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.. .......+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 270 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 112234588999999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=338.14 Aligned_cols=257 Identities=20% Similarity=0.256 Sum_probs=194.3
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 84 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence 4579999999999999988899999998765432 2346788999999999999999999999999999999999974
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++.....++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 85 ~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 156 (288)
T 1ob3_A 85 DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RK 156 (288)
T ss_dssp EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cc
Confidence 999988532 3568999999999999999999999 899999999999999999999999999998654221 11
Q ss_pred eeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc---cc---cc--cc
Q 002943 691 SLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---SR---ID--EI 761 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~~--~i 761 (863)
.....||+.|+|||.+.+. .++.++|||||||+++||++|+.||...... ............ .. .. ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhcccc
Confidence 2334689999999999764 5899999999999999999999999764321 111111110000 00 00 00
Q ss_pred cCCccCC-------CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKG-------GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~-------~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.++.... .........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111100 000112345789999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=339.49 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=198.2
Q ss_pred hcceecccCcEEEEEEecCC----CCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ey 606 (863)
+.++||+|+||.||+|...+ +..+|||.+..... ...+.+.+|++++++++||||++++++|.+ ++..++||||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence 45899999999999998543 23589998765433 344678999999999999999999998754 5578999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 109 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 109 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp CTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999953 23568999999999999999999999 899999999999999999999999999998664322
Q ss_pred CC--CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 687 DS--GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 687 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. .......+|+.|+|||.+.+..++.++||||||++++||++ |.+||...... .+......... ..
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~~~~~------~~- 252 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRR------LL- 252 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHHTTCC------CC-
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhcCCC------CC-
Confidence 11 12233457889999999999999999999999999999999 55666543321 12221111000 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
..... ...+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 253 --~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 --QPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111 2358899999999999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=348.59 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=177.4
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
+.||+|+||.||+|... +|+.||||++... ....+.+|++++++++ ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999964 6899999998643 3467889999999997 99999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---eEEEeeccCcccCCCCCCCC
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~DFGla~~~~~~~~~~ 689 (863)
.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999954 3469999999999999999999999 8999999999999997665 899999999986643321
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-hhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-SLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...+. ...+..+.. ....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~i~~~~~------~~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDF------SFEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH-HHHHTTTCC------CCCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH-HHHHHcCCC------CCCc
Confidence 223456899999999999999999999999999999999999999764321111 11111 111111110 0000
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
.........+.+++.+|++.+|++||++.|++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 00011234688999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=342.68 Aligned_cols=257 Identities=20% Similarity=0.313 Sum_probs=189.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 86 (317)
T 2pmi_A 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD- 86 (317)
T ss_dssp -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-
T ss_pred eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-
Confidence 34578999999999999864 689999998865433 344678999999999999999999999999999999999997
Q ss_pred CChhhhhhccC--CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEA--STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~--~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.... .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 69999985432 223468999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---c--------
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---E-------- 755 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~-------- 755 (863)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+..... .
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhhhhh
Confidence 12334689999999999764 6899999999999999999999999764321 11111111000 0
Q ss_pred -------------cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 -------------SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 -------------~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.+.+.+...... ...+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000011111111122 235889999999999999999998864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=349.85 Aligned_cols=251 Identities=18% Similarity=0.191 Sum_probs=202.3
Q ss_pred hhcceecccCcEEEEEEe------cCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGT------LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR---HENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~------~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~L 602 (863)
.+.++||+|+||+||+|. ..+++.||||++... ...++..|++++++++ |+||+++++++...+..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 345899999999999994 456889999998654 3457888888888887 9999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC-CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-----------CCe
Q 002943 603 VYPFMSNGSLQDRLYGEAS-TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-----------SMC 670 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-----------~~~ 670 (863)
||||+++|+|.+++..... ....+++..++.|+.|+++||+|||+ .+|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999964322 34579999999999999999999999 89999999999999998 899
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAK 750 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~ 750 (863)
+||+|||+|+.+.............||..|+|||++.+..++.++|||||||++|||+||+.||...... .
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~-------- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-E-------- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-E--------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-c--------
Confidence 9999999997654333333344567999999999999999999999999999999999999998542210 0
Q ss_pred hcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHHHhhcc
Q 002943 751 PFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYR-PSMVDIVRELEDAFII 809 (863)
Q Consensus 751 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R-Psm~eVl~~L~~~~~~ 809 (863)
..++..+..... ...+.+++..|++.+|.+| |+++++.+.|++.+..
T Consensus 293 ---------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 ---------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 001111111122 2346678889999999998 6899999999988743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=343.86 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=197.9
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 34568999999999999985 579999999887533 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.........+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999996543345678999999999999999999999 899999999999999999999999999998664322
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+...+. ....... .
T Consensus 191 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~----~~~~~~~----~ 259 (310)
T 2wqm_A 191 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIE----QCDYPPL----P 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHH----TTCSCCC----C
T ss_pred c--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhh----cccCCCC----c
Confidence 1 12334689999999999999999999999999999999999999975321 1111111111 1111110 0
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.... ...+.+++.+|++.+|++||++.||++.|+++....
T Consensus 260 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1112 235889999999999999999999999999887443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=346.03 Aligned_cols=242 Identities=24% Similarity=0.346 Sum_probs=196.6
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 3458999999999999995 678999999876432 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 92 -~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 92 -GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp -CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred -CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 78999998542 468999999999999999999999 789999999999999999999999999998765332
Q ss_pred CCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+....... .+ ....+ ...+
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~----~i~~~------~~~~ 227 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FK----KVNSC------VYVM 227 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BC----CCCSS------CCCC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HH----HHHcC------CCCC
Confidence 2234569999999999988775 7899999999999999999999976432111 00 00000 0011
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ...+.+++.+|++.||.+|||+.|+++
T Consensus 228 p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDFL----SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cccC----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112 235789999999999999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.96 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=203.8
Q ss_pred hhcceecccCcEEEEEEecCC---------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccc-------------
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD---------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVP------------- 589 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~---------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~------------- 589 (863)
.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 446899999999999999653 789999987654 46889999999999999998
Q ss_pred --eeeeEee-CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec
Q 002943 590 --LLGYCCE-NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD 666 (863)
Q Consensus 590 --l~g~~~~-~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld 666 (863)
+++++.. .+..++||||+ +|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEE
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEc
Confidence 6777776 67889999999 99999999643 23579999999999999999999999 8999999999999999
Q ss_pred CCC--eEEEeeccCcccCCCCCCC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCC
Q 002943 667 HSM--CAKVADFGFSKYAPQEGDS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRP 739 (863)
Q Consensus 667 ~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~ 739 (863)
.++ .+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 9999999999876533211 112334699999999999999999999999999999999999999976432
Q ss_pred CCcchhHHhhhhcccccccccccCCccC-CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 740 RNEWSLVEWAKPFIRESRIDEIVDPSIK-GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 740 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~-~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
. ...+........ .....+.++... ... ...+.+++.+|++.+|++||++.||++.|++++....
T Consensus 274 ~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 274 N-TEDIMKQKQKFV--DKPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp C-HHHHHHHHHHHH--HSCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred C-HHHHHHHHHhcc--CChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 1 111222211111 111112221111 011 2458899999999999999999999999999875433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=357.45 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=199.5
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.+.||+|+||.||++.. .+|+.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 345568999999999999985 5789999998765432 2346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAP 683 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~~ 683 (863)
+++|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 92 ~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 92 VTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999954 3468999999999999999999999 8999999999999998 56889999999998765
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+.. +.. ....
T Consensus 165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~----~~~-~~~~ 234 (444)
T 3soa_A 165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKA----GAY-DFPS 234 (444)
T ss_dssp TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH----TCC-CCCT
T ss_pred CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHh----CCC-CCCc
Confidence 4322 2234579999999999999999999999999999999999999997532 1122221111 110 0001
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. ... ...+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEW-DTV----TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 112 235789999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.62 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=205.9
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence 44689999999999999754 367899999875433 33457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccC------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 605 PFMSNGSLQDRLYGEA------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
||+++|+|.+++.... .....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCcc
Confidence 9999999999995421 112457899999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+. .+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~~ 257 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFVM----EGG 257 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHHHH----TTC
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHHHHHH----cCC
Confidence 986543322222223456889999999999999999999999999999999 8999875421 11222111 111
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
... ... .....+.+++.+|++.+|++||++.|+++.|++.+.
T Consensus 258 ~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 258 LLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCC-----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 100 111 223458899999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=352.51 Aligned_cols=266 Identities=25% Similarity=0.393 Sum_probs=204.4
Q ss_pred hhcceecccCcEEEEEEec-----CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC--eeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-----PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND--QQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ 604 (863)
.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEE
Confidence 4468999999999999983 468899999988766666778999999999999999999999987654 689999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999543 3468999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc----ccccc
Q 002943 685 EGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR----ESRID 759 (863)
Q Consensus 685 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~----~~~~~ 759 (863)
.... .......++..|+|||.+.+..++.++||||||++++||+||+.|+..... ...+....... ...+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhHHHHH
Confidence 3221 111223467789999999988899999999999999999999998753210 00000000000 00000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+.+...............+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111000111223346889999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=345.79 Aligned_cols=271 Identities=29% Similarity=0.377 Sum_probs=207.7
Q ss_pred HHHHHHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhc--CCcccccceeeeEeeCC---
Q 002943 524 QYLEAATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSA--IRHENLVPLLGYCCEND--- 598 (863)
Q Consensus 524 ~~l~~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~--- 598 (863)
.+.....+.+.+.||+|+||.||+|+. +|+.||||++... ..+.+.+|.+++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344445556679999999999999998 5899999998643 34677889998887 78999999999998876
Q ss_pred -eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-----CCCccccCCCCCCeEecCCCeEE
Q 002943 599 -QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-----GRSVIHRDVKSSNILLDHSMCAK 672 (863)
Q Consensus 599 -~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDik~~NILld~~~~~k 672 (863)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||... .++|+||||||+|||++.++.+|
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 78999999999999999943 35899999999999999999999210 28999999999999999999999
Q ss_pred EeeccCcccCCCCCCCC--ceeeeecCCCCCCccccccCC------CCcccceechhhHHHHHHhC----------CCCC
Q 002943 673 VADFGFSKYAPQEGDSG--FSLEVRGTAGYLDPEYYSTQH------LSAKSDVFSFGVVLLEIISG----------REPL 734 (863)
Q Consensus 673 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SfGvvl~ElltG----------~~p~ 734 (863)
|+|||+++......... ......||..|+|||.+.+.. ++.++|||||||++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999997654332110 123346899999999997652 33689999999999999999 6777
Q ss_pred CCCCCCCcchhHHhhhhcccccccccccCCccCCC-CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 735 NTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG-YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 735 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
....... .....+...... ....+.+... ...++...+.+++.+||+.+|++||++.||++.|+++...
T Consensus 268 ~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPSD-PSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCSS-CCHHHHHHHHTT-----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcCc-ccHHHHHHHHHH-----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 6543221 111222111111 1111222111 1235667899999999999999999999999999998743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=352.26 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=198.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 44589999999999999965 57899999887543 23345688999999887 899999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++......
T Consensus 135 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 135 VNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 999999999953 2468999999999999999999999 899999999999999999999999999998643222
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc--chhHHhhhhcccccccccccCC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE--WSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....++....+.... .
T Consensus 208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~ 279 (396)
T 4dc2_A 208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------I 279 (396)
T ss_dssp --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------C
T ss_pred --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------c
Confidence 223456799999999999999999999999999999999999999975432111 111111111111111 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHH---HHHHHHHHh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMV---DIVRELEDA 806 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~---eVl~~L~~~ 806 (863)
.+.... ...+.+++.+|++.+|++||++. .+.+.++..
T Consensus 280 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 280 RIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 111122 23578999999999999999963 344445443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=351.27 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=198.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 44689999999999999854 68899999876532 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 98 LGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp TTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 99999999943 3468999999999999999999999 899999999999999999999999999998765332
Q ss_pred CCceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..........+........ .
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------~ 237 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV----------V 237 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC----------C
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc----------c
Confidence 2334579999999999974 458899999999999999999999997654332222222111100 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCC-HHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPS-MVDIV 800 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-m~eVl 800 (863)
.....+ ...+.+++.+|++.+|++||+ +.+|.
T Consensus 238 ~~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 238 TYPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 111122 245889999999999999998 55554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=340.21 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=200.7
Q ss_pred hhcceecccCcEEEEEEecCC----CCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|...+ +..||||++.... ....+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 346899999999999998532 3469999887653 2345789999999999999999999999865 456899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 94 YPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp CTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999999542 3458999999999999999999999 899999999999999999999999999998764332
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+.... +.. ..
T Consensus 168 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~----~~~-----~~ 234 (281)
T 3cc6_A 168 Y-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK----GDR-----LP 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH----TCC-----CC
T ss_pred c-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc----CCC-----CC
Confidence 1 11223457889999999999999999999999999999998 99999754321 12221111 100 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.... ....+.+++.+|++.+|++||++.|+++.|+++++.+
T Consensus 235 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 235 KPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 1111 2235889999999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.15 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=192.0
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.++||+|+||.||+++.. +|+.||||++.+. .....+.+.+|.++++.+ +||||+++++++...+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 345689999999999999864 6899999988654 223446688999999988 69999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 105 FVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999542 468999999999999999999999 89999999999999999999999999999864322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..+.+.+.. +. ..
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~----~~------~~ 242 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILN----DE------VV 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----CC------CC
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HHHHHHHHc----CC------CC
Confidence 1 223445799999999999988999999999999999999999999976431 112111111 10 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+.... ...+.+++.+|++.+|++||++
T Consensus 243 ~p~~~----~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 243 YPTWL----HEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCC----CHHHHHHHHHHhhhCHHHccCC
Confidence 11112 2347889999999999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=343.83 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=193.0
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
++||+|+||.||+|.. .+|+.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 6799999999999985 47899999998877666678899999999985 799999999999999999999999999999
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe---EEEeeccCcccCCCCCCC-
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC---AKVADFGFSKYAPQEGDS- 688 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DFGla~~~~~~~~~- 688 (863)
.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++........
T Consensus 99 ~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 99 LSHIHKR----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp HHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 9999542 468999999999999999999999 89999999999999998776 999999999865432211
Q ss_pred ----CceeeeecCCCCCCcccccc-----CCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhH-------Hhhhh
Q 002943 689 ----GFSLEVRGTAGYLDPEYYST-----QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLV-------EWAKP 751 (863)
Q Consensus 689 ----~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~-------~~~~~ 751 (863)
.......||..|+|||.+.. ..++.++|||||||++|||++|+.||......+. +... .....
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 11123458999999999875 4578999999999999999999999986543221 0000 00000
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+..+.. ...++ ... .....+.+++.+|++.||++|||+.|+++
T Consensus 252 ~i~~~~~-~~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 252 SIQEGKY-EFPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHCCC-CCCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhccCc-ccCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0111100 00000 000 12245889999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.89 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=196.3
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.+.||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 455679999999999999985 468999999876554 334578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~ 684 (863)
++|+|.+++.........+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999996543344679999999999999999999999 899999999999999 4568899999999986643
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. ......||..|+|||.+. ..++.++||||||++++||++|+.||..... ..+....... .....
T Consensus 180 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~--~~~~~----- 245 (285)
T 3is5_A 180 DE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYK--EPNYA----- 245 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC--CCCCC-----
T ss_pred cc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccC--Ccccc-----
Confidence 22 223456899999999885 5689999999999999999999999976431 1111111110 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...... ...+.+++.+|++.+|++||++.|+++
T Consensus 246 ~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 VECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111 235778999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.83 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=201.8
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ey 606 (863)
.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++|+||
T Consensus 32 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred EEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 4468999999999999995 6799999998876666667789999999999999999999999973 3478899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.........+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999996544445679999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCC-------ceeeeecCCCCCCccccccCC---CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 687 DSG-------FSLEVRGTAGYLDPEYYSTQH---LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 687 ~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
... ......||..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .+........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~--- 264 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQNQL--- 264 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHCC----
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhccC---
Confidence 100 001234799999999987554 68899999999999999999999954211110 1111111000
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
. . .........+.+++.+|++.+|.+||++.|+++.|+.+.
T Consensus 265 ------~--~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 265 ------S--I--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---------C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ------C--C--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 0 001112235889999999999999999999999999765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.42 Aligned_cols=271 Identities=20% Similarity=0.275 Sum_probs=209.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCC--eeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCEND--QQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ey~ 607 (863)
.+.++||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 34589999999999999965 58999999987543 234567889999999999999999999998765 679999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe----cCCCeEEEeeccCcccCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla~~~~ 683 (863)
++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 92 ~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 92 PCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999995432 22349999999999999999999999 899999999999999 888899999999998764
Q ss_pred CCCCCCceeeeecCCCCCCcccccc--------CCCCcccceechhhHHHHHHhCCCCCCCCCCCC-cchhHHhhhhccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST--------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN-EWSLVEWAKPFIR 754 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~-~~~l~~~~~~~~~ 754 (863)
... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...+.........
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 332 1223569999999999865 467789999999999999999999997543221 1111111111111
Q ss_pred cccccccc---------CCc--cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 755 ESRIDEIV---------DPS--IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 755 ~~~~~~i~---------d~~--l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
...+..+. ... ............+.+++.+|++.||++||++.|+++.|++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111000 001 11233456677888999999999999999999999999988753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=334.55 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=200.9
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 445689999999999999964 78999999876543 3345788999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999983 23468999999999999999999999 89999999999999999999999999999865433222
Q ss_pred CceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||..|+|||.+.+..+ +.++||||||++++||++|+.||....... ..+..|...... ..+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-------~~~--- 230 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTY-------LNP--- 230 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTTCTT-------STT---
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhcccc-------cCc---
Confidence 22334568999999999987665 779999999999999999999997643221 122222221100 000
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112235788999999999999999998865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=347.89 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=183.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||++++++|...+..++||||+++|
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 34589999999999999965 58899999987543 3467889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~~~ 687 (863)
+|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 134 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 134 ELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp BHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 99999943 3468999999999999999999999 89999999999999975 8999999999998664321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+..... .... ....+ ..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~----~~~~-~~~~~-~~ 275 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRIL----NCEY-YFISP-WW 275 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHH----TTCC-CCCTT-TT
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHH----hCCC-ccCCc-hh
Confidence 223456899999999999999999999999999999999999999754321 11111111 1100 00011 11
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. +....+.+++.+|++.+|++||++.|+++
T Consensus 276 ~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 D----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 22345889999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.02 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.4
Q ss_pred hcc-eecccCcEEEEEEec---CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 533 YKT-LIGEGGFGSVYRGTL---PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 533 f~~-~LG~G~fG~Vy~g~~---~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+ .||+|+||.||+|.. .+++.||||++..... ...+++.+|++++++++||||+++++++ +.+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 344 899999999999953 3468899998875532 2356899999999999999999999999 66778999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 99 AELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp CTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 999999999954 2458999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 687 DSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+.+.. +.. +
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~~~-----~ 239 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEK----GER-----M 239 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT----TCC-----C
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----CCC-----C
Confidence 211 1122346788999999998889999999999999999999 9999976432 122222211 110 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.... .....+.+++.+|++.+|++||++.||++.|++++..
T Consensus 240 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 GCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 2234588999999999999999999999999998744
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=337.58 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=194.8
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.++||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 34579999999999999964 689999998865433 234678899999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 85 Q-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp E-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred C-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 5 66666532 23569999999999999999999999 899999999999999999999999999998764322
Q ss_pred CceeeeecCCCCCCccccccCC-CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccc---cccc
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESR---IDEI 761 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~---~~~i 761 (863)
.......||..|+|||.+.+.. ++.++|||||||+++||++|+.|+..... ............. ... ....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhccc
Confidence 1223456899999999998765 79999999999999999999888643221 1111111111000 000 0000
Q ss_pred cC---------CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VD---------PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d---------~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+ ..............+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00000111122345789999999999999999999865
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=346.48 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=186.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEe--------eCCeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCC--------ENDQQI 601 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~--------~~~~~~ 601 (863)
.+.++||+|+||.||+|.. .+|+.||||++........+.+.+|+.++.++. ||||+++++++. .....+
T Consensus 31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 4568999999999999995 478999999887666666678999999999996 999999999994 334578
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
+|+||+. |+|.+++.... ....+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 111 lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 9999995 89999985422 23469999999999999999999999 66 999999999999999999999999999
Q ss_pred ccCCCCCCCC----------ceeeeecCCCCCCcccc---ccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH
Q 002943 680 KYAPQEGDSG----------FSLEVRGTAGYLDPEYY---STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746 (863)
Q Consensus 680 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 746 (863)
+......... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||....... +.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~ 262 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---IV 262 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---hh
Confidence 8765432211 11134589999999998 56678999999999999999999999997532110 00
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcccc
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~~ 811 (863)
. . ... ....... ...+.+++.+|++.+|++||++.|+++.|+.+.....
T Consensus 263 ~---~-----~~~----~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 N---G-----KYS----IPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------CC----CCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred c---C-----ccc----CCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 0 000 0000111 1237789999999999999999999999998875433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.94 Aligned_cols=269 Identities=25% Similarity=0.376 Sum_probs=193.6
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHH--HhcCCcccccceeeeEee-----CCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNF--LSAIRHENLVPLLGYCCE-----NDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~LV~ 604 (863)
.+.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ....++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 3458999999999999987 68999999986442 3344445544 556899999999986543 23568999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc------CCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA------GRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
||+++|+|.+++.. ...++..+++++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999943 23589999999999999999999831 12999999999999999999999999999
Q ss_pred cccCCCCCC------CCceeeeecCCCCCCcccccc-------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-
Q 002943 679 SKYAPQEGD------SGFSLEVRGTAGYLDPEYYST-------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS- 744 (863)
Q Consensus 679 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~- 744 (863)
++....... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.|+..........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987643221 111223459999999999976 356678999999999999999987765433211110
Q ss_pred -hHHhhhhccccccc-----ccccCCccCCC--CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 745 -LVEWAKPFIRESRI-----DEIVDPSIKGG--YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 745 -l~~~~~~~~~~~~~-----~~i~d~~l~~~--~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+............+ .....+.+... ........+.+++.+||+.+|++|||+.||++.|++++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00000000000000 00011111111 1223566799999999999999999999999999998843
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=343.05 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=197.7
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 34589999999999999864 79999999886542 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 89 EGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999953 3468999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+ ... . ..+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i---~~~-~------~~~p 223 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKI---LNA-E------LRFP 223 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH---HHC-C------CCCC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhC-C------CCCC
Confidence 234569999999999999999999999999999999999999997532 11111111 110 0 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+ ..+.+++.+|++.+|++|| ++.|+++
T Consensus 224 ~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1222 3578999999999999999 7777753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=359.37 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=205.5
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc-ccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH-ENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.++||+|+||.||+|.. .+++.||||++..... ..++..|+++++.++| +++..+..++.+.+..+|||||+ +
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 3458999999999999995 6799999998765433 3468899999999987 55666666777888899999999 9
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~~~ 686 (863)
++|.+++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++......
T Consensus 87 ~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 87 PSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999999532 3469999999999999999999999 899999999999999 688999999999998765432
Q ss_pred CCC-----ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 687 DSG-----FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 687 ~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
... ......||..|+|||.+.+..++.++|||||||+||||++|+.||............+..........+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA- 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH-
Confidence 211 12245699999999999999999999999999999999999999987654333222222211111111111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
+...+ ..++.+++..|++.+|++||++.+|+++|++++...
T Consensus 240 ----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 ----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11112 245889999999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.97 Aligned_cols=257 Identities=29% Similarity=0.406 Sum_probs=202.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCE--EEEEEcccC-CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQE--VAVKVRSST-STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~--vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|... +|.. +|||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 45689999999999999864 4554 489987643 234456799999999999 899999999999999999999999
Q ss_pred CCCCChhhhhhccC------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 607 MSNGSLQDRLYGEA------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 607 ~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
+++|+|.+++.... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEc
Confidence 99999999996542 223579999999999999999999999 899999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+...
T Consensus 185 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~--- 255 (327)
T 1fvr_A 185 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP--- 255 (327)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG---
T ss_pred ccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHhh---
Confidence 999997543211 1223457889999999998889999999999999999998 9999976431 11211111
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
.+. ...... .....+.+++.+|++.+|++||++.|+++.|+.++...
T Consensus 256 -~~~-----~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 -QGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -GTC-----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -cCC-----CCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 110 011111 12245889999999999999999999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=349.78 Aligned_cols=241 Identities=27% Similarity=0.415 Sum_probs=195.0
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
..+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|++++++++||||+++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 357899999999999985 67899999988754332 23578899999999999999999999999999999999996
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
|+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 -g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 138 -GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp -EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred -CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 7888888432 3568999999999999999999999 89999999999999999999999999999866432
Q ss_pred CceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 689 GFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||..... . +......... .+.
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~---~~~~~~~~~~------~~~ 272 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQNE------SPA 272 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHHHSC------CCC
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---H---HHHHHHHhcC------CCC
Confidence 2346899999999984 56789999999999999999999999975421 1 1111111111 111
Q ss_pred cC-CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 766 IK-GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 766 l~-~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+. ... ...+.+++.+||+.+|++|||+.|+++.
T Consensus 273 ~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 LQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 112 2347889999999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=348.24 Aligned_cols=263 Identities=18% Similarity=0.194 Sum_probs=195.6
Q ss_pred HhhcceecccCcEEEEEEecC----CCCEEEEEEcccCCCc-----------chHHHHHHHHHHhcCCcccccceeeeEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTSTQ-----------GTREFENELNFLSAIRHENLVPLLGYCC 595 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~~~ 595 (863)
+.+.+.||+|+||.||+|... ++..+|||+....... ..+.+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 345689999999999999965 5788999987755322 1234678889999999999999999998
Q ss_pred e----CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC--
Q 002943 596 E----NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-- 669 (863)
Q Consensus 596 ~----~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-- 669 (863)
. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 8 67889999999 9999999943 2379999999999999999999999 8999999999999999887
Q ss_pred eEEEeeccCcccCCCCCCC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch
Q 002943 670 CAKVADFGFSKYAPQEGDS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS 744 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~ 744 (863)
.+||+|||+++........ .......||..|+|||.+.+..++.++|||||||++|||++|+.||...... ...
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-PVA 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-HHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-cHH
Confidence 9999999999876432211 1113456999999999999999999999999999999999999999643211 111
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+ ......... .+...+...... ......+.+++.+|++.+|++||++.+|++.|+.+.
T Consensus 270 ~-~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 V-QTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp H-HHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred H-HHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1 111111110 011100000000 012235889999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=350.11 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=189.2
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||+||++... +|+.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 345689999999999999965 78999999887543 3346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe--EEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC--AKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 101 ~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 101 GELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 999999953 2458999999999999999999999 89999999999999987765 9999999998543221
Q ss_pred CCceeeeecCCCCCCccccccCCCCcc-cceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAK-SDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........ ............ . .+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~-~------~~ 241 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVK-Y------SI 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTC-C------CC
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCC-C------CC
Confidence 1234469999999999988887665 8999999999999999999976443221 111111111100 0 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.. .......+.+++.+|++.+|++|||+.|+++.
T Consensus 242 ~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 00112357899999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=332.24 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=199.9
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 445689999999999999964 5789999998877666778899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~~~ 686 (863)
++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 91 ~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 91 GELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 999999854 2458999999999999999999999 899999999999999 888999999999998765332
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|+|||.+.+. ++.++||||||++++||++|+.||..... ........ .+... ... ..
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~-~~~-~~ 230 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIR----EGTFT-FPE-KD 230 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HCCCC-CCH-HH
T ss_pred ---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----hCCCC-CCc-hh
Confidence 22344699999999998654 89999999999999999999999975431 11111111 11000 000 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. .....+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 11345889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.85 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=201.1
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ------GTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.+.||+|+||.||++... +|+.||||++...... ..+++.+|++++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4456789999999999999964 6899999987654322 35679999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC----eEEEeeccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM----CAKVADFGF 678 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGl 678 (863)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 93 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999943 3468999999999999999999999 8999999999999999887 799999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
++....... .....||+.|+|||.+.+..++.++||||||++++||++|+.||..... ......... ..
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~----~~- 234 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITS----VS- 234 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHT----TC-
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh----cc-
Confidence 987654321 2344689999999999999999999999999999999999999975321 111111110 00
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...++...... ...+.+++.+|++.+|++|||+.|+++
T Consensus 235 -~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 -YDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -CCCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -cccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011111112 235789999999999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.97 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=194.6
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccC-----CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST-----STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
.+.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 344568999999999999985 56889999987643 334557899999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCC------------------------------------CCccCChhhHHHHHHHHHHHHHHHHh
Q 002943 604 YPFMSNGSLQDRLYGEAS------------------------------------TRKTLDWPTRLSIALGAARGLMYLHT 647 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~------------------------------------~~~~l~~~~~~~ia~~ia~gL~yLH~ 647 (863)
|||+++|+|.+++..... ....+++.....++.|++.||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999842100 02234567788999999999999999
Q ss_pred ccCCCccccCCCCCCeEecCCC--eEEEeeccCcccCCCCCCC--CceeeeecCCCCCCcccccc--CCCCcccceechh
Q 002943 648 FAGRSVIHRDVKSSNILLDHSM--CAKVADFGFSKYAPQEGDS--GFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFG 721 (863)
Q Consensus 648 ~~~~~iiHrDik~~NILld~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfG 721 (863)
.+|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||.+.+ ..++.++||||||
T Consensus 187 ---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp ---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred ---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 8999999999999998776 8999999999865332211 12234569999999999975 6789999999999
Q ss_pred hHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 722 VVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 722 vvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
|++|||++|+.||...... .... ....... ....+.. ......+.+++.+|++.+|++||++.|+++
T Consensus 264 ~il~el~~g~~pf~~~~~~---~~~~---~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDA---DTIS---QVLNKKL--CFENPNY-----NVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC--CTTSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChH---HHHH---HHHhccc--ccCCccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999754311 1111 1111100 0000110 012235789999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.63 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=194.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|.+++.++ +||||+++++++...+..++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 34589999999999999964 688999999876532 2345678999999988 899999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 92 VNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999532 468999999999999999999999 899999999999999999999999999998643222
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc--hhHHhhhhcccccccccccCC
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW--SLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...+.....+.... .
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------~ 236 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------I 236 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------C
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------C
Confidence 1234457999999999999999999999999999999999999999753221110 11111111111111 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.+.... ...+.+++.+|++.+|++||++
T Consensus 237 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPRSL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 111122 2357889999999999999996
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.54 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=201.6
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee-----------
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE----------- 596 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----------- 596 (863)
..+...+.||+|+||.||+|... +|+.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 34445689999999999999975 79999999886543 467899999999999999999998864
Q ss_pred -----CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeE
Q 002943 597 -----NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCA 671 (863)
Q Consensus 597 -----~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~ 671 (863)
....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 44579999999999999999543 23468999999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh
Q 002943 672 KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP 751 (863)
Q Consensus 672 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~ 751 (863)
||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFT- 229 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHH-
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHH-
Confidence 9999999987654321 23346899999999999999999999999999999999999886421 11111
Q ss_pred cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 752 FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 752 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.... ..+...++ ..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 230 ~~~~--------~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLRD--------GIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHT--------TCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhhc--------ccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0111 11112222 247789999999999999999999999988764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=336.83 Aligned_cols=248 Identities=31% Similarity=0.450 Sum_probs=194.9
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC-CeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN-DQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||++.. .|+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||+++|
T Consensus 24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 4568999999999999987 48899999987543 457899999999999999999999997655 4789999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 101 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 999999532 12348899999999999999999999 899999999999999999999999999998654321
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
....++..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+...+.. + ..+.....
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~----~-----~~~~~~~~ 238 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK----G-----YKMDAPDG 238 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT----T-----CCCCCCTT
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----C-----CCCCCccc
Confidence 22357889999999999999999999999999999998 9999975432 112221111 1 01111112
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
....+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 239 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 239 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 23458899999999999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=344.32 Aligned_cols=241 Identities=21% Similarity=0.306 Sum_probs=185.4
Q ss_pred HhhcceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+++. .+|+.||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 34568999999999999986 478999999887542 2334568899999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 99 ILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999953 2458899999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ....+.+.. ..
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~----~~----- 237 (327)
T 3a62_A 172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILK----CK----- 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH----TC-----
T ss_pred ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHh----CC-----
Confidence 3221 122335689999999999999999999999999999999999999975421 111111111 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMV 797 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~ 797 (863)
..+.... ...+.+++.+|++.+|++||++.
T Consensus 238 -~~~p~~~----~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 238 -LNLPPYL----TQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp -CCCCTTS----CHHHHHHHHHHSCSCGGGSTTSS
T ss_pred -CCCCCCC----CHHHHHHHHHHHhcCHhhccCCC
Confidence 0111122 23578999999999999999543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.04 Aligned_cols=263 Identities=21% Similarity=0.297 Sum_probs=198.2
Q ss_pred hhcceeccc--CcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEG--GFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G--~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.++||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEc
Confidence 446899999 99999999965 79999999886543 23346788899999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 108 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 108 MAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp CTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred cCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999999543 23458999999999999999999999 899999999999999999999999999986542211
Q ss_pred C-----CCceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc----
Q 002943 687 D-----SGFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE---- 755 (863)
Q Consensus 687 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 755 (863)
. ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.+........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccccc
Confidence 1 111122368899999999987 5789999999999999999999999976543221 11110000000
Q ss_pred -----c-------------ccccccC---Ccc------CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 -----S-------------RIDEIVD---PSI------KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 -----~-------------~~~~i~d---~~l------~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ...+.+. +.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0000000 000 00011122345889999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=340.25 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=193.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCC
Confidence 4589999999999999964 5899999987654332 246788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 157 (311)
T 4agu_A 87 TVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-- 157 (311)
T ss_dssp EHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred chHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence 999998843 3468999999999999999999999 8999999999999999999999999999987643221
Q ss_pred ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh-hhhc-------ccc-ccc-
Q 002943 690 FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW-AKPF-------IRE-SRI- 758 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~-~~~~-------~~~-~~~- 758 (863)
......||..|+|||.+.+ ..++.++||||||++++||++|+.||......+....... .... +.. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2234568999999999976 5789999999999999999999999976432211111100 0000 000 000
Q ss_pred -ccccCCccCCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 -DEIVDPSIKGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 -~~i~d~~l~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.++.-.... .......+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000111100000 0112345789999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.87 Aligned_cols=259 Identities=22% Similarity=0.249 Sum_probs=195.6
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-----CcchHHHHHHHHHHhcCC---cccccceeeeEeeCC---
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-----TQGTREFENELNFLSAIR---HENLVPLLGYCCEND--- 598 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-----~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~--- 598 (863)
+.+.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++ ||||++++++|....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 34568999999999999995 578999999876432 122356778888887775 999999999998765
Q ss_pred --eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 599 --QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 599 --~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
..++||||+. |+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred ceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4789999996 6999999543 23349999999999999999999999 88999999999999999999999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc--
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR-- 754 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~-- 754 (863)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............
T Consensus 165 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 165 GLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLP 238 (308)
T ss_dssp SCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred ccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 9998764322 22345689999999999999999999999999999999999999976432 111111111100
Q ss_pred -cccccc-------ccCCccCCC---CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 -ESRIDE-------IVDPSIKGG---YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 -~~~~~~-------i~d~~l~~~---~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...... .+.+..... ...+....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 000000000 00112345789999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=346.92 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=202.1
Q ss_pred HhhcceecccCcEEEEEEec------CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 603 (863)
+.+.+.||+|+||.||+|.. .+++.||||++.... .....++.+|+.++++++||||+++++++...+..++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 34568999999999999984 257789999986543 33456789999999999999999999999999999999
Q ss_pred eecCCCCChhhhhhccCC---CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeecc
Q 002943 604 YPFMSNGSLQDRLYGEAS---TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFG 677 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFG 677 (863)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++ .+..+||+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999965432 22458999999999999999999999 8999999999999998 45569999999
Q ss_pred CcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 678 FSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 678 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
+++...............||..|+|||.+.+..++.++||||||+++|||+| |+.||.... ...+.+.+...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~---- 261 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSG---- 261 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTT----
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHHHhcC----
Confidence 9975533222222233457889999999999999999999999999999998 999997542 11222222211
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.. +..... ....+.+++.+||+.+|.+||++.||++.|+.+..
T Consensus 262 ~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 262 GR-----MDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----CCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00 011111 22358899999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=359.42 Aligned_cols=249 Identities=20% Similarity=0.222 Sum_probs=196.3
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|..++..++||||++++++|.+.+..+||||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 489999999999999975 57899999886532 22334589999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ...+++.....++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++....... .
T Consensus 159 g~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~ 231 (437)
T 4aw2_A 159 GDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 231 (437)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred CcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-c
Confidence 9999999542 3569999999999999999999999 8999999999999999999999999999986643322 1
Q ss_pred ceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 690 FSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+.. .. ....-|
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~---~~--~~~~~p 303 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMN---HK--ERFQFP 303 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT---HH--HHCCCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhh---cc--ccccCC
Confidence 223357999999999997 56789999999999999999999999975431 111111111 00 000011
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCC--CCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAY--RPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~ 801 (863)
......+ ..+.+++.+|+..+|++ ||++.|+++
T Consensus 304 ~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 304 TQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111222 34778899999888887 999998865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.63 Aligned_cols=195 Identities=27% Similarity=0.346 Sum_probs=170.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-----cccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-----HENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||.||+|+. .+++.||||++... ....+.+..|++++++++ ||||+++++++...+..++|||
T Consensus 38 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e 116 (360)
T 3llt_A 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116 (360)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEc
Confidence 3458999999999999996 57899999988642 234466788999999996 9999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC------------------
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH------------------ 667 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~------------------ 667 (863)
|+ +++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 117 ~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 117 PL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp CC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred CC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99 99999999643 23458999999999999999999999 89999999999999976
Q ss_pred -------CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 668 -------SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 668 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999865432 223468999999999999999999999999999999999999997643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.10 Aligned_cols=238 Identities=21% Similarity=0.333 Sum_probs=196.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l 106 (335)
T 3dls_A 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL 106 (335)
T ss_dssp EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence 3458999999999999984 5789999998876532 133568899999999999999999999999999999
Q ss_pred EeecCCCC-ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 603 VYPFMSNG-SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 603 V~ey~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 v~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 107 VMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999877 99999843 3469999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
..... ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... . ...
T Consensus 180 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~---------~~~ 239 (335)
T 3dls_A 180 LERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------T---------VEA 239 (335)
T ss_dssp CCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------G---------TTT
T ss_pred CCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------H---------Hhh
Confidence 65432 2234569999999999988776 7899999999999999999999964211 0 000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
...+ .... ...+.+++.+|++.+|++||++.|+++.
T Consensus 240 ~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0112 2358899999999999999999999763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=349.02 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=197.6
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||.||+|+.. +|+.||||+++... ....+.+..|.+++.++ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 44689999999999999964 68999999886542 33456678899999887 899999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 100 LNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 999999999953 2468999999999999999999999 899999999999999999999999999998653222
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+.. + .+.+
T Consensus 173 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~----~------~~~~ 237 (345)
T 1xjd_A 173 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRM----D------NPFY 237 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----C------CCCC
T ss_pred --CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHh----C------CCCC
Confidence 12345679999999999999999999999999999999999999997542 1112221111 1 1111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHH-HHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMV-DIV 800 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl 800 (863)
.... ...+.+++.+|++.+|++||++. |+.
T Consensus 238 p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred Cccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1122 23578899999999999999997 553
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.79 Aligned_cols=245 Identities=24% Similarity=0.423 Sum_probs=178.7
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 3458999999999999985 579999999876432 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 94 ~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 94 HNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp TTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999532 3568999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|+|||.+.+..++.++||||||++++||++|+.||........ .. ... .. +..+.
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~----~~---~~~~~ 232 (278)
T 3cok_A 168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---LN---KVV----LA---DYEMP 232 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----SS---CCCCC
T ss_pred --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---HH---HHh----hc---ccCCc
Confidence 12235689999999999988899999999999999999999999976432111 00 000 00 11111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 122 235789999999999999999998865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=353.93 Aligned_cols=238 Identities=18% Similarity=0.205 Sum_probs=185.3
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHH---HHHhcCCccccccee-------eeEeeCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENEL---NFLSAIRHENLVPLL-------GYCCEND 598 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~~~~~ 598 (863)
+.+.||+|+||.||+|.. .+|+.||||++... .....+.|.+|+ +++++++||||++++ +++...+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 357899999999999996 56999999998743 334457889999 556666899999998 5555443
Q ss_pred -----------------eeEEEeecCCCCChhhhhhccC---CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCC
Q 002943 599 -----------------QQILVYPFMSNGSLQDRLYGEA---STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDV 658 (863)
Q Consensus 599 -----------------~~~LV~ey~~~gsL~~~L~~~~---~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDi 658 (863)
..++||||+ +|+|.+++.... .....+++..++.|+.|++.||+|||+ .+|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 278999999 689999996421 112346678999999999999999999 89999999
Q ss_pred CCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC-----------CCCcccceechhhHHHHH
Q 002943 659 KSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-----------HLSAKSDVFSFGVVLLEI 727 (863)
Q Consensus 659 k~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~SfGvvl~El 727 (863)
||+|||++.++.+||+|||+++.... ......| ..|+|||.+.+. .++.++|||||||++|||
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999985322 2334557 999999999887 899999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 728 ISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 728 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
++|+.||........ .. .+.. . ....+ ..+.+++.+||+.+|++||++.|+++
T Consensus 307 ltg~~Pf~~~~~~~~---~~------------~~~~-~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGG---SE------------WIFR-S-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CC---SG------------GGGS-S-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccc---hh------------hhhh-h-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999975432111 01 1110 0 01222 35889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.14 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=191.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCee----EEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQ----ILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~----~LV 603 (863)
.+.+.||+|+||.||++.. .+++.||||++...... ..+.+.+|++++++++||||+++++++...... ++|
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 4468999999999999995 67899999998765332 235788999999999999999999998766543 999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999532 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~-- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP-- 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCH--
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCc--
Confidence 43221 122335689999999999999999999999999999999999999975431 111111111110000
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHH-HHHHHh
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIV-RELEDA 806 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl-~~L~~~ 806 (863)
....... ...+.+++.+|++.+|++||+..+++ +.|...
T Consensus 240 -~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 -SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0001111 23578999999999999999766554 455444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.80 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=197.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 124 (350)
T 1rdq_E 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 3578999999999999964 68999999876542 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 125 GGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp TCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999542 358999999999999999999999 89999999999999999999999999999876432
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+. .+. ..+..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~----~~~------~~~p~ 259 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIV----SGK------VRFPS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HCC------CCCCT
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHH----cCC------CCCCC
Confidence 234569999999999999999999999999999999999999997532 111111111 111 11112
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 801 (863)
..+ ..+.+++.+|++.+|++||+ +.||++
T Consensus 260 ~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 HFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 222 35789999999999999998 666643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=333.52 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=195.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 44689999999999999964 6889999998755332 2467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 117 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 117 NGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999999532 468999999999999999999999 8999999999999999999999999999986643321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ..+......... .... ..
T Consensus 190 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~---~~~~----~~ 258 (309)
T 2h34_A 190 -TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---SVMGAHINQAIP---RPST----VR 258 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---HHHHHHHHSCCC---CGGG----TS
T ss_pred -ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---HHHHHHhccCCC---Cccc----cC
Confidence 112344689999999999999999999999999999999999999975321 111111111000 0000 11
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhhcc
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-SMVDIVRELEDAFII 809 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~~~ 809 (863)
... ...+.+++.+|++.+|++|| ++.++++.|+.++..
T Consensus 259 ~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 259 PGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp TTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 112 23578899999999999999 999999999988743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=333.02 Aligned_cols=243 Identities=22% Similarity=0.340 Sum_probs=195.2
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||+|... +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 344689999999999999965 79999999877543 33456788999999999 999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-------------------
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH------------------- 667 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~------------------- 667 (863)
+++|+|.+++.........+++..++.++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999996543333568999999999999999999999 89999999999999984
Q ss_pred CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH
Q 002943 668 SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~ 746 (863)
...+||+|||+++...... ...||..|+|||.+.+. .++.++||||||++++||++|+.++.... ...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~ 238 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----QWH 238 (289)
T ss_dssp CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----HHH
T ss_pred ceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----HHH
Confidence 4479999999998764322 23489999999999776 56689999999999999999988764321 111
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. ..+.. +.+....+ ..+.+++.+|++.+|++||++.|+++
T Consensus 239 ~~-----~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 EI-----RQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-----HTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 11111 11222222 35889999999999999999999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.71 Aligned_cols=246 Identities=23% Similarity=0.257 Sum_probs=195.5
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.++||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|+++++.++||||++++++|.+.+..++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 478999999999999965 6899999987652 223345688999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.. ..+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 154 g~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~ 224 (410)
T 3v8s_A 154 GDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224 (410)
T ss_dssp EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred CcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence 999999843 258899999999999999999999 8999999999999999999999999999987643321 1
Q ss_pred ceeeeecCCCCCCccccccCC----CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQH----LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ....+.+.. ... .+.-|.
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~---~~~--~~~~p~ 296 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMN---HKN--SLTFPD 296 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT---HHH--HCCCCT
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHh---ccc--cccCCC
Confidence 123457999999999998765 78899999999999999999999975321 111111111 000 000000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCC--CCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAY--RPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~--RPsm~eVl~ 801 (863)
....+ ..+.+++.+|++.+|++ ||++.||++
T Consensus 297 -~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 297 -DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 01122 34788999999999988 999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=358.89 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.++||+|+||.||++.. .+|+.||||++... .......+.+|++++++++||||++++++|...+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 3458999999999999985 57899999988653 3334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++..+..++.|++.||+|||+. ++|+||||||+||||+.++.+||+|||+++......
T Consensus 231 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 231 NGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp SSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 99999999953 24689999999999999999999962 679999999999999999999999999998643322
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+.. . . ..+.
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~---~-~------~~~p 369 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM---E-E------IRFP 369 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---C-C------CCCC
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHh---C-C------CCCC
Confidence 123345799999999999999999999999999999999999999975321 112211111 0 0 0111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+ ..+.+++.+|++.||++|| ++.|+++
T Consensus 370 ~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 RTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1222 3578999999999999999 8888764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.72 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=195.3
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+++.. +|+.||||++.... ....+.+..|.+++..+ +||||+++++++...+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 345689999999999999975 48899999886542 33456788999999988 79999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ..+++...+.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 102 YVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999532 358999999999999999999999 89999999999999999999999999999864322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+.. +. ..
T Consensus 175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~----~~------~~ 239 (353)
T 2i0e_A 175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIME----HN------VA 239 (353)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CC------CC
T ss_pred C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHh----CC------CC
Confidence 2 12334579999999999999999999999999999999999999997532 1122221111 10 11
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+.... ...+.+++.+|++.+|++||++
T Consensus 240 ~p~~~----s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 YPKSM----SKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 11122 2357899999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.53 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=198.0
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.+.||+|+||.||++... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 4456789999999999999965 689999998765432 135789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC----eEEEeeccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM----CAKVADFGF 678 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGl 678 (863)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+
T Consensus 86 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 86 ILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999953 3468999999999999999999999 8999999999999998877 899999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
++....... .....||+.|+|||.+.+..++.++||||||++++||++|+.||..... ......... ...
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----~~~ 228 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISA----VNY 228 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT----TCC
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHh----ccc
Confidence 987643221 2234689999999999999999999999999999999999999975421 111111110 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 759 ~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..++..... ....+.+++.+|++.+|++||++.|+++
T Consensus 229 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 --DFDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCcchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000001111 1235789999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.40 Aligned_cols=242 Identities=24% Similarity=0.370 Sum_probs=194.7
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 4589999999999999854 67899999875432 2334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 93 LGTVYRELQKL----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp TEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 99999999532 458999999999999999999998 899999999999999999999999999987554321
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....||..|+|||.+.+..++.++||||||++++||++|+.||..... ......... . ...+..
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~----~------~~~~~~ 228 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISR----V------EFTFPD 228 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH----T------CCCCCT
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHh----C------CCCCCC
Confidence 2345689999999999999999999999999999999999999975321 111111110 0 011111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.. ...+.+++.+|++.+|++||++.|+++.
T Consensus 229 ~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 229 FV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred cC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12 2357889999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=332.77 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=192.9
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~e 605 (863)
+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 457899999999999985 468899999876543 3345678999999999999999999999875 356899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEec-CCCeEEEeeccCcccC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLD-HSMCAKVADFGFSKYA 682 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld-~~~~~kl~DFGla~~~ 682 (863)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 110 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 110 LMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred ecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999953 2468999999999999999999999 66 99999999999997 8899999999999755
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
... ......||+.|+|||.+. +.++.++||||||++++||++|+.||..... ...+...... +....
T Consensus 183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~----~~~~~-- 249 (290)
T 1t4h_A 183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS----GVKPA-- 249 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTT----TCCCG--
T ss_pred ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhc----cCCcc--
Confidence 322 233456999999999886 4589999999999999999999999975432 1111111111 10010
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...... ...+.+++.+|++.+|.+|||+.|+++
T Consensus 250 --~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 --SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111 235889999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=349.68 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=186.4
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--------CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--------TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 601 (863)
+.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++|++++||||+++++++. .+..+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceE
Confidence 44568999999999999985 468999999876532 122346889999999999999999999975 45679
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccC
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGF 678 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGl 678 (863)
+||||+++|+|.+++. ....+++.....++.|++.||+|||+ .+|+||||||+|||++.+ ..+||+|||+
T Consensus 216 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 216 IVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp EEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred EEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 9999999999999884 34569999999999999999999999 899999999999999654 4599999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.+....
T Consensus 289 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~---- 359 (419)
T 3i6u_A 289 SKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS---- 359 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHT----
T ss_pred ceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhc----
Confidence 9876432 22334579999999999853 567889999999999999999999997643211 12221111
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.... .+..... ....+.+++.+|++.+|++||++.|+++
T Consensus 360 ~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 10000 0000011 2345889999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=346.46 Aligned_cols=245 Identities=18% Similarity=0.261 Sum_probs=187.0
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHh-cCCcccccceeeeEee----CCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLS-AIRHENLVPLLGYCCE----NDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~LV~ey~~ 608 (863)
++||+|+||+||++... +|+.||||++.. ...+.+|++++. ..+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999864 689999998853 246788998874 4589999999999875 567899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 143 gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 143 GGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp SEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999543 23469999999999999999999999 89999999999999997 789999999999865432
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+. .+.. ....+
T Consensus 218 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~-~~~~~ 289 (400)
T 1nxk_A 218 N---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY-EFPNP 289 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-CCCTT
T ss_pred C---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-cCCCc
Confidence 1 22345689999999999999999999999999999999999999976543221 01111111 1110 00001
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.. .. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 290 ~~-~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EW-SE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT-TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc-cc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 11 23458899999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=342.14 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=195.6
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||.||++... +|+.||||++..... .+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 445689999999999999864 688999999876533 346788888888 79999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC----CeEEEeeccCcccCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS----MCAKVADFGFSKYAPQ 684 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~~~~~ 684 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++....
T Consensus 100 gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 100 GGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp SCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 9999999943 3468999999999999999999999 899999999999998433 3599999999987643
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+...+. .+...
T Consensus 173 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~----- 241 (342)
T 2qr7_A 173 EN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS----- 241 (342)
T ss_dssp TT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC-----
T ss_pred CC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc-----
Confidence 32 12334568999999999988888999999999999999999999997643222222222111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+...........+.+++.+|++.||++||++.|+++
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122345789999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=356.08 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=199.4
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 34589999999999999964 79999999886542 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++. ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 99 SGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp SSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 9999999994 23569999999999999999999999 899999999999999999999999999998765332
Q ss_pred CCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+.... ..+...+. .+.. ..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~----~~~~------~~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKIC----DGIF------YT 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHH----TTCC------CC
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHh----cCCc------CC
Confidence 2234569999999999988765 6899999999999999999999975421 11222111 1100 01
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+ ..+.+++.+|++.+|++|||+.|+++
T Consensus 236 p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11122 35788999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=354.44 Aligned_cols=248 Identities=21% Similarity=0.225 Sum_probs=194.0
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.++||+|+||+||+++.. +|+.||||++.+.. ....+.+.+|.+++.+++||||+++++++.+.+..+|||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 478999999999999964 79999999986532 22335688999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....... .
T Consensus 146 g~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~ 218 (412)
T 2vd5_A 146 GDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-V 218 (412)
T ss_dssp CBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-c
Confidence 9999999542 2368999999999999999999999 8999999999999999999999999999987654321 1
Q ss_pred ceeeeecCCCCCCccccc-------cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 690 FSLEVRGTAGYLDPEYYS-------TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~-------~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~-----~~~ 290 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIVHYKE-----HLS 290 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHHH-----HCC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhccc-----CcC
Confidence 122357999999999997 35689999999999999999999999976431 111111110000 000
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCC---CCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYR---PSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~R---Psm~eVl~ 801 (863)
-|.+....+ ..+.+++.+|++ +|++| |++.|+++
T Consensus 291 ~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 291 LPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111222 357889999999 99998 57777743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=329.19 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=197.8
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 3458999999999999985 4689999998765432 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe---EEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC---AKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DFGla~~~~~~ 685 (863)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++......
T Consensus 89 ~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 89 GGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp SCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999988532 458999999999999999999999 89999999999999976655 999999999766432
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.. .....||+.|+|||.+.+..++.++||||||++++||++|+.||..... ..+...... +.. ....+.
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~----~~~-~~~~~~ 230 (284)
T 3kk8_A 162 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKA----GAY-DYPSPE 230 (284)
T ss_dssp CB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----TCC-CCCTTT
T ss_pred cc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHh----ccc-cCCchh
Confidence 21 2335689999999999999999999999999999999999999975321 111111111 100 000111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ...+.+++.+|++.+|++||++.|+++
T Consensus 231 -~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 -WDTV----TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112 235789999999999999999999977
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.88 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=198.5
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.+.||+|+||.||++... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 4455689999999999999964 789999999886655556778999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 90 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 90 GGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp SCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999998532 458999999999999999999999 899999999999999 78899999999999764322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
......||+.|+|||.+.+..++.++||||||++++||++|+.||..... ..+.+.... +.. . ....
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~----~~~-~-~~~~ 229 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKE----GYY-E-FESP 229 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH----CCC-C-CCTT
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHc----CCC-C-CCcc
Confidence 12334689999999999999999999999999999999999999975321 112211111 110 0 0111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ...+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDI----SESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122 245889999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=359.03 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=200.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.++||+|+||.||+|... +|+.||||++... .......+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 3579999999999999864 7999999988653 23345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 268 gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 268 GGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp SCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999999543 23458999999999999999999999 899999999999999999999999999998765332
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.+.... . ...+.
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~------~~~~p 409 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----V------PEEYS 409 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----C------CCCCC
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----c------cccCC
Confidence 23345799999999999998999999999999999999999999986432211 111111111 0 01111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
..++ ..+.+++.+|++.+|++|| ++.||++
T Consensus 410 ~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1222 3578999999999999999 5666654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=335.91 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=199.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey 606 (863)
.+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34589999999999999864 78999999886543 2334678999999999999999999998854 5678999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC-----ccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS-----VIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~-----iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+++|+|.+++.........+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999996544444569999999999999999999999 55 99999999999999999999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.... ...+.+.+. .+...
T Consensus 166 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~----~~~~~-- 234 (279)
T 2w5a_A 166 LNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIR----EGKFR-- 234 (279)
T ss_dssp C---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HTCCC--
T ss_pred ecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHh----hcccc--
Confidence 64321 11223468999999999999899999999999999999999999997642 112222111 11111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
.+...+ ...+.+++.+|++.+|++||++.||++.+.
T Consensus 235 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 ---RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111122 235889999999999999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.35 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=182.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 3458999999999999986 468999999876543 33456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcc----CCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 610 GSLQDRLYGE----ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 610 gsL~~~L~~~----~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+|.+++... ......+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999998531 1124568999999999999999999999 89999999999999999999999999999866433
Q ss_pred CCC---CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 686 GDS---GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 686 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .................
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQNDPPSLETGV 251 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTSSCCCTTC--
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhccCCCcccccc
Confidence 211 11233568999999999876 568999999999999999999999997643211 11111110000001111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.++.....++ ..+.+++.+|++.+|.+||++.|+++
T Consensus 252 ~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 252 QDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1222222333 35788999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.25 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=195.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
.+||+|+||.||+|.. .+++.||||.+........+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 5899999999999995 578999999988776666788999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcccCCCCCCCCcee
Q 002943 614 DRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGDSGFSL 692 (863)
Q Consensus 614 ~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~ 692 (863)
+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...... ....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 181 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTE 181 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cccc
Confidence 9996432 23456788899999999999999999 89999999999999987 8999999999998664321 1123
Q ss_pred eeecCCCCCCccccccCC--CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 693 EVRGTAGYLDPEYYSTQH--LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 693 ~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
...||..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ....+..... ...+.+....
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~-------~~~~~~~~~~ 251 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMF-------KVHPEIPESM 251 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHH-------CCCCCCCTTS
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhccc-------cccccccccC
Confidence 456899999999997653 789999999999999999999999643211 1000000000 0111222222
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+.+++.+|++.+|++||++.|+++
T Consensus 252 ----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 252 ----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 235788999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.94 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred hhcceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.||+|+||.||+++. .+|+.||||++.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 136 (355)
T 1vzo_A 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL 136 (355)
T ss_dssp EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence 4468999999999999986 478999999876532 23346678899999999 69999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 137 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999542 468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
.... ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ..+........
T Consensus 210 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~----- 281 (355)
T 1vzo_A 210 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS----- 281 (355)
T ss_dssp CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC-----
T ss_pred ccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc-----
Confidence 4322 1122345699999999999863 478999999999999999999999975432221 11111111110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVRE 802 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~~ 802 (863)
.+..... ....+.+++.+|++.+|++|| ++.|+++.
T Consensus 282 --~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --EPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --CCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1111112 223578899999999999999 78777653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.87 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=190.1
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||++ |
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K 84 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-E
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-c
Confidence 4578999999999999965 7899999987654332 22356689999999999999999999999999999999997 6
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 85 ~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~ 156 (324)
T 3mtl_A 85 DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KT 156 (324)
T ss_dssp EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cc
Confidence 999988543 3468999999999999999999999 899999999999999999999999999998654321 12
Q ss_pred eeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccccccC---
Q 002943 691 SLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRIDEIVD--- 763 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i~d--- 763 (863)
.....||..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+..... .........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchh
Confidence 233468999999999876 56899999999999999999999999764321 11111111110 000000000
Q ss_pred ------CccCCCC----cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 ------PSIKGGY----HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ------~~l~~~~----~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+...... .......+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0011235789999999999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.53 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=190.6
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---cchHHHHHHHHH-HhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---QGTREFENELNF-LSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+++.. +++.||||++.+... ...+.+..|..+ ++.++||||+++++++...+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 345689999999999999965 588999999865532 233456677776 577899999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++.. ...+++.....++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 120 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 120 YINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999954 2458899999999999999999999 89999999999999999999999999999864322
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+ .. +. ..
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i---~~-~~------~~ 257 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNI---LN-KP------LQ 257 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHH---HH-SC------CC
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH---Hh-cc------cC
Confidence 1 12334579999999999999999999999999999999999999997532 11111111 11 00 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~ 804 (863)
+....+ ..+.+++.+|++.+|.+||++.+.++.+.
T Consensus 258 ~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 258 LKPNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred CCCCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 111222 35788999999999999999976554443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.35 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=183.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc-c-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ-G-TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.||+|+||.||++.. .+|+.||||++...... . .+.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 3458999999999999995 57899999988654322 2 2334455566888999999999999999999999999996
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.........+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 69988885433345679999999999999999999999 6 899999999999999999999999999987643321
Q ss_pred CCceeeeecCCCCCCcccc----ccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 688 SGFSLEVRGTAGYLDPEYY----STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.....||+.|+|||.+ .+..++.++||||||++++||++|+.||...... ...+..... .. .
T Consensus 166 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~~------~ 231 (290)
T 3fme_A 166 ---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQVVE----EP------S 231 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHHHHH----SC------C
T ss_pred ---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHHHhc----cC------C
Confidence 2234689999999996 5567899999999999999999999999753211 111111111 10 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.... ......+.+++.+|++.+|++|||+.|+++
T Consensus 232 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11110 112235889999999999999999999977
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.18 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=194.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||++++++|.+.+..++||||+++
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 3579999999999999964 5899999987654432 245678999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 109 ~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 109 TILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred chHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999888632 3468999999999999999999999 8999999999999999999999999999986543221
Q ss_pred ceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhh----------hcc-cccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAK----------PFI-RESR 757 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~----------~~~-~~~~ 757 (863)
......||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+..... ..+ ....
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhccc
Confidence 22344689999999999875 78999999999999999999999997643211 1111100 000 0000
Q ss_pred cccccCCccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEIVDPSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+...... .....+.+++.+|++.+|++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111111111 12356889999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=351.35 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=189.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 3458899999999999985 46899999988654 233456788999999999999999999999655 35699
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|||||++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 145 v~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 9999965 5666662 248899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hHH--------hhh---
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LVE--------WAK--- 750 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~~--------~~~--- 750 (863)
... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.+....+... +.+ +..
T Consensus 215 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 215 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp --C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred CCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 432 22344679999999999999999999999999999999999999997643211100 000 000
Q ss_pred ----hcccc------cccccccCCccCCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 751 ----PFIRE------SRIDEIVDPSIKGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 751 ----~~~~~------~~~~~i~d~~l~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ..........+.... .......+.+++.+|++.||++|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000011111110000 1122456889999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.94 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=187.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC
Confidence 3458999999999999984 57899999998654332 34578899999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe-----cCCCeEEEeeccCcccCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL-----DHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl-----d~~~~~kl~DFGla~~~~ 683 (863)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++...
T Consensus 117 -~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 117 -NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp -EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred -CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 5999999532 358999999999999999999999 899999999999999 455669999999998654
Q ss_pred CCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc--cccccccc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF--IRESRIDE 760 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--~~~~~~~~ 760 (863)
... .......||..|+|||.+.+. .++.++|||||||+++||++|+.||....... .+....... ........
T Consensus 189 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 189 IPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSTT
T ss_pred Ccc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchhhhhh
Confidence 321 122334689999999999875 48999999999999999999999997643211 111111000 00000000
Q ss_pred c--------cCCccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 I--------VDPSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i--------~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ..+........ .....+.+++.+|++.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00001100000 12245789999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=348.42 Aligned_cols=198 Identities=27% Similarity=0.405 Sum_probs=158.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCC-cccccceeeeEeeCC--eeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIR-HENLVPLLGYCCEND--QQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~LV~e 605 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.++. ||||+++++++...+ ..++|||
T Consensus 12 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e 91 (388)
T 3oz6_A 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFD 91 (388)
T ss_dssp EEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEE
T ss_pred EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEec
Confidence 4458999999999999985 578999999875432 233467889999999997 999999999997554 6899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
||+ |+|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 92 YME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 997 699998843 368899999999999999999999 89999999999999999999999999999865331
Q ss_pred C-------------------CCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 686 G-------------------DSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 686 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
. .........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112234569999999999976 678999999999999999999999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=332.22 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=198.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4589999999999999965 58899999876543 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.. ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 99 RRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp TCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999998843 2468999999999999999999999 8999999999999999999999999999987643222
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||..|+|||.+.+..++.++||||||++++||++|+.||...... .... .. .... ..+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~-~~~~------~~~~~ 236 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYL---RI-KKNE------YSIPK 236 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HH-HTTC------CCCCT
T ss_pred -ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HH-hhcc------CCCcc
Confidence 223356899999999999988999999999999999999999999754211 1111 10 0000 01111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+ ..+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 HIN----PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 222 35788999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=333.04 Aligned_cols=244 Identities=24% Similarity=0.423 Sum_probs=200.9
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 357899999999999985 578999999886554 344578999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 106 ~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 175 (303)
T 3a7i_A 106 SALDLLE-----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 175 (303)
T ss_dssp EHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CC
T ss_pred cHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc--cc
Confidence 9999983 2468999999999999999999999 899999999999999999999999999998664322 11
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||..|+|||.+.+..++.++||||||++++||++|+.||..... ........ .+. .+.+...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~-----~~~~~~~~ 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIP----KNN-----PPTLEGNY 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSC-----CCCCCSSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhh----cCC-----CCCCcccc
Confidence 2345689999999999999999999999999999999999999975321 11111111 111 11222223
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
+ ..+.+++.+|++.+|++||++.|+++.
T Consensus 244 ~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 S----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 3 348899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=354.73 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=199.8
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.++||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 478999999999999964 69999999886542 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++.........+++...+.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-- 344 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-- 344 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--
Confidence 99999997654445679999999999999999999999 8999999999999999999999999999987654321
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc-chhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ..+.+.+. . .. ..+..
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~---~-~~------~~~p~ 414 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---E-QA------VTYPD 414 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH---H-CC------CCCCT
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh---h-cc------cCCCc
Confidence 22345799999999999999999999999999999999999999976432111 11111111 1 00 01111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVD 798 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e 798 (863)
.. ...+.+++.+|++.+|++||++.+
T Consensus 415 ~~----s~~~~~li~~lL~~dP~~R~~~~~ 440 (543)
T 3c4z_A 415 KF----SPASKDFCEALLQKDPEKRLGFRD 440 (543)
T ss_dssp TS----CHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred cc----CHHHHHHHHHhccCCHhHCCCCcc
Confidence 22 235788999999999999998743
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.91 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=193.3
Q ss_pred hhcceecccCcEEEEEEecC--CCC--EEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP--DGQ--EVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~--~g~--~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||.||+|++. +++ .||||++.... ....+.+.+|++++++++||||+++++++...+ .++|+
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~ 99 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVT 99 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeE
Confidence 45689999999999999852 333 68999876542 334578899999999999999999999998765 88999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 100 ELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp ECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred ecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999543 3468999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 685 EGDSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 685 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
..... ......+|..|+|||.+.+..++.++||||||++++||++ |+.||..... ..+..... ....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~---~~~~----- 242 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKID---KEGE----- 242 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---TSCC-----
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHH---ccCC-----
Confidence 32211 1223457888999999998889999999999999999999 9999975431 11221111 1110
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
...... .....+.+++.+|++.+|++||++.++++.|+++..
T Consensus 243 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 RLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 000111 123458899999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=334.30 Aligned_cols=246 Identities=18% Similarity=0.259 Sum_probs=194.2
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.||+|+||.||+|... +|+.||||++.... .....++.+|+.++.+++ ||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999864 68999999876543 233578899999999995 699999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~~~ 687 (863)
+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 115 ~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 189 (327)
T 3lm5_A 115 EIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189 (327)
T ss_dssp EGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred cHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc
Confidence 999998432 24569999999999999999999999 89999999999999998 78999999999987643321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ...
T Consensus 190 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~----------~~~ 253 (327)
T 3lm5_A 190 ---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVNV----------DYS 253 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC----------CCC
T ss_pred ---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccc----------ccC
Confidence 2345699999999999999999999999999999999999999975431 111111111000 000
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..........+.+++.+|++.+|++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0111112345789999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.06 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=194.5
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-----chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-----GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
+.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 344689999999999999965 6899999988653321 2357889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++ +|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 92 DFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp ECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99975 89888843 23568999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccc-
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRID- 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~- 759 (863)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ............ .....
T Consensus 165 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSS
T ss_pred Cc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhhhh
Confidence 22 122345689999999999764 588999999999999999999999876431 111111111000 00000
Q ss_pred --cccCC---ccCCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 --EIVDP---SIKGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 --~i~d~---~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+. ....... ......+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 0000011 112346889999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=335.10 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=190.4
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCC--cccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIR--HENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++.+++ |+||+++++++...+..++||| +
T Consensus 31 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 109 (313)
T 3cek_A 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 109 (313)
T ss_dssp EEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-c
Confidence 3458999999999999998889999999886543 234567899999999997 4999999999999999999999 6
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
.+++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||+++ +.+||+|||+++.......
T Consensus 110 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 110 GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp CSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 68999999953 2468999999999999999999999 89999999999999975 8999999999987654333
Q ss_pred CCceeeeecCCCCCCcccccc-----------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 688 SGFSLEVRGTAGYLDPEYYST-----------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
........||..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~------ 250 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH------ 250 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHH------
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHH------
Confidence 222334568999999999875 46888999999999999999999999754211 11111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
.++++.............+.+++.+|++.+|++||++.|+++.
T Consensus 251 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 ---AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111111111112357889999999999999999999763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=338.89 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=198.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 124 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCC
Confidence 4589999999999999964 58899999876543 2344678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+++|.+++.. ...+++.+++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 125 ~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 125 RRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp TCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999998843 2468999999999999999999999 8999999999999999999999999999987643222
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... .. .... ..+..
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~---~~-~~~~------~~~~~ 262 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYL---RI-KKNE------YSIPK 262 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HH-HHTC------CCCCT
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHH---HH-hcCC------CCCCc
Confidence 22345689999999999998999999999999999999999999975321 11111 10 0000 01111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+ ..+.+++.+|++.+|++||++.|+++
T Consensus 263 ~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 HIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 34778999999999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=339.08 Aligned_cols=263 Identities=19% Similarity=0.249 Sum_probs=195.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC--------Cee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN--------DQQ 600 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~ 600 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++... +..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEE
T ss_pred eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceE
Confidence 4458999999999999996 5789999998765432 2346788999999999999999999999873 468
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++||||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 100 ~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 100 YLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 99999997 577777743 23468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCC--CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 681 YAPQEGD--SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 681 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
....... ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.......................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 7643221 112234568999999999876 4589999999999999999999999986432111111111000000000
Q ss_pred cccc-----cC---CccCCCCc-HHH------HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 IDEI-----VD---PSIKGGYH-AEA------MWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 ~~~i-----~d---~~l~~~~~-~~~------~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... .+ ........ .+. ...+.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 00 00000011 111 234789999999999999999998865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=344.01 Aligned_cols=250 Identities=10% Similarity=0.040 Sum_probs=178.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC---cchHHHHHHHHHHhcC--Cccccccee-------eeEeeC-
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST---QGTREFENELNFLSAI--RHENLVPLL-------GYCCEN- 597 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~~~~- 597 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 3458999999999999995 4789999999877543 2345677785444444 699988755 344332
Q ss_pred ----------------CeeEEEeecCCCCChhhhhhccCCCCccCChhhH------HHHHHHHHHHHHHHHhccCCCccc
Q 002943 598 ----------------DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTR------LSIALGAARGLMYLHTFAGRSVIH 655 (863)
Q Consensus 598 ----------------~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~------~~ia~~ia~gL~yLH~~~~~~iiH 655 (863)
...++||||++ |+|.+++... ...+.+..+ +.++.|++.||+|||+ ++|+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 33799999998 9999999643 234566777 8899999999999999 89999
Q ss_pred cCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCC
Q 002943 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREP 733 (863)
Q Consensus 656 rDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p 733 (863)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865321 113457799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 734 LNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 734 ~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
|......... .|... .........+.-.........+.+++.+||+.+|++||++.|+++
T Consensus 293 f~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKG---SWKRP-----SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTT---CCCBC-----CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCccccc---chhhh-----hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9865432110 01000 000000011100001122345889999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.51 Aligned_cols=194 Identities=26% Similarity=0.395 Sum_probs=169.5
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 116 (360)
T 3eqc_A 37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116 (360)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCC
Confidence 3578999999999999964 78999999887653 233467899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
+|.+++... ..+++..+..++.+++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 117 SLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp BHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred CHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 999999542 358999999999999999999998 5 7999999999999999999999999998754221
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTR 737 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~ 737 (863)
......||+.|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122346899999999999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.37 Aligned_cols=191 Identities=21% Similarity=0.338 Sum_probs=150.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV 603 (863)
.+.++||+|+||.||+|... +|+.||||++..... ...+.+.+|+++|++++||||+++++++... +..++|
T Consensus 56 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp EECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEE
Confidence 44689999999999999854 789999998865432 3346789999999999999999999999543 568999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+ +|+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 136 LEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp ECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred Eecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9998 5799999843 3569999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCC-------------------------CceeeeecCCCCCCcccc-ccCCCCcccceechhhHHHHHHhC
Q 002943 684 QEGDS-------------------------GFSLEVRGTAGYLDPEYY-STQHLSAKSDVFSFGVVLLEIISG 730 (863)
Q Consensus 684 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~ElltG 730 (863)
..... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 32211 112345689999999976 456799999999999999999993
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.47 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=198.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 44689999999999999864 67899999875432 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 97 PRGELYKELQKH----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp TTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 999999999542 358999999999999999999999 899999999999999999999999999997654321
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||..... ....... .. . +..+.
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~---~~-~------~~~~~ 232 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRI---VN-V------DLKFP 232 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH---HT-T------CCCCC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHH---hc-c------ccCCC
Confidence 2234689999999999999999999999999999999999999975321 1111111 00 0 11111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+.+++.+|++.+|.+||++.|+++
T Consensus 233 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 122 235789999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.92 Aligned_cols=257 Identities=18% Similarity=0.251 Sum_probs=191.8
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC-------------
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN------------- 597 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------------- 597 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|++++++++||||+++++++...
T Consensus 10 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 3458999999999999985 6799999998765432 335799999999999999999998543
Q ss_pred -------------------------CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC
Q 002943 598 -------------------------DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652 (863)
Q Consensus 598 -------------------------~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 652 (863)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|||+ .+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LG 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TT
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---Cc
Confidence 34789999997 68888885433445679999999999999999999998 89
Q ss_pred ccccCCCCCCeEec-CCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhC
Q 002943 653 VIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISG 730 (863)
Q Consensus 653 iiHrDik~~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG 730 (863)
|+||||||+|||++ .++.+||+|||+++....... .....||..|+|||.+.+. .++.++|||||||+++||++|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 99999999999998 689999999999987643322 2344689999999998775 489999999999999999999
Q ss_pred CCCCCCCCCCCcchhHHhhhhccc---------ccccccccCCccCCC-----CcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 731 REPLNTRRPRNEWSLVEWAKPFIR---------ESRIDEIVDPSIKGG-----YHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 731 ~~p~~~~~~~~~~~l~~~~~~~~~---------~~~~~~i~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+.||......+ .+.+.+...-. .....+..-+.+... ........+.+++.+|++.+|++|||+
T Consensus 239 ~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 239 KPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99997643211 11111110000 000001101111110 111123458899999999999999999
Q ss_pred HHHHH
Q 002943 797 VDIVR 801 (863)
Q Consensus 797 ~eVl~ 801 (863)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.93 Aligned_cols=253 Identities=18% Similarity=0.288 Sum_probs=194.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEee--CCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCE--NDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++||||+
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 3458999999999999984 57899999998643 3577899999999997 9999999999987 56789999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQEG 686 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~~~ 686 (863)
++++|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 116 NNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999882 38899999999999999999999 8999999999999999766 89999999998765432
Q ss_pred CCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHH------------hhhhcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVE------------WAKPFI 753 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~------------~~~~~~ 753 (863)
. .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ...+.. +.....
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 223468999999999977 67899999999999999999999999643221 011111 110000
Q ss_pred c--cccccccc--------CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 R--ESRIDEIV--------DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ~--~~~~~~i~--------d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. .....+.. +..............+.+++.+|++.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000 000011111112346889999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=352.17 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=200.8
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
..+.+.++||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34556789999999999999964 78999999886543 334578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe---cCCCeEEEeeccCccc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL---DHSMCAKVADFGFSKY 681 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl---d~~~~~kl~DFGla~~ 681 (863)
||+.+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 106 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999853 3468999999999999999999999 899999999999999 5678999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
..... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.... ...+...+.. +... .
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~----~~~~-~ 246 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEK----GKYT-F 246 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CCCC-C
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHc----CCCC-C
Confidence 64332 2234569999999999876 68999999999999999999999997643 2222222211 1100 0
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+.. ......+.+++.+|++.+|++|||+.|+++
T Consensus 247 ~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00000 112345789999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.51 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=190.5
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 34589999999999999965 79999999876432 234567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 165 (276)
T 2h6d_A 94 SGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 165 (276)
T ss_dssp CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence 999999999542 358999999999999999999999 889999999999999999999999999998764322
Q ss_pred CCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|+|||.+.+..+ +.++||||||++++||++|+.||.... ...+.+.... +. ..+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~----~~------~~~ 230 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRG----GV------FYI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CC------CCC
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhc----Cc------ccC
Confidence 1233468999999999987765 689999999999999999999997532 1111111111 10 001
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ...+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 PEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112 235788999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.00 Aligned_cols=256 Identities=24% Similarity=0.298 Sum_probs=190.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV~e 605 (863)
+.++||+|+||.||+|+.. +|+.||||++.... +.+.+|+++|++++||||++++++|.... ..++|||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 4579999999999999974 69999999876532 23457999999999999999999985432 3679999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQ 684 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~ 684 (863)
|+++ +|.+.+.........+++..+..++.|+++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 6666664332345679999999999999999999999 899999999999999954 6789999999987643
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc-------c--
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI-------R-- 754 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~-------~-- 754 (863)
... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.+...- .
T Consensus 210 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 210 GEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHHHH
T ss_pred CCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHhh
Confidence 322 2235689999999998765 7899999999999999999999999764321 11222111100 0
Q ss_pred ccccccccCCccCCC-----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKGG-----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~-----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.....+..-+.+... +.......+.+|+.+|++.+|++||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000111111111111 11112346889999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.93 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=196.3
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc--------chHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ--------GTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3489999999999999975 7999999987655321 135678999999999 79999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 178 v~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999953 2468999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCceeeeecCCCCCCcccccc------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYST------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES 756 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 756 (863)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+.. +
T Consensus 251 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~----~ 320 (365)
T 2y7j_A 251 EPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMIME----G 320 (365)
T ss_dssp CTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----T
T ss_pred CCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh----C
Confidence 54322 234569999999999864 357889999999999999999999997532 1111111111 1
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+.. .. ....+.+++.+|++.+|++||++.|+++
T Consensus 321 ~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 000000 01 1235889999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.35 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=194.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||.||+|...+ .+|||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 113 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence 345899999999999998754 49999876543 33446788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC---
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG--- 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~--- 686 (863)
++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 114 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 114 RTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999943 23468999999999999999999999 8999999999999998 6799999999987653211
Q ss_pred CCCceeeeecCCCCCCcccccc---------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYST---------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
.........||..|+|||.+.. ..++.++||||||+++|||++|+.||..... ..+..... .+.
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~----~~~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMG----TGM 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHH----TTC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhc----cCC
Confidence 1112233458999999999864 4578899999999999999999999975431 11111111 111
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
....... .. ...+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 260 ~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 260 KPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 11 12478999999999999999999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=350.46 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=194.2
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.+.||+|+||+||+|... ++..||||++.... ......+.+|++++++++||||++++++|.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3455689999999999999964 68999999876543 33457889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAP 683 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~ 683 (863)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 118 ~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 118 YKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999988532 458999999999999999999999 89999999999999976 4569999999998764
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||..... ..+...+.. +.. ....
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~----~~~-~~~~ 258 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEK----GKY-TFDS 258 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----TCC-CCCS
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCC-CCCc
Confidence 322 223456999999999886 5689999999999999999999999976432 112221111 100 0001
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.. ... ...+.+++.+|++.+|.+|||+.|+++
T Consensus 259 ~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111 112 235789999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.51 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=194.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCCcccccceeeeEe--eCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS----TQGTREFENELNFLSAIRHENLVPLLGYCC--ENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~LV~ 604 (863)
.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +.+..++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 3458999999999999996 468999999876542 344578999999999999999999999984 456789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||++++ |.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp ECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred hhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 999876 77777432 24568999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCceeeeecCCCCCCccccccCC--CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQH--LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
...........||..|+|||.+.+.. .+.++||||||++++||++|+.||.... ...+.+.+. .+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~----~~~----- 229 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIG----KGS----- 229 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHH----HCC-----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHh----cCC-----
Confidence 33333334456899999999987654 3779999999999999999999997532 111111111 111
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~ 802 (863)
..+.... ...+.+++.+|++.+|++||++.|+++.
T Consensus 230 -~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -YAIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -CCCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -CCCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111122 2357899999999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=340.20 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=192.1
Q ss_pred HHHHHHHHHhh--cceecccCcEEEEEEecCCCCEEEEEEcccCCCcc-----------hHHHHHHHHHHhcCCcccccc
Q 002943 523 LQYLEAATQQY--KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG-----------TREFENELNFLSAIRHENLVP 589 (863)
Q Consensus 523 ~~~l~~~t~~f--~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 589 (863)
.+++.....+| .+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 34455544444 48999999999999998889999999875533221 267899999999999999999
Q ss_pred eeeeEeeC-----CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeE
Q 002943 590 LLGYCCEN-----DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNIL 664 (863)
Q Consensus 590 l~g~~~~~-----~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NIL 664 (863)
+++++... ...++||||++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 99998543 35799999997 788888853 34569999999999999999999999 89999999999999
Q ss_pred ecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc
Q 002943 665 LDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743 (863)
Q Consensus 665 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 743 (863)
++.++.+||+|||+++...... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999998543322 2234568999999999877 67899999999999999999999999764311
Q ss_pred hhHHhhhhcccccc-----------cccccCCccC---CC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 744 SLVEWAKPFIRESR-----------IDEIVDPSIK---GG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 744 ~l~~~~~~~~~~~~-----------~~~i~d~~l~---~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.............. ..+.+...+. .. ........+.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111110000000 0000000000 00 00112345889999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.61 Aligned_cols=257 Identities=19% Similarity=0.271 Sum_probs=188.0
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEe--------------eC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC--------------EN 597 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--------------~~ 597 (863)
..+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++. +.
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3578999999999999965 58999999987766666788999999999999999999999873 44
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeec
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADF 676 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DF 676 (863)
+..++||||++ |+|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+||
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred CceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 67899999997 79999983 2468999999999999999999999 8999999999999997 6789999999
Q ss_pred cCcccCCCCCC-CCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc-
Q 002943 677 GFSKYAPQEGD-SGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI- 753 (863)
Q Consensus 677 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~- 753 (863)
|+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||...... ..........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~ 242 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILESIP 242 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHSC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 99987643211 111223457899999998865 67899999999999999999999999764321 1111111000
Q ss_pred --ccccccccc-------CCccC-CCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 --RESRIDEIV-------DPSIK-GGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 --~~~~~~~i~-------d~~l~-~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......++. ..... .... ......+.+++.+|++.+|++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000 00000 0000 012345889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=337.75 Aligned_cols=259 Identities=21% Similarity=0.269 Sum_probs=198.3
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC--------cccccceeeeEe----eC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR--------HENLVPLLGYCC----EN 597 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~----~~ 597 (863)
+.+.++||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++. ..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 44568999999999999984 56889999998643 334567889999999996 788999999987 55
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCC-------
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSM------- 669 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~------- 669 (863)
...++||||+ +++|.+++... ....+++..++.++.|++.||+|||+ + +|+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 6789999999 67777776432 23569999999999999999999999 7 899999999999999775
Q ss_pred ------------------------------------------eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccc
Q 002943 670 ------------------------------------------CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707 (863)
Q Consensus 670 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 707 (863)
.+||+|||+++..... .....||..|+|||.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence 7999999999876432 22346899999999999
Q ss_pred cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch---hHHhhhhc------------------c-cccccccccCCc
Q 002943 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS---LVEWAKPF------------------I-RESRIDEIVDPS 765 (863)
Q Consensus 708 ~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~---l~~~~~~~------------------~-~~~~~~~i~d~~ 765 (863)
+..++.++|||||||++|||++|+.||.......... ........ + ..+.+..+.+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999998654332111 00000000 0 000111110000
Q ss_pred c---------CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 I---------KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l---------~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. .-....+....+.+++.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234566778999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=345.00 Aligned_cols=196 Identities=22% Similarity=0.325 Sum_probs=162.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV 603 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++|++++|+||+++++++... +..++|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 4468999999999999985 4688999999865432 3346789999999999999999999999776 578999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||++ |+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 109 ~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 99985 699999943 3569999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCC--------------------CceeeeecCCCCCCcccc-ccCCCCcccceechhhHHHHHHhCCCCCC
Q 002943 684 QEGDS--------------------GFSLEVRGTAGYLDPEYY-STQHLSAKSDVFSFGVVLLEIISGREPLN 735 (863)
Q Consensus 684 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~SfGvvl~ElltG~~p~~ 735 (863)
..... .......||..|+|||.+ ....++.++|||||||+++||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43211 122456789999999986 55679999999999999999998655553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=341.31 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=189.2
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe------eEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQ------QILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~LV~e 605 (863)
.+.++||+|+||.||+|+..++..+|+|++..... ...+|+++++.++||||+++++++...+. .++|||
T Consensus 43 ~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 43 TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 44589999999999999987777799997754332 23479999999999999999999965443 789999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeeccCcccCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~~~~~ 684 (863)
|++++.+. .+.........+++..+..++.|+++||+|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 119 ~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 119 YVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp CCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99765443 332222234579999999999999999999999 8999999999999999 799999999999987643
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh------------
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP------------ 751 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~------------ 751 (863)
... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......+ .+.+....
T Consensus 195 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp TCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHH
T ss_pred CCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhh
Confidence 322 2234689999999998765 58999999999999999999999997643211 11111110
Q ss_pred --cccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 752 --FIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 752 --~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+....+...+.......+.+++.+|++.+|++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000000011112346889999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=349.29 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=198.3
Q ss_pred HHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
..+.+.++||+|+||+||++... +|+.||||++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 34566799999999999999964 7899999987543 23345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYA 682 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~ 682 (863)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999988542 468999999999999999999999 8999999999999995 5668999999999876
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.... ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||..... ..+...+.. +.... .
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~----~~~~~-~ 242 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVET----GKYAF-D 242 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH----TCCCS-C
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCCCC-C
Confidence 4332 1233469999999999875 589999999999999999999999976431 122221111 11000 0
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+.. ......+.+++.+|++.+|++|||+.|+++
T Consensus 243 ~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Cccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 112235789999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.40 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=188.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEND------QQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 3457899999999999986 5799999998865432 23467889999999999999999999997663 4599
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+ +++|.+++.. ..+++.....++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 99999 8899999843 358899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc--------
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI-------- 753 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~-------- 753 (863)
... .....+|..|+|||.+.+ ..++.++||||+||+++||++|+.||...... ..........
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHH
Confidence 432 223468999999999887 68999999999999999999999999764321 1111110000
Q ss_pred ---cccc-------cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 ---RESR-------IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ---~~~~-------~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... +.......+. .........+.+++.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 0000000010 001112345889999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=328.57 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=192.7
Q ss_pred HHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--------cchHHHHHHHHHHhcCCcccccceeeeEeeCCe
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--------QGTREFENELNFLSAIRHENLVPLLGYCCENDQ 599 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 599 (863)
..+.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 3455678999999999999986 4688999998765321 22346889999999999999999999987655
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe---EEEeec
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC---AKVADF 676 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DF 676 (863)
.++||||+++|+|.+++. ....+++.....++.|++.||+|||+ .+|+||||||+|||++.++. +||+||
T Consensus 89 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999984 23568999999999999999999999 89999999999999987654 999999
Q ss_pred cCcccCCCCCCCCceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc
Q 002943 677 GFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 677 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|+++..... .......||..|+|||.+. ...++.++|||||||++|||++|+.||....... .+......
T Consensus 162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 999876432 1123346899999999974 4678899999999999999999999997643221 12221111
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+... ..+..... ....+.+++.+|++.+|++||++.|+++
T Consensus 235 --~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Cccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00011111 2345889999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=364.65 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=200.7
Q ss_pred HhhcceecccCcEEEEEEecC----CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP----DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~----~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|... .+..||||++..... ...+.|.+|+.++++++||||+++++++. .+..++|||
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E 470 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 470 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence 345688999999999999864 246799998765433 33467999999999999999999999985 456899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 471 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 471 LCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred cCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999542 3468999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+.. +.. +
T Consensus 545 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~----~~~-----~ 611 (656)
T 2j0j_A 545 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN----GER-----L 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHH----TCC-----C
T ss_pred cc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHc----CCC-----C
Confidence 22 12233457889999999999999999999999999999997 9999976431 122222111 100 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
.+.. .....+.+++.+||+.+|++||++.|+++.|+.++.
T Consensus 612 ~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 612 PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111 223458899999999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=334.98 Aligned_cols=254 Identities=19% Similarity=0.202 Sum_probs=186.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEND------QQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 3458899999999999985 468899999886543 233467889999999999999999999997665 6799
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||++ |+|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999996 57888883 248899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc--------
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR-------- 754 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 754 (863)
... .......||..|+|||.+.+..++.++|||||||+++||++|+.||...... .....+.....
T Consensus 178 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 178 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHHHHT
T ss_pred ccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHH
Confidence 432 1223456899999999999999999999999999999999999999764321 11110000000
Q ss_pred -----------------ccccccccCCccCCC---CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 -----------------ESRIDEIVDPSIKGG---YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 -----------------~~~~~~i~d~~l~~~---~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
............... ........+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000000000 01223567889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=342.26 Aligned_cols=195 Identities=25% Similarity=0.328 Sum_probs=167.6
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC------CcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI------RHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.++||+|+||.||+|.. .+++.||||++... ....+++.+|+++++.+ +|+||+++++++...+..++||
T Consensus 100 ~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 4468999999999999985 46899999988653 23346778888888887 5679999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe--EEEeeccCcccC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC--AKVADFGFSKYA 682 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~--~kl~DFGla~~~ 682 (863)
||+. ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 179 e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 179 ELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp CCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred eccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 9995 7999998543 23458999999999999999999999 79999999999999999887 999999999765
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 253 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 253 HQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 432 223468999999999999999999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=335.52 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=194.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV~ 604 (863)
.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++... ...++|+
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 3458999999999999985 46889999988754332 346789999999999999999999999765 3679999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+. |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 110 DLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp ECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9996 699998843 358999999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCC-CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc---ccc
Q 002943 685 EGDS-GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES---RID 759 (863)
Q Consensus 685 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~ 759 (863)
.... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ........... .+.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHH
Confidence 3221 11234579999999998754 4589999999999999999999999976542221 11111000000 000
Q ss_pred cccC--------C-ccCCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVD--------P-SIKGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d--------~-~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+ . .-..... ......+.+++.+|++.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0 0000000 011245789999999999999999999865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=349.56 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=194.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-------------cchHHHHHHHHHHhcCCcccccceeeeEeeC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-------------QGTREFENELNFLSAIRHENLVPLLGYCCEN 597 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 597 (863)
.+.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 39 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 118 (504)
T 3q5i_A 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118 (504)
T ss_dssp EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34589999999999999964 688999998765431 2346789999999999999999999999999
Q ss_pred CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---eEEEe
Q 002943 598 DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM---CAKVA 674 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~---~~kl~ 674 (863)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999998542 468999999999999999999999 8999999999999998765 69999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||..... ..+...+..
T Consensus 192 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~--- 261 (504)
T 3q5i_A 192 DFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVEK--- 261 (504)
T ss_dssp CCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---
T ss_pred ECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHc---
Confidence 999998765432 223456999999999986 4689999999999999999999999976431 122221111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+... .+...... ....+.+++.+|++.+|.+|||+.|+++
T Consensus 262 -~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 -GKYY--FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -CCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCC--CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1100 00000011 1235889999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.90 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=193.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 34578999999999999965 58999999988776677788999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....... ..
T Consensus 102 ~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 173 (302)
T 2j7t_A 102 AVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QK 173 (302)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC
T ss_pred cHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cc
Confidence 999998542 3468999999999999999999999 899999999999999999999999999975321110 01
Q ss_pred eeeeecCCCCCCcccc-----ccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 691 SLEVRGTAGYLDPEYY-----STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~-----~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.....||..|+|||.+ ....++.++||||||+++|||++|+.||..... .... ...... .......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~~~-~~~~~~~-- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVL---LKIAKS-DPPTLLT-- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH---HHHHHS-CCCCCSS--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHH---HHHhcc-CCcccCC--
Confidence 1234589999999998 366789999999999999999999999975431 1111 111111 0000000
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 245 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112235889999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.84 Aligned_cols=198 Identities=23% Similarity=0.340 Sum_probs=153.1
Q ss_pred ceecccCcEEEEEEecC---CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey~~~ 609 (863)
++||+|+||+||+|... +++.||||++.... ..+.+.+|+++|++++||||+++++++.. ....++||||++
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 58999999999999864 57899999986543 33578899999999999999999999954 668899999996
Q ss_pred CChhhhhhccC-----CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe----cCCCeEEEeeccCcc
Q 002943 610 GSLQDRLYGEA-----STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----DHSMCAKVADFGFSK 680 (863)
Q Consensus 610 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----d~~~~~kl~DFGla~ 680 (863)
|+|.+++.... .....+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 68888874221 122359999999999999999999999 899999999999999 778999999999998
Q ss_pred cCCCCCCC-CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 681 YAPQEGDS-GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 681 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 76432211 222345789999999999874 58999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=329.63 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=198.2
Q ss_pred HhhcceecccCcEEEEEEec--CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc------ccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL--PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN------LVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~--~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++|+| ++++++++...+..++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 34568999999999999985 36889999988643 234567889999999998765 9999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---------------
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--------------- 667 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--------------- 667 (863)
||||+ +++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 95 VFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999 89999999543 23468899999999999999999999 89999999999999987
Q ss_pred ----CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc
Q 002943 668 ----SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743 (863)
Q Consensus 668 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 743 (863)
++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999865432 12346899999999999999999999999999999999999999764321111
Q ss_pred hhHHhhhhcccc-----ccc---------------------ccccCCcc-CCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 744 SLVEWAKPFIRE-----SRI---------------------DEIVDPSI-KGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 744 ~l~~~~~~~~~~-----~~~---------------------~~i~d~~l-~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
............ ... .....+.. ...........+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111100000000 000 00000000 001123445678999999999999999999
Q ss_pred HHHHH
Q 002943 797 VDIVR 801 (863)
Q Consensus 797 ~eVl~ 801 (863)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=362.78 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=196.4
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccC---CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSST---STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.++||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..+ +||||+++++++.+.+..+||||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 345689999999999999964 6889999998753 234456788999999988 79999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||||+.++++||+|||+++.....
T Consensus 423 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999543 468999999999999999999999 89999999999999999999999999999864332
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.... ...+.+.+. . +. ..
T Consensus 496 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~---~-~~------~~ 560 (674)
T 3pfq_A 496 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIM---E-HN------VA 560 (674)
T ss_dssp T--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH---S-SC------CC
T ss_pred C--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHHH---h-CC------CC
Confidence 2 22345679999999999999999999999999999999999999997642 112222111 1 10 01
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
+.... ...+.+|+.+|++.+|++||++
T Consensus 561 ~p~~~----s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 561 YPKSM----SKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCccC----CHHHHHHHHHHccCCHHHCCCC
Confidence 11122 2357899999999999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=328.18 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=195.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||.||+|... +|+.||||++.... ..+++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 32 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 34589999999999999865 58999999887543 4577899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+++...... ..
T Consensus 110 ~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (314)
T 3com_A 110 SVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AK 181 (314)
T ss_dssp EHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SC
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cc
Confidence 99999853 23568999999999999999999999 899999999999999999999999999997654321 12
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||..|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ..... +.+. .
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~~-----~~~~--~ 247 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMI----PTNPP-----PTFR--K 247 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHSCC-----CCCS--S
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHH----hcCCC-----cccC--C
Confidence 2344689999999999998999999999999999999999999975421 1111100 00000 0000 0
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......+.+++.+|++.+|.+||++.|+++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111235889999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.12 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=194.1
Q ss_pred hhcceecccCcEEEEEEec--CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcC---CcccccceeeeEe-----eCCe
Q 002943 532 QYKTLIGEGGFGSVYRGTL--PDGQEVAVKVRSSTS--TQGTREFENELNFLSAI---RHENLVPLLGYCC-----ENDQ 599 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~--~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~~~~ 599 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++++ +||||++++++|. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3458999999999999986 468899999876433 22334677888877776 8999999999997 5567
Q ss_pred eEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCc
Q 002943 600 QILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFS 679 (863)
Q Consensus 600 ~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla 679 (863)
.++||||++ |+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred EEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 899999997 79999995432 3458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---cc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ES 756 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~ 756 (863)
+...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ..
T Consensus 168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 168 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGG
T ss_pred ccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCcc
Confidence 8664321 22345689999999999999999999999999999999999999976432 111111111000 00
Q ss_pred ccc-------cccC----CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 RID-------EIVD----PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 ~~~-------~i~d----~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... .... ..+ ..........+.+++.+|++.+|++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 000 0011112345789999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.25 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=190.0
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEee------CCeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCE------NDQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~LV~ 604 (863)
+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++.. .+..++||
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 458999999999999996 578999999886543 3457889999999999 79999999999987 46789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp ECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999999543 23568999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCCceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.. .......||..|+|||.+. +..++.++|||||||++|||++|+.||..... ........ .....
T Consensus 182 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~~~ 252 (326)
T 2x7f_A 182 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP----RNPAP 252 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSCCC
T ss_pred Cc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh----cCccc
Confidence 21 1123346899999999987 56789999999999999999999999975431 11111110 01111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+ ...+.+++.+|++.+|++||++.|+++
T Consensus 253 ~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 1112 235889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.25 Aligned_cols=259 Identities=18% Similarity=0.222 Sum_probs=182.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCe-------eEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQ-------QILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-------~~LV~ 604 (863)
+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++.++.++||||+++++++...+. .++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 358999999999999996 468999999876543 334566788999999999999999999976443 78999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHH--hccCCCccccCCCCCCeEecC-CCeEEEeeccCccc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH--TFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKY 681 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~~ 681 (863)
||+++ +|.+.+.........+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 99975 555555332234567899999999999999999999 6 89999999999999997 89999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc-------
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI------- 753 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~------- 753 (863)
...... .....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+........
T Consensus 182 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 182 LSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred cCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHHHcCCCCHHHH
Confidence 654322 2234689999999998665 48999999999999999999999997643211 1111111000
Q ss_pred ----cccccccccCC------ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 ----RESRIDEIVDP------SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 ----~~~~~~~i~d~------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+. .............+.+++.+|++.+|++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 0000111123457889999999999999999998864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=332.80 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=199.3
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcc-----------------hHHHHHHHHHHhcCCcccccceeeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQG-----------------TREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~-----------------~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
.+.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++++++
T Consensus 34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3458999999999999999 89999999876442211 17899999999999999999999999
Q ss_pred eeCCeeEEEeecCCCCChhhhhhc----cCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe
Q 002943 595 CENDQQILVYPFMSNGSLQDRLYG----EASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC 670 (863)
Q Consensus 595 ~~~~~~~LV~ey~~~gsL~~~L~~----~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~ 670 (863)
.+.+..++||||+++|+|.+++.. .......+++..++.++.|++.||+|||+ ..+|+||||||+|||++.++.
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSC
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCc
Confidence 999999999999999999999321 11224679999999999999999999997 268999999999999999999
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC-CCCc-ccceechhhHHHHHHhCCCCCCCCCCCCcchhHHh
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSA-KSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~ 748 (863)
+||+|||+++..... ......||..|+|||.+.+. .++. ++||||||++++||++|+.||...... ..+.+.
T Consensus 191 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~ 264 (348)
T 2pml_X 191 VKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELFNN 264 (348)
T ss_dssp EEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHHHH
T ss_pred EEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH
Confidence 999999999865432 22345689999999999877 5666 999999999999999999999764321 222222
Q ss_pred hhhcccc-c-ccccccCCccC---CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 749 AKPFIRE-S-RIDEIVDPSIK---GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 749 ~~~~~~~-~-~~~~i~d~~l~---~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+...... . .......+... ..........+.+++.+|++.+|.+||++.|+++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111000 0 00000000000 0000122346889999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=336.95 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=177.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 3457899999999999984 578999999986543 23346788999999999999999999998754 56799
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 112 v~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred Eeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 99999 7899998832 468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc------
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE------ 755 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 755 (863)
... .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+......
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELL 254 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHH
T ss_pred ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence 422 234568999999999877 67899999999999999999999999764321 111111110000
Q ss_pred -----cccccccC--CccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 -----SRIDEIVD--PSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 -----~~~~~i~d--~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+. +... .... .....+.+|+.+|++.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 0000 0000 11235789999999999999999998865
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.21 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=196.2
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC---------cchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeE
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST---------QGTREFENELNFLSAIR-HENLVPLLGYCCENDQQI 601 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 601 (863)
+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++ ||||+++++++...+..+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 4588999999999999964 689999998865431 12356789999999996 999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999953 2468999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccc------cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYS------TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE 755 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~ 755 (863)
...... .....||..|+|||.+. ...++.++||||||++++||++|+.||.... ..........
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~---- 243 (298)
T 1phk_A 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMS---- 243 (298)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----
T ss_pred cCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHhc----
Confidence 653321 23356899999999985 4568899999999999999999999997532 1111111111
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 SRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+... ...+ ........+.+++.+|++.+|++||++.|+++
T Consensus 244 ~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1100 0001 01122345889999999999999999999865
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.00 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=188.0
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee-------------
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE------------- 596 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------------- 596 (863)
+.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 34468999999999999995 47999999988643 3345678999999999999999999998865
Q ss_pred CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeec
Q 002943 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADF 676 (863)
Q Consensus 597 ~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DF 676 (863)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred CCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 35678999999999999999542 3467889999999999999999999 89999999999999999999999999
Q ss_pred cCcccCCCCCC------------CCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcc
Q 002943 677 GFSKYAPQEGD------------SGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743 (863)
Q Consensus 677 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 743 (863)
|+++....... ........||..|+|||.+.+. .++.++||||||+++|||++ ||... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~ 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----M 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----h
Confidence 99986643211 1112345689999999999764 78999999999999999998 44321 1
Q ss_pred hhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 744 SLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 744 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+..... ... ...+...........+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ERVNILKKL-RSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHH-HST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhc-ccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111 000 011111222233445789999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=340.36 Aligned_cols=249 Identities=23% Similarity=0.294 Sum_probs=185.4
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4789999999998776668999999987643 235678999999886 89999999999999999999999995 799
Q ss_pred hhhhhccCCCCcc---CChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-------------CeEEEeec
Q 002943 613 QDRLYGEASTRKT---LDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-------------MCAKVADF 676 (863)
Q Consensus 613 ~~~L~~~~~~~~~---l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-------------~~~kl~DF 676 (863)
.+++......... ..+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 9999654322221 2455678899999999999999 899999999999999654 58999999
Q ss_pred cCcccCCCCCCCC--ceeeeecCCCCCCcccccc-------CCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhH
Q 002943 677 GFSKYAPQEGDSG--FSLEVRGTAGYLDPEYYST-------QHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLV 746 (863)
Q Consensus 677 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 746 (863)
|+++......... ......||+.|+|||.+.+ ..++.++|||||||++|||++ |+.||...... . .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~---~ 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-E---S 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-H---H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-H---H
Confidence 9998775432211 1234569999999999975 578999999999999999999 99999754221 1 1
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......... +.+...........+.+++.+|++.+|++||++.||++
T Consensus 249 ~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111100 11111123455677899999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.35 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=189.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc--chHHHHHHHHHHhcCCcccccceeeeEeeCCee------EE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ--GTREFENELNFLSAIRHENLVPLLGYCCENDQQ------IL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~------~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++++++||||+++++++...+.. ++
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 3457899999999999985 46899999988754322 346788999999999999999999999877655 99
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||+. ++|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 125 v~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 999996 78988872 348999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc-------
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR------- 754 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~------- 754 (863)
... .....||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ...........
T Consensus 195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcHHHH
Confidence 432 223468999999999987 68899999999999999999999999764311 11111100000
Q ss_pred ----ccccccc---cCCccCCCC---cHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ----ESRIDEI---VDPSIKGGY---HAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ----~~~~~~i---~d~~l~~~~---~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....... +........ .......+.+++.+|++.+|++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000 000000000 0012346889999999999999999998865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.65 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=199.3
Q ss_pred HHHHHHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEE
Q 002943 526 LEAATQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 526 l~~~t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 602 (863)
.....+.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 33445556789999999999999965 78999999876543 3445789999999999999999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC---CeEEEeeccCc
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS---MCAKVADFGFS 679 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~---~~~kl~DFGla 679 (863)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988532 358999999999999999999999 899999999999999754 47999999999
Q ss_pred ccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 680 KYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 680 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
+....... .....||..|+|||.+.+ .++.++||||||++++||++|+.||.... ...+.+.+. .+...
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~----~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVE----TGKYA 240 (287)
T ss_dssp GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----HCCCC
T ss_pred eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHH----cCCCC
Confidence 87643321 223458899999999865 48999999999999999999999997642 112222111 11100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+....... ...+.+++.+|++.+|++||++.|+++
T Consensus 241 --~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 --FDLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --CCSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000000112 235889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=328.61 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=189.3
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCe------eEEE
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQ------QILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~LV 603 (863)
+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 457899999999999985 4689999998865432 234678899999999999999999999987654 4999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+. |+|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 108 ~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 108 MPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 99996 68988772 248999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcc---------
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI--------- 753 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~--------- 753 (863)
.. .....||..|+|||.+.+ ..++.++|||||||+++||++|+.||...... ..........
T Consensus 178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHHT
T ss_pred CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHH
Confidence 22 223468999999999877 67899999999999999999999999764321 1111110000
Q ss_pred --ccc-------ccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 754 --RES-------RIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 754 --~~~-------~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... .+.....+.+. .........+.+++.+|++.+|++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00000000110 111122346889999999999999999998864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=329.53 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=191.9
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV~ 604 (863)
.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++... ...++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 34589999999999999964 689999998865432 2346788999999999999999999988764 6789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+. |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 94 ELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 9996 699998843 358999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCC--------ceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc-
Q 002943 685 EGDSG--------FSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR- 754 (863)
Q Consensus 685 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~- 754 (863)
..... ......||..|+|||.+.. ..++.++|||||||+++||++|+.||....... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Confidence 22111 1123468999999998764 678999999999999999999999997643111 1110000000
Q ss_pred ---ccc--------cccccC--CccCCC----CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ---ESR--------IDEIVD--PSIKGG----YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ---~~~--------~~~i~d--~~l~~~----~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ..+.+. +..... ........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 000000 000000 00012345789999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.16 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=174.6
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHH-HHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELN-FLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|+.||||++..... ...+++..|+. +++.++||||+++++++...+..++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~- 104 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS- 104 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-
Confidence 3478999999999999964 789999998875532 23345666666 7788899999999999999999999999997
Q ss_pred CChhhhhhcc-CCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGE-ASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~-~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++... ......+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 5888777421 1124578999999999999999999999 6 89999999999999999999999999998764322
Q ss_pred CCceeeeecCCCCCCcccc----ccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 688 SGFSLEVRGTAGYLDPEYY----STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
......||..|+|||.+ .+..++.++||||||+++|||++|+.||...... .+....... +..
T Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~----- 247 (327)
T 3aln_A 181 --AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVVK-GDP----- 247 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC-SCC-----
T ss_pred --ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHhc-CCC-----
Confidence 12234689999999998 4567899999999999999999999999753211 011111111 111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+...........+.+++.+|++.+|++||++.|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111112345889999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=330.16 Aligned_cols=197 Identities=25% Similarity=0.319 Sum_probs=166.3
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cc-----cccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HE-----NLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||+||+|... +++.||||++... ....+++..|+++++.++ |+ +|+++++++...+..++||
T Consensus 57 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 34589999999999999854 6889999998643 233467788999988885 44 4999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CCCeEEEeeccCcccC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HSMCAKVADFGFSKYA 682 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DFGla~~~ 682 (863)
||++ |+|.+++.... ...+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus 136 e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp ECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred ecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 9995 69999996432 24589999999999999999999952 27899999999999994 5788999999999876
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 212 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 212 GQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 223468999999999999999999999999999999999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=328.26 Aligned_cols=259 Identities=17% Similarity=0.261 Sum_probs=195.2
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-----------cccccceeeeEeeCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-----------HENLVPLLGYCCEND 598 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~~ 598 (863)
+.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++ |+||+++++++...+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 34568999999999999995 57899999988643 233467889999999886 899999999998654
Q ss_pred ----eeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEec------C
Q 002943 599 ----QQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLD------H 667 (863)
Q Consensus 599 ----~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld------~ 667 (863)
..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+ + +|+||||||+|||++ .
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred CCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 789999999 99999999543 23458999999999999999999999 7 899999999999994 4
Q ss_pred CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCc----c
Q 002943 668 SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE----W 743 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~----~ 743 (863)
.+.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 558999999999876432 1234689999999999999999999999999999999999999986432111 0
Q ss_pred hhHHhhh-----------------hcccc-cccccccCCcc---------CCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 744 SLVEWAK-----------------PFIRE-SRIDEIVDPSI---------KGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 744 ~l~~~~~-----------------~~~~~-~~~~~i~d~~l---------~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
.+.+... ..+.. +....+..... ...........+.+++.+|++.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111000 00000 00000000000 012345667789999999999999999999
Q ss_pred HHHHH
Q 002943 797 VDIVR 801 (863)
Q Consensus 797 ~eVl~ 801 (863)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=325.31 Aligned_cols=239 Identities=26% Similarity=0.426 Sum_probs=188.4
Q ss_pred HHHhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC------cchHHHHHHHHHHhcC----CcccccceeeeEeeC
Q 002943 529 ATQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST------QGTREFENELNFLSAI----RHENLVPLLGYCCEN 597 (863)
Q Consensus 529 ~t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l----~H~niv~l~g~~~~~ 597 (863)
..+.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++.++ +|+||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 3455568999999999999985 5789999999865533 1234567899999998 899999999999999
Q ss_pred CeeEEEeec-CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEee
Q 002943 598 DQQILVYPF-MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVAD 675 (863)
Q Consensus 598 ~~~~LV~ey-~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~D 675 (863)
+..++|+|| +.+++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999 789999999954 2358999999999999999999999 7899999999999999 899999999
Q ss_pred ccCcccCCCCCCCCceeeeecCCCCCCccccccCCCC-cccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 676 FGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS-AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 676 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
||+++...... .....||..|+|||.+.+..+. .++||||||+++|||++|+.||.... .+..
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~------- 247 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE------- 247 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-------
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-------
Confidence 99998765332 2344689999999999877664 58999999999999999999996421 1110
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. ..+.... ...+.+++.+|++.+|++||++.|+++
T Consensus 248 -~~------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -AE------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -TC------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hc------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0111122 235788999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=325.27 Aligned_cols=259 Identities=20% Similarity=0.259 Sum_probs=195.3
Q ss_pred HhhcceecccCcEEEEEEecC-CC-CEEEEEEcccCCCcchHHHHHHHHHHhcCCccc------ccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DG-QEVAVKVRSSTSTQGTREFENELNFLSAIRHEN------LVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g-~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~~L 602 (863)
+.+.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|++++++++|++ ++.+.+++...+..++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI 99 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence 345689999999999999853 34 78999998643 234567889999999998876 8999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe-----------------
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL----------------- 665 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl----------------- 665 (863)
||||+ +++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||+
T Consensus 100 v~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 100 AFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccc
Confidence 99999 77787777542 23468999999999999999999999 899999999999999
Q ss_pred --cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc
Q 002943 666 --DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW 743 (863)
Q Consensus 666 --d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~ 743 (863)
+.++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 66889999999999865432 12346899999999999999999999999999999999999999764321111
Q ss_pred hhHHhhhhccccc-----cccc---------------------ccCCc-cCCCCcHHHHHHHHHHHHHccCcCCCCCCCH
Q 002943 744 SLVEWAKPFIRES-----RIDE---------------------IVDPS-IKGGYHAEAMWRMVEVALACIEPFSAYRPSM 796 (863)
Q Consensus 744 ~l~~~~~~~~~~~-----~~~~---------------------i~d~~-l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm 796 (863)
............. .... ...+. ........+...+.+++.+|++.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 1111000000000 0000 00000 0001122345578899999999999999999
Q ss_pred HHHHH
Q 002943 797 VDIVR 801 (863)
Q Consensus 797 ~eVl~ 801 (863)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 98864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=325.14 Aligned_cols=245 Identities=19% Similarity=0.264 Sum_probs=167.0
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ey~~~ 609 (863)
++||+|+||.||+|... +|+.||||++... .+...+....++.++||||+++++++.. +...++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 57999999999999965 6999999988643 1222233344667799999999999976 4458999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~~ 686 (863)
|+|.+++... ....+++.+++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 111 g~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~ 185 (336)
T 3fhr_A 111 GELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185 (336)
T ss_dssp EEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence 9999999643 23469999999999999999999999 89999999999999976 4569999999998654321
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........+.. .+
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~------~~ 252 (336)
T 3fhr_A 186 ----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY------GF 252 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CC
T ss_pred ----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc------cc
Confidence 2234689999999999888899999999999999999999999975432111 0000000000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...........+.+++.+|++.+|++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001122345889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=334.61 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=183.0
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
..++||+|+||+||.....+|+.||||++.... ...+.+|+++|+++ +||||+++++++.+.+..++||||+. |+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 357899999999665555689999999886543 23467899999999 79999999999999999999999995 69
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-----CCeEEEeeccCcccCCCCC
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-----SMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DFGla~~~~~~~ 686 (863)
|.+++... ...+.+...+.++.|+++||+|||+ .+|+||||||+|||++. ...+||+|||+++......
T Consensus 104 L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 104 LQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp HHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred HHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99999543 2345566778999999999999999 89999999999999943 3468899999998765332
Q ss_pred CC-CceeeeecCCCCCCccccc---cCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 687 DS-GFSLEVRGTAGYLDPEYYS---TQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 687 ~~-~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
.. .......||+.|+|||.+. ...++.++|||||||+++||++ |+.||..... ..... ....... ..
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~~---~~~~~~~-~~ 249 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANI---LLGACSL-DC 249 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHHH---HTTCCCC-TT
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHHH---HhccCCc-cc
Confidence 11 2233456999999999997 4567889999999999999999 9999964321 11110 0000000 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+. ........+.+++.+|++.+|++||++.||++
T Consensus 250 ----~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ----LH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----SC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 11123345778999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.77 Aligned_cols=236 Identities=23% Similarity=0.364 Sum_probs=192.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc------chHHHHHHHHHHhcCC--cccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ------GTREFENELNFLSAIR--HENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~L 602 (863)
.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++++++ |+||+++++++...+..++
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~l 125 (320)
T 3a99_A 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125 (320)
T ss_dssp EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEE
Confidence 4468999999999999984 57899999987655322 2356788999999996 5999999999999999999
Q ss_pred EeecCCC-CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec-CCCeEEEeeccCcc
Q 002943 603 VYPFMSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSK 680 (863)
Q Consensus 603 V~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld-~~~~~kl~DFGla~ 680 (863)
|+|++.+ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 126 v~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 126 ILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 9999976 899999953 3468999999999999999999999 8999999999999999 78999999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
...... .....||..|+|||.+.+..+ +.++||||||+++|||++|+.||.... ... . +..
T Consensus 199 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~---~-----~~~- 260 (320)
T 3a99_A 199 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII---R-----GQV- 260 (320)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---H-----CCC-
T ss_pred cccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh---c-----ccc-
Confidence 765321 223468999999999987765 678999999999999999999996421 000 0 000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+....+ ..+.+++.+|++.+|++||++.|+++
T Consensus 261 -----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 -----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cccccCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111222 35789999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.92 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=204.0
Q ss_pred HHhhcceecccCcEEEEEEec-CCCCEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEee------CCeeE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCE------NDQQI 601 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~ 601 (863)
.+.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 345568999999999999996 46899999987654 23345678999999999999999999998765 66789
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCe---EEEeeccC
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMC---AKVADFGF 678 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~---~kl~DFGl 678 (863)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 95 LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999996532 23468999999999999999999999 89999999999999996654 99999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.... ....|..........
T Consensus 171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC-----
T ss_pred cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccch
Confidence 98765432 2234569999999999999999999999999999999999999997531 233333322211111
Q ss_pred ccccCCc------------cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHH-----HHHHHHHhhc
Q 002943 759 DEIVDPS------------IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVD-----IVRELEDAFI 808 (863)
Q Consensus 759 ~~i~d~~------------l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~e-----Vl~~L~~~~~ 808 (863)
....... ............+.+++..|++.||++|||+.| ..+.++.++.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 1111110 011223345667899999999999999999988 5567776654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.40 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=173.7
Q ss_pred hcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc-c-hHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ-G-TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 4578999999999999964 7899999988755332 2 233445556788889999999999999999999999999 4
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCC-CccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR-SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~-~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+.+..+... ....+++..++.++.|+++||+|||+ + +|+||||||+|||++.++.+||+|||+++......
T Consensus 108 ~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 108 TCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 555544422 13468999999999999999999998 5 89999999999999999999999999997654322
Q ss_pred CceeeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 689 GFSLEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
......||..|+|||.+. ...++.++||||||+++|||++|+.||..... ...... ...... .
T Consensus 180 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~---~~~~~~------~ 247 (318)
T 2dyl_A 180 -AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLT---KVLQEE------P 247 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHH---HHHHSC------C
T ss_pred -cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHH---HHhccC------C
Confidence 123446899999999994 45688999999999999999999999975321 111111 111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+... ......+.+++.+|++.+|.+||++.|+++
T Consensus 248 ~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011100 011235789999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=326.81 Aligned_cols=237 Identities=18% Similarity=0.173 Sum_probs=177.8
Q ss_pred cceecccCcEEEEEEe-cCCCCEEEEEEcccCCC---cchHHHHHHHHHHhcCCc-ccccceeee---------------
Q 002943 534 KTLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTST---QGTREFENELNFLSAIRH-ENLVPLLGY--------------- 593 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~---~~~~~f~~E~~~l~~l~H-~niv~l~g~--------------- 593 (863)
.++||+|+||.||+|. ..+|+.||||++..... ...+.|.+|+.+++.++| +|......+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 4789999999999999 56799999998774332 235789999999999987 322211111
Q ss_pred ------Eee-----CCeeEEEeecCCCCChhhhhhcc---CCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCC
Q 002943 594 ------CCE-----NDQQILVYPFMSNGSLQDRLYGE---ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVK 659 (863)
Q Consensus 594 ------~~~-----~~~~~LV~ey~~~gsL~~~L~~~---~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik 659 (863)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+ ++|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence 111 12346666655 78999888421 2335678999999999999999999999 899999999
Q ss_pred CCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCcccc----------ccCCCCcccceechhhHHHHHHh
Q 002943 660 SSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY----------STQHLSAKSDVFSFGVVLLEIIS 729 (863)
Q Consensus 660 ~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDV~SfGvvl~Ellt 729 (863)
|+|||++.++.+||+|||+++..... .....| +.|+|||.+ ....++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999865432 233457 999999999 55568889999999999999999
Q ss_pred CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 730 GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 730 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
|+.||........ ...++... ...+ ..+.+++.+||+.+|++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~---------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGG---------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSC---------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhh---------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999975432111 01111100 1122 45889999999999999999888854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=346.66 Aligned_cols=236 Identities=20% Similarity=0.283 Sum_probs=190.1
Q ss_pred hhcceecccCcEEEEEEecC--CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCe-----eEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP--DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQ-----QILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~--~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~LV 603 (863)
.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||++++++|...+. .+||
T Consensus 83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv 162 (681)
T 2pzi_A 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162 (681)
T ss_dssp EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence 45689999999999999864 689999998865432 344678999999999999999999999987765 6999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++++|.+++. ..++|.+++.++.||+.||+|||+ ++|+||||||+|||++.+ .+||+|||+++...
T Consensus 163 ~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 163 MEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999998772 268999999999999999999999 899999999999999986 89999999998764
Q ss_pred CCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. ....||++|+|||.+.+.. +.++|||||||+++||++|..|+....... +.
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~---- 285 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP---- 285 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC----
T ss_pred cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc----
Confidence 32 2346999999999987654 889999999999999999988876421100 00
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhh
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRP-SMVDIVRELEDAF 807 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~ 807 (863)
...........+.+++.+|++.+|++|| ++.++.+.|..++
T Consensus 286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0001112234688999999999999999 5777777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=303.25 Aligned_cols=228 Identities=14% Similarity=0.089 Sum_probs=179.6
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||.||+|... +|+.||||++...... ..+.|.+|++++++++||||+++++++...+..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 345689999999999999965 5899999998765432 236789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++++|.+++.. .....+..+++.|++.||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 113 ~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp CCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred cCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999932 13455788999999999999999 899999999999999999999998443
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC-c
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP-S 765 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~-~ 765 (863)
|++ .++.++|||||||++|||+||+.||.......... ......... ...+ .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~----~~~~~~ 227 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQ----PIEPAD 227 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSC----BCCHHH
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccC----CCChhh
Confidence 333 36889999999999999999999998654322100 000000000 0000 0
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+... ....+.+++.+||+.||++| |+.|+++.|+++..
T Consensus 228 ~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 1111 22458899999999999999 99999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=300.78 Aligned_cols=220 Identities=18% Similarity=0.278 Sum_probs=173.1
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHH-hcCCcccccceeeeEee----CCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFL-SAIRHENLVPLLGYCCE----NDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~LV~ey~~ 608 (863)
++||+|+||.||++.. .+++.||||++.. ...+.+|++++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 6799999999999985 5789999998853 35678899888 56689999999999987 677899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 99 GGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp SCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999999643 23468999999999999999999999 89999999999999998 7899999999987542
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
+..++.++|||||||++|||++|+.||........ ..... ..+....
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~--------~~~~~~~ 218 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMK--------TRIRMGQ 218 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------CCSC--------CSSCTTC
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---hHHHH--------HHHhhcc
Confidence 13467899999999999999999999975432110 00000 0000000
Q ss_pred cCCCCc----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYH----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ... ......+.+++.+|++.+|++||++.|+++
T Consensus 219 ~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp C--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 001 112345889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=309.79 Aligned_cols=241 Identities=17% Similarity=0.199 Sum_probs=179.9
Q ss_pred HHHHhhcceecccCcEEEEEEecCCCCEEEEEEcccCCC--------cchHHHHHHHHHHhcCC---------cccccce
Q 002943 528 AATQQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST--------QGTREFENELNFLSAIR---------HENLVPL 590 (863)
Q Consensus 528 ~~t~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~--------~~~~~f~~E~~~l~~l~---------H~niv~l 590 (863)
...+.+.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34566779999999999999998 789999998876532 23377899999999886 5555555
Q ss_pred ee-----------------eEee-------------CCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHH
Q 002943 591 LG-----------------YCCE-------------NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAAR 640 (863)
Q Consensus 591 ~g-----------------~~~~-------------~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~ 640 (863)
.+ ++.+ .+..++||||+++|++.+.+.. ..+++.....++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 54 4443 6789999999999987777622 45899999999999999
Q ss_pred HHHHHH-hccCCCccccCCCCCCeEecCCC--------------------eEEEeeccCcccCCCCCCCCceeeeecCCC
Q 002943 641 GLMYLH-TFAGRSVIHRDVKSSNILLDHSM--------------------CAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699 (863)
Q Consensus 641 gL~yLH-~~~~~~iiHrDik~~NILld~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 699 (863)
||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 7 7899999999999999886 9999999999876421 3469999
Q ss_pred CCCccccccCCCCcccceechhhH-HHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc-ccCCccCCCCcHHHHHH
Q 002943 700 YLDPEYYSTQHLSAKSDVFSFGVV-LLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE-IVDPSIKGGYHAEAMWR 777 (863)
Q Consensus 700 y~aPE~~~~~~~s~ksDV~SfGvv-l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-i~d~~l~~~~~~~~~~~ 777 (863)
|+|||.+.+.. +.++||||+|++ .+++++|..||... .|....... .... .................
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDK-MLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHH-HHHTCCCSSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHh-hhhhhccCcccchhhhhhcCHH
Confidence 99999998766 889999998776 77788899888421 111110000 0000 00001111112345677
Q ss_pred HHHHHHHccCcCCCCCCCHHHHH
Q 002943 778 MVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 778 l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
+.+++.+|++.+ |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999966 888876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=287.82 Aligned_cols=186 Identities=19% Similarity=0.135 Sum_probs=130.1
Q ss_pred ceecccCcEEEEEEe-cCCCCEEEEEEcccCCC----------cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 535 TLIGEGGFGSVYRGT-LPDGQEVAVKVRSSTST----------QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~-~~~g~~vAVK~~~~~~~----------~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
...+.|++|.+..++ .--|+.+|||++..... ...++|.+|+++|+++ +|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 345667777666554 33588999998865421 2235799999999999 69999999999999999999
Q ss_pred EeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccC
Q 002943 603 VYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~ 682 (863)
||||++|++|.++|.. ..+++. .+|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+..
T Consensus 320 VMEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999943 234554 3589999999999999 99999999999999999999999999999976
Q ss_pred CCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCC
Q 002943 683 PQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733 (863)
Q Consensus 683 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p 733 (863)
.... .......||++|||||.+.+ ++..++|+||+|++++++.++..+
T Consensus 390 ~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 5432 22344679999999999875 467789999999998887666444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=262.38 Aligned_cols=184 Identities=20% Similarity=0.274 Sum_probs=147.7
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCCc--------chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ--------GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.++||+|+||.||+|.. .++.+++|+....... ..+.|.+|++++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999955 5788999975443221 12458999999999999999988888888888999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++.. ++.++.|+++||+|||+ ++|+||||||+|||+++ .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999942 56899999999999999 89999999999999999 9999999999977542
Q ss_pred CCCC-----ceeeeecCCCCCCcccccc--CCCCcccceechhhHHHHHHhCCCCCC
Q 002943 686 GDSG-----FSLEVRGTAGYLDPEYYST--QHLSAKSDVFSFGVVLLEIISGREPLN 735 (863)
Q Consensus 686 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~SfGvvl~ElltG~~p~~ 735 (863)
.... ......||+.|||||++.. ..|+.++|+||..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111 1134579999999999987 567888999999999999998887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-22 Score=213.48 Aligned_cols=141 Identities=16% Similarity=0.134 Sum_probs=116.0
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCCC------------------cchHHHHHHHHHHhcCCcccccceeeeEe
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST------------------QGTREFENELNFLSAIRHENLVPLLGYCC 595 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 595 (863)
.+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 488999999999999997799999998864322 12356889999999999 5 77777654
Q ss_pred eCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEee
Q 002943 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVAD 675 (863)
Q Consensus 596 ~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~D 675 (863)
. +..++||||+++|+|.+ +. ......++.|+++||+|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred c-cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 3 56699999999999998 51 12345799999999999999 8999999999999999 99999999
Q ss_pred ccCcccCCCCCCCCceeeeecCCCCCCcccccc
Q 002943 676 FGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708 (863)
Q Consensus 676 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 708 (863)
||+|+. +..++|||++..
T Consensus 236 FG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE---------------TTSTTHHHHHHH
T ss_pred CCCCeE---------------CCCCCHHHHHHH
Confidence 999873 345789998753
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9e-19 Score=173.55 Aligned_cols=150 Identities=18% Similarity=0.158 Sum_probs=103.1
Q ss_pred EEEEeeccCCCCCCCcccCCCCCCCceeeCCCCCC-CccccccceeeecCCCCCCCCcHHHhhhcccCCCCceeecccCC
Q 002943 192 KLVGRYDLGRSDNELSFRYPDDPFDRIWIPKLSPE-PTTFSTSFTTNISDNNAKVTVPLQVLQTALTDPNRLMFLHTDLD 270 (863)
Q Consensus 192 ~~~~R~n~G~~~~~~~irypdD~~dR~W~p~~~~~-~~~~~~~~~~~~~~~~~~~~~P~~V~~TA~~~~~~~~~~~~~~~ 270 (863)
+++.|+|||++. +. |..+|.|.+|.... ....+.... ... ....+.+|+.||||||..+.++.| ..+.
T Consensus 5 ~~~~~INcGg~~----~~---d~~gr~w~~D~~~~~~g~~~~~~~-~~~-~~~~~~~~~~lY~TaR~~~~~~tY--~f~v 73 (174)
T 2jwp_A 5 KVIWAVNAGGES----HV---DVHGIHYRKDPLEGRVGRASDYGM-KLP-ILRSNPEDQVLYQTERYNEDSFGY--DIPI 73 (174)
T ss_dssp HEEEEEEETSSS----EE---ETTTEEECSSCSSTTCCCCCCCCT-TSC-CSSSCHHHHHTTTCCCCCCSCEEE--EEEC
T ss_pred cEEEEEECCCCC----cc---CCCCCEEcCCcCcccCCccccccc-ceE-ecccCCCCchhhhhhccCCCCeEE--EEEe
Confidence 357899999976 22 67899999995421 111110000 000 011245789999999986655443 4444
Q ss_pred CCCcceEEEEEEeecccccCCCCeEEEEEEECCccccccchhhhc-Cc---ceeEEEEEe------------ecCCceEE
Q 002943 271 SGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILAL-GS---NYAKLALNV------------TANGSLNL 334 (863)
Q Consensus 271 ~~~~~y~v~lhFaEi~~~~~~~~~R~F~I~ing~~~~~~~di~~~-~~---~~~~~~~~~------------~~~g~~~~ 334 (863)
++++.|.|+|||||+.. ++.++|+|||||||+++.++||+... |. .+.++.+.+ ..+|.++|
T Consensus 74 ~~~G~Y~VrLhF~ei~~--~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I 151 (174)
T 2jwp_A 74 KEEGEYVLVLKFAEVYF--AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSV 151 (174)
T ss_dssp CSCEEEEEEEEEECCSC--CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEE
T ss_pred CCCeEEEEEEEEecccc--CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEE
Confidence 55679999999999964 55789999999999999999999864 22 234444443 35788999
Q ss_pred EEeeecCCCccccccceeeeEEe
Q 002943 335 TLVNVLNGSVFGPICNAYEILQV 357 (863)
Q Consensus 335 ~l~~t~~~S~lppilNa~Ei~~v 357 (863)
++.+. +.-.|+|||+||++-
T Consensus 152 ~f~p~---~~~~a~inaIEI~~~ 171 (174)
T 2jwp_A 152 EFVKG---YYDNPKVCALFIMKG 171 (174)
T ss_dssp EEECS---SSCSSSEEEEEEESS
T ss_pred EEecc---CCCCcEEEEEEEEeC
Confidence 99853 356799999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=181.30 Aligned_cols=134 Identities=18% Similarity=0.170 Sum_probs=104.7
Q ss_pred hcceecccCcEEEEEEec-CCCCE--EEEEEcccCCCc------------------------chHHHHHHHHHHhcCCcc
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQE--VAVKVRSSTSTQ------------------------GTREFENELNFLSAIRHE 585 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~--vAVK~~~~~~~~------------------------~~~~f~~E~~~l~~l~H~ 585 (863)
+.+.||+|+||.||+|.. .+|+. ||||++...... ....+.+|+++|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 347899999999999997 68888 999986543111 012578999999999988
Q ss_pred cc--cceeeeEeeCCeeEEEeecCCC-C----ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHH-hccCCCccccC
Q 002943 586 NL--VPLLGYCCENDQQILVYPFMSN-G----SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH-TFAGRSVIHRD 657 (863)
Q Consensus 586 ni--v~l~g~~~~~~~~~LV~ey~~~-g----sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~iiHrD 657 (863)
++ ..++.+ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| + .+|+|||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 64 333332 367899999942 4 66665421 235677899999999999999 7 8999999
Q ss_pred CCCCCeEecCCCeEEEeeccCcccC
Q 002943 658 VKSSNILLDHSMCAKVADFGFSKYA 682 (863)
Q Consensus 658 ik~~NILld~~~~~kl~DFGla~~~ 682 (863)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.1e-15 Score=168.92 Aligned_cols=136 Identities=13% Similarity=0.123 Sum_probs=94.8
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCC-----c---------chHHHHHHHHHHhcCCcccccceeeeEe---
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTST-----Q---------GTREFENELNFLSAIRHENLVPLLGYCC--- 595 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~-----~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~--- 595 (863)
+.+.||+|+||.||+|...+|+.||||+++.... . .......+.++.....|+|++++.....
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 4578999999999999999999999998653210 0 0111223333333334444444432111
Q ss_pred ---eCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC---
Q 002943 596 ---ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM--- 669 (863)
Q Consensus 596 ---~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~--- 669 (863)
.....+|||||+++++|.+... ......++.|++.+|.|||+ .+||||||||.|||+++++
T Consensus 179 ~p~~~~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 179 EPIAQSRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CEEEEETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSS
T ss_pred eeeeccCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCcc
Confidence 1123479999999988876541 12345688999999999999 8899999999999998776
Q ss_pred -------eEEEeeccCccc
Q 002943 670 -------CAKVADFGFSKY 681 (863)
Q Consensus 670 -------~~kl~DFGla~~ 681 (863)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 489999987653
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=129.34 Aligned_cols=138 Identities=9% Similarity=0.015 Sum_probs=90.2
Q ss_pred EEEecCCCCCcccCCCCcEEecCCCeecCCCCcccccC------CCCCcccccccccccCCCCcceeeecccCCCeeeEe
Q 002943 35 VSIACCADSDFIGKYPPVNWKPDDAWFPDKKDCRAITR------PAVNNKFYDRVLDFGIDSGKRCYNLSTIKGQDYLIR 108 (863)
Q Consensus 35 ~sidCG~~~~~~~~~~~~~~~~D~~~~~~~~~~~~~~~------~~~~~~~~~~~r~f~~~~~~~cY~~~~~~~~~ylvR 108 (863)
.+||||+.. .+|. .|++|.+|..|...|........ ....+..|+|+|.|+. ..||.+|+.++|+|+||
T Consensus 8 ~~INcGg~~-~~d~-~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~---~~tY~f~v~~~G~Y~Vr 82 (174)
T 2jwp_A 8 WAVNAGGES-HVDV-HGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED---SFGYDIPIKEEGEYVLV 82 (174)
T ss_dssp EEEEETSSS-EEET-TTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS---CEEEEEECCSCEEEEEE
T ss_pred EEEECCCCC-ccCC-CCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC---CeEEEEEeCCCeEEEEE
Confidence 569999754 4554 79999999776423322111100 1112347899999982 56999999889999999
Q ss_pred EEeeccCCCCCCCCcceeEEEcceee-EEEeCC-----CCce-eeEEEE-------------ecCCceEEeecCC-CCCc
Q 002943 109 GTFLNGDNVETPLISSFNVLVGVTPL-SLVNST-----EDSV-VEGIFK-------------AANDYIDFCLDKK-DGDP 167 (863)
Q Consensus 109 ~~F~yg~~~~~~~~~~Fd~~~~~~~w-~~vn~~-----~~~~-~e~i~~-------------~~~~~~~vcl~~~-~~~p 167 (863)
+||..-.+.. .....|||++++... ...+.. ...+ .+..+. ...+.+.|.|.++ .+.|
T Consensus 83 LhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a 161 (174)
T 2jwp_A 83 LKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP 161 (174)
T ss_dssp EEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSS
T ss_pred EEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCc
Confidence 9998776543 223469999988722 222221 1122 344433 2455688888665 6889
Q ss_pred eeeeEeeeecC
Q 002943 168 YISGLEVRPLN 178 (863)
Q Consensus 168 fIs~lEl~~l~ 178 (863)
|||||||++..
T Consensus 162 ~inaIEI~~~~ 172 (174)
T 2jwp_A 162 KVCALFIMKGT 172 (174)
T ss_dssp SEEEEEEESSC
T ss_pred EEEEEEEEeCc
Confidence 99999999854
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=1.5e-10 Score=122.08 Aligned_cols=138 Identities=15% Similarity=0.094 Sum_probs=109.3
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+...++.|+.+.||+.... |+.+++|+...........+.+|+++++.+. |.++.++++++...+..++||||+++.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 3567788888999999864 6899999876533233456899999999985 6778889999998889999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA------------------------------------------ 649 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------ 649 (863)
|.+.+. +......++.+++++|+.||+..
T Consensus 97 l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 97 CSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 987641 12234578899999999999810
Q ss_pred --------------CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 650 --------------GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 650 --------------~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1448999999999999887667899998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=4.6e-10 Score=117.70 Aligned_cols=131 Identities=19% Similarity=0.132 Sum_probs=98.8
Q ss_pred eec-ccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 536 LIG-EGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 536 ~LG-~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.++ .|..+.||+....+|..+++|+.... ....+..|+++++.+++.+ +.+++++....+..++||||+++.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998878889999986543 2356889999999997555 45588888877788999999999888
Q ss_pred hhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 002943 613 QDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA------------------------------------------- 649 (863)
Q Consensus 613 ~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------------- 649 (863)
. ... . ....++.++++.|+.||+..
T Consensus 103 ~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 210 1 12356777788888888632
Q ss_pred ------------CCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 650 ------------GRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 650 ------------~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
...++|+|++|.|||++++..++|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998887778999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=6.9e-09 Score=114.74 Aligned_cols=140 Identities=16% Similarity=0.277 Sum_probs=105.9
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcc--cCC-CcchHHHHHHHHHHhcCC--cccccceeeeEeeC---CeeEEEeec
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRS--STS-TQGTREFENELNFLSAIR--HENLVPLLGYCCEN---DQQILVYPF 606 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~LV~ey 606 (863)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568999999999998754 678888765 322 123457889999999997 45678889988776 458999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-------------------------------------
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA------------------------------------- 649 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------------------- 649 (863)
+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9988775422 124678888999999999999999721
Q ss_pred ------------------CCCccccCCCCCCeEecCCC--eEEEeeccCccc
Q 002943 650 ------------------GRSVIHRDVKSSNILLDHSM--CAKVADFGFSKY 681 (863)
Q Consensus 650 ------------------~~~iiHrDik~~NILld~~~--~~kl~DFGla~~ 681 (863)
...++|+|+++.|||++.++ .+.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 25699999999999999765 368999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=5.5e-09 Score=112.75 Aligned_cols=186 Identities=20% Similarity=0.225 Sum_probs=120.7
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-ccc--ccceeeeEeeCC---eeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HEN--LVPLLGYCCEND---QQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~LV~ey~~ 608 (863)
+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+.+..+...+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999874 56888875432 33467889999998884 332 334444443333 3478999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhc----------------------------------------
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF---------------------------------------- 648 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------------------------------------- 648 (863)
+.+|.+... ..++..++..++.++++.|+.||..
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865432 2356677788888888888888851
Q ss_pred ---------------cCCCccccCCCCCCeEecC--CCeEEEeeccCcccCCCCCCCCceee------------eecCCC
Q 002943 649 ---------------AGRSVIHRDVKSSNILLDH--SMCAKVADFGFSKYAPQEGDSGFSLE------------VRGTAG 699 (863)
Q Consensus 649 ---------------~~~~iiHrDik~~NILld~--~~~~kl~DFGla~~~~~~~~~~~~~~------------~~gt~~ 699 (863)
....++|+|+++.||++++ +..+.|+||+.+.......+-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1135899999999999998 56789999999875432111000000 000011
Q ss_pred CCC-ccccccCCCCcccceechhhHHHHHHhCCCCC
Q 002943 700 YLD-PEYYSTQHLSAKSDVFSFGVVLLEIISGREPL 734 (863)
Q Consensus 700 y~a-PE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~ 734 (863)
... |+.... .....+.|++|.+++++.+|+.+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 122 222211 112358999999999999998765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=98.24 E-value=8.9e-07 Score=95.81 Aligned_cols=81 Identities=26% Similarity=0.464 Sum_probs=66.4
Q ss_pred ccchhhHHHHHhHHHHhhcccccccccCccC--CCCCCCcccceeecCCCCceEEEEEecCcCcccc--cCCCcccCCcc
Q 002943 364 TDQADVNVIRKVRDELKKYNKENKVLESWSG--DPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQG--ILPLSVTGLTH 439 (863)
Q Consensus 364 t~~~d~~al~~~k~~~~~~~~~~~~~~~W~g--dpc~p~~w~gv~C~~~~~~~~l~~l~ls~n~l~G--~iP~~~~~l~~ 439 (863)
+.++|+.||+++|+++. +|. .+.+|.. |||. +.|.||.|+......+++.|+|++|+++| .+|..+++++.
T Consensus 3 c~~~~~~aL~~~k~~~~---~~~-~l~~W~~~~~~C~-~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLG---NPT-TLSSWLPTTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTT---CCG-GGTTCCTTSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCHHHHHHHHHHHHhcC---Ccc-cccCCCCCCCCCc-CCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 56789999999999984 343 7889973 3442 34999999765444689999999999999 99999999999
Q ss_pred ccccccc-cCC
Q 002943 440 LEKFRGF-CGS 449 (863)
Q Consensus 440 L~~l~~s-~n~ 449 (863)
|+.|+++ +|.
T Consensus 78 L~~L~L~~~n~ 88 (313)
T 1ogq_A 78 LNFLYIGGINN 88 (313)
T ss_dssp CSEEEEEEETT
T ss_pred CCeeeCCCCCc
Confidence 9999998 565
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=9.6e-06 Score=87.38 Aligned_cols=135 Identities=19% Similarity=0.188 Sum_probs=91.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc---cccceeeeEe-eCCeeEEEeecCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE---NLVPLLGYCC-ENDQQILVYPFMSNG 610 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~LV~ey~~~g 610 (863)
+.++.|....||+. |..+++|+-. .......+.+|.++|+.+.+. .+.+.+.++. ..+..++||||+++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888999998 5678888742 222346788999999999753 3556666664 345578999999998
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF------------------------------------------ 648 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------ 648 (863)
.|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8866321 1123334444444444444444431
Q ss_pred ---------------cCCCccccCCCCCCeEecC---CCe-EEEeeccCccc
Q 002943 649 ---------------AGRSVIHRDVKSSNILLDH---SMC-AKVADFGFSKY 681 (863)
Q Consensus 649 ---------------~~~~iiHrDik~~NILld~---~~~-~kl~DFGla~~ 681 (863)
....++|+|+++.|||++. ++. ..|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2245799999999999987 344 58999987754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-05 Score=84.45 Aligned_cols=136 Identities=18% Similarity=0.134 Sum_probs=95.5
Q ss_pred ceecccCcE-EEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFG-SVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG-~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+-++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556554 68988764 5678999975432 3457888999998885 3346678899999999999999999988
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF------------------------------------------- 648 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~------------------------------------------- 648 (863)
+.+.... ....+..++.++++.|+-||..
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7765421 1122334555555555555531
Q ss_pred ------------cCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 649 ------------AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 649 ------------~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
....++|+|+.+.|||++++..+-|.||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999888788999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1e-05 Score=88.97 Aligned_cols=80 Identities=8% Similarity=0.051 Sum_probs=56.8
Q ss_pred cee-cccCcEEEEEEecC-------CCCEEEEEEcccCC---CcchHHHHHHHHHHhcCCc---ccccceeeeEeeC---
Q 002943 535 TLI-GEGGFGSVYRGTLP-------DGQEVAVKVRSSTS---TQGTREFENELNFLSAIRH---ENLVPLLGYCCEN--- 597 (863)
Q Consensus 535 ~~L-G~G~fG~Vy~g~~~-------~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~--- 597 (863)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78889999998764 26788999765432 1123567889999998853 2466778877655
Q ss_pred CeeEEEeecCCCCChhh
Q 002943 598 DQQILVYPFMSNGSLQD 614 (863)
Q Consensus 598 ~~~~LV~ey~~~gsL~~ 614 (863)
+..++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999998876653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.05 E-value=6.4e-06 Score=101.00 Aligned_cols=89 Identities=18% Similarity=0.209 Sum_probs=69.2
Q ss_pred ceeeeEEeeccc---ccccchhhHHHHHhHHHHhhcccccccccCccCCC----CCC--Ccc------------cceeec
Q 002943 350 NAYEILQVRQWV---QETDQADVNVIRKVRDELKKYNKENKVLESWSGDP----CRP--STW------------RGVYCN 408 (863)
Q Consensus 350 Na~Ei~~v~~~~---~~t~~~d~~al~~~k~~~~~~~~~~~~~~~W~gdp----c~p--~~w------------~gv~C~ 408 (863)
|+++=...+|+. ..+..+|+.||+++|+++.. | +|+.+. +.| |+| .||.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~d~~ALl~~k~~l~~---~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~ 320 (876)
T 4ecn_A 249 NKLTKDANVPIQLKETAEYIKDYKALKAIWEALDG---K-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320 (876)
T ss_dssp TSEEEEEEEEECCCCCCHHHHHHHHHHHHHHHTTG---G-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEEC
T ss_pred cccccccccceeccccccchHHHHHHHHHHHHcCC---C-----CCCcCCCcccccCCccccccccccccccCcCceEec
Confidence 333444444443 24567899999999999943 2 797443 334 899 999996
Q ss_pred CCCCceEEEEEecCcCcccccCCCcccCCcccccccc-ccCC
Q 002943 409 TRNGSITITGLDLSSGQIQGILPLSVTGLTHLEKFRG-FCGS 449 (863)
Q Consensus 409 ~~~~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~-s~n~ 449 (863)
. ..+|+.|+|++|+|+|.+|+.+++|+.|+.|++ ++|.
T Consensus 321 ~---~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~ 359 (876)
T 4ecn_A 321 N---NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSE 359 (876)
T ss_dssp T---TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTH
T ss_pred C---CCCEEEEECccCCCCCcCchHHhccccceEeeeccccc
Confidence 5 357999999999999999999999999999999 7774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.77 E-value=7.3e-05 Score=81.19 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=80.8
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc--cccceee------eEeeCCeeEEEeecC
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE--NLVPLLG------YCCENDQQILVYPFM 607 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~LV~ey~ 607 (863)
.|+.|..+.||+....+| .+++|+.... ..++..|.++++.+... .+.+++. +....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455677899999987655 4889987642 23445566666665421 2233332 123456788999999
Q ss_pred CCCChh--------------hhhhccCCC---C-------ccCChhhHH-------------------------------
Q 002943 608 SNGSLQ--------------DRLYGEAST---R-------KTLDWPTRL------------------------------- 632 (863)
Q Consensus 608 ~~gsL~--------------~~L~~~~~~---~-------~~l~~~~~~------------------------------- 632 (863)
++..+. ..+|..... . ..-.|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 112211100 0 112332211
Q ss_pred HHHHHHHHHHHHHHh----------ccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 633 SIALGAARGLMYLHT----------FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 633 ~ia~~ia~gL~yLH~----------~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
.+...+.+++++|+. .....++|+|+++.|||++.+..+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123445667763 134789999999999999888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=7.1e-05 Score=83.57 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=49.3
Q ss_pred ceecccCcEEEEEEecC-CCCEEEEEEcccCCC-------cchHHHHHHHHHHhcCCc--cccc-ceeeeEeeCCeeEEE
Q 002943 535 TLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-------QGTREFENELNFLSAIRH--ENLV-PLLGYCCENDQQILV 603 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-------~~~~~f~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~LV 603 (863)
+.||.|.++.||++... +++.++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999864 568899997543211 123456789999888742 4444 44443 34557899
Q ss_pred eecCCCC
Q 002943 604 YPFMSNG 610 (863)
Q Consensus 604 ~ey~~~g 610 (863)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=97.72 E-value=1.9e-05 Score=94.04 Aligned_cols=82 Identities=23% Similarity=0.274 Sum_probs=63.6
Q ss_pred cccchhhHHHHHhHHHHhhcc-----cccccccCccCC-CCCCCcc---cceeecCCCCceEEEEEecCcCcccccCCCc
Q 002943 363 ETDQADVNVIRKVRDELKKYN-----KENKVLESWSGD-PCRPSTW---RGVYCNTRNGSITITGLDLSSGQIQGILPLS 433 (863)
Q Consensus 363 ~t~~~d~~al~~~k~~~~~~~-----~~~~~~~~W~gd-pc~p~~w---~gv~C~~~~~~~~l~~l~ls~n~l~G~iP~~ 433 (863)
....+|+.||.++++++..++ ++.....+|+.+ +| |.| .||.|+.. .+|+.|+|++|+|+|.+|+.
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~--c~w~~~~GV~C~~~---~~V~~L~L~~~~l~g~lp~~ 100 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL--DMWGAQPGVSLNSN---GRVTGLSLEGFGASGRVPDA 100 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG--GGTTCCTTEEECTT---CCEEEEECTTSCCEEEECGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc--ccccCCCCeEEcCC---CCEEEEEecCcccCCcCChH
Confidence 345689999999999986432 111234478733 44 789 99999653 57999999999999999999
Q ss_pred ccCCccccccccccCC
Q 002943 434 VTGLTHLEKFRGFCGS 449 (863)
Q Consensus 434 ~~~l~~L~~l~~s~n~ 449 (863)
+++|+.|+.|+++.|.
T Consensus 101 l~~L~~L~~L~Ls~N~ 116 (636)
T 4eco_A 101 IGQLTELEVLALGSHG 116 (636)
T ss_dssp GGGCTTCCEEESCCGG
T ss_pred HhcCccceEEECcCCc
Confidence 9999999999998874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=1.9e-05 Score=96.17 Aligned_cols=68 Identities=29% Similarity=0.440 Sum_probs=52.8
Q ss_pred ccchhhHHHHHhHHHHhhcccccccccCcc-CCCCCCCcccceeecCCCCceEEEEEecCcCccccc---CCCcccCCcc
Q 002943 364 TDQADVNVIRKVRDELKKYNKENKVLESWS-GDPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQGI---LPLSVTGLTH 439 (863)
Q Consensus 364 t~~~d~~al~~~k~~~~~~~~~~~~~~~W~-gdpc~p~~w~gv~C~~~~~~~~l~~l~ls~n~l~G~---iP~~~~~l~~ 439 (863)
...+|..||+++|+++. ||. .+.+|+ +++| |.|.||.|+ ..+++.|||++++++|. +|+.+++|+.
T Consensus 9 ~~~~~~~all~~k~~~~---~~~-~l~~W~~~~~~--C~w~gv~C~----~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLP---DKN-LLPDWSSNKNP--CTFDGVTCR----DDKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp CHHHHHHHHHHHHTTCS---CTT-SSTTCCTTSCG--GGSTTEEEE----TTEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred CCHHHHHHHHHHHhhCC---Ccc-cccCCCCCCCC--cCCcceEEC----CCcEEEEECCCCCcCCccCccChhHhccCc
Confidence 45679999999999984 666 899997 5555 899999997 24799999999999998 6654444433
Q ss_pred cc
Q 002943 440 LE 441 (863)
Q Consensus 440 L~ 441 (863)
|+
T Consensus 79 L~ 80 (768)
T 3rgz_A 79 LE 80 (768)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00032 Score=74.48 Aligned_cols=74 Identities=19% Similarity=0.210 Sum_probs=55.2
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc---cccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE---NLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+|.|..+.||+.++.||+.+.||+...........|..|++.|+.|.-. .+.+.+++ +..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 568999999999999999999999987655444456788999999888422 23444443 23478999998765
Q ss_pred h
Q 002943 612 L 612 (863)
Q Consensus 612 L 612 (863)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0005 Score=73.98 Aligned_cols=138 Identities=14% Similarity=0.135 Sum_probs=91.3
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC---cccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR---HENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.|. ...+.+.++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4688999999999986 5678899976543 3467889999998884 2567888888888888999999999876
Q ss_pred hhh-----------hhhccCC-C-----------------CccCChhhHH---HHH--HH--------------HHHH-H
Q 002943 612 LQD-----------RLYGEAS-T-----------------RKTLDWPTRL---SIA--LG--------------AARG-L 642 (863)
Q Consensus 612 L~~-----------~L~~~~~-~-----------------~~~l~~~~~~---~ia--~~--------------ia~g-L 642 (863)
+.. .||.... . ...-+|.... ++. .+ +... .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 421 2232211 0 0012343221 111 11 1111 2
Q ss_pred HHHHh-ccCCCccccCCCCCCeEecCCCeEEEeecc
Q 002943 643 MYLHT-FAGRSVIHRDVKSSNILLDHSMCAKVADFG 677 (863)
Q Consensus 643 ~yLH~-~~~~~iiHrDik~~NILld~~~~~kl~DFG 677 (863)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 2346799999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0015 Score=73.36 Aligned_cols=79 Identities=19% Similarity=0.227 Sum_probs=46.2
Q ss_pred CCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccC---CCCcccceechhhHHHH
Q 002943 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ---HLSAKSDVFSFGVVLLE 726 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~SfGvvl~E 726 (863)
.+.++|+|+++.|||++.+. ++|.||+.+......-+-.... ..-...|++|+..... ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 47899999999999998876 9999999887543211100000 0001234555544311 11123455577777777
Q ss_pred HHhC
Q 002943 727 IISG 730 (863)
Q Consensus 727 lltG 730 (863)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0024 Score=68.67 Aligned_cols=142 Identities=15% Similarity=0.139 Sum_probs=80.5
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc--cceeee------EeeCCeeEEEeecC
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL--VPLLGY------CCENDQQILVYPFM 607 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g~------~~~~~~~~LV~ey~ 607 (863)
.|+.|....+|+....+| .+++|+.... ....++..|++++..+...++ .+++.. ....+..+++++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 466788899999987666 6788977652 122456678888877753222 233321 12235678999999
Q ss_pred CCCChhh--------------hhhccCC----CC----ccCChhhHHH------------HHHHHHHHHHHHHhc----c
Q 002943 608 SNGSLQD--------------RLYGEAS----TR----KTLDWPTRLS------------IALGAARGLMYLHTF----A 649 (863)
Q Consensus 608 ~~gsL~~--------------~L~~~~~----~~----~~l~~~~~~~------------ia~~ia~gL~yLH~~----~ 649 (863)
++..+.. .+|.... .. ....|...+. +...+.+.++.|+.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8765321 1221100 00 0112332110 111244556666542 2
Q ss_pred CCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 650 ~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
...++|+|+.+.|||++++....|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3569999999999999987666899998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.009 Score=64.53 Aligned_cols=142 Identities=13% Similarity=0.116 Sum_probs=74.2
Q ss_pred eecccCcEE-EEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcc--cccceeeeEeeCCeeEEEeecCCCCCh
Q 002943 536 LIGEGGFGS-VYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHE--NLVPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 536 ~LG~G~fG~-Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
.|+.|.... +|+....+|..+++|....... .++..|+.+++.+... .+.+++.++.+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554444 6677665577787876443221 3455677777777432 3445666543333 789999977676
Q ss_pred hhhhhccC---------------------CC-CccCChhhH---------------H-----HHHHHHHHHHHHHHh---
Q 002943 613 QDRLYGEA---------------------ST-RKTLDWPTR---------------L-----SIALGAARGLMYLHT--- 647 (863)
Q Consensus 613 ~~~L~~~~---------------------~~-~~~l~~~~~---------------~-----~ia~~ia~gL~yLH~--- 647 (863)
.+++.... .. ...++.... + .....+.+.++.|.+
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 55442110 00 001111000 0 000111222233311
Q ss_pred ccCCCccccCCCCCCeEecCC----CeEEEeeccCcccC
Q 002943 648 FAGRSVIHRDVKSSNILLDHS----MCAKVADFGFSKYA 682 (863)
Q Consensus 648 ~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~~~ 682 (863)
.....++|+|+.+.|||++.+ ..+.|.||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123579999999999999875 68999999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.01 Score=63.80 Aligned_cols=142 Identities=12% Similarity=0.122 Sum_probs=82.3
Q ss_pred eecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccc--ccceeee-----EeeCCeeEEEeecCC
Q 002943 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN--LVPLLGY-----CCENDQQILVYPFMS 608 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~LV~ey~~ 608 (863)
.|+ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..++|++|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999988788889999875332 23456777888888775322 3344432 122445678999998
Q ss_pred CCChhh-----------h---hhccCC-----CCccCChhhH----HH---------------HHHHHHHHHHHHHhc--
Q 002943 609 NGSLQD-----------R---LYGEAS-----TRKTLDWPTR----LS---------------IALGAARGLMYLHTF-- 648 (863)
Q Consensus 609 ~gsL~~-----------~---L~~~~~-----~~~~l~~~~~----~~---------------ia~~ia~gL~yLH~~-- 648 (863)
+..+.. . +|.... ....+++... .. +...+.+.++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 754321 0 121100 0111222110 00 011112223333321
Q ss_pred --cCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 649 --AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 649 --~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999999 4 899999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0024 Score=68.16 Aligned_cols=70 Identities=10% Similarity=0.137 Sum_probs=44.5
Q ss_pred ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEeecC-CCCCh
Q 002943 535 TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYPFM-SNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ey~-~~gsL 612 (863)
+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++. +++++ ..+.-++|+||+ ++-+|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999998 56888876543221 22346788888877544443 45544 344457899999 55444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0039 Score=70.17 Aligned_cols=72 Identities=14% Similarity=0.182 Sum_probs=49.4
Q ss_pred ceecccCcEEEEEEecCC--------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-cceeeeEeeCCeeEEEee
Q 002943 535 TLIGEGGFGSVYRGTLPD--------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-VPLLGYCCENDQQILVYP 605 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~e 605 (863)
+.|+.|-...+|+....+ +..+.+|+.... .....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998753 578999987432 112556689999998864444 456665432 38999
Q ss_pred cCCCCCh
Q 002943 606 FMSNGSL 612 (863)
Q Consensus 606 y~~~gsL 612 (863)
|+++-+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9976443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.024 Score=64.12 Aligned_cols=73 Identities=11% Similarity=0.121 Sum_probs=47.5
Q ss_pred ceecccCcEEEEEEecCC-CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-cceeeeEeeCCeeEEEeecCCCCCh
Q 002943 535 TLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-VPLLGYCCENDQQILVYPFMSNGSL 612 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~ey~~~gsL 612 (863)
+.|+.|-...+|+....+ +..+++|+....... .-....|..+++.|...++ .++++.+. + .+|+||+++-+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467788889999998765 578889976543221 1123688999998875555 45666652 2 359999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.07 E-value=0.011 Score=64.82 Aligned_cols=73 Identities=12% Similarity=0.129 Sum_probs=44.5
Q ss_pred ceecccCcEEEEEEecCC---------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEe
Q 002943 535 TLIGEGGFGSVYRGTLPD---------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVY 604 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~---------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~ 604 (863)
+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...+++ ++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 356778788999988654 26888997654322 112346788888888644443 555443 2 36899
Q ss_pred ecCCCCCh
Q 002943 605 PFMSNGSL 612 (863)
Q Consensus 605 ey~~~gsL 612 (863)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.00094 Score=72.34 Aligned_cols=84 Identities=14% Similarity=0.145 Sum_probs=62.6
Q ss_pred ccchhhHHHHHhHHHHhhcccccccccCcc---CCCCCCCcccceeecCC------CCceEEEEEecCcCcccccCCCcc
Q 002943 364 TDQADVNVIRKVRDELKKYNKENKVLESWS---GDPCRPSTWRGVYCNTR------NGSITITGLDLSSGQIQGILPLSV 434 (863)
Q Consensus 364 t~~~d~~al~~~k~~~~~~~~~~~~~~~W~---gdpc~p~~w~gv~C~~~------~~~~~l~~l~ls~n~l~G~iP~~~ 434 (863)
...+|..||+++|..+. .++.+.+.+|. ...-..|.|.|+.|... .....++.|+|++|+++ .+|..+
T Consensus 24 ~~~~~~~aLl~~k~~~~--~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYN--ADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCHHHHHHHHHHHHH--HCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cCchHHHHHHHHHHhcc--CCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 44678999999999984 34556778894 11122378999999521 11235889999999998 889999
Q ss_pred cCCccccccccccCCC
Q 002943 435 TGLTHLEKFRGFCGSE 450 (863)
Q Consensus 435 ~~l~~L~~l~~s~n~~ 450 (863)
++++.|+.|+++.|.-
T Consensus 101 ~~l~~L~~L~L~~n~l 116 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGL 116 (328)
T ss_dssp GGGTTCSEEEEESSCC
T ss_pred hhCCCCCEEECCCCCc
Confidence 9999999999887763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.027 Score=62.01 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=80.3
Q ss_pred eecccCcEEEEEEecC--------CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-cceeeeEeeCCeeEEEeec
Q 002943 536 LIGEGGFGSVYRGTLP--------DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-VPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~--------~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~ey 606 (863)
.|..|-...+|+.... +++.+.+|+.... ......+.+|.++++.+.-.++ .++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4556777889998875 3578999985432 2334567789999988853333 455665543 289999
Q ss_pred CCCCChhhh-----------------hhccCC-CCccCC--hhhHHHHHHHHH-------------------HHHHHHHh
Q 002943 607 MSNGSLQDR-----------------LYGEAS-TRKTLD--WPTRLSIALGAA-------------------RGLMYLHT 647 (863)
Q Consensus 607 ~~~gsL~~~-----------------L~~~~~-~~~~l~--~~~~~~ia~~ia-------------------~gL~yLH~ 647 (863)
+++.+|..- ||.... ..+... |.+..++..++. +.+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987655311 121111 111122 333333333221 22333332
Q ss_pred -----ccCCCccccCCCCCCeEecCC----CeEEEeeccCcc
Q 002943 648 -----FAGRSVIHRDVKSSNILLDHS----MCAKVADFGFSK 680 (863)
Q Consensus 648 -----~~~~~iiHrDik~~NILld~~----~~~kl~DFGla~ 680 (863)
.....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123469999999999999876 689999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.093 Score=56.79 Aligned_cols=68 Identities=13% Similarity=0.217 Sum_probs=43.6
Q ss_pred cccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc---ccccceeee------EeeCCeeEEEeecCC
Q 002943 538 GEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH---ENLVPLLGY------CCENDQQILVYPFMS 608 (863)
Q Consensus 538 G~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~------~~~~~~~~LV~ey~~ 608 (863)
|.|....||+....+| .+++|+...... ..|+.+++.|.. +++.+.+.. +...+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3333689999998777 899997655432 356666665532 224444432 233567789999999
Q ss_pred CCCh
Q 002943 609 NGSL 612 (863)
Q Consensus 609 ~gsL 612 (863)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.22 E-value=0.26 Score=49.33 Aligned_cols=101 Identities=11% Similarity=0.057 Sum_probs=65.0
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
-||.+.|.. .+.+++..+.+.++.|.+.+|.-+-... .+ ..+=+.|..|+|..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 479999954 3568999999999999999987662111 11 1223446899999999988763 1110
Q ss_pred ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR 731 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~ 731 (863)
.....+.|||... ...+.+.=|||+|+++|.-+-=.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1122456788763 34567888999999999988733
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.80 E-value=0.18 Score=56.27 Aligned_cols=73 Identities=10% Similarity=0.121 Sum_probs=47.4
Q ss_pred ceecccCcEEEEEEecCC--------CCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-cceeeeEeeCCeeEEEee
Q 002943 535 TLIGEGGFGSVYRGTLPD--------GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-VPLLGYCCENDQQILVYP 605 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~e 605 (863)
+.|..|-...+|+....+ +..+++|+...... ..-...+|.++++.+.-.++ .++++.+ . -.+|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 356667788899988753 57899998654322 22234678888888854344 3444432 2 378999
Q ss_pred cCCCCCh
Q 002943 606 FMSNGSL 612 (863)
Q Consensus 606 y~~~gsL 612 (863)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=92.48 E-value=0.053 Score=55.03 Aligned_cols=51 Identities=18% Similarity=0.116 Sum_probs=42.8
Q ss_pred CcccceeecCCC-------CceEEEEEecCcCcccccCCCcccCCccccccccccCCC
Q 002943 400 STWRGVYCNTRN-------GSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 400 ~~w~gv~C~~~~-------~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
|.|+++.|+... -...++.|+|++|++++..|..+.+++.|+.|+++.|.-
T Consensus 19 Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l 76 (229)
T 3e6j_A 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL 76 (229)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCC
Confidence 689999997532 113588999999999999999999999999999988764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=90.38 E-value=0.13 Score=55.37 Aligned_cols=55 Identities=20% Similarity=0.330 Sum_probs=44.0
Q ss_pred CCCCCcccceeecCC---------CCceEEEEEecCc-CcccccCCCcccCCccccccccccCCC
Q 002943 396 PCRPSTWRGVYCNTR---------NGSITITGLDLSS-GQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 396 pc~p~~w~gv~C~~~---------~~~~~l~~l~ls~-n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
.|..|.|..+.|+.. .....|+.|+|++ |+|++..|..+++|+.|+.|+++.|.-
T Consensus 4 ~c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 68 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68 (347)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCC
T ss_pred cCccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcc
Confidence 465588999999764 1123588999996 999998888899999999999988863
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=89.96 E-value=0.13 Score=51.01 Aligned_cols=55 Identities=18% Similarity=0.178 Sum_probs=43.3
Q ss_pred CCCCCCcccceeecCCCC-------ceEEEEEecCcCcccccCCCcccCCccccccccccCCC
Q 002943 395 DPCRPSTWRGVYCNTRNG-------SITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 395 dpc~p~~w~gv~C~~~~~-------~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
+.|. |.|+++.|+...- ...++.|++++|++++..+..+++++.|+.|+++.|.-
T Consensus 3 ~~C~-C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (208)
T 2o6s_A 3 SRCS-CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL 64 (208)
T ss_dssp TTCE-EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCCE-ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCcc
Confidence 3563 7899999975321 12588999999999987777789999999999988753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=89.55 E-value=0.14 Score=49.27 Aligned_cols=55 Identities=22% Similarity=0.267 Sum_probs=43.3
Q ss_pred CCCCCCcccceeecCCC-------CceEEEEEecCcCcccccCCCcccCCccccccccccCCC
Q 002943 395 DPCRPSTWRGVYCNTRN-------GSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 395 dpc~p~~w~gv~C~~~~-------~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
+.|. |.|+++.|+..+ -...++.|++++|++++..+..+++++.|+.|+++.|.-
T Consensus 3 ~~C~-C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (177)
T 2o6r_A 3 SRCS-CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI 64 (177)
T ss_dssp TTCE-EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCCE-eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcc
Confidence 3563 789999997532 113689999999999987777789999999999987753
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=89.23 E-value=0.15 Score=48.93 Aligned_cols=54 Identities=22% Similarity=0.193 Sum_probs=43.9
Q ss_pred CCCCCcccceeecCCC-------CceEEEEEecCcCcccccCCCcccCCccccccccccCCC
Q 002943 396 PCRPSTWRGVYCNTRN-------GSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 396 pc~p~~w~gv~C~~~~-------~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
.|. |.|+.+.|+... -...++.|+|++|++++..|..+.+++.|+.|+++.|.-
T Consensus 6 ~C~-C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 66 (170)
T 3g39_A 6 QCS-CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL 66 (170)
T ss_dssp CCE-EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred cCC-cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCc
Confidence 464 689999997431 113578999999999999999999999999999988864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.48 E-value=1.2 Score=49.10 Aligned_cols=28 Identities=32% Similarity=0.498 Sum_probs=23.8
Q ss_pred ccccCCCCCCeEe------cCCCeEEEeeccCcc
Q 002943 653 VIHRDVKSSNILL------DHSMCAKVADFGFSK 680 (863)
Q Consensus 653 iiHrDik~~NILl------d~~~~~kl~DFGla~ 680 (863)
++|+|+.+.|||+ +++..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456779999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=82.42 E-value=0.56 Score=49.31 Aligned_cols=55 Identities=22% Similarity=0.283 Sum_probs=41.6
Q ss_pred CCCCCCcccceeecCCC-------CceEEEEEecCcCcccccCCCcccCCccccccccccCCC
Q 002943 395 DPCRPSTWRGVYCNTRN-------GSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGSE 450 (863)
Q Consensus 395 dpc~p~~w~gv~C~~~~-------~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~~ 450 (863)
++|. |.|+++.|+..+ -...++.|+|++|+++...+..+.+++.|+.|+++.|.-
T Consensus 3 ~~C~-C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l 64 (306)
T 2z66_A 3 SRCS-CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64 (306)
T ss_dssp TTCE-EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCCe-eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCcc
Confidence 4564 789999997532 112689999999999954444579999999999987753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=82.09 E-value=0.53 Score=52.50 Aligned_cols=55 Identities=22% Similarity=0.234 Sum_probs=39.4
Q ss_pred CCCC-CCcccc--eeecCCC------CceEEEEEecCcCcccccCCCcccCCccccccccccCC
Q 002943 395 DPCR-PSTWRG--VYCNTRN------GSITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGS 449 (863)
Q Consensus 395 dpc~-p~~w~g--v~C~~~~------~~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~ 449 (863)
|||. +|.|.+ +.|+..+ -...++.|||++|++++..|..+++++.|+.|+++.|.
T Consensus 2 ~p~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 65 (455)
T 3v47_A 2 DPGTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQT 65 (455)
T ss_dssp -----CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCS
T ss_pred CCccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCc
Confidence 4553 356665 8886432 11358899999999999999999999999999887764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=80.20 E-value=0.64 Score=53.28 Aligned_cols=50 Identities=22% Similarity=0.238 Sum_probs=38.5
Q ss_pred CCcccceeecCCCC---------ceEEEEEecCcCcccccCCCcccCCccccccccccCC
Q 002943 399 PSTWRGVYCNTRNG---------SITITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGS 449 (863)
Q Consensus 399 p~~w~gv~C~~~~~---------~~~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~ 449 (863)
+|.|.|+ |+-... ...++.|||++|++++..|..+.+++.|+.|+++.|.
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 61 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCC
Confidence 3788888 753221 1258899999999999888888999999988887765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 863 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-64
Identities = 73/275 (26%), Positives = 127/275 (46%), Gaps = 27/275 (9%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
IG G FG+VY+G +VAVK+ ++ + Q + F+NE+ L RH N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
Q +V + SL L+ + + IA A+G+ YLH +S+
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ---H 710
IHRD+KS+NI L + K+ DFG + + S ++ G+ ++ PE Q
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKGG 769
S +SDV++FG+VL E+++G+ P + R++ +V S++ ++K
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK-- 243
Query: 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+ C++ RP I+ +E
Sbjct: 244 ----------RLMAECLKKKRDERPLFPQILASIE 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 7e-63
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 29/290 (10%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
IG+G FG V+RG G+EVAVK+ SS + + E E+ +RHEN++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 597 NDQQI----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA--- 649
++ LV + +GSL D L R T+ + +AL A GL +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 650 --GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD--SGFSLEVRGTAGYLDPEY 705
++ HRD+KS NIL+ + +AD G + D GT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 706 YSTQ------HLSAKSDVFSFGVVLLEIISGREPLNT----RRPRNEWSLVEWAKPFIRE 755
++D+++ G+V EI + P + + + +R+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 756 SRIDEIVDPSIKGGYH-AEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
++ + P+I + EA+ M ++ C A R + + I + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-61
Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 25/273 (9%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G G FG V+ G +VAVK S F E N + ++H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ ++ +M NGSL D L + + L L +A A G+ ++ R+ IH
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKS 715
RD++++NIL+ ++ K+ADFG ++ + + + + PE + + KS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 716 DVFSFGVVLLEIISGREPLNTRRPRNE-WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEA 774
DV+SFG++L EI++ E +E +R E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------------- 237
Query: 775 MWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
+ ++ C + RP+ + LED F
Sbjct: 238 --ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 80/271 (29%), Positives = 118/271 (43%), Gaps = 29/271 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
IG+G FG V G G +VAVK + +T + F E + ++ +RH NLV LLG
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 596 ENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
E + +V +M+ GSL D L R L L +L + YL G + +
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125
Query: 655 HRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAK 714
HRD+ + N+L+ AKV+DFG +K A D+G + PE + S K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTK 180
Query: 715 SDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEA 774
SDV+SFG++L EI S P L + R+++ G
Sbjct: 181 SDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYKMDAPDGCPPA- 228
Query: 775 MWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ EV C +A RPS + + +LE
Sbjct: 229 ---VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 25/280 (8%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+ IG G FG V+ G + +VA+K +F E + + H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G C E LV+ FM +G L D L + R T L + L G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE---A 120
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+ + N L+ + KV+DFG +++ + S + + PE +S
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771
S+KSDV+SFGV++ E+ S + R+ +VE R + P +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGFR------LYKPRL----- 226
Query: 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
A + ++ C + RP+ ++R+L + I E+
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE--IAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 61/270 (22%), Positives = 107/270 (39%), Gaps = 25/270 (9%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G G FG V G +VA+K+ + EF E + + HE LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
++ +M+NG L + L R L + + YL + + +HR
Sbjct: 71 QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSD 716
D+ + N L++ KV+DFG S+Y + + S+ + + PE S+KSD
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 717 VFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAM 775
+++FGV++ EI S G+ P + R E
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE--------------- 228
Query: 776 WRMVEVALACIEPFSAYRPSMVDIVRELED 805
++ + +C + RP+ ++ + D
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 31/299 (10%)
Query: 532 QYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQG-TREFENELNFLSAIRHEN 586
+ +IG G FG VY GTL D AVK + + G +F E + H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 587 LVPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
++ LLG C ++ +V P+M +G L++ + E + L A+G+ +L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFL 146
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK--YAPQEGDSGFSLEVRGTAGYLDP 703
+ + +HRD+ + N +LD KVADFG ++ Y + + ++
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E TQ + KSDV+SFGV+L E+++ P P + + + ++ R ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQ 255
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDS 822
P + EV L C P + RPS ++V + I E+ +++
Sbjct: 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA--IFSTFIGEHYVHVNA 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 6e-57
Identities = 73/312 (23%), Positives = 115/312 (36%), Gaps = 47/312 (15%)
Query: 522 SLQYLEAATQQYKTL--IGEGGFGSVYRGTLP------DGQEVAVKV-RSSTSTQGTREF 572
L LE + + IGEG FG V++ P VAVK+ + S +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 573 ENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGE------------- 619
+ E ++ + N+V LLG C L++ +M+ G L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 620 -------ASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAK 672
+ L +L IA A G+ YL +HRD+ + N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 673 VADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGRE 732
+ADFG S+ ++ PE + +SDV+++GVVL EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 733 PLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAY 792
P + E ++R+ I + + + C A
Sbjct: 241 Q-----PYYGMAHEEVIY-YVRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 793 RPSMVDIVRELE 804
RPS I R L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-56
Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 29/278 (10%)
Query: 537 IGEGGFGSVYRGTL---PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
+G G FGSV +G +VA+KV + T T E E + + + +V L+G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
C+ + +LV G L L G+ R+ + + + G+ YL ++
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYLDPEYYSTQHL 711
+HRD+ + N+LL + AK++DFG SK + + + + PE + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 712 SAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770
S++SDV+S+GV + E +S G++P + + +E K
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP---------- 239
Query: 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
+ + C RP + + + + +
Sbjct: 240 ------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 1e-56
Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 24/287 (8%)
Query: 532 QYKTLIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPL 590
K +G G +G VY G VAVK + + EF E + I+H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQL 78
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
LG C ++ FM+ G+L D L R+ + L +A + + YL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK--- 133
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
++ IHRD+ + N L+ + KVADFG S+ + + + + + PE +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNK 192
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770
S KSDV++FGV+L EI + ++ + E+++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMER 237
Query: 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYM 817
++ E+ AC + + RPS +I + E E++ S+ +
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET-MFQESSISDEV 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-56
Identities = 66/291 (22%), Positives = 112/291 (38%), Gaps = 39/291 (13%)
Query: 536 LIGEGGFGSVYRGTL------PDGQEVAVKVRSSTSTQGTRE-FENELNFLSAI-RHENL 587
+G G FG V T VAVK+ ++ RE +EL LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGE--------------ASTRKTLDWPTRLS 633
V LLG C +++ + G L + L + LD LS
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
+ A+G+ +L + ++ IHRD+ + NILL H K+ DFG ++ + +
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753
R ++ PE + +SDV+S+G+ L E+ S P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256
Query: 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+++ + A M ++ C + RP+ IV+ +E
Sbjct: 257 ----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-56
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 23/271 (8%)
Query: 537 IGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE 596
+G+G FG V+ GT VA+K T F E + +RHE LV L
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 82
Query: 597 NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHR 656
+ +V +MS GSL D L GE T K L P + +A A G+ Y+ + +HR
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 137
Query: 657 DVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSD 716
D++++NIL+ ++ KVADFG ++ + + + + PE + KSD
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 717 VFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMW 776
V+SFG++L E+ + E +++ + R E +
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYRMPCPPECPE------------- 241
Query: 777 RMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
+ ++ C RP+ + LED F
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-56
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 14/220 (6%)
Query: 526 LEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSA 581
+E ++ + +G G G V++ + P G +A K+ R EL L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 582 IRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARG 641
+V G + + + M GSL L + +++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 642 LMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
L YL ++HRDVK SNIL++ K+ DFG S + GT Y+
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYM 170
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRN 741
PE H S +SD++S G+ L+E+ GR P+ +
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-55
Identities = 63/280 (22%), Positives = 108/280 (38%), Gaps = 28/280 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IG G +G + DG+ + K S + + +E+N L ++H N+V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 593 YCCE--NDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH--TF 648
+ N +V + G L + R+ LD L + L H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
G +V+HRD+K +N+ LD K+ DFG ++ D+ F+ GT Y+ PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMSPEQMNR 188
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768
+ KSD++S G +L E+ + P + + K RI +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----RRIPYRYSDELN- 243
Query: 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
E+ + +RPS+ +I LE+ I
Sbjct: 244 -----------EIITRMLNLKDYHRPSVEEI---LENPLI 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-55
Identities = 61/286 (21%), Positives = 108/286 (37%), Gaps = 29/286 (10%)
Query: 537 IGEGGFGSVYRGTLPD---GQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G FG+V +G + VAVK+ + E E N + + + +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G CE + +LV G L L + + + + + G+ YL
Sbjct: 75 G-ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYLDPEYYSTQH 710
+ +HRD+ + N+LL AK++DFG SK + + + + + PE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770
S+KSDV+SFGV++ E S + P E +++ G
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTA------MLEKGERMGCPAGC 235
Query: 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEY 816
E M ++ C RP + L + + N +
Sbjct: 236 PRE----MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-55
Identities = 63/276 (22%), Positives = 121/276 (43%), Gaps = 28/276 (10%)
Query: 536 LIGEGGFGSVYRGTLPDGQE-----VAVKVRSSTSTQGTR-EFENELNFLSAIRHENLVP 589
+IG G FG VY+G L VA+K + T+ R +F E + H N++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L G + +++ +M NG+L L + + + G A G+ YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN-- 128
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL-EVRGTAGYLDPEYYST 708
+ +HRD+ + NIL++ ++ KV+DFG S+ + ++ ++ + + PE S
Sbjct: 129 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768
+ ++ SDV+SFG+V+ E+++ E +E + + ++ +
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAINDGFRL 232
Query: 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+ + ++ + C + A RP DIV L+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 1e-54
Identities = 71/321 (22%), Positives = 136/321 (42%), Gaps = 44/321 (13%)
Query: 518 VQIFSLQYLEAATQQYKT-----------LIGEGGFGSVYRGTLP----DGQEVAVKV-R 561
+ F+ + A +++ +IG G FG V G L VA+K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 562 SSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEAS 621
S + + R+F +E + + H N++ L G ++ +++ FM NGSL L
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-- 121
Query: 622 TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681
+ + G A G+ YL + +HRD+ + NIL++ ++ KV+DFG S++
Sbjct: 122 -DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 682 APQEGDSGF---SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738
+ +L + + PE + ++ SDV+S+G+V+ E++S E
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----- 232
Query: 739 PRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVD 798
P + + + ++ R+ +D + ++ L C + +RP
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPS----------ALHQLMLDCWQKDRNHRPKFGQ 282
Query: 799 IVRELEDAFIIENNASEYMKS 819
IV L+ +I N S +K+
Sbjct: 283 IVNTLDK--MIRNPNS--LKA 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 64/282 (22%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 536 LIGEGGFGSVYRGTLP-DGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G+G FG+VY +A+KV + E+ S +RH N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
GY + + L+ + G++ L D + A L Y H+ +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS---K 125
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
VIHRD+K N+LL + K+ADFG+S +AP S + GT YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771
K D++S GV+ E + G+ P + + + + + V +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-----TFPDFVTEGAR---- 232
Query: 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNA 813
++ ++ + RP + ++ LE +I N++
Sbjct: 233 --------DLISRLLKHNPSQRPMLREV---LEHPWITANSS 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-54
Identities = 66/296 (22%), Positives = 112/296 (37%), Gaps = 44/296 (14%)
Query: 536 LIGEGGFGSVYRGTLPD------GQEVAVKVRSSTSTQGTRE-FENELNFLSAI-RHENL 587
++G G FG V T +VAVK+ + RE +EL ++ + HEN+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYG-------------------EASTRKTLDW 628
V LLG C + L++ + G L + L E L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 629 PTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688
L A A+G+ +L +S +HRD+ + N+L+ H K+ DFG ++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEW 748
R ++ PE + KSDV+S+G++L EI S P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+++ K A + + +C S RPS ++ L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-54
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 38/290 (13%)
Query: 532 QYKTLIGEGGFGSVYRGTLPDG---QEVAVK-VRSSTSTQGTREFENELNFLSAI-RHEN 586
+++ +IGEG FG V + + + A+K ++ S R+F EL L + H N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGE------------ASTRKTLDWPTRLSI 634
++ LLG C L + +G+L D L ST TL L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
A ARG+ YL + IHRD+ + NIL+ + AK+ADFG S+
Sbjct: 133 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---G 186
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754
R ++ E + + SDV+S+GV+L EI+S P + E + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQ 241
Query: 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
R+++ ++ + + ++ C RPS I+ L
Sbjct: 242 GYRLEKPLNCDDE----------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 8e-54
Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 532 QYKTLIGEGGFGSVYRGTLPD-GQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLV 588
++ IG G F +VY+G + EVA + + F+ E L ++H N+V
Sbjct: 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 589 PLLGYCCENDQQ----ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
+ +LV M++G+L+ L K + S +GL +
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQF 127
Query: 645 LHTFAGRSVIHRDVKSSNILL-DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
LHT +IHRD+K NI + + K+ D G + + F+ V GT ++ P
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E Y ++ DV++FG+ +LE+ + P + +N + ++ + D++
Sbjct: 183 EMYEEKY-DESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTSGVKPASFDKVAI 239
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
P +K E+ CI R S+ D+ L AF
Sbjct: 240 PEVK------------EIIEGCIRQNKDERYSIKDL---LNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 2e-53
Identities = 66/316 (20%), Positives = 116/316 (36%), Gaps = 45/316 (14%)
Query: 515 PMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQG 568
P ++F E + + L IG G FG+VY + + + VA+K S +
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 569 TREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDW 628
++ E+ FL +RH N + G LV + + +K L
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQE 114
Query: 629 PTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688
++ GA +GL YLH+ ++IHRDVK+ NILL K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS- 170
Query: 689 GFSLEVRGTAGYLDPEYYSTQ---HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNE-WS 744
GT ++ PE K DV+S G+ +E+ + PL + +
Sbjct: 171 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+ + P ++ E +C++ RP+ + L+
Sbjct: 226 IAQNESPALQSGHWSE----------------YFRNFVDSCLQKIPQDRPTSEVL---LK 266
Query: 805 DAFIIENNASEYMKSI 820
F++ + +
Sbjct: 267 HRFVLRERPPTVIMDL 282
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-52
Identities = 58/275 (21%), Positives = 120/275 (43%), Gaps = 28/275 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
++G G FG+VY+G +P+G++V + V R +TS + +E +E ++++ + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
LLG C + Q++ M G L D + + + L+ + A+G+ YL
Sbjct: 76 LLGICLTSTVQLITQ-LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-- 129
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
R ++HRD+ + N+L+ K+ DFG +K E + + ++ E +
Sbjct: 130 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 710 HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769
+ +SDV+S+GV + E+++ P +E I I++ +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERLP 233
Query: 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
+ + + C + RP +++ E
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 27/279 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
+GEG +G V + VAVK+ + + E+ + HEN+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
E + Q L + S G L DR+ + P G++YLH +
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 654 IHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL-S 712
HRD+K N+LLD K++DFG + ++ GT Y+ PE + +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
DV+S G+VL +++G + + +W + + +I D +
Sbjct: 185 EPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPL----- 237
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
+ + + R ++ DI +D + +
Sbjct: 238 -------ALLHKILVENPSARITIPDI---KKDRWYNKP 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 31/278 (11%)
Query: 537 IGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCC 595
+G+G FG VY+ + A KV + S + ++ E++ L++ H N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 596 ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIH 655
+ ++ F + G++ + + L + L YLH +IH
Sbjct: 80 YENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 656 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY-----YSTQH 710
RD+K+ NIL K+ADFG S + S GT ++ PE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 191
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770
K+DV+S G+ L+E+ P + P + ++P + K
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA--QPSRWSSNFK--- 246
Query: 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
+ C+E R + + L+ F+
Sbjct: 247 ---------DFLKKCLEKNVDARWTTSQL---LQHPFV 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 30/282 (10%)
Query: 530 TQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHEN 586
++Y IG+G G+VY + GQEVA++ + NE+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+V L D+ +V +++ GSL D + +D ++ + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY 706
+ VIHRD+KS NILL K+ DFGF E + + GT ++ PE
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766
+ + K D++S G++ +E+I G P P L A E + E +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNGTPELQNPEKLSAIF 246
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
+ + C++ R S ++ L+ F+
Sbjct: 247 R------------DFLNRCLDMDVEKRGSAKEL---LQHQFL 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-51
Identities = 69/299 (23%), Positives = 113/299 (37%), Gaps = 40/299 (13%)
Query: 536 LIGEGGFGSVYRGT------LPDGQEVAVKVRSSTSTQGT-REFENELNFLSAIRHENLV 588
+G G FG V + VAVK+ +T R +EL L I H V
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 589 PLLGYCC--ENDQQILVYPFMSNGSLQDRLYG------------EASTRKTLDWPTRLSI 634
L C +++ F G+L L E + L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEV 694
+ A+G+ +L + R IHRD+ + NILL K+ DFG ++ ++ D +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 695 RGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754
R ++ PE + + +SDV+SFGV+L EI S P + E ++
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLK 251
Query: 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNA 813
E D + M + L C + RP+ ++V L + +++ NA
Sbjct: 252 EGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN--LLQANA 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 9e-51
Identities = 67/278 (24%), Positives = 105/278 (37%), Gaps = 29/278 (10%)
Query: 537 IGEGGFGSVYRGTLP----DGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G FG V RG VAVK + + +F E+N + ++ H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
L G +V GSL DRL + T A+ A G+ YL +
Sbjct: 76 LYG-VVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE-VRGTAGYLDPEYYST 708
+ IHRD+ + N+LL K+ DFG + PQ D E + + PE T
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768
+ S SD + FGV L E+ + + P + + +E +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806
+ + V + C RP+ V + L +A
Sbjct: 239 ----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 30/276 (10%)
Query: 536 LIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPL 590
IGEG FG V++G VA+K + ++ RE F E + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
+G EN ++ + G L+ L + +LD + + A + L YL +
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
+ +HRD+ + N+L+ + C K+ DFG S+Y S + + ++ PE + +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFRR 185
Query: 711 LSAKSDVFSFGVVLLEII-SGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769
++ SDV+ FGV + EI+ G +P + + +E +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP--------- 236
Query: 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ + C + RP ++ +L
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 4e-49
Identities = 72/354 (20%), Positives = 124/354 (35%), Gaps = 34/354 (9%)
Query: 515 PMPVQIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE 571
P PV+I L+ Y +G G FG V+R T G A K +
Sbjct: 14 PQPVEIKHDHVLD----HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 69
Query: 572 FENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTR 631
E+ +S +RH LV L ++++ +++Y FMS G L +++ E +
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEA 126
Query: 632 LSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL--DHSMCAKVADFGFSKYAPQEGDSG 689
+ +GL ++H + +H D+K NI+ S K+ DFG + +
Sbjct: 127 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQ 180
Query: 690 FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA 749
GTA + PE + + +D++S GV+ ++SG P V+
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 750 KPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809
+ +S I + + + R ++ LE ++
Sbjct: 241 DWNMDDSAFSGISED-------------GKDFIRKLLLADPNTRMTIHQA---LEHPWLT 284
Query: 810 ENNASEYMKSIDSIGGYSIGGSARYSRRIVIPPTPTATESSLVNSQTIVPPEPR 863
NA I S I S + P P S +S P+
Sbjct: 285 PGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEY 338
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 7e-49
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 31/282 (10%)
Query: 537 IGEGGFGSVYRGTL------PDGQEVAVKV-RSSTSTQGTREFENELNFLSAIRHENLVP 589
+G+G FG VY G VA+K + S + EF NE + + ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLY------GEASTRKTLDWPTRLSIALGAARGLM 643
LLG + +++ M+ G L+ L + +A A G+
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 644 YLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDP 703
YL+ +HRD+ + N ++ K+ DFG ++ + + ++ P
Sbjct: 148 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 704 EYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
E + SDV+SFGVVL EI + E P S + + F+ E + + D
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLR-FVMEGGLLDKPD 258
Query: 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805
+ E+ C + RPS ++I+ +++
Sbjct: 259 ---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-48
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 40/291 (13%)
Query: 536 LIGEGGFGSVYRGTLP--------DGQEVAVKV-RSSTSTQGTREFENELNFLSAI-RHE 585
+GEG FG V +VAVK+ +S + + + +E+ + I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLY------------GEASTRKTLDWPTRLS 633
N++ LLG C ++ ++ + S G+L++ L + + L +S
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 634 IALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE 693
A ARG+ YL + + IHRD+ + N+L+ K+ADFG ++ +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 694 VRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFI 753
R ++ PE + + +SDV+SFGV+L EI + P E L + K
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLKEGH 254
Query: 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELE 804
R + + + + C + RP+ +V +L+
Sbjct: 255 RMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-47
Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 11/232 (4%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
++GEG F +V L +E A+K+ R E + +S + H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
++++ + NG L + + D L YLH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG---K 127
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
+IHRD+K NILL+ M ++ DFG +K E + GTA Y+ PE + +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
SD+++ G ++ ++++G P + + + E + D
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 1e-45
Identities = 51/282 (18%), Positives = 105/282 (37%), Gaps = 28/282 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G FG V+R G+ K ++ +NE++ ++ + H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ + +L+ F+S G L DR+ E + ++ A GL ++H S++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 655 HRDVKSSNILLD--HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
H D+K NI+ + + K+ DFG + TA + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
+D+++ GV+ ++SG P V+ E +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP--------- 257
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNAS 814
+ ++ R ++ D LE ++ ++++
Sbjct: 258 ----EAKDFIKNLLQKEPRKRLTVHDA---LEHPWLKGDHSN 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 4e-45
Identities = 63/276 (22%), Positives = 106/276 (38%), Gaps = 29/276 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
++G GG V+ L ++VAVKV + F E +A+ H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 592 GYCCENDQQI----LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
+V ++ +L+D ++ T + + + A + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSL-EVRGTAGYLDPEYY 706
+IHRDVK +NI++ + KV DFG ++ G+S V GTA YL PE
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766
+ A+SDV+S G VL E+++G P P + P +R + +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD-- 244
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRE 802
+ V L + R +R
Sbjct: 245 -----------LDAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-43
Identities = 48/291 (16%), Positives = 107/291 (36%), Gaps = 29/291 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G FG V+R + K T + E++ L+ RH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ ++++ F+S + +R+ ++ L+ +S L +LH+ ++
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 655 HRDVKSSNILLDH--SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
H D++ NI+ S K+ +FG ++ + + Y PE + +S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR---LLFTAPEYYAPEVHQHDVVS 181
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
+D++S G ++ ++SG P + + A+ E EI
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE-------- 233
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKSIDSI 823
++ + R + + L+ ++ + K I ++
Sbjct: 234 -----AMDFVDRLLVKERKSRMTASEA---LQHPWLKQKIERVSTKVIRTL 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 8e-43
Identities = 57/290 (19%), Positives = 99/290 (34%), Gaps = 26/290 (8%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
IG G FG +Y GT + G+EVA+K+ + + E ++ +P + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
++ + SL+D + T L +A + Y+H ++ I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125
Query: 655 HRDVKSSNIL---LDHSMCAKVADFGFSKYAPQEGDSGFSL-----EVRGTAGYLDPEYY 706
HRDVK N L + DFG +K + GTA Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 707 STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766
S + D+ S G VL+ G P + + E + I+ +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK--- 242
Query: 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEY 816
GY +E C +P + + + F + + +Y
Sbjct: 243 --GYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-41
Identities = 61/285 (21%), Positives = 101/285 (35%), Gaps = 31/285 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FENELNFLSAIRHENLVPLLGY 593
++G G F V + VA+K + + +G ENE+ L I+H N+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 594 CCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSV 653
L+ +S G L DR+ + + + YLH +
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GI 128
Query: 654 IHRDVKSSNILL---DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
+HRD+K N+L D ++DFG SK E GT GY+ PE + +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770
S D +S GV+ ++ G P + + A+ D+I D
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS------ 239
Query: 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASE 815
+ +E R + L+ +I + A +
Sbjct: 240 -------AKDFIRHLMEKDPEKRFTCEQA---LQHPWIAGDTALD 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 56/233 (24%), Positives = 88/233 (37%), Gaps = 14/233 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLS-AIRHENLVPL 590
++G+G FG V+ Q A+K E LS A H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 591 LGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAG 650
+ V +++ G L + + D A GL +LH+
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQH 710
+ +++RD+K NILLD K+ADFG K + GT Y+ PE Q
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179
Query: 711 LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
+ D +SFGV+L E++ G+ P + + + + PF E D
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 152 bits (385), Expect = 5e-41
Identities = 55/240 (22%), Positives = 94/240 (39%), Gaps = 21/240 (8%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKV---RSSTSTQGTREFENE---LNFLSAIRHENLV 588
+IG GGFG VY D G+ A+K + QG NE L+ +S +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
+ D+ + M+ G L L S A GL ++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHN- 125
Query: 649 AGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST 708
R V++RD+K +NILLD +++D G + ++ GT GY+ PE
Sbjct: 126 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQK 179
Query: 709 -QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767
+ +D FS G +L +++ G P + +++ + + + P ++
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELR 237
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (376), Expect = 9e-41
Identities = 67/290 (23%), Positives = 104/290 (35%), Gaps = 43/290 (14%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--------RSSTSTQGTRE-FENELNFLSAIR-H 584
++G G V R P +E AVK+ S+ Q RE E++ L + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMY 644
N++ L N LV+ M G L D L + + TL I +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125
Query: 645 LHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
LH +++HRD+K NILLD M K+ DFGFS EV GT YL PE
Sbjct: 126 LHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPE 179
Query: 705 YYSTQHL------SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758
+ D++S GV++ +++G P R+ ++
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 759 DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
D+ D + ++ + R + + L F
Sbjct: 240 DDYSDT-------------VKDLVSRFLVVQPQKRYTAEEA---LAHPFF 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (378), Expect = 1e-40
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 16/232 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
+G G FG V+ +G+ A+KV + +E LS + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
G + Q ++ ++ G L L + P A L YLH+ +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS---K 123
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
+I+RD+K NILLD + K+ DFGF+KY P + + GT Y+ PE ST+
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPY 178
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
+ D +SFG+++ E+++G P + + A+ +++ D
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 2e-39
Identities = 51/287 (17%), Positives = 95/287 (33%), Gaps = 28/287 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
IGEG FG ++ GT L + Q+VA+K S + +E + +P + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVI 654
+ ++ + SL+D L + T A + +H +S++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123
Query: 655 HRDVKSSNILLD-----HSMCAKVADFGFSKYAPQEGDSGFSLE-----VRGTAGYLDPE 704
+RD+K N L+ ++ V DFG K+ + GTA Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
+ + S + D+ + G V + + G P + E + + + E+
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA- 242
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
G+ E + P + N
Sbjct: 243 ----GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-39
Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 20/291 (6%)
Query: 519 QIFSLQYLEAATQQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTRE-FEN 574
Q+F + +Y L IGEG +G V + VA+K S Q +
Sbjct: 2 QVFDV------GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 55
Query: 575 ELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSI 634
E+ L RHEN++ + + + ++ L + + L
Sbjct: 56 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYF 114
Query: 635 ALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYA-PQEGDSGFSLE 693
RGL Y+H+ +V+HRD+K SN+LL+ + K+ DFG ++ A P +GF E
Sbjct: 115 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 694 VRGTAGYLDPEYYSTQHLSAKS-DVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF 752
T Y PE KS D++S G +L E++S R + ++ + +
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 753 IRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+ ++ I++ + + V F +D++ ++
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWN----RLFPNADSKALDLLDKM 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 30/301 (9%)
Query: 529 ATQQYKTL--IGEGGFGSVYRGT--LPDGQEVAVK-VRSSTSTQGTRE----FENELNFL 579
A QQY+ + IGEG +G V++ G+ VA+K VR T +G L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 580 SAIRHENLVPLLGYCC--ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALG 637
H N+V L C D++ + + Y + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 638 AARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGT 697
RGL +LH+ V+HRD+K NIL+ S K+ADFG ++ + V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVT 178
Query: 698 AGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV----------E 747
Y PE + D++S G + E+ + ++ + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 748 WAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807
W + + + + ++ L C+ A R S L +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSHPY 295
Query: 808 I 808
Sbjct: 296 F 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (361), Expect = 1e-38
Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 12/236 (5%)
Query: 532 QYKTL--IGEGGFGSVYRGTLPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENL 587
+Y L IGEG +G VY+ G+ A+K E++ L ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 588 VPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHT 647
V L + +LV+ + + L+ T S L G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 648 FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
R V+HRD+K N+L++ K+ADFG ++ E+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMG 174
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
++ S D++S G + E+++G ++ + + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 16/233 (6%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV-----RSSTSTQGTREFENELNFLSAIRHENLVP 589
+GEG F +VY+ Q VA+K RS R E+ L + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 590 LLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
LL LV+ FM L + L +GL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYST- 708
++HRD+K +N+LLD + K+ADFG +K + T Y PE
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGA 175
Query: 709 QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761
+ D+++ G +L E++ L ++ + + E + ++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 25/288 (8%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
IGEG +G VY+ G+ VA+K + + E++ L + H N+V LL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
++ LV+ F+ + + +AS + P S +GL + H+
Sbjct: 69 VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HR 122
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
V+HRD+K N+L++ K+ADFG ++ + ++ EV ++ S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYYS 181
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRP--------RNEWSLVEWAKPFIRESRIDEIVDP 764
D++S G + E+++ R R + E P + + P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 765 SIKGGYHAEAMWRMVEVAL----ACIEPFSAYRPSMVDIVRELEDAFI 808
++ + + E + R S L F
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAHPFF 286
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 2e-37
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 18/238 (7%)
Query: 532 QYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHE 585
Q+ + +G G FG V G A+K+ + + NE L A+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
LV L +N +V +++ G + L P A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H+ +I+RD+K N+L+D +V DFGF+K + + GT L PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
++ + D ++ GV++ E+ +G P +P + + K ++ D
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 41/282 (14%), Positives = 98/282 (34%), Gaps = 28/282 (9%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLS-AIRHENLVPLLGY 593
++G G G V + ++ A+K+ Q + E+ A + ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 594 C----CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA 649
++V + G L R+ + + I + YLH+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS-- 129
Query: 650 GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQ 709
++ HRDVK N+L + +A + T Y+ PE +
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 710 HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769
D++S GV++ ++ G P + + + R+ + P+ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIEN 811
+E + ++ ++ R ++ + + +I+++
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTITEF---MNHPWIMQS 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 9e-37
Identities = 56/295 (18%), Positives = 104/295 (35%), Gaps = 37/295 (12%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIRHENLV 588
+G G F V + G + A K +SS + E E++ L I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 589 PLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
L IL+ ++ G L D L +++L G+ YLH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 649 AGRSVIHRDVKSSNILLDHSMCA----KVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE 704
+ H D+K NI+L K+ DFG + + + GT ++ PE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPE 186
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
+ + L ++D++S GV+ ++SG P + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT-SA 245
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIENNASEYMKS 819
K + + R ++ D L+ +I + + + S
Sbjct: 246 LAK------------DFIRRLLVKDPKKRMTIQDS---LQHPWIKPKDTQQALSS 285
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/284 (19%), Positives = 93/284 (32%), Gaps = 47/284 (16%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV------RSSTSTQGTREFENELNFLSAIR--HEN 586
L+G GGFGSVY G + D VA+K E+ L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 587 LVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
++ LL + D +L+ E R L S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 647 TFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
V+HRD+K NIL+D + K+ DFG + F GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPPEW 180
Query: 706 YST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
++ + V+S G++L +++ G P + + V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-----------FFRQRVSS 229
Query: 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808
+ + C+ + RP+ +I ++
Sbjct: 230 ECQ------------HLIRWCLALRPSDRPTFEEI---QNHPWM 258
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-36
Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 16/278 (5%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHE 585
Y+ L +G G +G+V G +VA+K R S + EL L +RHE
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N++ LL ++ F G+ + L + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H +IHRD+K N+ ++ K+ DFG ++ + DS + V
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVI 190
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765
+ + D++S G ++ E+I+G+ ++ + + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
K + A + P V+++ ++
Sbjct: 251 AKNYMKGLPELEKKDFA----SILTNASPLAVNLLEKM 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 18/234 (7%)
Query: 536 LIGEGGFGSVYRGTLPD-GQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+IG G FG VY+ L D G+ VA+K Q R EL + + H N+V L +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 595 CENDQQ------ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTF 648
+ ++ LV ++ + + + ++TL R L Y+H+
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 649 AGRSVIHRDVKSSNILLDH-SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYS 707
+ HRD+K N+LLD + K+ DFG +K + + +
Sbjct: 141 --FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIFG 196
Query: 708 TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761
++ DV+S G VL E++ G+ ++ + +I E+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 13/209 (6%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHE 585
Q+Y+ L IGEG +G+V++ + VA+K E+ L ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
N+V L + + LV+ F + LD S +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEY 705
H+ R+V+HRD+K N+L++ + K+A+FG ++ +S EV
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 173
Query: 706 YSTQHLSAKSDVFSFGVVLLEIISGREPL 734
+ + S D++S G + E+ + PL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-34
Identities = 55/232 (23%), Positives = 84/232 (36%), Gaps = 13/232 (5%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV---RSSTSTQGTREFENELNFLSAIRHENLVPLL 591
L+G+G FG V G+ A+K+ + E L RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 592 GYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
+D+ V + + G L L S + L YLH+ R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 652 SVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL 711
V++RD+K N++LD K+ DFG K +G + GT YL PE
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDY 182
Query: 712 SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763
D + GVV+ E++ GR P + + L+ + + E
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 51/281 (18%), Positives = 102/281 (36%), Gaps = 24/281 (8%)
Query: 537 IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLGY 593
IG+G FG V++ GQ+VA+K + E+ L ++HEN+V L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 594 CCENDQQI--------LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
C LV+ F + + GL Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI 133
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLE--VRGTAGYLDP 703
H ++HRD+K++N+L+ K+ADFG ++ +S + T Y P
Sbjct: 134 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 704 EYY-STQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762
E + D++ G ++ E+ + + +++ +L+ I +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+ + Y + + + + P +D++ +L
Sbjct: 251 NYEL---YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 54/271 (19%), Positives = 95/271 (35%), Gaps = 14/271 (5%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHENLVPLLG 592
+G G +GSV G VAVK R S + EL L ++HEN++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 593 YCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS 652
L + L + RGL Y+H+
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 653 VIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLS 712
+IHRD+K SN+ ++ K+ DFG +++ E + H +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHYN 197
Query: 713 AKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYHA 772
D++S G ++ E+++GR ++ L+ + +I S + +
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 773 EAMWRMVEVALACIEPFSAYRPSMVDIVREL 803
+ A F P VD++ ++
Sbjct: 258 LTQMPKMNFA----NVFIGANPLAVDLLEKM 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 116 bits (290), Expect = 7e-29
Identities = 39/205 (19%), Positives = 82/205 (40%), Gaps = 22/205 (10%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGY 593
+G G + V+ + + ++V VK+ + + + E+ L +R N++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 594 CCENDQQ--ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGR 651
+ + LV+ ++N + +TL + L Y H+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---M 148
Query: 652 SVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYY-STQ 709
++HRDVK N+++DH ++ D+G +++ + + + PE Q
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELLVDYQ 205
Query: 710 HLSAKSDVFSFGVVLLEIISGREPL 734
D++S G +L +I +EP
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-28
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 24/227 (10%)
Query: 531 QQYKTL--IGEGGFGSVYRGT-LPDGQEVAVKV--RSSTSTQGTREFENELNFLSAIRHE 585
++Y+ L IG G G V + VA+K R + + EL + + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 586 NLVPLLGYCC------ENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAA 639
N++ LL E LV M Q + LD +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 640 RGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAG 699
G+ +LH+ +IHRD+K SNI++ K+ DFG ++ G S T
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 183
Query: 700 YLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV 746
Y PE D++S G ++ E++ + R ++W+ V
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 20/243 (8%)
Query: 536 LIGEGGFGSVYRGTL----PDGQEVAVKV----RSSTSTQGTREFENELNFLSAIRHENL 587
++G G +G V+ G+ A+KV + T E L IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 588 VPLLGYCCENDQQI-LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLH 646
+ L Y + + ++ L+ +++ G L L R+ L +LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLH 146
Query: 647 TFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPE-- 704
+I+RD+K NILLD + + DFG S ++ + + GT Y+ P+
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLS-KEFVADETERAYDFCGTIEYMAPDIV 202
Query: 705 YYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764
D +S GV++ E+++G P +N + + + E + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEMSA 261
Query: 765 SIK 767
K
Sbjct: 262 LAK 264
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 107 bits (267), Expect = 1e-25
Identities = 34/212 (16%), Positives = 69/212 (32%), Gaps = 17/212 (8%)
Query: 536 LIGEGGFGSVYRGT-LPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYC 594
+G G F +V+ + + VA+K+ T E+E+ L + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 595 CENDQQIL-VYPFMSNGSLQDRLYGE-----------ASTRKTLDWPTRLSIALGAARGL 642
+ ++L + + + E + + I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 643 MYLHTFAGRSVIHRDVKSSNILLD-HSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYL 701
Y+H G +IH D+K N+L++ + + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 702 DPEYYSTQHLSAKSDVFSFGVVLLEIISGREP 733
PE +D++S ++ E+I+G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.0 bits (199), Expect = 4e-18
Identities = 25/155 (16%), Positives = 45/155 (29%), Gaps = 21/155 (13%)
Query: 536 LIGEGGFGSVYRGTLPDGQEVAVKV-RSSTST---------QGTREFENELNFLSAIRHE 585
L+GEG +V+ E VK + ++ G F +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 586 NLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYL 645
L L G Y + N L + +A + + +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 646 HTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680
+ R ++H D+ N+L+ + DF S
Sbjct: 120 YH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 7e-10
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 5/70 (7%)
Query: 378 ELKKYNKENKVLESW--SGDPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQGILPL--S 433
++KK L SW + D C TW GV C+T + + LDLS + P+ S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS 71
Query: 434 VTGLTHLEKF 443
+ L +L
Sbjct: 72 LANLPYLNFL 81
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.42 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 93.87 | |
| d2o14a1 | 146 | Hypothetical protein YxiM {Bacillus subtilis [TaxI | 86.75 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 84.5 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 84.44 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-50 Score=430.86 Aligned_cols=267 Identities=25% Similarity=0.413 Sum_probs=205.4
Q ss_pred cCHHHHHHHHHhhc-----------ceecccCcEEEEEEecC-CC---CEEEEEEcccCC-CcchHHHHHHHHHHhcCCc
Q 002943 521 FSLQYLEAATQQYK-----------TLIGEGGFGSVYRGTLP-DG---QEVAVKVRSSTS-TQGTREFENELNFLSAIRH 584 (863)
Q Consensus 521 ~~~~~l~~~t~~f~-----------~~LG~G~fG~Vy~g~~~-~g---~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H 584 (863)
++++++.+++.+|. ++||+|+||+||+|.+. +| ..||||++.... ....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 56677777777662 57999999999999864 23 258999876543 3345689999999999999
Q ss_pred ccccceeeeEeeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeE
Q 002943 585 ENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNIL 664 (863)
Q Consensus 585 ~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NIL 664 (863)
||||+++|+|.+.+..++|||||++|+|.+++.. ....++|.++++++.|||+||+|||+ ++|+||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 9999999999999999999999999999998853 23469999999999999999999999 89999999999999
Q ss_pred ecCCCeEEEeeccCcccCCCCCCCCc---eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCC
Q 002943 665 LDHSMCAKVADFGFSKYAPQEGDSGF---SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPR 740 (863)
Q Consensus 665 ld~~~~~kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~ 740 (863)
|+.++++||+|||+|+.......... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||.....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999997754332211 122457899999999999999999999999999999998 8999976432
Q ss_pred CcchhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 741 NEWSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 741 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..+...+....+ ...+.++...+.+++.+||+.+|++||||.||++.|+++++.
T Consensus 240 --~~~~~~i~~~~~-------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 --QDVINAIEQDYR-------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHHHHHHHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHHHcCCC-------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 223332221110 011122344688999999999999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=421.18 Aligned_cols=252 Identities=29% Similarity=0.462 Sum_probs=198.5
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++|||||+++|+|...+..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 356899999999999999988999999998764 3445789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ....++|..++.++.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 87 L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 87 LSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp HHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 9999854 34568999999999999999999999 8999999999999999999999999999987654322 223
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhC-CCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISG-REPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....||..|+|||.+.+..++.++|||||||++|||+|+ ++|+.... ...+.+.+....+ ...|.
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~~~~------~~~p~----- 225 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFR------LYKPR----- 225 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHHTCC------CCCCT-----
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHhcCC------CCCcc-----
Confidence 345689999999999999999999999999999999995 55554321 2223332222111 11111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
.+..++.+++.+||+.+|++||||+||++.|+++.
T Consensus 226 --~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 --LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 12345889999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=417.60 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=199.0
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++||||+++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence 4579999999999999874 36999998654 34456789999999999999999999999864 5689999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++++.. ...++|..++.++.|||+||+|||+ ++||||||||+||||+.++.+||+|||+|+..........
T Consensus 89 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 89 SLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp EHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999543 3469999999999999999999999 8999999999999999999999999999988765444444
Q ss_pred eeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 691 SLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .+...+..... .|.+.
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~--------~p~~~ 232 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYL--------SPDLS 232 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSC--------CCCGG
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCC--------CCcch
Confidence 456679999999999864 358999999999999999999999997643211 11111111111 11110
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....++...+.+++.+||+.+|++||||.||++.|+.+.
T Consensus 233 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 233 -KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999999775
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=421.05 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=204.9
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.+.+.||+|+||+||+|.+++++.||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 4568899999999999999888999999987543 445789999999999999999999998854 56789999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ....++|..+++|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+...... ....
T Consensus 94 L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~ 167 (272)
T d1qpca_ 94 LVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAR 167 (272)
T ss_dssp HHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECC
T ss_pred HHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc-cccc
Confidence 99988533 23459999999999999999999999 899999999999999999999999999999775432 2223
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....||+.|+|||++.++.++.++|||||||++|||+||..|+.... ....+.+.+.. + ..+.....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~----~-----~~~~~p~~-- 234 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLER----G-----YRMVRPDN-- 234 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHT----T-----CCCCCCTT--
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHh----c-----CCCCCccc--
Confidence 34568999999999999999999999999999999999665543322 11222222221 1 01111112
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
....+.+++.+||+.+|++||||.||+++|++.+
T Consensus 235 --~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 235 --CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2345889999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-49 Score=423.48 Aligned_cols=258 Identities=27% Similarity=0.367 Sum_probs=210.6
Q ss_pred HHhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 530 TQQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
.+.+.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||||++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3455689999999999999965 58899999987543 446789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ....++|..++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+...... .
T Consensus 97 ~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~ 170 (287)
T d1opja_ 97 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 170 (287)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-S
T ss_pred CcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC-c
Confidence 99999999643 34579999999999999999999999 899999999999999999999999999999765432 2
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......||+.|+|||++.+..++.|+|||||||++|||++|..|+..... ...+.+.+.. + ...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~~----~---------~~~ 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEK----D---------YRM 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHT----T---------CCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHhc----C---------CCC
Confidence 223345689999999999999999999999999999999997776643221 1122222211 1 111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..+......+.+|+.+||+.+|++||||.||++.|+.+++.
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11112234688999999999999999999999999988643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=414.79 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=199.3
Q ss_pred hhcceecccCcEEEEEEecCCC-----CEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDG-----QEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g-----~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||+||+|.+++. ..||||++..... ...++|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 3468999999999999986532 3799998865433 334579999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+.+|+|.+++... ...++|.++++++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 90 ~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 90 YMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999988532 3569999999999999999999999 89999999999999999999999999999977543
Q ss_pred CCC-CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDS-GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
... .......||+.|||||++.+..++.++|||||||++|||++|..|+..... ...+.+.+.. +
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~----~-------- 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAIND----G-------- 229 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHT----T--------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHHhc----c--------
Confidence 322 223345689999999999999999999999999999999997666543221 1222222221 1
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.....+.++...+.+|+.+||+.+|++||||.||+++|+++++.
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111222335688999999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=406.29 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=209.1
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.|.++||+|+||+||+|++++++.||||+++.... ..++|++|++++++++||||++++|+|.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 35689999999999999998899999999876543 45789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++..+++++.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 86 l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (258)
T d1k2pa_ 86 LLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS 158 (258)
T ss_dssp HHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred HHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence 99998543 3568999999999999999999999 8999999999999999999999999999987654322 223
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
....||..|+|||.+.+..++.|+|||||||++|||+| |+.||..... ..+...+. .+. ....|.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~----~~~--~~~~p~----- 224 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIA----QGL--RLYRPH----- 224 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHH----TTC--CCCCCT-----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHH----hCC--CCCCcc-----
Confidence 34568999999999999999999999999999999998 8999976532 12222111 111 111111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
.....+.+++.+||+.+|++|||++||++.|.++
T Consensus 225 --~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 --LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224688999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=411.91 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=199.5
Q ss_pred ceecccCcEEEEEEecC---CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 535 TLIGEGGFGSVYRGTLP---DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 34689999886543 2334689999999999999999999999864 567899999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS- 688 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~- 688 (863)
|+|.+++.. ...++|..+++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999953 3469999999999999999999999 89999999999999999999999999999876543222
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..+...+. .+.. +..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~----~~~~-----~~~- 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE----KGER-----MGC- 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH----TTCC-----CCC-
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHH----cCCC-----CCC-
Confidence 12234568999999999999999999999999999999998 8999976432 22222222 1111 111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+..+...+.+|+.+||+.+|++||||+||++.|+..+
T Consensus 232 ---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1122345889999999999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=410.92 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=203.1
Q ss_pred eecccCcEEEEEEecC---CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 536 LIGEGGFGSVYRGTLP---DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 536 ~LG~G~fG~Vy~g~~~---~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+||+|+||+||+|.+. ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.. +..+|||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999753 355799999876543 345789999999999999999999999864 56899999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC-Cc
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS-GF 690 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~-~~ 690 (863)
|.+++.. .+..+++..+++++.|+|+||+|||+ ++|+||||||+||||+.++.+||+|||+|+........ ..
T Consensus 95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 9999843 34579999999999999999999999 89999999999999999999999999999977543221 12
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+...+. .+... ...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~----~~~~~-----~~p-- 234 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIE----QGKRM-----ECP-- 234 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHH----TTCCC-----CCC--
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHH----cCCCC-----CCC--
Confidence 233468999999999999999999999999999999998 9999986432 22222222 12111 111
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
......+.+|+.+||+.+|++||||.+|++.|+.+.
T Consensus 235 --~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 235 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 122345889999999999999999999999999876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=408.34 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=199.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..+|||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 3458999999999999996 579999999886543 23446799999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
|+|.+++. ....+++.+...++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.........
T Consensus 88 g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 88 GELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999994 34579999999999999999999999 899999999999999999999999999999775443333
Q ss_pred ceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 690 FSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
......||+.|||||++.+..+ +.++|||||||++|||+||+.||........ ....+...... .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~~~~~~-------~------ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY-------L------ 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHHTTCTT-------S------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCC-------C------
Confidence 4455679999999999988776 5789999999999999999999976432111 11111111000 0
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111235778999999999999999999853
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=417.72 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=204.6
Q ss_pred HhhcceecccCcEEEEEEecCC------CCEEEEEEcccC-CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD------GQEVAVKVRSST-STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~------g~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~L 602 (863)
+.+.++||+|+||+||+|+... ...||||++... .....+.|.+|+.+|.++ +|||||+++++|.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 4556899999999999998532 236999987654 334456899999999998 89999999999999999999
Q ss_pred EeecCCCCChhhhhhccCC-------------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCe
Q 002943 603 VYPFMSNGSLQDRLYGEAS-------------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNI 663 (863)
Q Consensus 603 V~ey~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NI 663 (863)
||||+++|+|.++|+.... ....++|..++.++.||++||+|||+ ++||||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcc
Confidence 9999999999999965421 12458999999999999999999999 8999999999999
Q ss_pred EecCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCc
Q 002943 664 LLDHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNE 742 (863)
Q Consensus 664 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~ 742 (863)
|++.++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||+||||+| |+.||.......
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~- 274 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA- 274 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987765444333345678999999999999999999999999999999998 899997643221
Q ss_pred chhHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 002943 743 WSLVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELED 805 (863)
Q Consensus 743 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~ 805 (863)
.+.+.+.... .+ ..+......+.+|+.+||+.+|++||||+||++.|..
T Consensus 275 -~~~~~~~~~~---------~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 -NFYKLIQNGF---------KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp -HHHHHHHTTC---------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHhcCC---------CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1222221111 11 1111223468899999999999999999999999963
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=410.59 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=201.5
Q ss_pred HhhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
..+.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 4567899999999999999988889999998654 4456789999999999999999999999854 5678999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++++... ...++|.+++.++.|||.||+|||+ ++|+||||||+|||||.++++||+|||+|+...... ...
T Consensus 97 ~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 170 (285)
T d1fmka3 97 SLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 170 (285)
T ss_dssp BHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred chhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence 9999985432 3469999999999999999999999 899999999999999999999999999998764332 222
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGY 770 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 770 (863)
.....||+.|+|||++..+.++.++|||||||++|||+||..|+.... ....+..++.... .+..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~~~~---------~~~~---- 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY---------RMPC---- 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC---------CCCC----
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcC---------CCCC----
Confidence 344568999999999999999999999999999999999766654322 1222333322111 0111
Q ss_pred cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 771 HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 771 ~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+...++.+++.+||+.+|++||+|.+|+++|++.+
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1122346889999999999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=398.06 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=201.4
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 34568999999999999996 46899999987643 234457789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. ...+++.....++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 88 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred cCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 999999999953 3468999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
......||+.|||||.+.+..++.++|||||||+||||++|+.||..... ..+.+.+. .+. +.+
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~----~~~------~~~ 223 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRIS----RVE------FTF 223 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH----TTC------CCC
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCC------CCC
Confidence 23345799999999999999999999999999999999999999975321 11211111 111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ...+.+++.+|++.||++|||+.|+++
T Consensus 224 p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1122 235788999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=404.41 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=191.2
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEee--CCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCE--NDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~ey 606 (863)
.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++.+ .+..++||||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 4458999999999999985 5799999998866542 234678999999999999999999999865 4567899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc--CCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA--GRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
+++|+|.+++.........+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 9999999999654444567999999999999999999999832 23599999999999999999999999999997754
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. .......||+.|||||.+.+..++.++|||||||++|||+||+.||.... ...+...+ ..+...
T Consensus 167 ~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i----~~~~~~----- 232 (269)
T d2java1 167 DT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKI----REGKFR----- 232 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH----HHTCCC-----
T ss_pred CC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHH----HcCCCC-----
Confidence 32 22345679999999999999999999999999999999999999997542 11222211 111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 RIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122223 35888999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-47 Score=408.90 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=206.8
Q ss_pred hcceecccCcEEEEEEecC------CCCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.||+|+||+||+|+.. +++.||||++...... ..++|.+|+++|++++||||++++++|...+..++|||
T Consensus 17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence 4589999999999999853 4678999998765433 35679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhccC--------------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEe
Q 002943 606 FMSNGSLQDRLYGEA--------------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILL 665 (863)
Q Consensus 606 y~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILl 665 (863)
|+++|+|.++++... .....++|..++.|+.|++.||+|||+ ++||||||||+||||
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEE
Confidence 999999999996432 113358999999999999999999999 899999999999999
Q ss_pred cCCCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCC-CCCCCCCCCCcch
Q 002943 666 DHSMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR-EPLNTRRPRNEWS 744 (863)
Q Consensus 666 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~-~p~~~~~~~~~~~ 744 (863)
|.++.+||+|||+|+...............||+.|+|||.+.+..++.|+|||||||++|||++|. +||.... ...
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~---~~e 250 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA---HEE 250 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHH
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC---HHH
Confidence 999999999999998765444444444567899999999999999999999999999999999986 5676532 222
Q ss_pred hHHhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 745 LVEWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 745 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
+...+. ++...+ .. ......+.+|+.+||+.+|++||||.||+++|+++.
T Consensus 251 ~~~~v~----~~~~~~-----~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 251 VIYYVR----DGNILA-----CP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHH----TTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHH----cCCCCC-----CC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 333222 222111 11 122345889999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=399.80 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=202.3
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+++|+
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 347899999999999985 5799999999877666667789999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++.. ..+++.+...++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 104 L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~ 173 (293)
T d1yhwa1 104 LTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (293)
T ss_dssp HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccc
Confidence 9998743 358999999999999999999999 899999999999999999999999999998765432 223
Q ss_pred eeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCCCc
Q 002943 692 LEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGGYH 771 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 771 (863)
....||+.|+|||.+.+..++.++|||||||++|||+||+.||..... ...... ....+. .. + ...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~---~~~~~~-~~-----~--~~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYL---IATNGT-PE-----L--QNP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH---HHHHCS-CC-----C--SSG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHH---HHhCCC-CC-----C--CCc
Confidence 445799999999999999999999999999999999999999975321 111111 111110 00 1 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 772 AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 772 ~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345789999999999999999999854
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=397.04 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=194.0
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEee----CCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCE----NDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ 604 (863)
.|+++||+|+||+||+|... +++.||+|++.... ....+.|.+|+++|++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35678999999999999964 68899999876543 3344678999999999999999999999865 34578999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCC--ccccCCCCCCeEec-CCCeEEEeeccCccc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRS--VIHRDVKSSNILLD-HSMCAKVADFGFSKY 681 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~--iiHrDik~~NILld-~~~~~kl~DFGla~~ 681 (863)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999953 3468999999999999999999998 55 99999999999996 588999999999986
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEI 761 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i 761 (863)
... .......||+.|||||.+.+ +++.++|||||||++|||++|+.||..... ...+.+.+.. +...
T Consensus 165 ~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~----~~~~-- 231 (270)
T d1t4ha_ 165 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTS----GVKP-- 231 (270)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTT----TCCC--
T ss_pred ccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHc----CCCC--
Confidence 532 22345679999999999865 699999999999999999999999975321 1112222111 1110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 VDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+.+.... ..++.+++.+||+.+|++|||+.|+++
T Consensus 232 --~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 --ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111112 234788999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=402.87 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=204.2
Q ss_pred hhcceecccCcEEEEEEecCCC----CEEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeC-CeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDG----QEVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCEN-DQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g----~~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV~e 605 (863)
+|+++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+. +..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567999999999999996432 25899988653 344457899999999999999999999998764 57899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
||++|+|.++++.. ...+++..+++++.|+|+||.|||+ ++|+||||||+||||++++.+||+|||+++.....
T Consensus 110 ~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999998543 4467889999999999999999999 89999999999999999999999999999976543
Q ss_pred CCC--CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 686 GDS--GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 686 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
... .......||..|+|||.+.+..++.++||||||+++|||+||+.||..... ...+..++.. +. ....
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~----g~--~~~~ 255 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQ----GR--RLLQ 255 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TC--CCCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc----CC--CCCC
Confidence 222 122345689999999999999999999999999999999998888764321 1222232221 11 1111
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
|. .+...+.+++.+||+.+|++||+|.||++.|+.++.
T Consensus 256 p~-------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 PE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 122458899999999999999999999999998863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=401.22 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=201.0
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
+.+.||+|+||+||+|+. .+|+.||||++........+.|.+|+++|++++|||||++++++.+.+..++||||+++|+
T Consensus 16 i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 457899999999999995 5789999999987777777899999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
|.+++... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 96 L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~ 167 (288)
T d2jfla1 96 VDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 167 (288)
T ss_dssp HHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHH
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccc
Confidence 99998532 3469999999999999999999999 899999999999999999999999999997653211 112
Q ss_pred eeeecCCCCCCccccc-----cCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 692 LEVRGTAGYLDPEYYS-----TQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
....||+.|+|||++. ...++.++|||||||++|||+||+.||...... .+...+.. +.... +
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~----~~~~~-----~ 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK----SEPPT-----L 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHH----SCCCC-----C
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHc----CCCCC-----C
Confidence 2456999999999984 456889999999999999999999999764321 11111111 11111 1
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.........+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122345789999999999999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=404.60 Aligned_cols=253 Identities=21% Similarity=0.378 Sum_probs=199.5
Q ss_pred hhcceecccCcEEEEEEecC-CCC----EEEEEEcccC-CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQ----EVAVKVRSST-STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~----~vAVK~~~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
.+.++||+|+||+||+|... +|+ +||||.+... ..+..++|.+|++++++++|||||+++|+|.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 44589999999999999854 454 5889987643 345568899999999999999999999999865 5678889
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+.+|+|.+++... ...+++..+++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 91 ~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 91 LMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999988543 4579999999999999999999999 89999999999999999999999999999987655
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
..........||+.|+|||.+.++.++.++|||||||+||||+| |+.||+..... .+...+.. +.. +
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~----~~~-----~ 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK----GER-----L 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH----TCC-----C
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CCC-----C
Confidence 44444455679999999999999999999999999999999999 88898764321 12222111 110 0
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
..+..+...+.+++.+||+.+|++||||.||++.|+.+.
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111123346889999999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=392.02 Aligned_cols=247 Identities=31% Similarity=0.445 Sum_probs=196.4
Q ss_pred hhcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEee-CCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCE-NDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ey~~~g 610 (863)
.|.+.||+|+||.||+|.+ .|++||||+++.. ...++|.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 4568899999999999998 4789999998654 345789999999999999999999999965 45689999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.++|+.. ....++|..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 999999543 23468999999999999999999999 89999999999999999999999999999865432
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKGG 769 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 769 (863)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||.... ...+..++.... .+.+...
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~---~~~~~~~i~~~~---------~~~~~~~ 224 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKGY---------KMDAPDG 224 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC---GGGHHHHHTTTC---------CCCCCTT
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHcCC---------CCCCCcc
Confidence 223458899999999999999999999999999999998 677776532 223444433211 1111112
Q ss_pred CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhh
Q 002943 770 YHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAF 807 (863)
Q Consensus 770 ~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~ 807 (863)
...++.+++.+||+.||++||||.||+++|+++.
T Consensus 225 ----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 225 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2245789999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=403.42 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=197.9
Q ss_pred HhhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCC-eeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCEND-QQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~~ 601 (863)
+.+.++||+|+||.||+|... +++.||||+++.... ...+++.+|.+.+.++ +|+||+.+++++.+.+ ..+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 455689999999999999842 356899999875433 3456788888888887 6899999999987654 689
Q ss_pred EEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 602 LVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
+|||||++|+|.++|+.... ....++|.+++.++.||++||+|||+ ++|+||||||+||||++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCC
Confidence 99999999999999965321 23458999999999999999999999 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCC-CCCCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR-EPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||...... ..+...
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~~~ 249 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR 249 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence 99999999999776554444445567999999999999999999999999999999999974 577653321 111111
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+..+.. +..... ...++.+++.+||+.+|++||||.||++.|+++++
T Consensus 250 ----~~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 250 ----LKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HhcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111 111112 22358899999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=408.15 Aligned_cols=196 Identities=27% Similarity=0.395 Sum_probs=172.1
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCC-CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS-TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
+.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||+++++|.+.+..++|||||++|
T Consensus 10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg 89 (322)
T d1s9ja_ 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 89 (322)
T ss_dssp EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 358999999999999995 578999999887553 333567899999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
+|.+++... ..+++..+..++.|++.||.|||+. ++|+||||||+|||+++++.+||+|||+|+..... .
T Consensus 90 ~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~ 159 (322)
T d1s9ja_ 90 SLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 159 (322)
T ss_dssp EHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----T
T ss_pred cHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----c
Confidence 999999542 4689999999999999999999972 37999999999999999999999999999865322 1
Q ss_pred eeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCC
Q 002943 691 SLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRR 738 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~ 738 (863)
.....||+.|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=399.20 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=200.4
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeec
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
+.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 34568999999999999986 57999999987643 233456799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+++|+|.+++.. .+.+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999853 3469999999999999999999999 899999999999999999999999999999876544
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+. .+. ..+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~----~~~------~~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKII----KLE------YDF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH----TTC------CCC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHH----cCC------CCC
Confidence 4444455679999999999999999999999999999999999999997532 112221111 111 111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
....+ ..+.+++.+|++.||++|||+.|+++
T Consensus 230 p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 12222 35789999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=400.18 Aligned_cols=268 Identities=27% Similarity=0.360 Sum_probs=200.5
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHH--HHHHHHHhcCCcccccceeeeEeeCC----eeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREF--ENELNFLSAIRHENLVPLLGYCCEND----QQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f--~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~ey 606 (863)
+.+.||+|+||.||+|++ +|+.||||+++... .+++ +.|+..+.+++|||||+++|+|.+.+ ..++||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 457899999999999997 68899999886442 2333 34555666789999999999998764 57899999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhcc-----CCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFA-----GRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
|++|+|.++|+. ..++|..+++++.|+|.||+|||+.+ .++|+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999953 35899999999999999999999742 36999999999999999999999999999987
Q ss_pred CCCCCCC--CceeeeecCCCCCCccccccCC------CCcccceechhhHHHHHHhCCCCCCCCCCCCcch--h--HHhh
Q 002943 682 APQEGDS--GFSLEVRGTAGYLDPEYYSTQH------LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS--L--VEWA 749 (863)
Q Consensus 682 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~--l--~~~~ 749 (863)
....... .......||+.|+|||++.+.. ++.|+|||||||+||||+||+.|+.......... . ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6543321 1223467999999999987643 5678999999999999999998875433211100 0 0000
Q ss_pred hhcccccccccccCCccCCCC-cHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 750 KPFIRESRIDEIVDPSIKGGY-HAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 750 ~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
..........+..+|.+.... ..+....+.+++.+||+.||++||||.||++.|+++...
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 000001111122233332222 335667799999999999999999999999999988743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=399.52 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=196.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
...+.||+|+||+||+|+. .+|+.||||++...... ..+.|.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 3457899999999999985 57899999998765433 2357899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|..++.. ...+++.++..++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+|+.....
T Consensus 98 ~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 98 LGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred CCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999876632 3569999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCceeeeecCCCCCCcccccc---CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 688 SGFSLEVRGTAGYLDPEYYST---QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ..... .... +......
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~---~i~~-~~~~~~~-- 235 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY---HIAQ-NESPALQ-- 235 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH---HHHH-SCCCCCS--
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHH---HHHh-CCCCCCC--
Confidence 23469999999999864 4689999999999999999999999975321 11111 1111 1111111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1112 235889999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=399.30 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=210.2
Q ss_pred HHhhcceecccCcEEEEEEec------CCCCEEEEEEcccCCCc-chHHHHHHHHHHhcC-CcccccceeeeEeeCCeeE
Q 002943 530 TQQYKTLIGEGGFGSVYRGTL------PDGQEVAVKVRSSTSTQ-GTREFENELNFLSAI-RHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 530 t~~f~~~LG~G~fG~Vy~g~~------~~g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 601 (863)
...+.++||+|+||.||+|++ .+++.||||+++..... ...+|.+|+.+++++ +|||||+++|+|.+.+..+
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~ 103 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence 345678999999999999974 34678999998765433 345789999999999 6999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC--------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC
Q 002943 602 LVYPFMSNGSLQDRLYGEAS--------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH 667 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~ 667 (863)
+||||+++|+|.++++.... ....+++..+++++.||++||+|||+ ++|+||||||+|||++.
T Consensus 104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180 (311)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccc
Confidence 99999999999999965421 23468999999999999999999999 89999999999999999
Q ss_pred CCeEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhH
Q 002943 668 SMCAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLV 746 (863)
Q Consensus 668 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~ 746 (863)
++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+|+......+ .+.
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~~~ 258 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFY 258 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 99999999999998765544444455679999999999999999999999999999999999 455554432211 122
Q ss_pred HhhhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 747 EWAKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 747 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
+.+....+ +.... .....+.+|+.+||+.+|++||||.||+++|++.+.
T Consensus 259 ~~i~~~~~---------~~~~~----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 KMIKEGFR---------MLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHTCC---------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCC---------CCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 22211110 11111 123458899999999999999999999999998763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=395.07 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=195.5
Q ss_pred HhhcceecccCcEEEEEEecCC----CCEEEEEEcccCCCc-chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEee
Q 002943 531 QQYKTLIGEGGFGSVYRGTLPD----GQEVAVKVRSSTSTQ-GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYP 605 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~~----g~~vAVK~~~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~e 605 (863)
+.+.+.||+|+||.||+|+... +..||||.++..... ..+.|.+|+++|++++|||||+++|+|. .+..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 3456899999999999998642 356899988654433 3467999999999999999999999996 467899999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~ 685 (863)
|+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 88 ~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 88 LCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred eccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999998743 24568999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhcccccccccccCC
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDP 764 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 764 (863)
.. .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+.+.+.. +...
T Consensus 162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~----~~~~----- 228 (273)
T d1mp8a_ 162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIEN----GERL----- 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHT----TCCC-----
T ss_pred cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----CCCC-----
Confidence 22 22344568999999999999999999999999999999998 8999976532 222222221 1111
Q ss_pred ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 765 SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 765 ~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
.+. ......+.+++.+||+.+|++|||+.||++.|+.+++.
T Consensus 229 ~~~----~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 PMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 12234688999999999999999999999999988743
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=396.26 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=206.3
Q ss_pred hhcceecccCcEEEEEEecC--------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeE
Q 002943 532 QYKTLIGEGGFGSVYRGTLP--------DGQEVAVKVRSSTST-QGTREFENELNFLSAI-RHENLVPLLGYCCENDQQI 601 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~--------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 601 (863)
.+.+.||+|+||.||+|+.. ++..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 45689999999999999852 235799999876544 3457889999999888 7999999999999999999
Q ss_pred EEeecCCCCChhhhhhccCC------------CCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC
Q 002943 602 LVYPFMSNGSLQDRLYGEAS------------TRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM 669 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~ 669 (863)
+||||+++|+|.+++..... ....+++.++++++.|++.||+|||+ ++||||||||+|||++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCC
Confidence 99999999999999964421 23569999999999999999999999 8999999999999999999
Q ss_pred eEEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 002943 670 CAKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEW 748 (863)
Q Consensus 670 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~ 748 (863)
.+||+|||+++...............||+.|+|||.+.++.++.|+|||||||++|||++ |+.||..... ..+.+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~~~~~ 249 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EELFKL 249 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HHHHHH
Confidence 999999999998765544444455678999999999999999999999999999999998 7888865431 122222
Q ss_pred hhhcccccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 749 AKPFIRESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 749 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+. .+. .+...... ...+.+++.+||+.+|++|||+.||++.|++++++
T Consensus 250 i~----~~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 250 LK----EGH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HH----TTC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----cCC-----CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 21 111 11111122 23588999999999999999999999999998743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-44 Score=397.75 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=203.8
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 44568999999999999985 57999999998776666667899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CCCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.. ....+++.....++.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.....
T Consensus 108 g~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 179 (350)
T d1koaa2 108 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 179 (350)
T ss_dssp CBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred CCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence 999999843 23469999999999999999999999 8999999999999995 4678999999999876533
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+..-+... .... ++...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~--~~~~----~~~~~ 249 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSC--DWNM----DDSAF 249 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT--CCCS----CCGGG
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhC--CCCC----Ccccc
Confidence 234456799999999999999999999999999999999999999975421 1111111110 0000 11111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. ....+.+++.+|++.||++|||+.|+++
T Consensus 250 ~~----~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SG----ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GG----CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1235788999999999999999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-45 Score=393.30 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=185.9
Q ss_pred HhhcceecccCcEEEEEEecC-CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 355689999999999999964 689999998875542 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999953 3569999999999999999999999 8999999999999994 5789999999999876432
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
. ......||+.|||||.+.+..++.++|||||||++|||++|+.||.... ...+...+.. +.. . .+..
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~----~~~-~-~~~~ 231 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILK----AEY-E-FDSP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHT----TCC-C-CCTT
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhc----cCC-C-CCCc
Confidence 2 2234579999999999999999999999999999999999999997532 1122222111 100 0 0111
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..... ...+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122 235789999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=396.12 Aligned_cols=256 Identities=29% Similarity=0.395 Sum_probs=203.3
Q ss_pred hhcceecccCcEEEEEEecCC-CC--EEEEEEcccC-CCcchHHHHHHHHHHhcC-CcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTLPD-GQ--EVAVKVRSST-STQGTREFENELNFLSAI-RHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~~-g~--~vAVK~~~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.++||+|+||+||+|++.+ |. .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 456899999999999999753 44 4788876543 344567899999999999 799999999999999999999999
Q ss_pred CCCCChhhhhhccC------------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 607 MSNGSLQDRLYGEA------------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 607 ~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
+++|+|.++|+... .....++|..+++++.|||+||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEc
Confidence 99999999996541 234679999999999999999999999 899999999999999999999999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCC-CCCCCCCCCcchhHHhhhhcc
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGRE-PLNTRRPRNEWSLVEWAKPFI 753 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~-p~~~~~~~~~~~l~~~~~~~~ 753 (863)
|||+++....... .....||..|+|||.+....++.++|||||||++|||++|.. ||.... ...+.+.+..
T Consensus 170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~~-- 241 (309)
T d1fvra_ 170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQ-- 241 (309)
T ss_dssp CTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGGG--
T ss_pred ccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHh--
Confidence 9999986543222 223468999999999999999999999999999999999764 565432 2223333222
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 754 RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 754 ~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+. .+.. +......+.+++.+||+.+|++||||.||++.|+++++.
T Consensus 242 --~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 --GY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --TC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --cC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 1111 112234688999999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=393.28 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=193.8
Q ss_pred hhcceecccCcEEEEEEecC--CC--CEEEEEEcccCC---CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP--DG--QEVAVKVRSSTS---TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~--~g--~~vAVK~~~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||+||+|++. ++ ..||||++.... .+..++|.+|+++|++++|||||+++|+|.+ +..++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 45688999999999999853 33 378999876542 3345789999999999999999999999965 4678999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.+++... ...+++..+++++.|+|+||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 90 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp ECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999988543 3469999999999999999999999 8999999999999999999999999999997754
Q ss_pred CCCCC-ceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHh-CCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 685 EGDSG-FSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIIS-GREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 685 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
..... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... ...+..++.. .+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~---~~~~---- 233 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDK---EGER---- 233 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHT---SCCC----
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHh---CCCC----
Confidence 43322 2233457889999999999999999999999999999998 899997542 2223232221 1110
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDA 806 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~ 806 (863)
+...... ...+.+++.+||+.+|++||||.||++.|+++
T Consensus 234 -~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -LPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0111122 23588999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-44 Score=394.46 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=204.5
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
+.+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..+|||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 44568999999999999985 57999999998776655567889999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec--CCCeEEEeeccCcccCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD--HSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld--~~~~~kl~DFGla~~~~~~~~ 687 (863)
|+|.+++.. ....+++.+...|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999988732 34469999999999999999999999 8999999999999998 6789999999999877543
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+...+.. +... ..+...
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~----~~~~--~~~~~~ 252 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKR----CDWE--FDEDAF 252 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHH----CCCC--CCSSTT
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCCC--CCcccc
Confidence 234456799999999999999999999999999999999999999975431 122221111 1000 111111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
...+ ..+.+++.+|++.||.+|||+.|+++
T Consensus 253 ~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVS----PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222 35789999999999999999999965
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=395.31 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=208.0
Q ss_pred hhcceecccCcEEEEEEecC------CCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTLP------DGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||+||+|.+. +++.||||+++.... +....|.+|++++++++|||||+++|+|...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 45688999999999999863 367899999875433 33456899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccC------CCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccC
Q 002943 605 PFMSNGSLQDRLYGEA------STRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGF 678 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGl 678 (863)
||+++|+|.++++... .....+++..+++++.|+|+||.|||+ ++|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999986431 223457999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCC-CCCCCCCCCCcchhHHhhhhcccccc
Q 002943 679 SKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGR-EPLNTRRPRNEWSLVEWAKPFIRESR 757 (863)
Q Consensus 679 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 757 (863)
|+...............||+.|+|||.+.+..++.++||||||+++|||+||+ .||.... ...+.+.+. .+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~~i~----~~~ 252 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRFVM----EGG 252 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHHHH----TTC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hCC
Confidence 98775444333344456899999999999999999999999999999999985 6665432 111222111 111
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhc
Q 002943 758 IDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFI 808 (863)
Q Consensus 758 ~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~ 808 (863)
... .. ......+.+++.+||+.+|++||||.||+++|++.++
T Consensus 253 ~~~-----~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 253 LLD-----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCC-----Cc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 11 1123468899999999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=387.75 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=199.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCC------cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST------QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.+.||+|+||+||+|+. .+|+.||||++..... ...+.|.+|+++|++++|||||++++++.+.+..+|||
T Consensus 13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4568999999999999996 5799999998765422 23467999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC----eEEEeeccCcc
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM----CAKVADFGFSK 680 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~----~~kl~DFGla~ 680 (863)
|||++|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+
T Consensus 93 E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 93 ELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999953 2469999999999999999999999 8999999999999998776 59999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDE 760 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 760 (863)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+...- .....
T Consensus 166 ~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~--~~~~~ 237 (293)
T d1jksa_ 166 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVN--YEFED 237 (293)
T ss_dssp ECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTC--CCCCH
T ss_pred hcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHHHHHhcC--CCCCc
Confidence 765332 22345689999999999999999999999999999999999999976431 11111111100 00000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ----~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 ----EYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001 12235789999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-43 Score=376.71 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=197.0
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc---chHHHHHHHHHHhcCCcccccceeeeEeeCC----eeEEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---GTREFENELNFLSAIRHENLVPLLGYCCEND----QQILV 603 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV 603 (863)
.+.+.||+|+||+||+|+. .+|+.||||+++..... ..+.|.+|++++++++|||||++++++...+ ..+||
T Consensus 10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 4568999999999999985 57999999998765432 3457899999999999999999999997654 37899
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+++|+|.+++.. ...+++.+.+.++.||+.||+|||+ ++|+||||||+|||++.++..+|+|||+++...
T Consensus 90 mE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999998843 3469999999999999999999999 899999999999999999999999999987654
Q ss_pred CCCC-CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccccccc
Q 002943 684 QEGD-SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIV 762 (863)
Q Consensus 684 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 762 (863)
.... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||..... . +.............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~---~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---V---SVAYQHVREDPIPP-- 234 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H---HHHHHHHHCCCCCG--
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---H---HHHHHHHhcCCCCC--
Confidence 3322 2223446799999999999999999999999999999999999999975421 1 11111111111100
Q ss_pred CCccCCCCcHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhh
Q 002943 763 DPSIKGGYHAEAMWRMVEVALACIEPFSAYRP-SMVDIVRELEDAF 807 (863)
Q Consensus 763 d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RP-sm~eVl~~L~~~~ 807 (863)
....... ...+.+++.+|++.||++|| |++++.+.|.++.
T Consensus 235 -~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 -SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0011112 23588999999999999999 8999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=385.30 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=200.5
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||.||+|+. .+|+.||||++++. .....+.+.+|+++|++++||||+++++++.+.+..++|||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 4568999999999999995 57999999998654 2334577899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|.+++.. ...+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 ~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 88 NGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp TTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred CCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 99999999854 3468889999999999999999999 899999999999999999999999999998764332
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+.+... .+. ..+.
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~----~~~------~~~p 225 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELIL----MEE------IRFP 225 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HCC------CCCC
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHh----cCC------CCCC
Confidence 223456799999999999999999999999999999999999999976431 12222111 111 1112
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 801 (863)
...+ ..+.+++.+|++.||++||+ +.|+++
T Consensus 226 ~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2233 34778999999999999996 666654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-43 Score=382.73 Aligned_cols=241 Identities=25% Similarity=0.371 Sum_probs=198.9
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~ 607 (863)
.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence 4568999999999999996 56999999988643 2344578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGD 687 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~ 687 (863)
++|+|..++.. ...+++.....++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 87 ~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 87 EGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred CCccccccccc----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999998843 3467888899999999999999999 89999999999999999999999999999876532
Q ss_pred CCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccC
Q 002943 688 SGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIK 767 (863)
Q Consensus 688 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 767 (863)
.....||+.|||||.+.+..++.++|||||||++|||+||+.||..... ..+...+. . +. ..+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i~---~-~~------~~~p 221 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKIL---N-AE------LRFP 221 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH---H-CC------CCCC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---HHHHHHHH---c-CC------CCCC
Confidence 2345799999999999999999999999999999999999999976421 11111111 1 11 1111
Q ss_pred CCCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 768 GGYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 768 ~~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
...+ ..+.+++.+|++.+|.+|| ++.|+++
T Consensus 222 ~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1222 3478899999999999996 7888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=376.08 Aligned_cols=254 Identities=22% Similarity=0.257 Sum_probs=192.5
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCc-----chHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ-----GTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5899999999999996 46999999988654322 23568999999999999999999999999999999999998
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
++++.... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 84 TDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred chHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 88777665 234568999999999999999999999 8999999999999999999999999999987654322
Q ss_pred CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccccccc---
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESRIDEI--- 761 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~i--- 761 (863)
......||+.|+|||.+... .++.++|||||||++|||+||+.||..... ......+..... .......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhcc
Confidence 22335689999999998754 579999999999999999999999975432 111111111100 0000000
Q ss_pred ---cC-CccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 762 ---VD-PSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 762 ---~d-~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. .... .... .....+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 0000 0010 11245889999999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-42 Score=369.49 Aligned_cols=247 Identities=25% Similarity=0.313 Sum_probs=198.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc---------chHHHHHHHHHHhcCC-cccccceeeeEeeCCee
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ---------GTREFENELNFLSAIR-HENLVPLLGYCCENDQQ 600 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~---------~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 600 (863)
.+.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 3468999999999999985 57999999998654322 1235889999999997 99999999999999999
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
+||||||++|+|.+++.. ...+++.+...++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999953 3469999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCcccccc------CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYST------QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR 754 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~ 754 (863)
...... ......||..|+|||.+.+ ..++.++||||+||+++||++|+.||..... ....+.+.
T Consensus 159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~---- 228 (277)
T d1phka_ 159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIM---- 228 (277)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----
T ss_pred EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHH----
Confidence 775432 2234569999999999863 3468899999999999999999999976431 11111111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 ESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.+... ............+.+++.+|++.+|++|||+.||++
T Consensus 229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11110 000111122345889999999999999999998854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=378.65 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=192.7
Q ss_pred ceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcC-CcccccceeeeEee----CCeeEEEeecCC
Q 002943 535 TLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAI-RHENLVPLLGYCCE----NDQQILVYPFMS 608 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~LV~ey~~ 608 (863)
++||+|+||+||+|+. .+|+.||||+++. .+.+.+|++++.++ +|||||++++++.+ +...++|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 5799999999999985 5799999998864 35678899987655 89999999999865 456899999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC---CCeEEEeeccCcccCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH---SMCAKVADFGFSKYAPQE 685 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~---~~~~kl~DFGla~~~~~~ 685 (863)
+|+|.++|... ....+++.+...++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 93 gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 93 GGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp SEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999999542 23569999999999999999999999 89999999999999985 567999999999876543
Q ss_pred CCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCc
Q 002943 686 GDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPS 765 (863)
Q Consensus 686 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 765 (863)
.. .....||+.|||||++.+..++.++|||||||+||||+||+.||........ ..........+. ..
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~------~~ 235 (335)
T d2ozaa1 168 NS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ------YE 235 (335)
T ss_dssp CC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS------SS
T ss_pred Cc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC------CC
Confidence 22 2345799999999999999999999999999999999999999975432111 111111111100 00
Q ss_pred cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 766 IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 766 l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+...........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111223456889999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-42 Score=380.71 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=193.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHH---HHHHHHhcCCcccccceeeeEeeCCeeEEEe
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFE---NELNFLSAIRHENLVPLLGYCCENDQQILVY 604 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~---~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 604 (863)
.+.++||+|+||.||+|+. .+|+.||||++.... ......+. .|+++++.++|||||++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 4468999999999999995 469999999875432 12223344 4477788889999999999999999999999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+++|+|.++|.. ...+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 87 DLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999953 3467899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccC
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVD 763 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 763 (863)
.. .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+...+...... . .
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----~------~ 225 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M------A 225 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS----C------C
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----C------C
Confidence 32 234569999999999975 4689999999999999999999999986543222111111110 0 1
Q ss_pred CccCCCCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 002943 764 PSIKGGYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIVR 801 (863)
Q Consensus 764 ~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl~ 801 (863)
+.+....+ ..+.+++.+||+.||++||| +.|+++
T Consensus 226 ~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11112223 34789999999999999999 466653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=379.16 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=197.6
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCC---CcchHHHHHHHHHHh-cCCcccccceeeeEeeCCeeEEEeec
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS---TQGTREFENELNFLS-AIRHENLVPLLGYCCENDQQILVYPF 606 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~LV~ey 606 (863)
.+.+.||+|+||+||+|+. .+|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..++||||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy 84 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 84 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEee
Confidence 4568999999999999996 468999999986532 334456777777765 68999999999999999999999999
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
|++|+|.+++.. ...+++.+...++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 85 LNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred cCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999953 3458899999999999999999999 899999999999999999999999999998664332
Q ss_pred CCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCcc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSI 766 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 766 (863)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+... ..+...+. .+ .+.+
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~----~~------~~~~ 222 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIR----MD------NPFY 222 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH----HC------CCCC
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHH----cC------CCCC
Confidence 223445799999999999999999999999999999999999999976431 11211111 11 1111
Q ss_pred CCCCcHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 002943 767 KGGYHAEAMWRMVEVALACIEPFSAYRPSMV-DIVR 801 (863)
Q Consensus 767 ~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~-eVl~ 801 (863)
....+ ..+.+++.+|++.||++||++. |+++
T Consensus 223 p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11222 3478999999999999999996 6643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-42 Score=380.66 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=198.4
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC---CCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST---STQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMS 608 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~ 608 (863)
+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++...+..++||||+.
T Consensus 45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence 347999999999999986 57999999987643 23345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCC
Q 002943 609 NGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 609 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|+|.+++... ..+++.....++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 125 ~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 125 GGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp TCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred ccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999532 468999999999999999999999 89999999999999999999999999999876432
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.... ...+...+.. +. +....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~----~~------~~~p~ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVS----GK------VRFPS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CC------CCCCT
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhc----CC------CCCCc
Confidence 234579999999999999999999999999999999999999997532 1122221111 11 11111
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRP-----SMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RP-----sm~eVl~ 801 (863)
..+ ..+.+++.+|++.||.+|+ ++.|+++
T Consensus 260 ~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 260 HFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 222 3578999999999999994 7888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=372.63 Aligned_cols=247 Identities=17% Similarity=0.244 Sum_probs=199.2
Q ss_pred hhcceecccCcEEEEEEecC-CCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.+.||+|+||+||+|... +|+.||||+++... .....+.+|+++|++++|||||++++++.+.+..++|||||++|
T Consensus 8 ~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 45689999999999999864 68899999987653 23456889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC--CCeEEEeeccCcccCCCCCCC
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH--SMCAKVADFGFSKYAPQEGDS 688 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~--~~~~kl~DFGla~~~~~~~~~ 688 (863)
+|.+++.. ....+++.+...++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++.....
T Consensus 87 ~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--- 157 (321)
T d1tkia_ 87 DIFERINT---SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp BHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred cHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC---
Confidence 99999943 23468999999999999999999999 89999999999999985 458999999999876432
Q ss_pred CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccccccCCccCC
Q 002943 689 GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRIDEIVDPSIKG 768 (863)
Q Consensus 689 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 768 (863)
.......+|+.|+|||...+..++.++||||+||++|||++|+.||..... ..+...+.. +.. ..+.....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~----~~~--~~~~~~~~ 228 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMN----AEY--TFDEEAFK 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHH----TCC--CCCHHHHT
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CCC--CCChhhcc
Confidence 223456799999999999999999999999999999999999999976431 111111111 000 00000001
Q ss_pred CCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 769 GYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 769 ~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. ...+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 234789999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-41 Score=364.35 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=193.8
Q ss_pred cceecccCcEEEEEEecCCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCCC
Q 002943 534 KTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNGS 611 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~gs 611 (863)
.++||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+..++++||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 47899999999999999899999999886543 2335789999999999999999999999999999999999998777
Q ss_pred hhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCce
Q 002943 612 LQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGFS 691 (863)
Q Consensus 612 L~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~~ 691 (863)
+..+. .....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|........ ..
T Consensus 87 ~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 157 (286)
T d1ob3a_ 87 KKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY 157 (286)
T ss_dssp HHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHH----hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc--cc
Confidence 76665 234679999999999999999999999 8999999999999999999999999999987643221 22
Q ss_pred eeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhh--cccccc---cccc--cC
Q 002943 692 LEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKP--FIRESR---IDEI--VD 763 (863)
Q Consensus 692 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~--~~~~~~---~~~i--~d 763 (863)
....|++.|+|||.+... .++.++|||||||+++||++|+.||......+. +.+-... ...... .... .+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhhhhcc
Confidence 334589999999998764 568999999999999999999999976432111 1110000 000000 0000 00
Q ss_pred CccC-------CCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 PSIK-------GGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 ~~l~-------~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... ..........+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0001112235789999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=366.20 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=192.5
Q ss_pred cceecccCcEEEEEEec-CCCCEEEEEEcccCC--CcchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCCC
Q 002943 534 KTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTS--TQGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSNG 610 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~g 610 (863)
.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++.+++..++||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 47999999999999995 679999999886543 23457899999999999999999999999999999999999965
Q ss_pred ChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCCc
Q 002943 611 SLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSGF 690 (863)
Q Consensus 611 sL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~~ 690 (863)
++.+++.. .....+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 86 ~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~ 158 (298)
T d1gz8a_ 86 DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 158 (298)
T ss_dssp EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BC
T ss_pred chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc--cc
Confidence 44445432 234569999999999999999999999 899999999999999999999999999998764322 22
Q ss_pred eeeeecCCCCCCccccccCC-CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc--ccccc---cccccC-
Q 002943 691 SLEVRGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF--IRESR---IDEIVD- 763 (863)
Q Consensus 691 ~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--~~~~~---~~~i~d- 763 (863)
.....||+.|+|||.+.... ++.++|||||||++|||++|+.||......+. +..-.... ..+.. .....+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccccccc
Confidence 33456999999999877665 57899999999999999999999976432111 11100000 00000 000000
Q ss_pred -CccC--CCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 764 -PSIK--GGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 764 -~~l~--~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+... .... ......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 0000 011245788999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=366.94 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=191.4
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCc------chHHHHHHHHHHhcCC--cccccceeeeEeeCCeeEE
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQ------GTREFENELNFLSAIR--HENLVPLLGYCCENDQQIL 602 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~L 602 (863)
.+.++||+|+||+||+|+. .+|+.||||++...... ..+++.+|+++|++++ |||||++++++.+.+..++
T Consensus 7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l 86 (273)
T d1xwsa_ 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL 86 (273)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence 4568999999999999995 57999999987654221 2245789999999997 8999999999999999999
Q ss_pred EeecCCC-CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-CCeEEEeeccCcc
Q 002943 603 VYPFMSN-GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-SMCAKVADFGFSK 680 (863)
Q Consensus 603 V~ey~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-~~~~kl~DFGla~ 680 (863)
||||+.+ +++.+++.. ...+++.+...++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 87 v~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 87 ILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999976 678787743 3468999999999999999999999 89999999999999985 5799999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCC-CcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHL-SAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+.. +.
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~--------~~-- 220 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR--------GQ-- 220 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH--------CC--
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh--------cc--
Confidence 75432 2334579999999999987765 567999999999999999999996421 1110 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
..+....+ ..+.+++.+|++.||++|||++|+++
T Consensus 221 ----~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 ----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111223 35788999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=363.39 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=190.2
Q ss_pred hcceecccCcEEEEEEec-CC-CCEEEEEEcccCC--CcchHHHHHHHHHHhcC---CcccccceeeeEee-----CCee
Q 002943 533 YKTLIGEGGFGSVYRGTL-PD-GQEVAVKVRSSTS--TQGTREFENELNFLSAI---RHENLVPLLGYCCE-----NDQQ 600 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~-g~~vAVK~~~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~~~~ 600 (863)
+.++||+|+||+||+|+. .+ ++.||||++.... ......+.+|+++|+.+ +||||++++++|.. ....
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~ 90 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 90 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence 357999999999999985 34 6679999876542 22344677888877766 79999999999853 3467
Q ss_pred EEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 601 ILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 601 ~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
++++||++++++..... .....+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++
T Consensus 91 ~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 91 TLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 89999998887765542 234568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccc----
Q 002943 681 YAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRES---- 756 (863)
Q Consensus 681 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 756 (863)
..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+...............
T Consensus 165 ~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 165 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 65432 22345679999999999999999999999999999999999999997643211111000000000000
Q ss_pred --cc-----ccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 757 --RI-----DEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 757 --~~-----~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.. ........ ..........+.+|+.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000 0011112235778999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=357.35 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=197.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceee-eEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLG-YCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||+||+|+. .+|+.||||++..... .+++..|++++++++|+|++..++ +..+.+..++||||+ +
T Consensus 10 ~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 4568999999999999985 5789999998765432 356889999999998877666555 456777889999999 5
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEec---CCCeEEEeeccCcccCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLD---HSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld---~~~~~kl~DFGla~~~~~~~ 686 (863)
|+|.+.+.. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+......
T Consensus 87 ~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 87 PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 677666632 23569999999999999999999999 8999999999999975 45679999999998765432
Q ss_pred CC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhH-Hhhhhccccccccc
Q 002943 687 DS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLV-EWAKPFIRESRIDE 760 (863)
Q Consensus 687 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~~ 760 (863)
.. .......||+.|||||.+.+..++.++|||||||++|||+||+.||............ .+....... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch--
Confidence 21 1223457999999999999999999999999999999999999999765433222111 111110000 00
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhccc
Q 002943 761 IVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFIIE 810 (863)
Q Consensus 761 i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~~ 810 (863)
+.+.... ..++.+++..|++.+|++||++.++.+.|+.++..+
T Consensus 238 ---~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0111122 235888999999999999999999999999886543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.4e-40 Score=352.74 Aligned_cols=260 Identities=19% Similarity=0.231 Sum_probs=205.3
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc-ccccceeeeEeeCCeeEEEeecCCC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH-ENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
.+.+.||+|+||+||+|+. .+|+.||||++.... ...++.+|++.++.++| +|++.+++++..+...++||||+ +
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 4568999999999999995 478999999876543 23567889999999975 89999999999999999999999 7
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecC-----CCeEEEeeccCcccCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDH-----SMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~-----~~~~kl~DFGla~~~~~ 684 (863)
|+|.+++... ...+++.+...++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 85 ~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 85 PSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 8999988542 3468999999999999999999999 89999999999999974 57899999999987643
Q ss_pred CCCC-----CceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 685 EGDS-----GFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 685 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.||..............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3211 12234579999999999999999999999999999999999999998655433322222221111111111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhhcc
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVRELEDAFII 809 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~~L~~~~~~ 809 (863)
+ +.... +.++.+++..|++.+|++||+++.+.+.|++++..
T Consensus 239 ~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 239 E-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp H-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 1 11122 23578889999999999999999999999988743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=357.30 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=190.0
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccC--CCcchHHHHHHHHHHhcCCcccccceeeeEee--------CCeeE
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSST--STQGTREFENELNFLSAIRHENLVPLLGYCCE--------NDQQI 601 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~~~~~ 601 (863)
+.++||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 457999999999999995 57999999987544 23345778999999999999999999999865 34578
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+.++.+.... .....++......++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 94 iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 94 LVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeee
Confidence 999999888776555 234568888999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCCC--CceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccccccc
Q 002943 682 APQEGDS--GFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRI 758 (863)
Q Consensus 682 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 758 (863)
....... .......||+.|+|||.+.+. .++.++|||||||+++||++|+.||........................
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 6533221 112234699999999998765 6899999999999999999999999764321111111111100000000
Q ss_pred ccc--------cCCccCCCCcH-H------HHHHHHHHHHHccCcCCCCCCCHHHHH
Q 002943 759 DEI--------VDPSIKGGYHA-E------AMWRMVEVALACIEPFSAYRPSMVDIV 800 (863)
Q Consensus 759 ~~i--------~d~~l~~~~~~-~------~~~~l~~l~~~C~~~~P~~RPsm~eVl 800 (863)
... ........... + ....+.+|+.+|++.||++|||++|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 000 00000000111 1 123467899999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=360.08 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=188.2
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccccceeeeEeeC------CeeEEEee
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENLVPLLGYCCEN------DQQILVYP 605 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~LV~e 605 (863)
..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++||||++++++|... ...+||||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 357899999999999996 4699999999865432 235799999999999999999998643 24689999
Q ss_pred cCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC-eEEEeeccCcccCCC
Q 002943 606 FMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM-CAKVADFGFSKYAPQ 684 (863)
Q Consensus 606 y~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~-~~kl~DFGla~~~~~ 684 (863)
||+++.+....+ .......+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 100 y~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 100 YVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred ccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 998664444332 22335579999999999999999999999 8999999999999999764 899999999987654
Q ss_pred CCCCCceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhh-----------hhc
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWA-----------KPF 752 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~-----------~~~ 752 (863)
... .....||..|+|||.+.+ ..++.++||||+||+++||++|+.||......+ .+.... ...
T Consensus 176 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 176 GEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp TSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHH
T ss_pred Ccc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhhh
Confidence 322 233569999999998765 468999999999999999999999997543211 111110 000
Q ss_pred c---cccccccccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 753 I---RESRIDEIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 753 ~---~~~~~~~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ........................+.+|+.+|++.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000000000011112335788999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=356.57 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=190.1
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC-cchHHHHHHHHHHhcCCcccccceeeeEeeCC----eeEEEeec
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST-QGTREFENELNFLSAIRHENLVPLLGYCCEND----QQILVYPF 606 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~ey 606 (863)
..++||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.... ..+++++|
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 348999999999999984 6899999999875443 33467899999999999999999999997653 33555667
Q ss_pred CCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCC
Q 002943 607 MSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 607 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~ 686 (863)
+.+|+|.+++.. ..+++.....++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 92 LMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 779999999943 358999999999999999999999 899999999999999999999999999998764432
Q ss_pred CC-CceeeeecCCCCCCcccccc-CCCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccc-------
Q 002943 687 DS-GFSLEVRGTAGYLDPEYYST-QHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESR------- 757 (863)
Q Consensus 687 ~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 757 (863)
.. .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 21 12334569999999999854 5678999999999999999999999976432111111000000000000
Q ss_pred -ccc--ccCCccCCCCcH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 758 -IDE--IVDPSIKGGYHA-----EAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 758 -~~~--i~d~~l~~~~~~-----~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
... ...+... .... ....++.+++.+|++.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 244 KARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 0000 11135789999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-39 Score=354.30 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=185.7
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCC------eeEEE
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEND------QQILV 603 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV 603 (863)
..++||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+ +.++|
T Consensus 22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 101 (346)
T d1cm8a_ 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 101 (346)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence 347899999999999995 5699999999875432 23467889999999999999999999997665 46999
Q ss_pred eecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCC
Q 002943 604 YPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAP 683 (863)
Q Consensus 604 ~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~ 683 (863)
|||+ +.+|..+.. ...+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 102 MPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred Eecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccC
Confidence 9999 567777663 2469999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhc--------cc
Q 002943 684 QEGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPF--------IR 754 (863)
Q Consensus 684 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~--------~~ 754 (863)
.. .+...||+.|+|||.+.+. .++.++||||+||+++||++|+.||.................. ..
T Consensus 173 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred Cc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 32 2345689999999998764 5689999999999999999999999764321110000000000 00
Q ss_pred c-------cccccccCC---ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 E-------SRIDEIVDP---SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 ~-------~~~~~i~d~---~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
. ....+.... .+....+ ..+.+|+.+|++.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000000 0111122 34678999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-39 Score=344.18 Aligned_cols=258 Identities=19% Similarity=0.216 Sum_probs=196.5
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeCCeeEEEeecCCC
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCENDQQILVYPFMSN 609 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ey~~~ 609 (863)
..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+.+|++++||||++++++|...+..++|+|++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 347999999999999995 5789999998765432 3357889999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCCCCCCC
Q 002943 610 GSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSG 689 (863)
Q Consensus 610 gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~~~~~~ 689 (863)
++|..++. ..+.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 86 DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred cccccccc----cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 99988774 34568899999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeeeecCCCCCCccccccCC-CCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhccc---ccc---ccccc
Q 002943 690 FSLEVRGTAGYLDPEYYSTQH-LSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIR---ESR---IDEIV 762 (863)
Q Consensus 690 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~---~~~i~ 762 (863)
......++..|+|||.+.... ++.++|||||||+++||++|+.||..... .......+..... ... .....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 223345788899999987665 68999999999999999999999754321 1111111110000 000 00000
Q ss_pred C--------Cc-cCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 763 D--------PS-IKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 763 d--------~~-l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
+ .. -...........+.+++.+|++.||++|||++||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 000111122335778999999999999999998854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=351.10 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=194.3
Q ss_pred HhhcceecccCcEEEEEEec----CCCCEEEEEEcccCC----CcchHHHHHHHHHHhcCCc-ccccceeeeEeeCCeeE
Q 002943 531 QQYKTLIGEGGFGSVYRGTL----PDGQEVAVKVRSSTS----TQGTREFENELNFLSAIRH-ENLVPLLGYCCENDQQI 601 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 601 (863)
+.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 45568999999999999974 248899999876432 2335678899999999977 89999999999999999
Q ss_pred EEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 602 LVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 602 LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
+||||+.+|+|.+++... ..++......++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999543 356778889999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCCCceeeeecCCCCCCccccccC--CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccccccc
Q 002943 682 APQEGDSGFSLEVRGTAGYLDPEYYSTQ--HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRESRID 759 (863)
Q Consensus 682 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 759 (863)
...... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+..... ..... ..
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~-~~--- 251 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL-KS--- 251 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH-HC---
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcc-cC---
Confidence 643322 223345699999999999764 4688999999999999999999999765433221111 01000 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHHccCcCCCCCCC-----HHHHH
Q 002943 760 EIVDPSIKGGYHAEAMWRMVEVALACIEPFSAYRPS-----MVDIV 800 (863)
Q Consensus 760 ~i~d~~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPs-----m~eVl 800 (863)
.+.+... ....+.+++.+|++.||++||| ++|++
T Consensus 252 ---~~~~~~~----~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 252 ---EPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp ---CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred ---CCCCccc----CCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 0111112 2345888999999999999996 56654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-38 Score=344.71 Aligned_cols=254 Identities=17% Similarity=0.285 Sum_probs=191.1
Q ss_pred hhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeC--CeeEEEeecC
Q 002943 532 QYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCEN--DQQILVYPFM 607 (863)
Q Consensus 532 ~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~LV~ey~ 607 (863)
.+.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||||+
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 4458999999999999995 57899999998643 3467899999999996 99999999998744 4689999999
Q ss_pred CCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCC-CeEEEeeccCcccCCCCC
Q 002943 608 SNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHS-MCAKVADFGFSKYAPQEG 686 (863)
Q Consensus 608 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~-~~~kl~DFGla~~~~~~~ 686 (863)
++|+|.++. +.+++.....++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+|+......
T Consensus 115 ~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 115 NNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999998764 358999999999999999999999 899999999999999864 579999999998765432
Q ss_pred CCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcc-----------hhHHhhhhccc
Q 002943 687 DSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW-----------SLVEWAKPFIR 754 (863)
Q Consensus 687 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~-----------~l~~~~~~~~~ 754 (863)
. .....+|..|+|||.+.+. .++.++||||+||+++||++|+.||......... ....|......
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 2345689999999998765 4799999999999999999999999764321100 00011100000
Q ss_pred --ccccccccCC--------ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 755 --ESRIDEIVDP--------SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 755 --~~~~~~i~d~--------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.......... .............+.+|+.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000111112235789999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-38 Score=345.28 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=183.0
Q ss_pred cceecccCcEEEEEEecC-CCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEee------CCeeEEEe
Q 002943 534 KTLIGEGGFGSVYRGTLP-DGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCE------NDQQILVY 604 (863)
Q Consensus 534 ~~~LG~G~fG~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~LV~ 604 (863)
.++||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++|||||++++++.. ....++||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 479999999999999954 699999999875433 234568899999999999999999999964 36789999
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
||+.++.+ +.++ ..+++.....++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||+++....
T Consensus 102 Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 102 ELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp ECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcccc
Confidence 99965544 4442 358899999999999999999999 8999999999999999999999999999886643
Q ss_pred CCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcch-hH--------Hhhhh----
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWS-LV--------EWAKP---- 751 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~-l~--------~~~~~---- 751 (863)
.. ......||..|+|||.+.+..++.++||||+||+++||++|+.||.......... +. ++...
T Consensus 172 ~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred cc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 22 2344568999999999999999999999999999999999999997543110000 00 00000
Q ss_pred ---cccc------cccccccCCccCCC---CcHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 752 ---FIRE------SRIDEIVDPSIKGG---YHAEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 752 ---~~~~------~~~~~i~d~~l~~~---~~~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
.... .............. ........+.+|+.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00001111111111 12234567889999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=341.93 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=187.0
Q ss_pred hcceecccCcEEEEEEec-CCCCEEEEEEcccCCC--cchHHHHHHHHHHhcCCcccccceeeeEeeC-----CeeEEEe
Q 002943 533 YKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTST--QGTREFENELNFLSAIRHENLVPLLGYCCEN-----DQQILVY 604 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~LV~ 604 (863)
..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||+|++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 347899999999999984 5799999999876543 2345788999999999999999999998643 3446777
Q ss_pred ecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEeeccCcccCCC
Q 002943 605 PFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQ 684 (863)
Q Consensus 605 ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~DFGla~~~~~ 684 (863)
+|+.+|+|.+++.. +.+++.....++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.....
T Consensus 102 ~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 102 THLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc
Confidence 88889999999832 359999999999999999999999 8999999999999999999999999999976532
Q ss_pred CCCCCceeeeecCCCCCCccccccC-CCCcccceechhhHHHHHHhCCCCCCCCCCCCcchhHHhhhhcccc--------
Q 002943 685 EGDSGFSLEVRGTAGYLDPEYYSTQ-HLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEWSLVEWAKPFIRE-------- 755 (863)
Q Consensus 685 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 755 (863)
. .....||..|+|||.+.+. .++.++|||||||+++||++|+.||...... .....+......
T Consensus 174 ~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 174 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp G-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHTT
T ss_pred c-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhhh
Confidence 2 2334689999999987665 4688999999999999999999999764321 111111000000
Q ss_pred ---cccccccC--CccCCCCc-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 002943 756 ---SRIDEIVD--PSIKGGYH-----AEAMWRMVEVALACIEPFSAYRPSMVDIVR 801 (863)
Q Consensus 756 ---~~~~~i~d--~~l~~~~~-----~~~~~~l~~l~~~C~~~~P~~RPsm~eVl~ 801 (863)
........ +... ... ......+.+|+.+|++.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCC-CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000 0000 000 011234788999999999999999999865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-33 Score=309.32 Aligned_cols=262 Identities=17% Similarity=0.201 Sum_probs=186.0
Q ss_pred HhhcceecccCcEEEEEEec-CCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-----------cccccceeeeEeeC-
Q 002943 531 QQYKTLIGEGGFGSVYRGTL-PDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-----------HENLVPLLGYCCEN- 597 (863)
Q Consensus 531 ~~f~~~LG~G~fG~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~- 597 (863)
+.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 34568999999999999985 579999999987543 23457788999988885 57899999988654
Q ss_pred -CeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCC------e
Q 002943 598 -DQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSM------C 670 (863)
Q Consensus 598 -~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~------~ 670 (863)
...+++++++..+........ ......+++.....++.|++.||+|||+. .+|+||||||+||||+.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 455667776655543333221 23345688899999999999999999972 6899999999999998654 4
Q ss_pred EEEeeccCcccCCCCCCCCceeeeecCCCCCCccccccCCCCcccceechhhHHHHHHhCCCCCCCCCCCCcc----hhH
Q 002943 671 AKVADFGFSKYAPQEGDSGFSLEVRGTAGYLDPEYYSTQHLSAKSDVFSFGVVLLEIISGREPLNTRRPRNEW----SLV 746 (863)
Q Consensus 671 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SfGvvl~ElltG~~p~~~~~~~~~~----~l~ 746 (863)
+|++|||.++..... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... .+.
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865432 22356999999999999999999999999999999999999999764322111 111
Q ss_pred Hhhhhc-----------------ccccccccccCC----------ccCCCCcHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 002943 747 EWAKPF-----------------IRESRIDEIVDP----------SIKGGYHAEAMWRMVEVALACIEPFSAYRPSMVDI 799 (863)
Q Consensus 747 ~~~~~~-----------------~~~~~~~~i~d~----------~l~~~~~~~~~~~l~~l~~~C~~~~P~~RPsm~eV 799 (863)
..+... ........-+.. .............+.+++.+|++.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111100 000000000000 00112345567789999999999999999999998
Q ss_pred HH
Q 002943 800 VR 801 (863)
Q Consensus 800 l~ 801 (863)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 64
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=1.1e-21 Score=195.79 Aligned_cols=162 Identities=17% Similarity=0.196 Sum_probs=118.3
Q ss_pred hcceecccCcEEEEEEecCCCCEEEEEEcccCCCc------------------chHHHHHHHHHHhcCCcccccceeeeE
Q 002943 533 YKTLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQ------------------GTREFENELNFLSAIRHENLVPLLGYC 594 (863)
Q Consensus 533 f~~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~------------------~~~~f~~E~~~l~~l~H~niv~l~g~~ 594 (863)
+.++||+|+||+||+|+..+|++||||++...... .......|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 35799999999999999889999999976432110 012345688899999999998887653
Q ss_pred eeCCeeEEEeecCCCCChhhhhhccCCCCccCChhhHHHHHHHHHHHHHHHHhccCCCccccCCCCCCeEecCCCeEEEe
Q 002943 595 CENDQQILVYPFMSNGSLQDRLYGEASTRKTLDWPTRLSIALGAARGLMYLHTFAGRSVIHRDVKSSNILLDHSMCAKVA 674 (863)
Q Consensus 595 ~~~~~~~LV~ey~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iiHrDik~~NILld~~~~~kl~ 674 (863)
..+++|||+++..+.+ ++......++.|++++|+|||+ .+|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 2479999998755432 3445567899999999999999 899999999999999965 48999
Q ss_pred eccCcccCCCCCCCCceeeeecCCCCCC------ccccccCCCCcccceechhhHH
Q 002943 675 DFGFSKYAPQEGDSGFSLEVRGTAGYLD------PEYYSTQHLSAKSDVFSFGVVL 724 (863)
Q Consensus 675 DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDV~SfGvvl 724 (863)
|||+|+........ .|.. .|++ .+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999765422110 0111 0111 34678889999965433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.61 E-value=1.3e-08 Score=107.47 Aligned_cols=81 Identities=26% Similarity=0.461 Sum_probs=68.0
Q ss_pred ccchhhHHHHHhHHHHhhcccccccccCcc--CCCCCCCcccceeecCCCCceEEEEEecCcCcccc--cCCCcccCCcc
Q 002943 364 TDQADVNVIRKVRDELKKYNKENKVLESWS--GDPCRPSTWRGVYCNTRNGSITITGLDLSSGQIQG--ILPLSVTGLTH 439 (863)
Q Consensus 364 t~~~d~~al~~~k~~~~~~~~~~~~~~~W~--gdpc~p~~w~gv~C~~~~~~~~l~~l~ls~n~l~G--~iP~~~~~l~~ 439 (863)
+.++|.+||+++|+++.+ +. ++.+|. +|+| .+.|.||+|+..++..+|+.|||++|+++| .||.++++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~---~~-~l~sW~~~~d~C-~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGN---PT-TLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTC---CG-GGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCHHHHHHHHHHHHHCCC---CC-cCCCCCCCCCCC-CCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 467899999999999854 33 689996 4555 357999999877777789999999999999 68999999999
Q ss_pred ccccccc-cCC
Q 002943 440 LEKFRGF-CGS 449 (863)
Q Consensus 440 L~~l~~s-~n~ 449 (863)
|++|+++ ||.
T Consensus 78 L~~L~Ls~~N~ 88 (313)
T d1ogqa_ 78 LNFLYIGGINN 88 (313)
T ss_dssp CSEEEEEEETT
T ss_pred ccccccccccc
Confidence 9999997 454
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=1.2e-05 Score=81.57 Aligned_cols=129 Identities=16% Similarity=0.127 Sum_probs=90.2
Q ss_pred cEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCC-cccccceeeeEeeCCeeEEEeecCCCCChhhhhhccC
Q 002943 542 FGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIR-HENLVPLLGYCCENDQQILVYPFMSNGSLQDRLYGEA 620 (863)
Q Consensus 542 fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ey~~~gsL~~~L~~~~ 620 (863)
...||+... +++.+.||+...........+.+|...+..+. +--+.+++.++...+..++||+++++.++.+....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-- 103 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-- 103 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT--
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc--
Confidence 468999875 56677889876665555567788998888774 43456778888888889999999999887654311
Q ss_pred CCCccCChhhHHHHHHHHHHHHHHHHhc----------------------------------------------------
Q 002943 621 STRKTLDWPTRLSIALGAARGLMYLHTF---------------------------------------------------- 648 (863)
Q Consensus 621 ~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------------------------------------------------- 648 (863)
......++.++++.++.||+.
T Consensus 104 -------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 104 -------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp -------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred -------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 111233444455555555531
Q ss_pred ----cCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 649 ----AGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 649 ----~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
....++|+|+.+.|||++++...-|.||+.+.
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237899999999999988777899998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=0.00019 Score=71.97 Aligned_cols=141 Identities=18% Similarity=0.139 Sum_probs=84.8
Q ss_pred ecccC-cEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCc--ccccceeeeEeeCCeeEEEeecCCCCChh
Q 002943 537 IGEGG-FGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRH--ENLVPLLGYCCENDQQILVYPFMSNGSLQ 613 (863)
Q Consensus 537 LG~G~-fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~ey~~~gsL~ 613 (863)
+..|. -..||+...+++..+.+|.-.... ...+..|.+.++.+.. -.+.++++++.+.+..++||+++++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 367999998888889999755433 2356788888877753 33566788888888889999999876653
Q ss_pred hhh-----------------hccCCCCccCChh--hHHH--------------------HHHHHHHHHHHHHhc----cC
Q 002943 614 DRL-----------------YGEASTRKTLDWP--TRLS--------------------IALGAARGLMYLHTF----AG 650 (863)
Q Consensus 614 ~~L-----------------~~~~~~~~~l~~~--~~~~--------------------ia~~ia~gL~yLH~~----~~ 650 (863)
+.. |........+.+. ..+. ........+..+... ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 311 1100000000000 0000 000111222333221 11
Q ss_pred CCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 651 RSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 651 ~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 248999999999999988778899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.01 E-value=0.0014 Score=70.35 Aligned_cols=75 Identities=13% Similarity=0.108 Sum_probs=47.1
Q ss_pred ceecccCcEEEEEEecCC-CCEEEEEEccc----CC---CcchHHHHHHHHHHhcCC-c--ccccceeeeEeeCCeeEEE
Q 002943 535 TLIGEGGFGSVYRGTLPD-GQEVAVKVRSS----TS---TQGTREFENELNFLSAIR-H--ENLVPLLGYCCENDQQILV 603 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~-g~~vAVK~~~~----~~---~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~LV 603 (863)
+.||.|....||+....+ ++.++||.-.. .. .........|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 67899995322 11 112234456888777663 2 334445444 45667899
Q ss_pred eecCCCCC
Q 002943 604 YPFMSNGS 611 (863)
Q Consensus 604 ~ey~~~gs 611 (863)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.39 E-value=0.0046 Score=64.18 Aligned_cols=136 Identities=13% Similarity=0.136 Sum_probs=79.0
Q ss_pred EEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-----ccee--eeEeeCCeeEEEeecCCCCChhh-
Q 002943 543 GSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-----VPLL--GYCCENDQQILVYPFMSNGSLQD- 614 (863)
Q Consensus 543 G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-----v~l~--g~~~~~~~~~LV~ey~~~gsL~~- 614 (863)
-.||+...++|+.+++|+.... ....+++..|...+..|....+ +..- ......+..+.+++++++..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999986544 3345678889988888853322 1111 12234556788999987643211
Q ss_pred ----h---------hhc----c-CCCCccCChh-------------------hHHHHHHHHHHHHHHHHh----ccCCCc
Q 002943 615 ----R---------LYG----E-ASTRKTLDWP-------------------TRLSIALGAARGLMYLHT----FAGRSV 653 (863)
Q Consensus 615 ----~---------L~~----~-~~~~~~l~~~-------------------~~~~ia~~ia~gL~yLH~----~~~~~i 653 (863)
+ +|. . ......+++. .+-.+...+.+.++.+.. .....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 111 0 0011122211 111122223333333332 223568
Q ss_pred cccCCCCCCeEecCCCeEEEeeccCccc
Q 002943 654 IHRDVKSSNILLDHSMCAKVADFGFSKY 681 (863)
Q Consensus 654 iHrDik~~NILld~~~~~kl~DFGla~~ 681 (863)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.42 E-value=0.019 Score=61.08 Aligned_cols=72 Identities=14% Similarity=0.168 Sum_probs=48.9
Q ss_pred ceecccCcEEEEEEecCCC--------CEEEEEEcccCCCcchHHHHHHHHHHhcCCccccc-ceeeeEeeCCeeEEEee
Q 002943 535 TLIGEGGFGSVYRGTLPDG--------QEVAVKVRSSTSTQGTREFENELNFLSAIRHENLV-PLLGYCCENDQQILVYP 605 (863)
Q Consensus 535 ~~LG~G~fG~Vy~g~~~~g--------~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~e 605 (863)
+.|+.|-.=.+|+...+++ ..|.+++... ........+|..+++.+.-.++. +++++|.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678888899999986543 4577776552 22334567899999888644554 66666532 67899
Q ss_pred cCCCCCh
Q 002943 606 FMSNGSL 612 (863)
Q Consensus 606 y~~~gsL 612 (863)
|+++-+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.42 E-value=0.091 Score=53.38 Aligned_cols=156 Identities=14% Similarity=0.064 Sum_probs=78.4
Q ss_pred CHHHHHHHHHhhc-------ceecccCcEEEEEEecCCCCEEEEEEcccCCCcchHHHHHHHHHHhcCCcccc-----cc
Q 002943 522 SLQYLEAATQQYK-------TLIGEGGFGSVYRGTLPDGQEVAVKVRSSTSTQGTREFENELNFLSAIRHENL-----VP 589 (863)
Q Consensus 522 ~~~~l~~~t~~f~-------~~LG~G~fG~Vy~g~~~~g~~vAVK~~~~~~~~~~~~f~~E~~~l~~l~H~ni-----v~ 589 (863)
+.++++..-.++. +.|..|---+.|+.+..+|+ +++|+..... ..++...|++++..|.+.++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 4455555544441 23445666788999876664 8899875432 23455667777777753322 21
Q ss_pred ee-e--eEeeCCeeEEEeecCCCCChhh--------------hhhcc------CCCCcc-----------------CChh
Q 002943 590 LL-G--YCCENDQQILVYPFMSNGSLQD--------------RLYGE------ASTRKT-----------------LDWP 629 (863)
Q Consensus 590 l~-g--~~~~~~~~~LV~ey~~~gsL~~--------------~L~~~------~~~~~~-----------------l~~~ 629 (863)
.. | +.........++.++.+..... .++.. ...... ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 1122345566666665532211 00100 000000 0001
Q ss_pred hHHHHHHHHHHHHHHHHh-ccCCCccccCCCCCCeEecCCCeEEEeeccCcc
Q 002943 630 TRLSIALGAARGLMYLHT-FAGRSVIHRDVKSSNILLDHSMCAKVADFGFSK 680 (863)
Q Consensus 630 ~~~~ia~~ia~gL~yLH~-~~~~~iiHrDik~~NILld~~~~~kl~DFGla~ 680 (863)
.....+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 233579999999999999998888899998764
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=93.87 E-value=0.06 Score=48.28 Aligned_cols=77 Identities=12% Similarity=0.059 Sum_probs=48.6
Q ss_pred ccCCCCCcceEEEEEEeecccccCCCCeEEEEEEECCccccccchhhhcCcceeEEEEEeecCCceEEEEeeecCCCccc
Q 002943 267 TDLDSGDYNYTLILYFLELNDSVKSSGQRVFDILINNERKKEKFDILALGSNYAKLALNVTANGSLNLTLVNVLNGSVFG 346 (863)
Q Consensus 267 ~~~~~~~~~y~v~lhFaEi~~~~~~~~~R~F~I~ing~~~~~~~di~~~~~~~~~~~~~~~~~g~~~~~l~~t~~~S~lp 346 (863)
|..+.++..|.|.++|.|.. ..++.+.|......+.- ......+.+++ .+|++++.+... ..-..
T Consensus 67 f~v~vPnG~Y~Vtv~~Gd~~---------~~~~~~eg~~~~~~~~g---~~~~~~~~V~V-tDG~L~l~ft~~--~~G~~ 131 (146)
T d2o14a1 67 FNVDLPNGLYEVKVTLGNTA---------RASVAAEGVFQVINMTG---DGAEDTFQIPV-TDGQLNLLVTEG--KAGTA 131 (146)
T ss_dssp EEEECCSEEEEEEEEESSCS---------EEEEEETTEEEEEEEES---TTCEEEEEEEE-CSSEEEEEEEES--STTSC
T ss_pred EEEECCCCeEEEEEEEecCC---------CccEEEeeEEeccccCC---ccEEEEEEEEE-ECCeEEEEEecC--CCCCc
Confidence 45556678899999999842 34677777665433211 11122233333 478899987643 23345
Q ss_pred cccceeeeEEee
Q 002943 347 PICNAYEILQVR 358 (863)
Q Consensus 347 pilNa~Ei~~v~ 358 (863)
|.|||+||-++.
T Consensus 132 ~~in~l~I~~~~ 143 (146)
T d2o14a1 132 FTLSALKIKKLS 143 (146)
T ss_dssp CEEEEEEEEEEE
T ss_pred cEEEEEEEEecc
Confidence 999999998874
|
| >d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Galactose-binding domain-like superfamily: Galactose-binding domain-like family: YxiM N-terminal domain-like domain: Hypothetical protein YxiM species: Bacillus subtilis [TaxId: 1423]
Probab=86.75 E-value=3.8 Score=35.95 Aligned_cols=78 Identities=13% Similarity=0.121 Sum_probs=48.7
Q ss_pred ceeeecccCCCeeeEeEEeeccCCCCCCCCcceeEEEcceeeEEEeCCCCceeeEEEEecCCceEEee--cCCCCCceee
Q 002943 93 RCYNLSTIKGQDYLIRGTFLNGDNVETPLISSFNVLVGVTPLSLVNSTEDSVVEGIFKAANDYIDFCL--DKKDGDPYIS 170 (863)
Q Consensus 93 ~cY~~~~~~~~~ylvR~~F~yg~~~~~~~~~~Fd~~~~~~~w~~vn~~~~~~~e~i~~~~~~~~~vcl--~~~~~~pfIs 170 (863)
.-|.+++ |+|.|.|++.|.- ....++.+.+-.=-.............+...+..+.+=| ..+...|=||
T Consensus 65 ~~f~v~v-PnG~Y~Vtv~~Gd--------~~~~~~~~eg~~~~~~~~g~~~~~~~~V~VtDG~L~l~ft~~~~G~~~~in 135 (146)
T d2o14a1 65 NTFNVDL-PNGLYEVKVTLGN--------TARASVAAEGVFQVINMTGDGAEDTFQIPVTDGQLNLLVTEGKAGTAFTLS 135 (146)
T ss_dssp CCEEEEC-CSEEEEEEEEESS--------CSEEEEEETTEEEEEEEESTTCEEEEEEEECSSEEEEEEEESSTTSCCEEE
T ss_pred ceEEEEC-CCCeEEEEEEEec--------CCCccEEEeeEEeccccCCccEEEEEEEEEECCeEEEEEecCCCCCccEEE
Confidence 3588888 8999999998753 112456665531111111112223445567777788766 3345689999
Q ss_pred eEeeeecCC
Q 002943 171 GLEVRPLND 179 (863)
Q Consensus 171 ~lEl~~l~~ 179 (863)
+|||.+..+
T Consensus 136 ~l~I~~~~d 144 (146)
T d2o14a1 136 ALKIKKLSD 144 (146)
T ss_dssp EEEEEEEES
T ss_pred EEEEEeccc
Confidence 999998764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.50 E-value=0.29 Score=44.03 Aligned_cols=55 Identities=24% Similarity=0.393 Sum_probs=34.7
Q ss_pred CCCCCCcccceeecCCC---------CceEEEEEecCcCc-ccccCCCcccCCccccccccccCC
Q 002943 395 DPCRPSTWRGVYCNTRN---------GSITITGLDLSSGQ-IQGILPLSVTGLTHLEKFRGFCGS 449 (863)
Q Consensus 395 dpc~p~~w~gv~C~~~~---------~~~~l~~l~ls~n~-l~G~iP~~~~~l~~L~~l~~s~n~ 449 (863)
+.|.++.+.++.|+..+ +...++.|++++|+ |+..-+..+.+++.|+.|+++.|.
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~ 67 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccc
Confidence 46777778899996421 11256677776553 655444557777777777776654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=84.44 E-value=0.15 Score=51.60 Aligned_cols=35 Identities=31% Similarity=0.505 Sum_probs=31.4
Q ss_pred EEEEEecCcCcccccCCCcccCCccccccccccCC
Q 002943 415 TITGLDLSSGQIQGILPLSVTGLTHLEKFRGFCGS 449 (863)
Q Consensus 415 ~l~~l~ls~n~l~G~iP~~~~~l~~L~~l~~s~n~ 449 (863)
.++.|+|++|+|+|.+|..+++++.|+.|+++.|.
T Consensus 245 ~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred ccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 57889999999999999999999999999988774
|